data_2rlp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rlp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -65.12 137.78 57.87 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.208 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -124.0 24.7 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.115 0.959 . . . . 0.0 109.184 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.1 150.79 24.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.666 -1.607 . . . . 0.0 107.823 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.01 152.55 84.47 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 123.66 0.6 . . . . 0.0 109.916 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.21 147.5 91.2 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.022 1.814 . . . . 0.0 110.347 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.95 165.57 19.51 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 113.447 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -110.35 150.11 29.25 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -123.07 178.93 4.86 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.684 -168.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.63 -58.69 3.13 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.77 0.428 . . . . 0.0 110.094 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -90.23 -11.85 39.75 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -123.11 150.94 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.569 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 33.1 mt -131.1 148.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 mt -74.01 129.95 38.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 117.918 0.326 . . . . 0.0 111.487 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 19.9 p -121.34 104.39 9.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.525 0.679 . . . . 0.0 110.342 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.27 173.03 22.09 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -93.82 119.34 32.64 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 117.263 0.532 . . . . 0.0 110.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -126.9 121.68 32.47 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 t -149.86 13.27 0.8 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.934 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.95 152.65 49.17 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 121.508 -0.745 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.05 -30.49 62.43 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.751 0.31 . . . . 0.0 110.917 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.1 p -114.41 118.13 32.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.576 0.703 . . . . 0.0 112.714 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -119.97 153.15 54.96 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.099 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.92 140.07 44.9 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.175 1.917 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -61.74 136.54 58.03 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.25 -0.34 40.69 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.221 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -82.29 119.25 23.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.97 144.17 25.73 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.804 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.28 123.9 51.28 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.122 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.99 121.44 45.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.444 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 53.2 m-85 -99.73 145.72 27.34 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.985 0.897 . . . . 0.0 113.334 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 50.1 tptt -85.2 128.19 34.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.322 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.8 m -82.58 107.3 15.12 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 165.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -40.11 153.98 0.2 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.086 1.354 . . . . 0.0 113.598 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.69 114.02 2.22 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.698 1.598 . . . . 0.0 108.898 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 114.03 -8.38 23.27 Favored Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.06 168.76 13.54 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -162.22 -179.27 6.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.0 p -139.63 -77.64 0.33 Allowed 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 58' ' ' SER . 24.8 mt -176.32 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 126.612 1.965 . . . . 0.0 106.203 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.25 -108.11 1.18 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.85 158.04 44.27 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.0 t -86.54 109.89 19.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.39 121.24 54.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.194 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.2 mtp -111.18 166.36 11.14 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -152.86 146.71 14.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.0 t -81.23 126.61 31.74 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 2.5 tpm_? -148.73 128.76 13.55 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 34.7 mmtp 67.77 12.16 8.71 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.42 -9.4 57.42 Favored Glycine 0 CA--C 1.495 -1.184 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.848 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -115.56 163.62 15.51 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.15 116.21 28.94 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 m -115.2 167.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.471 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.37 110.06 20.9 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.53 -45.89 92.17 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -115.71 91.06 28.71 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.147 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.99 -15.67 26.01 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.815 2.343 . . . . 0.0 111.661 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.19 -20.49 48.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.097 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.723 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -161.86 156.09 22.13 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.511 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 59.3 m -92.99 118.69 31.45 Favored 'General case' 0 C--N 1.27 -2.877 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -113.05 -179.48 3.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.0 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.4 mmtp -59.45 147.54 36.16 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.82 0.7 . . . . 0.0 111.565 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 131' ' ' THR . 10.9 ptp180 -98.17 143.13 25.73 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 55.2 Cg_endo -71.81 148.21 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.518 2.145 . . . . 0.0 111.533 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.06 -19.37 15.2 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.677 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.92 -163.55 52.48 Favored Glycine 0 CA--C 1.467 -2.958 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.793 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -73.21 129.47 86.04 Favored Pre-proline 0 C--N 1.261 -3.263 0 CA-C-N 114.427 -0.887 . . . . 0.0 112.539 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 84.4 Cg_endo -84.85 -3.36 9.78 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 C-N-CA 123.054 2.503 . . . . 0.0 111.748 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 114.35 3.85 Favored Glycine 1 N--CA 1.395 -4.043 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -99.91 175.38 5.79 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.025 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.449 HG22 ' OH ' ' A' ' 112' ' ' TYR . 5.4 t -151.22 145.19 17.77 Favored Pre-proline 0 N--CA 1.416 -2.167 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.24 -23.75 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.039 1.826 . . . . 0.0 111.331 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -127.56 105.14 8.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.84 168.04 11.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -142.08 169.44 17.59 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.7 155.75 38.95 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 p -128.95 141.0 51.41 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -98.21 129.02 44.97 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.566 0.698 . . . . 0.0 110.664 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.1 t -114.92 130.28 56.88 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.94 -16.06 33.41 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.36 -176.78 48.0 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -121.97 18.45 10.91 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.683 0.754 . . . . 0.0 109.519 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.21 169.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 30.3 m-85 -93.28 89.19 6.29 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.525 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.5 pt-20 -133.31 158.12 43.76 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.921 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 77.4 t80 -48.76 115.24 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.417 1.087 . . . . 0.0 110.969 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.08 -21.74 10.06 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.753 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -79.27 149.97 5.28 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.647 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.8 ttmp? -113.63 124.55 52.59 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.02 90.85 8.05 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.8 114.91 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.449 ' OH ' HG22 ' A' ' 91' ' ' THR . 58.9 t80 -79.94 138.46 37.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.7 167.55 16.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 118' ' ' TYR . 12.3 t -146.79 173.82 12.04 Favored 'General case' 0 N--CA 1.396 -3.172 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.278 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.09 155.33 20.69 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.881 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -50.78 -41.16 56.7 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.066 0.946 . . . . 0.0 112.205 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.96 64.88 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.581 ' HB2' ' SG ' ' A' ' 114' ' ' CYS . 34.8 m-85 -136.59 167.02 22.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 119.094 1.447 . . . . 0.0 111.159 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.52 -93.97 0.51 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 168.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.1 pp 175.74 158.01 0.23 Allowed 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.58 0.752 . . . . 0.0 111.499 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 96.1 mt -96.91 135.69 38.53 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 122.16 168.18 13.22 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -96.88 -28.99 13.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.4 mm -100.03 105.15 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.267 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -89.37 36.18 0.83 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.886 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.464 ' C ' ' HD3' ' A' ' 127' ' ' ARG . 23.0 p90 -165.21 174.1 10.61 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.184 0.516 . . . . 0.0 111.114 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 126' ' ' TYR . 1.4 mpp_? -139.46 132.36 29.3 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -113.01 147.81 36.39 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 118.437 0.562 . . . . 0.0 111.182 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 11.6 m -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.157 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -101.4 -166.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.506 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 28.7 p -59.5 -46.17 89.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 124.939 1.296 . . . . 0.0 112.728 -174.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.74 21.93 15.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 132.02 -155.5 21.49 Favored Glycine 0 C--N 1.288 -2.115 0 C-N-CA 119.394 -1.384 . . . . 0.0 113.624 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.48 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.6 m95 -81.49 146.15 30.36 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.225 0.536 . . . . 0.0 111.355 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.5 p -78.65 -25.21 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.884 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.79 -179.62 5.76 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -171.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -107.98 -155.59 0.56 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.689 0.796 . . . . 0.0 110.585 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.25 107.75 34.42 Favored Pre-proline 0 C--N 1.313 -0.984 0 O-C-N 122.039 -0.413 . . . . 0.0 110.344 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -66.89 133.61 31.89 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.486 2.124 . . . . 0.0 110.19 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.1 mm -86.83 123.9 40.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.648 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.91 105.97 1.44 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.409 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 29.8 mm-40 . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 124.597 1.159 . . . . 0.0 108.097 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.67 121.95 26.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.418 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.59 33.56 2.02 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.843 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 10.8 pt-20 -155.6 148.78 24.64 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.908 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.441 ' CD2' ' HB3' ' A' ' 37' ' ' TRP . 18.2 mt -73.27 153.12 90.33 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 123.794 0.838 . . . . 0.0 109.56 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.8 Cg_endo -62.58 130.09 28.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.693 1.595 . . . . 0.0 109.39 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 2.9 Cg_exo -72.87 126.91 11.72 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.65 1.567 . . . . 0.0 112.542 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 136.08 57.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -111.03 163.16 14.13 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -171.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.25 -33.82 67.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.53 0.681 . . . . 0.0 112.357 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 HG23 ' CE2' ' A' ' 56' ' ' TYR . 3.0 p -111.93 -0.33 15.83 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.663 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 58.8 mp0 -139.7 142.27 36.9 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.7 mt -123.2 152.75 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -77.91 136.21 37.99 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.089 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -120.68 105.9 11.21 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.62 -159.97 28.99 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -125.59 110.85 14.32 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 73.8 m95 -110.72 112.27 24.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -116.12 -11.13 11.41 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.303 -171.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -128.99 152.94 48.05 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 118.749 -1.181 . . . . 0.0 112.437 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 23' ' ' GLU . 54.6 tp60 -76.08 -23.69 55.0 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 p -116.36 122.77 45.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.512 0.672 . . . . 0.0 112.422 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.73 136.81 29.29 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.343 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 151.85 79.96 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.589 2.193 . . . . 0.0 112.043 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 20.3 tt0 -62.5 140.05 58.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.28 8.46 58.73 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.327 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.7 m -91.63 115.97 28.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.845 -0.178 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -85.56 144.18 28.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.564 0.697 . . . . 0.0 111.197 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.12 117.37 31.03 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.354 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.81 121.62 41.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 68.5 m-85 -104.96 152.5 22.61 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 65.1 tttm -109.89 136.3 49.41 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.569 -1.651 . . . . 0.0 107.144 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.6 m -78.49 17.64 0.65 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 65.24 159.42 0.13 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.458 0.647 . . . . 0.0 109.689 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.11 -8.01 18.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.568 1.512 . . . . 0.0 114.157 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.67 -5.42 20.62 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.047 -1.073 . . . . 0.0 115.223 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.8 m-85 -114.21 173.2 6.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.037 . . . . 0.0 109.182 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.0 179.13 6.68 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -165.12 -176.7 4.23 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -112.25 2.79 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.482 0.658 . . . . 0.0 109.749 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.75 155.13 14.85 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.94 135.76 57.48 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.018 0.481 . . . . 0.0 110.864 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.8 t -79.3 111.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -110.27 122.92 65.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.344 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.9 mtp -108.03 172.44 6.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.35 147.04 11.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.064 0.459 . . . . 0.0 109.897 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.0 128.31 35.09 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.628 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 42.9 ttp180 -150.07 120.72 7.5 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm 57.97 21.62 7.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.68 -17.87 55.89 Favored Glycine 0 N--CA 1.415 -2.704 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.44 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -103.83 154.86 19.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.128 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -93.18 121.46 34.56 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.42 170.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.506 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.56 119.99 29.52 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 120.713 0.292 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.5 -50.14 66.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -112.23 87.99 9.91 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.183 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.83 -7.76 18.63 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.176 2.584 . . . . 0.0 111.289 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.82 -11.99 57.81 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -112.84 140.32 47.73 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.326 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HB2' ' HZ1' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -157.76 152.33 25.0 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.1 m -91.83 112.87 24.97 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.762 0.791 . . . . 0.0 110.777 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -104.4 167.56 9.67 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.265 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.04 147.37 53.28 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -88.9 135.59 31.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.138 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.62 143.36 33.94 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.287 1.991 . . . . 0.0 110.074 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m -93.54 -20.4 20.28 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.612 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 -178.9 52.32 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -70.73 130.3 88.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 36.2 Cg_endo -69.86 91.34 0.52 Allowed 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.163 1.909 . . . . 0.0 111.227 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.38 -153.23 46.02 Favored Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.036 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.36 16.11 4.08 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -38.06 105.25 0.32 Allowed Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 126.133 1.773 . . . . 0.0 114.441 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -84.01 -24.22 2.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.369 2.046 . . . . 0.0 109.431 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -112.95 86.68 2.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.08 156.66 7.15 Favored Glycine 0 N--CA 1.411 -2.967 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 m -149.36 167.82 25.07 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.8 p90 -153.63 155.36 35.93 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.144 0.429 . . . . 0.0 110.725 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 p -121.13 143.82 48.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.16 136.16 40.48 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.8 t -114.39 2.08 14.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.454 0.645 . . . . 0.0 111.761 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.3 38.1 2.02 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.78 -172.58 19.49 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -120.72 20.43 11.71 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.839 0.828 . . . . 0.0 109.375 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.409 ' CG2' ' H ' ' A' ' 104' ' ' PHE . 7.5 p -134.76 156.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.409 ' H ' ' CG2' ' A' ' 103' ' ' VAL . 47.8 m-85 -87.07 89.01 7.85 Favored 'General case' 0 C--N 1.244 -3.999 0 CA-C-N 112.638 -2.074 . . . . 0.0 109.949 -173.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.05 150.41 41.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.033 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 55.1 t80 -47.96 112.78 0.61 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.431 0.634 . . . . 0.0 111.633 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.46 -19.99 7.96 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.754 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.31 141.82 13.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 117.468 0.634 . . . . 0.0 110.393 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.46 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.5 ttmp? -108.35 134.29 51.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.12 106.3 17.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 59.3 t -86.57 115.69 27.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 88' ' ' PRO . 18.8 m-85 -88.22 147.71 24.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.7 1.238 . . . . 0.0 112.998 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.453 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 27.9 m -155.55 177.64 11.15 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.5 t -140.38 -65.48 0.45 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 120.681 1.582 . . . . 0.0 110.051 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -146.29 -164.61 2.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.95 -43.83 17.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.479 0.656 . . . . 0.0 109.932 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.1 -11.63 61.13 Favored Glycine 0 C--N 1.305 -1.156 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.176 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 88.3 m-85 -123.11 129.33 51.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 65.7 mt-30 -122.85 -86.44 0.65 Allowed 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.616 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.644 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.6 pp -175.0 156.46 2.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 123.704 0.627 . . . . 0.0 112.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.37 156.18 16.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.68 179.02 24.69 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.523 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.01 -29.55 12.48 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.605 0.717 . . . . 0.0 109.508 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' ND2' ' A' ' 136' ' ' ASN . 47.4 mm -94.97 107.97 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.077 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -97.21 30.49 2.77 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.116 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 39.3 p90 -161.16 172.45 16.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.251 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -141.49 136.64 31.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 34.6 mt-10 -111.78 142.2 44.43 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.832 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 133' ' ' GLY . 11.8 m -74.52 89.51 2.18 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.492 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -99.4 -161.09 0.85 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.451 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 41.7 p -61.66 -36.01 79.59 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.49 -46.59 89.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.98 0.895 . . . . 0.0 110.242 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' A' ' 129' ' ' CYS . . . 136.44 -54.82 0.72 Allowed Glycine 0 N--CA 1.407 -3.285 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -139.37 130.88 27.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 110.787 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 55.4 p -77.79 164.5 25.16 Favored 'General case' 0 C--O 1.264 1.836 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.409 ' ND2' HG13 ' A' ' 124' ' ' ILE . 17.8 m120 61.11 -149.67 0.41 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -140.39 -174.33 3.92 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.8 mt -79.53 115.79 55.94 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 118.42 0.554 . . . . 0.0 109.617 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.95 136.52 66.25 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.945 1.764 . . . . 0.0 110.842 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -77.27 113.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.775 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 20.0 t -57.48 114.92 2.44 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.706 0.629 . . . . 0.0 109.452 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 7.0 tp10 . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.9 m-20 . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -77.65 129.68 35.88 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.202 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.64 17.68 19.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.354 0.597 . . . . 0.0 110.252 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.27 153.51 39.85 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 39' ' ' ASP . 2.7 mm? -83.63 157.18 64.61 Favored Pre-proline 1 N--CA 1.349 -5.49 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.46 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 17.7 Cg_endo -58.09 144.62 94.64 Favored 'Trans proline' 0 C--O 1.258 1.481 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.97 152.9 78.84 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.345 2.03 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -88.22 156.58 19.14 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -117.59 152.41 35.2 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.813 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -77.96 -30.26 50.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.817 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -107.76 -12.37 15.23 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 9.2 mp0 -123.17 174.04 7.51 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.107 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.6 144.61 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 37' ' ' TRP . 43.5 mt -70.44 132.84 46.19 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 p -74.1 -56.81 4.47 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.672 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.63 169.36 54.93 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -99.75 125.08 45.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.463 ' HB3' HD13 ' A' ' 24' ' ' LEU . 11.0 m95 -116.17 95.04 4.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 m -108.68 11.42 26.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.358 0.599 . . . . 0.0 110.947 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.672 ' O ' HD23 ' A' ' 24' ' ' LEU . 10.2 t70 -103.97 -157.74 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 25.0 mt-30 -129.5 -47.38 1.18 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 33.0 p -96.7 123.81 40.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.077 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.95 138.0 32.22 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.526 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.589 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 23.7 Cg_endo -62.3 145.2 96.03 Favored 'Trans proline' 0 C--O 1.259 1.542 0 C-N-CA 123.07 2.513 . . . . 0.0 113.146 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -63.74 128.74 37.17 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.24 9.18 32.21 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -92.56 118.11 30.66 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.593 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -88.36 143.21 27.15 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 121.341 0.591 . . . . 0.0 111.108 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.2 121.28 44.82 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -93.58 127.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.554 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 76.2 m-85 -104.28 131.86 51.16 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.751 0.786 . . . . 0.0 112.057 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -87.88 131.4 34.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.026 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.727 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.3 m -71.57 5.51 2.37 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 68.35 144.23 0.1 OUTLIER Pre-proline 0 N--CA 1.486 1.365 0 CA-C-O 121.624 0.726 . . . . 0.0 112.416 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.17 110.2 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.941 1.761 . . . . 0.0 109.864 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.27 -12.99 6.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.727 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 55.1 m-85 -125.53 175.21 7.69 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -166.85 179.23 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -163.92 175.75 10.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -83.28 -11.76 57.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.518 0.675 . . . . 0.0 109.788 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.2 145.27 10.03 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.75 148.83 41.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.003 0.402 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.52 114.26 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.23 125.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -114.26 168.24 10.01 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -151.56 144.11 16.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.4 t -74.1 118.38 16.99 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.197 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.1 ttp180 -150.08 122.56 8.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 66.61 27.41 9.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.488 0.715 . . . . 0.0 112.382 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.59 -14.45 62.82 Favored Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.824 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.88 153.26 28.19 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.557 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.497 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.4 m95 -85.82 115.05 23.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 168.25 4.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.953 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.74 106.32 18.38 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.674 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.69 -42.74 89.27 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.536 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 7.7 t-20 -130.92 99.05 18.46 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.955 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.03 -9.07 19.26 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.224 2.616 . . . . 0.0 112.195 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -83.74 -18.15 38.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.872 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.2 mmp_? -88.43 138.77 31.14 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.392 1.092 . . . . 0.0 113.471 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -149.3 151.66 34.55 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 100.0 m -95.62 116.3 28.65 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.24 1.019 . . . . 0.0 109.702 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 160.95 14.13 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.407 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.1 mmtp -56.96 140.78 47.69 Favored 'General case' 0 CA--C 1.491 -1.313 0 O-C-N 123.721 0.638 . . . . 0.0 109.762 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.0 ptm180 -76.62 144.38 73.41 Favored Pre-proline 0 C--N 1.284 -2.259 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.17 150.28 42.23 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 121.513 1.476 . . . . 0.0 108.823 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.8 m -107.54 -9.76 15.85 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.941 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.79 -151.28 47.48 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.552 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -93.74 120.18 66.32 Favored Pre-proline 0 C--N 1.269 -2.931 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.67 71.63 1.46 Allowed 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 123.345 2.696 . . . . 0.0 111.609 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 138' ' ' ILE . . . 65.16 -161.14 41.83 Favored Glycine 0 N--CA 1.42 -2.41 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 119.93 13.11 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.244 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 t -122.55 105.44 35.95 Favored Pre-proline 0 N--CA 1.426 -1.639 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.14 8.52 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.956 1.771 . . . . 0.0 113.124 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -140.25 17.16 2.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.663 0.268 . . . . 0.0 111.438 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . -136.15 165.48 24.91 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.701 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 113' ' ' THR . 3.0 m -130.97 164.78 24.6 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -158.77 161.46 36.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -124.72 143.14 50.92 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.54 135.47 39.34 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 7.4 t -124.85 17.87 8.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.467 0.651 . . . . 0.0 111.45 -173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.424 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -140.46 23.72 2.67 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.216 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.32 -178.87 20.0 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.62 11.69 26.43 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 108' ' ' VAL . 2.3 p -140.1 -172.5 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.845 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.399 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.28 79.91 1.65 Allowed 'General case' 1 C--N 1.237 -4.3 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.689 -175.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.1 pt-20 -130.68 155.27 46.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.69 116.49 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.977 0.798 . . . . 0.0 110.816 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.75 -19.84 6.53 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.343 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -83.27 140.64 15.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.7 ttmt -103.79 125.3 50.14 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 172.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.53 93.95 9.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.26 119.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.479 ' HH ' ' HB2' ' A' ' 141' ' ' CYS . 30.4 t80 -99.09 124.34 44.03 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.337 0.589 . . . . 0.0 110.812 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 95' ' ' THR . 1.2 m -162.97 148.5 11.91 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.521 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 59.5 m -113.98 -64.34 1.32 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.168 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -140.4 -168.92 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.76 -46.5 24.98 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.21 64.75 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 142' ' ' GLU . 89.7 m-85 -108.32 112.66 25.22 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 117.01 0.405 . . . . 0.0 110.743 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -119.24 -84.0 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.8 pp 172.52 157.82 0.1 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.861 0.864 . . . . 0.0 111.335 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.67 145.33 26.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.31 178.32 15.27 Favored Glycine 0 C--N 1.282 -2.444 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.395 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.07 -34.65 9.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.47 102.37 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.425 ' HB2' HD22 ' A' ' 120' ' ' LEU . 4.2 p-10 -89.9 28.15 1.42 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.49 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -162.13 172.78 15.28 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -151.35 120.72 6.84 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.009 0.818 . . . . 0.0 109.263 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.6 150.32 20.47 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.634 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.63 128.2 34.98 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.6 t70 -113.11 -164.48 0.92 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.492 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.0 p -70.1 -40.26 75.04 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.539 1.136 . . . . 0.0 113.356 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.15 -32.54 12.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 122.031 -0.418 . . . . 0.0 111.348 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.1 -162.26 26.68 Favored Glycine 0 C--N 1.288 -2.113 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.967 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -76.73 149.5 36.34 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.321 0.581 . . . . 0.0 110.138 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -87.42 136.74 32.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 70.54 -176.23 0.2 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.02 0.528 . . . . 0.0 111.186 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 23.1 t70 -113.85 -164.85 0.95 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 89' ' ' GLY . 46.6 mt -92.29 109.81 40.42 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 118.537 0.608 . . . . 0.0 109.427 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.42 132.83 48.45 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.975 1.783 . . . . 0.0 109.993 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.6 mp -74.64 110.23 8.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.193 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.479 ' HB2' ' HH ' ' A' ' 112' ' ' TYR . 53.1 t -56.48 121.97 10.87 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.188 0.93 . . . . 0.0 110.244 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 13.5 tp10 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.439 -0.997 0 CA-C-O 121.729 0.776 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.7 m -83.45 127.96 34.12 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.9 OUTLIER -102.94 20.58 17.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.827 0.822 . . . . 0.0 109.561 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.3 155.25 42.51 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.067 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 34.2 mt -78.38 157.24 78.01 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 123.352 0.661 . . . . 0.0 111.514 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.85 127.48 18.73 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.6 2.2 . . . . 0.0 110.771 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.02 122.3 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.903 1.735 . . . . 0.0 110.299 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.39 158.43 35.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.617 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -113.74 167.52 10.55 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -69.46 -38.61 77.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -106.58 -0.01 24.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -135.39 135.54 40.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.743 0.782 . . . . 0.0 111.979 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mt -125.2 143.31 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -64.09 149.68 47.11 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.556 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.8 p -105.5 111.07 23.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -171.77 16.96 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.964 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 t -104.2 136.58 43.54 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.528 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 76.7 m95 -139.82 106.01 5.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 m -135.25 16.15 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.593 0.711 . . . . 0.0 109.234 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.9 m-20 -100.5 -167.3 1.42 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.725 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.3 -65.19 0.78 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.015 0.436 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -86.75 119.66 27.22 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -123.64 136.63 27.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.829 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.67 144.97 85.89 Favored 'Trans proline' 0 C--O 1.258 1.495 0 C-N-CA 122.534 2.156 . . . . 0.0 110.845 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.1 tt0 -61.21 137.68 58.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.22 51.9 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.451 ' C ' HG21 ' A' ' 65' ' ' VAL . 66.9 m -88.6 114.78 25.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.718 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -92.83 139.12 30.88 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.101 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.46 121.63 45.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.18 130.21 43.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -114.49 149.78 35.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 111.651 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -101.52 147.73 26.04 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.676 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.5 m -85.97 15.7 4.77 Favored 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 123.577 0.751 . . . . 0.0 112.589 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 58.9 mtp180 69.83 158.61 0.16 Allowed Pre-proline 0 C--O 1.248 1.006 0 C-N-CA 123.225 0.61 . . . . 0.0 109.36 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.0 125.81 11.28 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 109.223 -1.106 . . . . 0.0 109.223 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 110.24 -11.92 31.24 Favored Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.031 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 84.3 m-85 -117.28 168.53 10.24 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.765 -0.844 . . . . 0.0 109.813 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.93 -176.95 5.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 p -154.07 156.75 37.88 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.81 -4.1 58.39 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.198 0.999 . . . . 0.0 110.457 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.45 -119.96 1.73 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -159.96 148.29 17.12 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.29 97.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.983 0.897 . . . . 0.0 109.161 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.93 121.84 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.726 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.4 mtp -107.58 172.53 6.78 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG21 ' C ' ' A' ' 46' ' ' THR . 11.4 p -159.13 145.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.379 0.609 . . . . 0.0 111.003 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.6 t -70.78 119.3 14.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.581 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 30.7 tpt180 -150.05 113.68 5.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 67.26 31.7 6.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.112 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.29 -16.39 52.84 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.474 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.27 152.0 25.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.061 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -90.06 114.35 26.22 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.33 171.53 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.579 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.08 124.09 35.91 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.47 -47.75 77.82 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -111.53 91.84 15.27 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.155 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.51 -23.79 16.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.631 2.221 . . . . 0.0 112.606 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.09 -22.16 49.41 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.041 0.924 . . . . 0.0 110.373 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.77 137.79 32.08 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.194 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.13 162.33 41.06 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -89.77 131.48 35.7 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.754 0.788 . . . . 0.0 111.413 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.04 165.56 20.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.881 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.3 mttt -58.45 146.93 33.42 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.4 ptm180 -82.9 154.85 67.91 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -83.09 164.66 15.19 Favored 'Trans proline' 0 N--CA 1.432 -2.14 0 C-N-CA 121.314 1.343 . . . . 0.0 109.6 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.0 -3.95 13.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.448 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.89 -116.02 4.7 Favored Glycine 0 CA--C 1.459 -3.454 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -137.33 144.17 44.43 Favored Pre-proline 0 C--N 1.265 -3.083 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.33 45.27 1.88 Allowed 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.704 2.269 . . . . 0.0 109.477 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.88 -147.71 33.94 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -170.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -161.85 122.02 2.56 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 t -107.28 120.23 48.4 Favored Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.273 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.91 -7.86 15.5 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.615 2.21 . . . . 0.0 112.785 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -129.43 12.49 5.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.55 160.41 24.47 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -128.13 168.03 15.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.9 p90 -154.35 163.03 40.8 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -131.51 141.73 49.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.4 mt -98.29 124.41 42.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.503 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 11.9 t -109.76 -18.91 13.33 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.79 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.72 30.21 9.01 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 119.582 -1.294 . . . . 0.0 111.091 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.58 -173.3 30.94 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -127.44 18.42 6.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.33 0.565 . . . . 0.0 110.554 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 108' ' ' VAL . 20.9 m -146.95 178.61 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -91.12 90.61 7.9 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.62 156.76 46.33 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.837 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.432 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 71.8 t80 -53.8 105.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.965 0.791 . . . . 0.0 111.36 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.39 -11.96 6.04 Favored Glycine 0 N--CA 1.418 -2.556 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.787 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 103' ' ' VAL . 19.1 m -82.95 141.34 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.015 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.503 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.0 ttmt -106.6 123.7 48.5 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 169.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 99.3 11.48 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 46.7 t -79.69 110.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.444 ' C ' ' HG1' ' A' ' 113' ' ' THR . 1.7 t80 -89.19 132.14 34.99 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 123.926 0.891 . . . . 0.0 108.77 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.444 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 4.1 m -155.12 156.53 35.96 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.28 -69.88 0.83 Allowed 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.167 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.64 -169.51 3.4 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.98 -50.65 11.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.722 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.45 73.9 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.636 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.73 130.06 23.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.43 0.633 . . . . 0.0 110.165 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -109.47 -76.79 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.7 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp 174.1 162.68 0.19 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.253 1.021 . . . . 0.0 110.282 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -97.46 143.81 27.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.13 159.37 12.94 Favored Glycine 0 C--N 1.289 -2.032 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.4 -27.48 22.73 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.557 0.694 . . . . 0.0 110.716 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.0 mm -95.93 103.15 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.022 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -92.87 33.56 1.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.072 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.83 174.07 15.84 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.262 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -134.26 127.44 31.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 18.3 mt-10 -111.33 143.18 42.53 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 118.654 0.661 . . . . 0.0 111.312 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.5 m -81.68 117.18 21.82 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.242 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.3 t70 -108.92 -165.38 1.02 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.466 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 61.2 p -67.31 -41.87 84.64 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.707 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.76 -30.66 20.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 -139.25 5.77 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.382 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.408 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 78.1 m95 -82.83 128.96 34.9 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.125 0.488 . . . . 0.0 110.473 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 p -63.36 -29.47 70.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.821 1.248 . . . . 0.0 113.427 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.37 170.08 14.09 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -105.54 174.32 5.93 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.99 110.47 4.65 Favored Pre-proline 0 C--N 1.319 -0.749 0 O-C-N 123.687 0.617 . . . . 0.0 111.723 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 130.49 29.61 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.152 1.901 . . . . 0.0 110.708 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.61 109.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.4 t -83.7 112.74 20.33 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.212 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.47 ' HB2' HD23 ' A' ' 121' ' ' LEU . 5.9 mm-40 . . . . . 0 CA--C 1.491 -1.322 0 C-N-CA 124.139 0.976 . . . . 0.0 108.902 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 N--CA 1.433 -1.305 0 CA-C-O 121.757 0.789 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.2 m -85.83 127.62 34.61 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.831 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.95 19.03 12.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.581 0.705 . . . . 0.0 110.528 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.14 157.13 43.14 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 39' ' ' ASP . 2.2 mm? -89.62 158.67 45.11 Favored Pre-proline 1 N--CA 1.342 -5.872 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.262 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.9 Cg_endo -58.81 138.38 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.028 2.485 . . . . 0.0 110.355 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 149.41 84.21 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.156 1.904 . . . . 0.0 112.577 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -89.61 143.45 26.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.82 168.3 10.02 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.436 0.636 . . . . 0.0 111.912 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -79.04 -33.95 44.27 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.805 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 p -98.28 -31.74 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.0 mp0 -114.83 146.22 41.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.73 0.3 . . . . 0.0 111.444 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.2 mt -120.35 146.19 25.58 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 37' ' ' TRP . 24.1 mt -75.84 130.22 38.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.1 p -99.02 127.67 44.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.92 -143.21 16.12 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 t -149.66 118.97 6.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.561 ' CD1' HD12 ' A' ' 33' ' ' LEU . 5.4 m95 -129.48 74.4 1.58 Allowed 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.856 0.836 . . . . 0.0 109.484 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 24.36 12.06 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.592 ' O ' HD23 ' A' ' 24' ' ' LEU . 24.3 m-20 -95.7 -150.76 0.33 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.943 -1.935 . . . . 0.0 111.863 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -132.41 -79.55 0.5 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 18.6 p -107.09 121.2 44.01 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -116.64 138.03 24.18 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.927 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.53 151.48 84.72 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.757 2.305 . . . . 0.0 111.938 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.62 136.33 57.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.17 4.31 53.81 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -85.63 118.87 25.41 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.8 pt20 -91.99 142.04 27.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.828 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.88 131.79 56.15 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.022 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.4 mt -99.89 134.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.631 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 51.6 m-85 -113.21 156.5 23.15 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.685 0.755 . . . . 0.0 112.966 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -101.39 137.57 39.55 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.819 1.647 . . . . 0.0 106.708 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.766 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 76.7 m -81.33 15.0 2.15 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 62.43 156.9 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 121.721 0.772 . . . . 0.0 111.545 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.74 107.08 2.25 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 120.744 0.963 . . . . 0.0 109.605 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 128.64 -24.49 4.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.671 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.766 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 60.2 m-85 -105.0 155.32 19.07 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' ARG . 28.6 ttm180 -136.18 168.7 18.9 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 123.872 0.869 . . . . 0.0 109.725 -171.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -164.69 154.4 13.61 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.126 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.87 -32.43 31.06 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.44 136.29 8.72 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.91 151.71 45.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.158 0.479 . . . . 0.0 111.134 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 79' ' ' LYS . 58.9 t -76.05 108.84 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.636 0.732 . . . . 0.0 109.761 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.49 122.19 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.097 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.416 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 84.7 mtp -104.39 170.25 8.01 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.3 p -152.07 143.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.216 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.03 121.5 22.08 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 124.09 0.956 . . . . 0.0 108.804 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -146.51 121.94 10.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 41.5 mmtm 63.71 20.35 12.18 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.798 0.839 . . . . 0.0 112.92 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.33 72.57 Favored Glycine 0 N--CA 1.423 -2.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.45 150.87 38.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.242 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.7 m95 -87.38 113.44 23.09 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.66 0.743 . . . . 0.0 109.525 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.59 171.81 3.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.227 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.16 118.01 27.44 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.416 ' H ' ' HA ' ' A' ' 64' ' ' MET . 5.1 tp -58.88 -46.05 88.73 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -120.31 96.56 49.13 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.928 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.99 -10.77 21.38 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 112.743 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.67 -29.99 36.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.952 0.882 . . . . 0.0 109.931 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -91.32 132.82 35.91 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.676 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.402 ' HA ' ' CG2' ' A' ' 62' ' ' VAL . 11.8 ptmm? -154.35 150.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 62.5 m -86.61 114.76 23.59 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.917 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.89 169.82 8.64 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.477 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 105' ' ' GLU . 32.6 mmtp -55.08 119.41 5.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.443 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 11.1 ptm180 -55.64 145.51 50.12 Favored Pre-proline 0 C--N 1.295 -1.779 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.261 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.45 158.84 32.69 Favored 'Trans proline' 0 C--O 1.256 1.396 0 C-N-CA 122.272 1.982 . . . . 0.0 109.161 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.45 -16.72 5.78 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.246 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.11 -154.53 46.53 Favored Glycine 0 CA--C 1.464 -3.149 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.809 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.97 134.86 31.01 Favored Pre-proline 0 C--N 1.252 -3.642 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.256 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.7 33.57 0.49 Allowed 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.841 2.361 . . . . 0.0 110.772 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.46 157.9 33.97 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -127.58 145.34 50.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -120.66 148.9 49.21 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.074 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.4 -25.65 18.01 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.316 2.011 . . . . 0.0 111.087 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -146.56 110.05 4.83 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.361 0.6 . . . . 0.0 110.489 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . 152.75 173.09 21.81 Favored Glycine 0 N--CA 1.425 -2.065 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.317 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 m -146.73 163.45 35.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -144.52 165.52 27.75 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.4 p -135.26 148.08 49.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.23 128.28 54.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 109' ' ' LYS . 12.5 t -121.44 6.82 10.09 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 108' ' ' VAL . . . -124.06 23.06 6.62 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.72 -178.0 29.27 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.13 11.48 15.25 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.544 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 p -140.36 -168.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.407 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -105.64 83.4 1.93 Allowed 'General case' 0 C--N 1.245 -3.944 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.961 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 10.4 pt-20 -138.78 162.56 34.42 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.7 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -51.98 120.65 5.58 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.095 0.872 . . . . 0.0 110.205 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.74 -12.36 22.87 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.193 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.544 HG11 ' O ' ' A' ' 103' ' ' VAL . 20.3 m -85.14 140.26 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.496 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -101.31 116.98 34.05 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.07 93.62 7.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -74.78 128.05 36.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.0 t80 -111.09 145.19 38.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.344 0.593 . . . . 0.0 111.185 -172.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 m -152.62 159.84 43.21 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 60.9 m -122.06 -68.39 0.9 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.488 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -133.91 -162.42 1.24 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.24 -55.01 4.11 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.34 0.591 . . . . 0.0 109.805 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.18 -23.38 59.14 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.969 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.45 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 86.8 m-85 -104.97 112.15 25.19 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 92.2 mt-30 -112.43 -87.83 0.54 Allowed 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.7 pp -178.87 145.2 0.28 Allowed 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 73.0 mt -87.51 139.76 30.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.62 170.05 12.98 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.67 -28.15 12.65 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.363 0.601 . . . . 0.0 110.335 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.84 99.36 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -87.07 30.71 0.74 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.846 0.858 . . . . 0.0 110.855 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 49.5 p90 -163.41 -177.83 5.53 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.516 -0.765 . . . . 0.0 108.96 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 131.51 16.0 Favored 'General case' 0 N--CA 1.403 -2.819 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 31.9 mt-10 -107.67 145.86 32.81 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.86 112.41 22.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -94.6 -161.94 0.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.439 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.4 p -67.6 -44.94 76.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.902 0.881 . . . . 0.0 109.945 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.38 -37.03 68.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.879 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.76 -152.13 24.21 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.64 126.79 29.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.4 p -59.87 -34.85 73.68 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.807 0.843 . . . . 0.0 112.111 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -132.73 169.46 16.66 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 5.8 p-10 -102.37 -99.84 0.28 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.101 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.483 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 26.9 mt -127.24 99.43 28.01 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.3 Cg_endo -53.56 140.28 65.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.01 1.807 . . . . 0.0 110.018 172.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.36 118.59 31.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 -171.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 64.6 m -59.13 94.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.217 1.007 . . . . 0.0 112.47 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 140' ' ' ILE . 68.4 mm-40 . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 32.5 m-20 . . . . . 0 C--O 1.242 0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.0 m -74.64 132.72 41.96 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.844 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.4 36.44 2.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.653 0.74 . . . . 0.0 109.395 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.18 158.06 32.0 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.213 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 19.2 mt -79.44 152.97 76.23 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 123.95 0.781 . . . . 0.0 110.31 175.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.27 131.7 42.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.542 2.161 . . . . 0.0 110.976 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.01 132.53 24.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.49 2.127 . . . . 0.0 113.23 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 mtm-85 -76.73 129.56 36.49 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -104.2 178.13 4.65 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.007 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -56.14 -44.62 79.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.862 0.465 . . . . 0.0 111.782 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 p -125.1 17.84 8.43 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.805 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 49.8 mp0 -135.35 134.4 39.76 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.312 0.577 . . . . 0.0 111.882 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -128.35 165.73 27.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -90.5 142.83 27.34 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -98.21 128.09 44.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.3 -165.35 12.46 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.2 m -130.98 124.53 31.17 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.406 ' HB3' HD22 ' A' ' 24' ' ' LEU . 76.0 m95 -122.4 121.48 36.76 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 m -132.74 3.4 3.8 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.966 0.413 . . . . 0.0 110.767 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 21.0 m-20 -95.63 -169.81 2.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.88 -59.57 1.34 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.241 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.3 p -93.82 124.4 37.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 57.6 m-85 -125.59 139.17 33.39 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.496 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 24.4 Cg_endo -61.44 142.56 95.78 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 123.178 2.586 . . . . 0.0 113.038 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.7 132.97 54.94 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.12 43.37 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -89.66 115.41 27.01 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -89.16 144.17 26.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.605 0.717 . . . . 0.0 111.437 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 128.62 55.82 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.43 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.34 128.54 49.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 70.1 m-85 -103.43 158.01 16.64 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 60.2 tttm -106.06 142.4 35.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.981 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.658 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 86.6 m -95.93 38.44 1.18 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.9 mmt180 62.22 163.23 0.11 Allowed Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.696 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.94 100.45 0.37 Allowed 'Trans proline' 0 N--CA 1.418 -2.935 0 C-N-CA 121.273 1.315 . . . . 0.0 109.228 167.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.87 -3.17 3.78 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.494 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.658 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 45.6 m-85 -130.47 -177.73 4.46 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -153.02 -176.35 5.73 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.591 0.756 . . . . 0.0 109.341 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.2 p -162.04 165.09 27.77 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.21 -13.87 27.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.366 0.603 . . . . 0.0 109.76 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.94 161.13 34.05 Favored Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -75.05 143.06 43.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 117.694 0.747 . . . . 0.0 111.418 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 50.0 t -77.45 109.15 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 174.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.91 123.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.109 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -112.06 168.81 9.31 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.8 p -152.39 145.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.328 0.585 . . . . 0.0 110.383 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.9 t -71.71 120.38 17.22 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.542 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.2 ttm-85 -152.21 120.38 6.28 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.59 28.13 13.27 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.218 1.007 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.89 -15.95 61.52 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.723 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -110.64 158.61 18.41 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.181 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.22 115.89 28.49 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.94 151.37 32.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.399 0.619 . . . . 0.0 111.713 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.98 109.59 1.32 Allowed 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.457 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.79 -52.21 64.07 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -110.79 92.73 15.18 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -20.96 22.75 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 122.394 2.063 . . . . 0.0 111.176 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 mt -74.86 -25.58 59.07 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.403 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -89.49 128.37 35.97 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.331 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HB2' ' HZ1' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.76 158.08 40.41 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 65.0 m -88.49 139.99 29.92 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.765 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 48.1 mt-30 -132.69 168.46 18.28 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.225 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.72 160.22 33.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.838 0.828 . . . . 0.0 113.15 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -110.82 137.61 20.86 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.44 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 9.6 Cg_endo -71.02 148.82 57.77 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.392 2.061 . . . . 0.0 112.698 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.13 -55.28 3.49 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.976 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.18 -156.08 20.64 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.003 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -87.82 111.84 44.94 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 123.635 0.774 . . . . 0.0 109.201 -175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 81.1 Cg_endo -76.72 9.95 2.45 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.916 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.75 135.9 2.87 Favored Glycine 0 N--CA 1.397 -3.922 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.144 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -106.26 107.74 18.9 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 t -125.09 124.6 25.35 Favored Pre-proline 0 N--CA 1.411 -2.384 0 CA-C-O 121.564 0.697 . . . . 0.0 112.155 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -89.84 2.61 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 122.269 1.979 . . . . 0.0 112.335 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.9 4.86 2.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.81 13.79 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 p -142.39 163.36 33.06 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.295 0.638 . . . . 0.0 109.934 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.4 p90 -130.31 154.36 47.71 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.189 0.306 . . . . 0.0 110.404 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 74.7 p -114.21 178.3 4.33 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.86 142.25 31.75 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 109' ' ' LYS . 8.8 t -127.88 -45.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.998 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.25 51.01 3.38 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.113 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 140.39 -176.84 21.14 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.42 10.61 10.55 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 121.16 0.505 . . . . 0.0 110.003 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.504 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.8 p -147.06 -164.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.432 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.361 -173.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 28.2 m-85 -100.23 82.49 2.52 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.8 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.47 154.98 50.61 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.466 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.18 112.89 0.8 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.137 0.898 . . . . 0.0 109.919 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.3 -27.61 4.2 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.908 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 103' ' ' VAL . 18.2 m -75.73 164.34 3.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.071 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HB3' HG23 ' A' ' 99' ' ' THR . 4.7 ttmp? -131.7 115.37 15.93 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.4 101.94 13.89 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.5 m -78.82 162.24 4.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 118.621 -1.231 . . . . 0.0 108.612 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.452 ' HE2' ' SG ' ' A' ' 141' ' ' CYS . 61.2 t80 -129.43 134.61 47.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.394 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -150.83 154.99 38.31 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 78.6 m -130.68 -41.08 1.19 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -153.55 -176.63 5.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -106.75 -40.31 5.55 Favored 'General case' 0 C--N 1.278 -2.533 0 O-C-N 123.633 0.583 . . . . 0.0 111.028 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.62 -37.1 94.19 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -122.98 125.59 45.55 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 48.2 mt-30 -99.15 -89.46 0.32 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -170.43 161.12 7.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.71 -61.28 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.53 158.14 13.59 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.293 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.43 -26.09 33.05 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.936 0.875 . . . . 0.0 109.932 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.92 95.26 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.55 29.63 0.68 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 21.7 p90 -162.12 174.33 13.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -173.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.463 HH22 ' HB3' ' A' ' 96' ' ' PHE . 2.2 mpp_? -134.14 122.37 22.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.485 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 26.5 mt-10 -103.62 150.58 23.84 Favored 'General case' 0 C--N 1.284 -2.271 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.744 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.3 m -81.2 121.73 26.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.748 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 131' ' ' THR . 11.8 t70 -96.55 -159.45 0.73 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 30.3 p -58.35 -62.15 2.05 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 124.183 0.993 . . . . 0.0 112.709 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.21 -24.27 15.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.57 -149.85 5.7 Favored Glycine 0 CA--C 1.486 -1.748 0 C-N-CA 118.603 -1.761 . . . . 0.0 113.489 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 73.2 m95 -93.52 147.69 22.75 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.191 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.8 p -77.69 -24.59 49.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.791 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -139.3 172.99 12.01 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.756 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 21.0 t70 -108.69 -158.25 0.64 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.486 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.5 mt -85.53 117.21 68.3 Favored Pre-proline 0 C--N 1.289 -2.065 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.75 143.78 46.99 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.222 1.948 . . . . 0.0 109.56 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.419 HG22 ' HG2' ' A' ' 142' ' ' GLU . 2.3 mp -94.73 124.65 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 122.118 -0.363 . . . . 0.0 111.667 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.452 ' SG ' ' HE2' ' A' ' 112' ' ' TYR . 64.4 m -77.8 111.49 13.67 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.161 0.984 . . . . 0.0 111.142 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG22 ' A' ' 140' ' ' ILE . 6.9 mm-40 . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.8 m-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.7 m -76.46 152.78 36.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.01 16.88 13.36 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.741 -174.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.94 160.61 28.02 Favored 'General case' 0 CA--C 1.462 -2.434 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -85.2 156.33 60.08 Favored Pre-proline 1 N--CA 1.355 -5.191 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.042 -177.492 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 6.5 Cg_endo -55.45 135.12 67.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.443 2.762 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.66 117.67 4.43 Favored 'Trans proline' 0 CA--C 1.519 -0.231 0 C-N-CA 123.023 2.482 . . . . 0.0 112.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.59 133.24 45.6 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 94.0 mtt180 -108.1 -179.74 3.98 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.513 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.583 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 59.7 t30 -89.38 -50.42 6.13 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.157 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 p -88.15 -9.16 54.05 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.4 mp0 -124.6 135.52 53.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.614 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mt -117.1 135.98 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.58 HD12 ' CD1' ' A' ' 37' ' ' TRP . 17.7 mt -67.97 117.66 10.12 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.427 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 p -96.77 100.25 11.8 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.91 -159.28 28.39 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -132.71 113.53 13.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CD1' HD12 ' A' ' 33' ' ' LEU . 10.1 m95 -125.18 84.67 2.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 m -118.66 5.94 11.6 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.207 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -85.25 -160.06 0.48 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.207 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -125.15 -69.26 0.8 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 23.3 p -93.38 133.69 36.37 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -128.48 141.29 40.97 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.49 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 35.1 Cg_endo -65.19 150.17 87.9 Favored 'Trans proline' 0 C--O 1.255 1.361 0 C-N-CA 122.718 2.279 . . . . 0.0 112.712 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.87 133.62 48.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 -6.11 38.81 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.516 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -80.96 118.52 22.52 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.23 152.88 21.66 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.937 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.44 131.95 54.12 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -102.98 126.12 57.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 63.4 m-85 -108.87 143.65 37.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.217 0.532 . . . . 0.0 112.202 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -93.66 142.68 27.08 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 85.4 m -90.19 40.34 1.0 Allowed 'General case' 0 C--N 1.279 -2.474 0 CA-C-O 120.521 0.2 . . . . 0.0 110.835 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 29' ' ' ASN . 22.0 mtp180 61.46 172.3 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 122.781 0.432 . . . . 0.0 110.689 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -76.12 -12.0 19.42 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 120.857 1.038 . . . . 0.0 112.225 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -104.18 -13.89 25.74 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 115.126 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 62.0 m-85 -114.23 176.07 5.2 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.137 -1.213 . . . . 0.0 109.806 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -152.55 -173.49 4.58 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -168.62 -175.01 2.32 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.79 -6.64 57.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.407 1.099 . . . . 0.0 109.062 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.31 -147.2 4.84 Favored Glycine 0 N--CA 1.403 -3.507 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -120.97 150.84 40.48 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.36 103.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.0 mm -101.0 119.53 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.927 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.1 169.84 8.47 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -155.23 147.51 12.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.609 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.35 123.49 24.72 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -152.19 124.22 8.06 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 62.33 26.17 15.64 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.783 0.833 . . . . 0.0 112.677 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.21 -9.9 74.17 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.761 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.87 162.43 20.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.471 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -92.63 112.0 23.8 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.29 167.62 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.396 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.553 0.216 . . . . 0.0 110.59 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -50.23 73.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.3 m120 -111.93 93.82 22.48 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.03 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -73.56 -11.72 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.438 2.092 . . . . 0.0 111.693 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.12 -11.99 58.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.503 0.668 . . . . 0.0 110.13 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 25.8 mmt180 -89.32 126.95 35.73 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.392 0.615 . . . . 0.0 110.13 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -146.37 144.68 29.91 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.0 m -93.41 117.43 30.07 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-O 121.239 0.543 . . . . 0.0 109.892 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -117.34 167.48 11.21 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.128 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.6 mttt -63.6 145.76 55.06 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.787 0.327 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.6 ptp180 -85.46 138.05 36.3 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 40.6 Cg_endo -68.24 154.75 71.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.791 2.327 . . . . 0.0 111.348 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.05 -2.29 18.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 -112.57 3.68 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.168 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -127.13 119.58 22.2 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 95.6 Cg_endo -79.24 34.54 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.877 3.052 . . . . 0.0 114.058 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.74 137.78 6.71 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.614 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.74 128.06 34.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.298 0.57 . . . . 0.0 109.729 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -139.57 107.36 7.11 Favored Pre-proline 0 N--CA 1.409 -2.518 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.25 12.0 2.95 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.448 2.098 . . . . 0.0 110.477 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 -54.82 2.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.764 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.91 -166.1 14.58 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.116 -1.04 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 m -132.27 170.93 14.35 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -142.64 153.41 43.42 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.642 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 72.2 p -107.66 -178.65 3.69 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -145.38 157.42 44.04 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 7.6 t -151.52 146.92 26.24 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.09 27.26 66.71 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.857 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.73 -44.59 0.21 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.181 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.03 13.24 9.08 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.42 171.75 14.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.4 m-85 -85.73 93.02 8.76 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.664 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -146.13 151.42 37.64 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.274 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.461 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 76.8 t80 -52.41 106.55 0.16 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.014 0.926 . . . . 0.0 111.208 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 139.47 -27.86 2.59 Favored Glycine 0 N--CA 1.422 -2.264 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.817 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 99' ' ' THR . 23.2 m -80.92 154.79 4.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.303 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -118.12 118.88 33.08 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.19 96.66 9.75 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' A' ' 97' ' ' THR . 1.0 OUTLIER -77.45 156.25 5.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.709 -178.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 46.6 t80 -114.78 139.19 49.92 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -141.44 164.59 29.82 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 7.2 t -146.66 -57.7 0.28 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.748 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.38 -174.18 4.14 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -83.55 -45.01 14.03 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 121.892 0.853 . . . . 0.0 108.833 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.98 -24.11 64.97 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.846 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -115.15 125.97 54.07 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 122.654 -0.321 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.453 ' C ' HD11 ' A' ' 120' ' ' LEU . 84.1 mm-40 -113.96 -87.36 0.57 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.453 HD11 ' C ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -162.15 161.49 28.08 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.247 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 88.7 mt -92.72 131.62 37.63 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.86 179.46 16.42 Favored Glycine 0 C--N 1.269 -3.154 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.417 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -102.87 -9.78 19.61 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.915 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.5 mm -122.66 121.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.059 0.457 . . . . 0.0 109.969 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -104.58 29.23 6.31 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.799 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -163.77 176.86 9.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.042 0.449 . . . . 0.0 111.39 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -141.97 126.94 18.31 Favored 'General case' 0 C--O 1.199 -1.583 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -104.11 147.74 27.07 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 118.555 0.616 . . . . 0.0 111.671 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.5 m -84.83 103.07 13.58 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.843 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.24 -167.95 1.47 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.3 p -64.55 -44.15 91.68 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.066 1.346 . . . . 0.0 110.745 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.56 -38.02 77.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.966 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.14 -115.11 0.7 Allowed Glycine 0 CA--C 1.486 -1.721 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.491 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 91.9 m95 -95.95 129.68 43.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.0 p -67.67 -26.93 66.44 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.604 0.762 . . . . 0.0 112.584 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -137.91 169.26 18.09 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -101.88 -171.75 2.03 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 123.824 0.703 . . . . 0.0 109.556 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.6 mt -74.98 113.2 22.44 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.586 0.354 . . . . 0.0 110.655 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 9.7 Cg_endo -66.48 141.17 60.24 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.399 2.066 . . . . 0.0 110.771 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.0 mm -92.66 119.73 40.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.446 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.9 m -64.59 118.85 9.44 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.529 0.518 . . . . 0.0 109.8 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 141' ' ' CYS . 11.7 mm-40 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.5 m -79.49 129.67 34.69 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.956 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.01 35.48 1.72 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.0 110.566 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -160.0 152.89 21.51 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.585 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -71.1 149.42 94.58 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 124.26 0.975 . . . . 0.0 108.969 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.33 131.54 45.77 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.541 2.161 . . . . 0.0 111.821 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 116.79 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.736 2.291 . . . . 0.0 112.311 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -61.49 127.14 30.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.29 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -81.36 153.64 26.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.831 -170.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -72.21 -24.87 61.47 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -128.35 7.45 5.89 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.3 mp0 -137.45 164.48 28.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.117 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.82 150.51 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -71.54 142.96 50.08 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.302 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.5 p -103.42 108.25 19.42 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.98 -164.71 25.51 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -138.93 98.72 3.6 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 48.8 m95 -92.82 144.21 25.51 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.15 31.06 0.34 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.24 161.27 36.68 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.681 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -93.85 -26.67 16.81 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.099 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -116.64 110.26 18.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.822 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -110.06 139.33 21.26 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.5 Cg_endo -60.62 146.24 97.44 Favored 'Trans proline' 0 C--O 1.254 1.299 0 C-N-CA 123.202 2.601 . . . . 0.0 112.971 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.0 138.03 57.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.1 7.22 56.43 Favored Glycine 0 N--CA 1.427 -1.96 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.287 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 98.5 m -88.16 112.03 22.27 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -84.2 140.22 31.86 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.276 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.57 56.57 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.2 mt -98.98 131.09 46.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 80.5 m-85 -115.73 138.95 50.62 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.672 0.748 . . . . 0.0 112.851 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -91.49 133.48 35.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.668 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.9 m -72.55 10.86 0.73 Allowed 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 66.77 154.78 0.13 Allowed Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.19 0.596 . . . . 0.0 111.219 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.62 98.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.117 1.878 . . . . 0.0 112.134 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 130.92 -13.65 5.52 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.391 -0.909 . . . . 0.0 114.212 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.668 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 82.2 m-85 -115.19 168.5 9.89 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.373 -1.075 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -146.49 169.38 19.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -165.79 -10.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 123.816 0.697 . . . . 0.0 110.023 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.2 tp 75.15 -52.56 0.66 Allowed 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.425 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.8 20.35 39.1 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 61.76 -167.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.16 0.984 . . . . 0.0 110.867 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.502 HG22 ' SG ' ' A' ' 80' ' ' CYS . 69.4 t -118.31 123.82 72.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 168.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -117.64 122.21 69.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.417 ' HE1' ' HB3' ' A' ' 71' ' ' TRP . 88.1 mtp -108.17 178.0 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -161.98 143.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.074 0.464 . . . . 0.0 110.403 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 t -70.38 125.19 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.919 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -152.69 119.18 5.62 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 120.634 0.254 . . . . 0.0 110.755 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 62.23 23.17 13.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.11 -20.0 51.89 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.458 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.74 154.11 20.94 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.05 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 64' ' ' MET . 82.4 m95 -88.22 116.47 26.44 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.06 172.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.57 124.69 35.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.93 -51.21 34.77 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -114.0 89.54 17.01 Favored Pre-proline 0 N--CA 1.426 -1.634 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.786 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.58 -25.41 15.01 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 122.378 2.052 . . . . 0.0 110.629 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.05 -25.69 64.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.138 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.3 mmp_? -85.28 138.38 32.35 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.3 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -161.6 144.57 12.22 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 62' ' ' VAL . 73.9 m -86.01 109.18 18.62 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-O 121.79 0.805 . . . . 0.0 111.776 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -106.39 167.14 10.04 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.174 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 98.8 mttt -62.24 135.26 57.4 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 123.29 0.369 . . . . 0.0 111.503 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.7 ptp180 -80.4 146.19 61.17 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.74 142.96 10.48 Favored 'Trans proline' 0 N--CA 1.424 -2.576 0 C-N-CA 121.675 1.583 . . . . 0.0 112.336 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.5 m -84.33 -30.77 25.24 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.93 104.44 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 O-C-N 124.237 0.961 . . . . 0.0 115.072 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.8 t60 64.02 111.33 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 123.858 0.863 . . . . 0.0 111.993 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 127' ' ' ARG . 88.0 Cg_endo -81.47 43.13 1.47 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 123.635 2.89 . . . . 0.0 112.506 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.496 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 85.64 -171.53 45.41 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -107.67 91.58 3.71 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 m -112.61 91.31 16.82 Favored Pre-proline 0 N--CA 1.421 -1.9 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.191 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.59 -29.73 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.567 2.178 . . . . 0.0 112.679 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -110.78 146.24 36.71 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.66 178.34 36.68 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -143.2 156.8 44.84 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.671 -0.311 . . . . 0.0 110.937 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 p90 -141.35 149.56 41.31 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.226 0.536 . . . . 0.0 110.358 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.8 p -116.12 147.36 41.42 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.576 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.61 135.99 51.44 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.6 t -115.74 -4.32 12.17 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.0 16.82 10.84 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.536 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.26 32.74 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -107.32 2.83 24.8 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 117.771 0.786 . . . . 0.0 110.059 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.9 p -142.17 -164.04 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.535 -170.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -98.98 74.0 1.98 Allowed 'General case' 0 C--N 1.245 -3.938 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.59 151.75 46.03 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.883 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 73.4 t80 -47.08 117.56 1.76 Allowed 'General case' 0 C--N 1.315 -0.904 0 O-C-N 124.574 1.171 . . . . 0.0 111.759 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.42 -14.06 20.75 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.872 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -82.42 141.57 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -111.22 122.53 48.11 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.414 ' HB3' ' HG2' ' A' ' 127' ' ' ARG . . . -94.86 95.54 8.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 55.5 t -79.36 122.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 77.0 t80 -98.48 144.57 27.68 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.824 0.821 . . . . 0.0 112.063 -172.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.94 156.81 46.0 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.9 t -131.04 -68.32 0.68 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.181 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.12 -173.34 3.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -85.2 -48.6 8.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.425 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.21 -23.8 60.49 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.154 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -116.9 116.95 28.41 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 15.5 mm-40 -109.0 -80.98 0.57 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.1 pp -170.59 137.0 1.31 Allowed 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.96 -47.16 69.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.758 1.223 . . . . 0.0 112.035 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.04 174.98 48.61 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.132 -0.486 . . . . 0.0 113.743 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.62 -30.02 23.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.849 0.833 . . . . 0.0 110.146 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.18 98.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.536 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.98 20.4 2.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.147 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -154.48 -177.63 6.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.482 ' NH1' HG12 ' A' ' 138' ' ' ILE . 8.2 ptp180 -154.13 128.22 8.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 174.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 21.4 mt-10 -103.75 143.17 33.15 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 122.151 -0.343 . . . . 0.0 111.347 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.9 t -88.44 104.42 16.77 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.1 t70 -98.04 -156.55 0.55 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.0 p -70.49 -53.25 17.03 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.088 0.955 . . . . 0.0 112.064 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.82 -25.63 27.99 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.184 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.81 -156.36 28.27 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.168 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.459 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.6 m95 -78.51 142.27 37.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.813 0.445 . . . . 0.0 110.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -90.04 131.8 35.73 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 72.16 -175.46 0.17 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.773 0.829 . . . . 0.0 111.652 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -123.54 168.47 12.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' HA3' ' A' ' 89' ' ' GLY . 21.4 mt -57.04 116.11 12.45 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.411 1.085 . . . . 0.0 110.032 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 18.2 Cg_endo -64.69 138.52 59.09 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.274 1.983 . . . . 0.0 111.777 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 1.9 mp -87.06 129.13 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 0.0 110.091 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 12.1 m -63.13 113.48 3.17 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 123.782 0.833 . . . . 0.0 111.759 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.8 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' THR . 72.8 m -70.61 137.64 50.15 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.683 0.615 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -107.04 19.1 20.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.703 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.61 161.54 41.97 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.33 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 mt -78.2 150.17 77.03 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 123.401 0.68 . . . . 0.0 109.245 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.33 139.77 84.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.84 1.693 . . . . 0.0 110.022 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.55 147.02 50.85 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.036 1.824 . . . . 0.0 112.583 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -91.45 146.18 24.02 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -116.93 171.75 7.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -88.56 -39.09 14.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.984 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 p -93.57 -12.51 29.37 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 3.4 mp0 -127.48 138.29 52.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.956 0.408 . . . . 0.0 110.719 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 12.8 mt -114.74 144.19 22.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -78.72 125.27 29.14 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.7 p -86.99 -32.07 20.25 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.26 165.85 54.11 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.424 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 m -97.87 106.05 18.29 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -109.37 136.66 48.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -148.04 -20.31 0.35 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.0 152.87 18.3 Favored 'General case' 0 C--O 1.201 -1.487 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.568 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 25.5 p -120.71 139.79 52.55 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.903 -0.498 . . . . 0.0 111.74 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.74 140.91 33.33 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 122.257 0.223 . . . . 0.0 110.952 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.2 Cg_endo -60.3 145.63 98.2 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.412 2.741 . . . . 0.0 112.045 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 67' ' ' ARG . 22.6 tt0 -68.98 144.13 54.21 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.21 0.09 54.27 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -86.68 111.21 20.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -86.4 147.89 25.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.26 120.79 37.12 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.59 119.13 40.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.337 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 58.9 m-85 -95.39 143.8 26.45 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.89 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 5.0 tppp? -89.45 126.98 35.78 Favored 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 64.6 m -79.95 21.49 0.56 Allowed 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' LYS . 18.8 mtp180 63.4 157.87 0.12 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 123.87 0.868 . . . . 0.0 112.273 -176.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.13 -2.35 8.73 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.026 1.817 . . . . 0.0 113.766 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -105.39 -1.64 40.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.882 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.6 m-85 -128.14 178.16 6.42 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.435 -1.038 . . . . 0.0 108.949 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -155.53 177.71 11.06 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -169.02 171.69 8.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.92 -35.55 20.44 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.28 143.63 15.36 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.45 160.41 32.78 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.478 0.639 . . . . 0.0 111.426 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.98 105.11 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mm -104.66 116.93 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.263 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.4 mtp -105.52 172.32 6.86 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.606 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.0 p -159.47 148.88 7.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.25 0.548 . . . . 0.0 110.559 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.41 117.37 12.87 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.459 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 44' ' ' GLU . 5.4 tpm_? -146.63 123.07 11.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.09 25.69 14.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 0.0 113.19 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.25 -11.5 70.38 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.802 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.25 166.11 11.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.473 0.654 . . . . 0.0 110.644 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -106.46 106.74 17.4 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 -161.52 0.3 Allowed 'Isoleucine or valine' 1 N--CA 1.37 -4.472 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.19 126.6 36.32 Favored 'General case' 1 C--N 1.228 -4.705 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.069 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.23 -57.8 3.63 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.439 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 13.0 t-20 -116.5 102.56 53.35 Favored Pre-proline 0 N--CA 1.419 -1.998 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.537 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.45 -0.89 11.09 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 122.976 2.451 . . . . 0.0 112.989 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 mt -89.8 -26.5 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.859 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 34.9 mmt180 -85.28 147.75 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.227 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.58 163.15 40.65 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.95 111.38 23.63 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.37 151.05 22.37 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.357 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.8 mttt -65.24 129.03 38.24 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.2 ptp180 -71.74 137.37 82.83 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.077 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 143.66 76.57 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 122.711 2.274 . . . . 0.0 110.728 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.2 m -101.17 -13.76 18.0 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.24 -173.27 55.28 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.111 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.512 ' HD2' ' O ' ' A' ' 89' ' ' GLY . 32.9 t60 -72.26 134.13 82.9 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.91 65.78 4.06 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.025 2.483 . . . . 0.0 111.894 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 87' ' ' HIS . . . 74.42 -95.33 0.86 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -178.94 138.53 0.15 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' HG22 ' A' ' 138' ' ' ILE . 96.4 m -144.82 99.86 4.69 Favored Pre-proline 0 C--N 1.286 -2.172 0 CA-C-O 121.127 0.489 . . . . 0.0 111.612 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.2 -50.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.554 1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 114.88 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -81.46 -34.42 31.41 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.828 -0.545 . . . . 0.0 111.191 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 150.56 30.68 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 m -111.35 -42.74 3.83 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 117.42 0.61 . . . . 0.0 110.696 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.2 p90 64.44 152.19 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.963 1.705 . . . . 0.0 115.11 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 p -124.13 143.64 50.36 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -103.82 137.04 42.4 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.456 HG23 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -119.29 -22.26 7.18 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.89 44.31 1.51 Allowed Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.09 20.16 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -128.35 15.89 6.61 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.92 178.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -93.32 85.98 5.16 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.18 145.59 50.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.576 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.448 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 63.8 t80 -46.47 126.82 8.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.25 -5.93 55.79 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.935 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.58 131.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.644 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.456 ' HB3' HG23 ' A' ' 99' ' ' THR . 40.7 ttmt -100.29 127.57 46.55 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 98.21 8.18 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.41 115.75 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 4.9 t80 -82.96 94.55 7.77 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.647 0.737 . . . . 0.0 110.678 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 p -105.82 151.13 24.9 Favored 'General case' 0 N--CA 1.402 -2.848 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.466 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.85 -166.14 1.17 Allowed 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.201 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -61.82 156.52 20.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.58 -42.43 11.13 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.609 1.564 . . . . 0.0 114.246 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.94 10.34 74.24 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.356 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -114.46 167.69 10.51 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.788 0.794 . . . . 0.0 111.738 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -133.45 -140.21 0.19 Allowed 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 102.539 -3.134 . . . . 0.0 102.539 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' CD1' ' HB2' ' A' ' 139' ' ' PRO . 1.3 pt? -160.28 152.78 20.88 Favored 'General case' 1 N--CA 1.335 -6.178 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.43 126.83 31.69 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.95 163.23 9.43 Favored Glycine 0 N--CA 1.402 -3.582 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.62 -24.58 14.09 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.276 1.036 . . . . 0.0 108.344 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.6 mm -102.48 101.64 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.498 ' HA ' HD11 ' A' ' 120' ' ' LEU . 30.3 p-10 -89.19 33.61 0.8 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.657 0.741 . . . . 0.0 111.269 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -165.18 171.24 13.96 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.398 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 124.87 14.73 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.122 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -99.04 142.37 30.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.6 t -82.12 126.57 32.18 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.01 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.8 t70 -117.28 -166.45 1.18 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.467 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.8 p -60.15 -48.74 80.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 124.894 1.278 . . . . 0.0 113.616 -172.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.65 -24.81 18.54 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.38 0.609 . . . . 0.0 111.515 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.37 -155.48 25.73 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -77.87 144.77 36.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.5 p -63.97 -34.85 78.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.858 0.837 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -138.48 152.43 48.28 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.28 2.5 p30 -82.36 -94.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.479 HG22 ' OG1' ' A' ' 91' ' ' THR . 7.3 mt -133.61 98.19 15.17 Favored Pre-proline 0 C--N 1.292 -1.91 0 O-C-N 121.573 -0.704 . . . . 0.0 109.672 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.499 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 1.1 Cg_endo -51.78 141.43 44.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 166.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.98 115.18 26.86 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.684 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.53 120.66 9.83 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 122.266 0.226 . . . . 0.0 110.914 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 121.649 0.738 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.2 142.82 32.82 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.89 16.4 15.18 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 122.153 0.978 . . . . 0.0 108.609 173.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.45 163.18 34.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.8 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 37' ' ' TRP . 21.5 mt -91.51 154.96 44.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 123.699 0.8 . . . . 0.0 111.005 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -64.79 130.9 27.45 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.224 1.949 . . . . 0.0 110.511 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.25 146.32 90.05 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.153 1.902 . . . . 0.0 111.358 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.45 146.91 23.32 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.53 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.4 mpt_? -104.22 174.86 5.69 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.515 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -82.3 -34.88 28.45 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -100.38 -5.12 27.73 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 1.5 mp0 -133.06 145.81 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.58 153.9 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.42 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -74.82 143.05 44.13 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 123.846 0.716 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 49' ' ' ILE . 17.0 p -80.33 -52.53 7.59 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.489 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.23 177.62 54.13 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.625 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -95.23 127.75 41.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 75.6 m95 -124.31 103.78 8.41 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.6 m -121.65 7.67 10.01 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.753 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 40' ' ' GLN . 8.5 t70 -119.52 -158.41 0.73 Allowed 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.444 ' HG3' HG22 ' A' ' 41' ' ' THR . 2.8 pt20 -142.24 -36.92 0.4 Allowed 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -97.23 103.81 15.77 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.657 0.742 . . . . 0.0 111.658 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -117.63 145.45 36.41 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.049 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.22 140.47 92.28 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 123.323 2.682 . . . . 0.0 112.132 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.6 tt0 -64.97 138.1 58.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.04 6.6 53.75 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 m -86.14 117.93 25.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -82.95 146.49 28.78 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.607 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.95 113.65 24.42 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.471 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 mt -88.4 129.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.6 m-85 -103.17 136.34 43.14 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 122.395 1.093 . . . . 0.0 113.038 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -75.7 -20.15 58.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.065 -1.88 . . . . 0.0 112.967 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.8 m 65.88 7.29 4.51 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 57.5 mtp180 68.45 165.82 0.13 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 55.1 Cg_endo -71.02 -22.16 26.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 120.956 1.104 . . . . 0.0 112.903 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.12 -17.93 48.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.745 -0.74 . . . . 0.0 114.467 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.2 m-85 -118.47 167.21 11.81 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -161.67 -175.42 4.72 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 0.0 109.898 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -166.84 -177.88 4.04 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.72 69.87 0.99 Allowed 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.064 0.935 . . . . 0.0 108.987 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.78 -21.21 0.6 Allowed Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.65 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.1 m120 72.33 149.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.619 1.168 . . . . 0.0 110.598 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.477 HG23 ' SG ' ' A' ' 80' ' ' CYS . 73.3 t -70.51 110.41 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.77 116.08 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.6 mtp -103.45 174.04 6.04 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -161.64 150.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.14 0.495 . . . . 0.0 109.832 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.19 127.41 35.74 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.427 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 49.0 ttp180 -149.83 131.87 15.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 65.51 20.58 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.916 0.486 . . . . 0.0 112.305 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.11 -13.73 66.96 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.663 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.99 159.19 16.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.356 0.598 . . . . 0.0 111.697 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -99.43 109.71 22.26 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.18 -156.07 0.17 Allowed 'Isoleucine or valine' 1 N--CA 1.363 -4.78 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.678 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.47 134.79 45.22 Favored 'General case' 1 C--N 1.223 -4.921 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -168.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.12 -58.81 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -117.6 88.83 30.72 Favored Pre-proline 0 N--CA 1.433 -1.309 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.89 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.24 -14.46 25.66 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.37 2.047 . . . . 0.0 110.688 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.68 -28.27 62.6 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.834 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -93.55 132.74 37.56 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.944 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.0 155.54 44.68 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 62' ' ' VAL . 36.0 m -94.31 116.22 28.57 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.538 0.685 . . . . 0.0 109.933 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -111.0 177.11 4.77 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.976 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.2 mmtp -57.21 145.22 32.31 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.867 0.729 . . . . 0.0 109.754 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -85.66 131.61 46.95 Favored Pre-proline 0 C--N 1.279 -2.472 0 C-N-CA 118.906 -1.118 . . . . 0.0 108.693 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 139.43 39.6 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.415 2.076 . . . . 0.0 110.089 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.7 m -101.04 -2.82 30.62 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.66 -96.75 1.89 Allowed Glycine 0 C--N 1.308 -0.984 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.597 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -143.85 125.54 8.24 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.8 Cg_exo -68.89 -53.78 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.666 2.244 . . . . 0.0 111.726 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.73 166.69 18.3 Favored Glycine 0 N--CA 1.419 -2.46 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.338 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.45 109.58 20.89 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -92.33 131.96 33.27 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.24 -31.75 52.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.75 139.96 52.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.578 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . 71.61 -165.4 53.66 Favored Glycine 0 C--N 1.304 -1.214 0 O-C-N 123.961 0.788 . . . . 0.0 113.351 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.442 ' HG1' ' C ' ' A' ' 94' ' ' GLY . 23.7 m -155.54 170.07 22.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CZ ' ' HG2' ' A' ' 88' ' ' PRO . 45.7 p90 -104.7 160.68 14.78 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.934 -0.479 . . . . 0.0 109.784 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -115.59 144.86 43.28 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -106.22 135.01 48.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 100' ' ' GLY 0.25 3.8 t -87.42 -86.01 0.16 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.496 ' H ' HG23 ' A' ' 99' ' ' THR . . . -87.02 52.77 4.43 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 118.15 0.432 . . . . 0.0 113.053 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.5 162.66 17.2 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -121.75 15.12 10.97 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.711 0.767 . . . . 0.0 109.102 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.9 175.35 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -93.55 88.55 5.93 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.0 pt-20 -133.25 154.85 50.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -50.05 119.54 3.69 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.537 0.684 . . . . 0.0 111.802 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.88 -19.76 18.04 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.839 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 105' ' ' GLU . 2.8 p -85.36 141.32 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HB2' ' HZ3' ' A' ' 109' ' ' LYS . 4.9 ttmp? -111.46 128.26 55.95 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.04 100.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.83 118.26 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.604 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -77.82 109.88 12.21 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.64 0.733 . . . . 0.0 110.616 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.17 109.15 12.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.03 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.578 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 97.7 m -129.84 111.07 12.23 Favored 'General case' 0 C--N 1.253 -3.628 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.76 -168.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 19.4 m120 57.25 -162.09 0.2 Allowed 'General case' 0 C--O 1.247 0.941 0 O-C-N 124.448 1.093 . . . . 0.0 112.744 172.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -121.48 -46.73 2.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.19 0.519 . . . . 0.0 110.477 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.47 72.82 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 68.8 m-85 -98.6 155.09 17.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -136.99 -88.46 0.28 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.4 pp 178.44 148.87 0.2 Allowed 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 123.895 0.747 . . . . 0.0 112.14 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.24 135.22 44.22 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.025 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.41 161.13 10.92 Favored Glycine 0 C--N 1.281 -2.516 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.82 -18.99 26.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.434 0.635 . . . . 0.0 109.838 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.444 HG13 ' ND2' ' A' ' 136' ' ' ASN . 41.1 mm -113.54 121.24 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.966 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -92.31 24.63 3.3 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.723 0.809 . . . . 0.0 111.557 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.519 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 38.0 p90 -163.04 178.45 8.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -151.39 128.2 10.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.649 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.0 mt-10 -103.82 154.42 19.62 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.2 t -92.44 105.65 17.8 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.251 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.35 175.48 7.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.574 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 73.8 p -52.46 -33.79 46.06 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.521 1.528 . . . . 0.0 112.444 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.15 -32.53 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.407 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.31 -159.48 28.89 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 95.2 m95 -67.74 128.92 38.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.314 0.578 . . . . 0.0 112.087 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.8 p -78.72 157.25 28.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.721 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.444 ' ND2' HG13 ' A' ' 124' ' ' ILE . 11.4 m120 65.82 -162.56 0.25 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -119.26 -163.1 0.95 Allowed 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.54 110.04 60.71 Favored Pre-proline 0 C--N 1.285 -2.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.76 137.91 82.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.959 1.773 . . . . 0.0 110.501 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 47.9 mm -89.33 103.91 14.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.14 111.18 1.42 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.253 0.549 . . . . 0.0 110.551 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.422 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 8.8 tp10 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.089 0.471 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.9 m -78.73 133.57 37.14 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.756 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.06 25.02 10.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.444 0.64 . . . . 0.0 110.096 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.42 155.19 38.1 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.851 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 32.0 mt -76.9 158.8 79.92 Favored Pre-proline 0 C--N 1.31 -1.13 0 O-C-N 123.738 0.649 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 141.4 74.23 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.319 2.012 . . . . 0.0 110.09 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.96 118.03 4.65 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 121.52 1.48 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -62.38 135.98 57.7 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.496 0.665 . . . . 0.0 110.194 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -85.94 176.89 7.81 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.769 -167.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -82.98 -24.1 33.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.963 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 p -132.29 10.27 4.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.92 0.391 . . . . 0.0 111.388 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 2.7 mp0 -133.7 158.78 42.42 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -133.34 163.42 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -85.58 156.65 20.64 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-O 120.81 0.338 . . . . 0.0 110.573 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -130.54 95.57 3.91 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 -149.5 15.38 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.2 m -131.13 117.79 19.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 117.836 0.818 . . . . 0.0 109.45 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.423 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 55.3 m95 -134.17 101.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.908 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.2 t -147.4 34.81 0.87 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 5.2 t70 -128.11 -163.86 1.31 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.588 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.93 -49.3 1.23 Allowed 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 70.1 p -95.43 127.12 41.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.73 136.98 26.4 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.857 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 37.4 Cg_endo -65.09 153.62 77.39 Favored 'Trans proline' 0 C--O 1.262 1.712 0 C-N-CA 122.825 2.35 . . . . 0.0 112.106 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.7 tt0 -67.49 139.99 57.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.97 2.2 55.0 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.202 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.427 ' C ' HG22 ' A' ' 65' ' ' VAL . 89.6 m -84.54 115.0 22.37 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -83.16 139.82 32.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.557 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.18 108.68 20.24 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.0 mt -87.71 115.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.799 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 84.6 m-85 -95.96 149.05 22.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.371 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.46 130.94 39.1 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.8 t -87.18 102.41 14.44 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -32.81 144.21 0.14 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.981 1.712 . . . . 0.0 113.623 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -56.52 111.19 0.71 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 123.423 2.749 . . . . 0.0 112.534 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.96 -19.86 5.16 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -111.88 166.62 11.05 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.578 -0.811 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -155.54 167.27 30.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.925 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -174.64 126.11 0.3 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.7 77.59 5.18 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.403 0.62 . . . . 0.0 110.697 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.01 -29.83 1.23 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 70.67 158.49 0.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.412 1.085 . . . . 0.0 112.859 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.88 110.93 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.43 121.43 67.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -109.4 176.52 5.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 HG22 ' C ' ' A' ' 46' ' ' THR . 9.9 p -159.97 142.92 5.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.139 0.495 . . . . 0.0 110.668 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.79 121.97 18.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.905 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttm180 -152.57 117.87 5.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.589 0.233 . . . . 0.0 110.527 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 40.3 mmtm 69.2 25.05 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.593 1.157 . . . . 0.0 112.826 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.38 -12.82 67.57 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.075 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.22 154.13 31.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -87.64 118.21 26.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.0 175.04 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.742 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.52 122.28 31.03 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.001 0.429 . . . . 0.0 111.258 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.08 -57.4 3.86 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.88 91.29 8.78 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.198 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.92 -15.44 16.63 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.476 2.118 . . . . 0.0 112.647 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 -28.94 59.98 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.672 0.749 . . . . 0.0 109.723 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -84.23 134.49 34.54 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.028 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -154.48 160.86 41.82 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 16.9 m -79.81 112.94 17.58 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-O 121.777 0.798 . . . . 0.0 112.312 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.48 153.14 23.27 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.35 146.38 43.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.818 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.12 145.66 49.69 Favored Pre-proline 0 N--CA 1.417 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.887 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.83 153.51 48.05 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 N-CA-C 108.03 -1.566 . . . . 0.0 108.03 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.1 m -91.3 -24.11 19.93 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.677 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.01 -115.52 3.99 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -146.09 131.31 9.13 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.94 34.41 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 123.015 2.476 . . . . 0.0 113.349 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.96 155.5 27.8 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.66 84.38 2.12 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 t -73.58 136.78 77.61 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.872 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.97 -28.46 19.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.172 1.915 . . . . 0.0 111.71 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.31 121.44 34.99 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 173.01 16.56 Favored Glycine 0 N--CA 1.424 -2.145 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 m -154.66 171.72 19.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -136.41 157.66 46.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.65 ' OG1' HG11 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -126.25 155.3 42.1 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.26 131.49 56.93 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.4 t -125.98 144.43 50.7 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.06 68.99 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.86 168.09 25.35 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -112.91 9.51 18.87 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.006 0.908 . . . . 0.0 108.963 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.3 p -136.19 -167.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.712 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.043 -173.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -105.46 101.48 11.01 Favored 'General case' 1 C--N 1.241 -4.109 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.163 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -156.37 152.86 28.08 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.536 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.8 t80 -54.07 114.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.94 0 O-C-N 124.021 0.826 . . . . 0.0 111.168 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.84 -19.81 5.2 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.576 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 103' ' ' VAL . 15.8 m -79.93 149.36 5.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.505 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.405 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.0 ttmp? -107.51 118.26 36.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.36 94.27 9.83 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.65 HG11 ' OG1' ' A' ' 97' ' ' THR . 2.7 p -89.33 121.23 39.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.515 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -84.23 141.41 31.02 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.333 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -141.73 163.89 31.68 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.22 -59.64 0.06 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 118.972 0.805 . . . . 0.0 111.736 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -147.26 -170.76 3.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.0 -51.04 3.8 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 123.882 0.873 . . . . 0.0 109.861 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.1 8.49 70.27 Favored Glycine 0 C--O 1.24 0.503 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.99 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -133.83 129.53 36.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.42 -135.78 0.2 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 167.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 125' ' ' ASN . 1.0 OUTLIER -153.23 153.57 32.96 Favored 'General case' 1 N--CA 1.334 -6.243 0 C-N-CA 118.991 -1.083 . . . . 0.0 108.411 -175.69 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.5 mm? -77.77 125.89 30.03 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-O 121.475 0.655 . . . . 0.0 109.431 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.25 150.14 7.38 Favored Glycine 0 C--N 1.273 -2.947 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.56 -22.76 22.23 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 122.162 0.982 . . . . 0.0 109.149 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.93 109.4 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.869 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HA ' HD12 ' A' ' 120' ' ' LEU . 32.0 p-10 -86.14 33.67 0.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.779 0.8 . . . . 0.0 110.863 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 50.1 p90 -167.07 176.52 6.82 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.95 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.85 119.42 7.97 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 23.6 mt-10 -87.76 155.39 19.93 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 52.4 t -75.38 139.46 42.39 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.42 167.47 12.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.502 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.5 p -55.87 -28.5 56.81 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.791 1.637 . . . . 0.0 112.894 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -108.43 -28.93 9.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.244 0.545 . . . . 0.0 111.555 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.7 -106.24 0.19 Allowed Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.964 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -127.54 145.35 50.89 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -74.59 -26.79 60.16 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -128.12 170.02 13.43 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -99.28 -170.14 1.87 Allowed 'General case' 0 C--N 1.285 -2.212 0 O-C-N 124.055 0.847 . . . . 0.0 110.365 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.43 113.1 53.91 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-O 120.365 0.126 . . . . 0.0 110.694 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB2' HD11 ' A' ' 120' ' ' LEU . 11.2 Cg_endo -70.24 152.94 67.1 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 122.601 2.2 . . . . 0.0 110.287 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.26 125.96 72.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 12.3 p -76.96 108.54 10.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.476 ' HB2' HD23 ' A' ' 121' ' ' LEU . 28.3 mt-10 . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 125.678 1.591 . . . . 0.0 107.166 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 121.72 0.771 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.0 m -76.02 140.33 41.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.024 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.85 20.02 19.61 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.602 0.715 . . . . 0.0 109.915 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.1 155.95 40.76 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -88.53 158.41 48.55 Favored Pre-proline 1 N--CA 1.367 -4.577 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.248 -176.966 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 13.2 Cg_endo -58.34 130.04 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.541 2.827 . . . . 0.0 111.829 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.14 122.86 5.89 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.526 2.15 . . . . 0.0 112.597 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.74 154.23 41.24 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.975 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -117.08 176.14 5.27 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.74 -23.35 64.32 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.253 0.549 . . . . 0.0 111.517 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 p -119.02 7.13 11.35 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.9 141.7 42.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.35 0.595 . . . . 0.0 112.148 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.95 151.92 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.526 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 3.6 mm? -67.84 155.52 39.17 Favored 'General case' 0 C--N 1.267 -2.981 0 O-C-N 123.629 0.581 . . . . 0.0 111.233 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 p -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.389 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 -163.4 38.84 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.782 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -121.09 108.21 13.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 18.7 m95 -107.52 88.16 2.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -104.11 4.74 34.54 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.774 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 40' ' ' GLN . 9.2 t70 -103.02 -150.02 0.41 Allowed 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.279 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 39.6 mt-30 -134.08 -57.8 0.86 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 69.8 p -88.03 122.12 31.25 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.171 -172.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -129.51 138.95 34.26 Favored Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.482 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.43 143.76 99.61 Favored 'Trans proline' 0 C--O 1.245 0.875 0 C-N-CA 123.316 2.677 . . . . 0.0 113.237 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 48.1 tt0 -63.6 131.65 48.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.965 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.36 4.59 46.83 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.444 ' C ' HG21 ' A' ' 65' ' ' VAL . 58.0 m -86.02 115.53 23.67 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -84.45 142.23 30.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.365 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.46 124.15 51.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -94.12 132.04 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -110.19 144.47 38.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -93.75 142.23 27.6 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.729 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 m -84.51 22.36 1.3 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 64.83 162.26 0.12 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.347 0.659 . . . . 0.0 110.112 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.63 112.5 3.38 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 120.509 0.806 . . . . 0.0 110.536 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.57 -26.22 6.04 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.333 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.729 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 89.5 m-85 -102.59 163.51 12.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.861 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -140.55 -178.79 5.68 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -143.67 -177.0 5.19 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.76 6.03 36.49 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.13 0.491 . . . . 0.0 109.745 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.04 -115.93 0.34 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -138.78 122.86 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' SG ' ' A' ' 80' ' ' CYS . 60.7 t -84.08 110.38 18.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.06 130.44 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.401 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -111.03 175.13 5.54 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG21 ' C ' ' A' ' 46' ' ' THR . 11.2 p -157.71 143.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-O 121.33 0.586 . . . . 0.0 111.275 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.8 t -75.31 123.85 26.06 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.474 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 70.0 ttt180 -155.53 134.24 11.92 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 62.61 21.04 12.44 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.736 0.814 . . . . 0.0 112.369 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.65 69.36 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.675 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -121.36 159.87 25.21 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.571 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.19 117.6 29.07 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.689 0.756 . . . . 0.0 110.36 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.73 169.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.022 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.69 125.77 35.0 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.84 -56.78 6.87 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 8.9 t-20 -120.88 100.66 46.03 Favored Pre-proline 0 N--CA 1.413 -2.299 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.271 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.66 -5.65 17.15 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.912 2.408 . . . . 0.0 112.779 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.5 mt -88.91 -20.46 24.51 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 122.164 0.983 . . . . 0.0 110.827 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.511 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 31.7 mmt180 -91.15 132.15 36.25 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.42 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -149.41 158.93 44.6 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 62' ' ' VAL . 81.7 m -97.66 107.23 19.68 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.058 0.932 . . . . 0.0 110.276 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.51 168.83 9.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.954 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.0 mttt -66.71 144.86 56.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -85.44 139.58 36.03 Favored Pre-proline 0 N--CA 1.427 -1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -68.81 140.45 46.41 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.351 1.368 . . . . 0.0 108.84 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.7 m -74.43 -38.33 63.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.291 0.567 . . . . 0.0 110.495 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.94 -86.03 0.38 Allowed Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -174.64 120.47 0.35 Allowed Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 123.33 0.652 . . . . 0.0 109.325 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.06 157.15 62.86 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.567 2.178 . . . . 0.0 109.011 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.07 138.42 26.72 Favored Glycine 0 N--CA 1.438 -1.209 0 O-C-N 123.955 0.784 . . . . 0.0 112.218 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.76 137.52 37.24 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.1 0.476 . . . . 0.0 109.909 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -126.15 141.19 38.98 Favored Pre-proline 0 N--CA 1.404 -2.733 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.834 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.13 -29.89 9.36 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.17 1.913 . . . . 0.0 110.8 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.72 109.67 16.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.73 157.0 9.57 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.296 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 m -137.92 164.5 28.86 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.7 p90 -129.5 155.78 45.2 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.027 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 42.1 p -100.64 164.83 11.7 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.945 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 93.3 mt -130.85 123.43 29.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.0 t -129.91 20.91 5.43 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.463 0.649 . . . . 0.0 112.653 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.23 33.23 1.83 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 105' ' ' GLU . . . 147.57 -151.57 23.81 Favored Glycine 0 N--CA 1.413 -2.877 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -175.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.76 3.24 1.25 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.406 0.603 . . . . 0.0 111.533 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.26 -172.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -85.2 95.47 9.18 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 108' ' ' VAL . 12.0 pt-20 -137.83 145.83 42.73 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.343 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 47.0 t80 -49.21 123.86 8.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.342 0.591 . . . . 0.0 111.766 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.52 58.54 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.864 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 105' ' ' GLU . 5.8 p -91.8 136.25 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.3 ttmt -101.62 132.26 47.39 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -109.11 101.9 10.91 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -88.45 132.19 34.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 119.401 -0.92 . . . . 0.0 108.828 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.413 ' HH ' ' HB2' ' A' ' 141' ' ' CYS . 5.9 t80 -98.31 123.97 42.69 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.555 0.693 . . . . 0.0 109.372 -173.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.0 m -144.34 158.32 43.8 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 71.5 m -125.41 -61.71 1.25 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.405 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -151.92 -166.06 2.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.45 -56.33 10.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.004 0.43 . . . . 0.0 111.05 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.1 -13.71 61.65 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.42 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.513 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -93.75 115.04 27.44 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.242 0.544 . . . . 0.0 111.548 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -113.08 -117.91 0.31 Allowed 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -165.69 156.66 13.68 Favored 'General case' 1 N--CA 1.354 -5.264 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.463 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -79.57 125.63 29.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.8 152.75 7.25 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.65 -10.32 32.21 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.126 0.489 . . . . 0.0 110.839 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -111.39 106.72 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.495 ' HA ' HD12 ' A' ' 120' ' ' LEU . 27.5 p-10 -90.62 34.96 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.421 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 42.0 p90 -163.63 169.22 18.89 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.45 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -132.39 134.75 45.53 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.421 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 41.3 mt-10 -114.28 130.51 56.65 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 18.7 t -79.32 114.15 18.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -105.45 -162.28 0.86 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.3 p -62.57 -42.76 99.75 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.12 -10.86 15.76 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.0 -163.22 34.15 Favored Glycine 0 CA--C 1.49 -1.496 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.837 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -82.91 144.06 30.3 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 117.143 0.472 . . . . 0.0 110.255 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -70.5 -20.79 62.82 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.235 0.541 . . . . 0.0 112.422 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -137.83 148.63 45.63 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -89.84 -103.14 0.09 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.654 0.596 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.7 mt -127.17 96.38 34.22 Favored Pre-proline 0 C--N 1.31 -1.151 0 O-C-N 120.782 -1.199 . . . . 0.0 111.754 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.482 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 6.5 Cg_endo -56.92 136.11 74.66 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 122.447 2.098 . . . . 0.0 108.575 167.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 140' ' ' ILE . 3.5 mp -87.15 115.86 28.56 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.963 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.83 -171.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.413 ' HB2' ' HH ' ' A' ' 112' ' ' TYR . 48.6 t -52.02 112.81 0.85 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.513 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 35.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.275 1.43 . . . . 0.0 109.481 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.673 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.0 m-20 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.31 0.576 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 84.9 m -77.19 139.75 39.97 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.314 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.64 25.86 10.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.732 0.777 . . . . 0.0 109.164 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.57 155.35 33.2 Favored 'General case' 0 CA--C 1.468 -2.199 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -86.88 156.98 55.11 Favored Pre-proline 1 N--CA 1.336 -6.161 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.528 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.1 Cg_endo -54.14 125.35 18.52 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.083 2.522 . . . . 0.0 110.99 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.46 110.85 3.18 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.499 1.466 . . . . 0.0 112.118 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.276 0.0 OUTLIER -72.14 161.24 31.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.081 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 72.1 mtp180 -122.93 -174.03 2.84 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -168.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -90.47 -14.33 32.99 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -99.9 -33.88 10.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.734 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 25.5 mp0 -121.04 145.93 47.25 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.233 0.54 . . . . 0.0 112.14 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mt -119.71 144.46 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.607 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.564 HD12 ' CD1' ' A' ' 37' ' ' TRP . 25.3 mt -74.67 128.24 35.07 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -112.96 100.35 8.57 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.9 171.1 21.3 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m -105.46 110.67 23.1 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.382 0.611 . . . . 0.0 111.261 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.564 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.7 m95 -132.34 82.24 2.0 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 m -108.43 -2.29 19.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.231 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.678 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.2 t70 -93.72 -136.29 0.19 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.909 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 27.3 mt-30 -144.11 -55.43 0.36 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 27.5 p -91.85 129.05 37.89 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -133.1 135.0 24.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.099 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.673 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 17.8 Cg_endo -60.59 148.65 90.55 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.228 2.619 . . . . 0.0 113.278 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.49 134.77 55.13 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.39 14.68 37.56 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.427 ' C ' HG21 ' A' ' 65' ' ' VAL . 90.4 m -94.29 119.33 32.91 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.349 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -89.3 150.09 22.75 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.454 0.645 . . . . 0.0 111.861 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 130.97 53.48 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.7 mt -101.56 126.62 55.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 66.4 m-85 -109.49 143.31 39.29 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -92.33 129.75 38.2 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 73.5 m -70.99 7.46 1.18 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.4 mtp180 71.78 154.17 0.15 Allowed Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.618 0.767 . . . . 0.0 111.263 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.52 129.09 17.22 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.792 1.661 . . . . 0.0 109.186 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 104.69 -6.43 44.62 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.329 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 36.3 m-85 -126.39 170.65 11.73 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -160.16 177.54 10.58 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.5 p -155.37 179.97 8.66 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.72 -22.34 56.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.865 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.02 -96.59 0.14 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -155.73 155.32 32.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.603 HG21 ' SG ' ' A' ' 80' ' ' CYS . 65.9 t -77.42 106.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.63 116.77 48.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.0 mtp -107.89 167.59 9.87 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 46' ' ' THR . 7.7 p -152.79 144.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.067 0.46 . . . . 0.0 110.088 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.43 118.84 12.81 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.577 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -151.12 115.22 5.02 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 37.6 mmtm 69.24 27.98 5.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.016 . . . . 0.0 112.615 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.22 87.41 Favored Glycine 0 C--N 1.294 -1.784 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.59 152.96 38.68 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.518 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 79.9 m95 -92.77 121.22 33.94 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.2 172.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.84 119.4 21.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.82 -49.39 73.04 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.49 91.84 6.37 Favored Pre-proline 0 C--N 1.29 -1.992 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.167 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.4 -3.13 13.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 0.0 112.984 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.17 8.38 44.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.239 0.542 . . . . 0.0 109.715 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -119.23 149.08 42.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.311 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.83 161.18 28.92 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.603 ' SG ' HG21 ' A' ' 62' ' ' VAL . 71.8 m -104.26 123.94 48.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.71 0.767 . . . . 0.0 109.746 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -112.32 165.63 12.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.71 157.45 17.76 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 117.962 0.346 . . . . 0.0 110.801 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.9 ptm180 -82.22 143.91 49.54 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 41.2 Cg_endo -72.75 157.16 52.42 Favored 'Trans proline' 0 N--CA 1.424 -2.617 0 N-CA-C 108.142 -1.522 . . . . 0.0 108.142 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -103.03 6.26 38.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.646 0.736 . . . . 0.0 110.224 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 -122.07 9.94 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.892 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -130.63 120.23 18.62 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 45.5 Cg_endo -75.76 139.52 22.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.73 1.62 . . . . 0.0 108.315 172.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -48.38 128.12 18.27 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.135 0.897 . . . . 0.0 113.638 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -98.29 178.09 5.17 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -148.8 147.1 23.42 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.99 -18.52 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.739 1.626 . . . . 0.0 111.088 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.5 -25.44 28.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.424 ' C ' ' HG1' ' A' ' 95' ' ' THR . . . -146.79 -147.74 4.62 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.723 -1.227 . . . . 0.0 114.072 -175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.424 ' HG1' ' C ' ' A' ' 94' ' ' GLY . 12.8 m -154.59 -169.3 3.17 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.402 ' H ' HG23 ' A' ' 95' ' ' THR . 38.5 p90 -148.62 161.74 41.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 119.274 0.943 . . . . 0.0 109.053 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 111' ' ' VAL . 63.7 p -109.1 -176.51 3.05 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.73 164.95 29.02 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.5 t -119.88 -148.76 0.42 Allowed 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.82 74.89 0.0 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 125.746 1.641 . . . . 0.0 115.938 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.79 -41.53 0.08 OUTLIER Glycine 0 C--N 1.276 -2.783 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.06 11.96 3.71 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.27 177.19 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 40.2 m-85 -90.79 87.78 6.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.55 150.82 44.15 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.553 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -45.32 115.38 0.91 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.477 1.11 . . . . 0.0 110.835 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.7 -33.92 2.87 Favored Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.73 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.37 135.79 26.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.495 1.14 . . . . 0.0 113.424 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -93.69 118.13 31.0 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.235 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -96.62 109.21 21.87 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.566 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.2 m -86.72 158.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.465 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 51.1 t80 -119.52 132.84 55.84 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.518 0.675 . . . . 0.0 110.201 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 7.3 m -153.08 157.81 40.98 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.413 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 81.8 m -120.74 -61.87 1.52 Allowed 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.148 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -153.48 -153.0 0.44 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.57 -47.0 7.03 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.14 -29.16 69.08 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.23 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.422 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 96.1 m-85 -107.93 126.49 52.75 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.14 -74.93 0.54 Allowed 'General case' 1 CA--C 1.416 -4.179 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.269 2.3 tp -172.34 154.75 3.33 Favored 'General case' 1 N--CA 1.282 -8.852 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.541 -168.186 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.677 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 22.8 mt -129.0 130.05 46.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 132.45 -168.36 22.71 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -110.29 -40.17 4.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 117.937 0.869 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.1 mm -97.67 100.74 11.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.709 -176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.93 32.12 0.68 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 -176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 35.0 p90 -161.27 173.17 15.42 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.539 0.685 . . . . 0.0 110.262 -175.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 88' ' ' PRO . 21.7 ptt180 -147.04 134.68 21.03 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.9 mt-10 -111.86 143.48 42.74 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.648 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.74 106.13 17.45 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.207 0.527 . . . . 0.0 109.831 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 131' ' ' THR . 10.4 t70 -100.89 -166.93 1.36 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.244 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.401 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 39.8 p -62.59 -43.44 98.8 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.048 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.5 -37.87 77.37 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.66 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 138.78 -147.14 19.01 Favored Glycine 0 N--CA 1.411 -2.982 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -65.82 122.48 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 p -60.21 -33.21 71.92 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.888 0.875 . . . . 0.0 111.778 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -132.1 165.69 23.46 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 25.8 t70 -98.72 -144.82 0.32 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.415 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 11.7 mt -89.16 113.65 57.12 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 3.4 Cg_endo -65.73 161.82 37.28 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.457 2.104 . . . . 0.0 111.263 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.81 136.46 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.438 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 40.9 t -104.18 102.7 12.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 179.6 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.55 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 11.0 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' THR . 59.8 m -75.99 133.93 40.29 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.244 0.618 . . . . 0.0 109.925 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.01 36.79 2.23 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.409 0.623 . . . . 0.0 109.635 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.16 155.94 31.82 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.825 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.28 153.25 74.14 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.23 132.39 46.49 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.05 1.834 . . . . 0.0 110.657 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.33 137.58 10.6 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.254 1.969 . . . . 0.0 112.682 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -80.25 126.02 30.6 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 30.4 mtp180 -99.53 178.24 4.92 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.178 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.45 -28.03 61.74 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.168 0.985 . . . . 0.0 109.996 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.419 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 1.1 p -107.06 -31.56 8.23 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.642 -175.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.662 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 30.1 mp0 -116.34 158.76 22.93 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.4 ' HB ' ' HG2' ' A' ' 51' ' ' LYS . 14.7 mt -144.01 148.4 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 151.42 42.28 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -126.67 156.89 40.32 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.69 -156.91 18.24 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.803 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -133.66 130.6 38.46 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -134.11 139.81 46.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -154.57 -5.03 0.15 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.385 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -113.97 163.65 14.84 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.031 -172.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.542 ' HA ' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER -83.9 -47.19 11.31 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.026 178.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 34.0 p -98.52 131.75 44.5 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.964 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -130.83 135.45 27.36 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.041 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.3 Cg_endo -61.71 148.9 92.01 Favored 'Trans proline' 0 C--O 1.257 1.474 0 C-N-CA 123.198 2.599 . . . . 0.0 112.001 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.45 139.87 58.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -11.25 55.69 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.062 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -68.54 118.34 11.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -93.4 138.77 31.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.558 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.2 119.72 39.95 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.815 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -93.2 111.78 25.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.1 m-85 -101.86 144.06 30.97 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 19.4 ptpt -89.0 161.45 16.58 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.35 118.85 34.73 Favored 'General case' 1 N--CA 1.368 -4.553 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -31.55 147.31 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 124.81 1.319 . . . . 0.0 111.507 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.62 -31.33 31.49 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.409 2.739 . . . . 0.0 115.339 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.429 ' C ' ' HG2' ' A' ' 83' ' ' ARG . . . -96.2 14.54 64.33 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.514 0.508 . . . . 0.0 112.515 177.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.91 167.97 16.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.139 -0.624 . . . . 0.0 110.093 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -157.9 -177.06 6.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 109.272 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -166.65 -167.99 1.08 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mp -88.78 3.93 49.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.98 -98.87 0.12 Allowed Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -141.93 158.22 44.04 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.8 t -88.21 107.98 18.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.67 108.46 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-O 121.835 0.826 . . . . 0.0 109.832 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mtp -97.73 175.15 6.28 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -157.04 147.79 10.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.676 -175.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.37 111.21 12.8 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -141.94 119.02 11.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt 64.53 22.1 12.6 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.591 1.157 . . . . 0.0 113.068 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.32 -8.62 69.5 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.387 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.63 161.01 17.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.235 0.54 . . . . 0.0 110.481 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -104.18 106.36 16.84 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 p -127.93 -153.59 0.13 Allowed 'Isoleucine or valine' 1 N--CA 1.371 -4.42 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.82 115.03 29.08 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 3.0 tm? -59.47 -55.0 40.09 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 167.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -120.0 97.52 49.41 Favored Pre-proline 0 N--CA 1.415 -2.193 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.098 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.08 -4.82 15.62 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 123.478 2.786 . . . . 0.0 112.624 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.87 -29.35 25.34 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.901 0.858 . . . . 0.0 109.066 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -91.36 131.44 36.85 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.919 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -158.89 154.11 25.47 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.662 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 73.8 m -84.77 106.18 16.11 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 122.022 0.915 . . . . 0.0 110.593 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -98.88 161.0 13.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.55 145.36 52.65 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.633 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' ' C ' ' A' ' 55' ' ' GLY . 12.2 ptp180 -85.77 137.86 35.73 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.08 142.96 63.5 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.282 1.988 . . . . 0.0 111.034 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.79 -27.91 63.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.8 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.14 -175.7 24.07 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.55 123.94 80.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.55 42.97 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 123.749 2.966 . . . . 0.0 112.845 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.446 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 72.28 -168.1 52.66 Favored Glycine 0 N--CA 1.412 -2.96 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.97 139.01 32.32 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -116.61 145.5 35.46 Favored Pre-proline 0 C--N 1.281 -2.391 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.36 -35.08 95.71 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.953 2.436 . . . . 0.0 111.415 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.32 150.37 19.85 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.74 163.46 11.49 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.522 -0.847 . . . . 0.0 110.992 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 m -145.44 172.58 12.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.65 159.64 42.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.661 ' OG1' HG11 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -118.33 152.13 36.39 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.26 138.5 46.56 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -127.24 13.38 7.17 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.496 0.665 . . . . 0.0 111.505 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.45 15.91 4.92 Favored Glycine 0 CA--C 1.494 -1.241 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.738 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.15 -173.15 31.36 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -110.64 3.08 19.0 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.629 0.715 . . . . 0.0 109.355 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.442 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.9 p -142.72 -168.49 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.366 -170.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.9 98.93 10.51 Favored 'General case' 1 C--N 1.239 -4.219 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.618 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.44 148.54 28.2 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.573 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.508 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.5 t80 -52.81 105.6 0.13 Allowed 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.292 0.995 . . . . 0.0 112.045 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.15 -8.23 4.76 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.857 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 103' ' ' VAL . 16.3 m -90.12 143.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.356 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' ' 99' ' ' THR . 40.3 ttmt -104.84 122.05 44.94 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.8 91.33 8.58 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.661 HG11 ' OG1' ' A' ' 97' ' ' THR . 1.4 p -82.07 118.15 29.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.866 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -92.82 141.36 28.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.926 0.87 . . . . 0.0 111.604 -168.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 m -146.61 155.02 42.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.7 t -130.46 -72.7 0.56 Allowed 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 117.009 -1.876 . . . . 0.0 112.493 -172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 0.9 OUTLIER -143.67 -169.7 3.14 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -176.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -90.85 -48.05 7.25 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.79 -10.92 85.76 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.845 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 79.3 m-85 -123.52 126.48 46.78 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -104.76 -88.51 0.43 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.0 pp 175.66 143.0 0.06 Allowed 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.461 1.104 . . . . 0.0 111.212 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.19 126.92 45.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.98 172.24 12.93 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -100.05 -23.62 14.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.242 1.02 . . . . 0.0 110.08 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 126' ' ' TYR . 35.2 mm -107.29 98.76 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.82 30.73 0.31 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.849 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.497 ' O ' HG21 ' A' ' 124' ' ' ILE . 39.4 p90 -170.23 -177.49 2.51 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.93 115.74 5.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.09 143.69 33.75 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.576 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.8 t -74.61 142.09 44.63 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.029 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -124.75 -165.47 1.39 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 p -70.8 -53.32 15.81 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.967 0.889 . . . . 0.0 111.75 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -103.09 2.22 34.41 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.168 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.03 -125.47 1.03 Allowed Glycine 0 C--N 1.291 -1.947 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -127.96 162.05 27.67 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.3 p -80.91 -24.89 37.92 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -141.8 172.68 12.36 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 17.9 t70 -99.75 -161.99 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 124.135 0.897 . . . . 0.0 109.504 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.485 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 25.9 mt -83.05 124.14 76.83 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.7 138.45 34.88 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.769 1.646 . . . . 0.0 109.863 172.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 33.6 mm -86.43 118.63 33.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.986 -175.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 76.6 m -53.72 107.28 0.24 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.582 0.552 . . . . 0.0 111.326 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.425 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 34.4 m-20 . . . . . 0 C--O 1.242 0.686 0 CA-C-O 121.074 0.464 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -77.16 145.12 37.91 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -177.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.79 18.4 12.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.62 157.78 38.71 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -87.43 159.64 49.73 Favored Pre-proline 1 N--CA 1.356 -5.135 0 C-N-CA 125.1 1.36 . . . . 0.0 110.389 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.71 150.09 78.93 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.516 2.81 . . . . 0.0 111.396 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.32 169.07 17.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.195 1.93 . . . . 0.0 112.244 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -117.25 150.71 38.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.04 165.49 15.97 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.331 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.91 -39.25 26.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 5.5 p -89.98 -8.12 52.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -140.98 146.87 37.87 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.7 mt -113.43 126.55 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.058 0 CA-C-O 122.138 0.971 . . . . 0.0 109.945 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.33 113.45 11.56 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.097 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.9 p -90.28 157.31 17.73 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 -175.51 22.26 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.2 m -123.36 99.54 6.38 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.78 68.52 0.69 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 m -97.8 10.97 38.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.413 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.587 ' O ' HD23 ' A' ' 24' ' ' LEU . 22.1 t70 -97.48 -138.7 0.28 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.455 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 54.8 mt-30 -151.03 -58.09 0.16 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.7 p -89.27 129.26 35.86 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.673 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -137.79 149.09 63.36 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 123.903 0.881 . . . . 0.0 108.779 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.547 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 27.5 Cg_endo -65.11 150.87 87.25 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 122.516 2.144 . . . . 0.0 112.472 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 27.8 tt0 -67.36 138.71 56.95 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.56 56.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.274 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -81.15 119.13 23.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 2.9 pt20 -85.54 145.92 27.15 Favored 'General case' 0 N--CA 1.417 -2.088 0 O-C-N 123.802 0.689 . . . . 0.0 110.305 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 124.81 52.91 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.66 117.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.052 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 74.3 m-85 -98.07 134.6 40.93 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.041 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -77.37 134.78 38.37 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.3 t -80.53 98.82 7.76 Favored 'General case' 0 N--CA 1.396 -3.139 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -38.49 137.14 0.84 Allowed Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 112.224 -2.262 . . . . 0.0 111.769 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.7 122.41 11.69 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.695 2.263 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 113.87 -10.67 23.07 Favored Glycine 0 C--N 1.289 -2.031 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.347 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.451 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 89.9 m-85 -125.23 168.77 13.01 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 122.168 -0.607 . . . . 0.0 110.488 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -157.01 175.0 14.68 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.974 0.91 . . . . 0.0 108.654 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.0 p -159.61 -160.86 0.86 Allowed 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.82 4.18 48.55 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.968 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.21 -119.14 0.65 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -121.4 157.33 30.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 61.5 t -91.16 115.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.4 mm -111.5 121.68 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 CA-C-O 121.362 0.601 . . . . 0.0 110.983 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.404 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 80.0 mtp -106.26 172.58 6.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.5 p -153.78 155.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.497 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.9 t -97.27 132.45 43.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 87.5 mtt180 -149.6 134.08 17.52 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 124.215 0.947 . . . . 0.0 110.127 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 62.79 23.79 14.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.42 -6.5 80.65 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.81 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.02 155.79 30.79 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.116 0.484 . . . . 0.0 110.886 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -93.6 120.65 34.13 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.372 0.606 . . . . 0.0 109.465 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.14 175.6 4.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.036 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.74 115.02 27.7 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.766 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.7 tm? -59.2 -54.54 45.79 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -122.27 99.46 43.15 Favored Pre-proline 0 N--CA 1.404 -2.762 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.757 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.14 -14.21 20.91 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.791 2.327 . . . . 0.0 112.031 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.75 -28.19 55.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.585 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -91.08 135.17 33.94 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.003 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.525 ' HZ1' ' HB3' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -168.23 151.07 5.52 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 97.4 m -81.58 109.39 15.98 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.731 0.777 . . . . 0.0 112.636 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -105.47 171.79 7.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.072 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -63.79 146.34 54.09 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.3 ptp180 -100.25 146.21 31.57 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 77.8 Cg_endo -82.85 152.01 14.6 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 121.932 1.755 . . . . 0.0 112.156 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.09 -1.19 34.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.493 0.663 . . . . 0.0 111.198 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.79 -92.45 1.12 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.253 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.59 129.9 21.54 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.1 36.08 0.6 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.913 3.075 . . . . 0.0 113.602 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 87.15 161.46 36.48 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.919 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -115.17 135.79 53.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -157.17 125.42 2.88 Favored Pre-proline 0 N--CA 1.416 -2.136 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.65 14.62 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.454 2.103 . . . . 0.0 111.602 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.06 -16.35 16.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.096 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.67 -162.42 28.68 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.066 -1.54 . . . . 0.0 113.2 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 t -134.74 -164.13 1.47 Allowed 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 123.27 0.628 . . . . 0.0 109.529 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 53.9 p90 -141.54 160.12 40.81 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.627 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 41.4 p -113.61 172.83 6.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 174.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.18 135.6 45.21 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 13.1 t -138.01 18.27 2.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.314 1.054 . . . . 0.0 111.307 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 108' ' ' VAL . . . -142.04 38.1 1.51 Allowed Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.39 -176.23 20.46 Favored Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.38 17.59 11.4 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.595 0.712 . . . . 0.0 109.598 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 p -144.67 -167.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 m-85 -104.31 93.72 4.96 Favored 'General case' 0 C--N 1.244 -3.983 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.974 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG11 ' A' ' 108' ' ' VAL . 11.4 pt-20 -142.39 152.11 42.5 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -51.4 114.52 1.25 Allowed 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.757 0.661 . . . . 0.0 110.445 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.47 -18.85 10.84 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.988 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 105' ' ' GLU . 5.9 p -81.17 138.1 20.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.361 0.601 . . . . 0.0 110.787 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.497 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.1 ttmp? -104.61 128.49 52.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -104.66 96.52 6.64 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG23 ' HG1' ' A' ' 97' ' ' THR . 0.8 OUTLIER -81.37 146.4 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -96.79 131.85 43.1 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.694 0.759 . . . . 0.0 109.977 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 m -151.91 157.66 42.12 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.27 -66.4 0.14 Allowed 'General case' 0 C--N 1.251 -3.692 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.578 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 49.8 m-80 -115.79 -177.56 3.19 Favored 'General case' 0 N--CA 1.398 -3.062 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.085 -174.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.51 -46.5 7.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.71 17.59 58.1 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.768 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 3.3 m-85 -125.45 150.63 47.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.244 -0.562 . . . . 0.0 109.941 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -122.1 -148.04 0.4 Allowed 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 171.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -142.99 154.79 44.37 Favored 'General case' 1 N--CA 1.332 -6.363 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.783 -169.469 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 142' ' ' GLU . 4.3 mm? -81.63 128.68 34.19 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.24 142.61 5.08 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.4 -18.15 42.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.673 0.749 . . . . 0.0 109.09 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.35 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.529 ' HA ' HD12 ' A' ' 120' ' ' LEU . 29.2 p-10 -86.3 28.46 0.83 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.273 0.558 . . . . 0.0 111.474 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -167.57 -177.6 3.61 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.182 -172.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.46 133.45 15.08 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 29.3 mt-10 -105.92 147.08 29.18 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 122.139 -0.351 . . . . 0.0 111.318 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.5 t -81.77 106.2 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.6 t70 -101.95 -160.82 0.81 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.517 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.7 p -63.84 -51.91 62.53 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 124.911 1.285 . . . . 0.0 112.877 -174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.12 -35.82 15.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.227 0.537 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.96 -151.97 10.45 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 79.7 m95 -76.91 139.99 40.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.267 0.533 . . . . 0.0 109.943 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.6 p -63.92 -32.43 73.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -138.21 176.51 8.64 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 11.1 t70 -92.6 -155.88 0.45 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.424 HD12 ' HA3' ' A' ' 89' ' ' GLY . 38.0 mt -99.17 111.44 61.0 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 122.964 0.506 . . . . 0.0 110.062 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.407 ' HB2' HD11 ' A' ' 120' ' ' LEU . 9.4 Cg_endo -61.62 145.42 97.63 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.363 2.042 . . . . 0.0 109.682 170.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.73 123.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.515 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 8.1 t -67.11 120.42 13.68 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB2' HD22 ' A' ' 121' ' ' LEU . 16.6 mm-40 . . . . . 0 C--N 1.313 -1.003 0 C-N-CA 125.343 1.457 . . . . 0.0 108.141 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.507 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 6.0 m-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 77.5 m -69.17 127.4 32.94 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.948 -178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.417 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.9 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.216 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.1 158.8 25.32 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.52 155.62 81.26 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.03 132.6 48.42 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.936 2.424 . . . . 0.0 112.747 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.54 110.94 3.11 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 122.468 2.112 . . . . 0.0 112.018 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -58.55 147.38 32.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.075 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -122.82 169.1 11.45 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.443 -170.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -35.88 26.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -127.82 14.82 6.94 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.942 0.401 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 4.1 mp0 -130.79 144.44 51.45 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.6 mt -133.46 156.48 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -78.35 145.78 35.05 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-O 121.276 0.56 . . . . 0.0 112.262 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -106.73 109.97 22.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.93 -138.32 9.06 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 t -151.04 132.23 14.45 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.468 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 68.6 m95 -135.82 122.09 20.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -143.73 24.12 1.71 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . 5.1 t70 -100.7 -173.29 2.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.622 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.13 -25.36 2.24 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.234 0.614 . . . . 0.0 110.18 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 6.9 p -142.45 131.18 22.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.839 0.352 . . . . 0.0 111.502 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 39' ' ' ASP . 31.3 m-85 -127.23 143.54 47.49 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.1 Cg_endo -62.56 147.21 95.14 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.7 2.267 . . . . 0.0 111.748 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.8 tt0 -67.73 129.55 40.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.06 1.46 28.39 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.572 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m -83.76 120.15 25.68 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -93.02 152.23 19.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.379 0.609 . . . . 0.0 111.924 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.99 130.84 53.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.609 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.9 mt -101.47 125.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.3 m-85 -102.33 143.7 31.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 54.7 tttm -92.45 141.5 28.45 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 93.6 m -90.59 16.71 8.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 65.81 161.57 0.13 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.315 0.646 . . . . 0.0 111.104 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.33 140.18 24.29 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 121.189 1.26 . . . . 0.0 110.2 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.66 0.07 60.91 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 92.8 m-85 -128.74 175.84 8.28 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.168 0.509 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -154.99 -171.64 3.9 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 p -163.27 154.3 16.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 120.895 0.379 . . . . 0.0 110.721 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.15 -27.21 59.65 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.44 141.22 7.06 Favored Glycine 0 N--CA 1.408 -3.213 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.36 142.54 51.94 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.15 0.58 . . . . 0.0 111.238 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.4 118.22 10.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -116.11 124.28 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -113.04 166.79 11.08 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.6 p -149.66 143.05 17.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.492 0.663 . . . . 0.0 110.137 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.26 122.75 19.49 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 125.159 1.384 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.0 ttt180 -160.85 132.91 5.92 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 66.19 25.7 10.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.12 0.568 . . . . 0.0 112.376 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 91.95 -10.96 73.35 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.574 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.57 171.92 12.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -93.45 123.35 36.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.33 168.11 9.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.056 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.17 114.89 18.48 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.721 0.296 . . . . 0.0 111.088 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.76 -39.02 92.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -143.65 98.87 5.28 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.72 -4.07 14.18 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.839 2.359 . . . . 0.0 113.101 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.65 -31.13 41.45 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.76 141.43 48.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.895 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -158.27 160.38 37.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -102.58 130.15 49.36 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -126.46 172.64 10.02 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.8 mmtp -64.86 151.52 45.31 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.033 0.533 . . . . 0.0 111.974 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -86.97 151.91 52.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 67.4 Cg_endo -77.07 160.83 33.13 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 121.535 1.49 . . . . 0.0 110.087 176.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -114.85 -22.51 9.6 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.344 -174.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.97 -179.2 53.39 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -78.33 128.12 78.99 Favored Pre-proline 0 C--N 1.289 -2.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 48.17 1.2 Allowed 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.076 3.184 . . . . 0.0 114.177 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.59 157.47 33.6 Favored Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.86 126.99 55.25 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.245 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.33 125.13 16.6 Favored Pre-proline 0 N--CA 1.412 -2.356 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -74.2 -10.88 22.88 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.286 1.991 . . . . 0.0 112.042 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -127.55 141.39 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.14 47.9 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.119 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -163.79 -169.2 1.82 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.201 0.5 . . . . 0.0 109.872 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 46.5 p90 -142.34 160.29 40.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.476 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.6 p -113.61 173.0 6.63 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.2 mt -140.99 118.13 11.27 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.485 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -113.14 -7.65 13.61 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.354 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.429 ' C ' HG11 ' A' ' 108' ' ' VAL . . . -113.84 28.94 8.11 Favored Glycine 0 CA--C 1.489 -1.562 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.03 -171.07 27.82 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -129.49 10.88 5.73 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.282 1.039 . . . . 0.0 109.616 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.02 174.73 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 31.0 m-85 -88.94 88.15 7.48 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.76 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.533 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.2 pt-20 -136.24 150.22 48.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.241 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -46.16 116.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.374 1.046 . . . . 0.0 111.027 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.15 -23.43 6.5 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.651 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.429 HG11 ' C ' ' A' ' 100' ' ' GLY . 19.9 m -77.71 139.12 19.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.07 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.485 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.9 ttmp? -102.4 120.43 40.5 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -101.31 101.3 11.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -84.24 139.96 16.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.777 -176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -97.31 113.54 25.19 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.5 m -117.89 159.38 23.2 Favored 'General case' 0 N--CA 1.402 -2.836 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.09 -62.04 0.73 Allowed 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.473 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -155.83 -170.06 3.29 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.74 -53.27 8.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.582 0.706 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.68 -12.75 82.5 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.721 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -112.41 121.82 45.95 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.019 0.128 . . . . 0.0 110.903 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -102.8 -114.93 0.21 Allowed 'General case' 0 CA--C 1.466 -2.276 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -163.64 156.35 18.11 Favored 'General case' 1 N--CA 1.337 -6.119 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.573 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 67.3 mt -89.92 103.78 16.41 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.104 0.954 . . . . 0.0 109.387 173.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.09 155.14 8.87 Favored Glycine 0 N--CA 1.41 -3.086 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -93.44 -18.3 22.49 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.937 0.875 . . . . 0.0 109.585 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.4 mm -112.38 106.16 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.502 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.4 p-10 -83.81 30.58 0.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.136 0.493 . . . . 0.0 111.399 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.46 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -164.2 178.2 7.77 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -173.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.98 138.6 45.54 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 22.6 mt-10 -111.48 136.69 50.29 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.89 107.63 14.76 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.64 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -100.39 -170.43 1.87 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 p -66.64 -40.66 88.82 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 124.525 1.13 . . . . 0.0 110.601 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.0 -35.79 62.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.025 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.37 -152.46 24.34 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.26 126.93 30.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.126 0.463 . . . . 0.0 109.794 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 p -58.94 -35.84 73.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 123.566 0.746 . . . . 0.0 112.913 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.08 167.33 17.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.9 -96.95 0.3 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -173.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 24.4 mt -132.81 92.75 25.54 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 121.656 -0.653 . . . . 0.0 111.316 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 3.3 Cg_endo -53.6 137.22 66.15 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 122.736 2.291 . . . . 0.0 109.32 166.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.7 mm -87.69 122.87 39.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.898 -173.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 21.0 t -52.29 124.41 13.16 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.952 0.342 . . . . 0.0 110.772 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.409 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.424 -1.744 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.239 0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.6 m -84.87 133.53 34.3 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.9 OUTLIER -106.67 27.49 8.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.851 0.834 . . . . 0.0 109.605 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 162.4 37.58 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.661 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -99.66 158.19 32.59 Favored Pre-proline 0 N--CA 1.39 -3.434 0 O-C-N 124.558 1.161 . . . . 0.0 110.277 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 17.9 Cg_endo -60.12 133.35 49.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.952 2.435 . . . . 0.0 110.684 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.89 170.66 19.55 Favored 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.27 139.02 51.33 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -113.37 -176.85 2.99 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -73.54 -27.12 61.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.4 p -116.94 0.5 12.45 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -133.3 140.4 47.43 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.515 0.674 . . . . 0.0 112.329 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -138.62 145.74 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.92 142.66 57.21 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.5 p -90.76 -28.32 18.35 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.568 0.699 . . . . 0.0 109.549 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.71 177.4 37.24 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.4 p -113.9 114.87 26.82 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 123.481 0.712 . . . . 0.0 110.316 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -110.48 110.77 21.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -115.89 3.52 13.74 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.631 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.661 ' O ' HD21 ' A' ' 24' ' ' LEU . 40.1 m-20 -101.91 -157.09 0.59 Allowed 'General case' 0 CA--C 1.479 -1.775 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.58 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -133.84 -58.84 0.86 Allowed 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 170.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.9 p -80.98 121.1 25.61 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.44 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 41.1 m-85 -129.33 145.0 54.97 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.086 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.03 143.56 66.24 Favored 'Trans proline' 0 C--O 1.262 1.695 0 C-N-CA 122.635 2.223 . . . . 0.0 111.086 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -63.16 138.82 58.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.36 1.73 50.69 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.203 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.433 ' C ' HG21 ' A' ' 65' ' ' VAL . 92.9 m -85.06 117.42 24.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -85.74 149.76 25.06 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.245 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.11 130.08 53.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -100.24 132.8 45.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.57 143.94 44.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.596 0.712 . . . . 0.0 112.595 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.24 142.52 27.31 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 171.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.708 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.8 m -86.8 27.8 0.95 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 61.62 166.61 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 121.451 0.643 . . . . 0.0 111.005 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.14 118.09 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.194 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 171.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.4 -23.38 7.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.069 -1.063 . . . . 0.0 113.051 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.708 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 95.8 m-85 -102.74 179.56 4.25 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 122.023 -0.693 . . . . 0.0 109.368 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -155.75 -174.75 5.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -171.95 168.7 5.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 98.4 mt -87.73 14.48 8.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.861 0.839 . . . . 0.0 110.081 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.05 -146.01 5.78 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.33 150.08 48.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.6 t -73.06 101.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.9 118.64 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.53 175.5 5.48 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.433 HG21 ' C ' ' A' ' 46' ' ' THR . 8.7 p -161.02 144.72 4.54 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.166 0.508 . . . . 0.0 110.464 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.72 121.78 18.6 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.111 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 64.3 ttt180 -150.14 124.34 9.47 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.415 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 14.6 mmmm 61.69 22.39 12.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 113.017 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.38 -10.41 65.15 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.487 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.22 157.31 25.08 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.167 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 85.4 m95 -88.59 117.25 27.41 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.14 174.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.39 125.89 37.24 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.462 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.22 -48.39 51.63 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -110.3 88.23 7.08 Favored Pre-proline 0 N--CA 1.429 -1.515 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.891 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -18.66 38.04 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.333 2.022 . . . . 0.0 111.758 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.61 -14.3 58.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.76 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 59' ' ' LEU . 25.4 mmt180 -95.65 123.44 39.21 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 121.693 0.759 . . . . 0.0 110.231 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -147.11 151.55 37.02 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.64 112.44 22.32 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.089 0.947 . . . . 0.0 110.918 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -108.14 172.68 6.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.766 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.5 159.0 24.29 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.615 0.722 . . . . 0.0 111.671 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -94.24 144.77 28.58 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 174.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 60.5 Cg_endo -73.35 163.64 37.27 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 121.733 1.622 . . . . 0.0 109.351 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.9 m -115.75 1.11 13.39 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.46 -170.79 53.49 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.752 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -88.35 117.42 68.36 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.34 102.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 113.257 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 88.85 125.48 2.53 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.952 175.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.12 19.0 5.3 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.749 0.785 . . . . 0.0 109.101 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -60.82 134.47 92.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.171 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.5 -4.66 1.97 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.395 2.063 . . . . 0.0 112.349 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.06 -33.66 5.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.09 0.471 . . . . 0.0 111.131 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.22 138.58 18.05 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.329 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.82 156.31 30.9 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.8 p90 -128.77 158.72 37.85 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.241 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 76.8 p -108.87 168.33 9.43 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.87 123.82 22.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.34 0.59 . . . . 0.0 110.089 175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.2 t -132.65 141.46 48.64 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.95 14.12 67.84 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.427 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.18 -52.1 0.05 OUTLIER Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.256 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.32 -3.68 2.1 Favored 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 124.236 1.014 . . . . 0.0 112.946 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 m -144.65 175.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.4 m-85 -78.33 94.4 4.83 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.22 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.71 151.11 35.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -42.82 129.33 4.28 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.01 -9.93 74.57 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.679 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.96 138.35 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.285 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.526 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.1 ttmt -105.22 120.52 41.75 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -99.8 99.8 10.66 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -79.18 136.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.479 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 52.8 t80 -102.83 129.18 49.42 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -147.6 149.64 32.91 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.73 -52.78 2.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 -174.6 4.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -87.17 -45.04 11.03 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.7 -32.79 61.11 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.354 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -86.16 119.22 26.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.379 0.609 . . . . 0.0 110.839 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 24.5 mt-30 -110.21 -159.89 0.7 Allowed 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.63 155.1 44.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -82.8 137.99 34.14 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.781 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.2 158.87 12.65 Favored Glycine 0 C--N 1.285 -2.286 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -92.4 -17.45 24.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.219 0.509 . . . . 0.0 110.9 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -112.03 109.42 28.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -86.28 22.64 1.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -151.12 176.22 11.38 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 77.0 mtm180 -142.24 127.92 19.19 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -106.96 138.68 42.68 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.7 t -81.38 97.38 7.7 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.137 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.2 175.47 10.56 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.54 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.6 p -49.47 -41.37 40.18 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 125.666 1.586 . . . . 0.0 112.252 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.46 -27.08 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.017 0.436 . . . . 0.0 111.412 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.96 -170.08 36.73 Favored Glycine 0 C--N 1.303 -1.302 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -65.2 141.57 58.61 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 117.22 0.51 . . . . 0.0 111.71 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.7 p -85.12 133.46 34.21 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 73.81 171.27 0.3 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.543 0.737 . . . . 0.0 110.003 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.552 ' O ' ' HD3' ' A' ' 127' ' ' ARG . 6.3 p-10 -111.87 -102.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.985 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.46 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 52.8 mt -126.95 102.65 24.49 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.72 138.17 81.48 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.042 1.828 . . . . 0.0 110.166 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.48 113.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.479 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 93.9 m -72.85 112.36 8.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.759 0.314 . . . . 0.0 111.402 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 32.9 mt-10 . . . . . 0 C--N 1.317 -0.83 0 C-N-CA 125.157 1.383 . . . . 0.0 108.523 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.966 0.412 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 41' ' ' THR . 70.1 m -79.9 132.04 35.99 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.505 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.22 13.62 26.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.324 0.583 . . . . 0.0 110.414 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.18 160.83 38.41 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.658 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 38.0 mt -84.33 157.42 62.05 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 123.968 0.792 . . . . 0.0 109.262 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 28.7 Cg_endo -64.01 133.2 37.43 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 121.668 1.579 . . . . 0.0 109.946 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.79 162.55 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.026 1.817 . . . . 0.0 111.712 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -98.21 146.73 25.32 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -114.1 173.55 6.39 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -65.09 -34.39 78.3 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -117.63 1.24 12.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -131.78 147.05 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.25 0.547 . . . . 0.0 111.669 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 12.6 mt -143.92 156.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 3.9 mm? -72.08 168.96 17.03 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-O 121.916 0.865 . . . . 0.0 112.594 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -123.85 145.48 49.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 171.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.09 -144.98 15.98 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.709 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -139.14 137.76 36.4 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 81.5 m95 -138.84 121.81 16.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.6 m -151.92 24.08 0.66 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.755 0.312 . . . . 0.0 111.331 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 15.8 m-20 -118.31 -169.63 1.74 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.1 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -119.27 -66.1 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.0 p -86.67 127.81 34.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -130.34 140.6 39.14 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.754 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.42 145.19 87.54 Favored 'Trans proline' 0 C--O 1.264 1.779 0 C-N-CA 122.616 2.211 . . . . 0.0 110.801 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.505 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 20.4 tt0 -65.44 140.99 58.66 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.75 57.36 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.206 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.409 ' C ' HG21 ' A' ' 65' ' ' VAL . 75.8 m -85.95 117.91 25.09 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.313 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -88.11 146.08 25.61 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.782 0.801 . . . . 0.0 111.31 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.55 119.67 36.93 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -92.06 120.15 40.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 61.4 m-85 -102.75 141.47 35.51 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -88.35 153.58 21.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.638 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.1 m -91.6 25.93 2.5 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 32' ' ' ILE . 70.0 mtp180 62.88 167.91 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.59 100.0 1.35 Allowed 'Trans proline' 0 N--CA 1.428 -2.365 0 CA-C-N 119.162 0.736 . . . . 0.0 110.912 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 135.5 -17.9 3.95 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.123 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.638 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.9 m-85 -110.12 173.15 6.46 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 109.881 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -152.1 -174.66 4.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -168.77 -178.16 3.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.05 14.05 9.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.727 0.775 . . . . 0.0 110.482 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.32 174.7 38.6 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.72 145.93 34.21 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 118.425 1.113 . . . . 0.0 109.362 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 90.8 t -74.19 111.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mm -106.18 122.84 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.011 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.6 mtp -112.07 172.77 6.71 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG21 ' C ' ' A' ' 46' ' ' THR . 8.2 p -157.41 145.31 10.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-O 121.335 0.588 . . . . 0.0 110.648 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.4 t -69.65 125.81 27.84 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.824 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.505 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 34.6 ttp180 -151.76 123.26 7.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm 62.37 25.96 15.5 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 124.267 1.027 . . . . 0.0 113.46 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.97 -15.74 61.19 Favored Glycine 0 N--CA 1.413 -2.883 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.515 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.69 163.7 15.73 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.706 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.418 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 82.1 m95 -97.19 123.87 41.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.329 0.585 . . . . 0.0 109.856 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 171.53 14.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.421 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.79 124.96 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -49.77 56.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -108.26 90.47 6.95 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.169 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.49 -11.95 26.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.791 2.327 . . . . 0.0 114.089 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -90.8 -19.87 22.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.087 0.47 . . . . 0.0 110.352 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 7.6 mmp_? -92.69 134.11 35.35 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.8 0.81 . . . . 0.0 112.468 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.09 166.3 32.92 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 172.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.9 m -91.96 129.4 37.93 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.59 0.709 . . . . 0.0 111.173 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.34 167.98 14.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.519 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 95.5 mttt -65.62 136.43 56.32 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.573 0.225 . . . . 0.0 111.351 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.7 ptp180 -78.35 147.01 71.59 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.45 159.46 32.51 Favored 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.868 1.712 . . . . 0.0 109.631 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.8 m -118.24 8.49 12.31 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 121.463 0.649 . . . . 0.0 111.488 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.33 -85.93 1.23 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.497 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -168.06 147.88 4.28 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.75 53.13 2.7 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.346 2.031 . . . . 0.0 111.615 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.97 -96.31 1.69 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.5 t70 169.56 126.63 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 125.493 1.517 . . . . 0.0 107.674 171.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -120.88 117.53 30.95 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.67 1.92 7.88 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.149 1.899 . . . . 0.0 111.112 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -115.19 -55.39 2.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.851 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 114' ' ' CYS . . . -73.54 150.58 43.55 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 m -92.63 -55.92 3.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . 0.274 1.9 p90 70.16 145.93 0.06 Allowed 'General case' 0 C--O 1.248 0.985 0 C-N-CA 126.558 1.943 . . . . 0.0 114.493 173.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.579 ' OG1' HG12 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -117.03 148.15 41.73 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.994 179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.57 HD22 ' CG1' ' A' ' 108' ' ' VAL . 83.0 mt -109.12 135.96 49.4 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.7 t -138.23 139.01 39.05 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.55 -26.36 16.53 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.18 164.69 34.17 Favored Glycine 0 CA--C 1.489 -1.568 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.463 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.7 t-20 -123.12 60.18 1.06 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 118.173 0.986 . . . . 0.0 110.006 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.513 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.0 m -168.65 -178.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.634 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 172.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.08 84.31 5.26 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.911 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.26 157.42 39.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.804 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.455 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 62.7 t80 -58.55 122.32 13.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.758 0.79 . . . . 0.0 111.767 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.5 -19.38 12.87 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CG1' HD22 ' A' ' 98' ' ' LEU . 24.1 t -71.72 129.94 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.723 0.773 . . . . 0.0 112.066 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.445 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.1 ttmt -102.91 119.71 39.32 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.61 93.24 7.03 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.579 HG12 ' OG1' ' A' ' 97' ' ' THR . 1.5 p -79.14 109.29 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-O 122.35 1.071 . . . . 0.0 109.116 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.537 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.8 t80 -80.89 103.56 10.81 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 113.837 -1.528 . . . . 0.0 110.878 -169.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 m -74.47 -38.29 62.96 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.644 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.455 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 45.8 t 72.73 -92.83 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.348 0 O-C-N 125.312 1.632 . . . . 0.0 108.906 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -137.2 -174.48 3.76 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.96 -42.67 14.71 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.57 0.7 . . . . 0.0 109.198 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.68 -22.9 54.94 Favored Glycine 0 C--N 1.308 -1.001 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.909 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.03 128.73 55.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.481 -0.423 . . . . 0.0 111.001 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -111.34 -148.15 0.43 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -117.22 166.72 11.93 Favored 'General case' 1 N--CA 1.376 -4.131 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.604 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.6 mt -97.32 106.12 18.39 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.559 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.6 166.2 14.43 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -84.68 -27.56 26.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.132 0.968 . . . . 0.0 108.515 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.0 109.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.31 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -97.43 23.88 7.16 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.141 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -159.01 178.31 10.2 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.399 0.619 . . . . 0.0 110.519 -173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -149.68 129.03 12.91 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.962 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -101.51 157.48 16.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 122.8 34.96 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.841 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.9 t70 -101.98 -169.12 1.63 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.473 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 48.5 p -71.72 -37.35 70.64 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 124.585 1.154 . . . . 0.0 108.492 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.05 -52.11 15.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.044 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.02 -150.25 16.07 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.23 137.73 45.15 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.024 0.912 . . . . 0.0 110.336 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.2 p -81.05 167.64 19.53 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.48 -111.39 0.27 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.325 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -167.8 -178.61 3.9 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 82.9 mt -94.93 103.83 12.87 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.537 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.4 Cg_endo -48.24 127.79 16.02 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.269 2.646 . . . . 0.0 112.584 -176.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.8 mm -75.06 115.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.732 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.3 m -61.61 121.4 12.67 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 . . . . . 0 N--CA 1.425 -1.697 0 C-N-CA 126.445 1.898 . . . . 0.0 107.791 178.633 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 35.4 m-20 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 120.751 0.31 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.8 m -65.67 139.93 58.44 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.89 18.74 13.94 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.357 0.599 . . . . 0.0 109.729 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.07 159.22 37.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.729 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 mt -79.5 153.3 76.19 Favored Pre-proline 0 C--N 1.31 -1.137 0 O-C-N 123.873 0.733 . . . . 0.0 109.15 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 128.67 30.72 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.457 2.104 . . . . 0.0 111.166 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.68 123.38 12.9 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.488 2.126 . . . . 0.0 111.409 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -68.1 149.55 49.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.501 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 2.1 mmp_? -112.51 178.56 4.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.229 -171.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -82.25 -58.94 2.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.48 -8.53 35.06 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.955 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.5 mp0 -109.02 142.53 39.58 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.985 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mt -133.09 150.4 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.848 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.75 140.42 53.44 Favored 'General case' 0 C--N 1.277 -2.58 0 O-C-N 124.245 0.966 . . . . 0.0 111.084 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.0 p -87.21 -34.33 19.03 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.207 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.4 167.43 26.1 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.434 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 p -105.26 118.23 36.02 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -99.71 161.97 13.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -130.79 -23.79 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -137.01 162.48 33.2 Favored 'General case' 0 C--O 1.183 -2.446 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.423 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.3 -29.48 26.34 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.498 0.666 . . . . 0.0 109.641 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.6 p -97.16 108.4 21.12 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-O 121.88 0.848 . . . . 0.0 112.431 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -118.1 157.83 47.75 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.511 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 47.6 Cg_endo -70.67 152.8 64.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 121.628 1.552 . . . . 0.0 110.875 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.42 151.8 45.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.24 74.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.617 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -83.05 121.14 26.65 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.956 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.01 146.45 23.85 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.675 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.88 117.03 29.06 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.44 130.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 65.1 m-85 -104.19 139.43 39.25 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -75.13 -29.51 60.55 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.319 -1.764 . . . . 0.0 113.656 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.7 m 71.29 3.05 4.51 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 72.86 152.35 0.14 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.96 108.87 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.554 2.17 . . . . 0.0 112.738 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.41 7.01 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.476 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 96.4 m-85 -98.81 168.14 10.32 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 122.103 -0.645 . . . . 0.0 110.465 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -133.21 -175.93 3.96 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -157.08 -175.93 5.69 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -104.76 16.22 26.41 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.123 0.487 . . . . 0.0 110.073 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.45 29.82 0.07 OUTLIER Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.49 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.56 144.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.977 1.311 . . . . 0.0 112.049 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.6 t -76.98 116.4 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.25 124.55 69.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.804 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.44 168.77 9.15 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.9 p -155.45 149.99 11.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.8 t -84.08 128.73 34.75 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.84 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.95 124.84 13.44 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.23 29.56 19.14 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.35 -17.48 58.88 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.934 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 167.17 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.715 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.79 122.46 46.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 -168.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.693 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.48 23.04 Favored 'General case' 1 C--N 1.225 -4.825 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.967 -171.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.85 -53.99 13.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.83 80.6 49.5 Favored Pre-proline 0 N--CA 1.419 -1.997 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.263 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.61 -13.06 22.44 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.743 2.295 . . . . 0.0 110.969 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.69 -30.1 68.69 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.714 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -81.25 143.56 32.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.566 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.8 158.65 43.54 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -94.57 106.95 18.94 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.45 160.75 14.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.95 146.56 39.54 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.11 140.23 61.54 Favored Pre-proline 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.421 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.51 145.47 47.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.095 1.863 . . . . 0.0 109.624 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.9 m -104.55 -14.99 15.46 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.997 0.427 . . . . 0.0 111.686 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.61 -167.67 54.77 Favored Glycine 0 N--CA 1.412 -2.927 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.433 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -68.74 119.73 71.1 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 124.323 1.049 . . . . 0.0 109.583 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 72.8 Cg_endo -80.34 -6.67 13.83 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.15 2.567 . . . . 0.0 112.295 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.73 134.65 6.2 Favored Glycine 0 N--CA 1.406 -3.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.93 174.39 7.26 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.861 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -162.53 127.37 2.07 Favored Pre-proline 0 N--CA 1.412 -2.362 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -88.85 -4.18 6.24 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.089 1.859 . . . . 0.0 111.555 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.71 -47.42 3.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.469 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.51 -172.31 25.83 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.262 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 m -145.98 167.37 23.48 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -143.72 157.52 44.33 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.255 0.479 . . . . 0.0 110.11 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.58 ' OG1' HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -119.95 154.0 35.1 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.794 0.684 . . . . 0.0 110.5 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 94.6 mt -115.2 133.33 56.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.1 t -127.39 148.17 50.27 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.72 -66.62 3.57 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.068 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.51 -43.24 6.59 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.427 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t30 75.37 -4.41 2.38 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 122.105 0.955 . . . . 0.0 111.684 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.16 -178.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -88.18 79.46 7.86 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.376 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.77 151.09 52.07 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.842 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -45.11 122.33 3.3 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.447 0.699 . . . . 0.0 111.756 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.36 -16.52 32.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.615 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.57 147.06 7.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 O-C-N 122.391 -0.476 . . . . 0.0 110.358 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 109' ' ' LYS . 4.4 ttmp? -114.45 127.57 55.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.37 88.01 3.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.58 HG12 ' OG1' ' A' ' 97' ' ' THR . 2.6 p -80.97 124.02 38.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.705 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -102.02 141.3 35.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.363 -168.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.27 161.94 34.87 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.29 -74.24 0.35 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.922 -1.511 . . . . 0.0 110.695 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -141.25 -177.79 5.29 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.56 152.54 21.05 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.38 -43.91 1.93 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.29 132.1 22.7 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -104.22 -61.43 1.45 Allowed 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.851 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 pp 179.52 157.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.387 1.054 . . . . 0.0 109.17 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 81.3 mt -97.71 132.03 43.72 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.71 148.12 5.67 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -84.51 -19.94 32.44 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.286 1.041 . . . . 0.0 109.581 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 126' ' ' TYR . 38.6 mm -103.06 92.46 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.046 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -83.17 29.69 0.48 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 124.763 1.225 . . . . 0.0 110.312 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 124' ' ' ILE . 52.4 p90 -161.7 179.05 8.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -142.03 121.5 13.24 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.438 ' HG3' ' CD2' ' A' ' 126' ' ' TYR . 48.3 mt-10 -103.07 141.43 35.83 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -91.44 112.16 23.96 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.196 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 131' ' ' THR . 21.3 t70 -99.76 -164.61 1.14 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.261 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.508 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 46.9 p -66.01 -42.53 89.56 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.447 1.099 . . . . 0.0 110.327 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.61 -41.48 79.46 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.162 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.55 -141.45 9.53 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.524 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.5 m95 -72.44 130.96 41.92 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 117.007 0.403 . . . . 0.0 111.557 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.2 p -83.82 129.09 34.94 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 74.73 166.92 0.29 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.74 0.781 . . . . 0.0 111.611 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.66 -173.29 2.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -71.66 116.57 49.15 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.08 129.07 24.59 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 121.505 1.47 . . . . 0.0 110.927 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.3 123.17 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.642 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 65.9 m -66.19 109.22 2.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.418 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 8.4 tp10 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.071 0.939 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.2 m -77.93 124.61 28.21 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.717 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.65 21.37 8.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.133 0.968 . . . . 0.0 109.589 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.73 155.82 43.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.163 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.5 150.35 79.42 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 124.151 0.907 . . . . 0.0 111.558 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.93 139.94 44.48 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.187 1.925 . . . . 0.0 109.655 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.22 155.81 66.63 Favored 'Trans proline' 0 C--N 1.328 -0.538 0 C-N-CA 122.56 2.173 . . . . 0.0 113.743 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -97.09 134.47 40.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -109.11 151.05 26.94 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.617 -173.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -64.6 -31.48 72.71 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.0 -15.68 16.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -133.87 137.04 44.74 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 112.347 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.73 158.98 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -94.07 142.21 27.65 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 119.012 0.824 . . . . 0.0 111.543 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.4 p -98.12 151.94 19.86 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.53 -155.01 20.82 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -133.54 114.86 14.04 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -122.69 99.23 6.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.7 m -135.0 -0.99 2.71 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.984 0.421 . . . . 0.0 110.348 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.33 150.1 22.04 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.522 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -82.61 -51.27 7.91 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.978 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 38.7 p -95.8 106.33 18.44 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.16 129.72 23.72 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.847 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.52 150.44 68.81 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.9 131.78 49.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.57 7.33 48.68 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.295 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -86.38 114.84 23.49 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.985 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -90.01 136.33 33.11 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-O 121.766 0.793 . . . . 0.0 111.669 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.38 121.33 43.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.074 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.12 113.46 31.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.101 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -83.59 136.46 34.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.377 1.084 . . . . 0.0 113.177 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.18 -28.6 68.9 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.095 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 15.9 t 72.43 -4.39 2.06 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.947 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 71.91 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 124.487 1.115 . . . . 0.0 111.472 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.47 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 55.8 Cg_endo -70.15 120.82 7.47 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 121.462 1.442 . . . . 0.0 110.381 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 118.19 -20.12 10.65 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 93.5 m-85 -101.52 170.44 8.2 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -156.64 169.1 25.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.6 p -143.87 -177.05 5.24 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.23 21.73 1.35 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.67 0.748 . . . . 0.0 110.737 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.9 -96.1 0.12 Allowed Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -154.57 150.62 27.93 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.44 105.93 4.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mm -105.84 120.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.617 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.5 mtp -106.73 164.99 11.64 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.35 145.83 16.86 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.742 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.114 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 48.1 t -73.68 121.37 20.64 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.288 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 34.2 ttt180 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 74.2 mmtt 65.12 23.65 12.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.82 0.848 . . . . 0.0 112.278 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.78 -2.43 72.84 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.889 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 153.24 47.43 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.77 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.2 121.66 28.27 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.771 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.04 173.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.655 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.23 123.64 29.2 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.77 -39.95 94.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -139.54 100.56 7.53 Favored Pre-proline 0 N--CA 1.422 -1.829 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.703 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.0 -3.38 13.7 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.846 2.364 . . . . 0.0 111.912 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.6 mt -91.09 -6.5 53.64 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 122.213 1.006 . . . . 0.0 109.801 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -99.39 122.59 42.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.961 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.35 147.62 40.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.988 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.1 m -87.39 128.22 35.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.659 0.742 . . . . 0.0 111.848 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -128.6 169.21 14.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 106' ' ' TYR . 48.0 mtmt -82.46 144.73 30.26 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 132' ' ' ASP . 12.8 ptm180 -67.32 156.77 87.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.643 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 160.76 30.43 Favored 'Trans proline' 0 C--O 1.256 1.397 0 C-N-CA 121.968 1.779 . . . . 0.0 109.769 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.9 m -127.31 1.27 6.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.511 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.91 1.04 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.753 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -155.23 135.87 8.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.97 13.63 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.973 2.449 . . . . 0.0 113.059 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -166.3 47.87 Favored Glycine 0 N--CA 1.41 -3.042 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.56 171.52 19.81 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -132.45 121.35 17.36 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.45 -43.72 43.11 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.416 2.744 . . . . 0.0 114.575 -171.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.24 26.49 5.91 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.63 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.501 ' HA3' ' SG ' ' A' ' 141' ' ' CYS . . . -142.13 174.94 23.01 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.265 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.21 168.09 19.8 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.406 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . 53.2 p90 -143.09 156.16 44.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.277 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 p -125.24 169.13 12.57 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 124.213 1.005 . . . . 0.0 108.864 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.64 164.36 19.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.387 0.613 . . . . 0.0 111.469 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.0 t -162.03 147.97 13.34 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 175.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 20.77 41.46 Favored Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.566 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.91 -58.8 0.32 Allowed Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 82.68 35.2 0.06 Allowed 'General case' 0 CA--C 1.457 -2.602 0 CA-C-O 123.807 1.765 . . . . 0.0 109.357 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 108' ' ' VAL . 8.2 p -156.29 -162.3 0.02 OUTLIER 'Isoleucine or valine' 1 N--CA 1.373 -4.294 0 CA-C-N 110.868 -2.878 . . . . 0.0 103.587 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -113.16 83.85 1.9 Allowed 'General case' 1 C--N 1.225 -4.848 0 CA-C-O 121.577 0.704 . . . . 0.0 111.554 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 25.4 pt-20 -143.36 163.5 32.88 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.368 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.451 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 58.8 t80 -49.78 131.94 22.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.311 1.007 . . . . 0.0 111.498 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.39 -13.31 63.04 Favored Glycine 0 N--CA 1.421 -2.344 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.45 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -77.25 145.21 10.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.572 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.7 ttmt -108.93 118.83 37.82 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.043 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.38 98.17 11.61 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -91.04 122.64 42.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 82.1 m-85 -96.04 141.59 29.26 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.303 1.049 . . . . 0.0 111.768 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -145.91 138.76 25.78 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 103.106 -2.924 . . . . 0.0 103.106 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 120' ' ' LEU . 58.6 m -95.38 -87.69 0.27 Allowed 'General case' 0 C--N 1.252 -3.668 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.622 -168.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -148.72 -173.05 4.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -49.82 -54.03 21.8 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.953 1.301 . . . . 0.0 112.816 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.69 13.22 27.45 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.389 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 114' ' ' CYS . 35.4 m-85 -114.87 128.48 56.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.97 -159.7 0.69 Allowed 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 163.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -139.29 151.89 46.81 Favored 'General case' 1 N--CA 1.334 -6.23 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.766 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 107.71 9.13 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.365 0.602 . . . . 0.0 111.064 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.52 140.55 4.21 Favored Glycine 0 N--CA 1.419 -2.458 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.185 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.72 -5.95 52.3 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.405 0.621 . . . . 0.0 111.312 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.408 HG21 ' ND2' ' A' ' 136' ' ' ASN . 44.2 mm -108.82 90.96 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -86.54 42.87 1.03 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.44 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -167.5 174.06 8.18 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.719 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 135' ' ' THR . 6.2 ptm180 -156.35 134.44 11.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -102.88 158.54 16.21 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.593 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -94.28 126.55 39.6 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.848 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 131' ' ' THR . 20.7 t70 -100.07 -156.05 0.53 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.521 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 51.2 p -66.4 -25.54 66.82 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 125.217 1.407 . . . . 0.0 113.761 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 12.8 t70 -129.58 -44.48 1.22 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.216 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.67 -172.4 15.18 Favored Glycine 0 CA--C 1.486 -1.744 0 C-N-CA 119.355 -1.402 . . . . 0.0 112.48 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -85.87 142.26 29.01 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.927 0.394 . . . . 0.0 110.236 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 75.2 p -79.21 170.77 16.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.408 ' ND2' HG21 ' A' ' 124' ' ' ILE . 12.8 m120 61.7 -155.06 0.35 Allowed 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -141.84 178.1 7.73 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.48 114.24 50.18 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HB2' HD13 ' A' ' 120' ' ' LEU . 18.9 Cg_endo -66.86 126.54 15.45 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.065 2.51 . . . . 0.0 111.243 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.44 128.81 39.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.501 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 68.8 m -81.27 111.24 17.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.04 0.448 . . . . 0.0 110.485 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.735 1.214 . . . . 0.0 109.998 -175.724 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 15.6 m-20 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 121.743 0.783 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -72.99 138.08 45.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.42 -177.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.08 30.61 7.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -164.81 158.24 17.25 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.541 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 18.5 mt -80.38 154.03 74.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 123.499 0.72 . . . . 0.0 109.469 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 9.8 Cg_endo -54.48 130.27 39.18 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.707 2.272 . . . . 0.0 111.196 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.11 126.48 13.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.206 1.937 . . . . 0.0 111.165 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -60.37 134.67 57.29 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 121.552 0.691 . . . . 0.0 109.695 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 3.3 mmp_? -87.06 174.59 8.57 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.546 -171.174 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -73.66 -43.71 58.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.59 0.556 . . . . 0.0 110.569 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 80' ' ' CYS . 4.3 p -122.74 19.02 10.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.584 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 1.8 mp0 -137.67 150.12 47.1 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.038 0.446 . . . . 0.0 111.611 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.8 mt -133.55 154.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.0 mm? -76.36 147.55 38.01 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.0 p -114.54 113.9 25.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.41 -155.13 26.18 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.2 m -137.95 98.35 3.63 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 85.1 m95 -95.23 97.5 9.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.263 -177.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 p -106.53 1.27 25.27 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.061 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 1.6 m-20 -119.48 -169.49 1.77 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.777 -171.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -129.95 -43.46 1.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 71.4 p -98.29 131.94 44.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.189 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 48.8 m-85 -138.64 154.93 73.62 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.478 0.711 . . . . 0.0 109.568 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.555 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 23.4 Cg_endo -65.73 150.6 86.03 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.354 2.036 . . . . 0.0 112.502 178.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.27 147.64 49.47 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.97 -10.95 70.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.604 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 91.9 m -67.77 116.3 8.29 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 122.302 0.241 . . . . 0.0 110.474 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 3.7 pt20 -93.66 125.09 38.08 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.315 1.055 . . . . 0.0 110.003 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.78 122.06 35.86 Favored 'General case' 0 C--N 1.271 -2.805 0 C-N-CA 125.539 1.535 . . . . 0.0 107.592 178.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.1 mt -93.25 118.23 38.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.648 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.7 m-85 -96.51 144.68 26.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.76 0.79 . . . . 0.0 112.988 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -89.31 132.65 34.83 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 13.4 t -82.2 37.52 0.5 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 59.74 154.51 0.1 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.712 1.205 . . . . 0.0 113.671 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.27 92.69 0.47 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 121.304 1.336 . . . . 0.0 110.491 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 137.65 -21.34 3.23 Favored Glycine 0 N--CA 1.429 -1.814 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.564 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.5 m-85 -103.39 168.63 9.04 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.11 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -150.89 176.28 11.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 176.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 t -160.08 -165.62 1.52 Allowed 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.89 -12.94 60.05 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.959 0.885 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.77 44.85 Favored Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 177.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.32 138.21 57.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.455 0.627 . . . . 0.0 109.717 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.57 123.91 25.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 47' ' ' GLN . 46.3 mm -117.52 125.58 74.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.014 -176.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 28' ' ' ARG . 86.9 mtp -124.36 134.44 53.14 Favored 'General case' 0 CA--C 1.424 -3.871 0 CA-C-O 121.515 0.674 . . . . 0.0 110.038 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 1.3 m -129.85 149.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.84 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.873 -168.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.01 128.66 34.68 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.29 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -153.71 121.88 6.13 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.25 32.2 12.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.807 0.843 . . . . 0.0 110.935 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.03 -18.28 36.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.463 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.69 165.68 11.09 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.402 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.1 m95 -106.02 116.07 31.3 Favored 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -127.41 -166.71 0.48 Allowed 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.652 -173.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.78 127.71 45.91 Favored 'General case' 1 C--N 1.218 -5.149 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.319 -172.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HB2' ' CG1' ' A' ' 65' ' ' VAL . 2.2 tm? -80.61 -54.82 5.31 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -106.87 94.37 10.43 Favored Pre-proline 0 N--CA 1.407 -2.578 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.687 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.74 -9.91 24.39 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.705 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 77' ' ' LEU . 2.8 mm? -90.0 26.81 1.74 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 110.347 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.86 139.88 53.55 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.241 179.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -166.86 145.26 5.14 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.584 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 50.0 m -78.02 126.49 30.9 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 122.116 0.96 . . . . 0.0 113.534 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -119.67 153.42 35.6 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.038 -179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -72.02 136.2 46.63 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.386 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.3 ptp180 -78.13 145.25 68.78 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.3 166.08 29.56 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.197 1.932 . . . . 0.0 112.185 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.6 m -120.05 8.09 10.95 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.066 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.96 -96.76 0.88 Allowed Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.785 177.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -150.1 138.61 12.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.85 53.68 4.51 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.122 2.548 . . . . 0.0 112.133 -177.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 75.55 -143.58 30.53 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.16 153.25 31.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -150.1 135.25 9.81 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.78 -60.12 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.919 1.746 . . . . 0.0 109.967 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -123.49 154.44 39.13 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.515 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 130.89 150.43 6.78 Favored Glycine 0 C--N 1.282 -2.466 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.427 ' N ' ' HA ' ' A' ' 114' ' ' CYS . 4.4 m -145.29 158.7 43.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -175.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -144.3 161.09 39.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -123.02 146.21 47.84 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 91.8 mt -104.41 153.88 20.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.603 0.24 . . . . 0.0 110.529 -176.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -149.05 138.93 21.99 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.14 -12.89 58.85 Favored Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.28 170.48 42.61 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -111.35 10.85 21.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 117.698 0.749 . . . . 0.0 109.65 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.8 p -141.04 -166.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 86.03 3.34 Favored 'General case' 1 C--N 1.241 -4.119 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.046 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' O ' HG13 ' A' ' 108' ' ' VAL . 12.2 pt-20 -136.59 151.99 49.96 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.795 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.539 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.9 t80 -48.01 124.42 7.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.229 0.538 . . . . 0.0 112.167 176.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.89 56.3 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.832 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 105' ' ' GLU . 4.5 p -83.65 144.76 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-N 117.492 0.646 . . . . 0.0 109.64 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 40.3 ttmt -111.03 125.98 54.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.44 95.31 7.57 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.15 114.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.09 132.83 34.26 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.3 m -142.66 -28.28 0.59 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -172.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.515 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 96.2 m 69.79 -99.09 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 177.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -148.76 -158.69 0.94 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.86 -58.05 3.53 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.915 0.486 . . . . 0.0 110.894 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.07 4.37 74.48 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.889 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -117.91 133.55 55.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -127.48 -100.01 0.36 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.2 pp -179.78 145.29 0.22 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.056 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.41 HD21 ' CB ' ' A' ' 142' ' ' GLU . 2.5 mm? -95.04 142.77 27.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.511 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.67 -173.86 18.15 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.06 -12.0 12.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.635 0.718 . . . . 0.0 111.078 178.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.59 114.96 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -91.61 17.74 8.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.493 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.57 179.06 9.22 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.298 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -158.35 130.5 6.89 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.606 171.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.27 157.16 17.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 -176.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 48.1 m -87.64 117.39 26.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.744 172.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 131' ' ' THR . 22.3 t70 -103.92 -158.69 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.513 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 63.3 p -67.54 -44.69 77.7 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 124.142 0.977 . . . . 0.0 112.965 -173.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.4 -43.42 17.36 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.747 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.93 -129.82 1.91 Allowed Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.839 -176.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -78.95 125.45 29.39 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 0.0 112.137 -172.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -65.53 -25.97 67.68 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.404 1.082 . . . . 0.0 112.699 -177.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -138.47 169.09 18.41 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 24.4 t70 -91.57 -174.31 3.84 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' HA3' ' A' ' 89' ' ' GLY . 55.7 mt -86.62 112.6 47.84 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 123.55 0.74 . . . . 0.0 109.251 -176.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.34 147.0 96.68 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.752 1.635 . . . . 0.0 109.811 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 41.6 mm -81.78 108.63 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.127 -173.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 19.9 t -63.3 119.12 9.04 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.41 ' CB ' HD21 ' A' ' 121' ' ' LEU . 22.7 mm-40 . . . . . 0 C--N 1.307 -1.241 0 C-N-CA 123.509 0.724 . . . . 0.0 109.217 -174.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 52.6 m-20 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.4 m -68.96 141.8 54.86 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.883 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.41 19.51 17.54 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.25 156.92 37.92 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 40' ' ' GLN . 3.6 mm? -85.69 153.97 58.49 Favored Pre-proline 1 N--CA 1.373 -4.276 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.964 -179.04 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 122.23 10.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 123.328 2.685 . . . . 0.0 112.32 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.58 131.94 31.38 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.282 1.988 . . . . 0.0 110.448 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -62.54 145.13 55.12 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.264 0.554 . . . . 0.0 110.43 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 18.8 mmm180 -98.1 166.17 11.55 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -81.72 -51.39 8.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.758 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.21 -1.8 57.63 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.141 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 18.1 mp0 -132.65 158.54 42.01 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.979 0.419 . . . . 0.0 111.993 -178.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -142.36 150.2 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.37 154.53 31.64 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.336 0.588 . . . . 0.0 110.705 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.5 p -91.11 -23.57 20.26 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.566 0.698 . . . . 0.0 111.138 177.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.87 -178.27 15.35 Favored Glycine 0 C--N 1.289 -2.029 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.2 t -103.13 149.84 24.23 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -138.07 138.82 39.15 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -142.21 16.48 2.07 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.217 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.549 ' C ' HD21 ' A' ' 24' ' ' LEU . 15.1 m-20 -128.93 124.91 36.35 Favored 'General case' 0 CA--C 1.465 -2.311 0 C-N-CA 118.464 -1.294 . . . . 0.0 112.276 -175.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.553 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 21.7 mp0 -54.11 -49.84 68.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 124.764 1.29 . . . . 0.0 112.868 -175.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -96.25 128.74 43.44 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.198 -1.001 . . . . 0.0 113.682 -172.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -134.92 148.75 68.27 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.541 176.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -69.0 149.13 71.38 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.444 2.096 . . . . 0.0 112.705 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -66.3 136.24 55.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.68 -3.92 36.66 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.437 -177.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -82.86 118.85 23.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -88.53 143.78 26.75 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.545 0.688 . . . . 0.0 111.982 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.24 114.45 27.94 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -89.36 127.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 90.6 m-85 -109.2 141.85 40.86 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.617 0.722 . . . . 0.0 111.988 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -89.67 147.69 23.73 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 168.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.777 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 91.2 m -102.44 37.47 1.9 Allowed 'General case' 0 C--N 1.249 -3.795 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.605 -174.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 65.86 159.6 0.13 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.574 0.702 . . . . 0.0 111.532 178.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.52 113.8 3.62 Favored 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 109.706 -0.921 . . . . 0.0 109.706 172.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.24 -20.43 10.48 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.593 178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.777 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.1 m-85 -107.1 161.32 14.86 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.578 178.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' HD3' ' A' ' 84' ' ' PRO . 16.0 ptt180 -160.79 -176.34 5.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.558 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.7 p -169.22 177.92 4.58 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 170.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.12 31.8 0.71 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.86 0.838 . . . . 0.0 110.213 177.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.0 -140.32 3.21 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -142.66 157.72 44.39 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -78.97 104.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.33 122.1 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.963 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.5 mtp -109.44 169.79 8.47 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.2 p -155.39 144.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.659 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t -68.4 123.15 20.0 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.716 177.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.4 ttm180 -157.19 129.84 7.53 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp 66.53 15.89 10.24 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.891 0.876 . . . . 0.0 112.45 177.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.58 65.87 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.959 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.67 172.34 9.35 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.459 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -103.58 119.65 39.32 Favored 'General case' 0 CA--C 1.462 -2.428 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.3 -170.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.943 -175.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.57 121.1 39.07 Favored 'General case' 1 C--N 1.22 -5.024 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.221 -172.319 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -71.43 -54.42 10.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -119.72 100.38 49.0 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.65 -4.45 13.51 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.042 2.495 . . . . 0.0 112.366 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.27 -31.94 22.83 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.633 -178.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -89.29 135.33 33.64 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.365 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 158.55 44.28 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . 0.383 67.5 m -95.59 127.67 41.81 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 117.745 -1.582 . . . . 0.0 114.82 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.36 -175.69 2.76 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.756 -2.02 . . . . 0.0 108.096 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -71.99 152.92 42.12 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.077 0.465 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.16 152.97 46.59 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HD3' ' NE ' ' A' ' 57' ' ' ARG . 66.2 Cg_endo -90.24 152.62 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.451 1.434 . . . . 0.0 112.84 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 70.9 m -124.96 76.79 1.56 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.55 93.51 0.01 OUTLIER Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.242 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t60 70.93 125.59 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.968 1.707 . . . . 0.0 111.42 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.69 38.68 0.4 Allowed 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 114.427 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 108.63 -127.72 8.73 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 138' ' ' ILE . 4.0 p30 -162.87 158.88 23.12 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -171.65 129.53 0.68 Allowed Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.51 -14.23 11.73 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.374 1.383 . . . . 0.0 111.016 174.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.46 89.32 2.37 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.354 0.597 . . . . 0.0 111.129 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 164.81 165.88 22.83 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.9 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -139.37 165.46 27.16 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -139.06 155.91 47.57 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 p -130.73 140.42 50.34 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -103.39 140.38 37.53 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.487 HG23 ' HB3' ' A' ' 109' ' ' LYS . 5.1 t -133.69 19.52 3.88 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 121.708 0.766 . . . . 0.0 111.876 -176.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.4 2.4 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.53 174.88 17.18 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -119.25 20.44 12.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 117.903 0.852 . . . . 0.0 109.751 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 108' ' ' VAL . 23.4 m -138.2 175.11 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -90.89 97.73 11.36 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.001 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.96 154.36 41.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.428 -177.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -51.19 116.87 2.23 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.306 1.004 . . . . 0.0 111.083 177.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.05 -25.18 7.18 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.278 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -74.72 137.77 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.344 178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.487 ' HB3' HG23 ' A' ' 99' ' ' THR . 39.5 ttmt -106.02 121.64 44.54 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.72 94.52 9.41 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.77 122.32 32.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -94.1 132.14 38.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -153.98 156.43 37.41 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 83.9 m -132.68 -72.62 0.51 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -178.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.95 -174.05 3.21 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.47 -51.53 6.46 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.352 0.596 . . . . 0.0 110.763 -177.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.27 -18.93 79.91 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.202 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -98.77 137.67 37.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.54 -107.42 0.37 Allowed 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.5 pp 179.19 141.5 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.779 1.232 . . . . 0.0 109.666 176.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 142' ' ' GLU . 4.1 mm? -89.11 134.75 33.89 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.407 0.622 . . . . 0.0 110.338 176.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.09 161.38 11.03 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -174.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -92.42 -21.65 20.08 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.469 0.652 . . . . 0.0 109.415 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.43 ' HB ' ' ND2' ' A' ' 136' ' ' ASN . 25.7 mm -104.99 106.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.953 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -88.15 24.9 1.72 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.535 1.134 . . . . 0.0 111.395 -175.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.408 ' CE1' HG22 ' A' ' 124' ' ' ILE . 47.4 p90 -159.58 171.61 19.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.256 0.551 . . . . 0.0 110.768 -173.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -135.18 131.74 37.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 12.8 mt-10 -104.37 139.1 39.81 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 118.242 0.473 . . . . 0.0 110.794 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.72 104.14 10.11 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.0 t70 -105.94 -159.81 0.72 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.973 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.493 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.2 p -60.7 -29.49 69.36 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.743 1.617 . . . . 0.0 114.555 -171.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -118.44 -28.56 5.7 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.553 0.692 . . . . 0.0 110.959 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.91 -157.11 28.44 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -176.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 97.3 m95 -74.0 130.62 40.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.871 0.367 . . . . 0.0 111.663 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 34.8 p -81.83 158.29 24.12 Favored 'General case' 0 C--O 1.266 1.945 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.43 ' ND2' ' HB ' ' A' ' 124' ' ' ILE . 54.9 t30 63.92 -171.79 0.18 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -126.48 -168.1 1.81 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.488 HD12 ' HA3' ' A' ' 89' ' ' GLY . 54.0 mt -82.61 117.69 69.35 Favored Pre-proline 0 C--N 1.282 -2.33 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.96 144.86 48.75 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.751 2.301 . . . . 0.0 110.894 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -93.7 112.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 122.118 -0.364 . . . . 0.0 110.871 -174.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.33 112.28 3.93 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.462 ' HB2' HD21 ' A' ' 121' ' ' LEU . 33.6 mt-10 . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.3 m-20 . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -84.52 125.08 32.08 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.89 23.59 7.84 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.01 161.27 40.47 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.394 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 mt -82.81 149.07 59.12 Favored Pre-proline 0 C--N 1.306 -1.313 0 O-C-N 123.998 0.811 . . . . 0.0 109.807 174.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -53.11 131.55 43.48 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 123.197 2.598 . . . . 0.0 113.312 -177.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -65.73 119.51 6.55 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 122.617 2.212 . . . . 0.0 110.277 176.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.64 142.58 56.35 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.766 0.793 . . . . 0.0 111.759 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 18.2 mmm180 -87.31 168.46 13.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.377 -171.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -35.4 17.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.046 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 p -107.8 6.31 27.38 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.772 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 10.3 mp0 -138.92 156.44 47.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.33 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.3 158.92 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.78 143.67 55.74 Favored 'General case' 0 C--N 1.269 -2.896 0 O-C-N 123.483 0.489 . . . . 0.0 110.553 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 p -71.73 -35.23 70.1 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.35 165.92 12.17 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -94.15 142.71 27.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 177.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.06 125.53 42.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -121.44 18.22 11.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.288 0.566 . . . . 0.0 110.738 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.79 -159.44 0.74 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.63 -35.01 0.18 Allowed 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 123.457 0.703 . . . . 0.0 110.355 177.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.7 p -107.88 126.21 52.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.798 -176.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -133.89 137.05 27.6 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.645 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 28.3 Cg_endo -63.08 147.37 94.39 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 123.126 2.551 . . . . 0.0 111.926 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.5 tt0 -63.56 129.85 41.9 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.23 30.33 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.9 m -81.4 113.31 19.4 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -86.35 143.78 27.68 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.136 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.57 119.95 37.17 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.0 mt -91.51 119.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 59.9 m-85 -98.45 145.61 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.042 0.925 . . . . 0.0 113.33 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -91.66 138.36 31.63 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.788 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 35.7 m -74.63 21.9 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 64.95 154.95 0.12 Allowed Pre-proline 0 N--CA 1.476 0.864 0 CA-C-O 121.678 0.751 . . . . 0.0 111.612 -173.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.4 104.19 0.42 Allowed 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.523 1.482 . . . . 0.0 110.866 174.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.12 -3.6 18.78 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.326 176.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.788 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.0 m-85 -120.89 165.91 14.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.133 -1.216 . . . . 0.0 109.819 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -156.18 179.32 9.35 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.433 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 23.7 p -145.46 -92.41 0.1 Allowed 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.703 0.764 . . . . 0.0 110.665 174.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -142.23 -47.2 0.35 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -177.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.92 -134.72 3.31 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 176.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -115.06 146.73 41.0 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.1 t -75.12 116.76 18.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.3 mm -110.5 122.92 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-O 121.455 0.645 . . . . 0.0 109.783 -176.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.3 mtp -109.3 171.84 7.2 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.5 p -157.74 142.69 8.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.76 122.19 20.24 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.304 176.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.3 ttm180 -156.52 127.51 6.87 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 66.19 17.06 10.65 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.58 80.36 Favored Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.897 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 9.6 pt-20 -117.4 159.06 23.38 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -104.12 109.3 21.04 Favored 'General case' 0 CA--C 1.455 -2.69 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.0 -164.54 0.39 Allowed 'Isoleucine or valine' 1 N--CA 1.362 -4.846 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.252 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.14 40.67 Favored 'General case' 1 C--N 1.218 -5.123 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.601 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.9 -39.76 66.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.86 102.18 13.64 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 1.5 8.27 Favored 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.98 2.453 . . . . 0.0 113.74 -175.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.92 -20.33 18.19 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.691 0.758 . . . . 0.0 111.385 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -85.02 130.96 34.53 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.387 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -156.55 147.95 22.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 55.7 m -97.03 123.47 40.77 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.594 0.711 . . . . 0.0 111.484 -176.137 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.99 42.51 2.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -167.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 88.2 mttt 76.6 -179.98 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.753 1.221 . . . . 0.0 111.044 -178.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 15.4 ptp180 -130.41 142.0 43.9 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.99 147.58 43.66 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.477 2.118 . . . . 0.0 109.633 173.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 m -102.32 -10.66 19.3 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.05 -117.2 4.43 Favored Glycine 0 CA--C 1.474 -2.481 0 C-N-CA 119.002 -1.571 . . . . 0.0 110.996 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -136.71 139.14 28.25 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -176.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.42 8.64 3.71 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.786 2.324 . . . . 0.0 111.143 178.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.3 -164.25 22.23 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -175.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.27 161.19 12.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -130.5 126.04 21.86 Favored Pre-proline 0 C--N 1.288 -2.086 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.182 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.29 10.1 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.548 2.165 . . . . 0.0 112.773 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -110.82 -12.16 14.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.498 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . -164.56 -146.66 4.84 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.792 -175.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.91 -172.86 4.21 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.804 0.442 . . . . 0.0 111.597 -175.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -148.11 166.42 27.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 p -130.49 159.09 38.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.551 0.74 . . . . 0.0 109.332 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.5 136.57 53.14 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.054 0.454 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 9.8 t -125.78 138.18 53.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.12 9.97 56.54 Favored Glycine 0 C--N 1.312 -0.77 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -175.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.01 167.73 11.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.06 31.52 5.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.797 0.798 . . . . 0.0 111.277 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.02 167.85 23.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.06 86.24 5.34 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.662 -176.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.92 154.16 49.52 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.397 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -51.29 120.6 5.18 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.714 0.634 . . . . 0.0 111.543 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.25 -20.05 7.12 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 99' ' ' THR . 10.5 m -83.51 146.48 6.86 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.427 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.493 ' HZ1' ' HB2' ' A' ' 109' ' ' LYS . 5.1 ttmp? -111.12 126.72 55.13 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.52 92.82 8.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.69 115.11 27.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -81.87 139.91 34.42 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.509 -177.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.14 143.31 22.34 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.498 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 77.6 m -122.57 -73.38 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.113 -174.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -161.1 -165.61 1.39 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -172.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -79.81 -43.25 22.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.778 0.799 . . . . 0.0 109.042 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.48 -12.84 79.72 Favored Glycine 0 C--N 1.31 -0.906 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.407 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -124.47 127.86 48.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.73 -130.46 0.26 Allowed 'General case' 0 CA--C 1.457 -2.632 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 166.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.525 HD11 ' CG ' ' A' ' 139' ' ' PRO . 0.3 OUTLIER -151.65 145.47 25.1 Favored 'General case' 1 N--CA 1.33 -6.467 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.996 -176.35 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.27 109.76 19.73 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.76 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 156.11 161.01 10.37 Favored Glycine 0 C--N 1.272 -3.017 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 -178.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -97.21 -5.96 35.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 118.183 0.991 . . . . 0.0 110.251 179.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.91 106.94 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.615 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.492 ' HA ' HD12 ' A' ' 120' ' ' LEU . 26.2 p-10 -84.7 30.99 0.54 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.616 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -166.35 179.93 5.34 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.451 0.643 . . . . 0.0 111.857 -172.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -139.83 131.61 27.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 169.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.573 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 25.2 mt-10 -99.92 136.22 40.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.1 t -81.39 123.02 28.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.158 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.0 t70 -118.55 -160.24 0.79 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 43.2 p -66.85 -51.47 55.2 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.824 1.25 . . . . 0.0 112.101 -174.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.03 -28.72 39.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.77 0.795 . . . . 0.0 110.693 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.61 -148.13 17.57 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -80.97 132.84 35.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.189 0.494 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 49.6 p -81.0 148.95 29.51 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.423 178.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 67.53 -173.75 0.19 Allowed 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.273 0.983 . . . . 0.0 108.93 174.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -117.38 -173.62 2.45 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.29 119.24 75.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 -174.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.525 ' CG ' HD11 ' A' ' 120' ' ' LEU . 9.6 Cg_endo -58.72 132.52 48.47 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.424 2.083 . . . . 0.0 108.706 174.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.03 106.62 8.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.8 t -61.42 118.17 6.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.165 0.507 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.448 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 10.2 tp10 . . . . . 0 N--CA 1.43 -1.445 0 C-N-CA 126.178 1.791 . . . . 0.0 106.651 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.7 m-20 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.9 m -74.37 138.23 43.27 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.97 15.17 29.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.344 0.592 . . . . 0.0 109.882 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.07 154.83 41.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.551 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 24.6 mt -75.12 149.82 85.16 Favored Pre-proline 0 C--O 1.253 1.289 0 O-C-N 124.073 0.858 . . . . 0.0 109.909 173.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 27.9 Cg_endo -58.84 142.02 98.56 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.828 2.352 . . . . 0.0 110.054 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.76 144.49 54.22 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.779 1.653 . . . . 0.0 111.67 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -76.21 141.76 41.69 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 24.7 mmm180 -98.28 162.03 13.4 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.647 -171.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -78.23 -42.22 31.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.342 0.592 . . . . 0.0 109.69 176.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.72 -7.72 21.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.648 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 2.8 mp0 -129.4 166.13 20.17 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.755 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.98 146.21 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.65 140.15 51.48 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.506 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -126.67 101.41 6.63 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.988 172.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.78 -160.09 33.64 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 -176.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 m -129.43 114.53 16.27 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 117.699 0.749 . . . . 0.0 109.532 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.412 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 80.8 m95 -120.81 128.27 52.71 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.189 -175.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 m -148.54 8.08 0.78 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.312 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.543 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.0 m-20 -120.93 -173.37 2.59 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.635 -174.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -112.41 -61.1 1.77 Allowed 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.1 p -85.9 122.65 30.26 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.51 -175.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 63.9 m-85 -126.76 136.05 28.21 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.272 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.673 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 17.9 Cg_endo -60.51 145.68 98.31 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.345 2.697 . . . . 0.0 113.535 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -62.85 120.47 11.37 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.89 12.89 14.94 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -175.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.6 m -92.38 113.23 25.45 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.567 176.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.9 149.21 25.38 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.643 0.59 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.25 133.84 51.36 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.759 0.824 . . . . 0.0 109.023 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.9 mt -102.59 129.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.5 m-85 -111.25 137.29 49.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -85.05 126.53 33.64 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.7 m -77.43 13.45 1.21 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 70.1 mtp180 69.64 150.11 0.12 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.512 0.725 . . . . 0.0 110.895 -172.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.71 120.67 7.43 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.728 1.619 . . . . 0.0 109.9 175.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.24 -13.98 13.71 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 72.8 m-85 -115.17 163.66 15.33 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -150.88 -179.31 7.17 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 p -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.57 -13.61 59.74 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.592 0.711 . . . . 0.0 109.899 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.58 144.53 9.72 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 174.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.21 154.71 39.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.708 0.754 . . . . 0.0 111.166 -178.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG23 ' SG ' ' A' ' 80' ' ' CYS . 76.7 t -71.49 102.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.25 118.41 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.2 mtp -107.27 171.45 7.37 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.04 146.48 12.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.64 122.32 23.0 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.825 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -153.39 124.71 7.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.934 0.397 . . . . 0.0 111.057 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 68.66 11.55 8.39 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.852 1.261 . . . . 0.0 112.519 178.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.78 -12.61 46.13 Favored Glycine 0 N--CA 1.427 -1.945 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.33 178.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.55 158.3 21.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.595 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m95 -91.22 115.5 28.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.93 171.2 6.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.267 -175.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.22 119.49 26.56 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.3 -49.67 63.31 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.35 89.43 5.9 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.705 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.66 -19.84 9.69 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.568 2.179 . . . . 0.0 111.475 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.3 mt -74.77 -29.55 61.16 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.252 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -84.78 158.72 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.936 178.891 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -175.68 156.16 1.83 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.964 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' A' ' 62' ' ' VAL . 60.2 m -93.64 123.82 37.22 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.738 -177.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.35 164.22 16.66 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 90.9 mttt -73.51 151.11 41.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.487 0.184 . . . . 0.0 110.958 -176.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.7 ptm180 -82.27 146.25 54.07 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.476 176.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 69.8 Cg_endo -79.42 151.74 22.98 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.42 2.08 . . . . 0.0 110.909 172.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.492 ' SG ' ' HA2' ' A' ' 133' ' ' GLY . 52.5 m -110.95 -9.23 14.43 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.804 177.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.55 175.42 47.63 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.699 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.74 123.19 89.05 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 56.3 Cg_endo -70.2 83.66 0.76 Allowed 'Trans proline' 0 C--O 1.254 1.283 0 C-N-CA 123.076 2.517 . . . . 0.0 113.017 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 138' ' ' ILE . . . 63.54 -142.55 47.07 Favored Glycine 0 C--O 1.215 -1.068 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.47 130.14 17.0 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 t -127.24 99.53 27.86 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-O 121.522 0.677 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.59 -39.41 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.485 2.123 . . . . 0.0 113.403 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.43 -20.49 17.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.33 176.91 18.77 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.739 -178.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 p -134.84 175.64 9.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 37.8 p90 -150.49 151.19 32.32 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.423 177.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.5 p -101.59 171.37 7.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 103' ' ' VAL . 96.2 mt -141.69 136.7 31.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 173.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -113.31 -62.28 1.61 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.73 56.02 4.9 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.749 -176.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . 158.13 -57.49 0.35 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.329 177.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 12.6 m120 87.74 18.17 0.07 Allowed 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.401 1.48 . . . . 0.0 107.873 -179.035 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 p -141.27 -161.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.819 0 CA-C-N 111.822 -2.444 . . . . 0.0 105.051 177.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 44.9 m-85 -112.07 86.26 2.31 Favored 'General case' 1 C--N 1.236 -4.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 -175.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -151.02 155.89 39.99 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.457 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.634 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 79.6 t80 -45.47 115.38 0.92 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 125.036 1.46 . . . . 0.0 112.273 -178.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.41 -21.76 6.0 Favored Glycine 0 N--CA 1.427 -1.959 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.1 137.51 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.886 -1.125 . . . . 0.0 111.438 177.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -106.61 110.78 23.07 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -81.72 92.46 6.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -81.58 124.37 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.928 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.411 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 7.7 t80 -84.27 130.62 34.8 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.08 150.03 43.69 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 26.6 m -130.18 148.72 52.05 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.9 173.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.411 1.069 . . . . 0.0 112.586 177.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -44.14 -53.02 6.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.626 1.57 . . . . 0.0 113.567 -176.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 22.45 34.82 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.139 -176.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -134.05 161.01 36.02 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.391 0.615 . . . . 0.0 111.691 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -156.39 -156.38 0.62 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 173.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 1.2 pp -140.26 142.52 35.75 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -175.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 142' ' ' GLU . 4.2 mm? -83.5 135.52 34.62 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.72 171.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.25 152.01 9.03 Favored Glycine 0 C--N 1.267 -3.289 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -174.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.74 -13.06 37.61 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 117.343 0.572 . . . . 0.0 111.912 -176.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -111.21 116.44 52.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -91.63 25.49 2.66 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.448 0.642 . . . . 0.0 111.123 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 28.5 p90 -156.49 177.32 11.6 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.75 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.628 ' NH1' HG12 ' A' ' 138' ' ' ILE . 15.2 ptt180 -157.36 128.4 6.7 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 37.6 mt-10 -103.67 142.24 34.68 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.78 98.89 7.98 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -103.86 -158.51 0.67 Allowed 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.692 -173.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.518 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 38.9 p -64.94 -38.48 91.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.741 1.217 . . . . 0.0 113.14 -172.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.5 -33.99 11.64 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 120.95 0.405 . . . . 0.0 110.326 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.492 ' HA2' ' SG ' ' A' ' 85' ' ' CYS . . . 161.24 -149.14 17.76 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.554 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -71.65 130.0 40.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.727 0.264 . . . . 0.0 110.766 -178.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.5 p -79.76 167.36 20.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.336 176.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.28 -101.99 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.04 0.936 . . . . 0.0 112.668 173.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 169.82 -158.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -177.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.628 HG12 ' NH1' ' A' ' 127' ' ' ARG . 62.6 mt -102.31 107.1 52.0 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 9.4 Cg_endo -58.37 137.36 80.05 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.483 1.456 . . . . 0.0 109.37 174.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.37 115.17 25.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.041 -171.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 8.8 t -75.09 99.81 4.04 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 123.437 0.461 . . . . 0.0 109.851 -178.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.462 ' HB2' HD21 ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.77 1.628 . . . . 0.0 108.234 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 12.8 m-20 . . . . . 0 C--O 1.243 0.742 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.6 m -61.38 139.98 58.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.32 16.44 15.77 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.542 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -156.45 161.35 40.08 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.702 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.06 153.44 79.95 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 123.984 0.914 . . . . 0.0 109.935 176.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.41 123.68 14.4 Favored 'Trans proline' 0 C--O 1.254 1.303 0 C-N-CA 122.273 1.982 . . . . 0.0 111.516 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -67.36 109.24 1.74 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -71.73 143.01 49.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.934 176.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -104.49 -171.81 1.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.25 -42.26 72.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.134 0.492 . . . . 0.0 110.316 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 15.8 p -109.63 11.68 24.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mp0 -138.28 134.25 34.11 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.706 -0.621 . . . . 0.0 112.601 -178.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.93 157.32 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.11 140.64 45.39 Favored 'General case' 0 C--N 1.264 -3.138 0 O-C-N 123.817 0.698 . . . . 0.0 110.735 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -73.51 -52.96 11.77 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.909 177.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.57 167.99 41.42 Favored Glycine 0 N--CA 1.421 -2.353 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.347 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 p -90.95 146.76 23.61 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 123.011 0.524 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -135.92 143.43 44.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.0 t -125.65 -44.12 1.84 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HE1' ' A' ' 42' ' ' TYR . 15.2 t70 -97.09 158.04 15.63 Favored 'General case' 0 C--O 1.186 -2.268 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -170.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -79.09 -30.01 43.62 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.21 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 77.9 p -101.08 119.95 39.5 Favored 'General case' 0 N--CA 1.41 -2.457 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.99 -174.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HE1' ' O ' ' A' ' 39' ' ' ASP . 40.4 m-85 -130.29 155.01 81.56 Favored Pre-proline 0 C--N 1.302 -1.46 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.078 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 147.09 88.94 Favored 'Trans proline' 0 C--O 1.252 1.208 0 C-N-CA 122.121 1.881 . . . . 0.0 111.555 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.9 146.75 49.38 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.8 9.12 62.94 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.992 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -89.08 120.32 30.38 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.87 -0.194 . . . . 0.0 111.222 177.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -87.01 157.0 19.54 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.323 0.582 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.09 126.51 41.32 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.76 130.52 46.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 80.6 m-85 -99.76 138.8 36.34 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -78.2 -18.41 55.51 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 127.209 2.204 . . . . 0.0 112.531 -173.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 97.4 m 67.22 -2.87 1.11 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 62.4 mtp180 69.76 153.97 0.14 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.531 0.732 . . . . 0.0 111.131 -174.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.49 121.4 7.94 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.794 1.663 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.534 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 111.92 -5.43 27.39 Favored Glycine 0 C--N 1.306 -1.123 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.357 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 41.0 m-85 -120.49 174.57 6.47 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -162.45 -173.33 3.52 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 p -151.09 168.08 25.73 Favored 'General case' 0 C--N 1.266 -3.048 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.3 tp -105.59 32.23 4.45 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.53 109.74 0.38 Allowed Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.4 ' O ' HG12 ' A' ' 63' ' ' ILE . 11.6 m120 -52.83 140.08 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 117.337 0.568 . . . . 0.0 111.695 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 93.0 t -64.86 112.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 61' ' ' ASN . 46.9 mm -113.2 118.37 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.69 170.94 7.59 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.1 p -156.21 148.32 11.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.9 t -81.25 134.29 35.58 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.242 -177.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.421 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 4.7 tpm_? -152.59 126.76 9.16 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 32.7 mmtp 63.12 18.49 10.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 175.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 99.81 -12.41 60.96 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.944 179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.32 168.24 10.14 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -101.3 121.74 42.43 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.84 179.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.65 39.61 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.219 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -68.95 -42.57 76.49 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.582 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 9.0 t-20 -127.8 97.44 30.04 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.959 173.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.13 -7.45 16.22 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 0.0 112.864 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.61 -27.3 51.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.534 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.582 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 29.3 mmt180 -92.69 153.76 18.76 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.992 -177.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -158.03 147.3 19.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.56 123.57 28.22 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.548 -178.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -121.28 167.76 12.37 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.96 157.32 22.08 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.345 0.593 . . . . 0.0 111.963 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.6 ptm180 -99.01 154.61 37.24 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 46.6 Cg_endo -73.15 151.46 49.45 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.519 1.479 . . . . 0.0 109.386 169.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -78.52 -46.52 19.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.557 0.694 . . . . 0.0 110.111 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.51 -125.86 3.61 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -176.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -141.4 116.64 7.13 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.36 41.72 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 124.08 3.187 . . . . 0.0 114.904 -174.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.34 -137.28 30.96 Favored Glycine 0 C--N 1.311 -0.815 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -149.21 -176.54 5.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 t -171.83 106.44 0.37 Allowed Pre-proline 0 C--N 1.289 -2.061 0 C-N-CA 125.477 1.511 . . . . 0.0 107.563 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.34 -17.58 18.71 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.368 2.045 . . . . 0.0 113.435 -175.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.64 ' CD1' ' HB3' ' A' ' 141' ' ' CYS . 0.1 OUTLIER -124.06 -5.22 7.91 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.641 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.97 -163.91 10.5 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -162.27 -177.98 6.04 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 117.277 0.538 . . . . 0.0 110.619 178.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -143.55 164.6 29.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.257 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 68.2 p -120.93 169.87 10.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.8 mt -129.64 135.38 48.46 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -120.43 1.38 10.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.256 0.551 . . . . 0.0 112.331 -174.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.74 24.9 4.8 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.28 148.19 5.61 Favored Glycine 0 N--CA 1.411 -2.977 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -174.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -93.59 32.7 1.36 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 122.517 1.151 . . . . 0.0 109.141 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.99 162.42 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.624 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.322 -174.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 45.0 m-85 -91.42 100.21 13.02 Favored 'General case' 0 C--N 1.26 -3.318 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.883 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.16 149.0 37.45 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.456 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 91.5 t80 -52.39 121.22 6.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.172 0.511 . . . . 0.0 110.473 177.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.5 -13.86 25.28 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.302 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.6 142.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 109.69 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.471 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.6 ttmp? -113.09 126.01 55.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -93.51 102.92 15.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.068 0.855 . . . . 0.0 108.898 177.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.453 HG21 ' HG1' ' A' ' 97' ' ' THR . 0.7 OUTLIER -87.84 126.67 41.35 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.281 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -93.17 142.5 27.24 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -135.17 155.75 50.17 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 44.1 t -158.92 100.48 1.58 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 47.67 -160.65 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 164.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -98.77 -64.93 0.99 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.003 -0.435 . . . . 0.0 111.126 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.72 34.12 2.98 Favored Glycine 0 N--CA 1.469 0.892 0 CA-C-O 121.492 0.496 . . . . 0.0 112.58 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.13 173.65 11.3 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 120' ' ' LEU . 43.6 mt-30 -130.27 -66.09 0.79 Allowed 'General case' 0 CA--C 1.432 -3.596 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 167.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.62 ' HB3' ' O ' ' A' ' 119' ' ' GLN . 1.5 pt? 165.36 157.46 0.02 OUTLIER 'General case' 1 N--CA 1.362 -4.86 0 N-CA-C 102.204 -3.258 . . . . 0.0 102.204 164.156 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.0 mt -97.26 112.53 24.29 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 119.521 1.055 . . . . 0.0 110.455 175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.23 150.54 5.3 Favored Glycine 0 C--N 1.283 -2.404 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.28 -32.27 43.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 117.787 0.794 . . . . 0.0 108.894 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -95.72 107.4 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.416 ' HA ' HD11 ' A' ' 120' ' ' LEU . 2.6 p-10 -88.04 29.45 0.94 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.881 0.848 . . . . 0.0 110.982 -175.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -162.24 175.68 11.4 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.937 -175.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.64 ' NH2' HG12 ' A' ' 138' ' ' ILE . 12.2 ttm180 -143.56 120.93 11.63 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.37 152.23 19.85 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.429 176.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 49.8 t -79.44 149.14 31.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 131' ' ' THR . 17.5 t70 -126.07 -177.97 4.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.436 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 39.5 p -61.42 -33.83 74.37 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.59 1.156 . . . . 0.0 113.303 -175.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.52 9.15 7.11 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.399 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.11 -126.08 1.11 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.543 -178.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -131.08 153.64 49.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.8 p -91.17 128.97 37.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 80.22 176.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.897 0.879 . . . . 0.0 111.994 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 12.2 t70 -105.12 -156.21 0.57 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -174.256 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.64 HG12 ' NH2' ' A' ' 127' ' ' ARG . 62.2 mt -101.94 101.92 20.97 Favored Pre-proline 0 N--CA 1.42 -1.926 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.501 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 7.3 Cg_endo -52.86 133.43 51.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 122.263 1.975 . . . . 0.0 108.05 172.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 140' ' ' ILE . 3.3 mp -86.97 123.75 40.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -171.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.64 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . 48.9 t -68.64 91.51 0.43 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 CA--C 1.496 -1.129 0 C-N-CA 126.274 1.83 . . . . 0.0 107.254 -175.323 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.653 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 41' ' ' THR . 82.3 m -80.76 133.37 35.64 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.336 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.71 33.6 3.98 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.143 0.973 . . . . 0.0 108.958 -178.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.85 158.11 37.52 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.979 -176.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 19.5 mt -85.0 154.46 60.75 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 123.872 0.733 . . . . 0.0 110.392 178.012 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.09 145.04 93.68 Favored 'Trans proline' 0 C--O 1.255 1.326 0 C-N-CA 122.338 2.025 . . . . 0.0 110.382 177.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.76 155.42 53.89 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.266 1.977 . . . . 0.0 112.777 -177.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -83.5 147.91 27.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 35.8 mtt180 -114.45 170.58 8.2 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -172.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -79.11 -40.55 30.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.795 -176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p -115.92 4.15 13.8 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.417 177.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 8.2 mp0 -131.63 153.92 49.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.663 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.25 156.64 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.457 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.4 mm? -77.24 149.35 35.46 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -99.25 156.53 16.93 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.48 -159.96 25.33 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.791 178.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -140.89 120.98 13.73 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.505 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 71.7 m95 -113.75 115.75 28.3 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -175.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -134.49 26.73 3.75 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.115 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 26.6 m-20 -126.92 -167.18 1.69 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.963 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.57 -53.57 0.77 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.714 0.406 . . . . 0.0 111.156 175.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.4 p -85.11 105.51 15.9 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.937 0.875 . . . . 0.0 113.106 -175.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -114.12 136.57 22.22 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.957 178.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.653 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 22.5 Cg_endo -63.12 150.25 89.17 Favored 'Trans proline' 0 C--O 1.257 1.472 0 C-N-CA 122.878 2.385 . . . . 0.0 112.215 -177.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.493 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -66.13 133.14 50.09 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.14 1.08 41.55 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.218 -176.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -82.33 114.64 20.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.206 178.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.429 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.3 113.28 25.97 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.14 121.31 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.781 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -98.55 140.75 32.31 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.944 0.878 . . . . 0.0 113.24 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 53' ' ' ARG . 61.7 tttm -94.2 111.97 23.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 171.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 98.2 m -79.11 32.61 0.22 Allowed 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 51' ' ' LYS . 80.8 mtt180 64.23 151.85 0.12 Allowed Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.148 1.379 . . . . 0.0 113.274 177.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 36.5 Cg_endo -67.95 124.74 12.19 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.326 1.35 . . . . 0.0 108.883 173.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.14 -19.89 10.78 Favored Glycine 0 C--N 1.297 -1.591 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 75.5 m-85 -114.4 170.1 8.55 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -155.18 179.08 9.49 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.5 p -170.81 135.22 1.07 Allowed 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.2 -43.8 85.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 114.27 3.91 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 172.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -64.31 155.36 32.43 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 123.817 0.363 . . . . 0.0 110.66 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.544 HG22 ' SG ' ' A' ' 80' ' ' CYS . 98.7 t -72.55 102.2 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.04 118.44 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.5 mtp -104.62 169.15 8.62 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.6 p -156.66 146.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.286 0.565 . . . . 0.0 109.905 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.62 122.53 23.31 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.739 177.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 31.9 ttt180 -152.77 134.29 14.47 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 34.0 mmtp 67.23 12.13 8.77 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.302 1.041 . . . . 0.0 112.507 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.62 -4.27 57.97 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.81 157.48 33.99 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.16 0.505 . . . . 0.0 110.834 177.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -87.84 117.16 26.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.62 176.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.028 -178.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.78 128.97 36.23 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.433 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.11 -50.92 43.71 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.46 91.13 6.64 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.755 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.28 -15.55 22.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.619 2.212 . . . . 0.0 112.084 -177.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.1 mt -83.37 -9.34 59.11 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.038 0.923 . . . . 0.0 111.018 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -102.99 138.69 39.53 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.914 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.433 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -145.88 162.16 38.37 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 172.456 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.544 ' SG ' HG22 ' A' ' 62' ' ' VAL . 83.1 m -101.79 130.26 48.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.572 -0.851 . . . . 0.0 113.016 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 172.79 7.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.955 -178.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.75 157.12 33.59 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -85.34 145.57 42.85 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.17 144.59 13.32 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.979 1.786 . . . . 0.0 109.582 176.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.6 m -103.53 5.81 37.0 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.268 0.556 . . . . 0.0 112.152 -173.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.31 -98.66 1.14 Allowed Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.927 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -152.58 142.68 15.09 Favored Pre-proline 0 C--N 1.278 -2.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.07 45.54 1.95 Allowed 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.523 2.815 . . . . 0.0 112.069 -176.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.4 -146.28 20.83 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.27 127.14 4.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 t -113.51 135.92 21.91 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.65 -35.07 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.759 2.306 . . . . 0.0 114.379 -178.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -143.53 11.19 1.67 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.091 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 176.96 32.17 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -137.56 174.65 10.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.37 156.79 34.49 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.61 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -118.94 154.88 32.3 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 175.076 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -120.74 135.58 55.1 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.456 HG21 ' HB3' ' A' ' 109' ' ' LYS . 8.5 t -112.99 139.04 48.99 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.16 -68.75 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.926 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.75 -72.48 0.82 Allowed Glycine 0 C--N 1.31 -0.868 0 CA-C-N 115.555 -0.322 . . . . 0.0 113.402 -173.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 82.24 18.44 0.34 Allowed 'General case' 0 CA--C 1.455 -2.684 0 CA-C-O 123.467 1.603 . . . . 0.0 108.599 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.21 165.04 1.13 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.215 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -88.47 85.32 6.83 Favored 'General case' 0 C--N 1.255 -3.503 0 O-C-N 123.673 0.608 . . . . 0.0 110.154 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 108' ' ' VAL . 11.7 pt-20 -133.33 162.26 32.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.266 -176.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -52.74 128.26 25.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.026 176.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.74 -19.52 53.1 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.173 178.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 105' ' ' GLU . 5.4 p -71.51 141.58 16.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.023 -177.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.456 ' HB3' HG21 ' A' ' 99' ' ' THR . 39.0 ttmt -106.07 121.53 44.32 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.37 97.35 9.77 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.61 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.2 p -87.51 112.78 23.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.532 ' OH ' ' HB2' ' A' ' 141' ' ' CYS . 15.3 t80 -81.21 139.42 35.53 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.203 -170.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -142.34 170.9 14.84 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.23 -89.67 0.59 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.802 177.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -138.26 -149.2 0.29 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.01 -51.77 5.3 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.359 -179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.31 -18.86 63.58 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.601 178.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.11 144.97 25.02 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -122.15 -68.47 0.89 Allowed 'General case' 0 CA--C 1.438 -3.348 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.786 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.263 1.0 OUTLIER 169.52 153.46 0.04 OUTLIER 'General case' 1 N--CA 1.297 -8.115 0 CA-C-N 111.605 -2.543 . . . . 0.0 105.145 -169.876 . . . . . . . . 5 4 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.786 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 36.6 tp -134.16 126.94 31.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.18 171.83 12.57 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.179 -1.969 . . . . 0.0 108.179 -176.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -92.52 -21.13 20.3 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 118.223 1.012 . . . . 0.0 110.814 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 136' ' ' ASN . 32.3 mm -114.33 114.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -94.87 19.85 9.64 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -175.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -159.03 174.18 15.32 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.31 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.424 ' NH2' ' HA ' ' A' ' 137' ' ' ASP . 8.5 ptm180 -151.88 127.82 10.34 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.34 171.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -99.53 160.7 14.09 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.026 0.53 . . . . 0.0 109.709 -178.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.3 t -98.55 114.82 27.4 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.955 175.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.24 -179.64 5.3 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 125.401 1.48 . . . . 0.0 108.385 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 51.2 p -62.54 -36.25 82.02 Favored 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 123.714 0.805 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.85 -34.85 24.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.52 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.29 -157.53 29.43 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -69.02 129.56 40.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.69 1.245 . . . . 0.0 110.886 -177.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -55.56 -38.9 69.93 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 125.054 1.341 . . . . 0.0 112.711 -174.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.434 HD22 HG13 ' A' ' 124' ' ' ILE . 11.6 t-20 -138.32 172.81 12.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -175.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 16.6 t70 -102.53 -168.69 1.56 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 123.422 0.451 . . . . 0.0 110.241 -176.12 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.495 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.2 mt -76.81 123.15 87.47 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 124.435 1.094 . . . . 0.0 111.05 -171.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -73.58 163.24 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.717 1.611 . . . . 0.0 109.762 172.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mm -84.45 133.1 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.532 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 21.3 t -83.0 120.42 25.7 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 121' ' ' LEU . 13.2 tp10 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -174.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 31.2 m-20 . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 121.064 0.459 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 142.41 43.94 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 124.555 1.142 . . . . 0.0 110.757 -172.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 19.99 14.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.925 0.869 . . . . 0.0 109.35 175.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.55 156.01 34.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.665 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.4 mt -77.4 158.25 79.37 Favored Pre-proline 0 C--O 1.253 1.238 0 O-C-N 123.759 0.662 . . . . 0.0 110.82 176.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 20.3 Cg_endo -62.03 135.05 52.83 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.337 2.024 . . . . 0.0 109.581 175.359 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.02 137.09 21.23 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 121.986 1.791 . . . . 0.0 112.926 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -76.25 143.66 40.82 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -121.62 175.86 6.0 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.533 -170.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -59.02 -26.08 64.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 0.0 113.21 -175.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -134.3 12.05 3.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.88 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 3.1 mp0 -132.57 140.23 48.17 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.71 -0.796 . . . . 0.0 113.082 -172.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -135.67 142.62 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.74 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.0 mm? -69.65 142.06 53.51 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.998 -179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 p -101.76 87.98 3.28 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.25 -169.49 40.44 Favored Glycine 0 C--N 1.275 -2.815 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.751 -175.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -117.68 109.6 16.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.496 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 48.7 m95 -129.5 126.01 37.66 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 t -160.94 25.01 0.14 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.36 -164.48 1.13 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.782 -1.553 . . . . 0.0 110.053 -172.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -123.83 -64.87 1.11 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.94 0.4 . . . . 0.0 110.91 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 p -105.6 146.23 29.94 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.33 153.99 56.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.78 1.232 . . . . 0.0 109.207 178.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 57.6 Cg_endo -73.47 152.93 49.61 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.019 1.813 . . . . 0.0 112.311 179.362 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.9 147.77 52.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.88 5.86 65.91 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.065 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -83.94 115.95 22.55 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.467 178.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -90.04 139.08 30.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.532 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.98 124.56 52.92 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.65 129.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -117.67 145.62 44.27 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.229 0.538 . . . . 0.0 112.303 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.16 152.85 18.92 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 m -92.97 28.68 2.03 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -174.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 66.29 155.48 0.13 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-O 121.384 0.611 . . . . 0.0 111.511 -177.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.71 108.23 1.02 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.763 1.642 . . . . 0.0 111.53 176.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.17 -23.18 4.95 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.955 177.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.9 m-85 -102.5 172.48 6.84 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -154.81 -179.45 8.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -170.6 -179.95 3.09 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.95 8.16 27.61 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 -161.51 27.75 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.93 147.42 26.16 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.83 117.72 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.22 124.94 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.655 -176.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.4 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 88.9 mtp -112.39 172.29 7.0 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.9 p -155.56 148.3 12.27 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.83 129.27 34.94 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 55.8 ttp180 -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 64.68 19.27 11.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.043 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 -12.48 62.0 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.949 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.1 157.77 24.22 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.169 0.509 . . . . 0.0 111.736 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.406 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.1 m95 -91.99 116.21 28.73 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.489 178.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.44 172.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.496 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.68 108.54 19.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.2 tm? -61.15 -49.93 75.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 172.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.18 90.39 9.71 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.557 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.93 -17.91 15.11 Favored 'Trans proline' 0 N--CA 1.479 0.656 0 C-N-CA 122.478 2.119 . . . . 0.0 111.04 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.38 -27.62 60.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.442 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -92.18 131.66 37.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.745 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -140.02 163.36 32.9 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 71.5 m -92.91 110.53 21.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -105.33 162.7 13.21 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.369 -174.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HD3' ' CE2' ' A' ' 56' ' ' TYR . 33.8 mmtp -70.25 157.38 37.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -94.35 134.36 25.71 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.831 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 37.9 Cg_endo -71.62 136.76 28.88 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.288 1.992 . . . . 0.0 110.674 176.13 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.9 -1.79 39.2 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.059 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.78 -123.24 9.71 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.852 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -103.28 136.46 19.22 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.29 75.22 1.03 Allowed 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.431 2.087 . . . . 0.0 113.602 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.32 -136.02 19.54 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.536 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.64 27.87 6.01 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.613 0.365 . . . . 0.0 110.233 -176.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -48.82 115.35 4.41 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.271 176.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.31 -53.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.688 2.259 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.16 154.5 49.47 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.37 -168.18 21.06 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -176.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 m -155.37 156.17 34.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 48.8 p90 -145.24 165.94 26.93 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.549 0.53 . . . . 0.0 111.216 -177.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 70.9 p -118.76 -178.02 3.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.921 -179.374 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.6 155.23 49.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 15.1 t -165.47 149.24 8.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.78 -0.79 88.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.949 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.03 -169.58 39.79 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.37 3.31 4.26 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-N 117.748 0.774 . . . . 0.0 112.808 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.471 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.7 p -156.78 -160.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.068 -1.053 . . . . 0.0 108.698 -173.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 26.0 m-85 -90.87 77.28 6.21 Favored 'General case' 1 C--N 1.243 -4.034 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.771 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 15.8 pt-20 -136.48 152.28 50.38 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.201 -174.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -49.63 124.52 9.71 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.091 0.869 . . . . 0.0 110.165 173.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.25 -22.85 10.93 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.381 179.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.8 m -76.87 144.43 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.741 -179.023 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 22.2 ttmm -106.45 106.94 17.71 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -86.86 99.35 11.77 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.491 HG22 ' HG1' ' A' ' 97' ' ' THR . 0.9 OUTLIER -80.61 130.33 36.09 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.412 -177.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.88 108.92 21.72 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.912 0.863 . . . . 0.0 109.157 -172.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 m -100.95 -31.53 11.08 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.883 -172.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 33.6 m 65.74 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -166.36 -154.34 0.18 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.7 -60.47 2.34 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.442 -178.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.82 73.98 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.533 -177.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -115.02 128.41 56.25 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.513 0.197 . . . . 0.0 111.145 178.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.41 -134.21 0.33 Allowed 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 167.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -157.52 161.38 38.81 Favored 'General case' 1 N--CA 1.336 -6.158 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.247 . . . . . . . . 4 4 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 142' ' ' GLU . 4.1 mm? -88.58 125.04 34.61 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.331 0.586 . . . . 0.0 109.954 172.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.07 148.45 5.45 Favored Glycine 0 C--N 1.278 -2.688 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.44 -16.52 39.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.112 0.958 . . . . 0.0 109.484 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -109.93 106.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.538 ' HA ' HD13 ' A' ' 120' ' ' LEU . 26.3 p-10 -88.91 36.66 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.48 0.657 . . . . 0.0 111.758 -172.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.416 ' CD1' ' HG3' ' A' ' 109' ' ' LYS . 26.2 p90 -159.19 178.3 10.15 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.63 -177.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.435 ' NH2' HG23 ' A' ' 138' ' ' ILE . 6.3 ptp180 -148.98 124.31 10.24 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 17.7 mt-10 -96.76 157.22 16.0 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.35 107.1 18.35 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.557 175.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.29 -164.43 1.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.3 p -65.53 -42.96 91.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.974 0.91 . . . . 0.0 110.04 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.32 -46.28 73.94 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.253 177.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.28 -139.09 7.43 Favored Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.45 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.9 m95 -70.86 126.7 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 -176.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.9 p -80.37 170.24 16.65 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.607 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.4 m120 70.45 -81.22 0.03 OUTLIER 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.253 1.021 . . . . 0.0 111.857 173.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.1 t0 163.57 -161.62 0.0 OUTLIER 'General case' 0 C--O 1.242 0.661 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.435 HG23 ' NH2' ' A' ' 127' ' ' ARG . 4.0 mp -107.05 96.64 15.55 Favored Pre-proline 0 C--N 1.284 -2.277 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' CB ' HD12 ' A' ' 120' ' ' LEU . 1.2 Cg_endo -47.33 123.7 8.2 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.811 2.341 . . . . 0.0 109.737 173.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.2 114.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.42 -174.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 14.0 t -59.67 112.86 1.97 Allowed 'General case' 0 C--O 1.254 1.336 0 O-C-N 123.794 0.683 . . . . 0.0 109.713 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.423 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -173.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.129 0.49 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -70.4 138.96 51.73 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.04 0.936 . . . . 0.0 110.116 -174.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.04 24.93 6.32 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.787 0.804 . . . . 0.0 108.948 176.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.14 160.78 33.36 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.611 -178.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.94 152.92 63.25 Favored Pre-proline 0 C--N 1.313 -0.993 0 O-C-N 123.614 0.571 . . . . 0.0 110.325 176.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -54.01 142.84 64.03 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.909 2.406 . . . . 0.0 113.172 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.65 112.43 2.86 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.429 2.086 . . . . 0.0 111.896 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -76.35 151.05 36.77 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.638 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -121.05 -179.84 4.16 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -174.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -90.53 -20.17 22.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.153 0.501 . . . . 0.0 109.705 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 -10.34 17.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 177.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -134.74 137.56 43.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.263 0.554 . . . . 0.0 111.649 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.33 163.52 24.16 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.796 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.3 mm? -91.78 151.0 20.8 Favored 'General case' 0 C--N 1.266 -3.059 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.9 p -112.47 101.21 9.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.1 -171.43 32.09 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -108.34 115.18 29.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 53.9 m95 -132.7 107.38 8.35 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.215 0.531 . . . . 0.0 109.94 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 t -153.38 28.64 0.5 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 174.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.37 -161.49 0.76 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.413 -168.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.36 -67.09 0.41 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 82.3 p -94.62 128.76 41.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.172 -173.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.44 157.54 77.85 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.66 147.17 39.8 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.261 1.974 . . . . 0.0 111.834 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 22.1 tt0 -64.73 137.21 57.67 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.212 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.54 7.79 50.63 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.3 m -83.82 119.52 24.94 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.849 177.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -87.56 146.41 25.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.31 0.576 . . . . 0.0 111.654 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.2 122.0 41.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.36 129.84 44.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -104.04 153.6 20.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.493 1.139 . . . . 0.0 113.986 -178.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' ARG . 64.0 tttp -103.65 118.35 36.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.872 172.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.5 m -69.73 12.31 0.21 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 123.98 0.912 . . . . 0.0 113.392 -178.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' LYS . 70.5 mtp180 66.89 154.41 0.13 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.133 0.973 . . . . 0.0 109.158 -170.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.87 -9.09 13.09 Favored 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 122.358 2.039 . . . . 0.0 115.091 -177.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.2 1.83 35.14 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.188 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.682 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 48.1 m-85 -123.49 173.28 8.13 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.349 -1.089 . . . . 0.0 111.475 -177.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.44 -172.57 4.17 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.888 0.875 . . . . 0.0 109.346 -175.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -174.08 162.49 3.8 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.47 -8.15 58.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.778 . . . . 0.0 109.861 177.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.33 -123.88 1.81 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.97 151.31 28.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.98 103.22 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.618 0.723 . . . . 0.0 109.114 177.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.5 mm -110.87 121.23 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.975 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.2 mtp -110.22 170.04 8.34 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 5.8 p -154.21 142.16 13.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.23 127.92 32.65 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.314 -178.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 53.5 ttp180 -150.5 125.83 10.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.19 35.3 12.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.715 0.806 . . . . 0.0 112.525 -179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.36 53.55 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.001 176.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.62 163.97 12.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.806 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -104.9 114.15 28.18 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -179.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 p -123.24 -167.33 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.367 -4.599 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.012 -171.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.66 113.24 25.23 Favored 'General case' 1 C--N 1.224 -4.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 114.145 -168.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.4 -52.93 10.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 172.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.57 92.56 14.35 Favored Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.267 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.74 -1.04 11.22 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.401 2.067 . . . . 0.0 111.96 178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.72 -5.19 51.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.222 0.534 . . . . 0.0 109.925 178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -112.79 144.84 41.65 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.203 0.525 . . . . 0.0 111.001 -175.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -156.34 147.75 22.52 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 173.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -83.74 113.14 20.69 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.672 177.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -105.59 163.96 12.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.07 -177.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 96.8 mttt -64.05 143.45 57.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.261 0.553 . . . . 0.0 111.452 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -84.13 145.39 45.97 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.48 157.67 44.76 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.539 1.493 . . . . 0.0 111.086 -177.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.3 m -107.66 7.61 28.62 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 -176.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.51 -102.63 1.31 Allowed Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.611 178.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -152.65 130.96 6.3 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.89 37.22 0.4 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 123.069 2.513 . . . . 0.0 111.789 -177.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.92 -176.87 54.55 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -172.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -124.4 -171.32 2.31 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -172.29 126.77 0.55 Allowed Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.6 -22.72 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.976 1.784 . . . . 0.0 113.694 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -129.86 -5.35 4.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.89 171.77 20.22 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.782 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -136.25 160.65 38.06 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.5 p90 -144.69 149.98 36.56 Favored 'General case' 0 N--CA 1.418 -2.042 0 O-C-N 123.332 0.395 . . . . 0.0 111.211 174.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 61.5 p -101.45 175.67 5.49 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.423 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -140.67 131.33 25.63 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -127.26 9.06 6.66 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.577 0.703 . . . . 0.0 112.233 -171.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.32 34.24 2.21 Favored Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.24 175.15 13.66 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 106.379 -2.688 . . . . 0.0 106.379 -172.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -124.12 24.18 8.24 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 118.417 1.109 . . . . 0.0 108.773 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.8 m -143.09 -177.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -89.96 85.38 6.33 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.039 -178.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.39 144.25 51.27 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.144 -178.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 72.5 t80 -49.18 114.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.885 0.874 . . . . 0.0 111.385 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 127.33 -22.04 5.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.529 -179.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.74 139.09 19.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 122.053 0.93 . . . . 0.0 111.133 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -108.13 117.14 33.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 170.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -90.37 97.64 11.3 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -79.88 127.26 39.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.669 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 59.7 t80 -114.07 143.88 44.04 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 -171.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 2.4 m -151.54 160.55 43.63 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.085 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 75.6 m -149.15 126.49 11.49 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 66.77 178.3 0.22 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.23 -47.77 3.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.847 -178.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.02 74.27 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.191 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -141.28 -177.92 5.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HB2' HD11 ' A' ' 120' ' ' LEU . 2.8 pt20 -153.79 -130.9 0.04 OUTLIER 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.191 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -99.26 163.88 12.36 Favored 'General case' 0 N--CA 1.386 -3.671 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.098 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' A' ' 142' ' ' GLU . 3.8 mm? -88.87 142.44 27.65 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 166.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.94 154.88 10.13 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -83.8 -26.71 29.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.937 0.875 . . . . 0.0 109.72 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.95 111.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.89 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.96 26.43 3.21 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.488 1.115 . . . . 0.0 110.716 -178.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 7.3 p90 -153.49 -178.12 6.79 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.343 -172.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -139.52 121.89 16.05 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 24.9 mt-10 -99.5 141.12 32.71 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.363 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.93 115.94 23.86 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.532 177.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.9 172.16 7.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.627 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.1 p -52.08 -39.38 59.62 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 125.347 1.459 . . . . 0.0 112.197 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.25 -33.47 19.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.902 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.73 -162.23 33.85 Favored Glycine 0 C--O 1.212 -1.281 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 134.69 47.85 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.541 0.671 . . . . 0.0 111.443 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -68.43 -25.79 65.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.241 0.616 . . . . 0.0 111.375 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -130.15 168.19 17.19 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -176.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -107.46 -104.44 0.35 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.389 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.5 96.74 32.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 4.7 Cg_endo -47.95 129.04 17.39 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.276 2.651 . . . . 0.0 111.64 178.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.2 mm -80.76 112.21 18.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.457 -173.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.669 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 57.4 m -79.24 114.13 17.93 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.785 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.468 ' HB3' HD22 ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.435 -1.19 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.356 0.598 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 138.4 58.41 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.404 -175.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.22 20.11 13.27 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.304 1.05 . . . . 0.0 108.772 175.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.84 153.6 39.36 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.624 179.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.66 157.58 69.46 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 144.49 96.45 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 122.073 1.849 . . . . 0.0 111.31 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.6 178.99 5.68 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.046 1.831 . . . . 0.0 111.53 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -94.41 158.7 15.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.48 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 10.5 mmt85 -103.94 166.41 10.43 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -77.04 -62.15 1.75 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -95.77 13.69 25.72 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.193 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 28' ' ' ARG . 4.8 mp0 -135.66 161.83 34.42 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.5 mt -134.4 150.52 30.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 37' ' ' TRP . 35.2 mt -71.84 143.32 49.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.532 0.605 . . . . 0.0 110.226 174.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 p -87.44 -33.24 19.13 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.174 0.512 . . . . 0.0 112.067 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.92 168.4 18.09 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.865 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -87.93 138.2 31.66 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 175.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 33' ' ' LEU . 75.9 m95 -130.28 117.8 20.37 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.307 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 m -130.31 4.81 4.78 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.217 0.532 . . . . 0.0 110.874 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.78 -165.76 1.28 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.09 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -140.7 -40.67 0.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.052 175.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.2 p -112.08 138.13 49.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.698 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -139.55 154.88 71.83 Favored Pre-proline 0 C--N 1.303 -1.434 0 C-N-CA 123.874 0.87 . . . . 0.0 109.067 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.83 148.65 28.66 Favored 'Trans proline' 0 C--O 1.257 1.462 0 C-N-CA 121.756 1.638 . . . . 0.0 111.056 175.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -62.05 145.44 53.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.15 1.3 59.56 Favored Glycine 0 C--N 1.298 -1.545 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.226 -179.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.9 m -83.93 118.12 23.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.421 0.153 . . . . 0.0 111.12 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.8 pt20 -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-O 121.925 0.869 . . . . 0.0 111.731 -176.578 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 113.02 19.09 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.97 114.92 27.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.123 -177.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.63 138.59 33.08 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.853 0.835 . . . . 0.0 112.353 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -80.41 139.04 36.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 12.2 t -84.57 10.29 11.42 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -170.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 67.24 133.32 0.04 OUTLIER Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.705 174.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.72 104.39 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.441 2.761 . . . . 0.0 114.093 -176.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.71 -24.37 5.2 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.177 177.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.575 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.7 m-85 -95.77 173.17 7.6 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.363 -0.493 . . . . 0.0 110.559 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -136.85 161.45 35.96 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.585 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 99.9 p -136.36 173.21 11.95 Favored 'General case' 0 N--CA 1.382 -3.847 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.325 177.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -83.71 -4.89 58.99 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.965 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.74 45.41 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 176.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.55 131.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.352 1.061 . . . . 0.0 112.691 -177.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.7 t -76.07 111.52 12.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -105.77 114.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-O 121.513 0.673 . . . . 0.0 109.788 -178.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtp -103.5 172.59 6.72 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.612 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.9 p -160.74 150.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.87 128.19 33.57 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 40.3 ttp180 -153.72 127.42 8.76 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 67.64 19.92 9.71 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.52 -14.74 64.48 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.158 178.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.89 172.99 6.52 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.166 0.508 . . . . 0.0 110.007 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -110.5 112.53 24.51 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.11 -158.44 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.372 -4.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.954 -175.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.49 129.53 39.66 Favored 'General case' 1 C--N 1.231 -4.552 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.508 -170.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -89.47 -57.45 2.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 171.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.7 m120 -112.29 95.05 29.18 Favored Pre-proline 0 N--CA 1.421 -1.911 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.163 178.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.71 -17.68 25.82 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.275 1.983 . . . . 0.0 111.382 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -79.14 -19.59 50.66 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.199 1.0 . . . . 0.0 110.834 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 29.6 mmt180 -81.11 129.7 34.68 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 174.064 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -145.21 152.73 40.45 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 16.9 m -104.95 114.81 29.23 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.189 0.995 . . . . 0.0 111.138 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -112.39 174.59 5.81 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.433 -178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -82.95 145.91 29.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.5 ptp180 -74.99 132.45 77.14 Favored Pre-proline 0 C--N 1.298 -1.648 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.214 178.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 47.2 Cg_endo -73.46 139.69 28.98 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 122.153 1.902 . . . . 0.0 110.115 176.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 m -89.49 -21.31 23.02 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.431 0.634 . . . . 0.0 109.761 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.61 -160.44 47.24 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.576 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.33 115.34 14.14 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 125.162 1.385 . . . . 0.0 110.653 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 138' ' ' ILE . 98.4 Cg_endo -78.76 -9.43 15.78 Favored 'Trans proline' 0 C--O 1.212 -0.794 0 C-N-CA 123.31 2.673 . . . . 0.0 113.151 -178.305 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 123.95 -155.65 17.93 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -145.05 157.9 43.98 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -150.11 125.99 5.04 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.78 -47.62 15.32 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.494 2.129 . . . . 0.0 111.445 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -109.82 140.04 44.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.414 ' C ' ' HG1' ' A' ' 95' ' ' THR . . . 105.46 -178.01 23.15 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.913 176.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 94' ' ' GLY . 13.8 m -158.04 166.97 31.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -123.49 159.35 29.27 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.239 176.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.587 ' OG1' HG12 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.98 159.39 25.7 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.422 177.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.69 139.86 52.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -113.32 -18.86 11.95 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.28 21.44 Favored Glycine 0 CA--C 1.5 -0.853 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.587 -174.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.64 -175.79 32.63 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -178.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.7 15.09 18.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.147 0.975 . . . . 0.0 109.083 178.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.65 172.3 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -96.5 100.41 12.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.216 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 108' ' ' VAL . 14.7 pt-20 -147.14 160.63 42.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 -174.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.5 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 92.6 t80 -55.14 116.28 2.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.127 0.489 . . . . 0.0 110.439 175.065 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.98 -18.91 11.29 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 105' ' ' GLU . 1.4 p -91.08 167.64 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -142.13 131.84 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.66 94.42 8.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.587 HG12 ' OG1' ' A' ' 97' ' ' THR . 3.7 p -93.49 114.71 30.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.883 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.65 144.09 26.51 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.387 1.089 . . . . 0.0 112.887 -173.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -134.81 150.83 50.56 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 103.479 -2.786 . . . . 0.0 103.479 174.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 118' ' ' TYR . 16.3 t -112.21 -80.92 0.59 Allowed 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.695 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 2.4 m-20 -137.7 -168.12 2.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.3 -43.17 70.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.264 0.554 . . . . 0.0 110.671 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.61 -1.91 46.69 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.81 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.702 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 91.2 m-85 -115.86 128.96 56.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 122.454 -0.439 . . . . 0.0 111.749 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 14.8 mm100 -139.2 -148.7 0.26 Allowed 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 170.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -111.66 169.88 8.52 Favored 'General case' 0 N--CA 1.382 -3.848 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.862 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.443 HD22 ' HB ' ' A' ' 140' ' ' ILE . 3.5 mm? -66.21 -64.26 0.9 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.765 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.23 -154.42 16.77 Favored Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.072 -0.967 . . . . 0.0 114.764 -173.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.68 -13.78 22.54 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.392 0.677 . . . . 0.0 111.435 -177.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 139' ' ' PRO . 45.8 mm -94.43 94.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 CA-C-O 122.293 1.044 . . . . 0.0 110.56 -175.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -94.31 26.49 3.33 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.494 -177.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.09 174.64 7.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.866 0.841 . . . . 0.0 112.54 -171.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HG3' ' CE3' ' A' ' 134' ' ' TRP . 9.1 ptm180 -140.67 132.19 27.0 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 170.051 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -110.91 157.37 19.94 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -168.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 46.3 m -90.62 116.56 28.6 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.659 0.742 . . . . 0.0 112.384 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -110.97 179.17 4.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.2 p -57.36 -35.74 70.32 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.918 0.887 . . . . 0.0 110.527 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.9 -35.19 67.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.781 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 139.43 -127.61 3.7 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -174.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.508 ' CE3' ' HG3' ' A' ' 127' ' ' ARG . 91.4 m95 -82.66 127.47 33.42 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 118.173 0.987 . . . . 0.0 109.749 178.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.2 p -62.64 -60.79 3.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.066 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.38 -173.4 2.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 12.2 t70 -113.01 -166.75 1.11 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.49 HD12 ' HA3' ' A' ' 89' ' ' GLY . 71.5 mt -82.14 124.97 78.18 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 122.949 0.5 . . . . 0.0 110.916 -173.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 16.3 Cg_endo -58.13 147.91 80.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.553 2.835 . . . . 0.0 111.789 178.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 37.1 mm -88.73 122.05 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.515 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 41.3 t -72.26 119.44 16.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.38 0.61 . . . . 0.0 111.079 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.671 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.4 m -69.31 137.39 52.93 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.681 -1.145 . . . . 0.0 107.969 -177.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -114.41 14.65 17.93 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.61 163.96 36.47 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.727 -175.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -98.0 159.06 31.74 Favored Pre-proline 0 N--CA 1.383 -3.825 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.721 -175.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.72 134.47 54.25 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 109.779 176.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.48 142.35 64.95 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.411 2.074 . . . . 0.0 113.439 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.405 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.97 134.61 35.39 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 171.092 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 31.8 mtp85 -118.99 179.52 4.13 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -169.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -78.51 -63.87 1.3 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.467 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 p -85.54 11.63 10.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.501 0.667 . . . . 0.0 112.44 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 4.0 mp0 -141.71 143.85 33.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.619 -176.155 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 51.9 mt -133.24 141.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.617 HD11 ' CD1' ' A' ' 37' ' ' TRP . 51.2 mt -71.94 141.16 49.46 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.751 0.657 . . . . 0.0 110.348 177.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -71.29 -61.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 178.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.28 52.61 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.308 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -103.83 114.44 28.7 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CD1' HD11 ' A' ' 33' ' ' LEU . 27.1 m95 -101.77 92.27 4.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.116 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -99.59 -5.91 28.26 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.122 -177.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.658 ' O ' HD23 ' A' ' 24' ' ' LEU . 6.0 m-20 -83.76 -163.1 0.72 Allowed 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -136.27 -54.74 0.75 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 45.3 p -90.98 129.02 37.03 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 121.528 0.68 . . . . 0.0 112.557 -176.038 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -135.91 153.29 76.96 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 123.814 0.846 . . . . 0.0 109.382 179.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.46 149.48 87.84 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.176 1.918 . . . . 0.0 112.441 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.73 135.59 49.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.7 7.66 50.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.038 -178.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -85.03 123.98 31.19 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.712 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -92.22 147.82 22.63 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.019 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.73 134.23 55.3 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.38 132.29 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 82.7 m-85 -109.57 136.34 49.11 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.469 175.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 36.1 mtpt -65.93 -26.81 67.76 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.211 1.004 . . . . 0.0 111.618 -176.114 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.656 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 19.2 m 71.33 8.74 6.41 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.472 -171.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 50.3 mtt180 66.57 170.2 0.1 Allowed Pre-proline 0 N--CA 1.494 1.752 0 CA-C-O 121.388 0.613 . . . . 0.0 111.198 -178.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.79 133.84 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 166.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.39 -17.11 34.36 Favored Glycine 0 C--N 1.302 -1.309 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.799 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 80.8 m-85 -118.85 161.94 19.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.176 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -149.23 -174.87 4.77 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 p -174.65 175.89 2.39 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.45 -8.94 58.79 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.78 48.09 0.1 OUTLIER Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 50.8 m-80 62.22 -172.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.657 0.783 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 53.7 t -110.86 116.13 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.8 114.39 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.766 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.5 mtp -105.75 167.32 9.85 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -151.39 146.39 15.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.2 t -84.75 132.23 34.46 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.768 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -154.27 120.75 5.44 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 65.88 38.22 5.15 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.197 0.999 . . . . 0.0 112.198 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.26 -16.16 24.73 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 114.962 -1.017 . . . . 0.0 114.084 176.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -110.38 154.97 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.399 0.6 . . . . 0.0 111.107 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 78.6 m95 -95.1 121.0 36.29 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.224 0.535 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.93 174.53 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.527 -176.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.18 125.25 30.04 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.29 -59.13 3.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -109.74 105.99 57.83 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.523 177.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.94 -14.14 40.37 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 123.428 2.752 . . . . 0.0 111.945 -178.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.44 -11.58 58.43 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.498 1.142 . . . . 0.0 109.876 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 42.0 mmt-85 -90.85 114.28 26.66 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.156 176.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -151.51 148.05 27.57 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.614 -177.252 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -86.24 108.97 18.61 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.567 -178.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -101.19 157.5 16.73 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.635 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 86.5 mttt -75.5 138.89 41.87 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.223 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 131' ' ' THR . 17.1 ptm180 -76.02 151.29 83.98 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.565 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 156.31 62.69 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.079 1.853 . . . . 0.0 111.796 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.3 m -114.3 5.53 15.8 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.651 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.36 -92.39 0.33 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.374 174.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -152.43 124.36 3.84 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -173.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.13 40.45 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 123.542 2.828 . . . . 0.0 112.865 -178.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 82.91 -179.43 52.99 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -177.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -103.72 162.63 12.92 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -161.45 109.76 1.22 Allowed Pre-proline 0 N--CA 1.42 -1.945 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.551 175.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.26 -50.72 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.905 1.737 . . . . 0.0 111.821 177.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -100.11 14.96 28.93 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -133.77 171.37 22.05 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.015 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 m -146.39 167.34 23.85 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 42.4 p90 -142.29 163.47 32.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.683 0.277 . . . . 0.0 111.038 -178.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 65.5 p -107.71 161.89 14.47 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.72 128.31 38.66 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -112.99 14.88 19.74 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.84 28.17 2.75 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.01 176.4 14.39 Favored Glycine 0 N--CA 1.411 -3.009 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 -173.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -112.25 32.5 5.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.12 165.69 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.184 -174.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -96.42 95.25 7.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 110.244 -177.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.98 155.65 49.94 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.567 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 52.2 t80 -50.9 124.47 11.3 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.072 0.857 . . . . 0.0 109.766 176.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.55 26.28 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.29 -1.433 . . . . 0.0 114.175 177.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.4 134.25 28.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 119.403 1.602 . . . . 0.0 109.498 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -97.83 117.19 31.59 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.02 104.71 16.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.506 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.1 m -87.65 130.32 37.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 139' ' ' PRO . 68.3 t80 -121.18 137.86 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.566 0.698 . . . . 0.0 112.051 -168.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.481 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 15.7 m -152.1 165.16 35.6 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.0 m -130.75 120.97 24.59 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.851 0.296 . . . . 0.0 110.529 -177.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 55.79 -155.64 0.28 Allowed 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.6 0.562 . . . . 0.0 110.317 178.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.5 -43.63 8.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.122 0.486 . . . . 0.0 110.835 177.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.39 11.72 68.54 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -173.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 70.0 m-85 -120.77 140.43 51.7 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.388 1.094 . . . . 0.0 111.9 177.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 42.5 mt-30 -133.96 -170.19 2.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 167.461 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -98.56 155.41 17.3 Favored 'General case' 2 N--CA 1.356 -5.143 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -175.716 . . . . . . . . 4 4 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.63 -31.99 57.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.302 -179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.16 174.6 53.19 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.202 177.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.65 -37.94 17.54 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.991 0.901 . . . . 0.0 109.592 -178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.1 mm -82.99 103.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.076 -175.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -87.71 25.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.428 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -159.15 173.87 15.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -148.84 118.02 6.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.846 174.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.25 146.25 23.98 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.876 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . 43.5 t -91.24 124.45 35.46 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.515 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.7 t70 -105.38 -164.84 1.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.518 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 28.6 p -54.06 -58.64 6.58 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 125.857 1.663 . . . . 0.0 112.761 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.22 -40.11 52.95 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 172.52 -155.45 23.28 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.525 -176.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 70.0 m95 -69.9 132.49 46.07 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 48.5 p -77.29 142.04 39.65 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 72.17 -168.79 0.14 Allowed 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.015 0.822 . . . . 0.0 109.245 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.91 -164.35 1.3 Allowed 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.475 HD12 ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt -86.28 107.97 15.56 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 7.1 Cg_endo -48.41 122.53 7.83 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.55 2.834 . . . . 0.0 112.196 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.0 mp -73.23 115.09 13.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.017 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 80.3 m -81.43 115.02 20.57 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.006 0.431 . . . . 0.0 111.437 179.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 . . . . . 0 C--N 1.303 -1.455 0 C-N-CA 124.327 1.051 . . . . 0.0 108.498 -179.64 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -65.12 137.78 57.87 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.208 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -124.0 24.7 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.115 0.959 . . . . 0.0 109.184 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.1 150.79 24.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.666 -1.607 . . . . 0.0 107.823 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.01 152.55 84.47 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 123.66 0.6 . . . . 0.0 109.916 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.21 147.5 91.2 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.022 1.814 . . . . 0.0 110.347 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.95 165.57 19.51 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 113.447 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -110.35 150.11 29.25 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -123.07 178.93 4.86 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.684 -168.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.63 -58.69 3.13 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.77 0.428 . . . . 0.0 110.094 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -90.23 -11.85 39.75 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -123.11 150.94 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.569 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 33.1 mt -131.1 148.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 mt -74.01 129.95 38.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 117.918 0.326 . . . . 0.0 111.487 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 19.9 p -121.34 104.39 9.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.525 0.679 . . . . 0.0 110.342 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.27 173.03 22.09 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -93.82 119.34 32.64 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 117.263 0.532 . . . . 0.0 110.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -126.9 121.68 32.47 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 t -149.86 13.27 0.8 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.934 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.95 152.65 49.17 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 121.508 -0.745 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.05 -30.49 62.43 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.751 0.31 . . . . 0.0 110.917 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.1 p -114.41 118.13 32.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.576 0.703 . . . . 0.0 112.714 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -119.97 153.15 54.96 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.099 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.92 140.07 44.9 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.175 1.917 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -61.74 136.54 58.03 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.25 -0.34 40.69 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.221 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -82.29 119.25 23.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.97 144.17 25.73 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.804 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.28 123.9 51.28 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.122 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.99 121.44 45.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.444 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 53.2 m-85 -99.73 145.72 27.34 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.985 0.897 . . . . 0.0 113.334 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 50.1 tptt -85.2 128.19 34.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.322 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.8 m -82.58 107.3 15.12 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 165.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -40.11 153.98 0.2 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.086 1.354 . . . . 0.0 113.598 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.69 114.02 2.22 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.698 1.598 . . . . 0.0 108.898 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 114.03 -8.38 23.27 Favored Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.06 168.76 13.54 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -162.22 -179.27 6.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.0 p -139.63 -77.64 0.33 Allowed 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 58' ' ' SER . 24.8 mt -176.32 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 126.612 1.965 . . . . 0.0 106.203 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.25 -108.11 1.18 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.85 158.04 44.27 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.0 t -86.54 109.89 19.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.39 121.24 54.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.194 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.2 mtp -111.18 166.36 11.14 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -152.86 146.71 14.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.0 t -81.23 126.61 31.74 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 2.5 tpm_? -148.73 128.76 13.55 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 34.7 mmtp 67.77 12.16 8.71 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.42 -9.4 57.42 Favored Glycine 0 CA--C 1.495 -1.184 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.848 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -115.56 163.62 15.51 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.15 116.21 28.94 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 m -115.2 167.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.471 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.37 110.06 20.9 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.53 -45.89 92.17 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -115.71 91.06 28.71 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.147 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.99 -15.67 26.01 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.815 2.343 . . . . 0.0 111.661 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.19 -20.49 48.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.097 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.723 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -161.86 156.09 22.13 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.511 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 59.3 m -92.99 118.69 31.45 Favored 'General case' 0 C--N 1.27 -2.877 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -113.05 -179.48 3.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.0 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.4 mmtp -59.45 147.54 36.16 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.82 0.7 . . . . 0.0 111.565 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 131' ' ' THR . 10.9 ptp180 -98.17 143.13 25.73 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 55.2 Cg_endo -71.81 148.21 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.518 2.145 . . . . 0.0 111.533 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.06 -19.37 15.2 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.677 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.92 -163.55 52.48 Favored Glycine 0 CA--C 1.467 -2.958 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.793 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -73.21 129.47 86.04 Favored Pre-proline 0 C--N 1.261 -3.263 0 CA-C-N 114.427 -0.887 . . . . 0.0 112.539 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 84.4 Cg_endo -84.85 -3.36 9.78 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 C-N-CA 123.054 2.503 . . . . 0.0 111.748 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 114.35 3.85 Favored Glycine 1 N--CA 1.395 -4.043 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -99.91 175.38 5.79 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.025 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.449 HG22 ' OH ' ' A' ' 112' ' ' TYR . 5.4 t -151.22 145.19 17.77 Favored Pre-proline 0 N--CA 1.416 -2.167 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.24 -23.75 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.039 1.826 . . . . 0.0 111.331 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -127.56 105.14 8.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.84 168.04 11.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -142.08 169.44 17.59 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.7 155.75 38.95 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 p -128.95 141.0 51.41 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -98.21 129.02 44.97 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.566 0.698 . . . . 0.0 110.664 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.1 t -114.92 130.28 56.88 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.94 -16.06 33.41 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.36 -176.78 48.0 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -121.97 18.45 10.91 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.683 0.754 . . . . 0.0 109.519 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 m -140.21 169.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 30.3 m-85 -93.28 89.19 6.29 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.525 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.5 pt-20 -133.31 158.12 43.76 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.921 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 77.4 t80 -48.76 115.24 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.417 1.087 . . . . 0.0 110.969 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.08 -21.74 10.06 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.753 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -79.27 149.97 5.28 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.647 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.8 ttmp? -113.63 124.55 52.59 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.02 90.85 8.05 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.8 114.91 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.449 ' OH ' HG22 ' A' ' 91' ' ' THR . 58.9 t80 -79.94 138.46 37.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.7 167.55 16.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 118' ' ' TYR . 12.3 t -146.79 173.82 12.04 Favored 'General case' 0 N--CA 1.396 -3.172 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.278 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.09 155.33 20.69 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.881 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -50.78 -41.16 56.7 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.066 0.946 . . . . 0.0 112.205 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.96 64.88 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.581 ' HB2' ' SG ' ' A' ' 114' ' ' CYS . 34.8 m-85 -136.59 167.02 22.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 119.094 1.447 . . . . 0.0 111.159 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.52 -93.97 0.51 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 168.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.1 pp 175.74 158.01 0.23 Allowed 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.58 0.752 . . . . 0.0 111.499 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 96.1 mt -96.91 135.69 38.53 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 122.16 168.18 13.22 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -96.88 -28.99 13.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.4 mm -100.03 105.15 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.267 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -89.37 36.18 0.83 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.886 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.464 ' C ' ' HD3' ' A' ' 127' ' ' ARG . 23.0 p90 -165.21 174.1 10.61 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.184 0.516 . . . . 0.0 111.114 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 126' ' ' TYR . 1.4 mpp_? -139.46 132.36 29.3 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -113.01 147.81 36.39 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 118.437 0.562 . . . . 0.0 111.182 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 11.6 m -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.157 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -101.4 -166.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.506 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 28.7 p -59.5 -46.17 89.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 124.939 1.296 . . . . 0.0 112.728 -174.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.74 21.93 15.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 132.02 -155.5 21.49 Favored Glycine 0 C--N 1.288 -2.115 0 C-N-CA 119.394 -1.384 . . . . 0.0 113.624 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.48 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.6 m95 -81.49 146.15 30.36 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.225 0.536 . . . . 0.0 111.355 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.5 p -78.65 -25.21 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.884 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.79 -179.62 5.76 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -171.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -107.98 -155.59 0.56 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.689 0.796 . . . . 0.0 110.585 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.25 107.75 34.42 Favored Pre-proline 0 C--N 1.313 -0.984 0 O-C-N 122.039 -0.413 . . . . 0.0 110.344 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -66.89 133.61 31.89 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.486 2.124 . . . . 0.0 110.19 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.1 mm -86.83 123.9 40.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.648 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.91 105.97 1.44 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.409 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 29.8 mm-40 . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 124.597 1.159 . . . . 0.0 108.097 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.67 121.95 26.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.418 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.59 33.56 2.02 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.843 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 10.8 pt-20 -155.6 148.78 24.64 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.908 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.441 ' CD2' ' HB3' ' A' ' 37' ' ' TRP . 18.2 mt -73.27 153.12 90.33 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 123.794 0.838 . . . . 0.0 109.56 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.8 Cg_endo -62.58 130.09 28.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.693 1.595 . . . . 0.0 109.39 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 2.9 Cg_exo -72.87 126.91 11.72 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.65 1.567 . . . . 0.0 112.542 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 136.08 57.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -111.03 163.16 14.13 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -171.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.25 -33.82 67.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.53 0.681 . . . . 0.0 112.357 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 HG23 ' CE2' ' A' ' 56' ' ' TYR . 3.0 p -111.93 -0.33 15.83 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.663 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 58.8 mp0 -139.7 142.27 36.9 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.7 mt -123.2 152.75 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -77.91 136.21 37.99 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.089 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -120.68 105.9 11.21 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.62 -159.97 28.99 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -125.59 110.85 14.32 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 73.8 m95 -110.72 112.27 24.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -116.12 -11.13 11.41 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.303 -171.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -128.99 152.94 48.05 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 118.749 -1.181 . . . . 0.0 112.437 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 23' ' ' GLU . 54.6 tp60 -76.08 -23.69 55.0 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 p -116.36 122.77 45.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.512 0.672 . . . . 0.0 112.422 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.73 136.81 29.29 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.343 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 151.85 79.96 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.589 2.193 . . . . 0.0 112.043 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 20.3 tt0 -62.5 140.05 58.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.28 8.46 58.73 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.327 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.7 m -91.63 115.97 28.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.845 -0.178 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -85.56 144.18 28.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.564 0.697 . . . . 0.0 111.197 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.12 117.37 31.03 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.354 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.81 121.62 41.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 68.5 m-85 -104.96 152.5 22.61 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 65.1 tttm -109.89 136.3 49.41 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.569 -1.651 . . . . 0.0 107.144 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.6 m -78.49 17.64 0.65 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 65.24 159.42 0.13 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.458 0.647 . . . . 0.0 109.689 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.11 -8.01 18.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.568 1.512 . . . . 0.0 114.157 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.67 -5.42 20.62 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.047 -1.073 . . . . 0.0 115.223 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.8 m-85 -114.21 173.2 6.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.037 . . . . 0.0 109.182 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.0 179.13 6.68 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -165.12 -176.7 4.23 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -112.25 2.79 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.482 0.658 . . . . 0.0 109.749 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.75 155.13 14.85 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.94 135.76 57.48 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.018 0.481 . . . . 0.0 110.864 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.8 t -79.3 111.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -110.27 122.92 65.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.344 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.9 mtp -108.03 172.44 6.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.35 147.04 11.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.064 0.459 . . . . 0.0 109.897 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.0 128.31 35.09 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.628 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 42.9 ttp180 -150.07 120.72 7.5 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm 57.97 21.62 7.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.68 -17.87 55.89 Favored Glycine 0 N--CA 1.415 -2.704 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.44 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -103.83 154.86 19.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.128 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -93.18 121.46 34.56 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.42 170.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.506 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.56 119.99 29.52 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 120.713 0.292 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.5 -50.14 66.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -112.23 87.99 9.91 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.183 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.83 -7.76 18.63 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.176 2.584 . . . . 0.0 111.289 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.82 -11.99 57.81 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -112.84 140.32 47.73 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.326 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HB2' ' HZ1' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -157.76 152.33 25.0 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.1 m -91.83 112.87 24.97 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.762 0.791 . . . . 0.0 110.777 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -104.4 167.56 9.67 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.265 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.04 147.37 53.28 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -88.9 135.59 31.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.138 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.62 143.36 33.94 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.287 1.991 . . . . 0.0 110.074 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m -93.54 -20.4 20.28 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.612 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 -178.9 52.32 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -70.73 130.3 88.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 36.2 Cg_endo -69.86 91.34 0.52 Allowed 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.163 1.909 . . . . 0.0 111.227 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.38 -153.23 46.02 Favored Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.036 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.36 16.11 4.08 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -38.06 105.25 0.32 Allowed Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 126.133 1.773 . . . . 0.0 114.441 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -84.01 -24.22 2.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.369 2.046 . . . . 0.0 109.431 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -112.95 86.68 2.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.08 156.66 7.15 Favored Glycine 0 N--CA 1.411 -2.967 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 m -149.36 167.82 25.07 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.8 p90 -153.63 155.36 35.93 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.144 0.429 . . . . 0.0 110.725 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 p -121.13 143.82 48.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.16 136.16 40.48 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.8 t -114.39 2.08 14.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.454 0.645 . . . . 0.0 111.761 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.3 38.1 2.02 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.78 -172.58 19.49 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -120.72 20.43 11.71 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.839 0.828 . . . . 0.0 109.375 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.409 ' CG2' ' H ' ' A' ' 104' ' ' PHE . 7.5 p -134.76 156.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.259 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.409 ' H ' ' CG2' ' A' ' 103' ' ' VAL . 47.8 m-85 -87.07 89.01 7.85 Favored 'General case' 0 C--N 1.244 -3.999 0 CA-C-N 112.638 -2.074 . . . . 0.0 109.949 -173.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.05 150.41 41.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.033 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 55.1 t80 -47.96 112.78 0.61 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.431 0.634 . . . . 0.0 111.633 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.46 -19.99 7.96 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.754 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.31 141.82 13.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 117.468 0.634 . . . . 0.0 110.393 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.46 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.5 ttmp? -108.35 134.29 51.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.12 106.3 17.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 59.3 t -86.57 115.69 27.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 88' ' ' PRO . 18.8 m-85 -88.22 147.71 24.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.7 1.238 . . . . 0.0 112.998 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.453 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 27.9 m -155.55 177.64 11.15 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.5 t -140.38 -65.48 0.45 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 120.681 1.582 . . . . 0.0 110.051 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -146.29 -164.61 2.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.95 -43.83 17.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.479 0.656 . . . . 0.0 109.932 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.1 -11.63 61.13 Favored Glycine 0 C--N 1.305 -1.156 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.176 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 88.3 m-85 -123.11 129.33 51.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 65.7 mt-30 -122.85 -86.44 0.65 Allowed 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.616 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.644 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.6 pp -175.0 156.46 2.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 123.704 0.627 . . . . 0.0 112.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.37 156.18 16.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.68 179.02 24.69 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.523 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.01 -29.55 12.48 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.605 0.717 . . . . 0.0 109.508 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.409 HG13 ' ND2' ' A' ' 136' ' ' ASN . 47.4 mm -94.97 107.97 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.077 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -97.21 30.49 2.77 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.116 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 39.3 p90 -161.16 172.45 16.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.251 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -141.49 136.64 31.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 34.6 mt-10 -111.78 142.2 44.43 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.832 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 133' ' ' GLY . 11.8 m -74.52 89.51 2.18 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.492 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -99.4 -161.09 0.85 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.451 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 41.7 p -61.66 -36.01 79.59 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.49 -46.59 89.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.98 0.895 . . . . 0.0 110.242 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' A' ' 129' ' ' CYS . . . 136.44 -54.82 0.72 Allowed Glycine 0 N--CA 1.407 -3.285 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -139.37 130.88 27.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 110.787 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 55.4 p -77.79 164.5 25.16 Favored 'General case' 0 C--O 1.264 1.836 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.409 ' ND2' HG13 ' A' ' 124' ' ' ILE . 17.8 m120 61.11 -149.67 0.41 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -140.39 -174.33 3.92 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.8 mt -79.53 115.79 55.94 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 118.42 0.554 . . . . 0.0 109.617 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.95 136.52 66.25 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.945 1.764 . . . . 0.0 110.842 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -77.27 113.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.775 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 20.0 t -57.48 114.92 2.44 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.706 0.629 . . . . 0.0 109.452 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 7.0 tp10 . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.9 m-20 . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -77.65 129.68 35.88 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.202 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.64 17.68 19.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.354 0.597 . . . . 0.0 110.252 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.27 153.51 39.85 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 39' ' ' ASP . 2.7 mm? -83.63 157.18 64.61 Favored Pre-proline 1 N--CA 1.349 -5.49 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.46 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 17.7 Cg_endo -58.09 144.62 94.64 Favored 'Trans proline' 0 C--O 1.258 1.481 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.97 152.9 78.84 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.345 2.03 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -88.22 156.58 19.14 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -117.59 152.41 35.2 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.813 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -77.96 -30.26 50.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.817 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -107.76 -12.37 15.23 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 9.2 mp0 -123.17 174.04 7.51 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.107 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.6 144.61 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 37' ' ' TRP . 43.5 mt -70.44 132.84 46.19 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 p -74.1 -56.81 4.47 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.672 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.63 169.36 54.93 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -99.75 125.08 45.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.463 ' HB3' HD13 ' A' ' 24' ' ' LEU . 11.0 m95 -116.17 95.04 4.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 m -108.68 11.42 26.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.358 0.599 . . . . 0.0 110.947 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.672 ' O ' HD23 ' A' ' 24' ' ' LEU . 10.2 t70 -103.97 -157.74 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 25.0 mt-30 -129.5 -47.38 1.18 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 33.0 p -96.7 123.81 40.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.077 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.95 138.0 32.22 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.526 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.589 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 23.7 Cg_endo -62.3 145.2 96.03 Favored 'Trans proline' 0 C--O 1.259 1.542 0 C-N-CA 123.07 2.513 . . . . 0.0 113.146 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -63.74 128.74 37.17 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.24 9.18 32.21 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -92.56 118.11 30.66 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.593 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -88.36 143.21 27.15 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 121.341 0.591 . . . . 0.0 111.108 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.2 121.28 44.82 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -93.58 127.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.554 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 76.2 m-85 -104.28 131.86 51.16 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.751 0.786 . . . . 0.0 112.057 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -87.88 131.4 34.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.026 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.727 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.3 m -71.57 5.51 2.37 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 68.35 144.23 0.1 OUTLIER Pre-proline 0 N--CA 1.486 1.365 0 CA-C-O 121.624 0.726 . . . . 0.0 112.416 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.17 110.2 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.941 1.761 . . . . 0.0 109.864 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.27 -12.99 6.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.727 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 55.1 m-85 -125.53 175.21 7.69 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -166.85 179.23 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -163.92 175.75 10.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -83.28 -11.76 57.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.518 0.675 . . . . 0.0 109.788 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.2 145.27 10.03 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.75 148.83 41.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.003 0.402 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.52 114.26 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.23 125.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -114.26 168.24 10.01 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -151.56 144.11 16.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.4 t -74.1 118.38 16.99 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.197 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.1 ttp180 -150.08 122.56 8.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 66.61 27.41 9.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.488 0.715 . . . . 0.0 112.382 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.59 -14.45 62.82 Favored Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.824 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.88 153.26 28.19 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.557 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.497 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.4 m95 -85.82 115.05 23.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 168.25 4.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.953 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.74 106.32 18.38 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.674 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.69 -42.74 89.27 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.536 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 7.7 t-20 -130.92 99.05 18.46 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.955 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.03 -9.07 19.26 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.224 2.616 . . . . 0.0 112.195 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -83.74 -18.15 38.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.872 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.2 mmp_? -88.43 138.77 31.14 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.392 1.092 . . . . 0.0 113.471 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -149.3 151.66 34.55 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 100.0 m -95.62 116.3 28.65 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.24 1.019 . . . . 0.0 109.702 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 160.95 14.13 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.407 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.1 mmtp -56.96 140.78 47.69 Favored 'General case' 0 CA--C 1.491 -1.313 0 O-C-N 123.721 0.638 . . . . 0.0 109.762 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.0 ptm180 -76.62 144.38 73.41 Favored Pre-proline 0 C--N 1.284 -2.259 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.17 150.28 42.23 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 121.513 1.476 . . . . 0.0 108.823 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.8 m -107.54 -9.76 15.85 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.941 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.79 -151.28 47.48 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.552 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -93.74 120.18 66.32 Favored Pre-proline 0 C--N 1.269 -2.931 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.67 71.63 1.46 Allowed 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 123.345 2.696 . . . . 0.0 111.609 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 138' ' ' ILE . . . 65.16 -161.14 41.83 Favored Glycine 0 N--CA 1.42 -2.41 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 119.93 13.11 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.244 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 t -122.55 105.44 35.95 Favored Pre-proline 0 N--CA 1.426 -1.639 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.14 8.52 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.956 1.771 . . . . 0.0 113.124 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -140.25 17.16 2.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.663 0.268 . . . . 0.0 111.438 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . -136.15 165.48 24.91 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.701 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 113' ' ' THR . 3.0 m -130.97 164.78 24.6 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -158.77 161.46 36.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -124.72 143.14 50.92 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.54 135.47 39.34 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.477 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 7.4 t -124.85 17.87 8.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.467 0.651 . . . . 0.0 111.45 -173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.424 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -140.46 23.72 2.67 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.216 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.32 -178.87 20.0 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.62 11.69 26.43 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 108' ' ' VAL . 2.3 p -140.1 -172.5 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.845 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.399 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.28 79.91 1.65 Allowed 'General case' 1 C--N 1.237 -4.3 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.689 -175.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.1 pt-20 -130.68 155.27 46.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.69 116.49 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.977 0.798 . . . . 0.0 110.816 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.75 -19.84 6.53 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.343 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -83.27 140.64 15.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.7 ttmt -103.79 125.3 50.14 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 172.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.53 93.95 9.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.26 119.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.479 ' HH ' ' HB2' ' A' ' 141' ' ' CYS . 30.4 t80 -99.09 124.34 44.03 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.337 0.589 . . . . 0.0 110.812 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 95' ' ' THR . 1.2 m -162.97 148.5 11.91 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.521 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 59.5 m -113.98 -64.34 1.32 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.168 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -140.4 -168.92 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.76 -46.5 24.98 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.21 64.75 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 142' ' ' GLU . 89.7 m-85 -108.32 112.66 25.22 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 117.01 0.405 . . . . 0.0 110.743 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -119.24 -84.0 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.8 pp 172.52 157.82 0.1 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.861 0.864 . . . . 0.0 111.335 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.67 145.33 26.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.31 178.32 15.27 Favored Glycine 0 C--N 1.282 -2.444 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.395 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.07 -34.65 9.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.47 102.37 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.425 ' HB2' HD22 ' A' ' 120' ' ' LEU . 4.2 p-10 -89.9 28.15 1.42 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.49 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -162.13 172.78 15.28 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -151.35 120.72 6.84 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.009 0.818 . . . . 0.0 109.263 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.6 150.32 20.47 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.634 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.63 128.2 34.98 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.6 t70 -113.11 -164.48 0.92 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.492 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.0 p -70.1 -40.26 75.04 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.539 1.136 . . . . 0.0 113.356 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.15 -32.54 12.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 122.031 -0.418 . . . . 0.0 111.348 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.1 -162.26 26.68 Favored Glycine 0 C--N 1.288 -2.113 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.967 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -76.73 149.5 36.34 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.321 0.581 . . . . 0.0 110.138 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -87.42 136.74 32.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 70.54 -176.23 0.2 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.02 0.528 . . . . 0.0 111.186 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 23.1 t70 -113.85 -164.85 0.95 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 89' ' ' GLY . 46.6 mt -92.29 109.81 40.42 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 118.537 0.608 . . . . 0.0 109.427 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.42 132.83 48.45 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.975 1.783 . . . . 0.0 109.993 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.6 mp -74.64 110.23 8.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.193 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.479 ' HB2' ' HH ' ' A' ' 112' ' ' TYR . 53.1 t -56.48 121.97 10.87 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.188 0.93 . . . . 0.0 110.244 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 13.5 tp10 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.439 -0.997 0 CA-C-O 121.729 0.776 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.7 m -83.45 127.96 34.12 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.9 OUTLIER -102.94 20.58 17.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.827 0.822 . . . . 0.0 109.561 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.3 155.25 42.51 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.067 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 34.2 mt -78.38 157.24 78.01 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 123.352 0.661 . . . . 0.0 111.514 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.85 127.48 18.73 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.6 2.2 . . . . 0.0 110.771 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.02 122.3 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.903 1.735 . . . . 0.0 110.299 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.39 158.43 35.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.617 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -113.74 167.52 10.55 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -69.46 -38.61 77.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -106.58 -0.01 24.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -135.39 135.54 40.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.743 0.782 . . . . 0.0 111.979 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mt -125.2 143.31 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -64.09 149.68 47.11 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.556 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.8 p -105.5 111.07 23.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -171.77 16.96 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.964 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 t -104.2 136.58 43.54 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.528 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 76.7 m95 -139.82 106.01 5.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 m -135.25 16.15 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.593 0.711 . . . . 0.0 109.234 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.9 m-20 -100.5 -167.3 1.42 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.725 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.3 -65.19 0.78 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.015 0.436 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -86.75 119.66 27.22 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -123.64 136.63 27.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.829 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.67 144.97 85.89 Favored 'Trans proline' 0 C--O 1.258 1.495 0 C-N-CA 122.534 2.156 . . . . 0.0 110.845 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.1 tt0 -61.21 137.68 58.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.22 51.9 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.451 ' C ' HG21 ' A' ' 65' ' ' VAL . 66.9 m -88.6 114.78 25.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.718 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -92.83 139.12 30.88 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.101 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.46 121.63 45.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.18 130.21 43.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -114.49 149.78 35.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 111.651 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -101.52 147.73 26.04 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.676 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.5 m -85.97 15.7 4.77 Favored 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 123.577 0.751 . . . . 0.0 112.589 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 58.9 mtp180 69.83 158.61 0.16 Allowed Pre-proline 0 C--O 1.248 1.006 0 C-N-CA 123.225 0.61 . . . . 0.0 109.36 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.0 125.81 11.28 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 109.223 -1.106 . . . . 0.0 109.223 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 110.24 -11.92 31.24 Favored Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.031 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 84.3 m-85 -117.28 168.53 10.24 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.765 -0.844 . . . . 0.0 109.813 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.93 -176.95 5.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 p -154.07 156.75 37.88 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.81 -4.1 58.39 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.198 0.999 . . . . 0.0 110.457 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.45 -119.96 1.73 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -159.96 148.29 17.12 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.29 97.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.983 0.897 . . . . 0.0 109.161 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.93 121.84 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.726 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.4 mtp -107.58 172.53 6.78 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG21 ' C ' ' A' ' 46' ' ' THR . 11.4 p -159.13 145.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.379 0.609 . . . . 0.0 111.003 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.6 t -70.78 119.3 14.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.581 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 30.7 tpt180 -150.05 113.68 5.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 67.26 31.7 6.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.112 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.29 -16.39 52.84 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.474 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.27 152.0 25.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.061 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -90.06 114.35 26.22 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.33 171.53 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.579 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.08 124.09 35.91 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.47 -47.75 77.82 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -111.53 91.84 15.27 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.155 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.51 -23.79 16.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.631 2.221 . . . . 0.0 112.606 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.09 -22.16 49.41 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.041 0.924 . . . . 0.0 110.373 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.77 137.79 32.08 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.194 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.13 162.33 41.06 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -89.77 131.48 35.7 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.754 0.788 . . . . 0.0 111.413 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.04 165.56 20.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.881 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.3 mttt -58.45 146.93 33.42 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.4 ptm180 -82.9 154.85 67.91 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -83.09 164.66 15.19 Favored 'Trans proline' 0 N--CA 1.432 -2.14 0 C-N-CA 121.314 1.343 . . . . 0.0 109.6 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.0 -3.95 13.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.448 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.89 -116.02 4.7 Favored Glycine 0 CA--C 1.459 -3.454 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -137.33 144.17 44.43 Favored Pre-proline 0 C--N 1.265 -3.083 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.33 45.27 1.88 Allowed 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.704 2.269 . . . . 0.0 109.477 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.88 -147.71 33.94 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -170.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -161.85 122.02 2.56 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 t -107.28 120.23 48.4 Favored Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.273 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.91 -7.86 15.5 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.615 2.21 . . . . 0.0 112.785 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -129.43 12.49 5.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.55 160.41 24.47 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -128.13 168.03 15.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.9 p90 -154.35 163.03 40.8 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -131.51 141.73 49.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.4 mt -98.29 124.41 42.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.503 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 11.9 t -109.76 -18.91 13.33 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.79 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.72 30.21 9.01 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 119.582 -1.294 . . . . 0.0 111.091 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.58 -173.3 30.94 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -127.44 18.42 6.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.33 0.565 . . . . 0.0 110.554 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 108' ' ' VAL . 20.9 m -146.95 178.61 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -91.12 90.61 7.9 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.62 156.76 46.33 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.837 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.432 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 71.8 t80 -53.8 105.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.965 0.791 . . . . 0.0 111.36 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.39 -11.96 6.04 Favored Glycine 0 N--CA 1.418 -2.556 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.787 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 103' ' ' VAL . 19.1 m -82.95 141.34 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.015 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.503 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.0 ttmt -106.6 123.7 48.5 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 169.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 99.3 11.48 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 46.7 t -79.69 110.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.444 ' C ' ' HG1' ' A' ' 113' ' ' THR . 1.7 t80 -89.19 132.14 34.99 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 123.926 0.891 . . . . 0.0 108.77 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.444 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 4.1 m -155.12 156.53 35.96 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.28 -69.88 0.83 Allowed 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.167 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.64 -169.51 3.4 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.98 -50.65 11.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.722 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.45 73.9 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.636 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.73 130.06 23.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.43 0.633 . . . . 0.0 110.165 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -109.47 -76.79 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.7 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp 174.1 162.68 0.19 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.253 1.021 . . . . 0.0 110.282 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -97.46 143.81 27.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.13 159.37 12.94 Favored Glycine 0 C--N 1.289 -2.032 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.4 -27.48 22.73 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.557 0.694 . . . . 0.0 110.716 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.0 mm -95.93 103.15 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.022 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -92.87 33.56 1.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.072 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.83 174.07 15.84 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.262 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -134.26 127.44 31.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 18.3 mt-10 -111.33 143.18 42.53 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 118.654 0.661 . . . . 0.0 111.312 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.5 m -81.68 117.18 21.82 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.242 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.3 t70 -108.92 -165.38 1.02 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.466 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 61.2 p -67.31 -41.87 84.64 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.707 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.76 -30.66 20.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 -139.25 5.77 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.382 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.408 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 78.1 m95 -82.83 128.96 34.9 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.125 0.488 . . . . 0.0 110.473 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 p -63.36 -29.47 70.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.821 1.248 . . . . 0.0 113.427 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.37 170.08 14.09 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -105.54 174.32 5.93 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.99 110.47 4.65 Favored Pre-proline 0 C--N 1.319 -0.749 0 O-C-N 123.687 0.617 . . . . 0.0 111.723 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 130.49 29.61 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.152 1.901 . . . . 0.0 110.708 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.61 109.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.4 t -83.7 112.74 20.33 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.212 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.47 ' HB2' HD23 ' A' ' 121' ' ' LEU . 5.9 mm-40 . . . . . 0 CA--C 1.491 -1.322 0 C-N-CA 124.139 0.976 . . . . 0.0 108.902 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 N--CA 1.433 -1.305 0 CA-C-O 121.757 0.789 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.2 m -85.83 127.62 34.61 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.831 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.95 19.03 12.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.581 0.705 . . . . 0.0 110.528 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.14 157.13 43.14 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 39' ' ' ASP . 2.2 mm? -89.62 158.67 45.11 Favored Pre-proline 1 N--CA 1.342 -5.872 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.262 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.9 Cg_endo -58.81 138.38 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.028 2.485 . . . . 0.0 110.355 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 149.41 84.21 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.156 1.904 . . . . 0.0 112.577 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -89.61 143.45 26.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.82 168.3 10.02 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.436 0.636 . . . . 0.0 111.912 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -79.04 -33.95 44.27 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.805 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 p -98.28 -31.74 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.0 mp0 -114.83 146.22 41.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.73 0.3 . . . . 0.0 111.444 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.2 mt -120.35 146.19 25.58 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 37' ' ' TRP . 24.1 mt -75.84 130.22 38.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.1 p -99.02 127.67 44.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.92 -143.21 16.12 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 t -149.66 118.97 6.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.561 ' CD1' HD12 ' A' ' 33' ' ' LEU . 5.4 m95 -129.48 74.4 1.58 Allowed 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.856 0.836 . . . . 0.0 109.484 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 24.36 12.06 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.592 ' O ' HD23 ' A' ' 24' ' ' LEU . 24.3 m-20 -95.7 -150.76 0.33 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.943 -1.935 . . . . 0.0 111.863 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -132.41 -79.55 0.5 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 18.6 p -107.09 121.2 44.01 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -116.64 138.03 24.18 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.927 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.53 151.48 84.72 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.757 2.305 . . . . 0.0 111.938 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.62 136.33 57.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.17 4.31 53.81 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -85.63 118.87 25.41 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.8 pt20 -91.99 142.04 27.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.828 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.88 131.79 56.15 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.022 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.4 mt -99.89 134.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.631 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 51.6 m-85 -113.21 156.5 23.15 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.685 0.755 . . . . 0.0 112.966 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -101.39 137.57 39.55 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.819 1.647 . . . . 0.0 106.708 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.766 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 76.7 m -81.33 15.0 2.15 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 62.43 156.9 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 121.721 0.772 . . . . 0.0 111.545 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.74 107.08 2.25 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 120.744 0.963 . . . . 0.0 109.605 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 128.64 -24.49 4.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.671 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.766 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 60.2 m-85 -105.0 155.32 19.07 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' ARG . 28.6 ttm180 -136.18 168.7 18.9 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 123.872 0.869 . . . . 0.0 109.725 -171.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -164.69 154.4 13.61 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.126 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.87 -32.43 31.06 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.44 136.29 8.72 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.91 151.71 45.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.158 0.479 . . . . 0.0 111.134 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 79' ' ' LYS . 58.9 t -76.05 108.84 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.636 0.732 . . . . 0.0 109.761 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.49 122.19 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.097 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.416 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 84.7 mtp -104.39 170.25 8.01 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.3 p -152.07 143.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.216 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.03 121.5 22.08 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 124.09 0.956 . . . . 0.0 108.804 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -146.51 121.94 10.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 41.5 mmtm 63.71 20.35 12.18 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.798 0.839 . . . . 0.0 112.92 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.33 72.57 Favored Glycine 0 N--CA 1.423 -2.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.45 150.87 38.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.242 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.7 m95 -87.38 113.44 23.09 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.66 0.743 . . . . 0.0 109.525 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.59 171.81 3.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.227 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.16 118.01 27.44 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' H ' ' HA ' ' A' ' 64' ' ' MET . 5.1 tp -58.88 -46.05 88.73 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -120.31 96.56 49.13 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.928 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.99 -10.77 21.38 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 112.743 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.67 -29.99 36.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.952 0.882 . . . . 0.0 109.931 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -91.32 132.82 35.91 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.676 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.402 ' HA ' ' CG2' ' A' ' 62' ' ' VAL . 11.8 ptmm? -154.35 150.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 62.5 m -86.61 114.76 23.59 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.917 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.89 169.82 8.64 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.477 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 105' ' ' GLU . 32.6 mmtp -55.08 119.41 5.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.443 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 11.1 ptm180 -55.64 145.51 50.12 Favored Pre-proline 0 C--N 1.295 -1.779 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.261 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.45 158.84 32.69 Favored 'Trans proline' 0 C--O 1.256 1.396 0 C-N-CA 122.272 1.982 . . . . 0.0 109.161 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.45 -16.72 5.78 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.246 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.11 -154.53 46.53 Favored Glycine 0 CA--C 1.464 -3.149 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.809 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.97 134.86 31.01 Favored Pre-proline 0 C--N 1.252 -3.642 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.256 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.7 33.57 0.49 Allowed 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.841 2.361 . . . . 0.0 110.772 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.46 157.9 33.97 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -127.58 145.34 50.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -120.66 148.9 49.21 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.074 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.4 -25.65 18.01 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.316 2.011 . . . . 0.0 111.087 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -146.56 110.05 4.83 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.361 0.6 . . . . 0.0 110.489 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . 152.75 173.09 21.81 Favored Glycine 0 N--CA 1.425 -2.065 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.317 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 m -146.73 163.45 35.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -144.52 165.52 27.75 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.4 p -135.26 148.08 49.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.23 128.28 54.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 109' ' ' LYS . 12.5 t -121.44 6.82 10.09 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 108' ' ' VAL . . . -124.06 23.06 6.62 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.72 -178.0 29.27 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.13 11.48 15.25 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.544 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 p -140.36 -168.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.407 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -105.64 83.4 1.93 Allowed 'General case' 0 C--N 1.245 -3.944 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.961 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 10.4 pt-20 -138.78 162.56 34.42 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.7 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -51.98 120.65 5.58 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.095 0.872 . . . . 0.0 110.205 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.74 -12.36 22.87 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.193 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.544 HG11 ' O ' ' A' ' 103' ' ' VAL . 20.3 m -85.14 140.26 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.496 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -101.31 116.98 34.05 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.07 93.62 7.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -74.78 128.05 36.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.0 t80 -111.09 145.19 38.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.344 0.593 . . . . 0.0 111.185 -172.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 m -152.62 159.84 43.21 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 60.9 m -122.06 -68.39 0.9 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.488 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -133.91 -162.42 1.24 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.24 -55.01 4.11 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.34 0.591 . . . . 0.0 109.805 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.18 -23.38 59.14 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.969 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.45 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 86.8 m-85 -104.97 112.15 25.19 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 92.2 mt-30 -112.43 -87.83 0.54 Allowed 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.7 pp -178.87 145.2 0.28 Allowed 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 73.0 mt -87.51 139.76 30.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.62 170.05 12.98 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.67 -28.15 12.65 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.363 0.601 . . . . 0.0 110.335 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.84 99.36 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -87.07 30.71 0.74 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.846 0.858 . . . . 0.0 110.855 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 49.5 p90 -163.41 -177.83 5.53 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.516 -0.765 . . . . 0.0 108.96 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 131.51 16.0 Favored 'General case' 0 N--CA 1.403 -2.819 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 31.9 mt-10 -107.67 145.86 32.81 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.86 112.41 22.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -94.6 -161.94 0.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.439 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.4 p -67.6 -44.94 76.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.902 0.881 . . . . 0.0 109.945 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.38 -37.03 68.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.879 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.76 -152.13 24.21 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.64 126.79 29.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.4 p -59.87 -34.85 73.68 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.807 0.843 . . . . 0.0 112.111 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -132.73 169.46 16.66 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 5.8 p-10 -102.37 -99.84 0.28 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.101 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.483 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 26.9 mt -127.24 99.43 28.01 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.3 Cg_endo -53.56 140.28 65.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.01 1.807 . . . . 0.0 110.018 172.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.36 118.59 31.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 -171.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 64.6 m -59.13 94.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.217 1.007 . . . . 0.0 112.47 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 140' ' ' ILE . 68.4 mm-40 . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 32.5 m-20 . . . . . 0 C--O 1.242 0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.0 m -74.64 132.72 41.96 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.844 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.4 36.44 2.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.653 0.74 . . . . 0.0 109.395 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.18 158.06 32.0 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.213 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 19.2 mt -79.44 152.97 76.23 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 123.95 0.781 . . . . 0.0 110.31 175.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.27 131.7 42.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.542 2.161 . . . . 0.0 110.976 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.01 132.53 24.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.49 2.127 . . . . 0.0 113.23 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 mtm-85 -76.73 129.56 36.49 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -104.2 178.13 4.65 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.007 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -56.14 -44.62 79.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.862 0.465 . . . . 0.0 111.782 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 p -125.1 17.84 8.43 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.805 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 49.8 mp0 -135.35 134.4 39.76 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.312 0.577 . . . . 0.0 111.882 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -128.35 165.73 27.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -90.5 142.83 27.34 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -98.21 128.09 44.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.3 -165.35 12.46 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.2 m -130.98 124.53 31.17 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.406 ' HB3' HD22 ' A' ' 24' ' ' LEU . 76.0 m95 -122.4 121.48 36.76 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 m -132.74 3.4 3.8 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.966 0.413 . . . . 0.0 110.767 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 21.0 m-20 -95.63 -169.81 2.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.88 -59.57 1.34 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.241 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.3 p -93.82 124.4 37.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 57.6 m-85 -125.59 139.17 33.39 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.496 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 24.4 Cg_endo -61.44 142.56 95.78 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 123.178 2.586 . . . . 0.0 113.038 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.7 132.97 54.94 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.12 43.37 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -89.66 115.41 27.01 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -89.16 144.17 26.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.605 0.717 . . . . 0.0 111.437 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 128.62 55.82 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.43 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.34 128.54 49.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 70.1 m-85 -103.43 158.01 16.64 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 60.2 tttm -106.06 142.4 35.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.981 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.658 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 86.6 m -95.93 38.44 1.18 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.9 mmt180 62.22 163.23 0.11 Allowed Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.696 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.94 100.45 0.37 Allowed 'Trans proline' 0 N--CA 1.418 -2.935 0 C-N-CA 121.273 1.315 . . . . 0.0 109.228 167.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.87 -3.17 3.78 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.494 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.658 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 45.6 m-85 -130.47 -177.73 4.46 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -153.02 -176.35 5.73 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.591 0.756 . . . . 0.0 109.341 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.2 p -162.04 165.09 27.77 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.21 -13.87 27.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.366 0.603 . . . . 0.0 109.76 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.94 161.13 34.05 Favored Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -75.05 143.06 43.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 117.694 0.747 . . . . 0.0 111.418 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 50.0 t -77.45 109.15 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 174.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.91 123.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.109 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -112.06 168.81 9.31 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.8 p -152.39 145.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.328 0.585 . . . . 0.0 110.383 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.9 t -71.71 120.38 17.22 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.542 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.2 ttm-85 -152.21 120.38 6.28 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.59 28.13 13.27 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.218 1.007 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.89 -15.95 61.52 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.723 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -110.64 158.61 18.41 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.181 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.22 115.89 28.49 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.94 151.37 32.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.399 0.619 . . . . 0.0 111.713 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.98 109.59 1.32 Allowed 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.457 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.79 -52.21 64.07 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -110.79 92.73 15.18 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -20.96 22.75 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 122.394 2.063 . . . . 0.0 111.176 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 mt -74.86 -25.58 59.07 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.403 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -89.49 128.37 35.97 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.331 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HB2' ' HZ1' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.76 158.08 40.41 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 65.0 m -88.49 139.99 29.92 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.765 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 48.1 mt-30 -132.69 168.46 18.28 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.225 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.72 160.22 33.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.838 0.828 . . . . 0.0 113.15 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -110.82 137.61 20.86 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.44 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 9.6 Cg_endo -71.02 148.82 57.77 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.392 2.061 . . . . 0.0 112.698 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.13 -55.28 3.49 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.976 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.18 -156.08 20.64 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.003 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -87.82 111.84 44.94 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 123.635 0.774 . . . . 0.0 109.201 -175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 81.1 Cg_endo -76.72 9.95 2.45 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.916 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.75 135.9 2.87 Favored Glycine 0 N--CA 1.397 -3.922 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.144 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -106.26 107.74 18.9 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 t -125.09 124.6 25.35 Favored Pre-proline 0 N--CA 1.411 -2.384 0 CA-C-O 121.564 0.697 . . . . 0.0 112.155 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -89.84 2.61 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 122.269 1.979 . . . . 0.0 112.335 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.9 4.86 2.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.81 13.79 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 p -142.39 163.36 33.06 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.295 0.638 . . . . 0.0 109.934 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.4 p90 -130.31 154.36 47.71 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.189 0.306 . . . . 0.0 110.404 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 74.7 p -114.21 178.3 4.33 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.86 142.25 31.75 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 109' ' ' LYS . 8.8 t -127.88 -45.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.998 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.25 51.01 3.38 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.113 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 140.39 -176.84 21.14 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.42 10.61 10.55 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 121.16 0.505 . . . . 0.0 110.003 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.504 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.8 p -147.06 -164.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.432 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.361 -173.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 28.2 m-85 -100.23 82.49 2.52 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.8 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.47 154.98 50.61 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.466 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.18 112.89 0.8 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.137 0.898 . . . . 0.0 109.919 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.3 -27.61 4.2 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.908 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 103' ' ' VAL . 18.2 m -75.73 164.34 3.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.071 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HB3' HG23 ' A' ' 99' ' ' THR . 4.7 ttmp? -131.7 115.37 15.93 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.4 101.94 13.89 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.5 m -78.82 162.24 4.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 118.621 -1.231 . . . . 0.0 108.612 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.452 ' HE2' ' SG ' ' A' ' 141' ' ' CYS . 61.2 t80 -129.43 134.61 47.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.394 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -150.83 154.99 38.31 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 78.6 m -130.68 -41.08 1.19 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -153.55 -176.63 5.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -106.75 -40.31 5.55 Favored 'General case' 0 C--N 1.278 -2.533 0 O-C-N 123.633 0.583 . . . . 0.0 111.028 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.62 -37.1 94.19 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -122.98 125.59 45.55 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 48.2 mt-30 -99.15 -89.46 0.32 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -170.43 161.12 7.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.71 -61.28 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.53 158.14 13.59 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.293 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.43 -26.09 33.05 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.936 0.875 . . . . 0.0 109.932 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.92 95.26 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.55 29.63 0.68 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 21.7 p90 -162.12 174.33 13.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -173.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.463 HH22 ' HB3' ' A' ' 96' ' ' PHE . 2.2 mpp_? -134.14 122.37 22.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.485 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 26.5 mt-10 -103.62 150.58 23.84 Favored 'General case' 0 C--N 1.284 -2.271 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.744 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.3 m -81.2 121.73 26.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.748 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 131' ' ' THR . 11.8 t70 -96.55 -159.45 0.73 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 30.3 p -58.35 -62.15 2.05 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 124.183 0.993 . . . . 0.0 112.709 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.21 -24.27 15.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.57 -149.85 5.7 Favored Glycine 0 CA--C 1.486 -1.748 0 C-N-CA 118.603 -1.761 . . . . 0.0 113.489 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 73.2 m95 -93.52 147.69 22.75 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.191 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.8 p -77.69 -24.59 49.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.791 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -139.3 172.99 12.01 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.756 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 21.0 t70 -108.69 -158.25 0.64 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.486 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.5 mt -85.53 117.21 68.3 Favored Pre-proline 0 C--N 1.289 -2.065 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.75 143.78 46.99 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.222 1.948 . . . . 0.0 109.56 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.419 HG22 ' HG2' ' A' ' 142' ' ' GLU . 2.3 mp -94.73 124.65 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 122.118 -0.363 . . . . 0.0 111.667 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.452 ' SG ' ' HE2' ' A' ' 112' ' ' TYR . 64.4 m -77.8 111.49 13.67 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.161 0.984 . . . . 0.0 111.142 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG22 ' A' ' 140' ' ' ILE . 6.9 mm-40 . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.8 m-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.7 m -76.46 152.78 36.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.01 16.88 13.36 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.741 -174.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.94 160.61 28.02 Favored 'General case' 0 CA--C 1.462 -2.434 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -85.2 156.33 60.08 Favored Pre-proline 1 N--CA 1.355 -5.191 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.042 -177.492 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 6.5 Cg_endo -55.45 135.12 67.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.443 2.762 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.66 117.67 4.43 Favored 'Trans proline' 0 CA--C 1.519 -0.231 0 C-N-CA 123.023 2.482 . . . . 0.0 112.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.59 133.24 45.6 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 94.0 mtt180 -108.1 -179.74 3.98 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.513 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.583 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 59.7 t30 -89.38 -50.42 6.13 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.157 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 p -88.15 -9.16 54.05 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.4 mp0 -124.6 135.52 53.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.614 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mt -117.1 135.98 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.58 HD12 ' CD1' ' A' ' 37' ' ' TRP . 17.7 mt -67.97 117.66 10.12 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.427 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 p -96.77 100.25 11.8 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.91 -159.28 28.39 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -132.71 113.53 13.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CD1' HD12 ' A' ' 33' ' ' LEU . 10.1 m95 -125.18 84.67 2.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 m -118.66 5.94 11.6 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.207 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -85.25 -160.06 0.48 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.207 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -125.15 -69.26 0.8 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 23.3 p -93.38 133.69 36.37 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -128.48 141.29 40.97 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.49 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 35.1 Cg_endo -65.19 150.17 87.9 Favored 'Trans proline' 0 C--O 1.255 1.361 0 C-N-CA 122.718 2.279 . . . . 0.0 112.712 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.87 133.62 48.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 -6.11 38.81 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.516 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -80.96 118.52 22.52 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.23 152.88 21.66 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.937 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.44 131.95 54.12 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -102.98 126.12 57.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.457 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 63.4 m-85 -108.87 143.65 37.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.217 0.532 . . . . 0.0 112.202 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -93.66 142.68 27.08 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 85.4 m -90.19 40.34 1.0 Allowed 'General case' 0 C--N 1.279 -2.474 0 CA-C-O 120.521 0.2 . . . . 0.0 110.835 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 29' ' ' ASN . 22.0 mtp180 61.46 172.3 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 122.781 0.432 . . . . 0.0 110.689 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -76.12 -12.0 19.42 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 120.857 1.038 . . . . 0.0 112.225 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -104.18 -13.89 25.74 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 115.126 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 62.0 m-85 -114.23 176.07 5.2 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.137 -1.213 . . . . 0.0 109.806 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -152.55 -173.49 4.58 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -168.62 -175.01 2.32 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.79 -6.64 57.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.407 1.099 . . . . 0.0 109.062 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.31 -147.2 4.84 Favored Glycine 0 N--CA 1.403 -3.507 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -120.97 150.84 40.48 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.36 103.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.0 mm -101.0 119.53 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.927 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.1 169.84 8.47 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -155.23 147.51 12.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.609 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.35 123.49 24.72 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -152.19 124.22 8.06 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 62.33 26.17 15.64 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.783 0.833 . . . . 0.0 112.677 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.21 -9.9 74.17 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.761 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.87 162.43 20.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.471 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -92.63 112.0 23.8 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.29 167.62 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.396 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.553 0.216 . . . . 0.0 110.59 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -50.23 73.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.3 m120 -111.93 93.82 22.48 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.03 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -73.56 -11.72 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.438 2.092 . . . . 0.0 111.693 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.12 -11.99 58.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.503 0.668 . . . . 0.0 110.13 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 25.8 mmt180 -89.32 126.95 35.73 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.392 0.615 . . . . 0.0 110.13 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -146.37 144.68 29.91 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.0 m -93.41 117.43 30.07 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-O 121.239 0.543 . . . . 0.0 109.892 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -117.34 167.48 11.21 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.128 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.6 mttt -63.6 145.76 55.06 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.787 0.327 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.6 ptp180 -85.46 138.05 36.3 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 40.6 Cg_endo -68.24 154.75 71.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.791 2.327 . . . . 0.0 111.348 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.05 -2.29 18.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 -112.57 3.68 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.168 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -127.13 119.58 22.2 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 95.6 Cg_endo -79.24 34.54 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.877 3.052 . . . . 0.0 114.058 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.74 137.78 6.71 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.614 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.74 128.06 34.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.298 0.57 . . . . 0.0 109.729 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -139.57 107.36 7.11 Favored Pre-proline 0 N--CA 1.409 -2.518 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.25 12.0 2.95 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.448 2.098 . . . . 0.0 110.477 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 -54.82 2.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.764 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.91 -166.1 14.58 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.116 -1.04 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 m -132.27 170.93 14.35 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -142.64 153.41 43.42 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.642 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 72.2 p -107.66 -178.65 3.69 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -145.38 157.42 44.04 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 7.6 t -151.52 146.92 26.24 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.09 27.26 66.71 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.857 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.73 -44.59 0.21 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.181 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.03 13.24 9.08 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.42 171.75 14.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.4 m-85 -85.73 93.02 8.76 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.664 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -146.13 151.42 37.64 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.274 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.461 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 76.8 t80 -52.41 106.55 0.16 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.014 0.926 . . . . 0.0 111.208 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 139.47 -27.86 2.59 Favored Glycine 0 N--CA 1.422 -2.264 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.817 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 99' ' ' THR . 23.2 m -80.92 154.79 4.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.303 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -118.12 118.88 33.08 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.19 96.66 9.75 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' A' ' 97' ' ' THR . 1.0 OUTLIER -77.45 156.25 5.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.709 -178.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 46.6 t80 -114.78 139.19 49.92 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -141.44 164.59 29.82 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 7.2 t -146.66 -57.7 0.28 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.748 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.38 -174.18 4.14 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -83.55 -45.01 14.03 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 121.892 0.853 . . . . 0.0 108.833 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.98 -24.11 64.97 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.846 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -115.15 125.97 54.07 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 122.654 -0.321 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.453 ' C ' HD11 ' A' ' 120' ' ' LEU . 84.1 mm-40 -113.96 -87.36 0.57 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.453 HD11 ' C ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -162.15 161.49 28.08 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.247 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 88.7 mt -92.72 131.62 37.63 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.86 179.46 16.42 Favored Glycine 0 C--N 1.269 -3.154 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.417 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -102.87 -9.78 19.61 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.915 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.5 mm -122.66 121.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.059 0.457 . . . . 0.0 109.969 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -104.58 29.23 6.31 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.799 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -163.77 176.86 9.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.042 0.449 . . . . 0.0 111.39 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -141.97 126.94 18.31 Favored 'General case' 0 C--O 1.199 -1.583 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -104.11 147.74 27.07 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 118.555 0.616 . . . . 0.0 111.671 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.5 m -84.83 103.07 13.58 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.843 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.24 -167.95 1.47 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.3 p -64.55 -44.15 91.68 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.066 1.346 . . . . 0.0 110.745 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.56 -38.02 77.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.966 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.14 -115.11 0.7 Allowed Glycine 0 CA--C 1.486 -1.721 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.491 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 91.9 m95 -95.95 129.68 43.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.0 p -67.67 -26.93 66.44 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.604 0.762 . . . . 0.0 112.584 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -137.91 169.26 18.09 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -101.88 -171.75 2.03 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 123.824 0.703 . . . . 0.0 109.556 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.6 mt -74.98 113.2 22.44 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.586 0.354 . . . . 0.0 110.655 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 9.7 Cg_endo -66.48 141.17 60.24 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.399 2.066 . . . . 0.0 110.771 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.0 mm -92.66 119.73 40.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.446 -173.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.9 m -64.59 118.85 9.44 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.529 0.518 . . . . 0.0 109.8 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 141' ' ' CYS . 11.7 mm-40 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.5 m -79.49 129.67 34.69 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.956 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.01 35.48 1.72 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.0 110.566 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -160.0 152.89 21.51 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.585 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -71.1 149.42 94.58 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 124.26 0.975 . . . . 0.0 108.969 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.33 131.54 45.77 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.541 2.161 . . . . 0.0 111.821 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 116.79 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.736 2.291 . . . . 0.0 112.311 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -61.49 127.14 30.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.29 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -81.36 153.64 26.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.831 -170.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -72.21 -24.87 61.47 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -128.35 7.45 5.89 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.3 mp0 -137.45 164.48 28.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.117 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.82 150.51 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -71.54 142.96 50.08 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.302 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.5 p -103.42 108.25 19.42 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.98 -164.71 25.51 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -138.93 98.72 3.6 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 48.8 m95 -92.82 144.21 25.51 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.15 31.06 0.34 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.24 161.27 36.68 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.681 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -93.85 -26.67 16.81 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.099 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -116.64 110.26 18.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.822 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -110.06 139.33 21.26 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.5 Cg_endo -60.62 146.24 97.44 Favored 'Trans proline' 0 C--O 1.254 1.299 0 C-N-CA 123.202 2.601 . . . . 0.0 112.971 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.0 138.03 57.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.1 7.22 56.43 Favored Glycine 0 N--CA 1.427 -1.96 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.287 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 98.5 m -88.16 112.03 22.27 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -84.2 140.22 31.86 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.276 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.57 56.57 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.2 mt -98.98 131.09 46.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 80.5 m-85 -115.73 138.95 50.62 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.672 0.748 . . . . 0.0 112.851 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -91.49 133.48 35.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.668 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.9 m -72.55 10.86 0.73 Allowed 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 66.77 154.78 0.13 Allowed Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.19 0.596 . . . . 0.0 111.219 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.62 98.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.117 1.878 . . . . 0.0 112.134 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 130.92 -13.65 5.52 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.391 -0.909 . . . . 0.0 114.212 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.668 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 82.2 m-85 -115.19 168.5 9.89 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.373 -1.075 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -146.49 169.38 19.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.0 t -165.79 -10.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 123.816 0.697 . . . . 0.0 110.023 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.2 tp 75.15 -52.56 0.66 Allowed 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.425 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.8 20.35 39.1 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 61.76 -167.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.16 0.984 . . . . 0.0 110.867 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.502 HG22 ' SG ' ' A' ' 80' ' ' CYS . 69.4 t -118.31 123.82 72.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 168.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -117.64 122.21 69.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.417 ' HE1' ' HB3' ' A' ' 71' ' ' TRP . 88.1 mtp -108.17 178.0 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -161.98 143.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.074 0.464 . . . . 0.0 110.403 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 t -70.38 125.19 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.919 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -152.69 119.18 5.62 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 120.634 0.254 . . . . 0.0 110.755 -177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 62.23 23.17 13.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.11 -20.0 51.89 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.458 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.74 154.11 20.94 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.05 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 64' ' ' MET . 82.4 m95 -88.22 116.47 26.44 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.06 172.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.57 124.69 35.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.93 -51.21 34.77 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -114.0 89.54 17.01 Favored Pre-proline 0 N--CA 1.426 -1.634 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.786 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.58 -25.41 15.01 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 122.378 2.052 . . . . 0.0 110.629 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.05 -25.69 64.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.138 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.3 mmp_? -85.28 138.38 32.35 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.3 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -161.6 144.57 12.22 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 62' ' ' VAL . 73.9 m -86.01 109.18 18.62 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-O 121.79 0.805 . . . . 0.0 111.776 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -106.39 167.14 10.04 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.174 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 98.8 mttt -62.24 135.26 57.4 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 123.29 0.369 . . . . 0.0 111.503 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.7 ptp180 -80.4 146.19 61.17 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.74 142.96 10.48 Favored 'Trans proline' 0 N--CA 1.424 -2.576 0 C-N-CA 121.675 1.583 . . . . 0.0 112.336 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.5 m -84.33 -30.77 25.24 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.93 104.44 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 O-C-N 124.237 0.961 . . . . 0.0 115.072 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.8 t60 64.02 111.33 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 123.858 0.863 . . . . 0.0 111.993 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 127' ' ' ARG . 88.0 Cg_endo -81.47 43.13 1.47 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 123.635 2.89 . . . . 0.0 112.506 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.496 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 85.64 -171.53 45.41 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -107.67 91.58 3.71 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 m -112.61 91.31 16.82 Favored Pre-proline 0 N--CA 1.421 -1.9 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.191 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.59 -29.73 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.567 2.178 . . . . 0.0 112.679 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -110.78 146.24 36.71 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.66 178.34 36.68 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -143.2 156.8 44.84 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.671 -0.311 . . . . 0.0 110.937 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 p90 -141.35 149.56 41.31 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.226 0.536 . . . . 0.0 110.358 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.8 p -116.12 147.36 41.42 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.576 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.61 135.99 51.44 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.6 t -115.74 -4.32 12.17 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.0 16.82 10.84 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.536 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.26 32.74 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -107.32 2.83 24.8 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 117.771 0.786 . . . . 0.0 110.059 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.9 p -142.17 -164.04 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.535 -170.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -98.98 74.0 1.98 Allowed 'General case' 0 C--N 1.245 -3.938 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.59 151.75 46.03 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.883 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 73.4 t80 -47.08 117.56 1.76 Allowed 'General case' 0 C--N 1.315 -0.904 0 O-C-N 124.574 1.171 . . . . 0.0 111.759 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.42 -14.06 20.75 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.872 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -82.42 141.57 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -111.22 122.53 48.11 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.414 ' HB3' ' HG2' ' A' ' 127' ' ' ARG . . . -94.86 95.54 8.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 55.5 t -79.36 122.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 77.0 t80 -98.48 144.57 27.68 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.824 0.821 . . . . 0.0 112.063 -172.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.94 156.81 46.0 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.9 t -131.04 -68.32 0.68 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.181 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.12 -173.34 3.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -85.2 -48.6 8.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.425 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.21 -23.8 60.49 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.154 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -116.9 116.95 28.41 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 15.5 mm-40 -109.0 -80.98 0.57 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.1 pp -170.59 137.0 1.31 Allowed 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.96 -47.16 69.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.758 1.223 . . . . 0.0 112.035 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.04 174.98 48.61 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.132 -0.486 . . . . 0.0 113.743 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.62 -30.02 23.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.849 0.833 . . . . 0.0 110.146 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.18 98.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.536 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.98 20.4 2.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.147 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -154.48 -177.63 6.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' NH1' HG12 ' A' ' 138' ' ' ILE . 8.2 ptp180 -154.13 128.22 8.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 174.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 21.4 mt-10 -103.75 143.17 33.15 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 122.151 -0.343 . . . . 0.0 111.347 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.9 t -88.44 104.42 16.77 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.1 t70 -98.04 -156.55 0.55 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.0 p -70.49 -53.25 17.03 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.088 0.955 . . . . 0.0 112.064 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.82 -25.63 27.99 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.184 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.81 -156.36 28.27 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.168 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.459 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.6 m95 -78.51 142.27 37.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.813 0.445 . . . . 0.0 110.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -90.04 131.8 35.73 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 72.16 -175.46 0.17 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.773 0.829 . . . . 0.0 111.652 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -123.54 168.47 12.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' HA3' ' A' ' 89' ' ' GLY . 21.4 mt -57.04 116.11 12.45 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.411 1.085 . . . . 0.0 110.032 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 18.2 Cg_endo -64.69 138.52 59.09 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.274 1.983 . . . . 0.0 111.777 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 1.9 mp -87.06 129.13 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 0.0 110.091 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 12.1 m -63.13 113.48 3.17 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 123.782 0.833 . . . . 0.0 111.759 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.8 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' THR . 72.8 m -70.61 137.64 50.15 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.683 0.615 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -107.04 19.1 20.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.703 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.61 161.54 41.97 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.33 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 mt -78.2 150.17 77.03 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 123.401 0.68 . . . . 0.0 109.245 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.33 139.77 84.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.84 1.693 . . . . 0.0 110.022 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.55 147.02 50.85 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.036 1.824 . . . . 0.0 112.583 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -91.45 146.18 24.02 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -116.93 171.75 7.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -88.56 -39.09 14.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.984 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 p -93.57 -12.51 29.37 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 3.4 mp0 -127.48 138.29 52.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.956 0.408 . . . . 0.0 110.719 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 12.8 mt -114.74 144.19 22.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -78.72 125.27 29.14 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.7 p -86.99 -32.07 20.25 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.26 165.85 54.11 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.424 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 m -97.87 106.05 18.29 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -109.37 136.66 48.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -148.04 -20.31 0.35 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.0 152.87 18.3 Favored 'General case' 0 C--O 1.201 -1.487 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.568 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 25.5 p -120.71 139.79 52.55 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.903 -0.498 . . . . 0.0 111.74 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.74 140.91 33.33 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 122.257 0.223 . . . . 0.0 110.952 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.2 Cg_endo -60.3 145.63 98.2 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.412 2.741 . . . . 0.0 112.045 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 67' ' ' ARG . 22.6 tt0 -68.98 144.13 54.21 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.21 0.09 54.27 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -86.68 111.21 20.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -86.4 147.89 25.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.26 120.79 37.12 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.59 119.13 40.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.337 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 58.9 m-85 -95.39 143.8 26.45 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.89 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 5.0 tppp? -89.45 126.98 35.78 Favored 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 64.6 m -79.95 21.49 0.56 Allowed 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' LYS . 18.8 mtp180 63.4 157.87 0.12 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 123.87 0.868 . . . . 0.0 112.273 -176.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.13 -2.35 8.73 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.026 1.817 . . . . 0.0 113.766 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -105.39 -1.64 40.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.882 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.6 m-85 -128.14 178.16 6.42 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.435 -1.038 . . . . 0.0 108.949 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -155.53 177.71 11.06 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -169.02 171.69 8.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.92 -35.55 20.44 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.28 143.63 15.36 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.45 160.41 32.78 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.478 0.639 . . . . 0.0 111.426 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.98 105.11 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mm -104.66 116.93 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.263 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.4 mtp -105.52 172.32 6.86 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.606 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.0 p -159.47 148.88 7.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.25 0.548 . . . . 0.0 110.559 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.41 117.37 12.87 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.459 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 44' ' ' GLU . 5.4 tpm_? -146.63 123.07 11.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.09 25.69 14.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 0.0 113.19 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.25 -11.5 70.38 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.802 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.25 166.11 11.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.473 0.654 . . . . 0.0 110.644 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -106.46 106.74 17.4 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 -161.52 0.3 Allowed 'Isoleucine or valine' 1 N--CA 1.37 -4.472 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.19 126.6 36.32 Favored 'General case' 1 C--N 1.228 -4.705 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.069 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.23 -57.8 3.63 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.439 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 13.0 t-20 -116.5 102.56 53.35 Favored Pre-proline 0 N--CA 1.419 -1.998 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.537 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.45 -0.89 11.09 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 122.976 2.451 . . . . 0.0 112.989 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 mt -89.8 -26.5 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.859 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 34.9 mmt180 -85.28 147.75 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.227 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.58 163.15 40.65 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.95 111.38 23.63 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.37 151.05 22.37 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.357 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.8 mttt -65.24 129.03 38.24 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.2 ptp180 -71.74 137.37 82.83 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.077 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 143.66 76.57 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 122.711 2.274 . . . . 0.0 110.728 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.2 m -101.17 -13.76 18.0 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.24 -173.27 55.28 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.111 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.512 ' HD2' ' O ' ' A' ' 89' ' ' GLY . 32.9 t60 -72.26 134.13 82.9 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.91 65.78 4.06 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.025 2.483 . . . . 0.0 111.894 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 87' ' ' HIS . . . 74.42 -95.33 0.86 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -178.94 138.53 0.15 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.479 ' OG1' HG22 ' A' ' 138' ' ' ILE . 96.4 m -144.82 99.86 4.69 Favored Pre-proline 0 C--N 1.286 -2.172 0 CA-C-O 121.127 0.489 . . . . 0.0 111.612 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.2 -50.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.554 1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 114.88 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -81.46 -34.42 31.41 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.828 -0.545 . . . . 0.0 111.191 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 150.56 30.68 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 m -111.35 -42.74 3.83 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 117.42 0.61 . . . . 0.0 110.696 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.2 p90 64.44 152.19 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.963 1.705 . . . . 0.0 115.11 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 p -124.13 143.64 50.36 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -103.82 137.04 42.4 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.456 HG23 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -119.29 -22.26 7.18 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.89 44.31 1.51 Allowed Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.09 20.16 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -128.35 15.89 6.61 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.92 178.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -93.32 85.98 5.16 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.18 145.59 50.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.576 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.448 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 63.8 t80 -46.47 126.82 8.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.25 -5.93 55.79 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.935 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.58 131.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.644 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.456 ' HB3' HG23 ' A' ' 99' ' ' THR . 40.7 ttmt -100.29 127.57 46.55 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 98.21 8.18 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.41 115.75 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 4.9 t80 -82.96 94.55 7.77 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.647 0.737 . . . . 0.0 110.678 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 p -105.82 151.13 24.9 Favored 'General case' 0 N--CA 1.402 -2.848 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.466 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.85 -166.14 1.17 Allowed 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.201 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -61.82 156.52 20.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.58 -42.43 11.13 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.609 1.564 . . . . 0.0 114.246 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.94 10.34 74.24 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.356 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -114.46 167.69 10.51 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.788 0.794 . . . . 0.0 111.738 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -133.45 -140.21 0.19 Allowed 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 102.539 -3.134 . . . . 0.0 102.539 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' CD1' ' HB2' ' A' ' 139' ' ' PRO . 1.3 pt? -160.28 152.78 20.88 Favored 'General case' 1 N--CA 1.335 -6.178 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.43 126.83 31.69 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.95 163.23 9.43 Favored Glycine 0 N--CA 1.402 -3.582 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.62 -24.58 14.09 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.276 1.036 . . . . 0.0 108.344 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.6 mm -102.48 101.64 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.498 ' HA ' HD11 ' A' ' 120' ' ' LEU . 30.3 p-10 -89.19 33.61 0.8 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.657 0.741 . . . . 0.0 111.269 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -165.18 171.24 13.96 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.398 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 124.87 14.73 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.122 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -99.04 142.37 30.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.6 t -82.12 126.57 32.18 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.01 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.8 t70 -117.28 -166.45 1.18 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.467 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.8 p -60.15 -48.74 80.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 124.894 1.278 . . . . 0.0 113.616 -172.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.65 -24.81 18.54 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.38 0.609 . . . . 0.0 111.515 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.37 -155.48 25.73 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -77.87 144.77 36.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.5 p -63.97 -34.85 78.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.858 0.837 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -138.48 152.43 48.28 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.28 2.5 p30 -82.36 -94.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.479 HG22 ' OG1' ' A' ' 91' ' ' THR . 7.3 mt -133.61 98.19 15.17 Favored Pre-proline 0 C--N 1.292 -1.91 0 O-C-N 121.573 -0.704 . . . . 0.0 109.672 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.499 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 1.1 Cg_endo -51.78 141.43 44.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 166.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.98 115.18 26.86 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.684 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.53 120.66 9.83 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 122.266 0.226 . . . . 0.0 110.914 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 121.649 0.738 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.2 142.82 32.82 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.89 16.4 15.18 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 122.153 0.978 . . . . 0.0 108.609 173.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.45 163.18 34.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.8 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 37' ' ' TRP . 21.5 mt -91.51 154.96 44.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 123.699 0.8 . . . . 0.0 111.005 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -64.79 130.9 27.45 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.224 1.949 . . . . 0.0 110.511 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.25 146.32 90.05 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.153 1.902 . . . . 0.0 111.358 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.45 146.91 23.32 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.53 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.4 mpt_? -104.22 174.86 5.69 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.515 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -82.3 -34.88 28.45 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -100.38 -5.12 27.73 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 1.5 mp0 -133.06 145.81 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.58 153.9 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.42 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -74.82 143.05 44.13 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 123.846 0.716 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 49' ' ' ILE . 17.0 p -80.33 -52.53 7.59 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.489 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.23 177.62 54.13 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.625 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -95.23 127.75 41.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 75.6 m95 -124.31 103.78 8.41 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.6 m -121.65 7.67 10.01 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.753 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 40' ' ' GLN . 8.5 t70 -119.52 -158.41 0.73 Allowed 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.444 ' HG3' HG22 ' A' ' 41' ' ' THR . 2.8 pt20 -142.24 -36.92 0.4 Allowed 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -97.23 103.81 15.77 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.657 0.742 . . . . 0.0 111.658 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -117.63 145.45 36.41 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.049 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.22 140.47 92.28 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 123.323 2.682 . . . . 0.0 112.132 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.6 tt0 -64.97 138.1 58.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.04 6.6 53.75 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 m -86.14 117.93 25.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -82.95 146.49 28.78 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.607 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.95 113.65 24.42 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.471 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 mt -88.4 129.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.6 m-85 -103.17 136.34 43.14 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 122.395 1.093 . . . . 0.0 113.038 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -75.7 -20.15 58.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.065 -1.88 . . . . 0.0 112.967 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.8 m 65.88 7.29 4.51 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 57.5 mtp180 68.45 165.82 0.13 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 55.1 Cg_endo -71.02 -22.16 26.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 120.956 1.104 . . . . 0.0 112.903 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.12 -17.93 48.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.745 -0.74 . . . . 0.0 114.467 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.2 m-85 -118.47 167.21 11.81 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -161.67 -175.42 4.72 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 0.0 109.898 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -166.84 -177.88 4.04 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.72 69.87 0.99 Allowed 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.064 0.935 . . . . 0.0 108.987 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.78 -21.21 0.6 Allowed Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.65 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.1 m120 72.33 149.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.619 1.168 . . . . 0.0 110.598 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG23 ' SG ' ' A' ' 80' ' ' CYS . 73.3 t -70.51 110.41 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.77 116.08 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.6 mtp -103.45 174.04 6.04 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -161.64 150.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.14 0.495 . . . . 0.0 109.832 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.19 127.41 35.74 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.427 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 49.0 ttp180 -149.83 131.87 15.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 65.51 20.58 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.916 0.486 . . . . 0.0 112.305 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.11 -13.73 66.96 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.663 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.99 159.19 16.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.356 0.598 . . . . 0.0 111.697 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -99.43 109.71 22.26 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.18 -156.07 0.17 Allowed 'Isoleucine or valine' 1 N--CA 1.363 -4.78 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.678 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.47 134.79 45.22 Favored 'General case' 1 C--N 1.223 -4.921 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -168.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.12 -58.81 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -117.6 88.83 30.72 Favored Pre-proline 0 N--CA 1.433 -1.309 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.89 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.24 -14.46 25.66 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.37 2.047 . . . . 0.0 110.688 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.68 -28.27 62.6 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.834 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -93.55 132.74 37.56 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.944 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.0 155.54 44.68 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 62' ' ' VAL . 36.0 m -94.31 116.22 28.57 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.538 0.685 . . . . 0.0 109.933 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -111.0 177.11 4.77 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.976 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.2 mmtp -57.21 145.22 32.31 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.867 0.729 . . . . 0.0 109.754 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -85.66 131.61 46.95 Favored Pre-proline 0 C--N 1.279 -2.472 0 C-N-CA 118.906 -1.118 . . . . 0.0 108.693 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 139.43 39.6 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.415 2.076 . . . . 0.0 110.089 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.7 m -101.04 -2.82 30.62 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.66 -96.75 1.89 Allowed Glycine 0 C--N 1.308 -0.984 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.597 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -143.85 125.54 8.24 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.8 Cg_exo -68.89 -53.78 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.666 2.244 . . . . 0.0 111.726 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.73 166.69 18.3 Favored Glycine 0 N--CA 1.419 -2.46 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.338 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.45 109.58 20.89 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -92.33 131.96 33.27 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.24 -31.75 52.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.75 139.96 52.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.578 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . 71.61 -165.4 53.66 Favored Glycine 0 C--N 1.304 -1.214 0 O-C-N 123.961 0.788 . . . . 0.0 113.351 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HG1' ' C ' ' A' ' 94' ' ' GLY . 23.7 m -155.54 170.07 22.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CZ ' ' HG2' ' A' ' 88' ' ' PRO . 45.7 p90 -104.7 160.68 14.78 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.934 -0.479 . . . . 0.0 109.784 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -115.59 144.86 43.28 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -106.22 135.01 48.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 100' ' ' GLY 0.25 3.8 t -87.42 -86.01 0.16 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.496 ' H ' HG23 ' A' ' 99' ' ' THR . . . -87.02 52.77 4.43 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 118.15 0.432 . . . . 0.0 113.053 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.5 162.66 17.2 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -121.75 15.12 10.97 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.711 0.767 . . . . 0.0 109.102 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.9 175.35 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -93.55 88.55 5.93 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.0 pt-20 -133.25 154.85 50.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -50.05 119.54 3.69 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.537 0.684 . . . . 0.0 111.802 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.88 -19.76 18.04 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.839 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 105' ' ' GLU . 2.8 p -85.36 141.32 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HB2' ' HZ3' ' A' ' 109' ' ' LYS . 4.9 ttmp? -111.46 128.26 55.95 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.04 100.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.83 118.26 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.604 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -77.82 109.88 12.21 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.64 0.733 . . . . 0.0 110.616 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.17 109.15 12.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.03 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.578 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 97.7 m -129.84 111.07 12.23 Favored 'General case' 0 C--N 1.253 -3.628 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.76 -168.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 19.4 m120 57.25 -162.09 0.2 Allowed 'General case' 0 C--O 1.247 0.941 0 O-C-N 124.448 1.093 . . . . 0.0 112.744 172.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -121.48 -46.73 2.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.19 0.519 . . . . 0.0 110.477 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.47 72.82 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 68.8 m-85 -98.6 155.09 17.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -136.99 -88.46 0.28 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.4 pp 178.44 148.87 0.2 Allowed 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 123.895 0.747 . . . . 0.0 112.14 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.24 135.22 44.22 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.025 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.41 161.13 10.92 Favored Glycine 0 C--N 1.281 -2.516 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.82 -18.99 26.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.434 0.635 . . . . 0.0 109.838 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.444 HG13 ' ND2' ' A' ' 136' ' ' ASN . 41.1 mm -113.54 121.24 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.966 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -92.31 24.63 3.3 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.723 0.809 . . . . 0.0 111.557 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.519 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 38.0 p90 -163.04 178.45 8.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -151.39 128.2 10.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.649 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.0 mt-10 -103.82 154.42 19.62 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.2 t -92.44 105.65 17.8 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.251 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.35 175.48 7.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.574 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 73.8 p -52.46 -33.79 46.06 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.521 1.528 . . . . 0.0 112.444 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.15 -32.53 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.407 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.31 -159.48 28.89 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 95.2 m95 -67.74 128.92 38.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.314 0.578 . . . . 0.0 112.087 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.8 p -78.72 157.25 28.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.721 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.444 ' ND2' HG13 ' A' ' 124' ' ' ILE . 11.4 m120 65.82 -162.56 0.25 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -119.26 -163.1 0.95 Allowed 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.54 110.04 60.71 Favored Pre-proline 0 C--N 1.285 -2.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.76 137.91 82.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.959 1.773 . . . . 0.0 110.501 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 47.9 mm -89.33 103.91 14.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.14 111.18 1.42 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.253 0.549 . . . . 0.0 110.551 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.422 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 8.8 tp10 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.089 0.471 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.9 m -78.73 133.57 37.14 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.756 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.06 25.02 10.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.444 0.64 . . . . 0.0 110.096 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.42 155.19 38.1 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.851 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 32.0 mt -76.9 158.8 79.92 Favored Pre-proline 0 C--N 1.31 -1.13 0 O-C-N 123.738 0.649 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 141.4 74.23 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.319 2.012 . . . . 0.0 110.09 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.96 118.03 4.65 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 121.52 1.48 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -62.38 135.98 57.7 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.496 0.665 . . . . 0.0 110.194 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -85.94 176.89 7.81 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.769 -167.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -82.98 -24.1 33.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.963 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 p -132.29 10.27 4.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.92 0.391 . . . . 0.0 111.388 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 2.7 mp0 -133.7 158.78 42.42 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -133.34 163.42 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -85.58 156.65 20.64 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-O 120.81 0.338 . . . . 0.0 110.573 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -130.54 95.57 3.91 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 -149.5 15.38 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.2 m -131.13 117.79 19.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 117.836 0.818 . . . . 0.0 109.45 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.423 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 55.3 m95 -134.17 101.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.908 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.2 t -147.4 34.81 0.87 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 5.2 t70 -128.11 -163.86 1.31 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.588 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.93 -49.3 1.23 Allowed 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 70.1 p -95.43 127.12 41.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.73 136.98 26.4 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.857 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 37.4 Cg_endo -65.09 153.62 77.39 Favored 'Trans proline' 0 C--O 1.262 1.712 0 C-N-CA 122.825 2.35 . . . . 0.0 112.106 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.7 tt0 -67.49 139.99 57.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.97 2.2 55.0 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.202 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.427 ' C ' HG22 ' A' ' 65' ' ' VAL . 89.6 m -84.54 115.0 22.37 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -83.16 139.82 32.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.557 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.18 108.68 20.24 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.0 mt -87.71 115.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.799 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 84.6 m-85 -95.96 149.05 22.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.371 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.46 130.94 39.1 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.8 t -87.18 102.41 14.44 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -32.81 144.21 0.14 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.981 1.712 . . . . 0.0 113.623 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -56.52 111.19 0.71 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 123.423 2.749 . . . . 0.0 112.534 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.96 -19.86 5.16 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -111.88 166.62 11.05 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.578 -0.811 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -155.54 167.27 30.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.925 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -174.64 126.11 0.3 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.7 77.59 5.18 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.403 0.62 . . . . 0.0 110.697 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.01 -29.83 1.23 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 70.67 158.49 0.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.412 1.085 . . . . 0.0 112.859 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.88 110.93 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.43 121.43 67.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -109.4 176.52 5.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 HG22 ' C ' ' A' ' 46' ' ' THR . 9.9 p -159.97 142.92 5.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.139 0.495 . . . . 0.0 110.668 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.79 121.97 18.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.905 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttm180 -152.57 117.87 5.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.589 0.233 . . . . 0.0 110.527 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 40.3 mmtm 69.2 25.05 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.593 1.157 . . . . 0.0 112.826 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.38 -12.82 67.57 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.075 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.22 154.13 31.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -87.64 118.21 26.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.0 175.04 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.742 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.52 122.28 31.03 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.001 0.429 . . . . 0.0 111.258 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.08 -57.4 3.86 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.88 91.29 8.78 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.198 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.92 -15.44 16.63 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.476 2.118 . . . . 0.0 112.647 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 -28.94 59.98 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.672 0.749 . . . . 0.0 109.723 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -84.23 134.49 34.54 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.028 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -154.48 160.86 41.82 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 16.9 m -79.81 112.94 17.58 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-O 121.777 0.798 . . . . 0.0 112.312 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.48 153.14 23.27 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.35 146.38 43.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.818 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.12 145.66 49.69 Favored Pre-proline 0 N--CA 1.417 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.887 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.83 153.51 48.05 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 N-CA-C 108.03 -1.566 . . . . 0.0 108.03 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.1 m -91.3 -24.11 19.93 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.677 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.01 -115.52 3.99 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -146.09 131.31 9.13 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.94 34.41 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 123.015 2.476 . . . . 0.0 113.349 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.96 155.5 27.8 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.66 84.38 2.12 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 t -73.58 136.78 77.61 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.872 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.97 -28.46 19.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.172 1.915 . . . . 0.0 111.71 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.31 121.44 34.99 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 173.01 16.56 Favored Glycine 0 N--CA 1.424 -2.145 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 m -154.66 171.72 19.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -136.41 157.66 46.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.65 ' OG1' HG11 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -126.25 155.3 42.1 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.26 131.49 56.93 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.4 t -125.98 144.43 50.7 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.06 68.99 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.86 168.09 25.35 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -112.91 9.51 18.87 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.006 0.908 . . . . 0.0 108.963 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.3 p -136.19 -167.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.712 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.043 -173.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -105.46 101.48 11.01 Favored 'General case' 1 C--N 1.241 -4.109 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.163 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -156.37 152.86 28.08 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.536 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.8 t80 -54.07 114.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.94 0 O-C-N 124.021 0.826 . . . . 0.0 111.168 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.84 -19.81 5.2 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.576 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 103' ' ' VAL . 15.8 m -79.93 149.36 5.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.505 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.405 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.0 ttmp? -107.51 118.26 36.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.36 94.27 9.83 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.65 HG11 ' OG1' ' A' ' 97' ' ' THR . 2.7 p -89.33 121.23 39.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.515 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -84.23 141.41 31.02 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.333 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -141.73 163.89 31.68 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.22 -59.64 0.06 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 118.972 0.805 . . . . 0.0 111.736 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -147.26 -170.76 3.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.0 -51.04 3.8 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 123.882 0.873 . . . . 0.0 109.861 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.1 8.49 70.27 Favored Glycine 0 C--O 1.24 0.503 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.99 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -133.83 129.53 36.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.42 -135.78 0.2 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 167.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 125' ' ' ASN . 1.0 OUTLIER -153.23 153.57 32.96 Favored 'General case' 1 N--CA 1.334 -6.243 0 C-N-CA 118.991 -1.083 . . . . 0.0 108.411 -175.69 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.5 mm? -77.77 125.89 30.03 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-O 121.475 0.655 . . . . 0.0 109.431 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.25 150.14 7.38 Favored Glycine 0 C--N 1.273 -2.947 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.56 -22.76 22.23 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 122.162 0.982 . . . . 0.0 109.149 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.93 109.4 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.869 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HA ' HD12 ' A' ' 120' ' ' LEU . 32.0 p-10 -86.14 33.67 0.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.779 0.8 . . . . 0.0 110.863 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 50.1 p90 -167.07 176.52 6.82 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.95 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.85 119.42 7.97 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 23.6 mt-10 -87.76 155.39 19.93 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 52.4 t -75.38 139.46 42.39 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.42 167.47 12.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.502 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.5 p -55.87 -28.5 56.81 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.791 1.637 . . . . 0.0 112.894 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -108.43 -28.93 9.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.244 0.545 . . . . 0.0 111.555 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.7 -106.24 0.19 Allowed Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.964 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -127.54 145.35 50.89 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -74.59 -26.79 60.16 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -128.12 170.02 13.43 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -99.28 -170.14 1.87 Allowed 'General case' 0 C--N 1.285 -2.212 0 O-C-N 124.055 0.847 . . . . 0.0 110.365 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.43 113.1 53.91 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-O 120.365 0.126 . . . . 0.0 110.694 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB2' HD11 ' A' ' 120' ' ' LEU . 11.2 Cg_endo -70.24 152.94 67.1 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 122.601 2.2 . . . . 0.0 110.287 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.26 125.96 72.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 12.3 p -76.96 108.54 10.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.476 ' HB2' HD23 ' A' ' 121' ' ' LEU . 28.3 mt-10 . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 125.678 1.591 . . . . 0.0 107.166 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 121.72 0.771 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.0 m -76.02 140.33 41.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.024 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.85 20.02 19.61 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.602 0.715 . . . . 0.0 109.915 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.1 155.95 40.76 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -88.53 158.41 48.55 Favored Pre-proline 1 N--CA 1.367 -4.577 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.248 -176.966 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 13.2 Cg_endo -58.34 130.04 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.541 2.827 . . . . 0.0 111.829 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.14 122.86 5.89 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.526 2.15 . . . . 0.0 112.597 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.74 154.23 41.24 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.975 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -117.08 176.14 5.27 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.74 -23.35 64.32 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.253 0.549 . . . . 0.0 111.517 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 p -119.02 7.13 11.35 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.9 141.7 42.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.35 0.595 . . . . 0.0 112.148 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.95 151.92 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.526 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 3.6 mm? -67.84 155.52 39.17 Favored 'General case' 0 C--N 1.267 -2.981 0 O-C-N 123.629 0.581 . . . . 0.0 111.233 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 p -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.389 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 -163.4 38.84 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.782 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -121.09 108.21 13.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 18.7 m95 -107.52 88.16 2.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -104.11 4.74 34.54 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.774 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 40' ' ' GLN . 9.2 t70 -103.02 -150.02 0.41 Allowed 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.279 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 39.6 mt-30 -134.08 -57.8 0.86 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 69.8 p -88.03 122.12 31.25 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.171 -172.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -129.51 138.95 34.26 Favored Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.482 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.43 143.76 99.61 Favored 'Trans proline' 0 C--O 1.245 0.875 0 C-N-CA 123.316 2.677 . . . . 0.0 113.237 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 48.1 tt0 -63.6 131.65 48.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.965 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.36 4.59 46.83 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.444 ' C ' HG21 ' A' ' 65' ' ' VAL . 58.0 m -86.02 115.53 23.67 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -84.45 142.23 30.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.365 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.46 124.15 51.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -94.12 132.04 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -110.19 144.47 38.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -93.75 142.23 27.6 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.729 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 m -84.51 22.36 1.3 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 64.83 162.26 0.12 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.347 0.659 . . . . 0.0 110.112 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.63 112.5 3.38 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 120.509 0.806 . . . . 0.0 110.536 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.57 -26.22 6.04 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.333 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.729 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 89.5 m-85 -102.59 163.51 12.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.861 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -140.55 -178.79 5.68 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -143.67 -177.0 5.19 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.76 6.03 36.49 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.13 0.491 . . . . 0.0 109.745 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.04 -115.93 0.34 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -138.78 122.86 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' SG ' ' A' ' 80' ' ' CYS . 60.7 t -84.08 110.38 18.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.06 130.44 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.401 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -111.03 175.13 5.54 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG21 ' C ' ' A' ' 46' ' ' THR . 11.2 p -157.71 143.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-O 121.33 0.586 . . . . 0.0 111.275 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.8 t -75.31 123.85 26.06 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.474 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 70.0 ttt180 -155.53 134.24 11.92 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 62.61 21.04 12.44 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.736 0.814 . . . . 0.0 112.369 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.65 69.36 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.675 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -121.36 159.87 25.21 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.571 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.19 117.6 29.07 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.689 0.756 . . . . 0.0 110.36 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.73 169.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.022 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.69 125.77 35.0 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.84 -56.78 6.87 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 8.9 t-20 -120.88 100.66 46.03 Favored Pre-proline 0 N--CA 1.413 -2.299 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.271 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.66 -5.65 17.15 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.912 2.408 . . . . 0.0 112.779 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.5 mt -88.91 -20.46 24.51 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 122.164 0.983 . . . . 0.0 110.827 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.511 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 31.7 mmt180 -91.15 132.15 36.25 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.42 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -149.41 158.93 44.6 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 62' ' ' VAL . 81.7 m -97.66 107.23 19.68 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.058 0.932 . . . . 0.0 110.276 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.51 168.83 9.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.954 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.0 mttt -66.71 144.86 56.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -85.44 139.58 36.03 Favored Pre-proline 0 N--CA 1.427 -1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -68.81 140.45 46.41 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.351 1.368 . . . . 0.0 108.84 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.7 m -74.43 -38.33 63.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.291 0.567 . . . . 0.0 110.495 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.94 -86.03 0.38 Allowed Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -174.64 120.47 0.35 Allowed Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 123.33 0.652 . . . . 0.0 109.325 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.06 157.15 62.86 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.567 2.178 . . . . 0.0 109.011 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.07 138.42 26.72 Favored Glycine 0 N--CA 1.438 -1.209 0 O-C-N 123.955 0.784 . . . . 0.0 112.218 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.76 137.52 37.24 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.1 0.476 . . . . 0.0 109.909 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -126.15 141.19 38.98 Favored Pre-proline 0 N--CA 1.404 -2.733 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.834 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.13 -29.89 9.36 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.17 1.913 . . . . 0.0 110.8 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.72 109.67 16.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.73 157.0 9.57 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.296 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 m -137.92 164.5 28.86 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.7 p90 -129.5 155.78 45.2 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.027 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 42.1 p -100.64 164.83 11.7 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.945 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 93.3 mt -130.85 123.43 29.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.0 t -129.91 20.91 5.43 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.463 0.649 . . . . 0.0 112.653 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.23 33.23 1.83 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 105' ' ' GLU . . . 147.57 -151.57 23.81 Favored Glycine 0 N--CA 1.413 -2.877 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -175.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.76 3.24 1.25 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.406 0.603 . . . . 0.0 111.533 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.26 -172.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -85.2 95.47 9.18 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 108' ' ' VAL . 12.0 pt-20 -137.83 145.83 42.73 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.343 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 47.0 t80 -49.21 123.86 8.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.342 0.591 . . . . 0.0 111.766 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.52 58.54 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.864 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 105' ' ' GLU . 5.8 p -91.8 136.25 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.3 ttmt -101.62 132.26 47.39 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -109.11 101.9 10.91 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -88.45 132.19 34.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 119.401 -0.92 . . . . 0.0 108.828 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.413 ' HH ' ' HB2' ' A' ' 141' ' ' CYS . 5.9 t80 -98.31 123.97 42.69 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.555 0.693 . . . . 0.0 109.372 -173.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.0 m -144.34 158.32 43.8 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 71.5 m -125.41 -61.71 1.25 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.405 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -151.92 -166.06 2.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.45 -56.33 10.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.004 0.43 . . . . 0.0 111.05 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.1 -13.71 61.65 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.42 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.513 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -93.75 115.04 27.44 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.242 0.544 . . . . 0.0 111.548 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -113.08 -117.91 0.31 Allowed 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -165.69 156.66 13.68 Favored 'General case' 1 N--CA 1.354 -5.264 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.463 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -79.57 125.63 29.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.8 152.75 7.25 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.65 -10.32 32.21 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.126 0.489 . . . . 0.0 110.839 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -111.39 106.72 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.495 ' HA ' HD12 ' A' ' 120' ' ' LEU . 27.5 p-10 -90.62 34.96 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.421 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 42.0 p90 -163.63 169.22 18.89 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.45 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -132.39 134.75 45.53 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.421 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 41.3 mt-10 -114.28 130.51 56.65 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 18.7 t -79.32 114.15 18.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -105.45 -162.28 0.86 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.3 p -62.57 -42.76 99.75 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.12 -10.86 15.76 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.0 -163.22 34.15 Favored Glycine 0 CA--C 1.49 -1.496 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.837 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -82.91 144.06 30.3 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 117.143 0.472 . . . . 0.0 110.255 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -70.5 -20.79 62.82 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.235 0.541 . . . . 0.0 112.422 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -137.83 148.63 45.63 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -89.84 -103.14 0.09 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.654 0.596 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.7 mt -127.17 96.38 34.22 Favored Pre-proline 0 C--N 1.31 -1.151 0 O-C-N 120.782 -1.199 . . . . 0.0 111.754 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.482 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 6.5 Cg_endo -56.92 136.11 74.66 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 122.447 2.098 . . . . 0.0 108.575 167.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 140' ' ' ILE . 3.5 mp -87.15 115.86 28.56 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.963 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.83 -171.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.413 ' HB2' ' HH ' ' A' ' 112' ' ' TYR . 48.6 t -52.02 112.81 0.85 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.513 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 35.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.275 1.43 . . . . 0.0 109.481 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.673 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.0 m-20 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.31 0.576 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' THR . 84.9 m -77.19 139.75 39.97 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.314 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.64 25.86 10.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.732 0.777 . . . . 0.0 109.164 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.57 155.35 33.2 Favored 'General case' 0 CA--C 1.468 -2.199 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -86.88 156.98 55.11 Favored Pre-proline 1 N--CA 1.336 -6.161 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.528 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.1 Cg_endo -54.14 125.35 18.52 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.083 2.522 . . . . 0.0 110.99 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.46 110.85 3.18 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.499 1.466 . . . . 0.0 112.118 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.276 0.0 OUTLIER -72.14 161.24 31.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.081 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 72.1 mtp180 -122.93 -174.03 2.84 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -168.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -90.47 -14.33 32.99 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -99.9 -33.88 10.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.734 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 25.5 mp0 -121.04 145.93 47.25 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.233 0.54 . . . . 0.0 112.14 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mt -119.71 144.46 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.607 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.564 HD12 ' CD1' ' A' ' 37' ' ' TRP . 25.3 mt -74.67 128.24 35.07 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -112.96 100.35 8.57 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.9 171.1 21.3 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m -105.46 110.67 23.1 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.382 0.611 . . . . 0.0 111.261 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.564 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.7 m95 -132.34 82.24 2.0 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 m -108.43 -2.29 19.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.231 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.678 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.2 t70 -93.72 -136.29 0.19 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.909 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 27.3 mt-30 -144.11 -55.43 0.36 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 27.5 p -91.85 129.05 37.89 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -133.1 135.0 24.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.099 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.673 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 17.8 Cg_endo -60.59 148.65 90.55 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.228 2.619 . . . . 0.0 113.278 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.49 134.77 55.13 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.39 14.68 37.56 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.427 ' C ' HG21 ' A' ' 65' ' ' VAL . 90.4 m -94.29 119.33 32.91 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.349 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -89.3 150.09 22.75 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.454 0.645 . . . . 0.0 111.861 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 130.97 53.48 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.7 mt -101.56 126.62 55.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 66.4 m-85 -109.49 143.31 39.29 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -92.33 129.75 38.2 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 73.5 m -70.99 7.46 1.18 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.4 mtp180 71.78 154.17 0.15 Allowed Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.618 0.767 . . . . 0.0 111.263 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.52 129.09 17.22 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.792 1.661 . . . . 0.0 109.186 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 104.69 -6.43 44.62 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.329 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 36.3 m-85 -126.39 170.65 11.73 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -160.16 177.54 10.58 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.5 p -155.37 179.97 8.66 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.72 -22.34 56.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.865 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.02 -96.59 0.14 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -155.73 155.32 32.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.603 HG21 ' SG ' ' A' ' 80' ' ' CYS . 65.9 t -77.42 106.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.63 116.77 48.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.0 mtp -107.89 167.59 9.87 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 46' ' ' THR . 7.7 p -152.79 144.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.067 0.46 . . . . 0.0 110.088 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.43 118.84 12.81 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.577 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -151.12 115.22 5.02 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 37.6 mmtm 69.24 27.98 5.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.016 . . . . 0.0 112.615 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.22 87.41 Favored Glycine 0 C--N 1.294 -1.784 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.59 152.96 38.68 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.518 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 79.9 m95 -92.77 121.22 33.94 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.2 172.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.84 119.4 21.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.82 -49.39 73.04 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.49 91.84 6.37 Favored Pre-proline 0 C--N 1.29 -1.992 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.167 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.4 -3.13 13.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 0.0 112.984 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.17 8.38 44.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.239 0.542 . . . . 0.0 109.715 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -119.23 149.08 42.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.311 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.83 161.18 28.92 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.603 ' SG ' HG21 ' A' ' 62' ' ' VAL . 71.8 m -104.26 123.94 48.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.71 0.767 . . . . 0.0 109.746 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -112.32 165.63 12.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.71 157.45 17.76 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 117.962 0.346 . . . . 0.0 110.801 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.9 ptm180 -82.22 143.91 49.54 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 41.2 Cg_endo -72.75 157.16 52.42 Favored 'Trans proline' 0 N--CA 1.424 -2.617 0 N-CA-C 108.142 -1.522 . . . . 0.0 108.142 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -103.03 6.26 38.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.646 0.736 . . . . 0.0 110.224 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 -122.07 9.94 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.892 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -130.63 120.23 18.62 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 45.5 Cg_endo -75.76 139.52 22.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.73 1.62 . . . . 0.0 108.315 172.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -48.38 128.12 18.27 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.135 0.897 . . . . 0.0 113.638 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -98.29 178.09 5.17 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -148.8 147.1 23.42 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.99 -18.52 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.739 1.626 . . . . 0.0 111.088 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.5 -25.44 28.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' C ' ' HG1' ' A' ' 95' ' ' THR . . . -146.79 -147.74 4.62 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.723 -1.227 . . . . 0.0 114.072 -175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.424 ' HG1' ' C ' ' A' ' 94' ' ' GLY . 12.8 m -154.59 -169.3 3.17 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.402 ' H ' HG23 ' A' ' 95' ' ' THR . 38.5 p90 -148.62 161.74 41.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 119.274 0.943 . . . . 0.0 109.053 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 111' ' ' VAL . 63.7 p -109.1 -176.51 3.05 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.73 164.95 29.02 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.5 t -119.88 -148.76 0.42 Allowed 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.82 74.89 0.0 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 125.746 1.641 . . . . 0.0 115.938 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.79 -41.53 0.08 OUTLIER Glycine 0 C--N 1.276 -2.783 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.06 11.96 3.71 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.27 177.19 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 40.2 m-85 -90.79 87.78 6.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.55 150.82 44.15 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.553 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -45.32 115.38 0.91 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.477 1.11 . . . . 0.0 110.835 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.7 -33.92 2.87 Favored Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.73 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.37 135.79 26.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.495 1.14 . . . . 0.0 113.424 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -93.69 118.13 31.0 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.235 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -96.62 109.21 21.87 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.566 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.2 m -86.72 158.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.465 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 51.1 t80 -119.52 132.84 55.84 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.518 0.675 . . . . 0.0 110.201 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 7.3 m -153.08 157.81 40.98 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.413 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . 81.8 m -120.74 -61.87 1.52 Allowed 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.148 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -153.48 -153.0 0.44 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.57 -47.0 7.03 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.14 -29.16 69.08 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.23 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.422 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 96.1 m-85 -107.93 126.49 52.75 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.14 -74.93 0.54 Allowed 'General case' 1 CA--C 1.416 -4.179 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.269 2.3 tp -172.34 154.75 3.33 Favored 'General case' 1 N--CA 1.282 -8.852 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.541 -168.186 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.677 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 22.8 mt -129.0 130.05 46.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 132.45 -168.36 22.71 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -110.29 -40.17 4.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 117.937 0.869 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.1 mm -97.67 100.74 11.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.709 -176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.93 32.12 0.68 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 -176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 35.0 p90 -161.27 173.17 15.42 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.539 0.685 . . . . 0.0 110.262 -175.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 88' ' ' PRO . 21.7 ptt180 -147.04 134.68 21.03 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.9 mt-10 -111.86 143.48 42.74 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.648 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.74 106.13 17.45 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.207 0.527 . . . . 0.0 109.831 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 131' ' ' THR . 10.4 t70 -100.89 -166.93 1.36 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.244 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.401 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 39.8 p -62.59 -43.44 98.8 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.048 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.5 -37.87 77.37 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.66 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 138.78 -147.14 19.01 Favored Glycine 0 N--CA 1.411 -2.982 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -65.82 122.48 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 p -60.21 -33.21 71.92 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.888 0.875 . . . . 0.0 111.778 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -132.1 165.69 23.46 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 25.8 t70 -98.72 -144.82 0.32 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.415 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 11.7 mt -89.16 113.65 57.12 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 3.4 Cg_endo -65.73 161.82 37.28 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.457 2.104 . . . . 0.0 111.263 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.81 136.46 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.438 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 40.9 t -104.18 102.7 12.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 179.6 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.55 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 11.0 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' THR . 59.8 m -75.99 133.93 40.29 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.244 0.618 . . . . 0.0 109.925 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.01 36.79 2.23 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.409 0.623 . . . . 0.0 109.635 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.16 155.94 31.82 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.825 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.28 153.25 74.14 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.23 132.39 46.49 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.05 1.834 . . . . 0.0 110.657 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.33 137.58 10.6 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.254 1.969 . . . . 0.0 112.682 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -80.25 126.02 30.6 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 30.4 mtp180 -99.53 178.24 4.92 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.178 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.45 -28.03 61.74 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.168 0.985 . . . . 0.0 109.996 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.419 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 1.1 p -107.06 -31.56 8.23 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.642 -175.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.662 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 30.1 mp0 -116.34 158.76 22.93 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.4 ' HB ' ' HG2' ' A' ' 51' ' ' LYS . 14.7 mt -144.01 148.4 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 151.42 42.28 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -126.67 156.89 40.32 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.69 -156.91 18.24 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.803 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -133.66 130.6 38.46 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -134.11 139.81 46.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -154.57 -5.03 0.15 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.385 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -113.97 163.65 14.84 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.031 -172.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.542 ' HA ' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER -83.9 -47.19 11.31 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.026 178.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 34.0 p -98.52 131.75 44.5 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.964 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -130.83 135.45 27.36 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.041 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.3 Cg_endo -61.71 148.9 92.01 Favored 'Trans proline' 0 C--O 1.257 1.474 0 C-N-CA 123.198 2.599 . . . . 0.0 112.001 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.45 139.87 58.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -11.25 55.69 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.062 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -68.54 118.34 11.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -93.4 138.77 31.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.558 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.2 119.72 39.95 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.815 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -93.2 111.78 25.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.1 m-85 -101.86 144.06 30.97 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 19.4 ptpt -89.0 161.45 16.58 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.35 118.85 34.73 Favored 'General case' 1 N--CA 1.368 -4.553 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -31.55 147.31 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 124.81 1.319 . . . . 0.0 111.507 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.62 -31.33 31.49 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.409 2.739 . . . . 0.0 115.339 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.429 ' C ' ' HG2' ' A' ' 83' ' ' ARG . . . -96.2 14.54 64.33 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.514 0.508 . . . . 0.0 112.515 177.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.91 167.97 16.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.139 -0.624 . . . . 0.0 110.093 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -157.9 -177.06 6.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 109.272 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -166.65 -167.99 1.08 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mp -88.78 3.93 49.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.98 -98.87 0.12 Allowed Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -141.93 158.22 44.04 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.8 t -88.21 107.98 18.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.67 108.46 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-O 121.835 0.826 . . . . 0.0 109.832 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mtp -97.73 175.15 6.28 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -157.04 147.79 10.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.676 -175.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.37 111.21 12.8 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -141.94 119.02 11.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt 64.53 22.1 12.6 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.591 1.157 . . . . 0.0 113.068 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.32 -8.62 69.5 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.387 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.63 161.01 17.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.235 0.54 . . . . 0.0 110.481 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -104.18 106.36 16.84 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 p -127.93 -153.59 0.13 Allowed 'Isoleucine or valine' 1 N--CA 1.371 -4.42 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.82 115.03 29.08 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 3.0 tm? -59.47 -55.0 40.09 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 167.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -120.0 97.52 49.41 Favored Pre-proline 0 N--CA 1.415 -2.193 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.098 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.08 -4.82 15.62 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 123.478 2.786 . . . . 0.0 112.624 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.87 -29.35 25.34 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.901 0.858 . . . . 0.0 109.066 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -91.36 131.44 36.85 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.919 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -158.89 154.11 25.47 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.662 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 73.8 m -84.77 106.18 16.11 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 122.022 0.915 . . . . 0.0 110.593 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -98.88 161.0 13.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.55 145.36 52.65 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.633 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' ' C ' ' A' ' 55' ' ' GLY . 12.2 ptp180 -85.77 137.86 35.73 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.08 142.96 63.5 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.282 1.988 . . . . 0.0 111.034 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.79 -27.91 63.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.8 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.14 -175.7 24.07 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.55 123.94 80.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.55 42.97 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 123.749 2.966 . . . . 0.0 112.845 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 72.28 -168.1 52.66 Favored Glycine 0 N--CA 1.412 -2.96 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.97 139.01 32.32 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -116.61 145.5 35.46 Favored Pre-proline 0 C--N 1.281 -2.391 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.36 -35.08 95.71 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.953 2.436 . . . . 0.0 111.415 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.32 150.37 19.85 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.74 163.46 11.49 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.522 -0.847 . . . . 0.0 110.992 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 m -145.44 172.58 12.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.65 159.64 42.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.661 ' OG1' HG11 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -118.33 152.13 36.39 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.26 138.5 46.56 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -127.24 13.38 7.17 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.496 0.665 . . . . 0.0 111.505 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.45 15.91 4.92 Favored Glycine 0 CA--C 1.494 -1.241 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.738 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.15 -173.15 31.36 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -110.64 3.08 19.0 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.629 0.715 . . . . 0.0 109.355 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.442 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.9 p -142.72 -168.49 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.366 -170.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.9 98.93 10.51 Favored 'General case' 1 C--N 1.239 -4.219 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.618 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.44 148.54 28.2 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.573 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.508 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.5 t80 -52.81 105.6 0.13 Allowed 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.292 0.995 . . . . 0.0 112.045 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.15 -8.23 4.76 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.857 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 103' ' ' VAL . 16.3 m -90.12 143.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.356 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' ' 99' ' ' THR . 40.3 ttmt -104.84 122.05 44.94 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.8 91.33 8.58 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.661 HG11 ' OG1' ' A' ' 97' ' ' THR . 1.4 p -82.07 118.15 29.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.866 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -92.82 141.36 28.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.926 0.87 . . . . 0.0 111.604 -168.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 m -146.61 155.02 42.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.7 t -130.46 -72.7 0.56 Allowed 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 117.009 -1.876 . . . . 0.0 112.493 -172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 0.9 OUTLIER -143.67 -169.7 3.14 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -176.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -90.85 -48.05 7.25 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.79 -10.92 85.76 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.845 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 79.3 m-85 -123.52 126.48 46.78 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -104.76 -88.51 0.43 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.0 pp 175.66 143.0 0.06 Allowed 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.461 1.104 . . . . 0.0 111.212 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.19 126.92 45.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.98 172.24 12.93 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -100.05 -23.62 14.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.242 1.02 . . . . 0.0 110.08 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 126' ' ' TYR . 35.2 mm -107.29 98.76 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.82 30.73 0.31 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.849 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.497 ' O ' HG21 ' A' ' 124' ' ' ILE . 39.4 p90 -170.23 -177.49 2.51 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.93 115.74 5.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.09 143.69 33.75 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.576 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.8 t -74.61 142.09 44.63 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.029 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -124.75 -165.47 1.39 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 p -70.8 -53.32 15.81 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.967 0.889 . . . . 0.0 111.75 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -103.09 2.22 34.41 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.168 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.03 -125.47 1.03 Allowed Glycine 0 C--N 1.291 -1.947 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -127.96 162.05 27.67 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.3 p -80.91 -24.89 37.92 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -141.8 172.68 12.36 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 17.9 t70 -99.75 -161.99 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 124.135 0.897 . . . . 0.0 109.504 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.485 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 25.9 mt -83.05 124.14 76.83 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.7 138.45 34.88 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.769 1.646 . . . . 0.0 109.863 172.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 33.6 mm -86.43 118.63 33.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.986 -175.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 76.6 m -53.72 107.28 0.24 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.582 0.552 . . . . 0.0 111.326 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.425 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 34.4 m-20 . . . . . 0 C--O 1.242 0.686 0 CA-C-O 121.074 0.464 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -77.16 145.12 37.91 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -177.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.79 18.4 12.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.62 157.78 38.71 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -87.43 159.64 49.73 Favored Pre-proline 1 N--CA 1.356 -5.135 0 C-N-CA 125.1 1.36 . . . . 0.0 110.389 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.71 150.09 78.93 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.516 2.81 . . . . 0.0 111.396 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.32 169.07 17.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.195 1.93 . . . . 0.0 112.244 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -117.25 150.71 38.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.04 165.49 15.97 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.331 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.91 -39.25 26.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 5.5 p -89.98 -8.12 52.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -140.98 146.87 37.87 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.7 mt -113.43 126.55 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.058 0 CA-C-O 122.138 0.971 . . . . 0.0 109.945 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.33 113.45 11.56 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.097 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.9 p -90.28 157.31 17.73 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 -175.51 22.26 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.2 m -123.36 99.54 6.38 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.78 68.52 0.69 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 m -97.8 10.97 38.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.413 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.587 ' O ' HD23 ' A' ' 24' ' ' LEU . 22.1 t70 -97.48 -138.7 0.28 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.455 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 54.8 mt-30 -151.03 -58.09 0.16 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.7 p -89.27 129.26 35.86 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.673 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -137.79 149.09 63.36 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 123.903 0.881 . . . . 0.0 108.779 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.547 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 27.5 Cg_endo -65.11 150.87 87.25 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 122.516 2.144 . . . . 0.0 112.472 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 27.8 tt0 -67.36 138.71 56.95 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.56 56.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.274 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -81.15 119.13 23.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 2.9 pt20 -85.54 145.92 27.15 Favored 'General case' 0 N--CA 1.417 -2.088 0 O-C-N 123.802 0.689 . . . . 0.0 110.305 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 124.81 52.91 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.66 117.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.052 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 74.3 m-85 -98.07 134.6 40.93 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.041 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -77.37 134.78 38.37 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.3 t -80.53 98.82 7.76 Favored 'General case' 0 N--CA 1.396 -3.139 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -38.49 137.14 0.84 Allowed Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 112.224 -2.262 . . . . 0.0 111.769 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.7 122.41 11.69 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.695 2.263 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 113.87 -10.67 23.07 Favored Glycine 0 C--N 1.289 -2.031 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.347 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.451 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 89.9 m-85 -125.23 168.77 13.01 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 122.168 -0.607 . . . . 0.0 110.488 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -157.01 175.0 14.68 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.974 0.91 . . . . 0.0 108.654 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.0 p -159.61 -160.86 0.86 Allowed 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.82 4.18 48.55 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.968 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.21 -119.14 0.65 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -121.4 157.33 30.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 61.5 t -91.16 115.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.4 mm -111.5 121.68 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 CA-C-O 121.362 0.601 . . . . 0.0 110.983 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.404 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 80.0 mtp -106.26 172.58 6.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.5 p -153.78 155.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.497 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.9 t -97.27 132.45 43.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 87.5 mtt180 -149.6 134.08 17.52 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 124.215 0.947 . . . . 0.0 110.127 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 62.79 23.79 14.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.42 -6.5 80.65 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.81 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.02 155.79 30.79 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.116 0.484 . . . . 0.0 110.886 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -93.6 120.65 34.13 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.372 0.606 . . . . 0.0 109.465 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.14 175.6 4.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.036 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.74 115.02 27.7 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.766 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.7 tm? -59.2 -54.54 45.79 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -122.27 99.46 43.15 Favored Pre-proline 0 N--CA 1.404 -2.762 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.757 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.14 -14.21 20.91 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.791 2.327 . . . . 0.0 112.031 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.75 -28.19 55.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.585 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -91.08 135.17 33.94 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.003 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.525 ' HZ1' ' HB3' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -168.23 151.07 5.52 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 97.4 m -81.58 109.39 15.98 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.731 0.777 . . . . 0.0 112.636 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -105.47 171.79 7.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.072 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -63.79 146.34 54.09 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.3 ptp180 -100.25 146.21 31.57 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 77.8 Cg_endo -82.85 152.01 14.6 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 121.932 1.755 . . . . 0.0 112.156 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.09 -1.19 34.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.493 0.663 . . . . 0.0 111.198 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.79 -92.45 1.12 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.253 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.59 129.9 21.54 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.1 36.08 0.6 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.913 3.075 . . . . 0.0 113.602 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 87.15 161.46 36.48 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.919 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -115.17 135.79 53.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -157.17 125.42 2.88 Favored Pre-proline 0 N--CA 1.416 -2.136 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.65 14.62 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.454 2.103 . . . . 0.0 111.602 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.06 -16.35 16.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.096 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.67 -162.42 28.68 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.066 -1.54 . . . . 0.0 113.2 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 t -134.74 -164.13 1.47 Allowed 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 123.27 0.628 . . . . 0.0 109.529 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 53.9 p90 -141.54 160.12 40.81 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.627 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 41.4 p -113.61 172.83 6.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 174.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.18 135.6 45.21 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 13.1 t -138.01 18.27 2.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.314 1.054 . . . . 0.0 111.307 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 108' ' ' VAL . . . -142.04 38.1 1.51 Allowed Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.39 -176.23 20.46 Favored Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.38 17.59 11.4 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.595 0.712 . . . . 0.0 109.598 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.9 p -144.67 -167.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 m-85 -104.31 93.72 4.96 Favored 'General case' 0 C--N 1.244 -3.983 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.974 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG11 ' A' ' 108' ' ' VAL . 11.4 pt-20 -142.39 152.11 42.5 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -51.4 114.52 1.25 Allowed 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.757 0.661 . . . . 0.0 110.445 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.47 -18.85 10.84 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.988 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 105' ' ' GLU . 5.9 p -81.17 138.1 20.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.361 0.601 . . . . 0.0 110.787 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.497 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.1 ttmp? -104.61 128.49 52.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -104.66 96.52 6.64 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG23 ' HG1' ' A' ' 97' ' ' THR . 0.8 OUTLIER -81.37 146.4 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -96.79 131.85 43.1 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.694 0.759 . . . . 0.0 109.977 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 m -151.91 157.66 42.12 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.27 -66.4 0.14 Allowed 'General case' 0 C--N 1.251 -3.692 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.578 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 49.8 m-80 -115.79 -177.56 3.19 Favored 'General case' 0 N--CA 1.398 -3.062 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.085 -174.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.51 -46.5 7.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.71 17.59 58.1 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.768 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 3.3 m-85 -125.45 150.63 47.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.244 -0.562 . . . . 0.0 109.941 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -122.1 -148.04 0.4 Allowed 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 171.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -142.99 154.79 44.37 Favored 'General case' 1 N--CA 1.332 -6.363 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.783 -169.469 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 142' ' ' GLU . 4.3 mm? -81.63 128.68 34.19 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.24 142.61 5.08 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.4 -18.15 42.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.673 0.749 . . . . 0.0 109.09 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.35 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.529 ' HA ' HD12 ' A' ' 120' ' ' LEU . 29.2 p-10 -86.3 28.46 0.83 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.273 0.558 . . . . 0.0 111.474 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -167.57 -177.6 3.61 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.182 -172.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.46 133.45 15.08 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 29.3 mt-10 -105.92 147.08 29.18 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 122.139 -0.351 . . . . 0.0 111.318 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.5 t -81.77 106.2 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.6 t70 -101.95 -160.82 0.81 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.517 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.7 p -63.84 -51.91 62.53 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 124.911 1.285 . . . . 0.0 112.877 -174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.12 -35.82 15.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.227 0.537 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.96 -151.97 10.45 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 79.7 m95 -76.91 139.99 40.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.267 0.533 . . . . 0.0 109.943 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.6 p -63.92 -32.43 73.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -138.21 176.51 8.64 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 11.1 t70 -92.6 -155.88 0.45 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.424 HD12 ' HA3' ' A' ' 89' ' ' GLY . 38.0 mt -99.17 111.44 61.0 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 122.964 0.506 . . . . 0.0 110.062 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.407 ' HB2' HD11 ' A' ' 120' ' ' LEU . 9.4 Cg_endo -61.62 145.42 97.63 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.363 2.042 . . . . 0.0 109.682 170.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.73 123.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.515 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 8.1 t -67.11 120.42 13.68 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB2' HD22 ' A' ' 121' ' ' LEU . 16.6 mm-40 . . . . . 0 C--N 1.313 -1.003 0 C-N-CA 125.343 1.457 . . . . 0.0 108.141 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.507 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 6.0 m-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 77.5 m -69.17 127.4 32.94 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.948 -178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.9 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.216 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.1 158.8 25.32 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.52 155.62 81.26 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.03 132.6 48.42 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.936 2.424 . . . . 0.0 112.747 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.54 110.94 3.11 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 122.468 2.112 . . . . 0.0 112.018 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -58.55 147.38 32.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.075 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -122.82 169.1 11.45 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.443 -170.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -35.88 26.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -127.82 14.82 6.94 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.942 0.401 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 4.1 mp0 -130.79 144.44 51.45 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.6 mt -133.46 156.48 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -78.35 145.78 35.05 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-O 121.276 0.56 . . . . 0.0 112.262 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -106.73 109.97 22.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.93 -138.32 9.06 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 t -151.04 132.23 14.45 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.468 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 68.6 m95 -135.82 122.09 20.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -143.73 24.12 1.71 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . 5.1 t70 -100.7 -173.29 2.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.622 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.13 -25.36 2.24 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.234 0.614 . . . . 0.0 110.18 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 6.9 p -142.45 131.18 22.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.839 0.352 . . . . 0.0 111.502 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 39' ' ' ASP . 31.3 m-85 -127.23 143.54 47.49 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.1 Cg_endo -62.56 147.21 95.14 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.7 2.267 . . . . 0.0 111.748 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.8 tt0 -67.73 129.55 40.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.06 1.46 28.39 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.572 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m -83.76 120.15 25.68 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -93.02 152.23 19.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.379 0.609 . . . . 0.0 111.924 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.99 130.84 53.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.609 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.9 mt -101.47 125.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.3 m-85 -102.33 143.7 31.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 54.7 tttm -92.45 141.5 28.45 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 93.6 m -90.59 16.71 8.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 65.81 161.57 0.13 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.315 0.646 . . . . 0.0 111.104 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.33 140.18 24.29 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 121.189 1.26 . . . . 0.0 110.2 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.66 0.07 60.91 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 92.8 m-85 -128.74 175.84 8.28 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.168 0.509 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -154.99 -171.64 3.9 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 p -163.27 154.3 16.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 120.895 0.379 . . . . 0.0 110.721 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.15 -27.21 59.65 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.44 141.22 7.06 Favored Glycine 0 N--CA 1.408 -3.213 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.36 142.54 51.94 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.15 0.58 . . . . 0.0 111.238 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.4 118.22 10.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -116.11 124.28 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -113.04 166.79 11.08 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.6 p -149.66 143.05 17.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.492 0.663 . . . . 0.0 110.137 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.26 122.75 19.49 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 125.159 1.384 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.0 ttt180 -160.85 132.91 5.92 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 66.19 25.7 10.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.12 0.568 . . . . 0.0 112.376 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 91.95 -10.96 73.35 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.574 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.57 171.92 12.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -93.45 123.35 36.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.33 168.11 9.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.056 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.17 114.89 18.48 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.721 0.296 . . . . 0.0 111.088 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.76 -39.02 92.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -143.65 98.87 5.28 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.72 -4.07 14.18 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.839 2.359 . . . . 0.0 113.101 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.65 -31.13 41.45 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.76 141.43 48.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.895 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -158.27 160.38 37.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -102.58 130.15 49.36 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -126.46 172.64 10.02 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.8 mmtp -64.86 151.52 45.31 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.033 0.533 . . . . 0.0 111.974 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -86.97 151.91 52.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 67.4 Cg_endo -77.07 160.83 33.13 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 121.535 1.49 . . . . 0.0 110.087 176.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -114.85 -22.51 9.6 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.344 -174.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.97 -179.2 53.39 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -78.33 128.12 78.99 Favored Pre-proline 0 C--N 1.289 -2.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 48.17 1.2 Allowed 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.076 3.184 . . . . 0.0 114.177 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.59 157.47 33.6 Favored Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.86 126.99 55.25 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.245 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.33 125.13 16.6 Favored Pre-proline 0 N--CA 1.412 -2.356 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -74.2 -10.88 22.88 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.286 1.991 . . . . 0.0 112.042 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -127.55 141.39 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.14 47.9 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.119 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -163.79 -169.2 1.82 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.201 0.5 . . . . 0.0 109.872 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 46.5 p90 -142.34 160.29 40.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.476 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.6 p -113.61 173.0 6.63 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.2 mt -140.99 118.13 11.27 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.485 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -113.14 -7.65 13.61 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.354 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.429 ' C ' HG11 ' A' ' 108' ' ' VAL . . . -113.84 28.94 8.11 Favored Glycine 0 CA--C 1.489 -1.562 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.03 -171.07 27.82 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -129.49 10.88 5.73 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.282 1.039 . . . . 0.0 109.616 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.02 174.73 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 31.0 m-85 -88.94 88.15 7.48 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.76 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.533 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.2 pt-20 -136.24 150.22 48.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.241 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -46.16 116.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.374 1.046 . . . . 0.0 111.027 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.15 -23.43 6.5 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.651 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.429 HG11 ' C ' ' A' ' 100' ' ' GLY . 19.9 m -77.71 139.12 19.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.07 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.485 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.9 ttmp? -102.4 120.43 40.5 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -101.31 101.3 11.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -84.24 139.96 16.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.777 -176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -97.31 113.54 25.19 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.5 m -117.89 159.38 23.2 Favored 'General case' 0 N--CA 1.402 -2.836 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.09 -62.04 0.73 Allowed 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.473 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -155.83 -170.06 3.29 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.74 -53.27 8.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.582 0.706 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.68 -12.75 82.5 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.721 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -112.41 121.82 45.95 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.019 0.128 . . . . 0.0 110.903 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -102.8 -114.93 0.21 Allowed 'General case' 0 CA--C 1.466 -2.276 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -163.64 156.35 18.11 Favored 'General case' 1 N--CA 1.337 -6.119 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.573 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 67.3 mt -89.92 103.78 16.41 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.104 0.954 . . . . 0.0 109.387 173.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.09 155.14 8.87 Favored Glycine 0 N--CA 1.41 -3.086 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -93.44 -18.3 22.49 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.937 0.875 . . . . 0.0 109.585 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.4 mm -112.38 106.16 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.502 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.4 p-10 -83.81 30.58 0.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.136 0.493 . . . . 0.0 111.399 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.46 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -164.2 178.2 7.77 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -173.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.98 138.6 45.54 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 22.6 mt-10 -111.48 136.69 50.29 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.89 107.63 14.76 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.64 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -100.39 -170.43 1.87 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 p -66.64 -40.66 88.82 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 124.525 1.13 . . . . 0.0 110.601 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.0 -35.79 62.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.025 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.37 -152.46 24.34 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.26 126.93 30.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.126 0.463 . . . . 0.0 109.794 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 p -58.94 -35.84 73.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 123.566 0.746 . . . . 0.0 112.913 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.08 167.33 17.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.9 -96.95 0.3 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -173.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 24.4 mt -132.81 92.75 25.54 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 121.656 -0.653 . . . . 0.0 111.316 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 3.3 Cg_endo -53.6 137.22 66.15 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 122.736 2.291 . . . . 0.0 109.32 166.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.7 mm -87.69 122.87 39.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.898 -173.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 21.0 t -52.29 124.41 13.16 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.952 0.342 . . . . 0.0 110.772 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.409 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.424 -1.744 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.239 0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.6 m -84.87 133.53 34.3 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.9 OUTLIER -106.67 27.49 8.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.851 0.834 . . . . 0.0 109.605 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 162.4 37.58 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.661 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -99.66 158.19 32.59 Favored Pre-proline 0 N--CA 1.39 -3.434 0 O-C-N 124.558 1.161 . . . . 0.0 110.277 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 17.9 Cg_endo -60.12 133.35 49.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.952 2.435 . . . . 0.0 110.684 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.89 170.66 19.55 Favored 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.27 139.02 51.33 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -113.37 -176.85 2.99 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -73.54 -27.12 61.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.4 p -116.94 0.5 12.45 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -133.3 140.4 47.43 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.515 0.674 . . . . 0.0 112.329 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -138.62 145.74 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.92 142.66 57.21 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.5 p -90.76 -28.32 18.35 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.568 0.699 . . . . 0.0 109.549 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.71 177.4 37.24 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.4 p -113.9 114.87 26.82 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 123.481 0.712 . . . . 0.0 110.316 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -110.48 110.77 21.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -115.89 3.52 13.74 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.631 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.661 ' O ' HD21 ' A' ' 24' ' ' LEU . 40.1 m-20 -101.91 -157.09 0.59 Allowed 'General case' 0 CA--C 1.479 -1.775 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.58 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -133.84 -58.84 0.86 Allowed 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 170.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.9 p -80.98 121.1 25.61 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.44 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 41.1 m-85 -129.33 145.0 54.97 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.086 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.03 143.56 66.24 Favored 'Trans proline' 0 C--O 1.262 1.695 0 C-N-CA 122.635 2.223 . . . . 0.0 111.086 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -63.16 138.82 58.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.36 1.73 50.69 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.203 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.433 ' C ' HG21 ' A' ' 65' ' ' VAL . 92.9 m -85.06 117.42 24.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -85.74 149.76 25.06 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.245 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.11 130.08 53.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -100.24 132.8 45.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.57 143.94 44.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.596 0.712 . . . . 0.0 112.595 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.24 142.52 27.31 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 171.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.708 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.8 m -86.8 27.8 0.95 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 61.62 166.61 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 121.451 0.643 . . . . 0.0 111.005 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.14 118.09 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.194 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 171.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.4 -23.38 7.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.069 -1.063 . . . . 0.0 113.051 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.708 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 95.8 m-85 -102.74 179.56 4.25 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 122.023 -0.693 . . . . 0.0 109.368 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -155.75 -174.75 5.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -171.95 168.7 5.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 98.4 mt -87.73 14.48 8.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.861 0.839 . . . . 0.0 110.081 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.05 -146.01 5.78 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.33 150.08 48.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.6 t -73.06 101.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.9 118.64 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.53 175.5 5.48 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.433 HG21 ' C ' ' A' ' 46' ' ' THR . 8.7 p -161.02 144.72 4.54 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.166 0.508 . . . . 0.0 110.464 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.72 121.78 18.6 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.111 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 64.3 ttt180 -150.14 124.34 9.47 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.415 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 14.6 mmmm 61.69 22.39 12.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 113.017 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.38 -10.41 65.15 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.487 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.22 157.31 25.08 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.167 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 85.4 m95 -88.59 117.25 27.41 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.14 174.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.39 125.89 37.24 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.462 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.22 -48.39 51.63 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -110.3 88.23 7.08 Favored Pre-proline 0 N--CA 1.429 -1.515 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.891 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -18.66 38.04 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.333 2.022 . . . . 0.0 111.758 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.61 -14.3 58.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.76 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 59' ' ' LEU . 25.4 mmt180 -95.65 123.44 39.21 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 121.693 0.759 . . . . 0.0 110.231 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -147.11 151.55 37.02 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.64 112.44 22.32 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.089 0.947 . . . . 0.0 110.918 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -108.14 172.68 6.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.766 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.5 159.0 24.29 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.615 0.722 . . . . 0.0 111.671 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -94.24 144.77 28.58 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 174.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 60.5 Cg_endo -73.35 163.64 37.27 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 121.733 1.622 . . . . 0.0 109.351 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.9 m -115.75 1.11 13.39 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.46 -170.79 53.49 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.752 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -88.35 117.42 68.36 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.34 102.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 113.257 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 88.85 125.48 2.53 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.952 175.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.12 19.0 5.3 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.749 0.785 . . . . 0.0 109.101 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -60.82 134.47 92.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.171 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.5 -4.66 1.97 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.395 2.063 . . . . 0.0 112.349 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.06 -33.66 5.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.09 0.471 . . . . 0.0 111.131 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.22 138.58 18.05 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.329 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.82 156.31 30.9 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.8 p90 -128.77 158.72 37.85 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.241 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 76.8 p -108.87 168.33 9.43 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.87 123.82 22.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.34 0.59 . . . . 0.0 110.089 175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.2 t -132.65 141.46 48.64 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.95 14.12 67.84 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.427 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.18 -52.1 0.05 OUTLIER Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.256 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.32 -3.68 2.1 Favored 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 124.236 1.014 . . . . 0.0 112.946 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 m -144.65 175.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.4 m-85 -78.33 94.4 4.83 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.22 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.71 151.11 35.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -42.82 129.33 4.28 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.01 -9.93 74.57 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.679 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.96 138.35 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.285 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.526 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.1 ttmt -105.22 120.52 41.75 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -99.8 99.8 10.66 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -79.18 136.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.479 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 52.8 t80 -102.83 129.18 49.42 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -147.6 149.64 32.91 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.73 -52.78 2.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 -174.6 4.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -87.17 -45.04 11.03 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.7 -32.79 61.11 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.354 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -86.16 119.22 26.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.379 0.609 . . . . 0.0 110.839 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 24.5 mt-30 -110.21 -159.89 0.7 Allowed 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.63 155.1 44.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -82.8 137.99 34.14 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.781 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.2 158.87 12.65 Favored Glycine 0 C--N 1.285 -2.286 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -92.4 -17.45 24.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.219 0.509 . . . . 0.0 110.9 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -112.03 109.42 28.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -86.28 22.64 1.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -151.12 176.22 11.38 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 77.0 mtm180 -142.24 127.92 19.19 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -106.96 138.68 42.68 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.7 t -81.38 97.38 7.7 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.137 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.2 175.47 10.56 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.54 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.6 p -49.47 -41.37 40.18 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 125.666 1.586 . . . . 0.0 112.252 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.46 -27.08 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.017 0.436 . . . . 0.0 111.412 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.96 -170.08 36.73 Favored Glycine 0 C--N 1.303 -1.302 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -65.2 141.57 58.61 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 117.22 0.51 . . . . 0.0 111.71 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.7 p -85.12 133.46 34.21 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 73.81 171.27 0.3 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.543 0.737 . . . . 0.0 110.003 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.552 ' O ' ' HD3' ' A' ' 127' ' ' ARG . 6.3 p-10 -111.87 -102.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.985 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.46 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 52.8 mt -126.95 102.65 24.49 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.72 138.17 81.48 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.042 1.828 . . . . 0.0 110.166 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.48 113.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.479 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 93.9 m -72.85 112.36 8.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.759 0.314 . . . . 0.0 111.402 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 32.9 mt-10 . . . . . 0 C--N 1.317 -0.83 0 C-N-CA 125.157 1.383 . . . . 0.0 108.523 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.966 0.412 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 41' ' ' THR . 70.1 m -79.9 132.04 35.99 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.505 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.22 13.62 26.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.324 0.583 . . . . 0.0 110.414 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.18 160.83 38.41 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.658 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 38.0 mt -84.33 157.42 62.05 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 123.968 0.792 . . . . 0.0 109.262 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 28.7 Cg_endo -64.01 133.2 37.43 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 121.668 1.579 . . . . 0.0 109.946 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.79 162.55 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.026 1.817 . . . . 0.0 111.712 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -98.21 146.73 25.32 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -114.1 173.55 6.39 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -65.09 -34.39 78.3 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -117.63 1.24 12.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -131.78 147.05 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.25 0.547 . . . . 0.0 111.669 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 12.6 mt -143.92 156.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 3.9 mm? -72.08 168.96 17.03 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-O 121.916 0.865 . . . . 0.0 112.594 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -123.85 145.48 49.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 171.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.09 -144.98 15.98 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.709 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -139.14 137.76 36.4 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 81.5 m95 -138.84 121.81 16.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.6 m -151.92 24.08 0.66 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.755 0.312 . . . . 0.0 111.331 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 15.8 m-20 -118.31 -169.63 1.74 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.1 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -119.27 -66.1 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.0 p -86.67 127.81 34.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -130.34 140.6 39.14 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.754 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.42 145.19 87.54 Favored 'Trans proline' 0 C--O 1.264 1.779 0 C-N-CA 122.616 2.211 . . . . 0.0 110.801 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.505 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 20.4 tt0 -65.44 140.99 58.66 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.75 57.36 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.206 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.409 ' C ' HG21 ' A' ' 65' ' ' VAL . 75.8 m -85.95 117.91 25.09 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.313 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -88.11 146.08 25.61 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.782 0.801 . . . . 0.0 111.31 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.55 119.67 36.93 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -92.06 120.15 40.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 61.4 m-85 -102.75 141.47 35.51 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -88.35 153.58 21.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.638 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.1 m -91.6 25.93 2.5 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 32' ' ' ILE . 70.0 mtp180 62.88 167.91 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.59 100.0 1.35 Allowed 'Trans proline' 0 N--CA 1.428 -2.365 0 CA-C-N 119.162 0.736 . . . . 0.0 110.912 174.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 135.5 -17.9 3.95 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.123 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.638 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.9 m-85 -110.12 173.15 6.46 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 109.881 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -152.1 -174.66 4.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -168.77 -178.16 3.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.05 14.05 9.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.727 0.775 . . . . 0.0 110.482 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.32 174.7 38.6 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.72 145.93 34.21 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 118.425 1.113 . . . . 0.0 109.362 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 90.8 t -74.19 111.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mm -106.18 122.84 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.011 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.6 mtp -112.07 172.77 6.71 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG21 ' C ' ' A' ' 46' ' ' THR . 8.2 p -157.41 145.31 10.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-O 121.335 0.588 . . . . 0.0 110.648 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.4 t -69.65 125.81 27.84 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.824 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.505 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 34.6 ttp180 -151.76 123.26 7.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm 62.37 25.96 15.5 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 124.267 1.027 . . . . 0.0 113.46 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.97 -15.74 61.19 Favored Glycine 0 N--CA 1.413 -2.883 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.515 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.69 163.7 15.73 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.706 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.418 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 82.1 m95 -97.19 123.87 41.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.329 0.585 . . . . 0.0 109.856 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 171.53 14.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.421 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.79 124.96 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -49.77 56.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -108.26 90.47 6.95 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.169 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.49 -11.95 26.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.791 2.327 . . . . 0.0 114.089 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -90.8 -19.87 22.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.087 0.47 . . . . 0.0 110.352 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 7.6 mmp_? -92.69 134.11 35.35 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.8 0.81 . . . . 0.0 112.468 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.09 166.3 32.92 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 172.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.9 m -91.96 129.4 37.93 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.59 0.709 . . . . 0.0 111.173 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.34 167.98 14.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.519 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 95.5 mttt -65.62 136.43 56.32 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.573 0.225 . . . . 0.0 111.351 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.7 ptp180 -78.35 147.01 71.59 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.45 159.46 32.51 Favored 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.868 1.712 . . . . 0.0 109.631 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.8 m -118.24 8.49 12.31 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 121.463 0.649 . . . . 0.0 111.488 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.33 -85.93 1.23 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.497 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -168.06 147.88 4.28 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.75 53.13 2.7 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.346 2.031 . . . . 0.0 111.615 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.97 -96.31 1.69 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.5 t70 169.56 126.63 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 125.493 1.517 . . . . 0.0 107.674 171.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -120.88 117.53 30.95 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.67 1.92 7.88 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.149 1.899 . . . . 0.0 111.112 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -115.19 -55.39 2.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.851 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 114' ' ' CYS . . . -73.54 150.58 43.55 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 m -92.63 -55.92 3.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . 0.274 1.9 p90 70.16 145.93 0.06 Allowed 'General case' 0 C--O 1.248 0.985 0 C-N-CA 126.558 1.943 . . . . 0.0 114.493 173.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.579 ' OG1' HG12 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -117.03 148.15 41.73 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.994 179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.57 HD22 ' CG1' ' A' ' 108' ' ' VAL . 83.0 mt -109.12 135.96 49.4 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.7 t -138.23 139.01 39.05 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.55 -26.36 16.53 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.18 164.69 34.17 Favored Glycine 0 CA--C 1.489 -1.568 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.463 ' O ' HG12 ' A' ' 103' ' ' VAL . 48.7 t-20 -123.12 60.18 1.06 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 118.173 0.986 . . . . 0.0 110.006 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.513 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.0 m -168.65 -178.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.634 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 172.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.08 84.31 5.26 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.911 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.26 157.42 39.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.804 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.455 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 62.7 t80 -58.55 122.32 13.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.758 0.79 . . . . 0.0 111.767 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.5 -19.38 12.87 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CG1' HD22 ' A' ' 98' ' ' LEU . 24.1 t -71.72 129.94 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.723 0.773 . . . . 0.0 112.066 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.445 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.1 ttmt -102.91 119.71 39.32 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.61 93.24 7.03 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.579 HG12 ' OG1' ' A' ' 97' ' ' THR . 1.5 p -79.14 109.29 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-O 122.35 1.071 . . . . 0.0 109.116 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.537 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.8 t80 -80.89 103.56 10.81 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 113.837 -1.528 . . . . 0.0 110.878 -169.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 m -74.47 -38.29 62.96 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.644 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.455 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 45.8 t 72.73 -92.83 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.348 0 O-C-N 125.312 1.632 . . . . 0.0 108.906 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -137.2 -174.48 3.76 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.96 -42.67 14.71 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.57 0.7 . . . . 0.0 109.198 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.68 -22.9 54.94 Favored Glycine 0 C--N 1.308 -1.001 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.909 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.03 128.73 55.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.481 -0.423 . . . . 0.0 111.001 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -111.34 -148.15 0.43 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -117.22 166.72 11.93 Favored 'General case' 1 N--CA 1.376 -4.131 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.604 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.6 mt -97.32 106.12 18.39 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.559 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.6 166.2 14.43 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -84.68 -27.56 26.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.132 0.968 . . . . 0.0 108.515 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.0 109.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.31 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -97.43 23.88 7.16 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.141 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -159.01 178.31 10.2 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.399 0.619 . . . . 0.0 110.519 -173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -149.68 129.03 12.91 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.962 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -101.51 157.48 16.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 122.8 34.96 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.841 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.9 t70 -101.98 -169.12 1.63 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.473 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 48.5 p -71.72 -37.35 70.64 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 124.585 1.154 . . . . 0.0 108.492 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.05 -52.11 15.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.044 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.02 -150.25 16.07 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.23 137.73 45.15 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.024 0.912 . . . . 0.0 110.336 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.2 p -81.05 167.64 19.53 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.48 -111.39 0.27 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.325 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -167.8 -178.61 3.9 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 82.9 mt -94.93 103.83 12.87 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.537 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.4 Cg_endo -48.24 127.79 16.02 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.269 2.646 . . . . 0.0 112.584 -176.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.8 mm -75.06 115.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.732 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.3 m -61.61 121.4 12.67 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 . . . . . 0 N--CA 1.425 -1.697 0 C-N-CA 126.445 1.898 . . . . 0.0 107.791 178.633 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 35.4 m-20 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 120.751 0.31 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.8 m -65.67 139.93 58.44 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.89 18.74 13.94 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.357 0.599 . . . . 0.0 109.729 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.07 159.22 37.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.729 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 mt -79.5 153.3 76.19 Favored Pre-proline 0 C--N 1.31 -1.137 0 O-C-N 123.873 0.733 . . . . 0.0 109.15 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 128.67 30.72 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.457 2.104 . . . . 0.0 111.166 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.68 123.38 12.9 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.488 2.126 . . . . 0.0 111.409 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -68.1 149.55 49.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.501 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 2.1 mmp_? -112.51 178.56 4.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.229 -171.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -82.25 -58.94 2.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.48 -8.53 35.06 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.955 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.5 mp0 -109.02 142.53 39.58 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.985 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mt -133.09 150.4 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.848 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.75 140.42 53.44 Favored 'General case' 0 C--N 1.277 -2.58 0 O-C-N 124.245 0.966 . . . . 0.0 111.084 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.0 p -87.21 -34.33 19.03 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.207 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.4 167.43 26.1 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.434 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 p -105.26 118.23 36.02 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -99.71 161.97 13.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -130.79 -23.79 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -137.01 162.48 33.2 Favored 'General case' 0 C--O 1.183 -2.446 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.423 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.3 -29.48 26.34 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.498 0.666 . . . . 0.0 109.641 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.6 p -97.16 108.4 21.12 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-O 121.88 0.848 . . . . 0.0 112.431 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -118.1 157.83 47.75 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.511 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.597 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 47.6 Cg_endo -70.67 152.8 64.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 121.628 1.552 . . . . 0.0 110.875 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.42 151.8 45.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.24 74.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.617 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -83.05 121.14 26.65 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.956 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.01 146.45 23.85 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.675 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.88 117.03 29.06 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.44 130.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 65.1 m-85 -104.19 139.43 39.25 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -75.13 -29.51 60.55 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.319 -1.764 . . . . 0.0 113.656 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.7 m 71.29 3.05 4.51 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 72.86 152.35 0.14 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.96 108.87 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.554 2.17 . . . . 0.0 112.738 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.41 7.01 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.476 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 96.4 m-85 -98.81 168.14 10.32 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 122.103 -0.645 . . . . 0.0 110.465 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -133.21 -175.93 3.96 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -157.08 -175.93 5.69 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -104.76 16.22 26.41 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.123 0.487 . . . . 0.0 110.073 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.45 29.82 0.07 OUTLIER Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.49 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.56 144.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.977 1.311 . . . . 0.0 112.049 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.6 t -76.98 116.4 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.25 124.55 69.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.804 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.44 168.77 9.15 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.9 p -155.45 149.99 11.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.8 t -84.08 128.73 34.75 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.84 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.95 124.84 13.44 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.23 29.56 19.14 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.35 -17.48 58.88 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.934 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 167.17 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.715 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.79 122.46 46.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 -168.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.693 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.48 23.04 Favored 'General case' 1 C--N 1.225 -4.825 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.967 -171.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.85 -53.99 13.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.83 80.6 49.5 Favored Pre-proline 0 N--CA 1.419 -1.997 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.263 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.61 -13.06 22.44 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.743 2.295 . . . . 0.0 110.969 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.69 -30.1 68.69 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.714 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -81.25 143.56 32.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.566 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.8 158.65 43.54 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -94.57 106.95 18.94 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.45 160.75 14.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.95 146.56 39.54 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.11 140.23 61.54 Favored Pre-proline 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.421 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.51 145.47 47.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.095 1.863 . . . . 0.0 109.624 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.9 m -104.55 -14.99 15.46 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.997 0.427 . . . . 0.0 111.686 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.61 -167.67 54.77 Favored Glycine 0 N--CA 1.412 -2.927 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.433 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -68.74 119.73 71.1 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 124.323 1.049 . . . . 0.0 109.583 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 72.8 Cg_endo -80.34 -6.67 13.83 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.15 2.567 . . . . 0.0 112.295 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.73 134.65 6.2 Favored Glycine 0 N--CA 1.406 -3.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.93 174.39 7.26 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.861 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -162.53 127.37 2.07 Favored Pre-proline 0 N--CA 1.412 -2.362 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -88.85 -4.18 6.24 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.089 1.859 . . . . 0.0 111.555 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.71 -47.42 3.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.469 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.51 -172.31 25.83 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.262 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 m -145.98 167.37 23.48 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -143.72 157.52 44.33 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.255 0.479 . . . . 0.0 110.11 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.58 ' OG1' HG12 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -119.95 154.0 35.1 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.794 0.684 . . . . 0.0 110.5 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 94.6 mt -115.2 133.33 56.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.1 t -127.39 148.17 50.27 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.72 -66.62 3.57 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.068 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.51 -43.24 6.59 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.427 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t30 75.37 -4.41 2.38 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 122.105 0.955 . . . . 0.0 111.684 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.16 -178.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -88.18 79.46 7.86 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.376 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.77 151.09 52.07 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.842 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -45.11 122.33 3.3 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.447 0.699 . . . . 0.0 111.756 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.36 -16.52 32.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.615 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.57 147.06 7.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 O-C-N 122.391 -0.476 . . . . 0.0 110.358 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 109' ' ' LYS . 4.4 ttmp? -114.45 127.57 55.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.37 88.01 3.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.58 HG12 ' OG1' ' A' ' 97' ' ' THR . 2.6 p -80.97 124.02 38.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.705 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -102.02 141.3 35.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.363 -168.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.27 161.94 34.87 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.29 -74.24 0.35 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.922 -1.511 . . . . 0.0 110.695 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -141.25 -177.79 5.29 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.56 152.54 21.05 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.38 -43.91 1.93 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.29 132.1 22.7 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -104.22 -61.43 1.45 Allowed 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.851 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 pp 179.52 157.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.387 1.054 . . . . 0.0 109.17 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 81.3 mt -97.71 132.03 43.72 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.71 148.12 5.67 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -84.51 -19.94 32.44 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.286 1.041 . . . . 0.0 109.581 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 126' ' ' TYR . 38.6 mm -103.06 92.46 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.046 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -83.17 29.69 0.48 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 124.763 1.225 . . . . 0.0 110.312 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 124' ' ' ILE . 52.4 p90 -161.7 179.05 8.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -142.03 121.5 13.24 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.438 ' HG3' ' CD2' ' A' ' 126' ' ' TYR . 48.3 mt-10 -103.07 141.43 35.83 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -91.44 112.16 23.96 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.196 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 131' ' ' THR . 21.3 t70 -99.76 -164.61 1.14 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.261 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.508 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 46.9 p -66.01 -42.53 89.56 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.447 1.099 . . . . 0.0 110.327 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.61 -41.48 79.46 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.162 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.55 -141.45 9.53 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.524 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.5 m95 -72.44 130.96 41.92 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 117.007 0.403 . . . . 0.0 111.557 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.2 p -83.82 129.09 34.94 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 74.73 166.92 0.29 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.74 0.781 . . . . 0.0 111.611 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.66 -173.29 2.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.9 mt -71.66 116.57 49.15 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.08 129.07 24.59 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 121.505 1.47 . . . . 0.0 110.927 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.3 123.17 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.642 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 65.9 m -66.19 109.22 2.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.418 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 8.4 tp10 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.071 0.939 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.2 m -77.93 124.61 28.21 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.717 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.65 21.37 8.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.133 0.968 . . . . 0.0 109.589 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.73 155.82 43.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.163 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.5 150.35 79.42 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 124.151 0.907 . . . . 0.0 111.558 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.93 139.94 44.48 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.187 1.925 . . . . 0.0 109.655 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.22 155.81 66.63 Favored 'Trans proline' 0 C--N 1.328 -0.538 0 C-N-CA 122.56 2.173 . . . . 0.0 113.743 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -97.09 134.47 40.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -109.11 151.05 26.94 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.617 -173.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -64.6 -31.48 72.71 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.0 -15.68 16.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -133.87 137.04 44.74 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 112.347 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.73 158.98 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -94.07 142.21 27.65 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 119.012 0.824 . . . . 0.0 111.543 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.4 p -98.12 151.94 19.86 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.53 -155.01 20.82 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -133.54 114.86 14.04 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -122.69 99.23 6.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.7 m -135.0 -0.99 2.71 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.984 0.421 . . . . 0.0 110.348 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.33 150.1 22.04 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.522 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -82.61 -51.27 7.91 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.978 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 38.7 p -95.8 106.33 18.44 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.16 129.72 23.72 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.847 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.52 150.44 68.81 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.9 131.78 49.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.57 7.33 48.68 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.295 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -86.38 114.84 23.49 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.985 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -90.01 136.33 33.11 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-O 121.766 0.793 . . . . 0.0 111.669 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.38 121.33 43.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.074 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.12 113.46 31.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.101 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -83.59 136.46 34.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.377 1.084 . . . . 0.0 113.177 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.18 -28.6 68.9 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.095 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 15.9 t 72.43 -4.39 2.06 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.947 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 71.91 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 124.487 1.115 . . . . 0.0 111.472 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.47 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 55.8 Cg_endo -70.15 120.82 7.47 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 121.462 1.442 . . . . 0.0 110.381 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 118.19 -20.12 10.65 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 93.5 m-85 -101.52 170.44 8.2 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -156.64 169.1 25.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.6 p -143.87 -177.05 5.24 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.23 21.73 1.35 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.67 0.748 . . . . 0.0 110.737 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.9 -96.1 0.12 Allowed Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -154.57 150.62 27.93 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.44 105.93 4.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mm -105.84 120.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.617 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.5 mtp -106.73 164.99 11.64 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.35 145.83 16.86 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.742 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.114 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 48.1 t -73.68 121.37 20.64 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.288 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 34.2 ttt180 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 74.2 mmtt 65.12 23.65 12.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.82 0.848 . . . . 0.0 112.278 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.78 -2.43 72.84 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.889 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 153.24 47.43 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.77 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.2 121.66 28.27 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.771 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.04 173.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.655 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.23 123.64 29.2 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.77 -39.95 94.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -139.54 100.56 7.53 Favored Pre-proline 0 N--CA 1.422 -1.829 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.703 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.0 -3.38 13.7 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.846 2.364 . . . . 0.0 111.912 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.6 mt -91.09 -6.5 53.64 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 122.213 1.006 . . . . 0.0 109.801 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -99.39 122.59 42.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.961 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.35 147.62 40.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.988 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.1 m -87.39 128.22 35.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.659 0.742 . . . . 0.0 111.848 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -128.6 169.21 14.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 106' ' ' TYR . 48.0 mtmt -82.46 144.73 30.26 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 132' ' ' ASP . 12.8 ptm180 -67.32 156.77 87.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.643 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 160.76 30.43 Favored 'Trans proline' 0 C--O 1.256 1.397 0 C-N-CA 121.968 1.779 . . . . 0.0 109.769 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.9 m -127.31 1.27 6.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.511 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.91 1.04 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.753 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -155.23 135.87 8.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.97 13.63 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.973 2.449 . . . . 0.0 113.059 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -166.3 47.87 Favored Glycine 0 N--CA 1.41 -3.042 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.56 171.52 19.81 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -132.45 121.35 17.36 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.45 -43.72 43.11 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.416 2.744 . . . . 0.0 114.575 -171.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.24 26.49 5.91 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.63 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.501 ' HA3' ' SG ' ' A' ' 141' ' ' CYS . . . -142.13 174.94 23.01 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.265 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.21 168.09 19.8 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.406 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . 53.2 p90 -143.09 156.16 44.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.277 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 p -125.24 169.13 12.57 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 124.213 1.005 . . . . 0.0 108.864 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.64 164.36 19.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.387 0.613 . . . . 0.0 111.469 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.0 t -162.03 147.97 13.34 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 175.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 20.77 41.46 Favored Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.566 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.91 -58.8 0.32 Allowed Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 82.68 35.2 0.06 Allowed 'General case' 0 CA--C 1.457 -2.602 0 CA-C-O 123.807 1.765 . . . . 0.0 109.357 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 108' ' ' VAL . 8.2 p -156.29 -162.3 0.02 OUTLIER 'Isoleucine or valine' 1 N--CA 1.373 -4.294 0 CA-C-N 110.868 -2.878 . . . . 0.0 103.587 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -113.16 83.85 1.9 Allowed 'General case' 1 C--N 1.225 -4.848 0 CA-C-O 121.577 0.704 . . . . 0.0 111.554 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 25.4 pt-20 -143.36 163.5 32.88 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.368 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.451 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 58.8 t80 -49.78 131.94 22.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.311 1.007 . . . . 0.0 111.498 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.39 -13.31 63.04 Favored Glycine 0 N--CA 1.421 -2.344 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.45 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -77.25 145.21 10.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.572 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.7 ttmt -108.93 118.83 37.82 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.043 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.38 98.17 11.61 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -91.04 122.64 42.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 82.1 m-85 -96.04 141.59 29.26 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.303 1.049 . . . . 0.0 111.768 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -145.91 138.76 25.78 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 103.106 -2.924 . . . . 0.0 103.106 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 120' ' ' LEU . 58.6 m -95.38 -87.69 0.27 Allowed 'General case' 0 C--N 1.252 -3.668 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.622 -168.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -148.72 -173.05 4.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -49.82 -54.03 21.8 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.953 1.301 . . . . 0.0 112.816 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.69 13.22 27.45 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.389 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 114' ' ' CYS . 35.4 m-85 -114.87 128.48 56.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.97 -159.7 0.69 Allowed 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 163.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -139.29 151.89 46.81 Favored 'General case' 1 N--CA 1.334 -6.23 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.766 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 107.71 9.13 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.365 0.602 . . . . 0.0 111.064 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.52 140.55 4.21 Favored Glycine 0 N--CA 1.419 -2.458 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.185 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.72 -5.95 52.3 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.405 0.621 . . . . 0.0 111.312 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.408 HG21 ' ND2' ' A' ' 136' ' ' ASN . 44.2 mm -108.82 90.96 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -86.54 42.87 1.03 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.44 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -167.5 174.06 8.18 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.719 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 135' ' ' THR . 6.2 ptm180 -156.35 134.44 11.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -102.88 158.54 16.21 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.593 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -94.28 126.55 39.6 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.848 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 131' ' ' THR . 20.7 t70 -100.07 -156.05 0.53 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.521 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 51.2 p -66.4 -25.54 66.82 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 125.217 1.407 . . . . 0.0 113.761 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 12.8 t70 -129.58 -44.48 1.22 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.216 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.67 -172.4 15.18 Favored Glycine 0 CA--C 1.486 -1.744 0 C-N-CA 119.355 -1.402 . . . . 0.0 112.48 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -85.87 142.26 29.01 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.927 0.394 . . . . 0.0 110.236 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 75.2 p -79.21 170.77 16.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.408 ' ND2' HG21 ' A' ' 124' ' ' ILE . 12.8 m120 61.7 -155.06 0.35 Allowed 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -141.84 178.1 7.73 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.48 114.24 50.18 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HB2' HD13 ' A' ' 120' ' ' LEU . 18.9 Cg_endo -66.86 126.54 15.45 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.065 2.51 . . . . 0.0 111.243 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.44 128.81 39.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.501 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 68.8 m -81.27 111.24 17.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.04 0.448 . . . . 0.0 110.485 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.735 1.214 . . . . 0.0 109.998 -175.724 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 15.6 m-20 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 121.743 0.783 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -72.99 138.08 45.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.42 -177.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.08 30.61 7.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -164.81 158.24 17.25 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.541 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 18.5 mt -80.38 154.03 74.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 123.499 0.72 . . . . 0.0 109.469 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 9.8 Cg_endo -54.48 130.27 39.18 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.707 2.272 . . . . 0.0 111.196 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.11 126.48 13.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.206 1.937 . . . . 0.0 111.165 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -60.37 134.67 57.29 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 121.552 0.691 . . . . 0.0 109.695 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 3.3 mmp_? -87.06 174.59 8.57 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.546 -171.174 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -73.66 -43.71 58.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.59 0.556 . . . . 0.0 110.569 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 80' ' ' CYS . 4.3 p -122.74 19.02 10.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.584 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 1.8 mp0 -137.67 150.12 47.1 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.038 0.446 . . . . 0.0 111.611 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.8 mt -133.55 154.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.0 mm? -76.36 147.55 38.01 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.0 p -114.54 113.9 25.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.41 -155.13 26.18 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.2 m -137.95 98.35 3.63 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 85.1 m95 -95.23 97.5 9.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.263 -177.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 p -106.53 1.27 25.27 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.061 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 1.6 m-20 -119.48 -169.49 1.77 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.777 -171.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -129.95 -43.46 1.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 71.4 p -98.29 131.94 44.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.189 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 48.8 m-85 -138.64 154.93 73.62 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.478 0.711 . . . . 0.0 109.568 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.555 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 23.4 Cg_endo -65.73 150.6 86.03 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.354 2.036 . . . . 0.0 112.502 178.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.27 147.64 49.47 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.97 -10.95 70.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.604 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 91.9 m -67.77 116.3 8.29 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 122.302 0.241 . . . . 0.0 110.474 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 3.7 pt20 -93.66 125.09 38.08 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.315 1.055 . . . . 0.0 110.003 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.78 122.06 35.86 Favored 'General case' 0 C--N 1.271 -2.805 0 C-N-CA 125.539 1.535 . . . . 0.0 107.592 178.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.1 mt -93.25 118.23 38.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.648 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.7 m-85 -96.51 144.68 26.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.76 0.79 . . . . 0.0 112.988 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -89.31 132.65 34.83 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 13.4 t -82.2 37.52 0.5 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 59.74 154.51 0.1 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.712 1.205 . . . . 0.0 113.671 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.27 92.69 0.47 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 121.304 1.336 . . . . 0.0 110.491 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 137.65 -21.34 3.23 Favored Glycine 0 N--CA 1.429 -1.814 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.564 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.5 m-85 -103.39 168.63 9.04 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.11 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -150.89 176.28 11.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 176.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 t -160.08 -165.62 1.52 Allowed 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.89 -12.94 60.05 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.959 0.885 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.77 44.85 Favored Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 177.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.32 138.21 57.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.455 0.627 . . . . 0.0 109.717 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.57 123.91 25.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 47' ' ' GLN . 46.3 mm -117.52 125.58 74.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.014 -176.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 28' ' ' ARG . 86.9 mtp -124.36 134.44 53.14 Favored 'General case' 0 CA--C 1.424 -3.871 0 CA-C-O 121.515 0.674 . . . . 0.0 110.038 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 1.3 m -129.85 149.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.84 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.873 -168.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.01 128.66 34.68 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.29 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -153.71 121.88 6.13 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.25 32.2 12.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.807 0.843 . . . . 0.0 110.935 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.03 -18.28 36.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.463 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.69 165.68 11.09 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.402 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.1 m95 -106.02 116.07 31.3 Favored 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -127.41 -166.71 0.48 Allowed 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.652 -173.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.78 127.71 45.91 Favored 'General case' 1 C--N 1.218 -5.149 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.319 -172.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HB2' ' CG1' ' A' ' 65' ' ' VAL . 2.2 tm? -80.61 -54.82 5.31 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -106.87 94.37 10.43 Favored Pre-proline 0 N--CA 1.407 -2.578 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.687 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.74 -9.91 24.39 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.705 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 77' ' ' LEU . 2.8 mm? -90.0 26.81 1.74 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 110.347 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.86 139.88 53.55 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.241 179.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -166.86 145.26 5.14 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.584 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 50.0 m -78.02 126.49 30.9 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 122.116 0.96 . . . . 0.0 113.534 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -119.67 153.42 35.6 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.038 -179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -72.02 136.2 46.63 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.386 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.3 ptp180 -78.13 145.25 68.78 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.3 166.08 29.56 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.197 1.932 . . . . 0.0 112.185 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.6 m -120.05 8.09 10.95 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.066 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.96 -96.76 0.88 Allowed Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.785 177.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -150.1 138.61 12.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.85 53.68 4.51 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.122 2.548 . . . . 0.0 112.133 -177.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 75.55 -143.58 30.53 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.16 153.25 31.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -150.1 135.25 9.81 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.78 -60.12 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.919 1.746 . . . . 0.0 109.967 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -123.49 154.44 39.13 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.515 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 130.89 150.43 6.78 Favored Glycine 0 C--N 1.282 -2.466 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.427 ' N ' ' HA ' ' A' ' 114' ' ' CYS . 4.4 m -145.29 158.7 43.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -175.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -144.3 161.09 39.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -123.02 146.21 47.84 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 91.8 mt -104.41 153.88 20.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.603 0.24 . . . . 0.0 110.529 -176.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -149.05 138.93 21.99 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.14 -12.89 58.85 Favored Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.28 170.48 42.61 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -111.35 10.85 21.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 117.698 0.749 . . . . 0.0 109.65 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.8 p -141.04 -166.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -99.19 86.03 3.34 Favored 'General case' 1 C--N 1.241 -4.119 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.046 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' O ' HG13 ' A' ' 108' ' ' VAL . 12.2 pt-20 -136.59 151.99 49.96 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.795 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.539 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.9 t80 -48.01 124.42 7.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.229 0.538 . . . . 0.0 112.167 176.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.89 56.3 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.832 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 105' ' ' GLU . 4.5 p -83.65 144.76 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-N 117.492 0.646 . . . . 0.0 109.64 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 40.3 ttmt -111.03 125.98 54.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.44 95.31 7.57 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.15 114.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.09 132.83 34.26 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.3 m -142.66 -28.28 0.59 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -172.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.515 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 96.2 m 69.79 -99.09 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 177.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -148.76 -158.69 0.94 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.86 -58.05 3.53 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.915 0.486 . . . . 0.0 110.894 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.07 4.37 74.48 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.889 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -117.91 133.55 55.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -127.48 -100.01 0.36 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.2 pp -179.78 145.29 0.22 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.056 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.41 HD21 ' CB ' ' A' ' 142' ' ' GLU . 2.5 mm? -95.04 142.77 27.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.511 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.67 -173.86 18.15 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.06 -12.0 12.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.635 0.718 . . . . 0.0 111.078 178.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.59 114.96 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -91.61 17.74 8.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.493 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.57 179.06 9.22 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.298 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -158.35 130.5 6.89 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.606 171.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.27 157.16 17.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 -176.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 48.1 m -87.64 117.39 26.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.744 172.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 131' ' ' THR . 22.3 t70 -103.92 -158.69 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.513 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 63.3 p -67.54 -44.69 77.7 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 124.142 0.977 . . . . 0.0 112.965 -173.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.4 -43.42 17.36 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.747 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.93 -129.82 1.91 Allowed Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.839 -176.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -78.95 125.45 29.39 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 0.0 112.137 -172.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -65.53 -25.97 67.68 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.404 1.082 . . . . 0.0 112.699 -177.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -138.47 169.09 18.41 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 24.4 t70 -91.57 -174.31 3.84 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' HA3' ' A' ' 89' ' ' GLY . 55.7 mt -86.62 112.6 47.84 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 123.55 0.74 . . . . 0.0 109.251 -176.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.34 147.0 96.68 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.752 1.635 . . . . 0.0 109.811 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 41.6 mm -81.78 108.63 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.127 -173.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 19.9 t -63.3 119.12 9.04 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.41 ' CB ' HD21 ' A' ' 121' ' ' LEU . 22.7 mm-40 . . . . . 0 C--N 1.307 -1.241 0 C-N-CA 123.509 0.724 . . . . 0.0 109.217 -174.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 52.6 m-20 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.4 m -68.96 141.8 54.86 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.883 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.41 19.51 17.54 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.25 156.92 37.92 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 40' ' ' GLN . 3.6 mm? -85.69 153.97 58.49 Favored Pre-proline 1 N--CA 1.373 -4.276 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.964 -179.04 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.55 122.23 10.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 123.328 2.685 . . . . 0.0 112.32 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.58 131.94 31.38 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.282 1.988 . . . . 0.0 110.448 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -62.54 145.13 55.12 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.264 0.554 . . . . 0.0 110.43 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 18.8 mmm180 -98.1 166.17 11.55 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -81.72 -51.39 8.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.758 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.21 -1.8 57.63 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.141 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 18.1 mp0 -132.65 158.54 42.01 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.979 0.419 . . . . 0.0 111.993 -178.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -142.36 150.2 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.37 154.53 31.64 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.336 0.588 . . . . 0.0 110.705 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.5 p -91.11 -23.57 20.26 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.566 0.698 . . . . 0.0 111.138 177.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.87 -178.27 15.35 Favored Glycine 0 C--N 1.289 -2.029 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.2 t -103.13 149.84 24.23 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -138.07 138.82 39.15 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -178.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -142.21 16.48 2.07 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.217 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.549 ' C ' HD21 ' A' ' 24' ' ' LEU . 15.1 m-20 -128.93 124.91 36.35 Favored 'General case' 0 CA--C 1.465 -2.311 0 C-N-CA 118.464 -1.294 . . . . 0.0 112.276 -175.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.553 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 21.7 mp0 -54.11 -49.84 68.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 124.764 1.29 . . . . 0.0 112.868 -175.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -96.25 128.74 43.44 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.198 -1.001 . . . . 0.0 113.682 -172.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -134.92 148.75 68.27 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.541 176.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -69.0 149.13 71.38 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.444 2.096 . . . . 0.0 112.705 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -66.3 136.24 55.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.68 -3.92 36.66 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.437 -177.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -82.86 118.85 23.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -88.53 143.78 26.75 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.545 0.688 . . . . 0.0 111.982 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.24 114.45 27.94 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -89.36 127.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 90.6 m-85 -109.2 141.85 40.86 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.617 0.722 . . . . 0.0 111.988 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -89.67 147.69 23.73 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 168.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.777 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 91.2 m -102.44 37.47 1.9 Allowed 'General case' 0 C--N 1.249 -3.795 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.605 -174.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 65.86 159.6 0.13 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.574 0.702 . . . . 0.0 111.532 178.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.52 113.8 3.62 Favored 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 109.706 -0.921 . . . . 0.0 109.706 172.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.24 -20.43 10.48 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.593 178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.777 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.1 m-85 -107.1 161.32 14.86 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.578 178.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' HD3' ' A' ' 84' ' ' PRO . 16.0 ptt180 -160.79 -176.34 5.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.558 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.7 p -169.22 177.92 4.58 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 170.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.12 31.8 0.71 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.86 0.838 . . . . 0.0 110.213 177.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.0 -140.32 3.21 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -142.66 157.72 44.39 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -78.97 104.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.33 122.1 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.963 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.5 mtp -109.44 169.79 8.47 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.2 p -155.39 144.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.659 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t -68.4 123.15 20.0 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.716 177.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.4 ttm180 -157.19 129.84 7.53 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp 66.53 15.89 10.24 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.891 0.876 . . . . 0.0 112.45 177.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.58 65.87 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.959 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.67 172.34 9.35 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.459 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -103.58 119.65 39.32 Favored 'General case' 0 CA--C 1.462 -2.428 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.3 -170.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.943 -175.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.57 121.1 39.07 Favored 'General case' 1 C--N 1.22 -5.024 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.221 -172.319 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -71.43 -54.42 10.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -119.72 100.38 49.0 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.65 -4.45 13.51 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.042 2.495 . . . . 0.0 112.366 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.27 -31.94 22.83 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.633 -178.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -89.29 135.33 33.64 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.365 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 158.55 44.28 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . 0.383 67.5 m -95.59 127.67 41.81 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 117.745 -1.582 . . . . 0.0 114.82 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.36 -175.69 2.76 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.756 -2.02 . . . . 0.0 108.096 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -71.99 152.92 42.12 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.077 0.465 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.16 152.97 46.59 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HD3' ' NE ' ' A' ' 57' ' ' ARG . 66.2 Cg_endo -90.24 152.62 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.451 1.434 . . . . 0.0 112.84 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 70.9 m -124.96 76.79 1.56 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.55 93.51 0.01 OUTLIER Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.242 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t60 70.93 125.59 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.968 1.707 . . . . 0.0 111.42 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.69 38.68 0.4 Allowed 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 114.427 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 108.63 -127.72 8.73 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 138' ' ' ILE . 4.0 p30 -162.87 158.88 23.12 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -171.65 129.53 0.68 Allowed Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.51 -14.23 11.73 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.374 1.383 . . . . 0.0 111.016 174.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.46 89.32 2.37 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.354 0.597 . . . . 0.0 111.129 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 164.81 165.88 22.83 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.9 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -139.37 165.46 27.16 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -139.06 155.91 47.57 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 p -130.73 140.42 50.34 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -103.39 140.38 37.53 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.487 HG23 ' HB3' ' A' ' 109' ' ' LYS . 5.1 t -133.69 19.52 3.88 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 121.708 0.766 . . . . 0.0 111.876 -176.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.4 2.4 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.53 174.88 17.18 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -119.25 20.44 12.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 117.903 0.852 . . . . 0.0 109.751 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 108' ' ' VAL . 23.4 m -138.2 175.11 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -90.89 97.73 11.36 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.001 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.96 154.36 41.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.428 -177.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -51.19 116.87 2.23 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.306 1.004 . . . . 0.0 111.083 177.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.05 -25.18 7.18 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.278 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -74.72 137.77 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.344 178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.487 ' HB3' HG23 ' A' ' 99' ' ' THR . 39.5 ttmt -106.02 121.64 44.54 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.72 94.52 9.41 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.77 122.32 32.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -94.1 132.14 38.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -153.98 156.43 37.41 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 83.9 m -132.68 -72.62 0.51 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -178.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.95 -174.05 3.21 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.47 -51.53 6.46 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.352 0.596 . . . . 0.0 110.763 -177.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.27 -18.93 79.91 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.202 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -98.77 137.67 37.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.54 -107.42 0.37 Allowed 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.5 pp 179.19 141.5 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.779 1.232 . . . . 0.0 109.666 176.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 142' ' ' GLU . 4.1 mm? -89.11 134.75 33.89 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.407 0.622 . . . . 0.0 110.338 176.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.09 161.38 11.03 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -174.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -92.42 -21.65 20.08 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.469 0.652 . . . . 0.0 109.415 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.43 ' HB ' ' ND2' ' A' ' 136' ' ' ASN . 25.7 mm -104.99 106.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.953 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -88.15 24.9 1.72 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.535 1.134 . . . . 0.0 111.395 -175.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.408 ' CE1' HG22 ' A' ' 124' ' ' ILE . 47.4 p90 -159.58 171.61 19.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.256 0.551 . . . . 0.0 110.768 -173.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -135.18 131.74 37.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 12.8 mt-10 -104.37 139.1 39.81 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 118.242 0.473 . . . . 0.0 110.794 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.72 104.14 10.11 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.0 t70 -105.94 -159.81 0.72 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.973 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.493 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.2 p -60.7 -29.49 69.36 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.743 1.617 . . . . 0.0 114.555 -171.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -118.44 -28.56 5.7 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.553 0.692 . . . . 0.0 110.959 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.91 -157.11 28.44 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -176.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.445 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 97.3 m95 -74.0 130.62 40.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.871 0.367 . . . . 0.0 111.663 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 34.8 p -81.83 158.29 24.12 Favored 'General case' 0 C--O 1.266 1.945 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.43 ' ND2' ' HB ' ' A' ' 124' ' ' ILE . 54.9 t30 63.92 -171.79 0.18 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -126.48 -168.1 1.81 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.488 HD12 ' HA3' ' A' ' 89' ' ' GLY . 54.0 mt -82.61 117.69 69.35 Favored Pre-proline 0 C--N 1.282 -2.33 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.96 144.86 48.75 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.751 2.301 . . . . 0.0 110.894 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -93.7 112.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 122.118 -0.364 . . . . 0.0 110.871 -174.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.33 112.28 3.93 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.462 ' HB2' HD21 ' A' ' 121' ' ' LEU . 33.6 mt-10 . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.3 m-20 . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -84.52 125.08 32.08 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.89 23.59 7.84 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.01 161.27 40.47 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.394 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 mt -82.81 149.07 59.12 Favored Pre-proline 0 C--N 1.306 -1.313 0 O-C-N 123.998 0.811 . . . . 0.0 109.807 174.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -53.11 131.55 43.48 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 123.197 2.598 . . . . 0.0 113.312 -177.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -65.73 119.51 6.55 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 122.617 2.212 . . . . 0.0 110.277 176.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.64 142.58 56.35 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.766 0.793 . . . . 0.0 111.759 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 18.2 mmm180 -87.31 168.46 13.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.377 -171.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -35.4 17.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.046 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 p -107.8 6.31 27.38 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.772 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 10.3 mp0 -138.92 156.44 47.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.33 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.3 158.92 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.78 143.67 55.74 Favored 'General case' 0 C--N 1.269 -2.896 0 O-C-N 123.483 0.489 . . . . 0.0 110.553 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 p -71.73 -35.23 70.1 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.35 165.92 12.17 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -94.15 142.71 27.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 177.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.06 125.53 42.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -121.44 18.22 11.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.288 0.566 . . . . 0.0 110.738 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.79 -159.44 0.74 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.63 -35.01 0.18 Allowed 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 123.457 0.703 . . . . 0.0 110.355 177.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.7 p -107.88 126.21 52.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.798 -176.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -133.89 137.05 27.6 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.645 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 28.3 Cg_endo -63.08 147.37 94.39 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 123.126 2.551 . . . . 0.0 111.926 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.5 tt0 -63.56 129.85 41.9 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.23 30.33 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.9 m -81.4 113.31 19.4 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -86.35 143.78 27.68 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.136 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.57 119.95 37.17 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.0 mt -91.51 119.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 59.9 m-85 -98.45 145.61 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.042 0.925 . . . . 0.0 113.33 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -91.66 138.36 31.63 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.788 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 35.7 m -74.63 21.9 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 64.95 154.95 0.12 Allowed Pre-proline 0 N--CA 1.476 0.864 0 CA-C-O 121.678 0.751 . . . . 0.0 111.612 -173.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.4 104.19 0.42 Allowed 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.523 1.482 . . . . 0.0 110.866 174.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.12 -3.6 18.78 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.326 176.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.788 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.0 m-85 -120.89 165.91 14.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.133 -1.216 . . . . 0.0 109.819 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -156.18 179.32 9.35 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.433 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 23.7 p -145.46 -92.41 0.1 Allowed 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.703 0.764 . . . . 0.0 110.665 174.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -142.23 -47.2 0.35 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -177.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.92 -134.72 3.31 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 176.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -115.06 146.73 41.0 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.1 t -75.12 116.76 18.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.3 mm -110.5 122.92 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-O 121.455 0.645 . . . . 0.0 109.783 -176.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.3 mtp -109.3 171.84 7.2 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.5 p -157.74 142.69 8.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.76 122.19 20.24 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.304 176.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.3 ttm180 -156.52 127.51 6.87 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 66.19 17.06 10.65 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.58 80.36 Favored Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.897 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 9.6 pt-20 -117.4 159.06 23.38 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -104.12 109.3 21.04 Favored 'General case' 0 CA--C 1.455 -2.69 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.0 -164.54 0.39 Allowed 'Isoleucine or valine' 1 N--CA 1.362 -4.846 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.252 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.14 40.67 Favored 'General case' 1 C--N 1.218 -5.123 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.601 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.9 -39.76 66.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.86 102.18 13.64 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 1.5 8.27 Favored 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.98 2.453 . . . . 0.0 113.74 -175.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.92 -20.33 18.19 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.691 0.758 . . . . 0.0 111.385 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -85.02 130.96 34.53 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.387 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -156.55 147.95 22.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 55.7 m -97.03 123.47 40.77 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.594 0.711 . . . . 0.0 111.484 -176.137 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.99 42.51 2.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -167.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 88.2 mttt 76.6 -179.98 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.753 1.221 . . . . 0.0 111.044 -178.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 15.4 ptp180 -130.41 142.0 43.9 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.99 147.58 43.66 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.477 2.118 . . . . 0.0 109.633 173.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 m -102.32 -10.66 19.3 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.05 -117.2 4.43 Favored Glycine 0 CA--C 1.474 -2.481 0 C-N-CA 119.002 -1.571 . . . . 0.0 110.996 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -136.71 139.14 28.25 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -176.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.42 8.64 3.71 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.786 2.324 . . . . 0.0 111.143 178.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.3 -164.25 22.23 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -175.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.27 161.19 12.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -130.5 126.04 21.86 Favored Pre-proline 0 C--N 1.288 -2.086 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.182 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.29 10.1 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.548 2.165 . . . . 0.0 112.773 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -110.82 -12.16 14.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.498 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . -164.56 -146.66 4.84 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.792 -175.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.91 -172.86 4.21 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.804 0.442 . . . . 0.0 111.597 -175.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -148.11 166.42 27.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 p -130.49 159.09 38.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.551 0.74 . . . . 0.0 109.332 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.5 136.57 53.14 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.054 0.454 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 9.8 t -125.78 138.18 53.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.12 9.97 56.54 Favored Glycine 0 C--N 1.312 -0.77 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -175.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.01 167.73 11.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.06 31.52 5.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.797 0.798 . . . . 0.0 111.277 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.02 167.85 23.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.06 86.24 5.34 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.662 -176.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.92 154.16 49.52 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.397 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -51.29 120.6 5.18 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.714 0.634 . . . . 0.0 111.543 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.25 -20.05 7.12 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 99' ' ' THR . 10.5 m -83.51 146.48 6.86 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.427 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.493 ' HZ1' ' HB2' ' A' ' 109' ' ' LYS . 5.1 ttmp? -111.12 126.72 55.13 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.52 92.82 8.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.69 115.11 27.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -81.87 139.91 34.42 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.509 -177.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.14 143.31 22.34 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.498 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 77.6 m -122.57 -73.38 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.113 -174.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -161.1 -165.61 1.39 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -172.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -79.81 -43.25 22.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.778 0.799 . . . . 0.0 109.042 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.48 -12.84 79.72 Favored Glycine 0 C--N 1.31 -0.906 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.407 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -124.47 127.86 48.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.73 -130.46 0.26 Allowed 'General case' 0 CA--C 1.457 -2.632 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 166.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.525 HD11 ' CG ' ' A' ' 139' ' ' PRO . 0.3 OUTLIER -151.65 145.47 25.1 Favored 'General case' 1 N--CA 1.33 -6.467 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.996 -176.35 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.27 109.76 19.73 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.76 178.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 156.11 161.01 10.37 Favored Glycine 0 C--N 1.272 -3.017 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 -178.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -97.21 -5.96 35.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 118.183 0.991 . . . . 0.0 110.251 179.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.91 106.94 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.615 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.492 ' HA ' HD12 ' A' ' 120' ' ' LEU . 26.2 p-10 -84.7 30.99 0.54 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.616 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -166.35 179.93 5.34 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.451 0.643 . . . . 0.0 111.857 -172.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -139.83 131.61 27.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 169.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.573 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 25.2 mt-10 -99.92 136.22 40.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.1 t -81.39 123.02 28.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.158 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.0 t70 -118.55 -160.24 0.79 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 43.2 p -66.85 -51.47 55.2 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.824 1.25 . . . . 0.0 112.101 -174.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.03 -28.72 39.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.77 0.795 . . . . 0.0 110.693 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.61 -148.13 17.57 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -80.97 132.84 35.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.189 0.494 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 49.6 p -81.0 148.95 29.51 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.423 178.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 67.53 -173.75 0.19 Allowed 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.273 0.983 . . . . 0.0 108.93 174.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -117.38 -173.62 2.45 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.29 119.24 75.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 -174.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.525 ' CG ' HD11 ' A' ' 120' ' ' LEU . 9.6 Cg_endo -58.72 132.52 48.47 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.424 2.083 . . . . 0.0 108.706 174.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.03 106.62 8.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.8 t -61.42 118.17 6.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.165 0.507 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.448 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 10.2 tp10 . . . . . 0 N--CA 1.43 -1.445 0 C-N-CA 126.178 1.791 . . . . 0.0 106.651 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.7 m-20 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.9 m -74.37 138.23 43.27 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.97 15.17 29.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.344 0.592 . . . . 0.0 109.882 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.07 154.83 41.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.551 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 24.6 mt -75.12 149.82 85.16 Favored Pre-proline 0 C--O 1.253 1.289 0 O-C-N 124.073 0.858 . . . . 0.0 109.909 173.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 27.9 Cg_endo -58.84 142.02 98.56 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.828 2.352 . . . . 0.0 110.054 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.76 144.49 54.22 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.779 1.653 . . . . 0.0 111.67 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -76.21 141.76 41.69 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 24.7 mmm180 -98.28 162.03 13.4 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.647 -171.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -78.23 -42.22 31.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.342 0.592 . . . . 0.0 109.69 176.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.72 -7.72 21.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.648 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' ARG . 2.8 mp0 -129.4 166.13 20.17 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.755 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.98 146.21 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.65 140.15 51.48 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.506 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -126.67 101.41 6.63 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.988 172.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.78 -160.09 33.64 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 -176.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 m -129.43 114.53 16.27 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 117.699 0.749 . . . . 0.0 109.532 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.412 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 80.8 m95 -120.81 128.27 52.71 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.189 -175.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 m -148.54 8.08 0.78 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.312 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.543 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.0 m-20 -120.93 -173.37 2.59 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.635 -174.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -112.41 -61.1 1.77 Allowed 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.1 p -85.9 122.65 30.26 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.51 -175.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 63.9 m-85 -126.76 136.05 28.21 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.272 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.673 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 17.9 Cg_endo -60.51 145.68 98.31 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.345 2.697 . . . . 0.0 113.535 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -62.85 120.47 11.37 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.89 12.89 14.94 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -175.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.6 m -92.38 113.23 25.45 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.567 176.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.9 149.21 25.38 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.643 0.59 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.25 133.84 51.36 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.759 0.824 . . . . 0.0 109.023 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.9 mt -102.59 129.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.5 m-85 -111.25 137.29 49.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -85.05 126.53 33.64 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.7 m -77.43 13.45 1.21 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 70.1 mtp180 69.64 150.11 0.12 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.512 0.725 . . . . 0.0 110.895 -172.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.71 120.67 7.43 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.728 1.619 . . . . 0.0 109.9 175.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.24 -13.98 13.71 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 72.8 m-85 -115.17 163.66 15.33 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -150.88 -179.31 7.17 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 p -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.57 -13.61 59.74 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.592 0.711 . . . . 0.0 109.899 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.58 144.53 9.72 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 174.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.21 154.71 39.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.708 0.754 . . . . 0.0 111.166 -178.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG23 ' SG ' ' A' ' 80' ' ' CYS . 76.7 t -71.49 102.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.25 118.41 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.2 mtp -107.27 171.45 7.37 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.04 146.48 12.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.64 122.32 23.0 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.825 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -153.39 124.71 7.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.934 0.397 . . . . 0.0 111.057 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 68.66 11.55 8.39 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.852 1.261 . . . . 0.0 112.519 178.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.78 -12.61 46.13 Favored Glycine 0 N--CA 1.427 -1.945 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.33 178.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.55 158.3 21.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.595 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m95 -91.22 115.5 28.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.93 171.2 6.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.267 -175.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.22 119.49 26.56 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.3 -49.67 63.31 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.35 89.43 5.9 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.705 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.66 -19.84 9.69 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.568 2.179 . . . . 0.0 111.475 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.3 mt -74.77 -29.55 61.16 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.252 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.425 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -84.78 158.72 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.936 178.891 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -175.68 156.16 1.83 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.964 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' A' ' 62' ' ' VAL . 60.2 m -93.64 123.82 37.22 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.738 -177.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.35 164.22 16.66 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 90.9 mttt -73.51 151.11 41.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.487 0.184 . . . . 0.0 110.958 -176.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.7 ptm180 -82.27 146.25 54.07 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.476 176.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 69.8 Cg_endo -79.42 151.74 22.98 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.42 2.08 . . . . 0.0 110.909 172.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.492 ' SG ' ' HA2' ' A' ' 133' ' ' GLY . 52.5 m -110.95 -9.23 14.43 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.804 177.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.55 175.42 47.63 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.699 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.74 123.19 89.05 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 56.3 Cg_endo -70.2 83.66 0.76 Allowed 'Trans proline' 0 C--O 1.254 1.283 0 C-N-CA 123.076 2.517 . . . . 0.0 113.017 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 138' ' ' ILE . . . 63.54 -142.55 47.07 Favored Glycine 0 C--O 1.215 -1.068 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.47 130.14 17.0 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 t -127.24 99.53 27.86 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-O 121.522 0.677 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.59 -39.41 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.485 2.123 . . . . 0.0 113.403 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.43 -20.49 17.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.33 176.91 18.77 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.739 -178.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 p -134.84 175.64 9.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 37.8 p90 -150.49 151.19 32.32 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.423 177.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.5 p -101.59 171.37 7.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 103' ' ' VAL . 96.2 mt -141.69 136.7 31.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 173.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -113.31 -62.28 1.61 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.73 56.02 4.9 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.749 -176.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . 158.13 -57.49 0.35 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.329 177.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 12.6 m120 87.74 18.17 0.07 Allowed 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.401 1.48 . . . . 0.0 107.873 -179.035 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 p -141.27 -161.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.819 0 CA-C-N 111.822 -2.444 . . . . 0.0 105.051 177.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 44.9 m-85 -112.07 86.26 2.31 Favored 'General case' 1 C--N 1.236 -4.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 -175.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -151.02 155.89 39.99 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.457 178.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.634 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 79.6 t80 -45.47 115.38 0.92 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 125.036 1.46 . . . . 0.0 112.273 -178.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.41 -21.76 6.0 Favored Glycine 0 N--CA 1.427 -1.959 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.1 137.51 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.886 -1.125 . . . . 0.0 111.438 177.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -106.61 110.78 23.07 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -81.72 92.46 6.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -81.58 124.37 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.928 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.411 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 7.7 t80 -84.27 130.62 34.8 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.08 150.03 43.69 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 26.6 m -130.18 148.72 52.05 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.9 173.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.411 1.069 . . . . 0.0 112.586 177.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -44.14 -53.02 6.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.626 1.57 . . . . 0.0 113.567 -176.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 22.45 34.82 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.139 -176.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -134.05 161.01 36.02 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.391 0.615 . . . . 0.0 111.691 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -156.39 -156.38 0.62 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 173.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 1.2 pp -140.26 142.52 35.75 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -175.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 142' ' ' GLU . 4.2 mm? -83.5 135.52 34.62 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.72 171.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.25 152.01 9.03 Favored Glycine 0 C--N 1.267 -3.289 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -174.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.74 -13.06 37.61 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 117.343 0.572 . . . . 0.0 111.912 -176.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -111.21 116.44 52.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -91.63 25.49 2.66 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.448 0.642 . . . . 0.0 111.123 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 28.5 p90 -156.49 177.32 11.6 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.75 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.628 ' NH1' HG12 ' A' ' 138' ' ' ILE . 15.2 ptt180 -157.36 128.4 6.7 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 37.6 mt-10 -103.67 142.24 34.68 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.78 98.89 7.98 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -103.86 -158.51 0.67 Allowed 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.692 -173.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.518 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 38.9 p -64.94 -38.48 91.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.741 1.217 . . . . 0.0 113.14 -172.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.5 -33.99 11.64 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 120.95 0.405 . . . . 0.0 110.326 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.492 ' HA2' ' SG ' ' A' ' 85' ' ' CYS . . . 161.24 -149.14 17.76 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.554 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -71.65 130.0 40.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.727 0.264 . . . . 0.0 110.766 -178.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.5 p -79.76 167.36 20.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.336 176.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.28 -101.99 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.04 0.936 . . . . 0.0 112.668 173.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 169.82 -158.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -177.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.628 HG12 ' NH1' ' A' ' 127' ' ' ARG . 62.6 mt -102.31 107.1 52.0 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 9.4 Cg_endo -58.37 137.36 80.05 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.483 1.456 . . . . 0.0 109.37 174.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.37 115.17 25.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.041 -171.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 8.8 t -75.09 99.81 4.04 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 123.437 0.461 . . . . 0.0 109.851 -178.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.462 ' HB2' HD21 ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.77 1.628 . . . . 0.0 108.234 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 12.8 m-20 . . . . . 0 C--O 1.243 0.742 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.6 m -61.38 139.98 58.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.32 16.44 15.77 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.542 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -156.45 161.35 40.08 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.702 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.06 153.44 79.95 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 123.984 0.914 . . . . 0.0 109.935 176.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.41 123.68 14.4 Favored 'Trans proline' 0 C--O 1.254 1.303 0 C-N-CA 122.273 1.982 . . . . 0.0 111.516 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -67.36 109.24 1.74 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.803 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -71.73 143.01 49.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.934 176.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -104.49 -171.81 1.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.25 -42.26 72.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.134 0.492 . . . . 0.0 110.316 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 15.8 p -109.63 11.68 24.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mp0 -138.28 134.25 34.11 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.706 -0.621 . . . . 0.0 112.601 -178.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.93 157.32 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.11 140.64 45.39 Favored 'General case' 0 C--N 1.264 -3.138 0 O-C-N 123.817 0.698 . . . . 0.0 110.735 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -73.51 -52.96 11.77 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.909 177.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.57 167.99 41.42 Favored Glycine 0 N--CA 1.421 -2.353 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.347 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 p -90.95 146.76 23.61 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 123.011 0.524 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -135.92 143.43 44.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.0 t -125.65 -44.12 1.84 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HE1' ' A' ' 42' ' ' TYR . 15.2 t70 -97.09 158.04 15.63 Favored 'General case' 0 C--O 1.186 -2.268 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -170.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -79.09 -30.01 43.62 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.21 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 77.9 p -101.08 119.95 39.5 Favored 'General case' 0 N--CA 1.41 -2.457 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.99 -174.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HE1' ' O ' ' A' ' 39' ' ' ASP . 40.4 m-85 -130.29 155.01 81.56 Favored Pre-proline 0 C--N 1.302 -1.46 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.078 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 147.09 88.94 Favored 'Trans proline' 0 C--O 1.252 1.208 0 C-N-CA 122.121 1.881 . . . . 0.0 111.555 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.9 146.75 49.38 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.8 9.12 62.94 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.992 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -89.08 120.32 30.38 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.87 -0.194 . . . . 0.0 111.222 177.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -87.01 157.0 19.54 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.323 0.582 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.09 126.51 41.32 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.76 130.52 46.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 80.6 m-85 -99.76 138.8 36.34 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -78.2 -18.41 55.51 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 127.209 2.204 . . . . 0.0 112.531 -173.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 97.4 m 67.22 -2.87 1.11 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 62.4 mtp180 69.76 153.97 0.14 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.531 0.732 . . . . 0.0 111.131 -174.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.49 121.4 7.94 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.794 1.663 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.534 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 111.92 -5.43 27.39 Favored Glycine 0 C--N 1.306 -1.123 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.357 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 41.0 m-85 -120.49 174.57 6.47 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -162.45 -173.33 3.52 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 p -151.09 168.08 25.73 Favored 'General case' 0 C--N 1.266 -3.048 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.3 tp -105.59 32.23 4.45 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.53 109.74 0.38 Allowed Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.4 ' O ' HG12 ' A' ' 63' ' ' ILE . 11.6 m120 -52.83 140.08 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 117.337 0.568 . . . . 0.0 111.695 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 93.0 t -64.86 112.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 61' ' ' ASN . 46.9 mm -113.2 118.37 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.69 170.94 7.59 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.1 p -156.21 148.32 11.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.9 t -81.25 134.29 35.58 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.242 -177.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.421 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 4.7 tpm_? -152.59 126.76 9.16 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 32.7 mmtp 63.12 18.49 10.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 175.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 99.81 -12.41 60.96 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.944 179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.32 168.24 10.14 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -101.3 121.74 42.43 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.84 179.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.65 39.61 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.219 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -68.95 -42.57 76.49 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.582 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 9.0 t-20 -127.8 97.44 30.04 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.959 173.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.13 -7.45 16.22 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 0.0 112.864 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.61 -27.3 51.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.534 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.582 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 29.3 mmt180 -92.69 153.76 18.76 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.992 -177.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -158.03 147.3 19.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.56 123.57 28.22 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.548 -178.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -121.28 167.76 12.37 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.96 157.32 22.08 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.345 0.593 . . . . 0.0 111.963 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.6 ptm180 -99.01 154.61 37.24 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 46.6 Cg_endo -73.15 151.46 49.45 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.519 1.479 . . . . 0.0 109.386 169.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -78.52 -46.52 19.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.557 0.694 . . . . 0.0 110.111 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.51 -125.86 3.61 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -176.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -141.4 116.64 7.13 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.36 41.72 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 124.08 3.187 . . . . 0.0 114.904 -174.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.34 -137.28 30.96 Favored Glycine 0 C--N 1.311 -0.815 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -149.21 -176.54 5.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 t -171.83 106.44 0.37 Allowed Pre-proline 0 C--N 1.289 -2.061 0 C-N-CA 125.477 1.511 . . . . 0.0 107.563 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.34 -17.58 18.71 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.368 2.045 . . . . 0.0 113.435 -175.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.64 ' CD1' ' HB3' ' A' ' 141' ' ' CYS . 0.1 OUTLIER -124.06 -5.22 7.91 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.641 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.97 -163.91 10.5 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -162.27 -177.98 6.04 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 117.277 0.538 . . . . 0.0 110.619 178.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -143.55 164.6 29.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.257 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 68.2 p -120.93 169.87 10.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.8 mt -129.64 135.38 48.46 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -120.43 1.38 10.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.256 0.551 . . . . 0.0 112.331 -174.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.74 24.9 4.8 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.28 148.19 5.61 Favored Glycine 0 N--CA 1.411 -2.977 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -174.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -93.59 32.7 1.36 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 122.517 1.151 . . . . 0.0 109.141 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.99 162.42 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.624 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.322 -174.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 45.0 m-85 -91.42 100.21 13.02 Favored 'General case' 0 C--N 1.26 -3.318 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.883 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.16 149.0 37.45 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.456 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 91.5 t80 -52.39 121.22 6.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.172 0.511 . . . . 0.0 110.473 177.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.5 -13.86 25.28 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.302 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.6 142.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 109.69 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.6 ttmp? -113.09 126.01 55.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -93.51 102.92 15.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.068 0.855 . . . . 0.0 108.898 177.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.453 HG21 ' HG1' ' A' ' 97' ' ' THR . 0.7 OUTLIER -87.84 126.67 41.35 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.281 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -93.17 142.5 27.24 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -135.17 155.75 50.17 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 44.1 t -158.92 100.48 1.58 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 47.67 -160.65 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 164.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -98.77 -64.93 0.99 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.003 -0.435 . . . . 0.0 111.126 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.72 34.12 2.98 Favored Glycine 0 N--CA 1.469 0.892 0 CA-C-O 121.492 0.496 . . . . 0.0 112.58 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.13 173.65 11.3 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 120' ' ' LEU . 43.6 mt-30 -130.27 -66.09 0.79 Allowed 'General case' 0 CA--C 1.432 -3.596 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 167.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.62 ' HB3' ' O ' ' A' ' 119' ' ' GLN . 1.5 pt? 165.36 157.46 0.02 OUTLIER 'General case' 1 N--CA 1.362 -4.86 0 N-CA-C 102.204 -3.258 . . . . 0.0 102.204 164.156 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.0 mt -97.26 112.53 24.29 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 119.521 1.055 . . . . 0.0 110.455 175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.23 150.54 5.3 Favored Glycine 0 C--N 1.283 -2.404 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.28 -32.27 43.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 117.787 0.794 . . . . 0.0 108.894 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -95.72 107.4 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.416 ' HA ' HD11 ' A' ' 120' ' ' LEU . 2.6 p-10 -88.04 29.45 0.94 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.881 0.848 . . . . 0.0 110.982 -175.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -162.24 175.68 11.4 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.937 -175.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.64 ' NH2' HG12 ' A' ' 138' ' ' ILE . 12.2 ttm180 -143.56 120.93 11.63 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.37 152.23 19.85 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.429 176.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 49.8 t -79.44 149.14 31.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 131' ' ' THR . 17.5 t70 -126.07 -177.97 4.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.436 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 39.5 p -61.42 -33.83 74.37 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.59 1.156 . . . . 0.0 113.303 -175.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.52 9.15 7.11 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.399 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.11 -126.08 1.11 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.543 -178.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -131.08 153.64 49.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 59.8 p -91.17 128.97 37.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 80.22 176.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.897 0.879 . . . . 0.0 111.994 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 12.2 t70 -105.12 -156.21 0.57 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -174.256 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.64 HG12 ' NH2' ' A' ' 127' ' ' ARG . 62.2 mt -101.94 101.92 20.97 Favored Pre-proline 0 N--CA 1.42 -1.926 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.501 ' HB2' ' CD1' ' A' ' 120' ' ' LEU . 7.3 Cg_endo -52.86 133.43 51.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 122.263 1.975 . . . . 0.0 108.05 172.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 140' ' ' ILE . 3.3 mp -86.97 123.75 40.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -171.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.64 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . 48.9 t -68.64 91.51 0.43 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 CA--C 1.496 -1.129 0 C-N-CA 126.274 1.83 . . . . 0.0 107.254 -175.323 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.653 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 41' ' ' THR . 82.3 m -80.76 133.37 35.64 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.336 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.71 33.6 3.98 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.143 0.973 . . . . 0.0 108.958 -178.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.85 158.11 37.52 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.979 -176.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 19.5 mt -85.0 154.46 60.75 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 123.872 0.733 . . . . 0.0 110.392 178.012 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.09 145.04 93.68 Favored 'Trans proline' 0 C--O 1.255 1.326 0 C-N-CA 122.338 2.025 . . . . 0.0 110.382 177.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.76 155.42 53.89 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.266 1.977 . . . . 0.0 112.777 -177.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -83.5 147.91 27.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 35.8 mtt180 -114.45 170.58 8.2 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -172.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -79.11 -40.55 30.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.795 -176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p -115.92 4.15 13.8 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.417 177.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 8.2 mp0 -131.63 153.92 49.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.663 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.25 156.64 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.457 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.4 mm? -77.24 149.35 35.46 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -99.25 156.53 16.93 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.48 -159.96 25.33 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.791 178.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -140.89 120.98 13.73 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 71.7 m95 -113.75 115.75 28.3 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -175.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -134.49 26.73 3.75 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.115 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 26.6 m-20 -126.92 -167.18 1.69 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.963 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.57 -53.57 0.77 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.714 0.406 . . . . 0.0 111.156 175.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.4 p -85.11 105.51 15.9 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.937 0.875 . . . . 0.0 113.106 -175.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -114.12 136.57 22.22 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.957 178.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.653 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 22.5 Cg_endo -63.12 150.25 89.17 Favored 'Trans proline' 0 C--O 1.257 1.472 0 C-N-CA 122.878 2.385 . . . . 0.0 112.215 -177.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.493 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -66.13 133.14 50.09 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.14 1.08 41.55 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.218 -176.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -82.33 114.64 20.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.206 178.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.429 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.3 113.28 25.97 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.14 121.31 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.781 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -98.55 140.75 32.31 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.944 0.878 . . . . 0.0 113.24 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 53' ' ' ARG . 61.7 tttm -94.2 111.97 23.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 171.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 98.2 m -79.11 32.61 0.22 Allowed 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 51' ' ' LYS . 80.8 mtt180 64.23 151.85 0.12 Allowed Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.148 1.379 . . . . 0.0 113.274 177.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 36.5 Cg_endo -67.95 124.74 12.19 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.326 1.35 . . . . 0.0 108.883 173.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.14 -19.89 10.78 Favored Glycine 0 C--N 1.297 -1.591 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.624 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 75.5 m-85 -114.4 170.1 8.55 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -155.18 179.08 9.49 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.5 p -170.81 135.22 1.07 Allowed 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.2 -43.8 85.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 114.27 3.91 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 172.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -64.31 155.36 32.43 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 123.817 0.363 . . . . 0.0 110.66 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.544 HG22 ' SG ' ' A' ' 80' ' ' CYS . 98.7 t -72.55 102.2 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.04 118.44 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.5 mtp -104.62 169.15 8.62 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.6 p -156.66 146.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.286 0.565 . . . . 0.0 109.905 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.62 122.53 23.31 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.739 177.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 31.9 ttt180 -152.77 134.29 14.47 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 34.0 mmtp 67.23 12.13 8.77 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.302 1.041 . . . . 0.0 112.507 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.62 -4.27 57.97 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.81 157.48 33.99 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.16 0.505 . . . . 0.0 110.834 177.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -87.84 117.16 26.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.62 176.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.028 -178.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.78 128.97 36.23 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.433 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.11 -50.92 43.71 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.46 91.13 6.64 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.755 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.28 -15.55 22.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.619 2.212 . . . . 0.0 112.084 -177.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.1 mt -83.37 -9.34 59.11 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.038 0.923 . . . . 0.0 111.018 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -102.99 138.69 39.53 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.914 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.433 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -145.88 162.16 38.37 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 172.456 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.544 ' SG ' HG22 ' A' ' 62' ' ' VAL . 83.1 m -101.79 130.26 48.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.572 -0.851 . . . . 0.0 113.016 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 172.79 7.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.955 -178.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.75 157.12 33.59 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -85.34 145.57 42.85 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.17 144.59 13.32 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.979 1.786 . . . . 0.0 109.582 176.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.6 m -103.53 5.81 37.0 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.268 0.556 . . . . 0.0 112.152 -173.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.31 -98.66 1.14 Allowed Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.927 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -152.58 142.68 15.09 Favored Pre-proline 0 C--N 1.278 -2.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.07 45.54 1.95 Allowed 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.523 2.815 . . . . 0.0 112.069 -176.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.4 -146.28 20.83 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.27 127.14 4.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 t -113.51 135.92 21.91 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.65 -35.07 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.759 2.306 . . . . 0.0 114.379 -178.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -143.53 11.19 1.67 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.091 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 176.96 32.17 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -137.56 174.65 10.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.37 156.79 34.49 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.61 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -118.94 154.88 32.3 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 175.076 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -120.74 135.58 55.1 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.456 HG21 ' HB3' ' A' ' 109' ' ' LYS . 8.5 t -112.99 139.04 48.99 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.16 -68.75 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.926 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.75 -72.48 0.82 Allowed Glycine 0 C--N 1.31 -0.868 0 CA-C-N 115.555 -0.322 . . . . 0.0 113.402 -173.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 82.24 18.44 0.34 Allowed 'General case' 0 CA--C 1.455 -2.684 0 CA-C-O 123.467 1.603 . . . . 0.0 108.599 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.21 165.04 1.13 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.215 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -88.47 85.32 6.83 Favored 'General case' 0 C--N 1.255 -3.503 0 O-C-N 123.673 0.608 . . . . 0.0 110.154 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 108' ' ' VAL . 11.7 pt-20 -133.33 162.26 32.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.266 -176.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -52.74 128.26 25.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.026 176.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.74 -19.52 53.1 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.173 178.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 105' ' ' GLU . 5.4 p -71.51 141.58 16.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.023 -177.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.456 ' HB3' HG21 ' A' ' 99' ' ' THR . 39.0 ttmt -106.07 121.53 44.32 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.37 97.35 9.77 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.61 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.2 p -87.51 112.78 23.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.532 ' OH ' ' HB2' ' A' ' 141' ' ' CYS . 15.3 t80 -81.21 139.42 35.53 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.203 -170.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -142.34 170.9 14.84 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.23 -89.67 0.59 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.802 177.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -138.26 -149.2 0.29 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.01 -51.77 5.3 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.359 -179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.31 -18.86 63.58 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.601 178.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.11 144.97 25.02 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -122.15 -68.47 0.89 Allowed 'General case' 0 CA--C 1.438 -3.348 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.786 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.263 1.0 OUTLIER 169.52 153.46 0.04 OUTLIER 'General case' 1 N--CA 1.297 -8.115 0 CA-C-N 111.605 -2.543 . . . . 0.0 105.145 -169.876 . . . . . . . . 5 4 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.786 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 36.6 tp -134.16 126.94 31.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.18 171.83 12.57 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.179 -1.969 . . . . 0.0 108.179 -176.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -92.52 -21.13 20.3 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 118.223 1.012 . . . . 0.0 110.814 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 136' ' ' ASN . 32.3 mm -114.33 114.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -94.87 19.85 9.64 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -175.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -159.03 174.18 15.32 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.31 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.424 ' NH2' ' HA ' ' A' ' 137' ' ' ASP . 8.5 ptm180 -151.88 127.82 10.34 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.34 171.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -99.53 160.7 14.09 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.026 0.53 . . . . 0.0 109.709 -178.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.3 t -98.55 114.82 27.4 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.955 175.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.24 -179.64 5.3 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 125.401 1.48 . . . . 0.0 108.385 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 51.2 p -62.54 -36.25 82.02 Favored 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 123.714 0.805 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.85 -34.85 24.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.52 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.29 -157.53 29.43 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -69.02 129.56 40.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.69 1.245 . . . . 0.0 110.886 -177.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 24.3 p -55.56 -38.9 69.93 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 125.054 1.341 . . . . 0.0 112.711 -174.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.434 HD22 HG13 ' A' ' 124' ' ' ILE . 11.6 t-20 -138.32 172.81 12.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -175.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 16.6 t70 -102.53 -168.69 1.56 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 123.422 0.451 . . . . 0.0 110.241 -176.12 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.495 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.2 mt -76.81 123.15 87.47 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 124.435 1.094 . . . . 0.0 111.05 -171.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -73.58 163.24 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.717 1.611 . . . . 0.0 109.762 172.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mm -84.45 133.1 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.532 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 21.3 t -83.0 120.42 25.7 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 121' ' ' LEU . 13.2 tp10 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -174.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 31.2 m-20 . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 121.064 0.459 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 142.41 43.94 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 124.555 1.142 . . . . 0.0 110.757 -172.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 19.99 14.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.925 0.869 . . . . 0.0 109.35 175.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.55 156.01 34.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.665 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.4 mt -77.4 158.25 79.37 Favored Pre-proline 0 C--O 1.253 1.238 0 O-C-N 123.759 0.662 . . . . 0.0 110.82 176.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 20.3 Cg_endo -62.03 135.05 52.83 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.337 2.024 . . . . 0.0 109.581 175.359 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.02 137.09 21.23 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 121.986 1.791 . . . . 0.0 112.926 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -76.25 143.66 40.82 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -121.62 175.86 6.0 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.533 -170.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -59.02 -26.08 64.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 0.0 113.21 -175.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -134.3 12.05 3.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.88 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 3.1 mp0 -132.57 140.23 48.17 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.71 -0.796 . . . . 0.0 113.082 -172.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -135.67 142.62 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.74 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.0 mm? -69.65 142.06 53.51 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.998 -179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 p -101.76 87.98 3.28 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.25 -169.49 40.44 Favored Glycine 0 C--N 1.275 -2.815 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.751 -175.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -117.68 109.6 16.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.496 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 48.7 m95 -129.5 126.01 37.66 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 t -160.94 25.01 0.14 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.36 -164.48 1.13 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.782 -1.553 . . . . 0.0 110.053 -172.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -123.83 -64.87 1.11 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.94 0.4 . . . . 0.0 110.91 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 p -105.6 146.23 29.94 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.33 153.99 56.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.78 1.232 . . . . 0.0 109.207 178.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 57.6 Cg_endo -73.47 152.93 49.61 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.019 1.813 . . . . 0.0 112.311 179.362 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.9 147.77 52.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.88 5.86 65.91 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.065 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -83.94 115.95 22.55 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.467 178.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -90.04 139.08 30.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.532 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.98 124.56 52.92 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.65 129.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -117.67 145.62 44.27 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.229 0.538 . . . . 0.0 112.303 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.16 152.85 18.92 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 m -92.97 28.68 2.03 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -174.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 66.29 155.48 0.13 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-O 121.384 0.611 . . . . 0.0 111.511 -177.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.71 108.23 1.02 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.763 1.642 . . . . 0.0 111.53 176.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.17 -23.18 4.95 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.955 177.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.9 m-85 -102.5 172.48 6.84 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -154.81 -179.45 8.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -170.6 -179.95 3.09 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.95 8.16 27.61 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 -161.51 27.75 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.93 147.42 26.16 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.83 117.72 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.22 124.94 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.655 -176.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.4 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 88.9 mtp -112.39 172.29 7.0 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.9 p -155.56 148.3 12.27 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.83 129.27 34.94 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 55.8 ttp180 -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 64.68 19.27 11.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.043 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 -12.48 62.0 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.949 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.1 157.77 24.22 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.169 0.509 . . . . 0.0 111.736 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.406 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.1 m95 -91.99 116.21 28.73 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.489 178.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.44 172.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.496 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.68 108.54 19.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.2 tm? -61.15 -49.93 75.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 172.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.18 90.39 9.71 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.557 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.93 -17.91 15.11 Favored 'Trans proline' 0 N--CA 1.479 0.656 0 C-N-CA 122.478 2.119 . . . . 0.0 111.04 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.38 -27.62 60.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.442 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -92.18 131.66 37.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.745 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -140.02 163.36 32.9 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 71.5 m -92.91 110.53 21.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -105.33 162.7 13.21 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.369 -174.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HD3' ' CE2' ' A' ' 56' ' ' TYR . 33.8 mmtp -70.25 157.38 37.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -94.35 134.36 25.71 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.831 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 37.9 Cg_endo -71.62 136.76 28.88 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.288 1.992 . . . . 0.0 110.674 176.13 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.9 -1.79 39.2 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.059 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.78 -123.24 9.71 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.852 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -103.28 136.46 19.22 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.29 75.22 1.03 Allowed 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.431 2.087 . . . . 0.0 113.602 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.32 -136.02 19.54 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.536 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.64 27.87 6.01 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.613 0.365 . . . . 0.0 110.233 -176.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -48.82 115.35 4.41 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.271 176.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.31 -53.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.688 2.259 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.16 154.5 49.47 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.37 -168.18 21.06 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -176.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 m -155.37 156.17 34.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 48.8 p90 -145.24 165.94 26.93 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.549 0.53 . . . . 0.0 111.216 -177.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 70.9 p -118.76 -178.02 3.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.921 -179.374 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.6 155.23 49.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 15.1 t -165.47 149.24 8.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.78 -0.79 88.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.949 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.03 -169.58 39.79 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.37 3.31 4.26 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-N 117.748 0.774 . . . . 0.0 112.808 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.471 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.7 p -156.78 -160.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.068 -1.053 . . . . 0.0 108.698 -173.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 26.0 m-85 -90.87 77.28 6.21 Favored 'General case' 1 C--N 1.243 -4.034 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.771 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 15.8 pt-20 -136.48 152.28 50.38 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.201 -174.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -49.63 124.52 9.71 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.091 0.869 . . . . 0.0 110.165 173.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.25 -22.85 10.93 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.381 179.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.8 m -76.87 144.43 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.741 -179.023 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 22.2 ttmm -106.45 106.94 17.71 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -86.86 99.35 11.77 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.491 HG22 ' HG1' ' A' ' 97' ' ' THR . 0.9 OUTLIER -80.61 130.33 36.09 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.412 -177.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.88 108.92 21.72 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.912 0.863 . . . . 0.0 109.157 -172.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 m -100.95 -31.53 11.08 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.883 -172.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 33.6 m 65.74 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -166.36 -154.34 0.18 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.7 -60.47 2.34 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.442 -178.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.82 73.98 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.533 -177.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -115.02 128.41 56.25 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.513 0.197 . . . . 0.0 111.145 178.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.41 -134.21 0.33 Allowed 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 167.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -157.52 161.38 38.81 Favored 'General case' 1 N--CA 1.336 -6.158 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.247 . . . . . . . . 4 4 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 142' ' ' GLU . 4.1 mm? -88.58 125.04 34.61 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.331 0.586 . . . . 0.0 109.954 172.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.07 148.45 5.45 Favored Glycine 0 C--N 1.278 -2.688 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.44 -16.52 39.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.112 0.958 . . . . 0.0 109.484 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -109.93 106.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.538 ' HA ' HD13 ' A' ' 120' ' ' LEU . 26.3 p-10 -88.91 36.66 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.48 0.657 . . . . 0.0 111.758 -172.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.416 ' CD1' ' HG3' ' A' ' 109' ' ' LYS . 26.2 p90 -159.19 178.3 10.15 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.63 -177.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.435 ' NH2' HG23 ' A' ' 138' ' ' ILE . 6.3 ptp180 -148.98 124.31 10.24 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 17.7 mt-10 -96.76 157.22 16.0 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.35 107.1 18.35 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.557 175.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.29 -164.43 1.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.3 p -65.53 -42.96 91.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.974 0.91 . . . . 0.0 110.04 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.32 -46.28 73.94 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.253 177.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.28 -139.09 7.43 Favored Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.45 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.9 m95 -70.86 126.7 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 -176.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.9 p -80.37 170.24 16.65 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.607 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.4 m120 70.45 -81.22 0.03 OUTLIER 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.253 1.021 . . . . 0.0 111.857 173.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.1 t0 163.57 -161.62 0.0 OUTLIER 'General case' 0 C--O 1.242 0.661 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.435 HG23 ' NH2' ' A' ' 127' ' ' ARG . 4.0 mp -107.05 96.64 15.55 Favored Pre-proline 0 C--N 1.284 -2.277 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' CB ' HD12 ' A' ' 120' ' ' LEU . 1.2 Cg_endo -47.33 123.7 8.2 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.811 2.341 . . . . 0.0 109.737 173.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.2 114.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.42 -174.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 14.0 t -59.67 112.86 1.97 Allowed 'General case' 0 C--O 1.254 1.336 0 O-C-N 123.794 0.683 . . . . 0.0 109.713 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.423 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -173.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.129 0.49 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -70.4 138.96 51.73 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.04 0.936 . . . . 0.0 110.116 -174.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.04 24.93 6.32 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.787 0.804 . . . . 0.0 108.948 176.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.14 160.78 33.36 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.611 -178.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.94 152.92 63.25 Favored Pre-proline 0 C--N 1.313 -0.993 0 O-C-N 123.614 0.571 . . . . 0.0 110.325 176.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -54.01 142.84 64.03 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.909 2.406 . . . . 0.0 113.172 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.65 112.43 2.86 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.429 2.086 . . . . 0.0 111.896 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -76.35 151.05 36.77 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.638 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -121.05 -179.84 4.16 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -174.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -90.53 -20.17 22.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.153 0.501 . . . . 0.0 109.705 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 -10.34 17.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 177.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -134.74 137.56 43.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.263 0.554 . . . . 0.0 111.649 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.33 163.52 24.16 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.796 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.3 mm? -91.78 151.0 20.8 Favored 'General case' 0 C--N 1.266 -3.059 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.9 p -112.47 101.21 9.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.1 -171.43 32.09 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -108.34 115.18 29.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 53.9 m95 -132.7 107.38 8.35 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.215 0.531 . . . . 0.0 109.94 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 t -153.38 28.64 0.5 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 174.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.37 -161.49 0.76 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.413 -168.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.36 -67.09 0.41 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 82.3 p -94.62 128.76 41.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.172 -173.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.44 157.54 77.85 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.66 147.17 39.8 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.261 1.974 . . . . 0.0 111.834 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 22.1 tt0 -64.73 137.21 57.67 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.212 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.54 7.79 50.63 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.3 m -83.82 119.52 24.94 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.849 177.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -87.56 146.41 25.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.31 0.576 . . . . 0.0 111.654 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.2 122.0 41.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.36 129.84 44.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -104.04 153.6 20.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.493 1.139 . . . . 0.0 113.986 -178.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' ARG . 64.0 tttp -103.65 118.35 36.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.872 172.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.5 m -69.73 12.31 0.21 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 123.98 0.912 . . . . 0.0 113.392 -178.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' LYS . 70.5 mtp180 66.89 154.41 0.13 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.133 0.973 . . . . 0.0 109.158 -170.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.87 -9.09 13.09 Favored 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 122.358 2.039 . . . . 0.0 115.091 -177.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.2 1.83 35.14 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.188 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.682 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 48.1 m-85 -123.49 173.28 8.13 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.349 -1.089 . . . . 0.0 111.475 -177.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.44 -172.57 4.17 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.888 0.875 . . . . 0.0 109.346 -175.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -174.08 162.49 3.8 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.47 -8.15 58.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.778 . . . . 0.0 109.861 177.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.33 -123.88 1.81 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.97 151.31 28.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.98 103.22 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.618 0.723 . . . . 0.0 109.114 177.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.5 mm -110.87 121.23 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.975 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.2 mtp -110.22 170.04 8.34 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 5.8 p -154.21 142.16 13.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.23 127.92 32.65 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.314 -178.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 53.5 ttp180 -150.5 125.83 10.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.19 35.3 12.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.715 0.806 . . . . 0.0 112.525 -179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.36 53.55 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.001 176.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.62 163.97 12.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.806 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -104.9 114.15 28.18 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -179.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 p -123.24 -167.33 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.367 -4.599 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.012 -171.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.66 113.24 25.23 Favored 'General case' 1 C--N 1.224 -4.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 114.145 -168.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.4 -52.93 10.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 172.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.57 92.56 14.35 Favored Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.267 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.74 -1.04 11.22 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.401 2.067 . . . . 0.0 111.96 178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.72 -5.19 51.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.222 0.534 . . . . 0.0 109.925 178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -112.79 144.84 41.65 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.203 0.525 . . . . 0.0 111.001 -175.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -156.34 147.75 22.52 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 173.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -83.74 113.14 20.69 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.672 177.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -105.59 163.96 12.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.07 -177.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 96.8 mttt -64.05 143.45 57.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.261 0.553 . . . . 0.0 111.452 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -84.13 145.39 45.97 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.48 157.67 44.76 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.539 1.493 . . . . 0.0 111.086 -177.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.3 m -107.66 7.61 28.62 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 -176.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.51 -102.63 1.31 Allowed Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.611 178.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -152.65 130.96 6.3 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.89 37.22 0.4 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 123.069 2.513 . . . . 0.0 111.789 -177.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.92 -176.87 54.55 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -172.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -124.4 -171.32 2.31 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -172.29 126.77 0.55 Allowed Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.6 -22.72 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.976 1.784 . . . . 0.0 113.694 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -129.86 -5.35 4.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.89 171.77 20.22 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.782 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -136.25 160.65 38.06 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.5 p90 -144.69 149.98 36.56 Favored 'General case' 0 N--CA 1.418 -2.042 0 O-C-N 123.332 0.395 . . . . 0.0 111.211 174.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 61.5 p -101.45 175.67 5.49 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.423 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -140.67 131.33 25.63 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -127.26 9.06 6.66 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.577 0.703 . . . . 0.0 112.233 -171.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.32 34.24 2.21 Favored Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.24 175.15 13.66 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 106.379 -2.688 . . . . 0.0 106.379 -172.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -124.12 24.18 8.24 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 118.417 1.109 . . . . 0.0 108.773 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.8 m -143.09 -177.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -89.96 85.38 6.33 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.039 -178.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.39 144.25 51.27 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.144 -178.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 72.5 t80 -49.18 114.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.885 0.874 . . . . 0.0 111.385 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 127.33 -22.04 5.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.529 -179.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.74 139.09 19.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 122.053 0.93 . . . . 0.0 111.133 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -108.13 117.14 33.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 170.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -90.37 97.64 11.3 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -79.88 127.26 39.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.669 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 59.7 t80 -114.07 143.88 44.04 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 -171.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 2.4 m -151.54 160.55 43.63 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.085 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 75.6 m -149.15 126.49 11.49 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 66.77 178.3 0.22 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.23 -47.77 3.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.847 -178.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.02 74.27 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.191 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -141.28 -177.92 5.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HB2' HD11 ' A' ' 120' ' ' LEU . 2.8 pt20 -153.79 -130.9 0.04 OUTLIER 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.191 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -99.26 163.88 12.36 Favored 'General case' 0 N--CA 1.386 -3.671 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.098 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' A' ' 142' ' ' GLU . 3.8 mm? -88.87 142.44 27.65 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 166.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.94 154.88 10.13 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -83.8 -26.71 29.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.937 0.875 . . . . 0.0 109.72 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.95 111.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.89 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.96 26.43 3.21 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.488 1.115 . . . . 0.0 110.716 -178.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 7.3 p90 -153.49 -178.12 6.79 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.343 -172.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -139.52 121.89 16.05 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 24.9 mt-10 -99.5 141.12 32.71 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.363 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.93 115.94 23.86 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.532 177.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.9 172.16 7.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.627 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.1 p -52.08 -39.38 59.62 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 125.347 1.459 . . . . 0.0 112.197 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.25 -33.47 19.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.902 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.73 -162.23 33.85 Favored Glycine 0 C--O 1.212 -1.281 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 134.69 47.85 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.541 0.671 . . . . 0.0 111.443 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -68.43 -25.79 65.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.241 0.616 . . . . 0.0 111.375 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -130.15 168.19 17.19 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -176.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -107.46 -104.44 0.35 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.389 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.5 96.74 32.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 4.7 Cg_endo -47.95 129.04 17.39 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.276 2.651 . . . . 0.0 111.64 178.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.2 mm -80.76 112.21 18.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.457 -173.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.669 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 57.4 m -79.24 114.13 17.93 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.785 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.468 ' HB3' HD22 ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.435 -1.19 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.356 0.598 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 138.4 58.41 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.404 -175.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.22 20.11 13.27 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.304 1.05 . . . . 0.0 108.772 175.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.84 153.6 39.36 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.624 179.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.66 157.58 69.46 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 144.49 96.45 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 122.073 1.849 . . . . 0.0 111.31 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.6 178.99 5.68 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.046 1.831 . . . . 0.0 111.53 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -94.41 158.7 15.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 10.5 mmt85 -103.94 166.41 10.43 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -77.04 -62.15 1.75 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -95.77 13.69 25.72 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.193 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 28' ' ' ARG . 4.8 mp0 -135.66 161.83 34.42 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.5 mt -134.4 150.52 30.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 37' ' ' TRP . 35.2 mt -71.84 143.32 49.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.532 0.605 . . . . 0.0 110.226 174.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 p -87.44 -33.24 19.13 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.174 0.512 . . . . 0.0 112.067 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.92 168.4 18.09 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.865 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -87.93 138.2 31.66 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 175.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 33' ' ' LEU . 75.9 m95 -130.28 117.8 20.37 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.307 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 m -130.31 4.81 4.78 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.217 0.532 . . . . 0.0 110.874 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.78 -165.76 1.28 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.09 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -140.7 -40.67 0.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.052 175.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.2 p -112.08 138.13 49.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.698 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -139.55 154.88 71.83 Favored Pre-proline 0 C--N 1.303 -1.434 0 C-N-CA 123.874 0.87 . . . . 0.0 109.067 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.83 148.65 28.66 Favored 'Trans proline' 0 C--O 1.257 1.462 0 C-N-CA 121.756 1.638 . . . . 0.0 111.056 175.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -62.05 145.44 53.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.15 1.3 59.56 Favored Glycine 0 C--N 1.298 -1.545 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.226 -179.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.9 m -83.93 118.12 23.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.421 0.153 . . . . 0.0 111.12 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.8 pt20 -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-O 121.925 0.869 . . . . 0.0 111.731 -176.578 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 113.02 19.09 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.97 114.92 27.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.123 -177.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.63 138.59 33.08 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.853 0.835 . . . . 0.0 112.353 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -80.41 139.04 36.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 12.2 t -84.57 10.29 11.42 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -170.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 67.24 133.32 0.04 OUTLIER Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.705 174.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.72 104.39 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.441 2.761 . . . . 0.0 114.093 -176.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.71 -24.37 5.2 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.177 177.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.575 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.7 m-85 -95.77 173.17 7.6 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.363 -0.493 . . . . 0.0 110.559 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -136.85 161.45 35.96 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.585 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 99.9 p -136.36 173.21 11.95 Favored 'General case' 0 N--CA 1.382 -3.847 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.325 177.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -83.71 -4.89 58.99 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.965 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.74 45.41 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 176.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.55 131.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.352 1.061 . . . . 0.0 112.691 -177.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.7 t -76.07 111.52 12.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -105.77 114.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-O 121.513 0.673 . . . . 0.0 109.788 -178.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtp -103.5 172.59 6.72 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.612 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.9 p -160.74 150.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.87 128.19 33.57 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . 40.3 ttp180 -153.72 127.42 8.76 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 67.64 19.92 9.71 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.52 -14.74 64.48 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.158 178.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.89 172.99 6.52 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.166 0.508 . . . . 0.0 110.007 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -110.5 112.53 24.51 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.11 -158.44 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.372 -4.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.954 -175.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.49 129.53 39.66 Favored 'General case' 1 C--N 1.231 -4.552 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.508 -170.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -89.47 -57.45 2.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 171.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.7 m120 -112.29 95.05 29.18 Favored Pre-proline 0 N--CA 1.421 -1.911 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.163 178.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.71 -17.68 25.82 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.275 1.983 . . . . 0.0 111.382 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -79.14 -19.59 50.66 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.199 1.0 . . . . 0.0 110.834 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 29.6 mmt180 -81.11 129.7 34.68 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 174.064 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -145.21 152.73 40.45 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 16.9 m -104.95 114.81 29.23 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.189 0.995 . . . . 0.0 111.138 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -112.39 174.59 5.81 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.433 -178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -82.95 145.91 29.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.5 ptp180 -74.99 132.45 77.14 Favored Pre-proline 0 C--N 1.298 -1.648 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.214 178.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 47.2 Cg_endo -73.46 139.69 28.98 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 122.153 1.902 . . . . 0.0 110.115 176.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 m -89.49 -21.31 23.02 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.431 0.634 . . . . 0.0 109.761 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.61 -160.44 47.24 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.576 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.33 115.34 14.14 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 125.162 1.385 . . . . 0.0 110.653 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' O ' HD12 ' A' ' 138' ' ' ILE . 98.4 Cg_endo -78.76 -9.43 15.78 Favored 'Trans proline' 0 C--O 1.212 -0.794 0 C-N-CA 123.31 2.673 . . . . 0.0 113.151 -178.305 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 123.95 -155.65 17.93 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -145.05 157.9 43.98 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -150.11 125.99 5.04 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.78 -47.62 15.32 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.494 2.129 . . . . 0.0 111.445 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -109.82 140.04 44.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.414 ' C ' ' HG1' ' A' ' 95' ' ' THR . . . 105.46 -178.01 23.15 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.913 176.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 94' ' ' GLY . 13.8 m -158.04 166.97 31.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -123.49 159.35 29.27 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.239 176.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.587 ' OG1' HG12 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.98 159.39 25.7 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.422 177.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.69 139.86 52.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -113.32 -18.86 11.95 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.28 21.44 Favored Glycine 0 CA--C 1.5 -0.853 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.587 -174.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.64 -175.79 32.63 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -178.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.7 15.09 18.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.147 0.975 . . . . 0.0 109.083 178.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.65 172.3 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -96.5 100.41 12.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.216 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 108' ' ' VAL . 14.7 pt-20 -147.14 160.63 42.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 -174.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.5 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 92.6 t80 -55.14 116.28 2.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.127 0.489 . . . . 0.0 110.439 175.065 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.98 -18.91 11.29 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 105' ' ' GLU . 1.4 p -91.08 167.64 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -142.13 131.84 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.66 94.42 8.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.587 HG12 ' OG1' ' A' ' 97' ' ' THR . 3.7 p -93.49 114.71 30.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.883 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.65 144.09 26.51 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.387 1.089 . . . . 0.0 112.887 -173.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -134.81 150.83 50.56 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 103.479 -2.786 . . . . 0.0 103.479 174.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 118' ' ' TYR . 16.3 t -112.21 -80.92 0.59 Allowed 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.695 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 2.4 m-20 -137.7 -168.12 2.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.3 -43.17 70.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.264 0.554 . . . . 0.0 110.671 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.61 -1.91 46.69 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.81 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.702 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 91.2 m-85 -115.86 128.96 56.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 122.454 -0.439 . . . . 0.0 111.749 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 14.8 mm100 -139.2 -148.7 0.26 Allowed 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 170.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -111.66 169.88 8.52 Favored 'General case' 0 N--CA 1.382 -3.848 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.862 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.443 HD22 ' HB ' ' A' ' 140' ' ' ILE . 3.5 mm? -66.21 -64.26 0.9 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.765 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.23 -154.42 16.77 Favored Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.072 -0.967 . . . . 0.0 114.764 -173.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.68 -13.78 22.54 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.392 0.677 . . . . 0.0 111.435 -177.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 139' ' ' PRO . 45.8 mm -94.43 94.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 CA-C-O 122.293 1.044 . . . . 0.0 110.56 -175.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -94.31 26.49 3.33 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.494 -177.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.09 174.64 7.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.866 0.841 . . . . 0.0 112.54 -171.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HG3' ' CE3' ' A' ' 134' ' ' TRP . 9.1 ptm180 -140.67 132.19 27.0 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 170.051 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -110.91 157.37 19.94 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -168.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 46.3 m -90.62 116.56 28.6 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.659 0.742 . . . . 0.0 112.384 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -110.97 179.17 4.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.2 p -57.36 -35.74 70.32 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.918 0.887 . . . . 0.0 110.527 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.9 -35.19 67.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.781 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 139.43 -127.61 3.7 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -174.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.508 ' CE3' ' HG3' ' A' ' 127' ' ' ARG . 91.4 m95 -82.66 127.47 33.42 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 118.173 0.987 . . . . 0.0 109.749 178.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.2 p -62.64 -60.79 3.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.066 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.38 -173.4 2.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 12.2 t70 -113.01 -166.75 1.11 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.49 HD12 ' HA3' ' A' ' 89' ' ' GLY . 71.5 mt -82.14 124.97 78.18 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 122.949 0.5 . . . . 0.0 110.916 -173.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 16.3 Cg_endo -58.13 147.91 80.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.553 2.835 . . . . 0.0 111.789 178.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 37.1 mm -88.73 122.05 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.515 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 41.3 t -72.26 119.44 16.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.38 0.61 . . . . 0.0 111.079 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.671 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.4 m -69.31 137.39 52.93 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.681 -1.145 . . . . 0.0 107.969 -177.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -114.41 14.65 17.93 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.61 163.96 36.47 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.727 -175.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -98.0 159.06 31.74 Favored Pre-proline 0 N--CA 1.383 -3.825 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.721 -175.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.72 134.47 54.25 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 109.779 176.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.48 142.35 64.95 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.411 2.074 . . . . 0.0 113.439 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.405 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.97 134.61 35.39 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 171.092 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 31.8 mtp85 -118.99 179.52 4.13 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -169.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -78.51 -63.87 1.3 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.467 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 p -85.54 11.63 10.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.501 0.667 . . . . 0.0 112.44 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 4.0 mp0 -141.71 143.85 33.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.619 -176.155 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 51.9 mt -133.24 141.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.617 HD11 ' CD1' ' A' ' 37' ' ' TRP . 51.2 mt -71.94 141.16 49.46 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.751 0.657 . . . . 0.0 110.348 177.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -71.29 -61.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 178.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.28 52.61 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.308 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -103.83 114.44 28.7 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CD1' HD11 ' A' ' 33' ' ' LEU . 27.1 m95 -101.77 92.27 4.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.116 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -99.59 -5.91 28.26 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.122 -177.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.658 ' O ' HD23 ' A' ' 24' ' ' LEU . 6.0 m-20 -83.76 -163.1 0.72 Allowed 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -136.27 -54.74 0.75 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 45.3 p -90.98 129.02 37.03 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 121.528 0.68 . . . . 0.0 112.557 -176.038 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -135.91 153.29 76.96 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 123.814 0.846 . . . . 0.0 109.382 179.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.46 149.48 87.84 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.176 1.918 . . . . 0.0 112.441 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.73 135.59 49.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.7 7.66 50.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.038 -178.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -85.03 123.98 31.19 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.712 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -92.22 147.82 22.63 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.019 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.73 134.23 55.3 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.38 132.29 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 82.7 m-85 -109.57 136.34 49.11 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.469 175.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 32' ' ' ILE . 36.1 mtpt -65.93 -26.81 67.76 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.211 1.004 . . . . 0.0 111.618 -176.114 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.656 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 19.2 m 71.33 8.74 6.41 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.472 -171.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 50.3 mtt180 66.57 170.2 0.1 Allowed Pre-proline 0 N--CA 1.494 1.752 0 CA-C-O 121.388 0.613 . . . . 0.0 111.198 -178.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.79 133.84 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 166.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.39 -17.11 34.36 Favored Glycine 0 C--N 1.302 -1.309 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.799 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 80.8 m-85 -118.85 161.94 19.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.176 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -149.23 -174.87 4.77 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 p -174.65 175.89 2.39 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.45 -8.94 58.79 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.78 48.09 0.1 OUTLIER Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 50.8 m-80 62.22 -172.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.657 0.783 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 53.7 t -110.86 116.13 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.8 114.39 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.766 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.5 mtp -105.75 167.32 9.85 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -151.39 146.39 15.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.2 t -84.75 132.23 34.46 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.768 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -154.27 120.75 5.44 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 65.88 38.22 5.15 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.197 0.999 . . . . 0.0 112.198 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.26 -16.16 24.73 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 114.962 -1.017 . . . . 0.0 114.084 176.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -110.38 154.97 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.399 0.6 . . . . 0.0 111.107 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 78.6 m95 -95.1 121.0 36.29 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.224 0.535 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.93 174.53 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.527 -176.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.18 125.25 30.04 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.29 -59.13 3.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -109.74 105.99 57.83 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.523 177.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.94 -14.14 40.37 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 123.428 2.752 . . . . 0.0 111.945 -178.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.44 -11.58 58.43 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.498 1.142 . . . . 0.0 109.876 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 42.0 mmt-85 -90.85 114.28 26.66 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.156 176.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -151.51 148.05 27.57 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.614 -177.252 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -86.24 108.97 18.61 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.567 -178.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -101.19 157.5 16.73 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.635 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 86.5 mttt -75.5 138.89 41.87 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.223 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 131' ' ' THR . 17.1 ptm180 -76.02 151.29 83.98 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.565 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 156.31 62.69 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.079 1.853 . . . . 0.0 111.796 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.3 m -114.3 5.53 15.8 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.651 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.36 -92.39 0.33 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.374 174.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -152.43 124.36 3.84 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -173.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.13 40.45 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 123.542 2.828 . . . . 0.0 112.865 -178.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 82.91 -179.43 52.99 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -177.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -103.72 162.63 12.92 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -161.45 109.76 1.22 Allowed Pre-proline 0 N--CA 1.42 -1.945 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.551 175.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.26 -50.72 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.905 1.737 . . . . 0.0 111.821 177.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -100.11 14.96 28.93 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -133.77 171.37 22.05 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.015 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 m -146.39 167.34 23.85 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 42.4 p90 -142.29 163.47 32.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.683 0.277 . . . . 0.0 111.038 -178.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 65.5 p -107.71 161.89 14.47 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.72 128.31 38.66 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -112.99 14.88 19.74 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.84 28.17 2.75 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.01 176.4 14.39 Favored Glycine 0 N--CA 1.411 -3.009 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 -173.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -112.25 32.5 5.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.12 165.69 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.184 -174.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -96.42 95.25 7.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 110.244 -177.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.98 155.65 49.94 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.567 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 52.2 t80 -50.9 124.47 11.3 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.072 0.857 . . . . 0.0 109.766 176.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.55 26.28 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.29 -1.433 . . . . 0.0 114.175 177.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.4 134.25 28.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 119.403 1.602 . . . . 0.0 109.498 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -97.83 117.19 31.59 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.02 104.71 16.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.506 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.1 m -87.65 130.32 37.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 139' ' ' PRO . 68.3 t80 -121.18 137.86 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.566 0.698 . . . . 0.0 112.051 -168.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.481 ' HG1' ' C ' ' A' ' 112' ' ' TYR . 15.7 m -152.1 165.16 35.6 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.0 m -130.75 120.97 24.59 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.851 0.296 . . . . 0.0 110.529 -177.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 55.79 -155.64 0.28 Allowed 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.6 0.562 . . . . 0.0 110.317 178.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.5 -43.63 8.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.122 0.486 . . . . 0.0 110.835 177.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.39 11.72 68.54 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -173.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 70.0 m-85 -120.77 140.43 51.7 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.388 1.094 . . . . 0.0 111.9 177.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 42.5 mt-30 -133.96 -170.19 2.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 167.461 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -98.56 155.41 17.3 Favored 'General case' 2 N--CA 1.356 -5.143 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -175.716 . . . . . . . . 4 4 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.63 -31.99 57.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.302 -179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.16 174.6 53.19 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.202 177.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.65 -37.94 17.54 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.991 0.901 . . . . 0.0 109.592 -178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.1 mm -82.99 103.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.076 -175.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -87.71 25.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.428 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -159.15 173.87 15.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -148.84 118.02 6.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.846 174.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.25 146.25 23.98 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.876 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . 43.5 t -91.24 124.45 35.46 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.515 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.7 t70 -105.38 -164.84 1.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.518 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 28.6 p -54.06 -58.64 6.58 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 125.857 1.663 . . . . 0.0 112.761 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.22 -40.11 52.95 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 172.52 -155.45 23.28 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.525 -176.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 70.0 m95 -69.9 132.49 46.07 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 48.5 p -77.29 142.04 39.65 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 72.17 -168.79 0.14 Allowed 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.015 0.822 . . . . 0.0 109.245 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.91 -164.35 1.3 Allowed 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.475 HD12 ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt -86.28 107.97 15.56 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 7.1 Cg_endo -48.41 122.53 7.83 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.55 2.834 . . . . 0.0 112.196 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.0 mp -73.23 115.09 13.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.017 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 80.3 m -81.43 115.02 20.57 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.006 0.431 . . . . 0.0 111.437 179.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 . . . . . 0 C--N 1.303 -1.455 0 C-N-CA 124.327 1.051 . . . . 0.0 108.498 -179.64 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -65.12 137.78 57.87 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.208 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.428 ' HA ' HG22 ' A' ' 41' ' ' THR . 3.3 m-80 -124.0 24.7 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.115 0.959 . . . . 0.0 109.184 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.1 150.79 24.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.666 -1.607 . . . . 0.0 107.823 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.01 152.55 84.47 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 123.66 0.6 . . . . 0.0 109.916 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.21 147.5 91.2 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.022 1.814 . . . . 0.0 110.347 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.95 165.57 19.51 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 113.447 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -110.35 150.11 29.25 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 16.1 mtp180 -123.07 178.93 4.86 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.684 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.63 -58.69 3.13 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.77 0.428 . . . . 0.0 110.094 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -90.23 -11.85 39.75 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -123.11 150.94 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.569 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' A' ' 53' ' ' ARG . 33.1 mt -131.1 148.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 mt -74.01 129.95 38.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 117.918 0.326 . . . . 0.0 111.487 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 19.9 p -121.34 104.39 9.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.525 0.679 . . . . 0.0 110.342 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.27 173.03 22.09 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -93.82 119.34 32.64 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 117.263 0.532 . . . . 0.0 110.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -126.9 121.68 32.47 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 t -149.86 13.27 0.8 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.934 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.95 152.65 49.17 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 121.508 -0.745 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.05 -30.49 62.43 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.751 0.31 . . . . 0.0 110.917 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.1 p -114.41 118.13 32.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.576 0.703 . . . . 0.0 112.714 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -119.97 153.15 54.96 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.099 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.92 140.07 44.9 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.175 1.917 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -61.74 136.54 58.03 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.25 -0.34 40.69 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.221 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -82.29 119.25 23.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.9 pt20 -91.97 144.17 25.73 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.804 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.28 123.9 51.28 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.122 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.99 121.44 45.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.527 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 53.2 m-85 -99.73 145.72 27.34 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.985 0.897 . . . . 0.0 113.334 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 50.1 tptt -85.2 128.19 34.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.322 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.8 m -82.58 107.3 15.12 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 165.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HG2' HD11 ' A' ' 32' ' ' ILE . 76.1 mtp180 -40.11 153.98 0.2 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.086 1.354 . . . . 0.0 113.598 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.69 114.02 2.22 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.698 1.598 . . . . 0.0 108.898 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 114.03 -8.38 23.27 Favored Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.06 168.76 13.54 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -162.22 -179.27 6.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.0 p -139.63 -77.64 0.33 Allowed 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 58' ' ' SER . 24.8 mt -176.32 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 126.612 1.965 . . . . 0.0 106.203 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.25 -108.11 1.18 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.85 158.04 44.27 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.0 t -86.54 109.89 19.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.39 121.24 54.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.194 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.2 mtp -111.18 166.36 11.14 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -152.86 146.71 14.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.0 t -81.23 126.61 31.74 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 2.5 tpm_? -148.73 128.76 13.55 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 34.7 mmtp 67.77 12.16 8.71 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.42 -9.4 57.42 Favored Glycine 0 CA--C 1.495 -1.184 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.848 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -115.56 163.62 15.51 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.15 116.21 28.94 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 m -115.2 167.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.471 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.37 110.06 20.9 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.53 -45.89 92.17 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -115.71 91.06 28.71 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.147 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.99 -15.67 26.01 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.815 2.343 . . . . 0.0 111.661 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.19 -20.49 48.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.097 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.723 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -161.86 156.09 22.13 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 59.3 m -92.99 118.69 31.45 Favored 'General case' 0 C--N 1.27 -2.877 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -113.05 -179.48 3.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.0 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.4 mmtp -59.45 147.54 36.16 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.82 0.7 . . . . 0.0 111.565 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 131' ' ' THR . 10.9 ptp180 -98.17 143.13 25.73 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 55.2 Cg_endo -71.81 148.21 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.518 2.145 . . . . 0.0 111.533 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.06 -19.37 15.2 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.677 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.92 -163.55 52.48 Favored Glycine 0 CA--C 1.467 -2.958 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.793 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -73.21 129.47 86.04 Favored Pre-proline 0 C--N 1.261 -3.263 0 CA-C-N 114.427 -0.887 . . . . 0.0 112.539 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 84.4 Cg_endo -84.85 -3.36 9.78 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 C-N-CA 123.054 2.503 . . . . 0.0 111.748 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 114.35 3.85 Favored Glycine 1 N--CA 1.395 -4.043 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -99.91 175.38 5.79 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.025 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.459 HG21 ' OH ' ' A' ' 112' ' ' TYR . 5.4 t -151.22 145.19 17.77 Favored Pre-proline 0 N--CA 1.416 -2.167 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.24 -23.75 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.039 1.826 . . . . 0.0 111.331 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -127.56 105.14 8.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.84 168.04 11.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -142.08 169.44 17.59 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.7 155.75 38.95 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 p -128.95 141.0 51.41 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -98.21 129.02 44.97 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.566 0.698 . . . . 0.0 110.664 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.552 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.1 t -114.92 130.28 56.88 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.94 -16.06 33.41 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.36 -176.78 48.0 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -121.97 18.45 10.91 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.683 0.754 . . . . 0.0 109.519 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG11 ' A' ' 108' ' ' VAL . 30.0 m -140.21 169.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 30.3 m-85 -93.28 89.19 6.29 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.535 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.5 pt-20 -133.31 158.12 43.76 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.921 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 77.4 t80 -48.76 115.24 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.417 1.087 . . . . 0.0 110.969 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.08 -21.74 10.06 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.753 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 103' ' ' VAL . 11.4 m -79.27 149.97 5.28 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.8 ttmp? -113.63 124.55 52.59 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.02 90.85 8.05 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.8 114.91 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.459 ' OH ' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -79.94 138.46 37.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.7 167.55 16.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 118' ' ' TYR . 12.3 t -146.79 173.82 12.04 Favored 'General case' 0 N--CA 1.396 -3.172 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.278 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.09 155.33 20.69 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.881 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -50.78 -41.16 56.7 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.066 0.946 . . . . 0.0 112.205 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.96 64.88 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HB2' ' SG ' ' A' ' 114' ' ' CYS . 34.8 m-85 -136.59 167.02 22.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 119.094 1.447 . . . . 0.0 111.159 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.52 -93.97 0.51 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 168.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.1 pp 175.74 158.01 0.23 Allowed 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.58 0.752 . . . . 0.0 111.499 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 96.1 mt -96.91 135.69 38.53 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 122.16 168.18 13.22 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -96.88 -28.99 13.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.4 mm -100.03 105.15 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.267 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -89.37 36.18 0.83 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.886 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 127' ' ' ARG . 23.0 p90 -165.21 174.1 10.61 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.184 0.516 . . . . 0.0 111.114 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.471 ' HD3' ' C ' ' A' ' 126' ' ' TYR . 1.4 mpp_? -139.46 132.36 29.3 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -113.01 147.81 36.39 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 118.437 0.562 . . . . 0.0 111.182 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 11.6 m -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.157 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -101.4 -166.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.499 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 28.7 p -59.5 -46.17 89.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 124.939 1.296 . . . . 0.0 112.728 -174.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.74 21.93 15.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 132.02 -155.5 21.49 Favored Glycine 0 C--N 1.288 -2.115 0 C-N-CA 119.394 -1.384 . . . . 0.0 113.624 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.6 m95 -81.49 146.15 30.36 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.225 0.536 . . . . 0.0 111.355 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.5 p -78.65 -25.21 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.884 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.79 -179.62 5.76 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -171.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -107.98 -155.59 0.56 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.689 0.796 . . . . 0.0 110.585 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.25 107.75 34.42 Favored Pre-proline 0 C--N 1.313 -0.984 0 O-C-N 122.039 -0.413 . . . . 0.0 110.344 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 22.7 Cg_endo -66.89 133.61 31.89 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.486 2.124 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.1 mm -86.83 123.9 40.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.648 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.91 105.97 1.44 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 29.8 mm-40 . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 124.597 1.159 . . . . 0.0 108.097 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.6 m -80.67 121.95 26.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.418 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.422 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.5 m-20 -97.59 33.56 2.02 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.843 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 10.8 pt-20 -155.6 148.78 24.64 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.908 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.2 mt -73.27 153.12 90.33 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 123.794 0.838 . . . . 0.0 109.56 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.8 Cg_endo -62.58 130.09 28.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.693 1.595 . . . . 0.0 109.39 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 2.9 Cg_exo -72.87 126.91 11.72 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.65 1.567 . . . . 0.0 112.542 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.91 136.08 57.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 168.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 HH21 ' CD ' ' A' ' 31' ' ' GLU . 12.9 mtm180 -111.03 163.16 14.13 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -171.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.25 -33.82 67.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.53 0.681 . . . . 0.0 112.357 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 56' ' ' TYR . 3.0 p -111.93 -0.33 15.83 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.663 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 58.8 mp0 -139.7 142.27 36.9 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 53' ' ' ARG . 34.7 mt -123.2 152.75 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -77.91 136.21 37.99 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.089 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 51' ' ' LYS . 2.6 p -120.68 105.9 11.21 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.618 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.62 -159.97 28.99 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -125.59 110.85 14.32 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HB3' HD22 ' A' ' 24' ' ' LEU . 73.8 m95 -110.72 112.27 24.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -116.12 -11.13 11.41 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.303 -171.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -128.99 152.94 48.05 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 118.749 -1.181 . . . . 0.0 112.437 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.587 ' NE2' ' HA ' ' A' ' 23' ' ' GLU . 54.6 tp60 -76.08 -23.69 55.0 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.4 p -116.36 122.77 45.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.512 0.672 . . . . 0.0 112.422 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.73 136.81 29.29 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.343 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 151.85 79.96 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.589 2.193 . . . . 0.0 112.043 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.3 tt0 -62.5 140.05 58.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.28 8.46 58.73 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.327 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.7 m -91.63 115.97 28.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.845 -0.178 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.2 pt20 -85.56 144.18 28.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.564 0.697 . . . . 0.0 111.197 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.12 117.37 31.03 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.354 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.81 121.62 41.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 68.5 m-85 -104.96 152.5 22.61 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB2' HG23 ' A' ' 34' ' ' THR . 65.1 tttm -109.89 136.3 49.41 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.569 -1.651 . . . . 0.0 107.144 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.6 m -78.49 17.64 0.65 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HG2' HD11 ' A' ' 32' ' ' ILE . 77.6 mtp180 65.24 159.42 0.13 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.458 0.647 . . . . 0.0 109.689 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.11 -8.01 18.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.568 1.512 . . . . 0.0 114.157 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.67 -5.42 20.62 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.047 -1.073 . . . . 0.0 115.223 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.8 m-85 -114.21 173.2 6.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.037 . . . . 0.0 109.182 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.0 179.13 6.68 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -165.12 -176.7 4.23 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -112.25 2.79 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.482 0.658 . . . . 0.0 109.749 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.75 155.13 14.85 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.94 135.76 57.48 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.018 0.481 . . . . 0.0 110.864 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.8 t -79.3 111.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -110.27 122.92 65.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.344 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.9 mtp -108.03 172.44 6.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.3 p -156.35 147.04 11.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.064 0.459 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.0 128.31 35.09 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.628 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.9 ttp180 -150.07 120.72 7.5 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm 57.97 21.62 7.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.68 -17.87 55.89 Favored Glycine 0 N--CA 1.415 -2.704 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.44 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 72' ' ' VAL . 16.3 pt-20 -103.83 154.86 19.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.128 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -93.18 121.46 34.56 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 70' ' ' GLU . 34.0 m -123.42 170.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.506 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.56 119.99 29.52 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 120.713 0.292 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.5 -50.14 66.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -112.23 87.99 9.91 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.183 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.83 -7.76 18.63 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.176 2.584 . . . . 0.0 111.289 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.82 -11.99 57.81 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -112.84 140.32 47.73 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.326 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.76 152.33 25.0 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 64.1 m -91.83 112.87 24.97 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.762 0.791 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -104.4 167.56 9.67 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.265 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.04 147.37 53.28 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -88.9 135.59 31.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.138 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.62 143.36 33.94 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.287 1.991 . . . . 0.0 110.074 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m -93.54 -20.4 20.28 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.612 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 -178.9 52.32 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -70.73 130.3 88.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 36.2 Cg_endo -69.86 91.34 0.52 Allowed 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.163 1.909 . . . . 0.0 111.227 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.38 -153.23 46.02 Favored Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.036 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.36 16.11 4.08 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -38.06 105.25 0.32 Allowed Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 126.133 1.773 . . . . 0.0 114.441 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -84.01 -24.22 2.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.369 2.046 . . . . 0.0 109.431 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -112.95 86.68 2.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.08 156.66 7.15 Favored Glycine 0 N--CA 1.411 -2.967 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 m -149.36 167.82 25.07 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.8 p90 -153.63 155.36 35.93 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.144 0.429 . . . . 0.0 110.725 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 p -121.13 143.82 48.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.16 136.16 40.48 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.8 t -114.39 2.08 14.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.454 0.645 . . . . 0.0 111.761 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.3 38.1 2.02 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.78 -172.58 19.49 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -120.72 20.43 11.71 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.839 0.828 . . . . 0.0 109.375 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.76 156.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.259 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.07 89.01 7.85 Favored 'General case' 0 C--N 1.244 -3.999 0 CA-C-N 112.638 -2.074 . . . . 0.0 109.949 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.05 150.41 41.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.033 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.501 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 55.1 t80 -47.96 112.78 0.61 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.431 0.634 . . . . 0.0 111.633 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.46 -19.99 7.96 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.754 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.31 141.82 13.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 117.468 0.634 . . . . 0.0 110.393 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.616 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.5 ttmp? -108.35 134.29 51.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.12 106.3 17.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 59.3 t -86.57 115.69 27.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 88' ' ' PRO . 18.8 m-85 -88.22 147.71 24.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.7 1.238 . . . . 0.0 112.998 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.9 m -155.55 177.64 11.15 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.5 t -140.38 -65.48 0.45 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 120.681 1.582 . . . . 0.0 110.051 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -146.29 -164.61 2.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.95 -43.83 17.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.479 0.656 . . . . 0.0 109.932 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.1 -11.63 61.13 Favored Glycine 0 C--N 1.305 -1.156 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.176 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 88.3 m-85 -123.11 129.33 51.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 65.7 mt-30 -122.85 -86.44 0.65 Allowed 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.616 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.6 pp -175.0 156.46 2.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 123.704 0.627 . . . . 0.0 112.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.37 156.18 16.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.68 179.02 24.69 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.523 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.01 -29.55 12.48 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.605 0.717 . . . . 0.0 109.508 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.427 HG13 ' ND2' ' A' ' 136' ' ' ASN . 47.4 mm -94.97 107.97 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.077 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -97.21 30.49 2.77 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.116 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.466 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 39.3 p90 -161.16 172.45 16.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.251 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -141.49 136.64 31.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 34.6 mt-10 -111.78 142.2 44.43 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.832 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 133' ' ' GLY . 11.8 m -74.52 89.51 2.18 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.492 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -99.4 -161.09 0.85 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.427 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 41.7 p -61.66 -36.01 79.59 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.49 -46.59 89.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.98 0.895 . . . . 0.0 110.242 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 129' ' ' CYS . . . 136.44 -54.82 0.72 Allowed Glycine 0 N--CA 1.407 -3.285 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -139.37 130.88 27.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 110.787 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 55.4 p -77.79 164.5 25.16 Favored 'General case' 0 C--O 1.264 1.836 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.427 ' ND2' HG13 ' A' ' 124' ' ' ILE . 17.8 m120 61.11 -149.67 0.41 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -140.39 -174.33 3.92 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.8 mt -79.53 115.79 55.94 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 118.42 0.554 . . . . 0.0 109.617 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.95 136.52 66.25 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.945 1.764 . . . . 0.0 110.842 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -77.27 113.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.775 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 20.0 t -57.48 114.92 2.44 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.706 0.629 . . . . 0.0 109.452 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 7.0 tp10 . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.574 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.9 m-20 . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -77.65 129.68 35.88 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.202 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.64 17.68 19.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.354 0.597 . . . . 0.0 110.252 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.27 153.51 39.85 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 37' ' ' TRP . 2.7 mm? -83.63 157.18 64.61 Favored Pre-proline 1 N--CA 1.349 -5.49 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.46 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 17.7 Cg_endo -58.09 144.62 94.64 Favored 'Trans proline' 0 C--O 1.258 1.481 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.97 152.9 78.84 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.345 2.03 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -88.22 156.58 19.14 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -117.59 152.41 35.2 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.813 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -77.96 -30.26 50.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.817 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -107.76 -12.37 15.23 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 9.2 mp0 -123.17 174.04 7.51 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.107 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.6 144.61 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 37' ' ' TRP . 43.5 mt -70.44 132.84 46.19 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 p -74.1 -56.81 4.47 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.672 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.63 169.36 54.93 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -99.75 125.08 45.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.768 ' HB3' HD12 ' A' ' 24' ' ' LEU . 11.0 m95 -116.17 95.04 4.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 m -108.68 11.42 26.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.358 0.599 . . . . 0.0 110.947 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.665 ' O ' HD21 ' A' ' 24' ' ' LEU . 10.2 t70 -103.97 -157.74 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.52 ' HA ' HD21 ' A' ' 24' ' ' LEU . 77.0 mt-30 -129.5 -47.38 1.18 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 33.0 p -96.7 123.81 40.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.077 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.95 138.0 32.22 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.526 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 23.7 Cg_endo -62.3 145.2 96.03 Favored 'Trans proline' 0 C--O 1.259 1.542 0 C-N-CA 123.07 2.513 . . . . 0.0 113.146 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -63.74 128.74 37.17 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.24 9.18 32.21 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -92.56 118.11 30.66 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.593 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 pt20 -88.36 143.21 27.15 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 121.341 0.591 . . . . 0.0 111.108 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.2 121.28 44.82 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -93.58 127.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.554 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 76.2 m-85 -104.28 131.86 51.16 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.751 0.786 . . . . 0.0 112.057 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -87.88 131.4 34.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.026 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.3 m -71.57 5.51 2.37 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 68.35 144.23 0.1 OUTLIER Pre-proline 0 N--CA 1.486 1.365 0 CA-C-O 121.624 0.726 . . . . 0.0 112.416 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.17 110.2 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.941 1.761 . . . . 0.0 109.864 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.27 -12.99 6.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.732 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 55.1 m-85 -125.53 175.21 7.69 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -166.85 179.23 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -163.92 175.75 10.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -83.28 -11.76 57.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.518 0.675 . . . . 0.0 109.788 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.2 145.27 10.03 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.75 148.83 41.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.003 0.402 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 76.6 t -71.52 114.26 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.23 125.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -114.26 168.24 10.01 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -151.56 144.11 16.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.4 t -74.1 118.38 16.99 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.197 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.579 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.1 ttp180 -150.08 122.56 8.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 41.7 mmtm 66.61 27.41 9.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.488 0.715 . . . . 0.0 112.382 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.59 -14.45 62.82 Favored Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.824 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.88 153.26 28.19 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.557 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.4 m95 -85.82 115.05 23.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 168.25 4.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.953 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.74 106.32 18.38 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.674 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.69 -42.74 89.27 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 7.7 t-20 -130.92 99.05 18.46 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.955 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.03 -9.07 19.26 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.224 2.616 . . . . 0.0 112.195 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -83.74 -18.15 38.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.872 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.2 mmp_? -88.43 138.77 31.14 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.392 1.092 . . . . 0.0 113.471 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -149.3 151.66 34.55 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 100.0 m -95.62 116.3 28.65 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.24 1.019 . . . . 0.0 109.702 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 160.95 14.13 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.407 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.1 mmtp -56.96 140.78 47.69 Favored 'General case' 0 CA--C 1.491 -1.313 0 O-C-N 123.721 0.638 . . . . 0.0 109.762 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.0 ptm180 -76.62 144.38 73.41 Favored Pre-proline 0 C--N 1.284 -2.259 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.17 150.28 42.23 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 121.513 1.476 . . . . 0.0 108.823 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.8 m -107.54 -9.76 15.85 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.941 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.79 -151.28 47.48 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.552 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -93.74 120.18 66.32 Favored Pre-proline 0 C--N 1.269 -2.931 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.67 71.63 1.46 Allowed 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 123.345 2.696 . . . . 0.0 111.609 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 65.16 -161.14 41.83 Favored Glycine 0 N--CA 1.42 -2.41 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 119.93 13.11 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.244 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 t -122.55 105.44 35.95 Favored Pre-proline 0 N--CA 1.426 -1.639 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.14 8.52 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.956 1.771 . . . . 0.0 113.124 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -140.25 17.16 2.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.663 0.268 . . . . 0.0 111.438 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . -136.15 165.48 24.91 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.701 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 113' ' ' THR . 3.0 m -130.97 164.78 24.6 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -158.77 161.46 36.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -124.72 143.14 50.92 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.54 135.47 39.34 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 109' ' ' LYS . 7.4 t -124.85 17.87 8.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.467 0.651 . . . . 0.0 111.45 -173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.438 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -140.46 23.72 2.67 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.216 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.32 -178.87 20.0 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -108.62 11.69 26.43 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.426 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.3 p -140.1 -172.5 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.845 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.399 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.28 79.91 1.65 Allowed 'General case' 1 C--N 1.237 -4.3 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.689 -175.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.1 pt-20 -130.68 155.27 46.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.69 116.49 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.977 0.798 . . . . 0.0 110.816 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.75 -19.84 6.53 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.343 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.438 HG12 ' C ' ' A' ' 100' ' ' GLY . 12.6 m -83.27 140.64 15.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.7 ttmt -103.79 125.3 50.14 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 172.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.53 93.95 9.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.26 119.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.427 ' OH ' ' HA3' ' A' ' 94' ' ' GLY . 30.4 t80 -99.09 124.34 44.03 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.337 0.589 . . . . 0.0 110.812 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 95' ' ' THR . 1.2 m -162.97 148.5 11.91 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 59.5 m -113.98 -64.34 1.32 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.168 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -140.4 -168.92 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.76 -46.5 24.98 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.21 64.75 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 142' ' ' GLU . 89.7 m-85 -108.32 112.66 25.22 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 117.01 0.405 . . . . 0.0 110.743 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -119.24 -84.0 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.8 pp 172.52 157.82 0.1 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.861 0.864 . . . . 0.0 111.335 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.67 145.33 26.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.31 178.32 15.27 Favored Glycine 0 C--N 1.282 -2.444 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.395 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.07 -34.65 9.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' TYR . 37.3 mm -98.47 102.37 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.476 ' HB2' HD21 ' A' ' 120' ' ' LEU . 4.2 p-10 -89.9 28.15 1.42 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.49 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 124' ' ' ILE . 37.5 p90 -162.13 172.78 15.28 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -151.35 120.72 6.84 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.009 0.818 . . . . 0.0 109.263 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.6 150.32 20.47 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.634 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.63 128.2 34.98 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.6 t70 -113.11 -164.48 0.92 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.466 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.0 p -70.1 -40.26 75.04 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.539 1.136 . . . . 0.0 113.356 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.15 -32.54 12.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 122.031 -0.418 . . . . 0.0 111.348 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.1 -162.26 26.68 Favored Glycine 0 C--N 1.288 -2.113 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.967 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -76.73 149.5 36.34 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.321 0.581 . . . . 0.0 110.138 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -87.42 136.74 32.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 70.54 -176.23 0.2 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.02 0.528 . . . . 0.0 111.186 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -113.85 -164.85 0.95 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.757 HD11 ' HA3' ' A' ' 89' ' ' GLY . 46.6 mt -92.29 109.81 40.42 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 118.537 0.608 . . . . 0.0 109.427 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 14.6 Cg_endo -59.42 132.83 48.45 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.975 1.783 . . . . 0.0 109.993 175.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.6 mp -74.64 110.23 8.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.193 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 53.1 t -56.48 121.97 10.87 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.188 0.93 . . . . 0.0 110.244 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 13.5 tp10 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.439 -0.997 0 CA-C-O 121.729 0.776 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.7 m -83.45 127.96 34.12 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.94 20.58 17.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.827 0.822 . . . . 0.0 109.561 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.3 155.25 42.51 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.067 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 37' ' ' TRP . 34.2 mt -78.38 157.24 78.01 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 123.352 0.661 . . . . 0.0 111.514 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.0 Cg_endo -64.85 127.48 18.73 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.6 2.2 . . . . 0.0 110.771 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.6 Cg_exo -73.02 122.3 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.903 1.735 . . . . 0.0 110.299 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.39 158.43 35.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.617 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 15.0 mtp180 -113.74 167.52 10.55 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -69.46 -38.61 77.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.6 p -106.58 -0.01 24.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 46.1 mp0 -135.39 135.54 40.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.743 0.782 . . . . 0.0 111.979 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mt -125.2 143.31 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -64.09 149.68 47.11 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.556 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.8 p -105.5 111.07 23.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -171.77 16.96 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.964 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 t -104.2 136.58 43.54 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.569 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 76.7 m95 -139.82 106.01 5.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 m -135.25 16.15 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.593 0.711 . . . . 0.0 109.234 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.5 -167.3 1.42 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.725 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.3 -65.19 0.78 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.015 0.436 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -86.75 119.66 27.22 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -123.64 136.63 27.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.829 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.67 144.97 85.89 Favored 'Trans proline' 0 C--O 1.258 1.495 0 C-N-CA 122.534 2.156 . . . . 0.0 110.845 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.1 tt0 -61.21 137.68 58.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.22 51.9 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.463 ' C ' HG23 ' A' ' 65' ' ' VAL . 66.9 m -88.6 114.78 25.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.718 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 23.3 pt20 -92.83 139.12 30.88 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.101 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.46 121.63 45.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.18 130.21 43.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 72.9 m-85 -114.49 149.78 35.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 111.651 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -101.52 147.73 26.04 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.5 m -85.97 15.7 4.77 Favored 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 123.577 0.751 . . . . 0.0 112.589 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 58.9 mtp180 69.83 158.61 0.16 Allowed Pre-proline 0 C--O 1.248 1.006 0 C-N-CA 123.225 0.61 . . . . 0.0 109.36 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.0 125.81 11.28 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 109.223 -1.106 . . . . 0.0 109.223 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 110.24 -11.92 31.24 Favored Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.031 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 84.3 m-85 -117.28 168.53 10.24 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.765 -0.844 . . . . 0.0 109.813 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.93 -176.95 5.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 p -154.07 156.75 37.88 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.81 -4.1 58.39 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.198 0.999 . . . . 0.0 110.457 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.45 -119.96 1.73 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -159.96 148.29 17.12 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.29 97.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.983 0.897 . . . . 0.0 109.161 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.93 121.84 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.726 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.4 mtp -107.58 172.53 6.78 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 46' ' ' THR . 11.4 p -159.13 145.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.379 0.609 . . . . 0.0 111.003 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.6 t -70.78 119.3 14.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.581 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 30.7 tpt180 -150.05 113.68 5.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.3 mmtm 67.26 31.7 6.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.112 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.29 -16.39 52.84 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.474 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.27 152.0 25.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.061 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -90.06 114.35 26.22 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.33 171.53 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.579 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.08 124.09 35.91 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.47 -47.75 77.82 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -111.53 91.84 15.27 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.155 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.51 -23.79 16.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.631 2.221 . . . . 0.0 112.606 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.09 -22.16 49.41 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.041 0.924 . . . . 0.0 110.373 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.77 137.79 32.08 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.194 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.13 162.33 41.06 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -89.77 131.48 35.7 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.754 0.788 . . . . 0.0 111.413 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.04 165.56 20.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.881 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.3 mttt -58.45 146.93 33.42 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.4 ptm180 -82.9 154.85 67.91 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 72.5 Cg_endo -83.09 164.66 15.19 Favored 'Trans proline' 0 N--CA 1.432 -2.14 0 C-N-CA 121.314 1.343 . . . . 0.0 109.6 173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.0 -3.95 13.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.448 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.89 -116.02 4.7 Favored Glycine 0 CA--C 1.459 -3.454 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -137.33 144.17 44.43 Favored Pre-proline 0 C--N 1.265 -3.083 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.33 45.27 1.88 Allowed 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.704 2.269 . . . . 0.0 109.477 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.88 -147.71 33.94 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -170.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -161.85 122.02 2.56 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.0 t -107.28 120.23 48.4 Favored Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.273 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 4.9 Cg_exo -78.91 -7.86 15.5 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.615 2.21 . . . . 0.0 112.785 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -129.43 12.49 5.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.55 160.41 24.47 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -128.13 168.03 15.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.9 p90 -154.35 163.03 40.8 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -131.51 141.73 49.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.4 mt -98.29 124.41 42.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.9 t -109.76 -18.91 13.33 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.79 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.404 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -108.72 30.21 9.01 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 119.582 -1.294 . . . . 0.0 111.091 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.58 -173.3 30.94 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -127.44 18.42 6.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.33 0.565 . . . . 0.0 110.554 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.517 ' O ' HG11 ' A' ' 108' ' ' VAL . 20.9 m -146.95 178.61 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 66.8 m-85 -91.12 90.61 7.9 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.62 156.76 46.33 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.837 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 71.8 t80 -53.8 105.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.965 0.791 . . . . 0.0 111.36 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.39 -11.96 6.04 Favored Glycine 0 N--CA 1.418 -2.556 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.787 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 103' ' ' VAL . 19.1 m -82.95 141.34 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.015 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HB3' HG22 ' A' ' 99' ' ' THR . 37.0 ttmt -106.6 123.7 48.5 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 169.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 99.3 11.48 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 46.7 t -79.69 110.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -89.19 132.14 34.99 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 123.926 0.891 . . . . 0.0 108.77 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.1 m -155.12 156.53 35.96 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.28 -69.88 0.83 Allowed 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.167 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.64 -169.51 3.4 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.98 -50.65 11.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.722 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.45 73.9 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.636 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.73 130.06 23.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.43 0.633 . . . . 0.0 110.165 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -109.47 -76.79 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.7 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp 174.1 162.68 0.19 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.253 1.021 . . . . 0.0 110.282 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -97.46 143.81 27.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.13 159.37 12.94 Favored Glycine 0 C--N 1.289 -2.032 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.4 -27.48 22.73 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.557 0.694 . . . . 0.0 110.716 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.0 mm -95.93 103.15 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.022 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -92.87 33.56 1.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.072 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.83 174.07 15.84 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.262 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -134.26 127.44 31.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 18.3 mt-10 -111.33 143.18 42.53 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 118.654 0.661 . . . . 0.0 111.312 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 36.5 m -81.68 117.18 21.82 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.242 172.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.3 t70 -108.92 -165.38 1.02 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 61.2 p -67.31 -41.87 84.64 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.707 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.76 -30.66 20.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 -139.25 5.77 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.382 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 78.1 m95 -82.83 128.96 34.9 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.125 0.488 . . . . 0.0 110.473 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 p -63.36 -29.47 70.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.821 1.248 . . . . 0.0 113.427 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.37 170.08 14.09 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -105.54 174.32 5.93 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.99 110.47 4.65 Favored Pre-proline 0 C--N 1.319 -0.749 0 O-C-N 123.687 0.617 . . . . 0.0 111.723 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 130.49 29.61 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.152 1.901 . . . . 0.0 110.708 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.61 109.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.4 t -83.7 112.74 20.33 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.212 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB2' HD23 ' A' ' 121' ' ' LEU . 5.9 mm-40 . . . . . 0 CA--C 1.491 -1.322 0 C-N-CA 124.139 0.976 . . . . 0.0 108.902 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 N--CA 1.433 -1.305 0 CA-C-O 121.757 0.789 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.2 m -85.83 127.62 34.61 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.831 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.95 19.03 12.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.581 0.705 . . . . 0.0 110.528 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.14 157.13 43.14 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 39' ' ' ASP . 2.2 mm? -89.62 158.67 45.11 Favored Pre-proline 1 N--CA 1.342 -5.872 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.262 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.9 Cg_endo -58.81 138.38 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.028 2.485 . . . . 0.0 110.355 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 149.41 84.21 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.156 1.904 . . . . 0.0 112.577 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -89.61 143.45 26.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.82 168.3 10.02 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.436 0.636 . . . . 0.0 111.912 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -79.04 -33.95 44.27 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.805 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 p -98.28 -31.74 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.0 mp0 -114.83 146.22 41.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.73 0.3 . . . . 0.0 111.444 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.2 mt -120.35 146.19 25.58 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 37' ' ' TRP . 24.1 mt -75.84 130.22 38.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.1 p -99.02 127.67 44.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.92 -143.21 16.12 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 t -149.66 118.97 6.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.575 ' CD1' HD13 ' A' ' 33' ' ' LEU . 5.4 m95 -129.48 74.4 1.58 Allowed 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.856 0.836 . . . . 0.0 109.484 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 24.36 12.06 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.587 ' O ' HD21 ' A' ' 24' ' ' LEU . 24.3 m-20 -95.7 -150.76 0.33 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.943 -1.935 . . . . 0.0 111.863 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -132.41 -79.55 0.5 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 18.6 p -107.09 121.2 44.01 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -116.64 138.03 24.18 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.927 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.53 151.48 84.72 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.757 2.305 . . . . 0.0 111.938 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.4 tt0 -63.62 136.33 57.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.702 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.17 4.31 53.81 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -85.63 118.87 25.41 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 pt20 -91.99 142.04 27.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.828 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.88 131.79 56.15 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.022 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.4 mt -99.89 134.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.631 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 51.6 m-85 -113.21 156.5 23.15 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.685 0.755 . . . . 0.0 112.966 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 64.9 tttp -101.39 137.57 39.55 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.819 1.647 . . . . 0.0 106.708 173.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.781 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 76.7 m -81.33 15.0 2.15 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 67.8 mtp180 62.43 156.9 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 121.721 0.772 . . . . 0.0 111.545 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.74 107.08 2.25 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 120.744 0.963 . . . . 0.0 109.605 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 128.64 -24.49 4.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.671 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 60.2 m-85 -105.0 155.32 19.07 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.18 168.7 18.9 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 123.872 0.869 . . . . 0.0 109.725 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 58.6 p -164.69 154.4 13.61 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.126 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.87 -32.43 31.06 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.44 136.29 8.72 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.91 151.71 45.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.158 0.479 . . . . 0.0 111.134 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.05 108.84 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.636 0.732 . . . . 0.0 109.761 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.49 122.19 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.097 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 84.7 mtp -104.39 170.25 8.01 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.3 p -152.07 143.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.216 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.03 121.5 22.08 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 124.09 0.956 . . . . 0.0 108.804 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 57.2 ttp180 -146.51 121.94 10.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.5 mmtm 63.71 20.35 12.18 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.798 0.839 . . . . 0.0 112.92 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.33 72.57 Favored Glycine 0 N--CA 1.423 -2.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.45 150.87 38.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.242 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.44 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.7 m95 -87.38 113.44 23.09 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.66 0.743 . . . . 0.0 109.525 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.59 171.81 3.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.227 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.16 118.01 27.44 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 64' ' ' MET . 5.1 tp -58.88 -46.05 88.73 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -120.31 96.56 49.13 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.928 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.99 -10.77 21.38 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 112.743 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.67 -29.99 36.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.952 0.882 . . . . 0.0 109.931 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 37.3 mmt180 -91.32 132.82 35.91 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.676 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -154.35 150.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 62.5 m -86.61 114.76 23.59 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.917 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -112.89 169.82 8.64 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.477 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 105' ' ' GLU . 32.6 mmtp -55.08 119.41 5.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.443 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 11.1 ptm180 -55.64 145.51 50.12 Favored Pre-proline 0 C--N 1.295 -1.779 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.261 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.45 158.84 32.69 Favored 'Trans proline' 0 C--O 1.256 1.396 0 C-N-CA 122.272 1.982 . . . . 0.0 109.161 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.45 -16.72 5.78 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.246 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.11 -154.53 46.53 Favored Glycine 0 CA--C 1.464 -3.149 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.809 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.97 134.86 31.01 Favored Pre-proline 0 C--N 1.252 -3.642 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.256 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.7 33.57 0.49 Allowed 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.841 2.361 . . . . 0.0 110.772 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.46 157.9 33.97 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -127.58 145.34 50.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.8 t -120.66 148.9 49.21 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.074 -173.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 11.9 Cg_exo -72.4 -25.65 18.01 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.316 2.011 . . . . 0.0 111.087 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -146.56 110.05 4.83 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.361 0.6 . . . . 0.0 110.489 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . 152.75 173.09 21.81 Favored Glycine 0 N--CA 1.425 -2.065 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.317 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 m -146.73 163.45 35.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -144.52 165.52 27.75 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.4 p -135.26 148.08 49.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.23 128.28 54.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.548 HG22 ' HB3' ' A' ' 109' ' ' LYS . 12.5 t -121.44 6.82 10.09 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.435 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -124.06 23.06 6.62 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.72 -178.0 29.27 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.13 11.48 15.25 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.54 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 p -140.36 -168.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.407 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -105.64 83.4 1.93 Allowed 'General case' 0 C--N 1.245 -3.944 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.961 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 10.4 pt-20 -138.78 162.56 34.42 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.7 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -51.98 120.65 5.58 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.095 0.872 . . . . 0.0 110.205 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.74 -12.36 22.87 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.193 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 103' ' ' VAL . 20.3 m -85.14 140.26 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.496 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -101.31 116.98 34.05 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 127' ' ' ARG . . . -96.07 93.62 7.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -74.78 128.05 36.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.0 t80 -111.09 145.19 38.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.344 0.593 . . . . 0.0 111.185 -172.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 m -152.62 159.84 43.21 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 60.9 m -122.06 -68.39 0.9 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.488 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 15.7 m120 -133.91 -162.42 1.24 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.24 -55.01 4.11 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.34 0.591 . . . . 0.0 109.805 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.18 -23.38 59.14 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.969 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 86.8 m-85 -104.97 112.15 25.19 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 92.2 mt-30 -112.43 -87.83 0.54 Allowed 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.7 pp -178.87 145.2 0.28 Allowed 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 73.0 mt -87.51 139.76 30.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.62 170.05 12.98 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.67 -28.15 12.65 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.363 0.601 . . . . 0.0 110.335 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.84 99.36 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -87.07 30.71 0.74 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.846 0.858 . . . . 0.0 110.855 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.478 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 49.5 p90 -163.41 -177.83 5.53 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.516 -0.765 . . . . 0.0 108.96 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HD3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -148.76 131.51 16.0 Favored 'General case' 0 N--CA 1.403 -2.819 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 172.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 109' ' ' LYS . 31.9 mt-10 -107.67 145.86 32.81 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.86 112.41 22.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -94.6 -161.94 0.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.418 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.4 p -67.6 -44.94 76.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.902 0.881 . . . . 0.0 109.945 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.38 -37.03 68.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.879 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.76 -152.13 24.21 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.64 126.79 29.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.4 p -59.87 -34.85 73.68 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.807 0.843 . . . . 0.0 112.111 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -132.73 169.46 16.66 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 5.8 p-10 -102.37 -99.84 0.28 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.101 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.476 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 26.9 mt -127.24 99.43 28.01 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.3 Cg_endo -53.56 140.28 65.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.01 1.807 . . . . 0.0 110.018 172.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.36 118.59 31.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 -171.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 64.6 m -59.13 94.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.217 1.007 . . . . 0.0 112.47 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.4 mm-40 . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 32.5 m-20 . . . . . 0 C--O 1.242 0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.0 m -74.64 132.72 41.96 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.844 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -102.4 36.44 2.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.653 0.74 . . . . 0.0 109.395 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.18 158.06 32.0 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.213 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.2 mt -79.44 152.97 76.23 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 123.95 0.781 . . . . 0.0 110.31 175.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.27 131.7 42.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.542 2.161 . . . . 0.0 110.976 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.01 132.53 24.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.49 2.127 . . . . 0.0 113.23 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 mtm-85 -76.73 129.56 36.49 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -104.2 178.13 4.65 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.007 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -56.14 -44.62 79.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.862 0.465 . . . . 0.0 111.782 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 p -125.1 17.84 8.43 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.805 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 49.8 mp0 -135.35 134.4 39.76 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.312 0.577 . . . . 0.0 111.882 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -128.35 165.73 27.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.434 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -90.5 142.83 27.34 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -98.21 128.09 44.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.3 -165.35 12.46 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.2 m -130.98 124.53 31.17 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.607 ' HB3' HD22 ' A' ' 24' ' ' LEU . 76.0 m95 -122.4 121.48 36.76 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 m -132.74 3.4 3.8 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.966 0.413 . . . . 0.0 110.767 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 21.0 m-20 -95.63 -169.81 2.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.88 -59.57 1.34 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.241 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.3 p -93.82 124.4 37.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 57.6 m-85 -125.59 139.17 33.39 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.496 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.606 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 24.4 Cg_endo -61.44 142.56 95.78 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 123.178 2.586 . . . . 0.0 113.038 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.6 tt0 -61.7 132.97 54.94 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.12 43.37 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.403 ' C ' HG23 ' A' ' 65' ' ' VAL . 85.1 m -89.66 115.41 27.01 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.9 pt20 -89.16 144.17 26.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.605 0.717 . . . . 0.0 111.437 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 128.62 55.82 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.43 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.34 128.54 49.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 70.1 m-85 -103.43 158.01 16.64 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 60.2 tttm -106.06 142.4 35.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.981 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 86.6 m -95.93 38.44 1.18 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 29.9 mmt180 62.22 163.23 0.11 Allowed Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.696 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.94 100.45 0.37 Allowed 'Trans proline' 0 N--CA 1.418 -2.935 0 C-N-CA 121.273 1.315 . . . . 0.0 109.228 167.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.87 -3.17 3.78 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.494 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 45.6 m-85 -130.47 -177.73 4.46 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -153.02 -176.35 5.73 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.591 0.756 . . . . 0.0 109.341 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.2 p -162.04 165.09 27.77 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.21 -13.87 27.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.366 0.603 . . . . 0.0 109.76 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.94 161.13 34.05 Favored Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -75.05 143.06 43.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 117.694 0.747 . . . . 0.0 111.418 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 50.0 t -77.45 109.15 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 174.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.91 123.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.109 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 91.0 mtp -112.06 168.81 9.31 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.8 p -152.39 145.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.328 0.585 . . . . 0.0 110.383 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.9 t -71.71 120.38 17.22 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.542 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 44.2 ttm-85 -152.21 120.38 6.28 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.59 28.13 13.27 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.218 1.007 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.89 -15.95 61.52 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.723 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -110.64 158.61 18.41 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.181 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.22 115.89 28.49 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.94 151.37 32.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.399 0.619 . . . . 0.0 111.713 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.98 109.59 1.32 Allowed 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.457 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.79 -52.21 64.07 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -110.79 92.73 15.18 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -20.96 22.75 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 122.394 2.063 . . . . 0.0 111.176 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 mt -74.86 -25.58 59.07 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.403 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -89.49 128.37 35.97 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.331 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.76 158.08 40.41 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 65.0 m -88.49 139.99 29.92 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.765 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 48.1 mt-30 -132.69 168.46 18.28 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.225 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.72 160.22 33.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.838 0.828 . . . . 0.0 113.15 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -110.82 137.61 20.86 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.44 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 9.6 Cg_endo -71.02 148.82 57.77 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.392 2.061 . . . . 0.0 112.698 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.13 -55.28 3.49 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.976 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.18 -156.08 20.64 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.003 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -87.82 111.84 44.94 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 123.635 0.774 . . . . 0.0 109.201 -175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 81.1 Cg_endo -76.72 9.95 2.45 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.916 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 145.75 135.9 2.87 Favored Glycine 0 N--CA 1.397 -3.922 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -106.26 107.74 18.9 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 t -125.09 124.6 25.35 Favored Pre-proline 0 N--CA 1.411 -2.384 0 CA-C-O 121.564 0.697 . . . . 0.0 112.155 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -89.84 2.61 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 122.269 1.979 . . . . 0.0 112.335 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.9 4.86 2.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.81 13.79 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 p -142.39 163.36 33.06 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.295 0.638 . . . . 0.0 109.934 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.4 p90 -130.31 154.36 47.71 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.189 0.306 . . . . 0.0 110.404 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 74.7 p -114.21 178.3 4.33 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.86 142.25 31.75 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.8 t -127.88 -45.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.998 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.25 51.01 3.38 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.113 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 140.39 -176.84 21.14 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.42 10.61 10.55 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 121.16 0.505 . . . . 0.0 110.003 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.533 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.8 p -147.06 -164.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.432 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.361 -173.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 28.2 m-85 -100.23 82.49 2.52 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.8 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.47 154.98 50.61 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.466 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.18 112.89 0.8 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.137 0.898 . . . . 0.0 109.919 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.3 -27.61 4.2 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.908 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 103' ' ' VAL . 18.2 m -75.73 164.34 3.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.071 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -131.7 115.37 15.93 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.4 101.94 13.89 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.5 m -78.82 162.24 4.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 118.621 -1.231 . . . . 0.0 108.612 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.447 ' HE2' ' SG ' ' A' ' 141' ' ' CYS . 61.2 t80 -129.43 134.61 47.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.394 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -150.83 154.99 38.31 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 78.6 m -130.68 -41.08 1.19 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -153.55 -176.63 5.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -106.75 -40.31 5.55 Favored 'General case' 0 C--N 1.278 -2.533 0 O-C-N 123.633 0.583 . . . . 0.0 111.028 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.62 -37.1 94.19 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -122.98 125.59 45.55 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 48.2 mt-30 -99.15 -89.46 0.32 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 125' ' ' ASN . 2.0 pp -170.43 161.12 7.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.71 -61.28 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.53 158.14 13.59 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.293 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.43 -26.09 33.05 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.936 0.875 . . . . 0.0 109.932 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.92 95.26 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' HD11 ' A' ' 120' ' ' LEU . 4.0 p-10 -85.55 29.63 0.68 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 21.7 p90 -162.12 174.33 13.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -173.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 96' ' ' PHE . 2.2 mpp_? -134.14 122.37 22.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 26.5 mt-10 -103.62 150.58 23.84 Favored 'General case' 0 C--N 1.284 -2.271 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.744 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.3 m -81.2 121.73 26.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.748 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 131' ' ' THR . 11.8 t70 -96.55 -159.45 0.73 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 30.3 p -58.35 -62.15 2.05 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 124.183 0.993 . . . . 0.0 112.709 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.21 -24.27 15.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.57 -149.85 5.7 Favored Glycine 0 CA--C 1.486 -1.748 0 C-N-CA 118.603 -1.761 . . . . 0.0 113.489 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 73.2 m95 -93.52 147.69 22.75 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.191 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.8 p -77.69 -24.59 49.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.791 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -139.3 172.99 12.01 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.756 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 21.0 t70 -108.69 -158.25 0.64 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.5 mt -85.53 117.21 68.3 Favored Pre-proline 0 C--N 1.289 -2.065 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.75 143.78 46.99 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.222 1.948 . . . . 0.0 109.56 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 142' ' ' GLU . 2.3 mp -94.73 124.65 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 122.118 -0.363 . . . . 0.0 111.667 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 112' ' ' TYR . 64.4 m -77.8 111.49 13.67 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.161 0.984 . . . . 0.0 111.142 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 140' ' ' ILE . 6.9 mm-40 . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.8 m-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.7 m -76.46 152.78 36.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -119.01 16.88 13.36 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.741 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.94 160.61 28.02 Favored 'General case' 0 CA--C 1.462 -2.434 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -85.2 156.33 60.08 Favored Pre-proline 1 N--CA 1.355 -5.191 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.042 -177.492 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 6.5 Cg_endo -55.45 135.12 67.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.443 2.762 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.66 117.67 4.43 Favored 'Trans proline' 0 CA--C 1.519 -0.231 0 C-N-CA 123.023 2.482 . . . . 0.0 112.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.59 133.24 45.6 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 94.0 mtt180 -108.1 -179.74 3.98 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.513 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.595 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 59.7 t30 -89.38 -50.42 6.13 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.157 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 53' ' ' ARG . 7.7 p -88.15 -9.16 54.05 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.4 mp0 -124.6 135.52 53.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.614 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mt -117.1 135.98 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 37' ' ' TRP . 17.7 mt -67.97 117.66 10.12 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.427 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' LYS . 9.7 p -96.77 100.25 11.8 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.91 -159.28 28.39 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -132.71 113.53 13.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.61 ' CD1' HD13 ' A' ' 33' ' ' LEU . 10.1 m95 -125.18 84.67 2.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 m -118.66 5.94 11.6 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.207 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.598 ' O ' HD21 ' A' ' 24' ' ' LEU . 18.5 m-20 -85.25 -160.06 0.48 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.207 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -125.15 -69.26 0.8 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 23.3 p -93.38 133.69 36.37 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -128.48 141.29 40.97 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 35.1 Cg_endo -65.19 150.17 87.9 Favored 'Trans proline' 0 C--O 1.255 1.361 0 C-N-CA 122.718 2.279 . . . . 0.0 112.712 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -68.87 133.62 48.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 -6.11 38.81 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.516 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -80.96 118.52 22.52 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.4 pt20 -88.23 152.88 21.66 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.937 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.44 131.95 54.12 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -102.98 126.12 57.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 63.4 m-85 -108.87 143.65 37.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.217 0.532 . . . . 0.0 112.202 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' HG23 ' A' ' 34' ' ' THR . 63.4 tttm -93.66 142.68 27.08 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 85.4 m -90.19 40.34 1.0 Allowed 'General case' 0 C--N 1.279 -2.474 0 CA-C-O 120.521 0.2 . . . . 0.0 110.835 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 29' ' ' ASN . 22.0 mtp180 61.46 172.3 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 122.781 0.432 . . . . 0.0 110.689 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -76.12 -12.0 19.42 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 120.857 1.038 . . . . 0.0 112.225 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -104.18 -13.89 25.74 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 115.126 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 62.0 m-85 -114.23 176.07 5.2 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.137 -1.213 . . . . 0.0 109.806 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -152.55 -173.49 4.58 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -168.62 -175.01 2.32 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.79 -6.64 57.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.407 1.099 . . . . 0.0 109.062 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.31 -147.2 4.84 Favored Glycine 0 N--CA 1.403 -3.507 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -120.97 150.84 40.48 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 75.3 t -70.36 103.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.0 mm -101.0 119.53 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.927 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.1 169.84 8.47 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -155.23 147.51 12.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.609 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.35 123.49 24.72 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttt180 -152.19 124.22 8.06 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 62.33 26.17 15.64 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.783 0.833 . . . . 0.0 112.677 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.21 -9.9 74.17 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.761 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.87 162.43 20.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.471 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -92.63 112.0 23.8 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.29 167.62 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.396 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.553 0.216 . . . . 0.0 110.59 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -50.23 73.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.472 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 86.0 m-20 -111.93 93.82 22.48 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.03 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -73.56 -11.72 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.438 2.092 . . . . 0.0 111.693 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.12 -11.99 58.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.503 0.668 . . . . 0.0 110.13 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 25.8 mmt180 -89.32 126.95 35.73 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.392 0.615 . . . . 0.0 110.13 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -146.37 144.68 29.91 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.0 m -93.41 117.43 30.07 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-O 121.239 0.543 . . . . 0.0 109.892 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -117.34 167.48 11.21 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.128 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.6 mttt -63.6 145.76 55.06 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.787 0.327 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.6 ptp180 -85.46 138.05 36.3 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 40.6 Cg_endo -68.24 154.75 71.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.791 2.327 . . . . 0.0 111.348 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.05 -2.29 18.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 -112.57 3.68 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.168 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -127.13 119.58 22.2 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 95.6 Cg_endo -79.24 34.54 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.877 3.052 . . . . 0.0 114.058 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.74 137.78 6.71 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.614 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.74 128.06 34.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.298 0.57 . . . . 0.0 109.729 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -139.57 107.36 7.11 Favored Pre-proline 0 N--CA 1.409 -2.518 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.25 12.0 2.95 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.448 2.098 . . . . 0.0 110.477 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 -54.82 2.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.764 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.91 -166.1 14.58 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.116 -1.04 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 m -132.27 170.93 14.35 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 54.3 p90 -142.64 153.41 43.42 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.642 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 72.2 p -107.66 -178.65 3.69 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.431 HD22 HG21 ' A' ' 108' ' ' VAL . 96.2 mt -145.38 157.42 44.04 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 7.6 t -151.52 146.92 26.24 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.09 27.26 66.71 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.857 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.73 -44.59 0.21 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.181 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.03 13.24 9.08 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.42 171.75 14.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.4 m-85 -85.73 93.02 8.76 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.664 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -146.13 151.42 37.64 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.274 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 76.8 t80 -52.41 106.55 0.16 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.014 0.926 . . . . 0.0 111.208 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 139.47 -27.86 2.59 Favored Glycine 0 N--CA 1.422 -2.264 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.817 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' THR . 23.2 m -80.92 154.79 4.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.303 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -118.12 118.88 33.08 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 171.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.19 96.66 9.75 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.0 OUTLIER -77.45 156.25 5.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.709 -178.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.581 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 46.6 t80 -114.78 139.19 49.92 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -141.44 164.59 29.82 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 7.2 t -146.66 -57.7 0.28 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.748 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.38 -174.18 4.14 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -83.55 -45.01 14.03 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 121.892 0.853 . . . . 0.0 108.833 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.98 -24.11 64.97 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.846 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -115.15 125.97 54.07 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 122.654 -0.321 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.614 ' HB3' HD13 ' A' ' 120' ' ' LEU . 84.1 mm-40 -113.96 -87.36 0.57 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -162.15 161.49 28.08 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.247 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 88.7 mt -92.72 131.62 37.63 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.86 179.46 16.42 Favored Glycine 0 C--N 1.269 -3.154 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.417 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -102.87 -9.78 19.61 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.915 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 126' ' ' TYR . 48.5 mm -122.66 121.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.059 0.457 . . . . 0.0 109.969 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -104.58 29.23 6.31 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.799 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.9 p90 -163.77 176.86 9.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.042 0.449 . . . . 0.0 111.39 -173.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -141.97 126.94 18.31 Favored 'General case' 0 C--O 1.199 -1.583 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -104.11 147.74 27.07 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 118.555 0.616 . . . . 0.0 111.671 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.5 m -84.83 103.07 13.58 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.843 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.24 -167.95 1.47 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.3 p -64.55 -44.15 91.68 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.066 1.346 . . . . 0.0 110.745 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.56 -38.02 77.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.966 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.14 -115.11 0.7 Allowed Glycine 0 CA--C 1.486 -1.721 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 91.9 m95 -95.95 129.68 43.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.0 p -67.67 -26.93 66.44 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.604 0.762 . . . . 0.0 112.584 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.4 ' CG ' HG21 ' A' ' 124' ' ' ILE . 16.7 m120 -137.91 169.26 18.09 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -101.88 -171.75 2.03 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 123.824 0.703 . . . . 0.0 109.556 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.6 mt -74.98 113.2 22.44 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.586 0.354 . . . . 0.0 110.655 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.581 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 9.7 Cg_endo -66.48 141.17 60.24 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.399 2.066 . . . . 0.0 110.771 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 49.0 mm -92.66 119.73 40.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.446 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.9 m -64.59 118.85 9.44 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.529 0.518 . . . . 0.0 109.8 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.486 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 11.7 mm-40 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.5 m -79.49 129.67 34.69 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.956 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -98.01 35.48 1.72 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.0 110.566 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -160.0 152.89 21.51 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.585 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -71.1 149.42 94.58 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 124.26 0.975 . . . . 0.0 108.969 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.33 131.54 45.77 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.541 2.161 . . . . 0.0 111.821 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 116.79 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.736 2.291 . . . . 0.0 112.311 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -61.49 127.14 30.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.29 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -81.36 153.64 26.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.831 -170.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -72.21 -24.87 61.47 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -128.35 7.45 5.89 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.3 mp0 -137.45 164.48 28.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.117 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.82 150.51 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.46 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -71.54 142.96 50.08 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.302 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.5 p -103.42 108.25 19.42 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.98 -164.71 25.51 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -138.93 98.72 3.6 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 48.8 m95 -92.82 144.21 25.51 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.15 31.06 0.34 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.24 161.27 36.68 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.681 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -93.85 -26.67 16.81 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.099 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -116.64 110.26 18.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.822 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -110.06 139.33 21.26 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.5 Cg_endo -60.62 146.24 97.44 Favored 'Trans proline' 0 C--O 1.254 1.299 0 C-N-CA 123.202 2.601 . . . . 0.0 112.971 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.4 tt0 -66.0 138.03 57.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.1 7.22 56.43 Favored Glycine 0 N--CA 1.427 -1.96 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.287 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.432 ' C ' HG23 ' A' ' 65' ' ' VAL . 98.5 m -88.16 112.03 22.27 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.9 pt20 -84.2 140.22 31.86 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.276 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.57 56.57 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.2 mt -98.98 131.09 46.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 80.5 m-85 -115.73 138.95 50.62 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.672 0.748 . . . . 0.0 112.851 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -91.49 133.48 35.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.9 m -72.55 10.86 0.73 Allowed 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 66.77 154.78 0.13 Allowed Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.19 0.596 . . . . 0.0 111.219 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.62 98.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.117 1.878 . . . . 0.0 112.134 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.593 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 130.92 -13.65 5.52 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.391 -0.909 . . . . 0.0 114.212 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 82.2 m-85 -115.19 168.5 9.89 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.373 -1.075 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -146.49 169.38 19.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 59' ' ' LEU . 31.0 t -165.79 -10.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 123.816 0.697 . . . . 0.0 110.023 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 58' ' ' SER . 20.2 tp 75.15 -52.56 0.66 Allowed 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.425 173.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.8 20.35 39.1 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 61.76 -167.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.16 0.984 . . . . 0.0 110.867 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.504 HG23 ' SG ' ' A' ' 80' ' ' CYS . 69.4 t -118.31 123.82 72.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 168.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -117.64 122.21 69.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 64' ' ' MET . 88.1 mtp -108.17 178.0 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -161.98 143.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.074 0.464 . . . . 0.0 110.403 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 t -70.38 125.19 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.919 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.5 ttt180 -152.69 119.18 5.62 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 120.634 0.254 . . . . 0.0 110.755 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 62.23 23.17 13.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.11 -20.0 51.89 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.458 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.74 154.11 20.94 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.05 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -88.22 116.47 26.44 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.06 172.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.57 124.69 35.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.93 -51.21 34.77 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -114.0 89.54 17.01 Favored Pre-proline 0 N--CA 1.426 -1.634 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.786 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.58 -25.41 15.01 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 122.378 2.052 . . . . 0.0 110.629 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.05 -25.69 64.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.138 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.3 mmp_? -85.28 138.38 32.35 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.3 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -161.6 144.57 12.22 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 62' ' ' VAL . 73.9 m -86.01 109.18 18.62 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-O 121.79 0.805 . . . . 0.0 111.776 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -106.39 167.14 10.04 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.174 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 98.8 mttt -62.24 135.26 57.4 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 123.29 0.369 . . . . 0.0 111.503 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.7 ptp180 -80.4 146.19 61.17 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.74 142.96 10.48 Favored 'Trans proline' 0 N--CA 1.424 -2.576 0 C-N-CA 121.675 1.583 . . . . 0.0 112.336 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.5 m -84.33 -30.77 25.24 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.93 104.44 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 O-C-N 124.237 0.961 . . . . 0.0 115.072 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.8 t60 64.02 111.33 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 123.858 0.863 . . . . 0.0 111.993 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 127' ' ' ARG . 88.0 Cg_endo -81.47 43.13 1.47 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 123.635 2.89 . . . . 0.0 112.506 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 85.64 -171.53 45.41 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -107.67 91.58 3.71 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 m -112.61 91.31 16.82 Favored Pre-proline 0 N--CA 1.421 -1.9 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.191 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.59 -29.73 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.567 2.178 . . . . 0.0 112.679 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -110.78 146.24 36.71 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.66 178.34 36.68 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -143.2 156.8 44.84 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.671 -0.311 . . . . 0.0 110.937 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 p90 -141.35 149.56 41.31 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.226 0.536 . . . . 0.0 110.358 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.8 p -116.12 147.36 41.42 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.576 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.61 135.99 51.44 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -115.74 -4.32 12.17 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -119.0 16.82 10.84 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.536 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.26 32.74 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -107.32 2.83 24.8 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 117.771 0.786 . . . . 0.0 110.059 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.9 p -142.17 -164.04 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.535 -170.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -98.98 74.0 1.98 Allowed 'General case' 0 C--N 1.245 -3.938 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.59 151.75 46.03 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.883 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 73.4 t80 -47.08 117.56 1.76 Allowed 'General case' 0 C--N 1.315 -0.904 0 O-C-N 124.574 1.171 . . . . 0.0 111.759 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.42 -14.06 20.75 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.872 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -82.42 141.57 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 99' ' ' THR . 35.2 ttmt -111.22 122.53 48.11 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 127' ' ' ARG . . . -94.86 95.54 8.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 55.5 t -79.36 122.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 77.0 t80 -98.48 144.57 27.68 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.824 0.821 . . . . 0.0 112.063 -172.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.94 156.81 46.0 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.9 t -131.04 -68.32 0.68 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.181 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.12 -173.34 3.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -85.2 -48.6 8.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.425 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.21 -23.8 60.49 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.154 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -116.9 116.95 28.41 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 15.5 mm-40 -109.0 -80.98 0.57 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.1 pp -170.59 137.0 1.31 Allowed 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.96 -47.16 69.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.758 1.223 . . . . 0.0 112.035 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.04 174.98 48.61 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.132 -0.486 . . . . 0.0 113.743 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.62 -30.02 23.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.849 0.833 . . . . 0.0 110.146 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.18 98.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.536 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.98 20.4 2.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.147 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -154.48 -177.63 6.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.493 ' NH1' HG12 ' A' ' 138' ' ' ILE . 8.2 ptp180 -154.13 128.22 8.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 174.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 21.4 mt-10 -103.75 143.17 33.15 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 122.151 -0.343 . . . . 0.0 111.347 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -88.44 104.42 16.77 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.1 t70 -98.04 -156.55 0.55 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.471 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.0 p -70.49 -53.25 17.03 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.088 0.955 . . . . 0.0 112.064 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.82 -25.63 27.99 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.184 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.81 -156.36 28.27 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.168 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.6 m95 -78.51 142.27 37.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.813 0.445 . . . . 0.0 110.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -90.04 131.8 35.73 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 72.16 -175.46 0.17 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.773 0.829 . . . . 0.0 111.652 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -123.54 168.47 12.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.545 HD11 ' HA3' ' A' ' 89' ' ' GLY . 21.4 mt -57.04 116.11 12.45 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.411 1.085 . . . . 0.0 110.032 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 18.2 Cg_endo -64.69 138.52 59.09 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.274 1.983 . . . . 0.0 111.777 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 1.9 mp -87.06 129.13 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 0.0 110.091 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 12.1 m -63.13 113.48 3.17 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 123.782 0.833 . . . . 0.0 111.759 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.8 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 41' ' ' THR . 72.8 m -70.61 137.64 50.15 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.683 0.615 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.451 ' HA ' HG22 ' A' ' 41' ' ' THR . 89.4 m-20 -107.04 19.1 20.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.703 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.61 161.54 41.97 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.33 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 mt -78.2 150.17 77.03 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 123.401 0.68 . . . . 0.0 109.245 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.33 139.77 84.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.84 1.693 . . . . 0.0 110.022 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.55 147.02 50.85 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.036 1.824 . . . . 0.0 112.583 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -91.45 146.18 24.02 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -116.93 171.75 7.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 10.8 t30 -88.56 -39.09 14.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.984 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 p -93.57 -12.51 29.37 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 3.4 mp0 -127.48 138.29 52.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.956 0.408 . . . . 0.0 110.719 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 12.8 mt -114.74 144.19 22.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -78.72 125.27 29.14 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.7 p -86.99 -32.07 20.25 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.26 165.85 54.11 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.424 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 m -97.87 106.05 18.29 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -109.37 136.66 48.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -148.04 -20.31 0.35 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.0 152.87 18.3 Favored 'General case' 0 C--O 1.201 -1.487 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.568 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ASN . 25.5 p -120.71 139.79 52.55 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.903 -0.498 . . . . 0.0 111.74 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.74 140.91 33.33 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 122.257 0.223 . . . . 0.0 110.952 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.2 Cg_endo -60.3 145.63 98.2 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.412 2.741 . . . . 0.0 112.045 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 67' ' ' ARG . 22.6 tt0 -68.98 144.13 54.21 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.21 0.09 54.27 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -86.68 111.21 20.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.7 pt20 -86.4 147.89 25.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.26 120.79 37.12 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 HD12 ' A' ' 63' ' ' ILE . 66.7 mt -93.59 119.13 40.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.337 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 58.9 m-85 -95.39 143.8 26.45 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.89 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 5.0 tppp? -89.45 126.98 35.78 Favored 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 64.6 m -79.95 21.49 0.56 Allowed 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 18.8 mtp180 63.4 157.87 0.12 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 123.87 0.868 . . . . 0.0 112.273 -176.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.13 -2.35 8.73 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.026 1.817 . . . . 0.0 113.766 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -105.39 -1.64 40.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.882 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.6 m-85 -128.14 178.16 6.42 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.435 -1.038 . . . . 0.0 108.949 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -155.53 177.71 11.06 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -169.02 171.69 8.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.92 -35.55 20.44 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.28 143.63 15.36 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.45 160.41 32.78 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.478 0.639 . . . . 0.0 111.426 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.98 105.11 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 HG12 ' A' ' 49' ' ' ILE . 45.9 mm -104.66 116.93 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.263 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.4 mtp -105.52 172.32 6.86 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.606 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.0 p -159.47 148.88 7.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.25 0.548 . . . . 0.0 110.559 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.41 117.37 12.87 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.459 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 44' ' ' GLU . 5.4 tpm_? -146.63 123.07 11.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.09 25.69 14.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 0.0 113.19 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 94.25 -11.5 70.38 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.802 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.25 166.11 11.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.473 0.654 . . . . 0.0 110.644 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -106.46 106.74 17.4 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' ALA . 9.6 p -130.42 -161.52 0.3 Allowed 'Isoleucine or valine' 1 N--CA 1.37 -4.472 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -91.19 126.6 36.32 Favored 'General case' 1 C--N 1.228 -4.705 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.069 -169.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.23 -57.8 3.63 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 13.0 t-20 -116.5 102.56 53.35 Favored Pre-proline 0 N--CA 1.419 -1.998 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.537 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.45 -0.89 11.09 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 122.976 2.451 . . . . 0.0 112.989 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 mt -89.8 -26.5 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.859 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 34.9 mmt180 -85.28 147.75 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.227 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HG3' ' HG3' ' A' ' 81' ' ' GLN . 17.9 ptpt -154.58 163.15 40.65 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.95 111.38 23.63 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 49.6 mt-30 -101.37 151.05 22.37 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.357 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.8 mttt -65.24 129.03 38.24 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.2 ptp180 -71.74 137.37 82.83 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.077 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 143.66 76.57 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 122.711 2.274 . . . . 0.0 110.728 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.2 m -101.17 -13.76 18.0 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.24 -173.27 55.28 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.111 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.421 ' HE1' ' OD1' ' A' ' 90' ' ' ASP . 30.5 t-80 -72.26 134.13 82.9 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.91 65.78 4.06 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.025 2.483 . . . . 0.0 111.894 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.503 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 74.42 -95.33 0.86 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD1' ' HE1' ' A' ' 87' ' ' HIS . 18.8 t70 -178.94 138.53 0.15 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -144.82 99.86 4.69 Favored Pre-proline 0 C--N 1.286 -2.172 0 CA-C-O 121.127 0.489 . . . . 0.0 111.612 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.2 -50.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.554 1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 114.88 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -81.46 -34.42 31.41 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.828 -0.545 . . . . 0.0 111.191 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 150.56 30.68 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 m -111.35 -42.74 3.83 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 117.42 0.61 . . . . 0.0 110.696 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.405 ' HA ' ' H ' ' A' ' 113' ' ' THR . 4.2 p90 64.44 152.19 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.963 1.705 . . . . 0.0 115.11 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 p -124.13 143.64 50.36 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -103.82 137.04 42.4 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -119.29 -22.26 7.18 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.89 44.31 1.51 Allowed Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.09 20.16 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -128.35 15.89 6.61 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.92 178.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -93.32 85.98 5.16 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 12.3 pt-20 -127.18 145.59 50.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.576 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 63.8 t80 -46.47 126.82 8.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.25 -5.93 55.79 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.935 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.58 131.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.644 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.7 ttmt -100.29 127.57 46.55 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 98.21 8.18 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.41 115.75 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.429 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 4.9 t80 -82.96 94.55 7.77 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.647 0.737 . . . . 0.0 110.678 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.405 ' H ' ' HA ' ' A' ' 96' ' ' PHE . 1.7 p -105.82 151.13 24.9 Favored 'General case' 0 N--CA 1.402 -2.848 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.466 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.85 -166.14 1.17 Allowed 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.201 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -61.82 156.52 20.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.58 -42.43 11.13 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.609 1.564 . . . . 0.0 114.246 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.94 10.34 74.24 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.356 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -114.46 167.69 10.51 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.788 0.794 . . . . 0.0 111.738 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -133.45 -140.21 0.19 Allowed 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 102.539 -3.134 . . . . 0.0 102.539 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.3 pt? -160.28 152.78 20.88 Favored 'General case' 1 N--CA 1.335 -6.178 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 142' ' ' GLU . 0.5 OUTLIER -80.43 126.83 31.69 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 173.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.95 163.23 9.43 Favored Glycine 0 N--CA 1.402 -3.582 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.62 -24.58 14.09 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.276 1.036 . . . . 0.0 108.344 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.6 mm -102.48 101.64 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.74 ' HA ' HD11 ' A' ' 120' ' ' LEU . 30.3 p-10 -89.19 33.61 0.8 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.657 0.741 . . . . 0.0 111.269 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -165.18 171.24 13.96 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.398 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 124.87 14.73 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.122 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -99.04 142.37 30.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.6 t -82.12 126.57 32.18 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.01 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.8 t70 -117.28 -166.45 1.18 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.8 p -60.15 -48.74 80.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 124.894 1.278 . . . . 0.0 113.616 -172.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.65 -24.81 18.54 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.38 0.609 . . . . 0.0 111.515 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.37 -155.48 25.73 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -77.87 144.77 36.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.5 p -63.97 -34.85 78.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.858 0.837 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -138.48 152.43 48.28 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.28 2.5 p30 -82.36 -94.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.503 HD11 ' HA3' ' A' ' 89' ' ' GLY . 7.3 mt -133.61 98.19 15.17 Favored Pre-proline 0 C--N 1.292 -1.91 0 O-C-N 121.573 -0.704 . . . . 0.0 109.672 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.893 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.1 Cg_endo -51.78 141.43 44.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 166.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.98 115.18 26.86 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.684 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.53 120.66 9.83 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 122.266 0.226 . . . . 0.0 110.914 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 121.649 0.738 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.757 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.2 142.82 32.82 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -116.89 16.4 15.18 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 122.153 0.978 . . . . 0.0 108.609 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.45 163.18 34.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.8 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 37' ' ' TRP . 21.5 mt -91.51 154.96 44.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 123.699 0.8 . . . . 0.0 111.005 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.2 Cg_endo -64.79 130.9 27.45 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.224 1.949 . . . . 0.0 110.511 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.5 Cg_exo -64.25 146.32 90.05 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.153 1.902 . . . . 0.0 111.358 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -92.45 146.91 23.32 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.53 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.4 mpt_? -104.22 174.86 5.69 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.515 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -82.3 -34.88 28.45 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -100.38 -5.12 27.73 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 1.5 mp0 -133.06 145.81 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.58 153.9 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -74.82 143.05 44.13 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 123.846 0.716 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 49' ' ' ILE . 17.0 p -80.33 -52.53 7.59 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.489 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.23 177.62 54.13 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.625 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -95.23 127.75 41.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.655 ' HB3' HD22 ' A' ' 24' ' ' LEU . 75.6 m95 -124.31 103.78 8.41 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.6 m -121.65 7.67 10.01 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.753 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.52 -158.41 0.73 Allowed 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 41' ' ' THR . 18.2 pt20 -142.24 -36.92 0.4 Allowed 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -97.23 103.81 15.77 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.657 0.742 . . . . 0.0 111.658 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -117.63 145.45 36.41 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.049 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.22 140.47 92.28 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 123.323 2.682 . . . . 0.0 112.132 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.6 tt0 -64.97 138.1 58.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.04 6.6 53.75 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 m -86.14 117.93 25.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.7 pt20 -82.95 146.49 28.78 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.607 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.95 113.65 24.42 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 mt -88.4 129.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.6 m-85 -103.17 136.34 43.14 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 122.395 1.093 . . . . 0.0 113.038 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -75.7 -20.15 58.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.065 -1.88 . . . . 0.0 112.967 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.8 m 65.88 7.29 4.51 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 57.5 mtp180 68.45 165.82 0.13 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 55.1 Cg_endo -71.02 -22.16 26.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 120.956 1.104 . . . . 0.0 112.903 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.12 -17.93 48.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.745 -0.74 . . . . 0.0 114.467 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.2 m-85 -118.47 167.21 11.81 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -161.67 -175.42 4.72 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 0.0 109.898 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -166.84 -177.88 4.04 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.72 69.87 0.99 Allowed 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.064 0.935 . . . . 0.0 108.987 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.78 -21.21 0.6 Allowed Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.65 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.1 m120 72.33 149.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.619 1.168 . . . . 0.0 110.598 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' SG ' ' A' ' 80' ' ' CYS . 73.3 t -70.51 110.41 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.77 116.08 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.6 mtp -103.45 174.04 6.04 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -161.64 150.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.14 0.495 . . . . 0.0 109.832 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.19 127.41 35.74 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 49.0 ttp180 -149.83 131.87 15.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 65.51 20.58 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.916 0.486 . . . . 0.0 112.305 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.11 -13.73 66.96 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.663 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.99 159.19 16.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.356 0.598 . . . . 0.0 111.697 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -99.43 109.71 22.26 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 73' ' ' ALA . 12.1 p -127.18 -156.07 0.17 Allowed 'Isoleucine or valine' 1 N--CA 1.363 -4.78 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.678 -176.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -102.47 134.79 45.22 Favored 'General case' 1 C--N 1.223 -4.921 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -168.149 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.12 -58.81 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -117.6 88.83 30.72 Favored Pre-proline 0 N--CA 1.433 -1.309 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.89 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.24 -14.46 25.66 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.37 2.047 . . . . 0.0 110.688 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.68 -28.27 62.6 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.834 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 31.5 mmt180 -93.55 132.74 37.56 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.944 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.0 155.54 44.68 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 62' ' ' VAL . 36.0 m -94.31 116.22 28.57 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.538 0.685 . . . . 0.0 109.933 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -111.0 177.11 4.77 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.976 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.2 mmtp -57.21 145.22 32.31 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.867 0.729 . . . . 0.0 109.754 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 106' ' ' TYR . 12.2 ptm180 -85.66 131.61 46.95 Favored Pre-proline 0 C--N 1.279 -2.472 0 C-N-CA 118.906 -1.118 . . . . 0.0 108.693 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 139.43 39.6 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.415 2.076 . . . . 0.0 110.089 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.7 m -101.04 -2.82 30.62 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.66 -96.75 1.89 Allowed Glycine 0 C--N 1.308 -0.984 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.597 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -143.85 125.54 8.24 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.8 Cg_exo -68.89 -53.78 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.666 2.244 . . . . 0.0 111.726 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.73 166.69 18.3 Favored Glycine 0 N--CA 1.419 -2.46 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.338 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.45 109.58 20.89 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -92.33 131.96 33.27 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.24 -31.75 52.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.75 139.96 52.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.579 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . 71.61 -165.4 53.66 Favored Glycine 0 C--N 1.304 -1.214 0 O-C-N 123.961 0.788 . . . . 0.0 113.351 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.7 m -155.54 170.07 22.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 88' ' ' PRO . 45.7 p90 -104.7 160.68 14.78 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.934 -0.479 . . . . 0.0 109.784 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -115.59 144.86 43.28 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -106.22 135.01 48.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 100' ' ' GLY 0.25 3.8 t -87.42 -86.01 0.16 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.551 ' H ' HG23 ' A' ' 99' ' ' THR . . . -87.02 52.77 4.43 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 118.15 0.432 . . . . 0.0 113.053 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.5 162.66 17.2 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -121.75 15.12 10.97 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.711 0.767 . . . . 0.0 109.102 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.9 175.35 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -93.55 88.55 5.93 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.0 pt-20 -133.25 154.85 50.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . 70.0 t80 -50.05 119.54 3.69 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.537 0.684 . . . . 0.0 111.802 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.88 -19.76 18.04 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.839 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 105' ' ' GLU . 2.8 p -85.36 141.32 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -111.46 128.26 55.95 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.04 100.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.83 118.26 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.604 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -77.82 109.88 12.21 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.64 0.733 . . . . 0.0 110.616 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.17 109.15 12.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.03 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.579 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 97.7 m -129.84 111.07 12.23 Favored 'General case' 0 C--N 1.253 -3.628 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.76 -168.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 19.4 m120 57.25 -162.09 0.2 Allowed 'General case' 0 C--O 1.247 0.941 0 O-C-N 124.448 1.093 . . . . 0.0 112.744 172.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -121.48 -46.73 2.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.19 0.519 . . . . 0.0 110.477 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.47 72.82 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 68.8 m-85 -98.6 155.09 17.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -136.99 -88.46 0.28 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.4 pp 178.44 148.87 0.2 Allowed 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 123.895 0.747 . . . . 0.0 112.14 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.24 135.22 44.22 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.025 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.41 161.13 10.92 Favored Glycine 0 C--N 1.281 -2.516 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.82 -18.99 26.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.434 0.635 . . . . 0.0 109.838 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' ND2' ' A' ' 136' ' ' ASN . 41.1 mm -113.54 121.24 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.966 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.451 ' HB2' HD21 ' A' ' 120' ' ' LEU . 29.7 p-10 -92.31 24.63 3.3 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.723 0.809 . . . . 0.0 111.557 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 38.0 p90 -163.04 178.45 8.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -151.39 128.2 10.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.649 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.0 mt-10 -103.82 154.42 19.62 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.2 t -92.44 105.65 17.8 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.251 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.35 175.48 7.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.574 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 73.8 p -52.46 -33.79 46.06 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.521 1.528 . . . . 0.0 112.444 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.15 -32.53 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.407 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.31 -159.48 28.89 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 95.2 m95 -67.74 128.92 38.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.314 0.578 . . . . 0.0 112.087 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.8 p -78.72 157.25 28.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.721 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' HG13 ' A' ' 124' ' ' ILE . 11.4 m120 65.82 -162.56 0.25 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -119.26 -163.1 0.95 Allowed 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 60.4 mt -101.54 110.04 60.71 Favored Pre-proline 0 C--N 1.285 -2.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 11.2 Cg_endo -58.76 137.91 82.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.959 1.773 . . . . 0.0 110.501 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 47.9 mm -89.33 103.91 14.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.14 111.18 1.42 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.253 0.549 . . . . 0.0 110.551 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.432 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 8.8 tp10 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.089 0.471 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.9 m -78.73 133.57 37.14 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.756 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.06 25.02 10.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.444 0.64 . . . . 0.0 110.096 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.42 155.19 38.1 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.851 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 37' ' ' TRP . 32.0 mt -76.9 158.8 79.92 Favored Pre-proline 0 C--N 1.31 -1.13 0 O-C-N 123.738 0.649 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 141.4 74.23 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.319 2.012 . . . . 0.0 110.09 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.96 118.03 4.65 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 121.52 1.48 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -62.38 135.98 57.7 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.496 0.665 . . . . 0.0 110.194 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.562 HH11 ' HB3' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -85.94 176.89 7.81 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.769 -167.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -82.98 -24.1 33.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.963 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 p -132.29 10.27 4.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.92 0.391 . . . . 0.0 111.388 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 2.7 mp0 -133.7 158.78 42.42 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -133.34 163.42 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -85.58 156.65 20.64 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-O 120.81 0.338 . . . . 0.0 110.573 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -130.54 95.57 3.91 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 -149.5 15.38 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.2 m -131.13 117.79 19.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 117.836 0.818 . . . . 0.0 109.45 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.537 ' HB3' HD22 ' A' ' 24' ' ' LEU . 55.3 m95 -134.17 101.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.908 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.2 t -147.4 34.81 0.87 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.11 -163.86 1.31 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.588 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.93 -49.3 1.23 Allowed 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 70.1 p -95.43 127.12 41.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.73 136.98 26.4 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.857 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 37.4 Cg_endo -65.09 153.62 77.39 Favored 'Trans proline' 0 C--O 1.262 1.712 0 C-N-CA 122.825 2.35 . . . . 0.0 112.106 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.7 tt0 -67.49 139.99 57.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.97 2.2 55.0 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.202 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.437 ' C ' HG23 ' A' ' 65' ' ' VAL . 89.6 m -84.54 115.0 22.37 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.3 pt20 -83.16 139.82 32.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.557 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.18 108.68 20.24 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.0 mt -87.71 115.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.799 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 84.6 m-85 -95.96 149.05 22.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.371 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.46 130.94 39.1 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.8 t -87.18 102.41 14.44 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -32.81 144.21 0.14 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.981 1.712 . . . . 0.0 113.623 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -56.52 111.19 0.71 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 123.423 2.749 . . . . 0.0 112.534 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.96 -19.86 5.16 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -111.88 166.62 11.05 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.578 -0.811 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -155.54 167.27 30.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.925 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -174.64 126.11 0.3 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.7 77.59 5.18 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.403 0.62 . . . . 0.0 110.697 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.01 -29.83 1.23 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 70.67 158.49 0.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.412 1.085 . . . . 0.0 112.859 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.88 110.93 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.43 121.43 67.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -109.4 176.52 5.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 46' ' ' THR . 9.9 p -159.97 142.92 5.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.139 0.495 . . . . 0.0 110.668 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.79 121.97 18.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.905 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttm180 -152.57 117.87 5.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.589 0.233 . . . . 0.0 110.527 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 40.3 mmtm 69.2 25.05 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.593 1.157 . . . . 0.0 112.826 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.38 -12.82 67.57 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.075 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.22 154.13 31.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -87.64 118.21 26.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.0 175.04 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.742 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.52 122.28 31.03 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.001 0.429 . . . . 0.0 111.258 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.08 -57.4 3.86 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -108.88 91.29 8.78 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.198 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.92 -15.44 16.63 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.476 2.118 . . . . 0.0 112.647 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 -28.94 59.98 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.672 0.749 . . . . 0.0 109.723 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -84.23 134.49 34.54 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.028 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -154.48 160.86 41.82 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.509 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 16.9 m -79.81 112.94 17.58 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-O 121.777 0.798 . . . . 0.0 112.312 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.48 153.14 23.27 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.35 146.38 43.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.818 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.12 145.66 49.69 Favored Pre-proline 0 N--CA 1.417 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.887 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.83 153.51 48.05 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 N-CA-C 108.03 -1.566 . . . . 0.0 108.03 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.1 m -91.3 -24.11 19.93 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.677 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.01 -115.52 3.99 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -146.09 131.31 9.13 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.94 34.41 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 123.015 2.476 . . . . 0.0 113.349 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.96 155.5 27.8 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.66 84.38 2.12 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 t -73.58 136.78 77.61 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.872 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.97 -28.46 19.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.172 1.915 . . . . 0.0 111.71 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.31 121.44 34.99 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 173.01 16.56 Favored Glycine 0 N--CA 1.424 -2.145 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 m -154.66 171.72 19.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -136.41 157.66 46.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.661 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -126.25 155.3 42.1 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.26 131.49 56.93 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.4 t -125.98 144.43 50.7 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.06 68.99 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.86 168.09 25.35 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -112.91 9.51 18.87 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.006 0.908 . . . . 0.0 108.963 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.3 p -136.19 -167.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.712 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.043 -173.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -105.46 101.48 11.01 Favored 'General case' 1 C--N 1.241 -4.109 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.163 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -156.37 152.86 28.08 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.8 t80 -54.07 114.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.94 0 O-C-N 124.021 0.826 . . . . 0.0 111.168 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.84 -19.81 5.2 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.576 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 15.8 m -79.93 149.36 5.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.505 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -107.51 118.26 36.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.36 94.27 9.83 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.7 p -89.33 121.23 39.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.515 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -84.23 141.41 31.02 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.333 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -141.73 163.89 31.68 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.22 -59.64 0.06 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 118.972 0.805 . . . . 0.0 111.736 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -147.26 -170.76 3.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.0 -51.04 3.8 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 123.882 0.873 . . . . 0.0 109.861 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.1 8.49 70.27 Favored Glycine 0 C--O 1.24 0.503 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.99 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -133.83 129.53 36.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -94.42 -135.78 0.2 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 167.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -153.23 153.57 32.96 Favored 'General case' 1 N--CA 1.334 -6.243 0 C-N-CA 118.991 -1.083 . . . . 0.0 108.411 -175.69 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.5 mm? -77.77 125.89 30.03 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-O 121.475 0.655 . . . . 0.0 109.431 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.25 150.14 7.38 Favored Glycine 0 C--N 1.273 -2.947 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.56 -22.76 22.23 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 122.162 0.982 . . . . 0.0 109.149 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.93 109.4 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.869 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HD11 ' A' ' 120' ' ' LEU . 32.0 p-10 -86.14 33.67 0.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.779 0.8 . . . . 0.0 110.863 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 50.1 p90 -167.07 176.52 6.82 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.95 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.85 119.42 7.97 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 23.6 mt-10 -87.76 155.39 19.93 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 52.4 t -75.38 139.46 42.39 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.42 167.47 12.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.502 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.5 p -55.87 -28.5 56.81 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.791 1.637 . . . . 0.0 112.894 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -108.43 -28.93 9.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.244 0.545 . . . . 0.0 111.555 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.7 -106.24 0.19 Allowed Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.964 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -127.54 145.35 50.89 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -74.59 -26.79 60.16 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -128.12 170.02 13.43 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -99.28 -170.14 1.87 Allowed 'General case' 0 C--N 1.285 -2.212 0 O-C-N 124.055 0.847 . . . . 0.0 110.365 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.43 113.1 53.91 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-O 120.365 0.126 . . . . 0.0 110.694 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.727 ' HB2' HD12 ' A' ' 120' ' ' LEU . 11.2 Cg_endo -70.24 152.94 67.1 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 122.601 2.2 . . . . 0.0 110.287 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.26 125.96 72.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 12.3 p -76.96 108.54 10.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.633 ' HB2' HD23 ' A' ' 121' ' ' LEU . 28.3 mt-10 . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 125.678 1.591 . . . . 0.0 107.166 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 121.72 0.771 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.0 m -76.02 140.33 41.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.024 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -105.85 20.02 19.61 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.602 0.715 . . . . 0.0 109.915 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.1 155.95 40.76 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -88.53 158.41 48.55 Favored Pre-proline 1 N--CA 1.367 -4.577 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.248 -176.966 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 13.2 Cg_endo -58.34 130.04 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.541 2.827 . . . . 0.0 111.829 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.14 122.86 5.89 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.526 2.15 . . . . 0.0 112.597 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.74 154.23 41.24 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.975 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -117.08 176.14 5.27 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.74 -23.35 64.32 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.253 0.549 . . . . 0.0 111.517 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 p -119.02 7.13 11.35 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 5.2 mp0 -136.9 141.7 42.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.35 0.595 . . . . 0.0 112.148 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.95 151.92 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 3.6 mm? -67.84 155.52 39.17 Favored 'General case' 0 C--N 1.267 -2.981 0 O-C-N 123.629 0.581 . . . . 0.0 111.233 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 p -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.389 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 -163.4 38.84 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.782 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -121.09 108.21 13.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.52 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 18.7 m95 -107.52 88.16 2.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -104.11 4.74 34.54 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.774 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 24' ' ' LEU . 9.2 t70 -103.02 -150.02 0.41 Allowed 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.279 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -134.08 -57.8 0.86 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 69.8 p -88.03 122.12 31.25 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.171 -172.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -129.51 138.95 34.26 Favored Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.482 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.43 143.76 99.61 Favored 'Trans proline' 0 C--O 1.245 0.875 0 C-N-CA 123.316 2.677 . . . . 0.0 113.237 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 48.1 tt0 -63.6 131.65 48.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.965 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.36 4.59 46.83 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 65' ' ' VAL . 58.0 m -86.02 115.53 23.67 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.9 pt20 -84.45 142.23 30.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.365 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.46 124.15 51.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -94.12 132.04 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -110.19 144.47 38.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -93.75 142.23 27.6 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.734 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 m -84.51 22.36 1.3 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 64.83 162.26 0.12 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.347 0.659 . . . . 0.0 110.112 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 131' ' ' THR . 50.3 Cg_endo -71.63 112.5 3.38 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 120.509 0.806 . . . . 0.0 110.536 173.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.57 -26.22 6.04 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.333 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 89.5 m-85 -102.59 163.51 12.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.861 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -140.55 -178.79 5.68 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -143.67 -177.0 5.19 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.76 6.03 36.49 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.13 0.491 . . . . 0.0 109.745 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.04 -115.93 0.34 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -138.78 122.86 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 80' ' ' CYS . 60.7 t -84.08 110.38 18.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.06 130.44 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.401 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -111.03 175.13 5.54 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.456 HG23 ' C ' ' A' ' 46' ' ' THR . 11.2 p -157.71 143.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-O 121.33 0.586 . . . . 0.0 111.275 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.8 t -75.31 123.85 26.06 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.474 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 70.0 ttt180 -155.53 134.24 11.92 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 62.61 21.04 12.44 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.736 0.814 . . . . 0.0 112.369 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.65 69.36 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.675 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -121.36 159.87 25.21 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.571 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.406 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.5 m95 -90.19 117.6 29.07 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.689 0.756 . . . . 0.0 110.36 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.73 169.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.022 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.69 125.77 35.0 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.84 -56.78 6.87 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 174.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 8.9 t-20 -120.88 100.66 46.03 Favored Pre-proline 0 N--CA 1.413 -2.299 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.271 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.66 -5.65 17.15 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.912 2.408 . . . . 0.0 112.779 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.5 mt -88.91 -20.46 24.51 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 122.164 0.983 . . . . 0.0 110.827 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 31.7 mmt180 -91.15 132.15 36.25 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.42 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -149.41 158.93 44.6 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 62' ' ' VAL . 81.7 m -97.66 107.23 19.68 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.058 0.932 . . . . 0.0 110.276 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.51 168.83 9.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.954 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.0 mttt -66.71 144.86 56.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -85.44 139.58 36.03 Favored Pre-proline 0 N--CA 1.427 -1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.7 Cg_endo -68.81 140.45 46.41 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.351 1.368 . . . . 0.0 108.84 174.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.7 m -74.43 -38.33 63.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.291 0.567 . . . . 0.0 110.495 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.94 -86.03 0.38 Allowed Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -174.64 120.47 0.35 Allowed Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 123.33 0.652 . . . . 0.0 109.325 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 41.9 Cg_endo -69.06 157.15 62.86 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.567 2.178 . . . . 0.0 109.011 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -51.07 138.42 26.72 Favored Glycine 0 N--CA 1.438 -1.209 0 O-C-N 123.955 0.784 . . . . 0.0 112.218 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.76 137.52 37.24 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.1 0.476 . . . . 0.0 109.909 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -126.15 141.19 38.98 Favored Pre-proline 0 N--CA 1.404 -2.733 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.834 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.13 -29.89 9.36 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.17 1.913 . . . . 0.0 110.8 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.72 109.67 16.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.73 157.0 9.57 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.296 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 m -137.92 164.5 28.86 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.7 p90 -129.5 155.78 45.2 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.027 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.737 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 42.1 p -100.64 164.83 11.7 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.945 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 93.3 mt -130.85 123.43 29.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.0 t -129.91 20.91 5.43 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.463 0.649 . . . . 0.0 112.653 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 108' ' ' VAL . . . -143.23 33.23 1.83 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.443 ' HA3' ' CD ' ' A' ' 105' ' ' GLU . . . 147.57 -151.57 23.81 Favored Glycine 0 N--CA 1.413 -2.877 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -175.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -143.76 3.24 1.25 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.406 0.603 . . . . 0.0 111.533 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.26 -172.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 13.1 m-85 -85.2 95.47 9.18 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.0 pt-20 -137.83 145.83 42.73 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.343 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.404 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 47.0 t80 -49.21 123.86 8.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.342 0.591 . . . . 0.0 111.766 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.52 58.54 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.864 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.8 p -91.8 136.25 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.3 ttmt -101.62 132.26 47.39 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.737 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -109.11 101.9 10.91 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -88.45 132.19 34.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 119.401 -0.92 . . . . 0.0 108.828 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -98.31 123.97 42.69 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.555 0.693 . . . . 0.0 109.372 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.0 m -144.34 158.32 43.8 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 71.5 m -125.41 -61.71 1.25 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.405 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -151.92 -166.06 2.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.45 -56.33 10.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.004 0.43 . . . . 0.0 111.05 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.1 -13.71 61.65 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.42 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.495 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -93.75 115.04 27.44 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.242 0.544 . . . . 0.0 111.548 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -113.08 -117.91 0.31 Allowed 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -165.69 156.66 13.68 Favored 'General case' 1 N--CA 1.354 -5.264 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.463 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 95.4 mt -79.57 125.63 29.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.8 152.75 7.25 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.65 -10.32 32.21 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.126 0.489 . . . . 0.0 110.839 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -111.39 106.72 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.762 ' HA ' HD11 ' A' ' 120' ' ' LEU . 27.5 p-10 -90.62 34.96 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 42.0 p90 -163.63 169.22 18.89 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.45 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 88' ' ' PRO . 66.4 mtt180 -132.39 134.75 45.53 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 41.3 mt-10 -114.28 130.51 56.65 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 18.7 t -79.32 114.15 18.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -105.45 -162.28 0.86 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 54' ' ' PRO . 80.3 p -62.57 -42.76 99.75 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.12 -10.86 15.76 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.0 -163.22 34.15 Favored Glycine 0 CA--C 1.49 -1.496 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.837 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -82.91 144.06 30.3 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 117.143 0.472 . . . . 0.0 110.255 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -70.5 -20.79 62.82 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.235 0.541 . . . . 0.0 112.422 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -137.83 148.63 45.63 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -89.84 -103.14 0.09 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.654 0.596 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.488 HD11 ' HA3' ' A' ' 89' ' ' GLY . 29.7 mt -127.17 96.38 34.22 Favored Pre-proline 0 C--N 1.31 -1.151 0 O-C-N 120.782 -1.199 . . . . 0.0 111.754 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.832 ' HB2' HD12 ' A' ' 120' ' ' LEU . 6.5 Cg_endo -56.92 136.11 74.66 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 122.447 2.098 . . . . 0.0 108.575 167.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.5 mp -87.15 115.86 28.56 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.963 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.83 -171.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.02 112.81 0.85 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 35.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.275 1.43 . . . . 0.0 109.481 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.688 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.0 m-20 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.31 0.576 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 41' ' ' THR . 84.9 m -77.19 139.75 39.97 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.314 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.3 m-20 -106.64 25.86 10.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.732 0.777 . . . . 0.0 109.164 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.57 155.35 33.2 Favored 'General case' 0 CA--C 1.468 -2.199 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -86.88 156.98 55.11 Favored Pre-proline 1 N--CA 1.336 -6.161 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.528 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.1 Cg_endo -54.14 125.35 18.52 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.083 2.522 . . . . 0.0 110.99 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.46 110.85 3.18 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.499 1.466 . . . . 0.0 112.118 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.276 0.0 OUTLIER -72.14 161.24 31.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.081 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 72.1 mtp180 -122.93 -174.03 2.84 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -168.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -90.47 -14.33 32.99 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -99.9 -33.88 10.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.734 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 25.5 mp0 -121.04 145.93 47.25 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.233 0.54 . . . . 0.0 112.14 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mt -119.71 144.46 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.607 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 37' ' ' TRP . 25.3 mt -74.67 128.24 35.07 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -112.96 100.35 8.57 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.9 171.1 21.3 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m -105.46 110.67 23.1 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.382 0.611 . . . . 0.0 111.261 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CD1' HD13 ' A' ' 33' ' ' LEU . 2.7 m95 -132.34 82.24 2.0 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 m -108.43 -2.29 19.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.231 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.724 ' O ' HD21 ' A' ' 24' ' ' LEU . 16.2 t70 -93.72 -136.29 0.19 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.909 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -144.11 -55.43 0.36 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 27.5 p -91.85 129.05 37.89 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -133.1 135.0 24.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.099 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.688 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 17.8 Cg_endo -60.59 148.65 90.55 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.228 2.619 . . . . 0.0 113.278 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.49 134.77 55.13 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.39 14.68 37.56 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 65' ' ' VAL . 90.4 m -94.29 119.33 32.91 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.349 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.6 pt20 -89.3 150.09 22.75 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.454 0.645 . . . . 0.0 111.861 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 130.97 53.48 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.7 mt -101.56 126.62 55.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 66.4 m-85 -109.49 143.31 39.29 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 20.2 ttmm -92.33 129.75 38.2 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 73.5 m -70.99 7.46 1.18 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 68.4 mtp180 71.78 154.17 0.15 Allowed Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.618 0.767 . . . . 0.0 111.263 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.52 129.09 17.22 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.792 1.661 . . . . 0.0 109.186 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 104.69 -6.43 44.62 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.329 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 36.3 m-85 -126.39 170.65 11.73 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -160.16 177.54 10.58 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 49.5 p -155.37 179.97 8.66 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.72 -22.34 56.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.865 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.02 -96.59 0.14 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -155.73 155.32 32.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 80' ' ' CYS . 65.9 t -77.42 106.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.63 116.77 48.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.0 mtp -107.89 167.59 9.87 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 46' ' ' THR . 7.7 p -152.79 144.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.067 0.46 . . . . 0.0 110.088 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.43 118.84 12.81 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.577 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.4 ttt180 -151.12 115.22 5.02 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 69.24 27.98 5.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.016 . . . . 0.0 112.615 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.22 87.41 Favored Glycine 0 C--N 1.294 -1.784 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.59 152.96 38.68 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 79.9 m95 -92.77 121.22 33.94 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.2 172.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.84 119.4 21.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.82 -49.39 73.04 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.49 91.84 6.37 Favored Pre-proline 0 C--N 1.29 -1.992 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.167 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.4 -3.13 13.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 0.0 112.984 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.17 8.38 44.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.239 0.542 . . . . 0.0 109.715 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -119.23 149.08 42.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.311 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.83 161.18 28.92 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 62' ' ' VAL . 71.8 m -104.26 123.94 48.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.71 0.767 . . . . 0.0 109.746 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -112.32 165.63 12.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.71 157.45 17.76 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 117.962 0.346 . . . . 0.0 110.801 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.9 ptm180 -82.22 143.91 49.54 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 41.2 Cg_endo -72.75 157.16 52.42 Favored 'Trans proline' 0 N--CA 1.424 -2.617 0 N-CA-C 108.142 -1.522 . . . . 0.0 108.142 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -103.03 6.26 38.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.646 0.736 . . . . 0.0 110.224 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 -122.07 9.94 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.892 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -130.63 120.23 18.62 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 45.5 Cg_endo -75.76 139.52 22.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.73 1.62 . . . . 0.0 108.315 172.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.438 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -48.38 128.12 18.27 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.135 0.897 . . . . 0.0 113.638 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -98.29 178.09 5.17 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 94' ' ' GLY . 3.0 t -148.8 147.1 23.42 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.99 -18.52 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.739 1.626 . . . . 0.0 111.088 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.5 -25.44 28.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 114' ' ' CYS . . . -146.79 -147.74 4.62 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.723 -1.227 . . . . 0.0 114.072 -175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 96' ' ' PHE . 12.8 m -154.59 -169.3 3.17 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.589 ' H ' HG22 ' A' ' 95' ' ' THR . 38.5 p90 -148.62 161.74 41.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 119.274 0.943 . . . . 0.0 109.053 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG22 ' A' ' 111' ' ' VAL . 63.7 p -109.1 -176.51 3.05 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 108' ' ' VAL . 96.0 mt -143.73 164.95 29.02 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 109' ' ' LYS . 7.5 t -119.88 -148.76 0.42 Allowed 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.82 74.89 0.0 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 125.746 1.641 . . . . 0.0 115.938 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.79 -41.53 0.08 OUTLIER Glycine 0 C--N 1.276 -2.783 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.06 11.96 3.71 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.27 177.19 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 40.2 m-85 -90.79 87.78 6.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.55 150.82 44.15 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.553 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -45.32 115.38 0.91 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.477 1.11 . . . . 0.0 110.835 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.7 -33.92 2.87 Favored Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.73 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 98' ' ' LEU . 35.0 m -74.37 135.79 26.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.495 1.14 . . . . 0.0 113.424 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -93.69 118.13 31.0 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.235 170.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -96.62 109.21 21.87 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.2 m -86.72 158.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 51.1 t80 -119.52 132.84 55.84 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.518 0.675 . . . . 0.0 110.201 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.3 m -153.08 157.81 40.98 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.465 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 81.8 m -120.74 -61.87 1.52 Allowed 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.148 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -153.48 -153.0 0.44 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.57 -47.0 7.03 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.14 -29.16 69.08 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.23 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 96.1 m-85 -107.93 126.49 52.75 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.14 -74.93 0.54 Allowed 'General case' 1 CA--C 1.416 -4.179 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.269 2.3 tp -172.34 154.75 3.33 Favored 'General case' 1 N--CA 1.282 -8.852 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.541 -168.186 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 22.8 mt -129.0 130.05 46.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 132.45 -168.36 22.71 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -110.29 -40.17 4.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 117.937 0.869 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.1 mm -97.67 100.74 11.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.709 -176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.458 ' HB3' HD22 ' A' ' 120' ' ' LEU . 28.5 p-10 -86.93 32.12 0.68 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 35.0 p90 -161.27 173.17 15.42 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.539 0.685 . . . . 0.0 110.262 -175.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 88' ' ' PRO . 21.7 ptt180 -147.04 134.68 21.03 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.457 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.9 mt-10 -111.86 143.48 42.74 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.648 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.74 106.13 17.45 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.207 0.527 . . . . 0.0 109.831 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.89 -166.93 1.36 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.244 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -62.59 -43.44 98.8 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.048 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.5 -37.87 77.37 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.66 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 138.78 -147.14 19.01 Favored Glycine 0 N--CA 1.411 -2.982 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -65.82 122.48 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 p -60.21 -33.21 71.92 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.888 0.875 . . . . 0.0 111.778 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -132.1 165.69 23.46 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 25.8 t70 -98.72 -144.82 0.32 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.438 HD11 ' HA3' ' A' ' 89' ' ' GLY . 11.7 mt -89.16 113.65 57.12 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.483 ' HB2' HD11 ' A' ' 120' ' ' LEU . 3.4 Cg_endo -65.73 161.82 37.28 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.457 2.104 . . . . 0.0 111.263 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.9 mp -74.81 136.46 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.448 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 40.9 t -104.18 102.7 12.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 179.6 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 11.0 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 41' ' ' THR . 59.8 m -75.99 133.93 40.29 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.244 0.618 . . . . 0.0 109.925 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -104.01 36.79 2.23 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.409 0.623 . . . . 0.0 109.635 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.16 155.94 31.82 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.825 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.7 mt -80.28 153.25 74.14 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.23 132.39 46.49 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.05 1.834 . . . . 0.0 110.657 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.33 137.58 10.6 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.254 1.969 . . . . 0.0 112.682 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -80.25 126.02 30.6 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 30.4 mtp180 -99.53 178.24 4.92 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.178 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.45 -28.03 61.74 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.168 0.985 . . . . 0.0 109.996 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -107.06 -31.56 8.23 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.642 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.681 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 30.1 mp0 -116.34 158.76 22.93 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' HG2' ' A' ' 51' ' ' LYS . 14.7 mt -144.01 148.4 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 151.42 42.28 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -126.67 156.89 40.32 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.69 -156.91 18.24 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.803 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -133.66 130.6 38.46 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.0 m95 -134.11 139.81 46.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -154.57 -5.03 0.15 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.385 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -113.97 163.65 14.84 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.031 -172.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -83.9 -47.19 11.31 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.026 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 34.0 p -98.52 131.75 44.5 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.964 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -130.83 135.45 27.36 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.041 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.3 Cg_endo -61.71 148.9 92.01 Favored 'Trans proline' 0 C--O 1.257 1.474 0 C-N-CA 123.198 2.599 . . . . 0.0 112.001 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.45 139.87 58.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -11.25 55.69 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.062 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -68.54 118.34 11.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HA ' HG23 ' A' ' 65' ' ' VAL . 23.2 pt20 -93.4 138.77 31.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.558 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.2 119.72 39.95 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.815 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -93.2 111.78 25.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.1 m-85 -101.86 144.06 30.97 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 19.4 ptpt -89.0 161.45 16.58 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.35 118.85 34.73 Favored 'General case' 1 N--CA 1.368 -4.553 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -31.55 147.31 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 124.81 1.319 . . . . 0.0 111.507 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.62 -31.33 31.49 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.409 2.739 . . . . 0.0 115.339 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' C ' ' HG2' ' A' ' 83' ' ' ARG . . . -96.2 14.54 64.33 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.514 0.508 . . . . 0.0 112.515 177.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.91 167.97 16.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.139 -0.624 . . . . 0.0 110.093 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -157.9 -177.06 6.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 109.272 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -166.65 -167.99 1.08 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mp -88.78 3.93 49.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.98 -98.87 0.12 Allowed Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -141.93 158.22 44.04 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 65.8 t -88.21 107.98 18.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.67 108.46 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-O 121.835 0.826 . . . . 0.0 109.832 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mtp -97.73 175.15 6.28 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -157.04 147.79 10.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.676 -175.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.37 111.21 12.8 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 40.9 ttm180 -141.94 119.02 11.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 66.9 mmtt 64.53 22.1 12.6 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.591 1.157 . . . . 0.0 113.068 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.32 -8.62 69.5 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.387 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.63 161.01 17.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.235 0.54 . . . . 0.0 110.481 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -104.18 106.36 16.84 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 73' ' ' ALA . 13.5 p -127.93 -153.59 0.13 Allowed 'Isoleucine or valine' 1 N--CA 1.371 -4.42 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -109.82 115.03 29.08 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 3.0 tm? -59.47 -55.0 40.09 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 167.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -120.0 97.52 49.41 Favored Pre-proline 0 N--CA 1.415 -2.193 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.098 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.08 -4.82 15.62 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 123.478 2.786 . . . . 0.0 112.624 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.87 -29.35 25.34 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.901 0.858 . . . . 0.0 109.066 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -91.36 131.44 36.85 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.919 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.89 154.11 25.47 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.681 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 73.8 m -84.77 106.18 16.11 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 122.022 0.915 . . . . 0.0 110.593 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -98.88 161.0 13.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.55 145.36 52.65 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.633 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HG2' ' C ' ' A' ' 55' ' ' GLY . 12.2 ptp180 -85.77 137.86 35.73 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.08 142.96 63.5 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.282 1.988 . . . . 0.0 111.034 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.79 -27.91 63.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.8 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.14 -175.7 24.07 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.55 123.94 80.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.55 42.97 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 123.749 2.966 . . . . 0.0 112.845 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 72.28 -168.1 52.66 Favored Glycine 0 N--CA 1.412 -2.96 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.97 139.01 32.32 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -116.61 145.5 35.46 Favored Pre-proline 0 C--N 1.281 -2.391 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.36 -35.08 95.71 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.953 2.436 . . . . 0.0 111.415 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.32 150.37 19.85 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.74 163.46 11.49 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.522 -0.847 . . . . 0.0 110.992 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 m -145.44 172.58 12.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.65 159.64 42.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -118.33 152.13 36.39 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.26 138.5 46.56 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -127.24 13.38 7.17 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.496 0.665 . . . . 0.0 111.505 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -132.45 15.91 4.92 Favored Glycine 0 CA--C 1.494 -1.241 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.738 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.15 -173.15 31.36 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -110.64 3.08 19.0 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.629 0.715 . . . . 0.0 109.355 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 104' ' ' PHE . 3.9 p -142.72 -168.49 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.366 -170.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 103' ' ' VAL . 28.6 m-85 -96.9 98.93 10.51 Favored 'General case' 1 C--N 1.239 -4.219 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.618 -177.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.44 148.54 28.2 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.573 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.516 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.5 t80 -52.81 105.6 0.13 Allowed 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.292 0.995 . . . . 0.0 112.045 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.15 -8.23 4.76 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.857 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 103' ' ' VAL . 16.3 m -90.12 143.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.356 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -104.84 122.05 44.94 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.8 91.33 8.58 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.4 p -82.07 118.15 29.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.866 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -92.82 141.36 28.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.926 0.87 . . . . 0.0 111.604 -168.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 m -146.61 155.02 42.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.7 t -130.46 -72.7 0.56 Allowed 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 117.009 -1.876 . . . . 0.0 112.493 -172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 7.7 m-20 -143.67 -169.7 3.14 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -176.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -90.85 -48.05 7.25 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.79 -10.92 85.76 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.845 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 79.3 m-85 -123.52 126.48 46.78 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -104.76 -88.51 0.43 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.0 pp 175.66 143.0 0.06 Allowed 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.461 1.104 . . . . 0.0 111.212 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.19 126.92 45.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.98 172.24 12.93 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -100.05 -23.62 14.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.242 1.02 . . . . 0.0 110.08 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 126' ' ' TYR . 35.2 mm -107.29 98.76 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.82 30.73 0.31 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.849 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 124' ' ' ILE . 39.4 p90 -170.23 -177.49 2.51 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.93 115.74 5.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 31.7 mt-10 -80.09 143.69 33.75 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.576 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.8 t -74.61 142.09 44.63 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.029 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -124.75 -165.47 1.39 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 p -70.8 -53.32 15.81 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.967 0.889 . . . . 0.0 111.75 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -103.09 2.22 34.41 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.168 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.03 -125.47 1.03 Allowed Glycine 0 C--N 1.291 -1.947 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -127.96 162.05 27.67 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.3 p -80.91 -24.89 37.92 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -141.8 172.68 12.36 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 17.9 t70 -99.75 -161.99 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 124.135 0.897 . . . . 0.0 109.504 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.566 HD11 ' HA3' ' A' ' 89' ' ' GLY . 25.9 mt -83.05 124.14 76.83 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.7 138.45 34.88 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.769 1.646 . . . . 0.0 109.863 172.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 33.6 mm -86.43 118.63 33.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.986 -175.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 76.6 m -53.72 107.28 0.24 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.582 0.552 . . . . 0.0 111.326 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG2' HG22 ' A' ' 140' ' ' ILE . 7.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 34.4 m-20 . . . . . 0 C--O 1.242 0.686 0 CA-C-O 121.074 0.464 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -77.16 145.12 37.91 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -177.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -119.79 18.4 12.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.62 157.78 38.71 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -87.43 159.64 49.73 Favored Pre-proline 1 N--CA 1.356 -5.135 0 C-N-CA 125.1 1.36 . . . . 0.0 110.389 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.71 150.09 78.93 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.516 2.81 . . . . 0.0 111.396 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.32 169.07 17.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.195 1.93 . . . . 0.0 112.244 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -117.25 150.71 38.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.04 165.49 15.97 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.331 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.91 -39.25 26.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 5.5 p -89.98 -8.12 52.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -140.98 146.87 37.87 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.7 mt -113.43 126.55 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.058 0 CA-C-O 122.138 0.971 . . . . 0.0 109.945 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.33 113.45 11.56 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.097 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.9 p -90.28 157.31 17.73 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 -175.51 22.26 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.2 m -123.36 99.54 6.38 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.78 68.52 0.69 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 m -97.8 10.97 38.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.413 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.708 ' O ' HD21 ' A' ' 24' ' ' LEU . 22.1 t70 -97.48 -138.7 0.28 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.42 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 54.8 mt-30 -151.03 -58.09 0.16 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.7 p -89.27 129.26 35.86 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.673 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -137.79 149.09 63.36 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 123.903 0.881 . . . . 0.0 108.779 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 27.5 Cg_endo -65.11 150.87 87.25 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 122.516 2.144 . . . . 0.0 112.472 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 27.8 tt0 -67.36 138.71 56.95 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.56 56.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.274 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -81.15 119.13 23.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.1 pt20 -85.54 145.92 27.15 Favored 'General case' 0 N--CA 1.417 -2.088 0 O-C-N 123.802 0.689 . . . . 0.0 110.305 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 124.81 52.91 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.66 117.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.052 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 74.3 m-85 -98.07 134.6 40.93 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.041 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -77.37 134.78 38.37 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.3 t -80.53 98.82 7.76 Favored 'General case' 0 N--CA 1.396 -3.139 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -38.49 137.14 0.84 Allowed Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 112.224 -2.262 . . . . 0.0 111.769 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.7 122.41 11.69 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.695 2.263 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 113.87 -10.67 23.07 Favored Glycine 0 C--N 1.289 -2.031 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.347 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 89.9 m-85 -125.23 168.77 13.01 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 122.168 -0.607 . . . . 0.0 110.488 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -157.01 175.0 14.68 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.974 0.91 . . . . 0.0 108.654 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.0 p -159.61 -160.86 0.86 Allowed 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.82 4.18 48.55 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.968 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.21 -119.14 0.65 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -121.4 157.33 30.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 61.5 t -91.16 115.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.4 mm -111.5 121.68 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 CA-C-O 121.362 0.601 . . . . 0.0 110.983 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.413 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 80.0 mtp -106.26 172.58 6.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.5 p -153.78 155.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.497 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.9 t -97.27 132.45 43.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 87.5 mtt180 -149.6 134.08 17.52 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 124.215 0.947 . . . . 0.0 110.127 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 62.79 23.79 14.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.42 -6.5 80.65 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.81 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.02 155.79 30.79 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.116 0.484 . . . . 0.0 110.886 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -93.6 120.65 34.13 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.372 0.606 . . . . 0.0 109.465 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.14 175.6 4.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.036 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.74 115.02 27.7 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.766 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.7 tm? -59.2 -54.54 45.79 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -122.27 99.46 43.15 Favored Pre-proline 0 N--CA 1.404 -2.762 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.757 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.14 -14.21 20.91 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.791 2.327 . . . . 0.0 112.031 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.75 -28.19 55.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.585 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 8.9 mmp_? -91.08 135.17 33.94 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.003 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.23 151.07 5.52 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.533 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 97.4 m -81.58 109.39 15.98 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.731 0.777 . . . . 0.0 112.636 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -105.47 171.79 7.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.072 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -63.79 146.34 54.09 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.3 ptp180 -100.25 146.21 31.57 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 77.8 Cg_endo -82.85 152.01 14.6 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 121.932 1.755 . . . . 0.0 112.156 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.09 -1.19 34.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.493 0.663 . . . . 0.0 111.198 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.79 -92.45 1.12 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.253 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.59 129.9 21.54 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.1 36.08 0.6 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.913 3.075 . . . . 0.0 113.602 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.629 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 87.15 161.46 36.48 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.919 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -115.17 135.79 53.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.515 HG21 ' HE1' ' A' ' 112' ' ' TYR . 9.9 t -157.17 125.42 2.88 Favored Pre-proline 0 N--CA 1.416 -2.136 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.65 14.62 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.454 2.103 . . . . 0.0 111.602 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.06 -16.35 16.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.096 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 114' ' ' CYS . . . -179.67 -162.42 28.68 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.066 -1.54 . . . . 0.0 113.2 -176.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 t -134.74 -164.13 1.47 Allowed 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 123.27 0.628 . . . . 0.0 109.529 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 53.9 p90 -141.54 160.12 40.81 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.627 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 41.4 p -113.61 172.83 6.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 174.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.18 135.6 45.21 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 109' ' ' LYS . 13.1 t -138.01 18.27 2.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.314 1.054 . . . . 0.0 111.307 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 108' ' ' VAL . . . -142.04 38.1 1.51 Allowed Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.39 -176.23 20.46 Favored Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.38 17.59 11.4 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.595 0.712 . . . . 0.0 109.598 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 104' ' ' PHE . 4.9 p -144.67 -167.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 m-85 -104.31 93.72 4.96 Favored 'General case' 0 C--N 1.244 -3.983 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.974 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.4 pt-20 -142.39 152.11 42.5 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -51.4 114.52 1.25 Allowed 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.757 0.661 . . . . 0.0 110.445 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.47 -18.85 10.84 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.988 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.9 p -81.17 138.1 20.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.361 0.601 . . . . 0.0 110.787 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.1 ttmp? -104.61 128.49 52.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -104.66 96.52 6.64 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -81.37 146.4 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.049 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 91' ' ' THR . 63.0 t80 -96.79 131.85 43.1 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.694 0.759 . . . . 0.0 109.977 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 m -151.91 157.66 42.12 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.452 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -154.27 -66.4 0.14 Allowed 'General case' 0 C--N 1.251 -3.692 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.578 -173.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 49.8 m-80 -115.79 -177.56 3.19 Favored 'General case' 0 N--CA 1.398 -3.062 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.085 -174.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.51 -46.5 7.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.71 17.59 58.1 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.768 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 3.3 m-85 -125.45 150.63 47.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.244 -0.562 . . . . 0.0 109.941 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -122.1 -148.04 0.4 Allowed 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 171.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -142.99 154.79 44.37 Favored 'General case' 1 N--CA 1.332 -6.363 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.783 -169.469 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.3 mm? -81.63 128.68 34.19 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.24 142.61 5.08 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.4 -18.15 42.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.673 0.749 . . . . 0.0 109.09 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.35 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.747 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.2 p-10 -86.3 28.46 0.83 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.273 0.558 . . . . 0.0 111.474 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 111' ' ' VAL . 47.1 p90 -167.57 -177.6 3.61 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.182 -172.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.46 133.45 15.08 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 29.3 mt-10 -105.92 147.08 29.18 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 122.139 -0.351 . . . . 0.0 111.318 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.5 t -81.77 106.2 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.6 t70 -101.95 -160.82 0.81 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.7 p -63.84 -51.91 62.53 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 124.911 1.285 . . . . 0.0 112.877 -174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.12 -35.82 15.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.227 0.537 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.96 -151.97 10.45 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 79.7 m95 -76.91 139.99 40.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.267 0.533 . . . . 0.0 109.943 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.6 p -63.92 -32.43 73.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -138.21 176.51 8.64 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -92.6 -155.88 0.45 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.629 HD11 ' HA3' ' A' ' 89' ' ' GLY . 38.0 mt -99.17 111.44 61.0 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 122.964 0.506 . . . . 0.0 110.062 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 120' ' ' LEU . 9.4 Cg_endo -61.62 145.42 97.63 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.363 2.042 . . . . 0.0 109.682 170.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.73 123.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.515 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 8.1 t -67.11 120.42 13.68 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HD23 ' A' ' 121' ' ' LEU . 16.6 mm-40 . . . . . 0 C--N 1.313 -1.003 0 C-N-CA 125.343 1.457 . . . . 0.0 108.141 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 6.0 m-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 77.5 m -69.17 127.4 32.94 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.948 -178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.57 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.9 m-20 -100.14 31.85 3.19 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.216 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.1 158.8 25.32 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.4 mt -77.52 155.62 81.26 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.03 132.6 48.42 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.936 2.424 . . . . 0.0 112.747 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.54 110.94 3.11 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 122.468 2.112 . . . . 0.0 112.018 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -58.55 147.38 32.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.075 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -122.82 169.1 11.45 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.443 -170.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -50.05 -35.88 26.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -127.82 14.82 6.94 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.942 0.401 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 4.1 mp0 -130.79 144.44 51.45 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.428 HD11 ' HG2' ' A' ' 53' ' ' ARG . 8.6 mt -133.46 156.48 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -78.35 145.78 35.05 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-O 121.276 0.56 . . . . 0.0 112.262 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -106.73 109.97 22.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.93 -138.32 9.06 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 t -151.04 132.23 14.45 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.543 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.6 m95 -135.82 122.09 20.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -143.73 24.12 1.71 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . 5.1 t70 -100.7 -173.29 2.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.622 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.13 -25.36 2.24 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.234 0.614 . . . . 0.0 110.18 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 22' ' ' ASN . 6.9 p -142.45 131.18 22.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.839 0.352 . . . . 0.0 111.502 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 39' ' ' ASP . 31.3 m-85 -127.23 143.54 47.49 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.1 Cg_endo -62.56 147.21 95.14 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.7 2.267 . . . . 0.0 111.748 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.8 tt0 -67.73 129.55 40.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.06 1.46 28.39 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.572 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m -83.76 120.15 25.68 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.7 pt20 -93.02 152.23 19.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.379 0.609 . . . . 0.0 111.924 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.99 130.84 53.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.609 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.9 mt -101.47 125.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.3 m-85 -102.33 143.7 31.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 54.7 tttm -92.45 141.5 28.45 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 93.6 m -90.59 16.71 8.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 32' ' ' ILE . 79.0 mtt180 65.81 161.57 0.13 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.315 0.646 . . . . 0.0 111.104 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 40.3 Cg_endo -75.33 140.18 24.29 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 121.189 1.26 . . . . 0.0 110.2 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.66 0.07 60.91 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 92.8 m-85 -128.74 175.84 8.28 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.168 0.509 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 57' ' ' ARG . 4.0 ptm180 -154.99 -171.64 3.9 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 p -163.27 154.3 16.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 120.895 0.379 . . . . 0.0 110.721 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.15 -27.21 59.65 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.44 141.22 7.06 Favored Glycine 0 N--CA 1.408 -3.213 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.36 142.54 51.94 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.15 0.58 . . . . 0.0 111.238 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.4 118.22 10.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -116.11 124.28 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -113.04 166.79 11.08 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.6 p -149.66 143.05 17.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.492 0.663 . . . . 0.0 110.137 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.26 122.75 19.49 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 125.159 1.384 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.0 ttt180 -160.85 132.91 5.92 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 72.4 mmtt 66.19 25.7 10.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.12 0.568 . . . . 0.0 112.376 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 91.95 -10.96 73.35 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.574 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.57 171.92 12.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -93.45 123.35 36.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.33 168.11 9.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.056 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.17 114.89 18.48 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.721 0.296 . . . . 0.0 111.088 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.76 -39.02 92.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -143.65 98.87 5.28 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.72 -4.07 14.18 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.839 2.359 . . . . 0.0 113.101 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.65 -31.13 41.45 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.76 141.43 48.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.895 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -158.27 160.38 37.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -102.58 130.15 49.36 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -126.46 172.64 10.02 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.8 mmtp -64.86 151.52 45.31 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.033 0.533 . . . . 0.0 111.974 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -86.97 151.91 52.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 67.4 Cg_endo -77.07 160.83 33.13 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 121.535 1.49 . . . . 0.0 110.087 176.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -114.85 -22.51 9.6 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.344 -174.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.97 -179.2 53.39 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -78.33 128.12 78.99 Favored Pre-proline 0 C--N 1.289 -2.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 48.17 1.2 Allowed 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.076 3.184 . . . . 0.0 114.177 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 90.59 157.47 33.6 Favored Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.86 126.99 55.25 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.245 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 9.8 t -135.33 125.13 16.6 Favored Pre-proline 0 N--CA 1.412 -2.356 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 9.6 Cg_exo -74.2 -10.88 22.88 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.286 1.991 . . . . 0.0 112.042 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -127.55 141.39 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.14 47.9 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.119 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -163.79 -169.2 1.82 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.201 0.5 . . . . 0.0 109.872 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 46.5 p90 -142.34 160.29 40.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.476 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.6 p -113.61 173.0 6.63 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.2 mt -140.99 118.13 11.27 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -113.14 -7.65 13.61 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.354 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -113.84 28.94 8.11 Favored Glycine 0 CA--C 1.489 -1.562 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.03 -171.07 27.82 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -129.49 10.88 5.73 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.282 1.039 . . . . 0.0 109.616 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 108' ' ' VAL . 35.5 m -140.02 174.73 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 31.0 m-85 -88.94 88.15 7.48 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.76 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.543 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.2 pt-20 -136.24 150.22 48.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.241 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -46.16 116.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.374 1.046 . . . . 0.0 111.027 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.15 -23.43 6.5 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.651 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG12 ' C ' ' A' ' 100' ' ' GLY . 19.9 m -77.71 139.12 19.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.07 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.9 ttmp? -102.4 120.43 40.5 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -101.31 101.3 11.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -84.24 139.96 16.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.777 -176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -97.31 113.54 25.19 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.5 m -117.89 159.38 23.2 Favored 'General case' 0 N--CA 1.402 -2.836 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.09 -62.04 0.73 Allowed 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.473 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -155.83 -170.06 3.29 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.74 -53.27 8.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.582 0.706 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.68 -12.75 82.5 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.721 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -112.41 121.82 45.95 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.019 0.128 . . . . 0.0 110.903 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -102.8 -114.93 0.21 Allowed 'General case' 0 CA--C 1.466 -2.276 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -163.64 156.35 18.11 Favored 'General case' 1 N--CA 1.337 -6.119 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.573 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 67.3 mt -89.92 103.78 16.41 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.104 0.954 . . . . 0.0 109.387 173.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.09 155.14 8.87 Favored Glycine 0 N--CA 1.41 -3.086 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -93.44 -18.3 22.49 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.937 0.875 . . . . 0.0 109.585 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.4 mm -112.38 106.16 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.815 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.4 p-10 -83.81 30.58 0.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.136 0.493 . . . . 0.0 111.399 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -164.2 178.2 7.77 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -173.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.98 138.6 45.54 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 22.6 mt-10 -111.48 136.69 50.29 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.89 107.63 14.76 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.64 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -100.39 -170.43 1.87 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 p -66.64 -40.66 88.82 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 124.525 1.13 . . . . 0.0 110.601 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.0 -35.79 62.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.025 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.37 -152.46 24.34 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.26 126.93 30.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.126 0.463 . . . . 0.0 109.794 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 p -58.94 -35.84 73.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 123.566 0.746 . . . . 0.0 112.913 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -129.08 167.33 17.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.9 -96.95 0.3 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -173.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.427 HD11 ' HA3' ' A' ' 89' ' ' GLY . 24.4 mt -132.81 92.75 25.54 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 121.656 -0.653 . . . . 0.0 111.316 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.844 ' HB2' HD12 ' A' ' 120' ' ' LEU . 3.3 Cg_endo -53.6 137.22 66.15 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 122.736 2.291 . . . . 0.0 109.32 166.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 31.7 mm -87.69 122.87 39.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.898 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 21.0 t -52.29 124.41 13.16 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.952 0.342 . . . . 0.0 110.772 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.424 -1.744 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.239 0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.6 m -84.87 133.53 34.3 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -106.67 27.49 8.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.851 0.834 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 162.4 37.58 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -99.66 158.19 32.59 Favored Pre-proline 0 N--CA 1.39 -3.434 0 O-C-N 124.558 1.161 . . . . 0.0 110.277 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 17.9 Cg_endo -60.12 133.35 49.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.952 2.435 . . . . 0.0 110.684 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.89 170.66 19.55 Favored 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -117.27 139.02 51.33 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -113.37 -176.85 2.99 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -73.54 -27.12 61.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 21.4 p -116.94 0.5 12.45 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -133.3 140.4 47.43 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.515 0.674 . . . . 0.0 112.329 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -138.62 145.74 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.92 142.66 57.21 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.5 p -90.76 -28.32 18.35 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.568 0.699 . . . . 0.0 109.549 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.71 177.4 37.24 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.4 p -113.9 114.87 26.82 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 123.481 0.712 . . . . 0.0 110.316 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -110.48 110.77 21.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -115.89 3.52 13.74 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.631 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.643 ' O ' HD21 ' A' ' 24' ' ' LEU . 40.1 m-20 -101.91 -157.09 0.59 Allowed 'General case' 0 CA--C 1.479 -1.775 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.58 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -133.84 -58.84 0.86 Allowed 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 170.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.9 p -80.98 121.1 25.61 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.44 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 41.1 m-85 -129.33 145.0 54.97 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.086 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.03 143.56 66.24 Favored 'Trans proline' 0 C--O 1.262 1.695 0 C-N-CA 122.635 2.223 . . . . 0.0 111.086 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -63.16 138.82 58.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.36 1.73 50.69 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.203 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.442 ' C ' HG23 ' A' ' 65' ' ' VAL . 92.9 m -85.06 117.42 24.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 pt20 -85.74 149.76 25.06 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.245 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.11 130.08 53.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -100.24 132.8 45.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.57 143.94 44.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.596 0.712 . . . . 0.0 112.595 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.24 142.52 27.31 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 171.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.713 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.8 m -86.8 27.8 0.95 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 70.2 mtp180 61.62 166.61 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 121.451 0.643 . . . . 0.0 111.005 -174.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.14 118.09 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.194 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 171.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.4 -23.38 7.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.069 -1.063 . . . . 0.0 113.051 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.713 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 95.8 m-85 -102.74 179.56 4.25 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 122.023 -0.693 . . . . 0.0 109.368 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -155.75 -174.75 5.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -171.95 168.7 5.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 98.4 mt -87.73 14.48 8.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.861 0.839 . . . . 0.0 110.081 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.05 -146.01 5.78 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.33 150.08 48.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.6 t -73.06 101.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.9 118.64 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.53 175.5 5.48 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.7 p -161.02 144.72 4.54 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.166 0.508 . . . . 0.0 110.464 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.72 121.78 18.6 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.111 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 64.3 ttt180 -150.14 124.34 9.47 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 14.6 mmmm 61.69 22.39 12.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 113.017 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.38 -10.41 65.15 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.487 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.22 157.31 25.08 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.167 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 85.4 m95 -88.59 117.25 27.41 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.14 174.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.39 125.89 37.24 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.462 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.22 -48.39 51.63 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.3 88.23 7.08 Favored Pre-proline 0 N--CA 1.429 -1.515 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.891 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 77' ' ' LEU . 38.3 Cg_endo -69.51 -18.66 38.04 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.333 2.022 . . . . 0.0 111.758 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 ' HG2' ' A' ' 76' ' ' PRO . 3.5 mm? -80.61 -14.3 58.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.76 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' NH1' ' HB2' ' A' ' 59' ' ' LEU . 25.4 mmt180 -95.65 123.44 39.21 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 121.693 0.759 . . . . 0.0 110.231 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.11 151.55 37.02 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.64 112.44 22.32 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.089 0.947 . . . . 0.0 110.918 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -108.14 172.68 6.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.766 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.5 159.0 24.29 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.615 0.722 . . . . 0.0 111.671 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -94.24 144.77 28.58 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 174.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 60.5 Cg_endo -73.35 163.64 37.27 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 121.733 1.622 . . . . 0.0 109.351 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.9 m -115.75 1.11 13.39 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.46 -170.79 53.49 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.752 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -88.35 117.42 68.36 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.34 102.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 113.257 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 88.85 125.48 2.53 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.952 175.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.12 19.0 5.3 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.749 0.785 . . . . 0.0 109.101 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -60.82 134.47 92.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.171 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.5 -4.66 1.97 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.395 2.063 . . . . 0.0 112.349 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.06 -33.66 5.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.09 0.471 . . . . 0.0 111.131 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.22 138.58 18.05 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.329 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.82 156.31 30.9 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.8 p90 -128.77 158.72 37.85 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.241 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 76.8 p -108.87 168.33 9.43 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.87 123.82 22.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.34 0.59 . . . . 0.0 110.089 175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.2 t -132.65 141.46 48.64 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.95 14.12 67.84 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.427 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.18 -52.1 0.05 OUTLIER Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.256 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 79.32 -3.68 2.1 Favored 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 124.236 1.014 . . . . 0.0 112.946 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 m -144.65 175.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.4 m-85 -78.33 94.4 4.83 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.22 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.71 151.11 35.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -42.82 129.33 4.28 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.01 -9.93 74.57 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.679 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.96 138.35 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.285 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.1 ttmt -105.22 120.52 41.75 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.676 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -99.8 99.8 10.66 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -79.18 136.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.478 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 52.8 t80 -102.83 129.18 49.42 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -147.6 149.64 32.91 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.73 -52.78 2.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 -174.6 4.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -87.17 -45.04 11.03 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.7 -32.79 61.11 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.354 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -86.16 119.22 26.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.379 0.609 . . . . 0.0 110.839 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 85.7 mt-30 -110.21 -159.89 0.7 Allowed 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.63 155.1 44.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -82.8 137.99 34.14 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.781 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.2 158.87 12.65 Favored Glycine 0 C--N 1.285 -2.286 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -92.4 -17.45 24.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.219 0.509 . . . . 0.0 110.9 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 126' ' ' TYR . 40.0 mm -112.03 109.42 28.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -86.28 22.64 1.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.4 p90 -151.12 176.22 11.38 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 77.0 mtm180 -142.24 127.92 19.19 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -106.96 138.68 42.68 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.7 t -81.38 97.38 7.7 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.137 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.2 175.47 10.56 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.54 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.6 p -49.47 -41.37 40.18 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 125.666 1.586 . . . . 0.0 112.252 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.46 -27.08 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.017 0.436 . . . . 0.0 111.412 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.96 -170.08 36.73 Favored Glycine 0 C--N 1.303 -1.302 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -65.2 141.57 58.61 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 117.22 0.51 . . . . 0.0 111.71 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.7 p -85.12 133.46 34.21 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 73.81 171.27 0.3 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.543 0.737 . . . . 0.0 110.003 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 127' ' ' ARG . 6.3 p-10 -111.87 -102.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.985 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 89' ' ' GLY . 52.8 mt -126.95 102.65 24.49 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 19.0 Cg_endo -59.72 138.17 81.48 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.042 1.828 . . . . 0.0 110.166 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.48 113.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.478 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 93.9 m -72.85 112.36 8.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.759 0.314 . . . . 0.0 111.402 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.56 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 32.9 mt-10 . . . . . 0 C--N 1.317 -0.83 0 C-N-CA 125.157 1.383 . . . . 0.0 108.523 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.966 0.412 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 41' ' ' THR . 70.1 m -79.9 132.04 35.99 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.505 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -96.22 13.62 26.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.324 0.583 . . . . 0.0 110.414 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.18 160.83 38.41 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.658 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 38.0 mt -84.33 157.42 62.05 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 123.968 0.792 . . . . 0.0 109.262 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 28.7 Cg_endo -64.01 133.2 37.43 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 121.668 1.579 . . . . 0.0 109.946 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.79 162.55 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.026 1.817 . . . . 0.0 111.712 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -98.21 146.73 25.32 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -114.1 173.55 6.39 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -65.09 -34.39 78.3 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -117.63 1.24 12.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -131.78 147.05 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.25 0.547 . . . . 0.0 111.669 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 53' ' ' ARG . 12.6 mt -143.92 156.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 3.9 mm? -72.08 168.96 17.03 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-O 121.916 0.865 . . . . 0.0 112.594 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -123.85 145.48 49.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 171.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.09 -144.98 15.98 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.709 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -139.14 137.76 36.4 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 81.5 m95 -138.84 121.81 16.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.6 m -151.92 24.08 0.66 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.755 0.312 . . . . 0.0 111.331 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 15.8 m-20 -118.31 -169.63 1.74 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.1 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -119.27 -66.1 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.0 p -86.67 127.81 34.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -130.34 140.6 39.14 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.754 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.42 145.19 87.54 Favored 'Trans proline' 0 C--O 1.264 1.779 0 C-N-CA 122.616 2.211 . . . . 0.0 110.801 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.546 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.4 tt0 -65.44 140.99 58.66 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.75 57.36 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.206 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' HG23 ' A' ' 65' ' ' VAL . 75.8 m -85.95 117.91 25.09 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.313 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -88.11 146.08 25.61 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.782 0.801 . . . . 0.0 111.31 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.55 119.67 36.93 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 63' ' ' ILE . 62.4 mt -92.06 120.15 40.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 61.4 m-85 -102.75 141.47 35.51 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -88.35 153.58 21.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.1 m -91.6 25.93 2.5 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 32' ' ' ILE . 70.0 mtp180 62.88 167.91 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -77.59 100.0 1.35 Allowed 'Trans proline' 0 N--CA 1.428 -2.365 0 CA-C-N 119.162 0.736 . . . . 0.0 110.912 174.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 135.5 -17.9 3.95 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.123 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.9 m-85 -110.12 173.15 6.46 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 109.881 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -152.1 -174.66 4.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -168.77 -178.16 3.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.05 14.05 9.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.727 0.775 . . . . 0.0 110.482 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.32 174.7 38.6 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.72 145.93 34.21 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 118.425 1.113 . . . . 0.0 109.362 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 90.8 t -74.19 111.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.421 HD12 HG12 ' A' ' 49' ' ' ILE . 44.6 mm -106.18 122.84 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.011 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.6 mtp -112.07 172.77 6.71 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.418 HG23 ' C ' ' A' ' 46' ' ' THR . 8.2 p -157.41 145.31 10.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-O 121.335 0.588 . . . . 0.0 110.648 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.4 t -69.65 125.81 27.84 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.824 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 34.6 ttp180 -151.76 123.26 7.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm 62.37 25.96 15.5 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 124.267 1.027 . . . . 0.0 113.46 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.97 -15.74 61.19 Favored Glycine 0 N--CA 1.413 -2.883 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.515 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.69 163.7 15.73 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.706 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.415 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 82.1 m95 -97.19 123.87 41.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.329 0.585 . . . . 0.0 109.856 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 171.53 14.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.421 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.79 124.96 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -49.77 56.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -108.26 90.47 6.95 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.169 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.49 -11.95 26.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.791 2.327 . . . . 0.0 114.089 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -90.8 -19.87 22.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.087 0.47 . . . . 0.0 110.352 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 7.6 mmp_? -92.69 134.11 35.35 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.8 0.81 . . . . 0.0 112.468 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 166.3 32.92 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 172.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.9 m -91.96 129.4 37.93 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.59 0.709 . . . . 0.0 111.173 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.34 167.98 14.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.519 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 95.5 mttt -65.62 136.43 56.32 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.573 0.225 . . . . 0.0 111.351 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.7 ptp180 -78.35 147.01 71.59 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.45 159.46 32.51 Favored 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.868 1.712 . . . . 0.0 109.631 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.8 m -118.24 8.49 12.31 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 121.463 0.649 . . . . 0.0 111.488 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.33 -85.93 1.23 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.497 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -168.06 147.88 4.28 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.75 53.13 2.7 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.346 2.031 . . . . 0.0 111.615 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 80.97 -96.31 1.69 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.5 t70 169.56 126.63 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 125.493 1.517 . . . . 0.0 107.674 171.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -120.88 117.53 30.95 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.67 1.92 7.88 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.149 1.899 . . . . 0.0 111.112 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -115.19 -55.39 2.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.851 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 114' ' ' CYS . . . -73.54 150.58 43.55 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 m -92.63 -55.92 3.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . 0.274 1.9 p90 70.16 145.93 0.06 Allowed 'General case' 0 C--O 1.248 0.985 0 C-N-CA 126.558 1.943 . . . . 0.0 114.493 173.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.611 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -117.03 148.15 41.73 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.994 179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.584 HD22 ' CG1' ' A' ' 108' ' ' VAL . 83.0 mt -109.12 135.96 49.4 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.7 t -138.23 139.01 39.05 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.55 -26.36 16.53 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.18 164.69 34.17 Favored Glycine 0 CA--C 1.489 -1.568 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.458 ' O ' HG13 ' A' ' 103' ' ' VAL . 48.7 t-20 -123.12 60.18 1.06 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 118.173 0.986 . . . . 0.0 110.006 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.0 m -168.65 -178.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.634 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 172.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.08 84.31 5.26 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.911 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.26 157.42 39.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.804 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 62.7 t80 -58.55 122.32 13.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.758 0.79 . . . . 0.0 111.767 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.5 -19.38 12.87 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.584 ' CG1' HD22 ' A' ' 98' ' ' LEU . 24.1 t -71.72 129.94 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.723 0.773 . . . . 0.0 112.066 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.1 ttmt -102.91 119.71 39.32 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.61 93.24 7.03 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.611 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.5 p -79.14 109.29 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-O 122.35 1.071 . . . . 0.0 109.116 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.8 t80 -80.89 103.56 10.81 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 113.837 -1.528 . . . . 0.0 110.878 -169.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 m -74.47 -38.29 62.96 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.644 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 45.8 t 72.73 -92.83 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.348 0 O-C-N 125.312 1.632 . . . . 0.0 108.906 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -137.2 -174.48 3.76 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.96 -42.67 14.71 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.57 0.7 . . . . 0.0 109.198 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.68 -22.9 54.94 Favored Glycine 0 C--N 1.308 -1.001 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.909 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.03 128.73 55.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.481 -0.423 . . . . 0.0 111.001 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -111.34 -148.15 0.43 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -117.22 166.72 11.93 Favored 'General case' 1 N--CA 1.376 -4.131 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.604 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 32.6 mt -97.32 106.12 18.39 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.559 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.6 166.2 14.43 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -84.68 -27.56 26.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.132 0.968 . . . . 0.0 108.515 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.0 109.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.31 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -97.43 23.88 7.16 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.141 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 37.2 p90 -159.01 178.31 10.2 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.399 0.619 . . . . 0.0 110.519 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -149.68 129.03 12.91 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.962 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 36.3 mt-10 -101.51 157.48 16.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 122.8 34.96 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.841 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.9 t70 -101.98 -169.12 1.63 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.439 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 48.5 p -71.72 -37.35 70.64 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 124.585 1.154 . . . . 0.0 108.492 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.05 -52.11 15.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.044 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.02 -150.25 16.07 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.23 137.73 45.15 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.024 0.912 . . . . 0.0 110.336 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.2 p -81.05 167.64 19.53 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.48 -111.39 0.27 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.325 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -167.8 -178.61 3.9 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.469 HD11 ' HA3' ' A' ' 89' ' ' GLY . 82.9 mt -94.93 103.83 12.87 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.4 Cg_endo -48.24 127.79 16.02 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.269 2.646 . . . . 0.0 112.584 -176.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.8 mm -75.06 115.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.732 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.3 m -61.61 121.4 12.67 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 N--CA 1.425 -1.697 0 C-N-CA 126.445 1.898 . . . . 0.0 107.791 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 35.4 m-20 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 120.751 0.31 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.8 m -65.67 139.93 58.44 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.6 m-20 -117.89 18.74 13.94 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.357 0.599 . . . . 0.0 109.729 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.07 159.22 37.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.729 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 mt -79.5 153.3 76.19 Favored Pre-proline 0 C--N 1.31 -1.137 0 O-C-N 123.873 0.733 . . . . 0.0 109.15 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 128.67 30.72 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.457 2.104 . . . . 0.0 111.166 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.68 123.38 12.9 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.488 2.126 . . . . 0.0 111.409 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -68.1 149.55 49.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.501 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.1 mmp_? -112.51 178.56 4.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.229 -171.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -82.25 -58.94 2.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.48 -8.53 35.06 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.955 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.5 mp0 -109.02 142.53 39.58 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.985 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mt -133.09 150.4 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.848 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.75 140.42 53.44 Favored 'General case' 0 C--N 1.277 -2.58 0 O-C-N 124.245 0.966 . . . . 0.0 111.084 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.0 p -87.21 -34.33 19.03 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.207 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.4 167.43 26.1 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.434 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 p -105.26 118.23 36.02 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -99.71 161.97 13.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -130.79 -23.79 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -137.01 162.48 33.2 Favored 'General case' 0 C--O 1.183 -2.446 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.423 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.3 -29.48 26.34 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.498 0.666 . . . . 0.0 109.641 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.6 p -97.16 108.4 21.12 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-O 121.88 0.848 . . . . 0.0 112.431 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -118.1 157.83 47.75 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.511 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 47.6 Cg_endo -70.67 152.8 64.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 121.628 1.552 . . . . 0.0 110.875 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.42 151.8 45.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.24 74.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.617 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -83.05 121.14 26.65 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.956 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.6 pt20 -91.01 146.45 23.85 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.675 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.88 117.03 29.06 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.44 130.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 65.1 m-85 -104.19 139.43 39.25 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -75.13 -29.51 60.55 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.319 -1.764 . . . . 0.0 113.656 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.7 m 71.29 3.05 4.51 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 72.86 152.35 0.14 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.96 108.87 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.554 2.17 . . . . 0.0 112.738 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.41 7.01 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.476 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 96.4 m-85 -98.81 168.14 10.32 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 122.103 -0.645 . . . . 0.0 110.465 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -133.21 -175.93 3.96 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -157.08 -175.93 5.69 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -104.76 16.22 26.41 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.123 0.487 . . . . 0.0 110.073 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.45 29.82 0.07 OUTLIER Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.49 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.56 144.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.977 1.311 . . . . 0.0 112.049 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.6 t -76.98 116.4 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.25 124.55 69.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.804 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.44 168.77 9.15 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.9 p -155.45 149.99 11.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.8 t -84.08 128.73 34.75 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.84 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.423 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -144.95 124.84 13.44 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -178.534 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 35.3 mmtp 59.23 29.56 19.14 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 94.35 -17.48 58.88 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.934 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 167.17 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.715 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.79 122.46 46.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 -168.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.693 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.48 23.04 Favored 'General case' 1 C--N 1.225 -4.825 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.967 -171.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.85 -53.99 13.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.83 80.6 49.5 Favored Pre-proline 0 N--CA 1.419 -1.997 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.263 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.61 -13.06 22.44 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.743 2.295 . . . . 0.0 110.969 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.3 mm? -68.69 -30.1 68.69 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.714 177.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -81.25 143.56 32.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.566 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.8 158.65 43.54 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -94.57 106.95 18.94 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.45 160.75 14.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.95 146.56 39.54 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.11 140.23 61.54 Favored Pre-proline 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.421 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.51 145.47 47.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.095 1.863 . . . . 0.0 109.624 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.9 m -104.55 -14.99 15.46 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.997 0.427 . . . . 0.0 111.686 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.61 -167.67 54.77 Favored Glycine 0 N--CA 1.412 -2.927 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.433 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -68.74 119.73 71.1 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 124.323 1.049 . . . . 0.0 109.583 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 72.8 Cg_endo -80.34 -6.67 13.83 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.15 2.567 . . . . 0.0 112.295 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 112.73 134.65 6.2 Favored Glycine 0 N--CA 1.406 -3.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.93 174.39 7.26 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.861 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -162.53 127.37 2.07 Favored Pre-proline 0 N--CA 1.412 -2.362 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -88.85 -4.18 6.24 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.089 1.859 . . . . 0.0 111.555 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.71 -47.42 3.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.469 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.51 -172.31 25.83 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.262 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 m -145.98 167.37 23.48 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -143.72 157.52 44.33 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.255 0.479 . . . . 0.0 110.11 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -119.95 154.0 35.1 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.794 0.684 . . . . 0.0 110.5 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 94.6 mt -115.2 133.33 56.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 109' ' ' LYS . 6.1 t -127.39 148.17 50.27 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.72 -66.62 3.57 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.068 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.51 -43.24 6.59 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.427 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t30 75.37 -4.41 2.38 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 122.105 0.955 . . . . 0.0 111.684 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.16 -178.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -88.18 79.46 7.86 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.376 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.77 151.09 52.07 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.842 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -45.11 122.33 3.3 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.447 0.699 . . . . 0.0 111.756 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.36 -16.52 32.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.615 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.57 147.06 7.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 O-C-N 122.391 -0.476 . . . . 0.0 110.358 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.449 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.4 ttmp? -114.45 127.57 55.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.37 88.01 3.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.6 p -80.97 124.02 38.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.705 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -102.02 141.3 35.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.363 -168.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.27 161.94 34.87 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.29 -74.24 0.35 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.922 -1.511 . . . . 0.0 110.695 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -141.25 -177.79 5.29 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.56 152.54 21.05 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.38 -43.91 1.93 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.29 132.1 22.7 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -104.22 -61.43 1.45 Allowed 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.851 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 125' ' ' ASN . 4.2 pp 179.52 157.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.387 1.054 . . . . 0.0 109.17 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 81.3 mt -97.71 132.03 43.72 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.71 148.12 5.67 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -84.51 -19.94 32.44 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.286 1.041 . . . . 0.0 109.581 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 126' ' ' TYR . 38.6 mm -103.06 92.46 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.046 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 120' ' ' LEU . 23.0 p-10 -83.17 29.69 0.48 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 124.763 1.225 . . . . 0.0 110.312 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 124' ' ' ILE . 52.4 p90 -161.7 179.05 8.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -142.03 121.5 13.24 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.451 ' HG3' ' CD2' ' A' ' 126' ' ' TYR . 48.3 mt-10 -103.07 141.43 35.83 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -91.44 112.16 23.96 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.196 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 131' ' ' THR . 21.3 t70 -99.76 -164.61 1.14 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.261 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.461 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 46.9 p -66.01 -42.53 89.56 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.447 1.099 . . . . 0.0 110.327 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.61 -41.48 79.46 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.162 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.55 -141.45 9.53 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.516 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.5 m95 -72.44 130.96 41.92 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 117.007 0.403 . . . . 0.0 111.557 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.2 p -83.82 129.09 34.94 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.9 m120 74.73 166.92 0.29 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.74 0.781 . . . . 0.0 111.611 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.66 -173.29 2.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.474 HD11 ' HA3' ' A' ' 89' ' ' GLY . 17.9 mt -71.66 116.57 49.15 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.08 129.07 24.59 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 121.505 1.47 . . . . 0.0 110.927 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.3 123.17 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.642 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 65.9 m -66.19 109.22 2.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.46 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 8.4 tp10 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.071 0.939 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.2 m -77.93 124.61 28.21 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.717 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -95.65 21.37 8.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.133 0.968 . . . . 0.0 109.589 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.73 155.82 43.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.163 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.5 150.35 79.42 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 124.151 0.907 . . . . 0.0 111.558 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.93 139.94 44.48 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.187 1.925 . . . . 0.0 109.655 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.22 155.81 66.63 Favored 'Trans proline' 0 C--N 1.328 -0.538 0 C-N-CA 122.56 2.173 . . . . 0.0 113.743 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -97.09 134.47 40.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -109.11 151.05 26.94 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.617 -173.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -64.6 -31.48 72.71 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.0 -15.68 16.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -133.87 137.04 44.74 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 112.347 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 56.4 mt -115.73 158.98 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HB3' ' NE1' ' A' ' 37' ' ' TRP . 33.3 mt -94.07 142.21 27.65 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 119.012 0.824 . . . . 0.0 111.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.4 p -98.12 151.94 19.86 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.53 -155.01 20.82 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -133.54 114.86 14.04 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' NE1' ' HB3' ' A' ' 33' ' ' LEU . 44.6 m95 -122.69 99.23 6.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.7 m -135.0 -0.99 2.71 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.984 0.421 . . . . 0.0 110.348 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.33 150.1 22.04 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.522 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -82.61 -51.27 7.91 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.978 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 38.7 p -95.8 106.33 18.44 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.16 129.72 23.72 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.847 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.52 150.44 68.81 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.9 131.78 49.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.57 7.33 48.68 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.295 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -86.38 114.84 23.49 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.985 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.4 pt20 -90.01 136.33 33.11 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-O 121.766 0.793 . . . . 0.0 111.669 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.38 121.33 43.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.074 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 63' ' ' ILE . 68.5 mt -97.12 113.46 31.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.101 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -83.59 136.46 34.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.377 1.084 . . . . 0.0 113.177 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 60.9 tttp -66.18 -28.6 68.9 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.095 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 15.9 t 72.43 -4.39 2.06 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.947 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 71.91 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 124.487 1.115 . . . . 0.0 111.472 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 55.8 Cg_endo -70.15 120.82 7.47 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 121.462 1.442 . . . . 0.0 110.381 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 118.19 -20.12 10.65 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 93.5 m-85 -101.52 170.44 8.2 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -156.64 169.1 25.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.6 p -143.87 -177.05 5.24 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.23 21.73 1.35 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.67 0.748 . . . . 0.0 110.737 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.9 -96.1 0.12 Allowed Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -154.57 150.62 27.93 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.44 105.93 4.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG12 ' A' ' 49' ' ' ILE . 45.3 mm -105.84 120.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.617 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.5 mtp -106.73 164.99 11.64 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 6.8 p -150.35 145.83 16.86 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.742 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.114 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 48.1 t -73.68 121.37 20.64 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.288 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 34.2 ttt180 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 74.2 mmtt 65.12 23.65 12.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.82 0.848 . . . . 0.0 112.278 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.78 -2.43 72.84 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.889 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 153.24 47.43 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.77 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.2 121.66 28.27 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.771 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.04 173.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.655 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.23 123.64 29.2 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.77 -39.95 94.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -139.54 100.56 7.53 Favored Pre-proline 0 N--CA 1.422 -1.829 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.703 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.0 -3.38 13.7 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.846 2.364 . . . . 0.0 111.912 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.6 mt -91.09 -6.5 53.64 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 122.213 1.006 . . . . 0.0 109.801 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 78' ' ' ARG . 20.1 mmt180 -99.39 122.59 42.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.961 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.35 147.62 40.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.988 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.1 m -87.39 128.22 35.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.659 0.742 . . . . 0.0 111.848 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -128.6 169.21 14.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 106' ' ' TYR . 48.0 mtmt -82.46 144.73 30.26 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.531 ' NH1' ' HA ' ' A' ' 132' ' ' ASP . 12.8 ptm180 -67.32 156.77 87.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.643 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 73.3 Cg_endo -77.92 160.76 30.43 Favored 'Trans proline' 0 C--O 1.256 1.397 0 C-N-CA 121.968 1.779 . . . . 0.0 109.769 172.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.9 m -127.31 1.27 6.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.511 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.91 1.04 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.753 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -155.23 135.87 8.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.97 13.63 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.973 2.449 . . . . 0.0 113.059 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 81.27 -166.3 47.87 Favored Glycine 0 N--CA 1.41 -3.042 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.56 171.52 19.81 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -132.45 121.35 17.36 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.45 -43.72 43.11 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.416 2.744 . . . . 0.0 114.575 -171.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.24 26.49 5.91 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.63 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -142.13 174.94 23.01 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.265 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.21 168.09 19.8 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.423 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . 53.2 p90 -143.09 156.16 44.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.277 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 p -125.24 169.13 12.57 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 124.213 1.005 . . . . 0.0 108.864 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.64 164.36 19.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.387 0.613 . . . . 0.0 111.469 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.0 t -162.03 147.97 13.34 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 175.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 20.77 41.46 Favored Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.566 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.91 -58.8 0.32 Allowed Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 82.68 35.2 0.06 Allowed 'General case' 0 CA--C 1.457 -2.602 0 CA-C-O 123.807 1.765 . . . . 0.0 109.357 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 8.2 p -156.29 -162.3 0.02 OUTLIER 'Isoleucine or valine' 1 N--CA 1.373 -4.294 0 CA-C-N 110.868 -2.878 . . . . 0.0 103.587 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 75.4 m-85 -113.16 83.85 1.9 Allowed 'General case' 1 C--N 1.225 -4.848 0 CA-C-O 121.577 0.704 . . . . 0.0 111.554 -176.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 25.4 pt-20 -143.36 163.5 32.88 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.368 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.454 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 58.8 t80 -49.78 131.94 22.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.311 1.007 . . . . 0.0 111.498 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.39 -13.31 63.04 Favored Glycine 0 N--CA 1.421 -2.344 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.45 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -77.25 145.21 10.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.572 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.7 ttmt -108.93 118.83 37.82 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.043 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.38 98.17 11.61 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -91.04 122.64 42.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 82.1 m-85 -96.04 141.59 29.26 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.303 1.049 . . . . 0.0 111.768 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -145.91 138.76 25.78 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 103.106 -2.924 . . . . 0.0 103.106 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 120' ' ' LEU . 58.6 m -95.38 -87.69 0.27 Allowed 'General case' 0 C--N 1.252 -3.668 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.622 -168.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -148.72 -173.05 4.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -49.82 -54.03 21.8 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.953 1.301 . . . . 0.0 112.816 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.69 13.22 27.45 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.389 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' CYS . 35.4 m-85 -114.87 128.48 56.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.97 -159.7 0.69 Allowed 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 163.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.612 ' HB3' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -139.29 151.89 46.81 Favored 'General case' 1 N--CA 1.334 -6.23 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.766 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 107.71 9.13 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.365 0.602 . . . . 0.0 111.064 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.52 140.55 4.21 Favored Glycine 0 N--CA 1.419 -2.458 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.185 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.72 -5.95 52.3 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.405 0.621 . . . . 0.0 111.312 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.418 HG21 ' ND2' ' A' ' 136' ' ' ASN . 44.2 mm -108.82 90.96 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB3' HD21 ' A' ' 120' ' ' LEU . 26.8 p-10 -86.54 42.87 1.03 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.44 -176.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -167.5 174.06 8.18 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.719 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 135' ' ' THR . 6.2 ptm180 -156.35 134.44 11.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -102.88 158.54 16.21 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.593 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -94.28 126.55 39.6 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.848 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 131' ' ' THR . 20.7 t70 -100.07 -156.05 0.53 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.51 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 51.2 p -66.4 -25.54 66.82 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 125.217 1.407 . . . . 0.0 113.761 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 12.8 t70 -129.58 -44.48 1.22 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.216 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.67 -172.4 15.18 Favored Glycine 0 CA--C 1.486 -1.744 0 C-N-CA 119.355 -1.402 . . . . 0.0 112.48 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -85.87 142.26 29.01 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.927 0.394 . . . . 0.0 110.236 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 75.2 p -79.21 170.77 16.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.418 ' ND2' HG21 ' A' ' 124' ' ' ILE . 12.8 m120 61.7 -155.06 0.35 Allowed 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -141.84 178.1 7.73 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.482 HD11 ' HA3' ' A' ' 89' ' ' GLY . 89.0 mt -82.48 114.24 50.18 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.582 ' HB2' HD12 ' A' ' 120' ' ' LEU . 18.9 Cg_endo -66.86 126.54 15.45 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.065 2.51 . . . . 0.0 111.243 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.44 128.81 39.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 68.8 m -81.27 111.24 17.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.04 0.448 . . . . 0.0 110.485 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.735 1.214 . . . . 0.0 109.998 -175.724 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 15.6 m-20 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 121.743 0.783 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -72.99 138.08 45.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.42 -177.861 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -116.08 30.61 7.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -164.81 158.24 17.25 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.541 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.5 mt -80.38 154.03 74.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 123.499 0.72 . . . . 0.0 109.469 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 9.8 Cg_endo -54.48 130.27 39.18 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.707 2.272 . . . . 0.0 111.196 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.11 126.48 13.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.206 1.937 . . . . 0.0 111.165 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -60.37 134.67 57.29 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 121.552 0.691 . . . . 0.0 109.695 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 3.3 mmp_? -87.06 174.59 8.57 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.546 -171.174 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -73.66 -43.71 58.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.59 0.556 . . . . 0.0 110.569 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 80' ' ' CYS . 4.3 p -122.74 19.02 10.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.611 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 1.8 mp0 -137.67 150.12 47.1 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.038 0.446 . . . . 0.0 111.611 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.8 mt -133.55 154.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.0 mm? -76.36 147.55 38.01 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.253 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 44.0 p -114.54 113.9 25.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.41 -155.13 26.18 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.2 m -137.95 98.35 3.63 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.566 ' HB3' HD22 ' A' ' 24' ' ' LEU . 85.1 m95 -95.23 97.5 9.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.263 -177.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 p -106.53 1.27 25.27 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.061 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 1.6 m-20 -119.48 -169.49 1.77 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.777 -171.082 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -129.95 -43.46 1.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 71.4 p -98.29 131.94 44.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.189 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 48.8 m-85 -138.64 154.93 73.62 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.478 0.711 . . . . 0.0 109.568 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 23.4 Cg_endo -65.73 150.6 86.03 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.354 2.036 . . . . 0.0 112.502 178.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.27 147.64 49.47 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.97 -10.95 70.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.604 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 91.9 m -67.77 116.3 8.29 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 122.302 0.241 . . . . 0.0 110.474 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 27.8 pt20 -93.66 125.09 38.08 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.315 1.055 . . . . 0.0 110.003 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.78 122.06 35.86 Favored 'General case' 0 C--N 1.271 -2.805 0 C-N-CA 125.539 1.535 . . . . 0.0 107.592 178.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.1 mt -93.25 118.23 38.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.648 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.7 m-85 -96.51 144.68 26.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.76 0.79 . . . . 0.0 112.988 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 34' ' ' THR . 57.6 tttp -89.31 132.65 34.83 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 13.4 t -82.2 37.52 0.5 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 59.74 154.51 0.1 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.712 1.205 . . . . 0.0 113.671 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.27 92.69 0.47 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 121.304 1.336 . . . . 0.0 110.491 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 137.65 -21.34 3.23 Favored Glycine 0 N--CA 1.429 -1.814 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.564 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.687 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.5 m-85 -103.39 168.63 9.04 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.11 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -150.89 176.28 11.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 176.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 t -160.08 -165.62 1.52 Allowed 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.89 -12.94 60.05 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.959 0.885 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.77 44.85 Favored Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 177.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.32 138.21 57.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.455 0.627 . . . . 0.0 109.717 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.57 123.91 25.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 47' ' ' GLN . 46.3 mm -117.52 125.58 74.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.014 -176.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 28' ' ' ARG . 86.9 mtp -124.36 134.44 53.14 Favored 'General case' 0 CA--C 1.424 -3.871 0 CA-C-O 121.515 0.674 . . . . 0.0 110.038 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.699 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 1.3 m -129.85 149.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.84 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.873 -168.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.01 128.66 34.68 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.29 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -153.71 121.88 6.13 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.25 32.2 12.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.807 0.843 . . . . 0.0 110.935 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.03 -18.28 36.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.463 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.69 165.68 11.09 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.402 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.1 m95 -106.02 116.07 31.3 Favored 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -127.41 -166.71 0.48 Allowed 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.652 -173.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.78 127.71 45.91 Favored 'General case' 1 C--N 1.218 -5.149 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.319 -172.136 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HB2' ' CG1' ' A' ' 65' ' ' VAL . 2.2 tm? -80.61 -54.82 5.31 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -106.87 94.37 10.43 Favored Pre-proline 0 N--CA 1.407 -2.578 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.687 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.74 -9.91 24.39 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.705 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -90.0 26.81 1.74 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 110.347 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.86 139.88 53.55 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.241 179.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -166.86 145.26 5.14 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 50.0 m -78.02 126.49 30.9 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 122.116 0.96 . . . . 0.0 113.534 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -119.67 153.42 35.6 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.038 -179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -72.02 136.2 46.63 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.386 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.3 ptp180 -78.13 145.25 68.78 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.3 166.08 29.56 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.197 1.932 . . . . 0.0 112.185 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.6 m -120.05 8.09 10.95 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.066 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.96 -96.76 0.88 Allowed Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.785 177.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -150.1 138.61 12.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.85 53.68 4.51 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.122 2.548 . . . . 0.0 112.133 -177.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.651 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 75.55 -143.58 30.53 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.16 153.25 31.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -150.1 135.25 9.81 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.78 -60.12 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.919 1.746 . . . . 0.0 109.967 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -123.49 154.44 39.13 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 130.89 150.43 6.78 Favored Glycine 0 C--N 1.282 -2.466 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 114' ' ' CYS . 4.4 m -145.29 158.7 43.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -175.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -144.3 161.09 39.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -123.02 146.21 47.84 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 91.8 mt -104.41 153.88 20.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.603 0.24 . . . . 0.0 110.529 -176.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -149.05 138.93 21.99 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.14 -12.89 58.85 Favored Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.28 170.48 42.61 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -111.35 10.85 21.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 117.698 0.749 . . . . 0.0 109.65 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 104' ' ' PHE . 5.8 p -141.04 -166.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.503 ' H ' HG22 ' A' ' 103' ' ' VAL . 29.4 m-85 -99.19 86.03 3.34 Favored 'General case' 1 C--N 1.241 -4.119 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.046 -176.995 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.2 pt-20 -136.59 151.99 49.96 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.795 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.9 t80 -48.01 124.42 7.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.229 0.538 . . . . 0.0 112.167 176.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.89 56.3 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.832 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 105' ' ' GLU . 4.5 p -83.65 144.76 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-N 117.492 0.646 . . . . 0.0 109.64 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -111.03 125.98 54.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.44 95.31 7.57 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.15 114.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.09 132.83 34.26 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.3 m -142.66 -28.28 0.59 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -172.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.533 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 96.2 m 69.79 -99.09 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 177.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -148.76 -158.69 0.94 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.21 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.86 -58.05 3.53 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.915 0.486 . . . . 0.0 110.894 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.07 4.37 74.48 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.889 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -117.91 133.55 55.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -127.48 -100.01 0.36 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.347 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.2 pp -179.78 145.29 0.22 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.056 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 142' ' ' GLU . 2.5 mm? -95.04 142.77 27.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.511 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.67 -173.86 18.15 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.06 -12.0 12.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.635 0.718 . . . . 0.0 111.078 178.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.59 114.96 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -91.61 17.74 8.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.493 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.57 179.06 9.22 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.298 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -158.35 130.5 6.89 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.606 171.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.27 157.16 17.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 -176.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 48.1 m -87.64 117.39 26.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.744 172.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 131' ' ' THR . 22.3 t70 -103.92 -158.69 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.49 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 63.3 p -67.54 -44.69 77.7 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 124.142 0.977 . . . . 0.0 112.965 -173.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.4 -43.42 17.36 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.747 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.93 -129.82 1.91 Allowed Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.839 -176.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -78.95 125.45 29.39 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 0.0 112.137 -172.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -65.53 -25.97 67.68 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.404 1.082 . . . . 0.0 112.699 -177.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -138.47 169.09 18.41 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -91.57 -174.31 3.84 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.651 HD11 ' HA3' ' A' ' 89' ' ' GLY . 55.7 mt -86.62 112.6 47.84 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 123.55 0.74 . . . . 0.0 109.251 -176.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.34 147.0 96.68 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.752 1.635 . . . . 0.0 109.811 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.494 HG22 ' HG2' ' A' ' 142' ' ' GLU . 41.6 mm -81.78 108.63 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.127 -173.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 19.9 t -63.3 119.12 9.04 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 140' ' ' ILE . 22.7 mm-40 . . . . . 0 C--N 1.307 -1.241 0 C-N-CA 123.509 0.724 . . . . 0.0 109.217 -174.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 52.6 m-20 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.4 m -68.96 141.8 54.86 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.883 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -112.41 19.51 17.54 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.25 156.92 37.92 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' CD2' ' HA ' ' A' ' 40' ' ' GLN . 3.6 mm? -85.69 153.97 58.49 Favored Pre-proline 1 N--CA 1.373 -4.276 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.964 -179.04 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 Cg_endo -53.55 122.23 10.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 123.328 2.685 . . . . 0.0 112.32 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.8 Cg_exo -64.58 131.94 31.38 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.282 1.988 . . . . 0.0 110.448 179.228 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -62.54 145.13 55.12 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.264 0.554 . . . . 0.0 110.43 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 18.8 mmm180 -98.1 166.17 11.55 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -81.72 -51.39 8.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.758 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.21 -1.8 57.63 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.141 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 18.1 mp0 -132.65 158.54 42.01 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.979 0.419 . . . . 0.0 111.993 -178.051 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -142.36 150.2 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.37 154.53 31.64 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.336 0.588 . . . . 0.0 110.705 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.5 p -91.11 -23.57 20.26 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.566 0.698 . . . . 0.0 111.138 177.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.87 -178.27 15.35 Favored Glycine 0 C--N 1.289 -2.029 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.2 t -103.13 149.84 24.23 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.194 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.568 ' HB3' HD12 ' A' ' 24' ' ' LEU . 8.2 m95 -138.07 138.82 39.15 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -178.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -142.21 16.48 2.07 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.217 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 24' ' ' LEU . 15.1 m-20 -128.93 124.91 36.35 Favored 'General case' 0 CA--C 1.465 -2.311 0 C-N-CA 118.464 -1.294 . . . . 0.0 112.276 -175.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.587 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 21.7 mp0 -54.11 -49.84 68.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 124.764 1.29 . . . . 0.0 112.868 -175.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -96.25 128.74 43.44 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.198 -1.001 . . . . 0.0 113.682 -172.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -134.92 148.75 68.27 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.541 176.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -69.0 149.13 71.38 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.444 2.096 . . . . 0.0 112.705 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -66.3 136.24 55.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.68 -3.92 36.66 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.437 -177.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -82.86 118.85 23.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.0 pt20 -88.53 143.78 26.75 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.545 0.688 . . . . 0.0 111.982 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.24 114.45 27.94 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.225 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -89.36 127.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.54 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 90.6 m-85 -109.2 141.85 40.86 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.617 0.722 . . . . 0.0 111.988 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -89.67 147.69 23.73 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 168.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.791 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 91.2 m -102.44 37.47 1.9 Allowed 'General case' 0 C--N 1.249 -3.795 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.605 -174.052 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 65.86 159.6 0.13 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.574 0.702 . . . . 0.0 111.532 178.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.52 113.8 3.62 Favored 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 109.706 -0.921 . . . . 0.0 109.706 172.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 131' ' ' THR . . . 118.24 -20.43 10.48 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.593 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.791 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.1 m-85 -107.1 161.32 14.86 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.578 178.17 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.474 ' NE ' ' HD3' ' A' ' 84' ' ' PRO . 16.0 ptt180 -160.79 -176.34 5.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.558 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.7 p -169.22 177.92 4.58 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 170.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.12 31.8 0.71 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.86 0.838 . . . . 0.0 110.213 177.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.0 -140.32 3.21 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -142.66 157.72 44.39 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -78.97 104.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.33 122.1 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.963 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.5 mtp -109.44 169.79 8.47 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.2 p -155.39 144.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.659 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t -68.4 123.15 20.0 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.716 177.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.4 ttm180 -157.19 129.84 7.53 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 35.7 mmtp 66.53 15.89 10.24 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.891 0.876 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.58 65.87 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.959 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.67 172.34 9.35 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.459 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -103.58 119.65 39.32 Favored 'General case' 0 CA--C 1.462 -2.428 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.3 -170.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.943 -175.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.57 121.1 39.07 Favored 'General case' 1 C--N 1.22 -5.024 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.221 -172.319 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -71.43 -54.42 10.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -119.72 100.38 49.0 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.65 -4.45 13.51 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.042 2.495 . . . . 0.0 112.366 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.27 -31.94 22.83 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.633 -178.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -89.29 135.33 33.64 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.365 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 158.55 44.28 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . 0.383 67.5 m -95.59 127.67 41.81 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 117.745 -1.582 . . . . 0.0 114.82 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.36 -175.69 2.76 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.756 -2.02 . . . . 0.0 108.096 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -71.99 152.92 42.12 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.077 0.465 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.16 152.97 46.59 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' NE ' ' A' ' 57' ' ' ARG . 66.2 Cg_endo -90.24 152.62 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.451 1.434 . . . . 0.0 112.84 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 70.9 m -124.96 76.79 1.56 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.55 93.51 0.01 OUTLIER Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.242 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 70.93 125.59 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.968 1.707 . . . . 0.0 111.42 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.69 38.68 0.4 Allowed 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 114.427 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 108.63 -127.72 8.73 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 138' ' ' ILE . 4.0 p30 -162.87 158.88 23.12 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -171.65 129.53 0.68 Allowed Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.51 -14.23 11.73 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.374 1.383 . . . . 0.0 111.016 174.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.46 89.32 2.37 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.354 0.597 . . . . 0.0 111.129 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 164.81 165.88 22.83 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.9 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -139.37 165.46 27.16 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -139.06 155.91 47.57 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 p -130.73 140.42 50.34 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -103.39 140.38 37.53 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 109' ' ' LYS . 5.1 t -133.69 19.52 3.88 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 121.708 0.766 . . . . 0.0 111.876 -176.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -141.9 25.4 2.4 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.53 174.88 17.18 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -119.25 20.44 12.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 117.903 0.852 . . . . 0.0 109.751 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' HG11 ' A' ' 108' ' ' VAL . 23.4 m -138.2 175.11 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' CYS . 52.7 m-85 -90.89 97.73 11.36 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.001 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.96 154.36 41.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.428 -177.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -51.19 116.87 2.23 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.306 1.004 . . . . 0.0 111.083 177.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.05 -25.18 7.18 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.278 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -74.72 137.77 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.344 178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.5 ttmt -106.02 121.64 44.54 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.72 94.52 9.41 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.77 122.32 32.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -94.1 132.14 38.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -153.98 156.43 37.41 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 83.9 m -132.68 -72.62 0.51 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.95 -174.05 3.21 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.47 -51.53 6.46 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.352 0.596 . . . . 0.0 110.763 -177.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.27 -18.93 79.91 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.202 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -98.77 137.67 37.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.54 -107.42 0.37 Allowed 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.5 pp 179.19 141.5 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.779 1.232 . . . . 0.0 109.666 176.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.1 mm? -89.11 134.75 33.89 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.407 0.622 . . . . 0.0 110.338 176.223 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.09 161.38 11.03 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -174.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -92.42 -21.65 20.08 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.469 0.652 . . . . 0.0 109.415 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' ND2' ' A' ' 136' ' ' ASN . 25.7 mm -104.99 106.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.953 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -88.15 24.9 1.72 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.535 1.134 . . . . 0.0 111.395 -175.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.418 ' CE1' HG23 ' A' ' 124' ' ' ILE . 47.4 p90 -159.58 171.61 19.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.256 0.551 . . . . 0.0 110.768 -173.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -135.18 131.74 37.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 12.8 mt-10 -104.37 139.1 39.81 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 118.242 0.473 . . . . 0.0 110.794 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.72 104.14 10.11 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.0 t70 -105.94 -159.81 0.72 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.973 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.2 p -60.7 -29.49 69.36 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.743 1.617 . . . . 0.0 114.555 -171.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -118.44 -28.56 5.7 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.553 0.692 . . . . 0.0 110.959 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.91 -157.11 28.44 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -176.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 97.3 m95 -74.0 130.62 40.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.871 0.367 . . . . 0.0 111.663 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 34.8 p -81.83 158.29 24.12 Favored 'General case' 0 C--O 1.266 1.945 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 124' ' ' ILE . 54.9 t30 63.92 -171.79 0.18 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -126.48 -168.1 1.81 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.656 HD11 ' HA3' ' A' ' 89' ' ' GLY . 54.0 mt -82.61 117.69 69.35 Favored Pre-proline 0 C--N 1.282 -2.33 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 33.8 Cg_endo -70.96 144.86 48.75 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.751 2.301 . . . . 0.0 110.894 177.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -93.7 112.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 122.118 -0.364 . . . . 0.0 110.871 -174.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.33 112.28 3.93 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.619 ' HB2' HD23 ' A' ' 121' ' ' LEU . 33.6 mt-10 . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.3 m-20 . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -84.52 125.08 32.08 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -97.89 23.59 7.84 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.01 161.27 40.47 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.394 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 mt -82.81 149.07 59.12 Favored Pre-proline 0 C--N 1.306 -1.313 0 O-C-N 123.998 0.811 . . . . 0.0 109.807 174.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.8 Cg_endo -53.11 131.55 43.48 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 123.197 2.598 . . . . 0.0 113.312 -177.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 18.6 Cg_exo -65.73 119.51 6.55 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 122.617 2.212 . . . . 0.0 110.277 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.64 142.58 56.35 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.766 0.793 . . . . 0.0 111.759 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 18.2 mmm180 -87.31 168.46 13.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.377 -171.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -88.16 -35.4 17.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.046 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.0 p -107.8 6.31 27.38 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.772 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 10.3 mp0 -138.92 156.44 47.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.33 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.3 158.92 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.78 143.67 55.74 Favored 'General case' 0 C--N 1.269 -2.896 0 O-C-N 123.483 0.489 . . . . 0.0 110.553 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 p -71.73 -35.23 70.1 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.35 165.92 12.17 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -94.15 142.71 27.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 177.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.06 125.53 42.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -121.44 18.22 11.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.288 0.566 . . . . 0.0 110.738 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.79 -159.44 0.74 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.425 ' HG3' HG23 ' A' ' 41' ' ' THR . 17.6 pt20 -149.63 -35.01 0.18 Allowed 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 123.457 0.703 . . . . 0.0 110.355 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.7 p -107.88 126.21 52.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.798 -176.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -133.89 137.05 27.6 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 28.3 Cg_endo -63.08 147.37 94.39 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 123.126 2.551 . . . . 0.0 111.926 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.5 tt0 -63.56 129.85 41.9 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.23 30.33 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.9 m -81.4 113.31 19.4 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.7 pt20 -86.35 143.78 27.68 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.136 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.57 119.95 37.17 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.0 mt -91.51 119.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 59.9 m-85 -98.45 145.61 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.042 0.925 . . . . 0.0 113.33 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 32.2 ttmt -91.66 138.36 31.63 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.087 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 35.7 m -74.63 21.9 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 72.9 mtp180 64.95 154.95 0.12 Allowed Pre-proline 0 N--CA 1.476 0.864 0 CA-C-O 121.678 0.751 . . . . 0.0 111.612 -173.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.4 104.19 0.42 Allowed 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.523 1.482 . . . . 0.0 110.866 174.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.12 -3.6 18.78 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.326 176.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.793 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.0 m-85 -120.89 165.91 14.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.133 -1.216 . . . . 0.0 109.819 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -156.18 179.32 9.35 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 23.7 p -145.46 -92.41 0.1 Allowed 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.703 0.764 . . . . 0.0 110.665 174.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -142.23 -47.2 0.35 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -177.353 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.92 -134.72 3.31 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 176.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -115.06 146.73 41.0 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.1 t -75.12 116.76 18.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.3 mm -110.5 122.92 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-O 121.455 0.645 . . . . 0.0 109.783 -176.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.3 mtp -109.3 171.84 7.2 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.5 p -157.74 142.69 8.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.76 122.19 20.24 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.304 176.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.3 ttm180 -156.52 127.51 6.87 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 66.19 17.06 10.65 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.58 80.36 Favored Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.897 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 9.6 pt-20 -117.4 159.06 23.38 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -104.12 109.3 21.04 Favored 'General case' 0 CA--C 1.455 -2.69 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.0 -164.54 0.39 Allowed 'Isoleucine or valine' 1 N--CA 1.362 -4.846 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.252 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.14 40.67 Favored 'General case' 1 C--N 1.218 -5.123 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.601 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.9 -39.76 66.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.86 102.18 13.64 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 1.5 8.27 Favored 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.98 2.453 . . . . 0.0 113.74 -175.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.92 -20.33 18.19 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.691 0.758 . . . . 0.0 111.385 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 31.1 mmt180 -85.02 130.96 34.53 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.387 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -156.55 147.95 22.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 55.7 m -97.03 123.47 40.77 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.594 0.711 . . . . 0.0 111.484 -176.137 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.99 42.51 2.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -167.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 88.2 mttt 76.6 -179.98 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.753 1.221 . . . . 0.0 111.044 -178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 15.4 ptp180 -130.41 142.0 43.9 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.99 147.58 43.66 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.477 2.118 . . . . 0.0 109.633 173.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 m -102.32 -10.66 19.3 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.015 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.05 -117.2 4.43 Favored Glycine 0 CA--C 1.474 -2.481 0 C-N-CA 119.002 -1.571 . . . . 0.0 110.996 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -136.71 139.14 28.25 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -176.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.42 8.64 3.71 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.786 2.324 . . . . 0.0 111.143 178.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 97.3 -164.25 22.23 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -175.114 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.27 161.19 12.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -130.5 126.04 21.86 Favored Pre-proline 0 C--N 1.288 -2.086 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.182 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.29 10.1 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.548 2.165 . . . . 0.0 112.773 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -110.82 -12.16 14.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.506 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . -164.56 -146.66 4.84 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.792 -175.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.91 -172.86 4.21 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.804 0.442 . . . . 0.0 111.597 -175.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -148.11 166.42 27.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 p -130.49 159.09 38.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.551 0.74 . . . . 0.0 109.332 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.5 136.57 53.14 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.054 0.454 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.8 t -125.78 138.18 53.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.12 9.97 56.54 Favored Glycine 0 C--N 1.312 -0.77 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -175.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.01 167.73 11.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -178.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.06 31.52 5.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.797 0.798 . . . . 0.0 111.277 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.02 167.85 23.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.06 86.24 5.34 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.662 -176.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.92 154.16 49.52 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.397 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -51.29 120.6 5.18 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.714 0.634 . . . . 0.0 111.543 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.25 -20.05 7.12 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 99' ' ' THR . 10.5 m -83.51 146.48 6.86 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.427 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.1 ttmp? -111.12 126.72 55.13 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.52 92.82 8.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.69 115.11 27.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -81.87 139.91 34.42 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.509 -177.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.14 143.31 22.34 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.506 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 77.6 m -122.57 -73.38 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.113 -174.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -161.1 -165.61 1.39 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -172.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -79.81 -43.25 22.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.778 0.799 . . . . 0.0 109.042 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.48 -12.84 79.72 Favored Glycine 0 C--N 1.31 -0.906 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.407 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -124.47 127.86 48.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.73 -130.46 0.26 Allowed 'General case' 0 CA--C 1.457 -2.632 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 166.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -151.65 145.47 25.1 Favored 'General case' 1 N--CA 1.33 -6.467 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.996 -176.35 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 94.6 mt -87.27 109.76 19.73 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.76 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 156.11 161.01 10.37 Favored Glycine 0 C--N 1.272 -3.017 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 -178.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -97.21 -5.96 35.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 118.183 0.991 . . . . 0.0 110.251 179.033 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.91 106.94 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.615 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.768 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.2 p-10 -84.7 30.99 0.54 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.616 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.585 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -166.35 179.93 5.34 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.451 0.643 . . . . 0.0 111.857 -172.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -139.83 131.61 27.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 169.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 25.2 mt-10 -99.92 136.22 40.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.1 t -81.39 123.02 28.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.158 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.0 t70 -118.55 -160.24 0.79 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.456 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 43.2 p -66.85 -51.47 55.2 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.824 1.25 . . . . 0.0 112.101 -174.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.03 -28.72 39.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.77 0.795 . . . . 0.0 110.693 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.61 -148.13 17.57 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -80.97 132.84 35.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.189 0.494 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 49.6 p -81.0 148.95 29.51 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.423 178.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 67.53 -173.75 0.19 Allowed 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.273 0.983 . . . . 0.0 108.93 174.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -117.38 -173.62 2.45 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.459 HD11 ' HA3' ' A' ' 89' ' ' GLY . 73.0 mt -81.29 119.24 75.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 -174.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CG ' HD12 ' A' ' 120' ' ' LEU . 9.6 Cg_endo -58.72 132.52 48.47 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.424 2.083 . . . . 0.0 108.706 174.623 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.1 mp -78.03 106.62 8.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.016 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.8 t -61.42 118.17 6.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.165 0.507 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 10.2 tp10 . . . . . 0 N--CA 1.43 -1.445 0 C-N-CA 126.178 1.791 . . . . 0.0 106.651 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.662 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.7 m-20 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.9 m -74.37 138.23 43.27 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.425 ' HA ' HG22 ' A' ' 41' ' ' THR . 5.0 m-20 -100.97 15.17 29.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.344 0.592 . . . . 0.0 109.882 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.07 154.83 41.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.551 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.6 mt -75.12 149.82 85.16 Favored Pre-proline 0 C--O 1.253 1.289 0 O-C-N 124.073 0.858 . . . . 0.0 109.909 173.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 27.9 Cg_endo -58.84 142.02 98.56 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.828 2.352 . . . . 0.0 110.054 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.76 144.49 54.22 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.779 1.653 . . . . 0.0 111.67 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -76.21 141.76 41.69 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 24.7 mmm180 -98.28 162.03 13.4 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.647 -171.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -78.23 -42.22 31.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.342 0.592 . . . . 0.0 109.69 176.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.72 -7.72 21.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.648 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.8 mp0 -129.4 166.13 20.17 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.755 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.98 146.21 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 37' ' ' TRP . 4.5 mm? -70.65 140.15 51.48 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.506 178.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -126.67 101.41 6.63 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.988 172.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.78 -160.09 33.64 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 -176.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 m -129.43 114.53 16.27 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 117.699 0.749 . . . . 0.0 109.532 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB3' HD22 ' A' ' 24' ' ' LEU . 80.8 m95 -120.81 128.27 52.71 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.189 -175.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 m -148.54 8.08 0.78 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.312 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.0 m-20 -120.93 -173.37 2.59 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.635 -174.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -112.41 -61.1 1.77 Allowed 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.1 p -85.9 122.65 30.26 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.51 -175.125 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 63.9 m-85 -126.76 136.05 28.21 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.272 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 17.9 Cg_endo -60.51 145.68 98.31 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.345 2.697 . . . . 0.0 113.535 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 18.5 tt0 -62.85 120.47 11.37 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.89 12.89 14.94 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -175.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.6 m -92.38 113.23 25.45 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.567 176.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.9 149.21 25.38 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.643 0.59 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.25 133.84 51.36 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.759 0.824 . . . . 0.0 109.023 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.9 mt -102.59 129.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.5 m-85 -111.25 137.29 49.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' A' ' 53' ' ' ARG . 53.5 tptt -85.05 126.53 33.64 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.7 m -77.43 13.45 1.21 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 70.1 mtp180 69.64 150.11 0.12 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.512 0.725 . . . . 0.0 110.895 -172.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.71 120.67 7.43 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.728 1.619 . . . . 0.0 109.9 175.269 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.24 -13.98 13.71 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 72.8 m-85 -115.17 163.66 15.33 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.62 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -150.88 -179.31 7.17 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 p -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.57 -13.61 59.74 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.592 0.711 . . . . 0.0 109.899 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.58 144.53 9.72 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 174.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.21 154.71 39.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.708 0.754 . . . . 0.0 111.166 -178.486 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.449 HG23 ' SG ' ' A' ' 80' ' ' CYS . 76.7 t -71.49 102.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.25 118.41 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.2 mtp -107.27 171.45 7.37 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.04 146.48 12.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.64 122.32 23.0 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.825 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.1 ttm180 -153.39 124.71 7.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.934 0.397 . . . . 0.0 111.057 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 61.8 mmtt 68.66 11.55 8.39 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.852 1.261 . . . . 0.0 112.519 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.78 -12.61 46.13 Favored Glycine 0 N--CA 1.427 -1.945 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.33 178.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.55 158.3 21.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.595 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m95 -91.22 115.5 28.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.93 171.2 6.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.267 -175.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.22 119.49 26.56 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.3 -49.67 63.31 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -108.35 89.43 5.9 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.705 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.66 -19.84 9.69 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.568 2.179 . . . . 0.0 111.475 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.3 mt -74.77 -29.55 61.16 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.252 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -84.78 158.72 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.936 178.891 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -175.68 156.16 1.83 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.964 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 62' ' ' VAL . 60.2 m -93.64 123.82 37.22 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.738 -177.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.35 164.22 16.66 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.639 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 90.9 mttt -73.51 151.11 41.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.487 0.184 . . . . 0.0 110.958 -176.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.7 ptm180 -82.27 146.25 54.07 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.476 176.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 69.8 Cg_endo -79.42 151.74 22.98 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.42 2.08 . . . . 0.0 110.909 172.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 133' ' ' GLY . 52.5 m -110.95 -9.23 14.43 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.804 177.009 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.55 175.42 47.63 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.699 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.74 123.19 89.05 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 56.3 Cg_endo -70.2 83.66 0.76 Allowed 'Trans proline' 0 C--O 1.254 1.283 0 C-N-CA 123.076 2.517 . . . . 0.0 113.017 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 63.54 -142.55 47.07 Favored Glycine 0 C--O 1.215 -1.068 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.47 130.14 17.0 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 t -127.24 99.53 27.86 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-O 121.522 0.677 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.59 -39.41 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.485 2.123 . . . . 0.0 113.403 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.43 -20.49 17.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.33 176.91 18.77 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.739 -178.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 p -134.84 175.64 9.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 37.8 p90 -150.49 151.19 32.32 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.423 177.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.5 p -101.59 171.37 7.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 103' ' ' VAL . 96.2 mt -141.69 136.7 31.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 173.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 109' ' ' LYS . 9.1 t -113.31 -62.28 1.61 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.73 56.02 4.9 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.749 -176.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.13 -57.49 0.35 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.329 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 m120 87.74 18.17 0.07 Allowed 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.401 1.48 . . . . 0.0 107.873 -179.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.418 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 p -141.27 -161.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.819 0 CA-C-N 111.822 -2.444 . . . . 0.0 105.051 177.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 44.9 m-85 -112.07 86.26 2.31 Favored 'General case' 1 C--N 1.236 -4.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 -175.58 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 15.1 pt-20 -151.02 155.89 39.99 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.457 178.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 79.6 t80 -45.47 115.38 0.92 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 125.036 1.46 . . . . 0.0 112.273 -178.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.41 -21.76 6.0 Favored Glycine 0 N--CA 1.427 -1.959 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.1 m -78.1 137.51 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.886 -1.125 . . . . 0.0 111.438 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.469 ' H ' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -106.61 110.78 23.07 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -81.72 92.46 6.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -81.58 124.37 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.928 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 7.7 t80 -84.27 130.62 34.8 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.08 150.03 43.69 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 118' ' ' TYR . 26.6 m -130.18 148.72 52.05 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.9 173.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.411 1.069 . . . . 0.0 112.586 177.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -44.14 -53.02 6.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.626 1.57 . . . . 0.0 113.567 -176.525 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 22.45 34.82 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.139 -176.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 114' ' ' CYS . 95.6 m-85 -134.05 161.01 36.02 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.391 0.615 . . . . 0.0 111.691 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -156.39 -156.38 0.62 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 173.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 1.2 pp -140.26 142.52 35.75 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -175.01 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.2 mm? -83.5 135.52 34.62 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.72 171.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.25 152.01 9.03 Favored Glycine 0 C--N 1.267 -3.289 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -174.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.74 -13.06 37.61 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 117.343 0.572 . . . . 0.0 111.912 -176.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -111.21 116.44 52.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' HD21 ' A' ' 120' ' ' LEU . 3.1 p-10 -91.63 25.49 2.66 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.448 0.642 . . . . 0.0 111.123 -176.57 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 28.5 p90 -156.49 177.32 11.6 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.75 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.66 ' NH1' HG12 ' A' ' 138' ' ' ILE . 15.2 ptt180 -157.36 128.4 6.7 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.441 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 37.6 mt-10 -103.67 142.24 34.68 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.78 98.89 7.98 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -103.86 -158.51 0.67 Allowed 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.692 -173.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 38.9 p -64.94 -38.48 91.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.741 1.217 . . . . 0.0 113.14 -172.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.5 -33.99 11.64 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 120.95 0.405 . . . . 0.0 110.326 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 85' ' ' CYS . . . 161.24 -149.14 17.76 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.554 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -71.65 130.0 40.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.727 0.264 . . . . 0.0 110.766 -178.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.5 p -79.76 167.36 20.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.336 176.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.28 -101.99 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.04 0.936 . . . . 0.0 112.668 173.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 169.82 -158.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -177.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.66 HG12 ' NH1' ' A' ' 127' ' ' ARG . 62.6 mt -102.31 107.1 52.0 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 9.4 Cg_endo -58.37 137.36 80.05 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.483 1.456 . . . . 0.0 109.37 174.075 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.37 115.17 25.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.041 -171.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 8.8 t -75.09 99.81 4.04 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 123.437 0.461 . . . . 0.0 109.851 -178.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.77 1.628 . . . . 0.0 108.234 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 12.8 m-20 . . . . . 0 C--O 1.243 0.742 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.6 m -61.38 139.98 58.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 41' ' ' THR . 6.2 m-20 -116.32 16.44 15.77 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.542 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -156.45 161.35 40.08 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.702 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.06 153.44 79.95 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 123.984 0.914 . . . . 0.0 109.935 176.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 Cg_endo -55.41 123.68 14.4 Favored 'Trans proline' 0 C--O 1.254 1.303 0 C-N-CA 122.273 1.982 . . . . 0.0 111.516 178.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.5 Cg_exo -67.36 109.24 1.74 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.803 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -71.73 143.01 49.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.934 176.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -104.49 -171.81 1.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.25 -42.26 72.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.134 0.492 . . . . 0.0 110.316 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 15.8 p -109.63 11.68 24.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mp0 -138.28 134.25 34.11 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.706 -0.621 . . . . 0.0 112.601 -178.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.93 157.32 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.11 140.64 45.39 Favored 'General case' 0 C--N 1.264 -3.138 0 O-C-N 123.817 0.698 . . . . 0.0 110.735 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -73.51 -52.96 11.77 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.909 177.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.57 167.99 41.42 Favored Glycine 0 N--CA 1.421 -2.353 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.347 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 p -90.95 146.76 23.61 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 123.011 0.524 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -135.92 143.43 44.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.0 t -125.65 -44.12 1.84 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HE1' ' A' ' 42' ' ' TYR . 15.2 t70 -97.09 158.04 15.63 Favored 'General case' 0 C--O 1.186 -2.268 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -170.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -79.09 -30.01 43.62 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.21 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 77.9 p -101.08 119.95 39.5 Favored 'General case' 0 N--CA 1.41 -2.457 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.99 -174.344 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HE1' ' O ' ' A' ' 39' ' ' ASP . 40.4 m-85 -130.29 155.01 81.56 Favored Pre-proline 0 C--N 1.302 -1.46 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.078 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 147.09 88.94 Favored 'Trans proline' 0 C--O 1.252 1.208 0 C-N-CA 122.121 1.881 . . . . 0.0 111.555 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.9 146.75 49.38 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.8 9.12 62.94 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.992 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -89.08 120.32 30.38 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.87 -0.194 . . . . 0.0 111.222 177.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 11.9 pt20 -87.01 157.0 19.54 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.323 0.582 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.09 126.51 41.32 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.76 130.52 46.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 80.6 m-85 -99.76 138.8 36.34 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -78.2 -18.41 55.51 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 127.209 2.204 . . . . 0.0 112.531 -173.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 97.4 m 67.22 -2.87 1.11 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 62.4 mtp180 69.76 153.97 0.14 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.531 0.732 . . . . 0.0 111.131 -174.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.49 121.4 7.94 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.794 1.663 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 111.92 -5.43 27.39 Favored Glycine 0 C--N 1.306 -1.123 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.357 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.566 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 41.0 m-85 -120.49 174.57 6.47 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -162.45 -173.33 3.52 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 p -151.09 168.08 25.73 Favored 'General case' 0 C--N 1.266 -3.048 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.3 tp -105.59 32.23 4.45 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.53 109.74 0.38 Allowed Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 63' ' ' ILE . 95.4 m-20 -52.83 140.08 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 117.337 0.568 . . . . 0.0 111.695 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 93.0 t -64.86 112.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 61' ' ' ASN . 46.9 mm -113.2 118.37 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.69 170.94 7.59 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.1 p -156.21 148.32 11.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.9 t -81.25 134.29 35.58 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.242 -177.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 4.7 tpm_? -152.59 126.76 9.16 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 32.7 mmtp 63.12 18.49 10.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 175.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 99.81 -12.41 60.96 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.944 179.152 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.32 168.24 10.14 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -101.3 121.74 42.43 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.84 179.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.65 39.61 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.219 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -68.95 -42.57 76.49 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.589 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 9.0 t-20 -127.8 97.44 30.04 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.959 173.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.13 -7.45 16.22 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 0.0 112.864 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.61 -27.3 51.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.534 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 29.3 mmt180 -92.69 153.76 18.76 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.992 -177.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -158.03 147.3 19.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.56 123.57 28.22 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.548 -178.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -121.28 167.76 12.37 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.96 157.32 22.08 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.345 0.593 . . . . 0.0 111.963 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.6 ptm180 -99.01 154.61 37.24 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 46.6 Cg_endo -73.15 151.46 49.45 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.519 1.479 . . . . 0.0 109.386 169.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -78.52 -46.52 19.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.557 0.694 . . . . 0.0 110.111 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.51 -125.86 3.61 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -176.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -141.4 116.64 7.13 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.36 41.72 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 124.08 3.187 . . . . 0.0 114.904 -174.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.34 -137.28 30.96 Favored Glycine 0 C--N 1.311 -0.815 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -149.21 -176.54 5.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 t -171.83 106.44 0.37 Allowed Pre-proline 0 C--N 1.289 -2.061 0 C-N-CA 125.477 1.511 . . . . 0.0 107.563 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.34 -17.58 18.71 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.368 2.045 . . . . 0.0 113.435 -175.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CD1' ' HB3' ' A' ' 141' ' ' CYS . 0.1 OUTLIER -124.06 -5.22 7.91 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.641 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.97 -163.91 10.5 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -162.27 -177.98 6.04 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 117.277 0.538 . . . . 0.0 110.619 178.453 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -143.55 164.6 29.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.257 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 68.2 p -120.93 169.87 10.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.8 mt -129.64 135.38 48.46 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -120.43 1.38 10.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.256 0.551 . . . . 0.0 112.331 -174.357 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.74 24.9 4.8 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.28 148.19 5.61 Favored Glycine 0 N--CA 1.411 -2.977 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -174.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -93.59 32.7 1.36 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 122.517 1.151 . . . . 0.0 109.141 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.99 162.42 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.624 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.322 -174.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 45.0 m-85 -91.42 100.21 13.02 Favored 'General case' 0 C--N 1.26 -3.318 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.883 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.16 149.0 37.45 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 91.5 t80 -52.39 121.22 6.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.172 0.511 . . . . 0.0 110.473 177.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.5 -13.86 25.28 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.302 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.6 142.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 109.69 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -113.09 126.01 55.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -93.51 102.92 15.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.068 0.855 . . . . 0.0 108.898 177.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.409 HG22 ' OG1' ' A' ' 97' ' ' THR . 0.7 OUTLIER -87.84 126.67 41.35 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.281 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -93.17 142.5 27.24 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -135.17 155.75 50.17 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.603 ' HB3' ' O ' ' A' ' 119' ' ' GLN . 44.1 t -158.92 100.48 1.58 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 47.67 -160.65 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 164.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -98.77 -64.93 0.99 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.003 -0.435 . . . . 0.0 111.126 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.72 34.12 2.98 Favored Glycine 0 N--CA 1.469 0.892 0 CA-C-O 121.492 0.496 . . . . 0.0 112.58 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.13 173.65 11.3 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 120' ' ' LEU . 43.6 mt-30 -130.27 -66.09 0.79 Allowed 'General case' 0 CA--C 1.432 -3.596 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 167.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.5 pt? 165.36 157.46 0.02 OUTLIER 'General case' 1 N--CA 1.362 -4.86 0 N-CA-C 102.204 -3.258 . . . . 0.0 102.204 164.156 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.0 mt -97.26 112.53 24.29 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 119.521 1.055 . . . . 0.0 110.455 175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.23 150.54 5.3 Favored Glycine 0 C--N 1.283 -2.404 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.28 -32.27 43.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 117.787 0.794 . . . . 0.0 108.894 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -95.72 107.4 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.645 ' HA ' HD11 ' A' ' 120' ' ' LEU . 2.6 p-10 -88.04 29.45 0.94 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.881 0.848 . . . . 0.0 110.982 -175.33 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -162.24 175.68 11.4 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.937 -175.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.653 ' NH2' HG12 ' A' ' 138' ' ' ILE . 12.2 ttm180 -143.56 120.93 11.63 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.37 152.23 19.85 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.429 176.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 49.8 t -79.44 149.14 31.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' THR . 17.5 t70 -126.07 -177.97 4.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 39.5 p -61.42 -33.83 74.37 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.59 1.156 . . . . 0.0 113.303 -175.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.52 9.15 7.11 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.399 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.11 -126.08 1.11 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.543 -178.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -131.08 153.64 49.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 130' ' ' ASP . 59.8 p -91.17 128.97 37.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.171 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 80.22 176.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.897 0.879 . . . . 0.0 111.994 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 12.2 t70 -105.12 -156.21 0.57 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -174.256 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.653 HG12 ' NH2' ' A' ' 127' ' ' ARG . 62.2 mt -101.94 101.92 20.97 Favored Pre-proline 0 N--CA 1.42 -1.926 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB2' HD12 ' A' ' 120' ' ' LEU . 7.3 Cg_endo -52.86 133.43 51.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 122.263 1.975 . . . . 0.0 108.05 172.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 140' ' ' ILE . 3.3 mp -86.97 123.75 40.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -171.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . 48.9 t -68.64 91.51 0.43 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 CA--C 1.496 -1.129 0 C-N-CA 126.274 1.83 . . . . 0.0 107.254 -175.323 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.638 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' THR . 82.3 m -80.76 133.37 35.64 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.336 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.71 33.6 3.98 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.143 0.973 . . . . 0.0 108.958 -178.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.85 158.11 37.52 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.979 -176.069 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.5 mt -85.0 154.46 60.75 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 123.872 0.733 . . . . 0.0 110.392 178.012 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.09 145.04 93.68 Favored 'Trans proline' 0 C--O 1.255 1.326 0 C-N-CA 122.338 2.025 . . . . 0.0 110.382 177.07 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.76 155.42 53.89 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.266 1.977 . . . . 0.0 112.777 -177.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -83.5 147.91 27.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 35.8 mtt180 -114.45 170.58 8.2 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -172.503 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -79.11 -40.55 30.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.795 -176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p -115.92 4.15 13.8 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.417 177.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.529 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 8.2 mp0 -131.63 153.92 49.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.663 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.25 156.64 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.457 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.015 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.4 mm? -77.24 149.35 35.46 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -99.25 156.53 16.93 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.48 -159.96 25.33 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.791 178.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -140.89 120.98 13.73 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' HD22 ' A' ' 24' ' ' LEU . 71.7 m95 -113.75 115.75 28.3 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -175.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -134.49 26.73 3.75 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.115 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 26.6 m-20 -126.92 -167.18 1.69 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.963 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.57 -53.57 0.77 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.714 0.406 . . . . 0.0 111.156 175.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.4 p -85.11 105.51 15.9 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.937 0.875 . . . . 0.0 113.106 -175.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -114.12 136.57 22.22 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.957 178.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.638 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 22.5 Cg_endo -63.12 150.25 89.17 Favored 'Trans proline' 0 C--O 1.257 1.472 0 C-N-CA 122.878 2.385 . . . . 0.0 112.215 -177.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.654 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -66.13 133.14 50.09 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.14 1.08 41.55 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.218 -176.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -82.33 114.64 20.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.206 178.594 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.0 pt20 -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.429 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.3 113.28 25.97 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.14 121.31 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.781 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 62.3 m-85 -98.55 140.75 32.31 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.944 0.878 . . . . 0.0 113.24 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -94.2 111.97 23.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 171.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 98.2 m -79.11 32.61 0.22 Allowed 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 64.23 151.85 0.12 Allowed Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.148 1.379 . . . . 0.0 113.274 177.078 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.95 124.74 12.19 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.326 1.35 . . . . 0.0 108.883 173.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.14 -19.89 10.78 Favored Glycine 0 C--N 1.297 -1.591 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 75.5 m-85 -114.4 170.1 8.55 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -155.18 179.08 9.49 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.5 p -170.81 135.22 1.07 Allowed 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.2 -43.8 85.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.652 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 114.27 3.91 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 172.501 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -64.31 155.36 32.43 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 123.817 0.363 . . . . 0.0 110.66 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.548 HG23 ' SG ' ' A' ' 80' ' ' CYS . 98.7 t -72.55 102.2 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.04 118.44 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 81.5 mtp -104.62 169.15 8.62 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.6 p -156.66 146.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.286 0.565 . . . . 0.0 109.905 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.62 122.53 23.31 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.739 177.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.654 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 31.9 ttt180 -152.77 134.29 14.47 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.208 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 34.0 mmtp 67.23 12.13 8.77 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.302 1.041 . . . . 0.0 112.507 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.62 -4.27 57.97 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.81 157.48 33.99 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.16 0.505 . . . . 0.0 110.834 177.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -87.84 117.16 26.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.21 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.62 176.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.028 -178.018 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' MET . . . -89.78 128.97 36.23 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.433 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.11 -50.92 43.71 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.46 91.13 6.64 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.755 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.28 -15.55 22.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.619 2.212 . . . . 0.0 112.084 -177.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.1 mt -83.37 -9.34 59.11 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.038 0.923 . . . . 0.0 111.018 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -102.99 138.69 39.53 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.914 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.88 162.16 38.37 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 172.456 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 62' ' ' VAL . 83.1 m -101.79 130.26 48.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.572 -0.851 . . . . 0.0 113.016 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 172.79 7.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.955 -178.048 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.75 157.12 33.59 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -85.34 145.57 42.85 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.092 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.17 144.59 13.32 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.979 1.786 . . . . 0.0 109.582 176.198 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.6 m -103.53 5.81 37.0 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.268 0.556 . . . . 0.0 112.152 -173.306 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.31 -98.66 1.14 Allowed Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.927 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -152.58 142.68 15.09 Favored Pre-proline 0 C--N 1.278 -2.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.07 45.54 1.95 Allowed 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.523 2.815 . . . . 0.0 112.069 -176.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 86.4 -146.28 20.83 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -175.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.27 127.14 4.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 t -113.51 135.92 21.91 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.65 -35.07 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.759 2.306 . . . . 0.0 114.379 -178.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -143.53 11.19 1.67 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.091 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 176.96 32.17 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -137.56 174.65 10.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.37 156.79 34.49 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.642 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -118.94 154.88 32.3 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 175.076 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 110' ' ' ALA . 96.7 mt -120.74 135.58 55.1 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.5 t -112.99 139.04 48.99 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.16 -68.75 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.926 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.75 -72.48 0.82 Allowed Glycine 0 C--N 1.31 -0.868 0 CA-C-N 115.555 -0.322 . . . . 0.0 113.402 -173.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 82.24 18.44 0.34 Allowed 'General case' 0 CA--C 1.455 -2.684 0 CA-C-O 123.467 1.603 . . . . 0.0 108.599 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.21 165.04 1.13 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.215 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -88.47 85.32 6.83 Favored 'General case' 0 C--N 1.255 -3.503 0 O-C-N 123.673 0.608 . . . . 0.0 110.154 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.7 pt-20 -133.33 162.26 32.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.266 -176.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -52.74 128.26 25.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.026 176.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.74 -19.52 53.1 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.173 178.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.4 p -71.51 141.58 16.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.023 -177.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.0 ttmt -106.07 121.53 44.32 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.462 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -95.37 97.35 9.77 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.466 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.642 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.2 p -87.51 112.78 23.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.541 ' OH ' ' HB2' ' A' ' 141' ' ' CYS . 15.3 t80 -81.21 139.42 35.53 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.203 -170.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -142.34 170.9 14.84 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.23 -89.67 0.59 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.802 177.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -138.26 -149.2 0.29 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.01 -51.77 5.3 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.359 -179.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.31 -18.86 63.58 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.601 178.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.11 144.97 25.02 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.15 -68.47 0.89 Allowed 'General case' 0 CA--C 1.438 -3.348 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.241 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.667 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.263 1.0 OUTLIER 169.52 153.46 0.04 OUTLIER 'General case' 1 N--CA 1.297 -8.115 0 CA-C-N 111.605 -2.543 . . . . 0.0 105.145 -169.876 . . . . . . . . 5 4 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.667 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 36.6 tp -134.16 126.94 31.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.18 171.83 12.57 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.179 -1.969 . . . . 0.0 108.179 -176.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -92.52 -21.13 20.3 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 118.223 1.012 . . . . 0.0 110.814 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 136' ' ' ASN . 32.3 mm -114.33 114.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.401 ' HB3' HD22 ' A' ' 120' ' ' LEU . 27.6 p-10 -94.87 19.85 9.64 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -175.148 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -159.03 174.18 15.32 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.31 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 137' ' ' ASP . 8.5 ptm180 -151.88 127.82 10.34 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.34 171.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -99.53 160.7 14.09 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.026 0.53 . . . . 0.0 109.709 -178.121 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.3 t -98.55 114.82 27.4 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.955 175.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.438 ' HB2' HG22 ' A' ' 135' ' ' THR . 17.3 t70 -92.24 -179.64 5.3 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 125.401 1.48 . . . . 0.0 108.385 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 p -62.54 -36.25 82.02 Favored 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 123.714 0.805 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.85 -34.85 24.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.52 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.29 -157.53 29.43 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -69.02 129.56 40.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.69 1.245 . . . . 0.0 110.886 -177.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 130' ' ' ASP . 24.3 p -55.56 -38.9 69.93 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 125.054 1.341 . . . . 0.0 112.711 -174.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.481 HD21 HG13 ' A' ' 124' ' ' ILE . 11.6 t-20 -138.32 172.81 12.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -175.134 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 16.6 t70 -102.53 -168.69 1.56 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 123.422 0.451 . . . . 0.0 110.241 -176.12 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 89' ' ' GLY . 34.2 mt -76.81 123.15 87.47 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 124.435 1.094 . . . . 0.0 111.05 -171.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -73.58 163.24 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.717 1.611 . . . . 0.0 109.762 172.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mm -84.45 133.1 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.541 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 21.3 t -83.0 120.42 25.7 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 121' ' ' LEU . 13.2 tp10 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -174.793 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 31.2 m-20 . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 121.064 0.459 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 142.41 43.94 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 124.555 1.142 . . . . 0.0 110.757 -172.41 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 41' ' ' THR . 7.4 m-20 -116.56 19.99 14.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.925 0.869 . . . . 0.0 109.35 175.528 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.55 156.01 34.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.665 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 37' ' ' TRP . 40.4 mt -77.4 158.25 79.37 Favored Pre-proline 0 C--O 1.253 1.238 0 O-C-N 123.759 0.662 . . . . 0.0 110.82 176.374 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 20.3 Cg_endo -62.03 135.05 52.83 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.337 2.024 . . . . 0.0 109.581 175.359 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.02 137.09 21.23 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 121.986 1.791 . . . . 0.0 112.926 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -76.25 143.66 40.82 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -121.62 175.86 6.0 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.533 -170.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -59.02 -26.08 64.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 0.0 113.21 -175.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -134.3 12.05 3.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.88 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 3.1 mp0 -132.57 140.23 48.17 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.71 -0.796 . . . . 0.0 113.082 -172.461 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -135.67 142.62 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.74 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.463 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.0 mm? -69.65 142.06 53.51 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.998 -179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 p -101.76 87.98 3.28 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.413 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.25 -169.49 40.44 Favored Glycine 0 C--N 1.275 -2.815 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.751 -175.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -117.68 109.6 16.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 48.7 m95 -129.5 126.01 37.66 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 t -160.94 25.01 0.14 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.487 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.36 -164.48 1.13 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.782 -1.553 . . . . 0.0 110.053 -172.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -123.83 -64.87 1.11 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.94 0.4 . . . . 0.0 110.91 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.6 p -105.6 146.23 29.94 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.493 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.33 153.99 56.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.78 1.232 . . . . 0.0 109.207 178.009 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 57.6 Cg_endo -73.47 152.93 49.61 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.019 1.813 . . . . 0.0 112.311 179.362 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.9 147.77 52.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.88 5.86 65.91 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.065 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -83.94 115.95 22.55 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.467 178.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.9 pt20 -90.04 139.08 30.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.532 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.98 124.56 52.92 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.65 129.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.304 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 31' ' ' GLU . 75.4 m-85 -117.67 145.62 44.27 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.229 0.538 . . . . 0.0 112.303 -178.679 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.16 152.85 18.92 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 m -92.97 28.68 2.03 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -174.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 66.29 155.48 0.13 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-O 121.384 0.611 . . . . 0.0 111.511 -177.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.71 108.23 1.02 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.763 1.642 . . . . 0.0 111.53 176.094 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.17 -23.18 4.95 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.955 177.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.689 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.9 m-85 -102.5 172.48 6.84 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -154.81 -179.45 8.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -170.6 -179.95 3.09 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.95 8.16 27.61 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 -161.51 27.75 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.93 147.42 26.16 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.83 117.72 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.22 124.94 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.655 -176.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.417 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 88.9 mtp -112.39 172.29 7.0 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.37 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.9 p -155.56 148.3 12.27 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.227 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.83 129.27 34.94 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 55.8 ttp180 -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 64.68 19.27 11.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.043 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 -12.48 62.0 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.949 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.1 157.77 24.22 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.169 0.509 . . . . 0.0 111.736 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.1 m95 -91.99 116.21 28.73 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.489 178.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.44 172.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.496 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.68 108.54 19.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.088 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.2 tm? -61.15 -49.93 75.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 172.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -110.18 90.39 9.71 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.557 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.93 -17.91 15.11 Favored 'Trans proline' 0 N--CA 1.479 0.656 0 C-N-CA 122.478 2.119 . . . . 0.0 111.04 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.38 -27.62 60.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.442 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -92.18 131.66 37.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.745 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -140.02 163.36 32.9 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 71.5 m -92.91 110.53 21.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -105.33 162.7 13.21 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.369 -174.315 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HD3' ' CE2' ' A' ' 56' ' ' TYR . 33.8 mmtp -70.25 157.38 37.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.664 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -94.35 134.36 25.71 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.831 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 37.9 Cg_endo -71.62 136.76 28.88 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.288 1.992 . . . . 0.0 110.674 176.13 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.9 -1.79 39.2 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.059 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.78 -123.24 9.71 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.852 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -103.28 136.46 19.22 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.7 Cg_exo -69.29 75.22 1.03 Allowed 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.431 2.087 . . . . 0.0 113.602 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.32 -136.02 19.54 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.536 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.64 27.87 6.01 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.613 0.365 . . . . 0.0 110.233 -176.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -48.82 115.35 4.41 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.271 176.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.31 -53.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.688 2.259 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.16 154.5 49.47 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.37 -168.18 21.06 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -176.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 m -155.37 156.17 34.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 48.8 p90 -145.24 165.94 26.93 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.549 0.53 . . . . 0.0 111.216 -177.662 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 70.9 p -118.76 -178.02 3.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.921 -179.374 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.6 155.23 49.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 15.1 t -165.47 149.24 8.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.778 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.78 -0.79 88.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.949 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.03 -169.58 39.79 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.401 HD22 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -131.37 3.31 4.26 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-N 117.748 0.774 . . . . 0.0 112.808 -175.324 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.7 p -156.78 -160.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.068 -1.053 . . . . 0.0 108.698 -173.394 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 26.0 m-85 -90.87 77.28 6.21 Favored 'General case' 1 C--N 1.243 -4.034 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.771 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.485 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 15.8 pt-20 -136.48 152.28 50.38 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.201 -174.025 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -49.63 124.52 9.71 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.091 0.869 . . . . 0.0 110.165 173.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.25 -22.85 10.93 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.381 179.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.8 m -76.87 144.43 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.741 -179.023 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.508 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 22.2 ttmm -106.45 106.94 17.71 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -86.86 99.35 11.77 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -80.61 130.33 36.09 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.412 -177.983 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.88 108.92 21.72 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.912 0.863 . . . . 0.0 109.157 -172.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 m -100.95 -31.53 11.08 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.883 -172.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 33.6 m 65.74 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -166.36 -154.34 0.18 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.358 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.7 -60.47 2.34 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.442 -178.745 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.82 73.98 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.533 -177.293 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -115.02 128.41 56.25 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.513 0.197 . . . . 0.0 111.145 178.213 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.41 -134.21 0.33 Allowed 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 167.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -157.52 161.38 38.81 Favored 'General case' 1 N--CA 1.336 -6.158 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.247 . . . . . . . . 4 4 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 142' ' ' GLU . 4.1 mm? -88.58 125.04 34.61 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.331 0.586 . . . . 0.0 109.954 172.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.07 148.45 5.45 Favored Glycine 0 C--N 1.278 -2.688 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.44 -16.52 39.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.112 0.958 . . . . 0.0 109.484 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -109.93 106.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.3 p-10 -88.91 36.66 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.48 0.657 . . . . 0.0 111.758 -172.823 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.442 ' CD1' ' HG3' ' A' ' 109' ' ' LYS . 26.2 p90 -159.19 178.3 10.15 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.63 -177.659 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' NH2' HG23 ' A' ' 138' ' ' ILE . 6.3 ptp180 -148.98 124.31 10.24 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.615 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 17.7 mt-10 -96.76 157.22 16.0 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.35 107.1 18.35 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.557 175.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.29 -164.43 1.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.3 p -65.53 -42.96 91.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.974 0.91 . . . . 0.0 110.04 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.32 -46.28 73.94 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.253 177.096 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.28 -139.09 7.43 Favored Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.132 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.9 m95 -70.86 126.7 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 -176.226 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.9 p -80.37 170.24 16.65 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.607 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.4 m120 70.45 -81.22 0.03 OUTLIER 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.253 1.021 . . . . 0.0 111.857 173.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.1 t0 163.57 -161.62 0.0 OUTLIER 'General case' 0 C--O 1.242 0.661 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.464 HG23 ' NH2' ' A' ' 127' ' ' ARG . 4.0 mp -107.05 96.64 15.55 Favored Pre-proline 0 C--N 1.284 -2.277 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.2 Cg_endo -47.33 123.7 8.2 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.811 2.341 . . . . 0.0 109.737 173.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.2 mp -68.2 114.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.42 -174.697 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 14.0 t -59.67 112.86 1.97 Allowed 'General case' 0 C--O 1.254 1.336 0 O-C-N 123.794 0.683 . . . . 0.0 109.713 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.508 ' HB3' HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -173.838 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.129 0.49 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -70.4 138.96 51.73 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.04 0.936 . . . . 0.0 110.116 -174.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.04 24.93 6.32 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.787 0.804 . . . . 0.0 108.948 176.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.14 160.78 33.36 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.611 -178.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 37' ' ' TRP . 41.1 mt -83.94 152.92 63.25 Favored Pre-proline 0 C--N 1.313 -0.993 0 O-C-N 123.614 0.571 . . . . 0.0 110.325 176.429 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -54.01 142.84 64.03 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.909 2.406 . . . . 0.0 113.172 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.65 112.43 2.86 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.429 2.086 . . . . 0.0 111.896 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -76.35 151.05 36.77 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.638 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -121.05 -179.84 4.16 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -174.848 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -90.53 -20.17 22.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.153 0.501 . . . . 0.0 109.705 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 -10.34 17.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 177.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -134.74 137.56 43.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.263 0.554 . . . . 0.0 111.649 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.33 163.52 24.16 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.796 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.459 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -91.78 151.0 20.8 Favored 'General case' 0 C--N 1.266 -3.059 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.9 p -112.47 101.21 9.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.1 -171.43 32.09 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -108.34 115.18 29.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.532 ' HB3' HD22 ' A' ' 24' ' ' LEU . 53.9 m95 -132.7 107.38 8.35 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.215 0.531 . . . . 0.0 109.94 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 t -153.38 28.64 0.5 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 174.23 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.37 -161.49 0.76 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.413 -168.012 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.36 -67.09 0.41 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 82.3 p -94.62 128.76 41.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.172 -173.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.44 157.54 77.85 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.66 147.17 39.8 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.261 1.974 . . . . 0.0 111.834 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 22.1 tt0 -64.73 137.21 57.67 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.212 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.54 7.79 50.63 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.3 m -83.82 119.52 24.94 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.849 177.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.1 pt20 -87.56 146.41 25.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.31 0.576 . . . . 0.0 111.654 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.2 122.0 41.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.405 HG12 HD12 ' A' ' 63' ' ' ILE . 61.1 mt -94.36 129.84 44.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -104.04 153.6 20.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.493 1.139 . . . . 0.0 113.986 -178.489 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -103.65 118.35 36.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.872 172.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.5 m -69.73 12.31 0.21 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 123.98 0.912 . . . . 0.0 113.392 -178.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.5 mtp180 66.89 154.41 0.13 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.133 0.973 . . . . 0.0 109.158 -170.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 23.0 Cg_endo -61.87 -9.09 13.09 Favored 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 122.358 2.039 . . . . 0.0 115.091 -177.296 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.2 1.83 35.14 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.188 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 48.1 m-85 -123.49 173.28 8.13 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.349 -1.089 . . . . 0.0 111.475 -177.351 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.44 -172.57 4.17 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.888 0.875 . . . . 0.0 109.346 -175.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -174.08 162.49 3.8 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.47 -8.15 58.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.778 . . . . 0.0 109.861 177.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.33 -123.88 1.81 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.97 151.31 28.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.98 103.22 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.618 0.723 . . . . 0.0 109.114 177.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 HG12 ' A' ' 49' ' ' ILE . 48.5 mm -110.87 121.23 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.975 178.558 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.2 mtp -110.22 170.04 8.34 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 5.8 p -154.21 142.16 13.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.23 127.92 32.65 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.314 -178.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.5 ttp180 -150.5 125.83 10.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.524 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 44.1 mmtm 63.19 35.3 12.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.715 0.806 . . . . 0.0 112.525 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.36 53.55 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.001 176.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.62 163.97 12.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.806 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -104.9 114.15 28.18 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -179.053 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 p -123.24 -167.33 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.367 -4.599 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.012 -171.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.66 113.24 25.23 Favored 'General case' 1 C--N 1.224 -4.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 114.145 -168.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.4 -52.93 10.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 172.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -110.57 92.56 14.35 Favored Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.267 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.74 -1.04 11.22 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.401 2.067 . . . . 0.0 111.96 178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.72 -5.19 51.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.222 0.534 . . . . 0.0 109.925 178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -112.79 144.84 41.65 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.203 0.525 . . . . 0.0 111.001 -175.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -156.34 147.75 22.52 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 173.344 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -83.74 113.14 20.69 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.672 177.459 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -105.59 163.96 12.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.07 -177.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 96.8 mttt -64.05 143.45 57.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.261 0.553 . . . . 0.0 111.452 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -84.13 145.39 45.97 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 71.5 Cg_endo -74.48 157.67 44.76 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.539 1.493 . . . . 0.0 111.086 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.3 m -107.66 7.61 28.62 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 -176.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.51 -102.63 1.31 Allowed Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.611 178.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -152.65 130.96 6.3 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.89 37.22 0.4 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 123.069 2.513 . . . . 0.0 111.789 -177.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 79.92 -176.87 54.55 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -172.541 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -124.4 -171.32 2.31 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -172.29 126.77 0.55 Allowed Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.272 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.6 -22.72 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.976 1.784 . . . . 0.0 113.694 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -129.86 -5.35 4.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.89 171.77 20.22 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.782 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -136.25 160.65 38.06 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.5 p90 -144.69 149.98 36.56 Favored 'General case' 0 N--CA 1.418 -2.042 0 O-C-N 123.332 0.395 . . . . 0.0 111.211 174.281 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 61.5 p -101.45 175.67 5.49 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.423 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -140.67 131.33 25.63 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.0 t -127.26 9.06 6.66 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.577 0.703 . . . . 0.0 112.233 -171.123 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.32 34.24 2.21 Favored Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.339 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.24 175.15 13.66 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 106.379 -2.688 . . . . 0.0 106.379 -172.156 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -124.12 24.18 8.24 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 118.417 1.109 . . . . 0.0 108.773 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.8 m -143.09 -177.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.6 m-85 -89.96 85.38 6.33 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.039 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.39 144.25 51.27 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.144 -178.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 72.5 t80 -49.18 114.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.885 0.874 . . . . 0.0 111.385 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 127.33 -22.04 5.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.529 -179.142 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.74 139.09 19.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 122.053 0.93 . . . . 0.0 111.133 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.489 ' HB3' HG22 ' A' ' 99' ' ' THR . 33.8 ttmt -108.13 117.14 33.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 170.508 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -90.37 97.64 11.3 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.463 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -79.88 127.26 39.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.528 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.668 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 59.7 t80 -114.07 143.88 44.04 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 -171.547 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -151.54 160.55 43.63 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 75.6 m -149.15 126.49 11.49 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 66.77 178.3 0.22 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.23 -47.77 3.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.847 -178.029 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.02 74.27 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.191 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -141.28 -177.92 5.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.634 ' HB2' HD13 ' A' ' 120' ' ' LEU . 10.0 pt20 -153.79 -130.9 0.04 OUTLIER 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.191 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -99.26 163.88 12.36 Favored 'General case' 0 N--CA 1.386 -3.671 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.098 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 142' ' ' GLU . 3.8 mm? -88.87 142.44 27.65 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 166.801 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.94 154.88 10.13 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -83.8 -26.71 29.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.937 0.875 . . . . 0.0 109.72 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.95 111.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.89 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.96 26.43 3.21 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.488 1.115 . . . . 0.0 110.716 -178.027 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.516 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 7.3 p90 -153.49 -178.12 6.79 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.343 -172.801 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -139.52 121.89 16.05 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.356 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 24.9 mt-10 -99.5 141.12 32.71 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.363 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.93 115.94 23.86 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.532 177.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.9 172.16 7.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.627 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.1 p -52.08 -39.38 59.62 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 125.347 1.459 . . . . 0.0 112.197 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.25 -33.47 19.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.902 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.73 -162.23 33.85 Favored Glycine 0 C--O 1.212 -1.281 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.217 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 134.69 47.85 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.541 0.671 . . . . 0.0 111.443 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -68.43 -25.79 65.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.241 0.616 . . . . 0.0 111.375 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -130.15 168.19 17.19 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -176.7 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -107.46 -104.44 0.35 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.389 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.426 HD11 ' HA3' ' A' ' 89' ' ' GLY . 30.8 mt -127.5 96.74 32.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.178 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 4.7 Cg_endo -47.95 129.04 17.39 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.276 2.651 . . . . 0.0 111.64 178.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.2 mm -80.76 112.21 18.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.457 -173.235 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.668 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 57.4 m -79.24 114.13 17.93 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.785 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.662 ' HB3' HD23 ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.435 -1.19 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.356 0.598 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 138.4 58.41 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.404 -175.12 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' HA ' HG22 ' A' ' 41' ' ' THR . 5.3 m-20 -118.22 20.11 13.27 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.304 1.05 . . . . 0.0 108.772 175.333 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.84 153.6 39.36 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.624 179.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.3 mt -81.66 157.58 69.46 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.224 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 144.49 96.45 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 122.073 1.849 . . . . 0.0 111.31 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.6 178.99 5.68 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.046 1.831 . . . . 0.0 111.53 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -94.41 158.7 15.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 10.5 mmt85 -103.94 166.41 10.43 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.299 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -77.04 -62.15 1.75 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -95.77 13.69 25.72 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.193 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 28' ' ' ARG . 4.8 mp0 -135.66 161.83 34.42 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.5 mt -134.4 150.52 30.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 37' ' ' TRP . 35.2 mt -71.84 143.32 49.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.532 0.605 . . . . 0.0 110.226 174.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 p -87.44 -33.24 19.13 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.174 0.512 . . . . 0.0 112.067 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.92 168.4 18.09 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.865 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -87.93 138.2 31.66 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 175.56 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 33' ' ' LEU . 75.9 m95 -130.28 117.8 20.37 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.307 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 m -130.31 4.81 4.78 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.217 0.532 . . . . 0.0 110.874 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.78 -165.76 1.28 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.09 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -140.7 -40.67 0.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.052 175.466 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 22' ' ' ASN . 40.2 p -112.08 138.13 49.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.698 -178.199 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -139.55 154.88 71.83 Favored Pre-proline 0 C--N 1.303 -1.434 0 C-N-CA 123.874 0.87 . . . . 0.0 109.067 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.83 148.65 28.66 Favored 'Trans proline' 0 C--O 1.257 1.462 0 C-N-CA 121.756 1.638 . . . . 0.0 111.056 175.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -62.05 145.44 53.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.15 1.3 59.56 Favored Glycine 0 C--N 1.298 -1.545 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.226 -179.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.9 m -83.93 118.12 23.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.421 0.153 . . . . 0.0 111.12 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.4 pt20 -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-O 121.925 0.869 . . . . 0.0 111.731 -176.578 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 113.02 19.09 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.97 114.92 27.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.123 -177.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 45.0 m-85 -95.63 138.59 33.08 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.853 0.835 . . . . 0.0 112.353 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 85.7 tttt -80.41 139.04 36.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.401 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 12.2 t -84.57 10.29 11.42 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -170.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 73.0 ttt180 67.24 133.32 0.04 OUTLIER Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.705 174.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.72 104.39 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.441 2.761 . . . . 0.0 114.093 -176.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.71 -24.37 5.2 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.177 177.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.7 m-85 -95.77 173.17 7.6 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.363 -0.493 . . . . 0.0 110.559 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -136.85 161.45 35.96 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.59 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 99.9 p -136.36 173.21 11.95 Favored 'General case' 0 N--CA 1.382 -3.847 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.325 177.23 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -83.71 -4.89 58.99 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.965 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.74 45.41 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 176.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.55 131.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.352 1.061 . . . . 0.0 112.691 -177.347 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.7 t -76.07 111.52 12.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -105.77 114.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-O 121.513 0.673 . . . . 0.0 109.788 -178.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtp -103.5 172.59 6.72 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.612 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.9 p -160.74 150.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.87 128.19 33.57 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 40.3 ttp180 -153.72 127.42 8.76 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 67.64 19.92 9.71 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.52 -14.74 64.48 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.158 178.186 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.89 172.99 6.52 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.166 0.508 . . . . 0.0 110.007 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -110.5 112.53 24.51 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.11 -158.44 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.372 -4.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.954 -175.194 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.49 129.53 39.66 Favored 'General case' 1 C--N 1.231 -4.552 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.508 -170.697 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.1 tm? -89.47 -57.45 2.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 171.387 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 86.7 m-20 -112.29 95.05 29.18 Favored Pre-proline 0 N--CA 1.421 -1.911 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.163 178.78 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.71 -17.68 25.82 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.275 1.983 . . . . 0.0 111.382 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -79.14 -19.59 50.66 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.199 1.0 . . . . 0.0 110.834 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 29.6 mmt180 -81.11 129.7 34.68 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 174.064 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -145.21 152.73 40.45 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 16.9 m -104.95 114.81 29.23 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.189 0.995 . . . . 0.0 111.138 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -112.39 174.59 5.81 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.433 -178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -82.95 145.91 29.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.683 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.5 ptp180 -74.99 132.45 77.14 Favored Pre-proline 0 C--N 1.298 -1.648 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.214 178.053 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 47.2 Cg_endo -73.46 139.69 28.98 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 122.153 1.902 . . . . 0.0 110.115 176.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 m -89.49 -21.31 23.02 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.431 0.634 . . . . 0.0 109.761 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.61 -160.44 47.24 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.576 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.33 115.34 14.14 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 125.162 1.385 . . . . 0.0 110.653 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 138' ' ' ILE . 98.4 Cg_endo -78.76 -9.43 15.78 Favored 'Trans proline' 0 C--O 1.212 -0.794 0 C-N-CA 123.31 2.673 . . . . 0.0 113.151 -178.305 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 123.95 -155.65 17.93 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -145.05 157.9 43.98 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -150.11 125.99 5.04 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.78 -47.62 15.32 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.494 2.129 . . . . 0.0 111.445 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -109.82 140.04 44.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.46 -178.01 23.15 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.913 176.62 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 m -158.04 166.97 31.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -123.49 159.35 29.27 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.239 176.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.594 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.98 159.39 25.7 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.422 177.935 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.69 139.86 52.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.2 t -113.32 -18.86 11.95 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.41 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.28 21.44 Favored Glycine 0 CA--C 1.5 -0.853 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.587 -174.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.64 -175.79 32.63 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -178.396 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.7 15.09 18.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.147 0.975 . . . . 0.0 109.083 178.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.65 172.3 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -96.5 100.41 12.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.216 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' VAL . 14.7 pt-20 -147.14 160.63 42.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 -174.075 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.507 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 92.6 t80 -55.14 116.28 2.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.127 0.489 . . . . 0.0 110.439 175.065 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.98 -18.91 11.29 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 105' ' ' GLU . 1.4 p -91.08 167.64 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.4 ttmt -142.13 131.84 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -179.619 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.66 94.42 8.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.594 HG13 ' OG1' ' A' ' 97' ' ' THR . 3.7 p -93.49 114.71 30.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.883 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.65 144.09 26.51 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.387 1.089 . . . . 0.0 112.887 -173.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -134.81 150.83 50.56 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 103.479 -2.786 . . . . 0.0 103.479 174.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 118' ' ' TYR . 16.3 t -112.21 -80.92 0.59 Allowed 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.695 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 2.4 m-20 -137.7 -168.12 2.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.3 -43.17 70.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.264 0.554 . . . . 0.0 110.671 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.61 -1.91 46.69 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.81 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.721 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 91.2 m-85 -115.86 128.96 56.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 122.454 -0.439 . . . . 0.0 111.749 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 14.8 mm100 -139.2 -148.7 0.26 Allowed 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 170.695 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -111.66 169.88 8.52 Favored 'General case' 0 N--CA 1.382 -3.848 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.862 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 140' ' ' ILE . 3.5 mm? -66.21 -64.26 0.9 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.765 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.23 -154.42 16.77 Favored Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.072 -0.967 . . . . 0.0 114.764 -173.051 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.68 -13.78 22.54 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.392 0.677 . . . . 0.0 111.435 -177.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 139' ' ' PRO . 45.8 mm -94.43 94.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 CA-C-O 122.293 1.044 . . . . 0.0 110.56 -175.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -94.31 26.49 3.33 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.494 -177.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.09 174.64 7.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.866 0.841 . . . . 0.0 112.54 -171.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HG3' ' CE3' ' A' ' 134' ' ' TRP . 9.1 ptm180 -140.67 132.19 27.0 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 170.051 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -110.91 157.37 19.94 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -168.166 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 46.3 m -90.62 116.56 28.6 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.659 0.742 . . . . 0.0 112.384 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -110.97 179.17 4.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.2 p -57.36 -35.74 70.32 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.918 0.887 . . . . 0.0 110.527 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.9 -35.19 67.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.781 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 139.43 -127.61 3.7 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -174.062 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.512 ' CE3' ' HG3' ' A' ' 127' ' ' ARG . 91.4 m95 -82.66 127.47 33.42 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 118.173 0.987 . . . . 0.0 109.749 178.145 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.2 p -62.64 -60.79 3.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.066 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.38 -173.4 2.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 12.2 t70 -113.01 -166.75 1.11 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.589 HD11 ' HA3' ' A' ' 89' ' ' GLY . 71.5 mt -82.14 124.97 78.18 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 122.949 0.5 . . . . 0.0 110.916 -173.351 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 16.3 Cg_endo -58.13 147.91 80.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.553 2.835 . . . . 0.0 111.789 178.516 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 121' ' ' LEU . 37.1 mm -88.73 122.05 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.515 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 41.3 t -72.26 119.44 16.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.38 0.61 . . . . 0.0 111.079 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 121' ' ' LEU . 9.8 tp10 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.4 m -69.31 137.39 52.93 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.681 -1.145 . . . . 0.0 107.969 -177.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 41' ' ' THR . 74.7 m-20 -114.41 14.65 17.93 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.61 163.96 36.47 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.727 -175.165 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -98.0 159.06 31.74 Favored Pre-proline 0 N--CA 1.383 -3.825 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.721 -175.645 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.72 134.47 54.25 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 109.779 176.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.48 142.35 64.95 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.411 2.074 . . . . 0.0 113.439 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.97 134.61 35.39 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 171.092 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 31.8 mtp85 -118.99 179.52 4.13 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -169.457 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -78.51 -63.87 1.3 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.467 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 p -85.54 11.63 10.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.501 0.667 . . . . 0.0 112.44 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 4.0 mp0 -141.71 143.85 33.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.619 -176.155 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 51.9 mt -133.24 141.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 37' ' ' TRP . 51.2 mt -71.94 141.16 49.46 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.751 0.657 . . . . 0.0 110.348 177.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -71.29 -61.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 178.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.28 52.61 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.308 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -103.83 114.44 28.7 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CD1' HD13 ' A' ' 33' ' ' LEU . 27.1 m95 -101.77 92.27 4.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.116 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -99.59 -5.91 28.26 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.122 -177.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' HD21 ' A' ' 24' ' ' LEU . 6.0 m-20 -83.76 -163.1 0.72 Allowed 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -136.27 -54.74 0.75 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 45.3 p -90.98 129.02 37.03 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 121.528 0.68 . . . . 0.0 112.557 -176.038 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 40.5 m-85 -135.91 153.29 76.96 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 123.814 0.846 . . . . 0.0 109.382 179.083 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.46 149.48 87.84 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.176 1.918 . . . . 0.0 112.441 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 tt0 -69.73 135.59 49.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.7 7.66 50.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.038 -178.03 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -85.03 123.98 31.19 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.712 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.0 pt20 -92.22 147.82 22.63 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.019 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.73 134.23 55.3 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.38 132.29 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 82.7 m-85 -109.57 136.34 49.11 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.469 175.406 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 53' ' ' ARG . 36.1 mtpt -65.93 -26.81 67.76 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.211 1.004 . . . . 0.0 111.618 -176.114 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.659 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 19.2 m 71.33 8.74 6.41 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.472 -171.309 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 50.3 mtt180 66.57 170.2 0.1 Allowed Pre-proline 0 N--CA 1.494 1.752 0 CA-C-O 121.388 0.613 . . . . 0.0 111.198 -178.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.79 133.84 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 166.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.39 -17.11 34.36 Favored Glycine 0 C--N 1.302 -1.309 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.799 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 80.8 m-85 -118.85 161.94 19.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.176 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -149.23 -174.87 4.77 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 p -174.65 175.89 2.39 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.45 -8.94 58.79 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.78 48.09 0.1 OUTLIER Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 50.8 m-80 62.22 -172.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.657 0.783 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 53.7 t -110.86 116.13 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.8 114.39 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.766 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.5 mtp -105.75 167.32 9.85 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -151.39 146.39 15.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.2 t -84.75 132.23 34.46 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.768 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 51.2 ttp180 -154.27 120.75 5.44 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 42.2 mmtm 65.88 38.22 5.15 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.197 0.999 . . . . 0.0 112.198 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.26 -16.16 24.73 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 114.962 -1.017 . . . . 0.0 114.084 176.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -110.38 154.97 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.399 0.6 . . . . 0.0 111.107 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.439 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 78.6 m95 -95.1 121.0 36.29 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.224 0.535 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.93 174.53 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.527 -176.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.18 125.25 30.04 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.29 -59.13 3.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -109.74 105.99 57.83 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.523 177.042 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.94 -14.14 40.37 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 123.428 2.752 . . . . 0.0 111.945 -178.608 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.44 -11.58 58.43 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.498 1.142 . . . . 0.0 109.876 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 42.0 mmt-85 -90.85 114.28 26.66 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.156 176.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.51 148.05 27.57 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.614 -177.252 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -86.24 108.97 18.61 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.567 -178.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -101.19 157.5 16.73 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.635 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 86.5 mttt -75.5 138.89 41.87 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.223 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HD3' ' O ' ' A' ' 131' ' ' THR . 17.1 ptm180 -76.02 151.29 83.98 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.565 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 156.31 62.69 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.079 1.853 . . . . 0.0 111.796 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.3 m -114.3 5.53 15.8 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.651 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.36 -92.39 0.33 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.374 174.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -152.43 124.36 3.84 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -173.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HE ' ' A' ' 127' ' ' ARG . 89.9 Cg_endo -80.13 40.45 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 123.542 2.828 . . . . 0.0 112.865 -178.054 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 82.91 -179.43 52.99 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -177.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -103.72 162.63 12.92 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.583 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -161.45 109.76 1.22 Allowed Pre-proline 0 N--CA 1.42 -1.945 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.551 175.479 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.26 -50.72 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.905 1.737 . . . . 0.0 111.821 177.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -100.11 14.96 28.93 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -133.77 171.37 22.05 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.015 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 m -146.39 167.34 23.85 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 42.4 p90 -142.29 163.47 32.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.683 0.277 . . . . 0.0 111.038 -178.578 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 65.5 p -107.71 161.89 14.47 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.72 128.31 38.66 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.251 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.0 t -112.99 14.88 19.74 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.84 28.17 2.75 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.01 176.4 14.39 Favored Glycine 0 N--CA 1.411 -3.009 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 -173.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -112.25 32.5 5.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.12 165.69 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.184 -174.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -96.42 95.25 7.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 110.244 -177.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.98 155.65 49.94 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.567 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.546 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 52.2 t80 -50.9 124.47 11.3 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.072 0.857 . . . . 0.0 109.766 176.41 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.55 26.28 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.29 -1.433 . . . . 0.0 114.175 177.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.4 134.25 28.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 119.403 1.602 . . . . 0.0 109.498 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -97.83 117.19 31.59 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.02 104.71 16.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.531 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.512 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.1 m -87.65 130.32 37.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HG2' ' A' ' 139' ' ' PRO . 68.3 t80 -121.18 137.86 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.566 0.698 . . . . 0.0 112.051 -168.446 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.7 m -152.1 165.16 35.6 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.462 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.0 m -130.75 120.97 24.59 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.851 0.296 . . . . 0.0 110.529 -177.306 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 55.79 -155.64 0.28 Allowed 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.6 0.562 . . . . 0.0 110.317 178.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.5 -43.63 8.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.122 0.486 . . . . 0.0 110.835 177.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.39 11.72 68.54 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -173.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 70.0 m-85 -120.77 140.43 51.7 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.388 1.094 . . . . 0.0 111.9 177.868 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 42.5 mt-30 -133.96 -170.19 2.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 167.461 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -98.56 155.41 17.3 Favored 'General case' 2 N--CA 1.356 -5.143 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -175.716 . . . . . . . . 4 4 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.63 -31.99 57.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.302 -179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.16 174.6 53.19 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.202 177.124 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.65 -37.94 17.54 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.991 0.901 . . . . 0.0 109.592 -178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.1 mm -82.99 103.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.076 -175.557 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.418 ' HB3' HD21 ' A' ' 120' ' ' LEU . 4.6 p-10 -87.71 25.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.428 -176.387 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -159.15 173.87 15.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.089 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' A' ' 88' ' ' PRO . 29.2 ptt-85 -148.84 118.02 6.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.846 174.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.25 146.25 23.98 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.876 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . 43.5 t -91.24 124.45 35.46 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.515 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.7 t70 -105.38 -164.84 1.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 28.6 p -54.06 -58.64 6.58 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 125.857 1.663 . . . . 0.0 112.761 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.22 -40.11 52.95 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 172.52 -155.45 23.28 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.525 -176.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 70.0 m95 -69.9 132.49 46.07 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.319 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 48.5 p -77.29 142.04 39.65 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 72.17 -168.79 0.14 Allowed 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.015 0.822 . . . . 0.0 109.245 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.91 -164.35 1.3 Allowed 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.416 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt -86.28 107.97 15.56 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 7.1 Cg_endo -48.41 122.53 7.83 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.55 2.834 . . . . 0.0 112.196 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.0 mp -73.23 115.09 13.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.017 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 80.3 m -81.43 115.02 20.57 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.006 0.431 . . . . 0.0 111.437 179.178 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 140' ' ' ILE . 65.9 mm-40 . . . . . 0 C--N 1.303 -1.455 0 C-N-CA 124.327 1.051 . . . . 0.0 108.498 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -65.12 137.78 57.87 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.208 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.428 ' HA ' HG22 ' A' ' 41' ' ' THR . 3.3 m-80 -124.0 24.7 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.115 0.959 . . . . 0.0 109.184 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.1 150.79 24.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.666 -1.607 . . . . 0.0 107.823 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.01 152.55 84.47 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 123.66 0.6 . . . . 0.0 109.916 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.21 147.5 91.2 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.022 1.814 . . . . 0.0 110.347 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.95 165.57 19.51 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 113.447 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -110.35 150.11 29.25 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 16.1 mtp180 -123.07 178.93 4.86 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.684 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.63 -58.69 3.13 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.77 0.428 . . . . 0.0 110.094 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -90.23 -11.85 39.75 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -123.11 150.94 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.569 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' A' ' 53' ' ' ARG . 33.1 mt -131.1 148.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 mt -74.01 129.95 38.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 117.918 0.326 . . . . 0.0 111.487 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 19.9 p -121.34 104.39 9.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.525 0.679 . . . . 0.0 110.342 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.27 173.03 22.09 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -93.82 119.34 32.64 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 117.263 0.532 . . . . 0.0 110.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -126.9 121.68 32.47 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 t -149.86 13.27 0.8 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.934 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.95 152.65 49.17 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 121.508 -0.745 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.05 -30.49 62.43 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.751 0.31 . . . . 0.0 110.917 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.1 p -114.41 118.13 32.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.576 0.703 . . . . 0.0 112.714 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -119.97 153.15 54.96 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.099 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.92 140.07 44.9 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.175 1.917 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -61.74 136.54 58.03 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.25 -0.34 40.69 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.221 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -82.29 119.25 23.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.9 pt20 -91.97 144.17 25.73 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.804 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.28 123.9 51.28 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.122 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.99 121.44 45.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.527 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 53.2 m-85 -99.73 145.72 27.34 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.985 0.897 . . . . 0.0 113.334 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 50.1 tptt -85.2 128.19 34.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.322 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.8 m -82.58 107.3 15.12 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 165.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HG2' HD11 ' A' ' 32' ' ' ILE . 76.1 mtp180 -40.11 153.98 0.2 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.086 1.354 . . . . 0.0 113.598 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.69 114.02 2.22 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.698 1.598 . . . . 0.0 108.898 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 114.03 -8.38 23.27 Favored Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.06 168.76 13.54 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -162.22 -179.27 6.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.0 p -139.63 -77.64 0.33 Allowed 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 58' ' ' SER . 24.8 mt -176.32 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 126.612 1.965 . . . . 0.0 106.203 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.25 -108.11 1.18 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.85 158.04 44.27 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.0 t -86.54 109.89 19.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.39 121.24 54.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.194 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.2 mtp -111.18 166.36 11.14 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -152.86 146.71 14.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.0 t -81.23 126.61 31.74 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 2.5 tpm_? -148.73 128.76 13.55 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 34.7 mmtp 67.77 12.16 8.71 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.42 -9.4 57.42 Favored Glycine 0 CA--C 1.495 -1.184 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.848 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -115.56 163.62 15.51 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.15 116.21 28.94 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 m -115.2 167.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.471 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.37 110.06 20.9 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.53 -45.89 92.17 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -115.71 91.06 28.71 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.147 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.99 -15.67 26.01 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.815 2.343 . . . . 0.0 111.661 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.19 -20.49 48.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.097 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.723 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -161.86 156.09 22.13 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 59.3 m -92.99 118.69 31.45 Favored 'General case' 0 C--N 1.27 -2.877 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -113.05 -179.48 3.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.0 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.4 mmtp -59.45 147.54 36.16 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.82 0.7 . . . . 0.0 111.565 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 131' ' ' THR . 10.9 ptp180 -98.17 143.13 25.73 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 55.2 Cg_endo -71.81 148.21 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.518 2.145 . . . . 0.0 111.533 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.06 -19.37 15.2 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.677 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.92 -163.55 52.48 Favored Glycine 0 CA--C 1.467 -2.958 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.793 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -73.21 129.47 86.04 Favored Pre-proline 0 C--N 1.261 -3.263 0 CA-C-N 114.427 -0.887 . . . . 0.0 112.539 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 84.4 Cg_endo -84.85 -3.36 9.78 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 C-N-CA 123.054 2.503 . . . . 0.0 111.748 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 114.35 3.85 Favored Glycine 1 N--CA 1.395 -4.043 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -99.91 175.38 5.79 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.025 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.459 HG21 ' OH ' ' A' ' 112' ' ' TYR . 5.4 t -151.22 145.19 17.77 Favored Pre-proline 0 N--CA 1.416 -2.167 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.24 -23.75 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.039 1.826 . . . . 0.0 111.331 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -127.56 105.14 8.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.84 168.04 11.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -142.08 169.44 17.59 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.7 155.75 38.95 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 p -128.95 141.0 51.41 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -98.21 129.02 44.97 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.566 0.698 . . . . 0.0 110.664 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.552 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.1 t -114.92 130.28 56.88 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.94 -16.06 33.41 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.36 -176.78 48.0 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -121.97 18.45 10.91 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.683 0.754 . . . . 0.0 109.519 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG11 ' A' ' 108' ' ' VAL . 30.0 m -140.21 169.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 30.3 m-85 -93.28 89.19 6.29 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.535 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.5 pt-20 -133.31 158.12 43.76 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.921 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 77.4 t80 -48.76 115.24 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.417 1.087 . . . . 0.0 110.969 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.08 -21.74 10.06 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.753 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 103' ' ' VAL . 11.4 m -79.27 149.97 5.28 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.8 ttmp? -113.63 124.55 52.59 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.02 90.85 8.05 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.8 114.91 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.459 ' OH ' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -79.94 138.46 37.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.7 167.55 16.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 118' ' ' TYR . 12.3 t -146.79 173.82 12.04 Favored 'General case' 0 N--CA 1.396 -3.172 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.278 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.09 155.33 20.69 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.881 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -50.78 -41.16 56.7 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.066 0.946 . . . . 0.0 112.205 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.96 64.88 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HB2' ' SG ' ' A' ' 114' ' ' CYS . 34.8 m-85 -136.59 167.02 22.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 119.094 1.447 . . . . 0.0 111.159 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.52 -93.97 0.51 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 168.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.1 pp 175.74 158.01 0.23 Allowed 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.58 0.752 . . . . 0.0 111.499 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 96.1 mt -96.91 135.69 38.53 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 122.16 168.18 13.22 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -96.88 -28.99 13.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.4 mm -100.03 105.15 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.267 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -89.37 36.18 0.83 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.886 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 127' ' ' ARG . 23.0 p90 -165.21 174.1 10.61 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.184 0.516 . . . . 0.0 111.114 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.471 ' HD3' ' C ' ' A' ' 126' ' ' TYR . 1.4 mpp_? -139.46 132.36 29.3 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -113.01 147.81 36.39 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 118.437 0.562 . . . . 0.0 111.182 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 11.6 m -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.157 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -101.4 -166.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.499 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 28.7 p -59.5 -46.17 89.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 124.939 1.296 . . . . 0.0 112.728 -174.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.74 21.93 15.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 132.02 -155.5 21.49 Favored Glycine 0 C--N 1.288 -2.115 0 C-N-CA 119.394 -1.384 . . . . 0.0 113.624 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.6 m95 -81.49 146.15 30.36 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.225 0.536 . . . . 0.0 111.355 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.5 p -78.65 -25.21 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.884 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.79 -179.62 5.76 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -171.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -107.98 -155.59 0.56 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.689 0.796 . . . . 0.0 110.585 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.25 107.75 34.42 Favored Pre-proline 0 C--N 1.313 -0.984 0 O-C-N 122.039 -0.413 . . . . 0.0 110.344 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 22.7 Cg_endo -66.89 133.61 31.89 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.486 2.124 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.1 mm -86.83 123.9 40.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.648 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.91 105.97 1.44 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 29.8 mm-40 . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 124.597 1.159 . . . . 0.0 108.097 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.6 m -80.67 121.95 26.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.418 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.5 m-20 -97.59 33.56 2.02 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.843 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 10.8 pt-20 -155.6 148.78 24.64 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.908 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.2 mt -73.27 153.12 90.33 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 123.794 0.838 . . . . 0.0 109.56 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.8 Cg_endo -62.58 130.09 28.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.693 1.595 . . . . 0.0 109.39 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 2.9 Cg_exo -72.87 126.91 11.72 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.65 1.567 . . . . 0.0 112.542 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.91 136.08 57.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 168.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 HH21 ' CD ' ' A' ' 31' ' ' GLU . 12.9 mtm180 -111.03 163.16 14.13 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -171.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.25 -33.82 67.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.53 0.681 . . . . 0.0 112.357 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 56' ' ' TYR . 3.0 p -111.93 -0.33 15.83 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.663 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 58.8 mp0 -139.7 142.27 36.9 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 53' ' ' ARG . 34.7 mt -123.2 152.75 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -77.91 136.21 37.99 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.089 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 51' ' ' LYS . 2.6 p -120.68 105.9 11.21 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.618 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.62 -159.97 28.99 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -125.59 110.85 14.32 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HB3' HD22 ' A' ' 24' ' ' LEU . 73.8 m95 -110.72 112.27 24.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -116.12 -11.13 11.41 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.303 -171.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -128.99 152.94 48.05 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 118.749 -1.181 . . . . 0.0 112.437 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.587 ' NE2' ' HA ' ' A' ' 23' ' ' GLU . 54.6 tp60 -76.08 -23.69 55.0 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.4 p -116.36 122.77 45.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.512 0.672 . . . . 0.0 112.422 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.73 136.81 29.29 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.343 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 151.85 79.96 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.589 2.193 . . . . 0.0 112.043 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.3 tt0 -62.5 140.05 58.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.28 8.46 58.73 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.327 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.7 m -91.63 115.97 28.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.845 -0.178 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.2 pt20 -85.56 144.18 28.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.564 0.697 . . . . 0.0 111.197 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.12 117.37 31.03 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.354 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.81 121.62 41.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 68.5 m-85 -104.96 152.5 22.61 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB2' HG23 ' A' ' 34' ' ' THR . 65.1 tttm -109.89 136.3 49.41 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.569 -1.651 . . . . 0.0 107.144 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.6 m -78.49 17.64 0.65 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HG2' HD11 ' A' ' 32' ' ' ILE . 77.6 mtp180 65.24 159.42 0.13 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.458 0.647 . . . . 0.0 109.689 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.11 -8.01 18.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.568 1.512 . . . . 0.0 114.157 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.67 -5.42 20.62 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.047 -1.073 . . . . 0.0 115.223 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.8 m-85 -114.21 173.2 6.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.037 . . . . 0.0 109.182 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.0 179.13 6.68 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -165.12 -176.7 4.23 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -112.25 2.79 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.482 0.658 . . . . 0.0 109.749 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.75 155.13 14.85 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.94 135.76 57.48 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.018 0.481 . . . . 0.0 110.864 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.8 t -79.3 111.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -110.27 122.92 65.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.344 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.9 mtp -108.03 172.44 6.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.3 p -156.35 147.04 11.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.064 0.459 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.0 128.31 35.09 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.628 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.9 ttp180 -150.07 120.72 7.5 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm 57.97 21.62 7.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.68 -17.87 55.89 Favored Glycine 0 N--CA 1.415 -2.704 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.44 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 72' ' ' VAL . 16.3 pt-20 -103.83 154.86 19.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.128 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -93.18 121.46 34.56 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 70' ' ' GLU . 34.0 m -123.42 170.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.506 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.56 119.99 29.52 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 120.713 0.292 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.5 -50.14 66.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -112.23 87.99 9.91 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.183 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.83 -7.76 18.63 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.176 2.584 . . . . 0.0 111.289 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.82 -11.99 57.81 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -112.84 140.32 47.73 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.326 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.76 152.33 25.0 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 64.1 m -91.83 112.87 24.97 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.762 0.791 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -104.4 167.56 9.67 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.265 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.04 147.37 53.28 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -88.9 135.59 31.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.138 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.62 143.36 33.94 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.287 1.991 . . . . 0.0 110.074 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m -93.54 -20.4 20.28 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.612 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 -178.9 52.32 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -70.73 130.3 88.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 36.2 Cg_endo -69.86 91.34 0.52 Allowed 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.163 1.909 . . . . 0.0 111.227 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.38 -153.23 46.02 Favored Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.036 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.36 16.11 4.08 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -38.06 105.25 0.32 Allowed Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 126.133 1.773 . . . . 0.0 114.441 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -84.01 -24.22 2.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.369 2.046 . . . . 0.0 109.431 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -112.95 86.68 2.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.08 156.66 7.15 Favored Glycine 0 N--CA 1.411 -2.967 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 m -149.36 167.82 25.07 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.8 p90 -153.63 155.36 35.93 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.144 0.429 . . . . 0.0 110.725 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 p -121.13 143.82 48.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.16 136.16 40.48 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.8 t -114.39 2.08 14.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.454 0.645 . . . . 0.0 111.761 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.3 38.1 2.02 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.78 -172.58 19.49 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -120.72 20.43 11.71 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.839 0.828 . . . . 0.0 109.375 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.76 156.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.259 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.07 89.01 7.85 Favored 'General case' 0 C--N 1.244 -3.999 0 CA-C-N 112.638 -2.074 . . . . 0.0 109.949 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.05 150.41 41.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.033 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.501 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 55.1 t80 -47.96 112.78 0.61 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.431 0.634 . . . . 0.0 111.633 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.46 -19.99 7.96 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.754 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.31 141.82 13.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 117.468 0.634 . . . . 0.0 110.393 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.616 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.5 ttmp? -108.35 134.29 51.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.12 106.3 17.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 59.3 t -86.57 115.69 27.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 88' ' ' PRO . 18.8 m-85 -88.22 147.71 24.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.7 1.238 . . . . 0.0 112.998 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.9 m -155.55 177.64 11.15 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.5 t -140.38 -65.48 0.45 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 120.681 1.582 . . . . 0.0 110.051 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -146.29 -164.61 2.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.95 -43.83 17.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.479 0.656 . . . . 0.0 109.932 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.1 -11.63 61.13 Favored Glycine 0 C--N 1.305 -1.156 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.176 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 88.3 m-85 -123.11 129.33 51.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 65.7 mt-30 -122.85 -86.44 0.65 Allowed 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.616 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.6 pp -175.0 156.46 2.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 123.704 0.627 . . . . 0.0 112.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.37 156.18 16.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.68 179.02 24.69 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.523 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.01 -29.55 12.48 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.605 0.717 . . . . 0.0 109.508 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.427 HG13 ' ND2' ' A' ' 136' ' ' ASN . 47.4 mm -94.97 107.97 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.077 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -97.21 30.49 2.77 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.116 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.466 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 39.3 p90 -161.16 172.45 16.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.251 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -141.49 136.64 31.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 34.6 mt-10 -111.78 142.2 44.43 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.832 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 133' ' ' GLY . 11.8 m -74.52 89.51 2.18 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.492 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -99.4 -161.09 0.85 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.427 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 41.7 p -61.66 -36.01 79.59 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.49 -46.59 89.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.98 0.895 . . . . 0.0 110.242 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 129' ' ' CYS . . . 136.44 -54.82 0.72 Allowed Glycine 0 N--CA 1.407 -3.285 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -139.37 130.88 27.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 110.787 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 55.4 p -77.79 164.5 25.16 Favored 'General case' 0 C--O 1.264 1.836 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.427 ' ND2' HG13 ' A' ' 124' ' ' ILE . 17.8 m120 61.11 -149.67 0.41 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -140.39 -174.33 3.92 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.8 mt -79.53 115.79 55.94 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 118.42 0.554 . . . . 0.0 109.617 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.95 136.52 66.25 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.945 1.764 . . . . 0.0 110.842 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -77.27 113.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.775 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 20.0 t -57.48 114.92 2.44 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.706 0.629 . . . . 0.0 109.452 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 7.0 tp10 . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.574 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.9 m-20 . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -77.65 129.68 35.88 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.202 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.64 17.68 19.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.354 0.597 . . . . 0.0 110.252 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.27 153.51 39.85 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 37' ' ' TRP . 2.7 mm? -83.63 157.18 64.61 Favored Pre-proline 1 N--CA 1.349 -5.49 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.46 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 17.7 Cg_endo -58.09 144.62 94.64 Favored 'Trans proline' 0 C--O 1.258 1.481 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.97 152.9 78.84 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.345 2.03 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -88.22 156.58 19.14 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -117.59 152.41 35.2 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.813 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -77.96 -30.26 50.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.817 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -107.76 -12.37 15.23 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 9.2 mp0 -123.17 174.04 7.51 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.107 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.6 144.61 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 37' ' ' TRP . 43.5 mt -70.44 132.84 46.19 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 p -74.1 -56.81 4.47 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.672 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.63 169.36 54.93 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -99.75 125.08 45.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.768 ' HB3' HD12 ' A' ' 24' ' ' LEU . 11.0 m95 -116.17 95.04 4.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 m -108.68 11.42 26.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.358 0.599 . . . . 0.0 110.947 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.665 ' O ' HD21 ' A' ' 24' ' ' LEU . 10.2 t70 -103.97 -157.74 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.52 ' HA ' HD21 ' A' ' 24' ' ' LEU . 77.0 mt-30 -129.5 -47.38 1.18 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 33.0 p -96.7 123.81 40.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.077 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.95 138.0 32.22 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.526 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 23.7 Cg_endo -62.3 145.2 96.03 Favored 'Trans proline' 0 C--O 1.259 1.542 0 C-N-CA 123.07 2.513 . . . . 0.0 113.146 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -63.74 128.74 37.17 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.24 9.18 32.21 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -92.56 118.11 30.66 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.593 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 pt20 -88.36 143.21 27.15 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 121.341 0.591 . . . . 0.0 111.108 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.2 121.28 44.82 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -93.58 127.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.554 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 76.2 m-85 -104.28 131.86 51.16 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.751 0.786 . . . . 0.0 112.057 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -87.88 131.4 34.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.026 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.3 m -71.57 5.51 2.37 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 68.35 144.23 0.1 OUTLIER Pre-proline 0 N--CA 1.486 1.365 0 CA-C-O 121.624 0.726 . . . . 0.0 112.416 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.17 110.2 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.941 1.761 . . . . 0.0 109.864 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.27 -12.99 6.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.732 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 55.1 m-85 -125.53 175.21 7.69 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -166.85 179.23 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -163.92 175.75 10.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -83.28 -11.76 57.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.518 0.675 . . . . 0.0 109.788 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.2 145.27 10.03 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.75 148.83 41.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.003 0.402 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 76.6 t -71.52 114.26 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.23 125.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -114.26 168.24 10.01 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -151.56 144.11 16.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.4 t -74.1 118.38 16.99 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.197 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.579 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.1 ttp180 -150.08 122.56 8.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 41.7 mmtm 66.61 27.41 9.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.488 0.715 . . . . 0.0 112.382 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.59 -14.45 62.82 Favored Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.824 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.88 153.26 28.19 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.557 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.4 m95 -85.82 115.05 23.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 168.25 4.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.953 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.74 106.32 18.38 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.674 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.69 -42.74 89.27 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 7.7 t-20 -130.92 99.05 18.46 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.955 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.03 -9.07 19.26 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.224 2.616 . . . . 0.0 112.195 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -83.74 -18.15 38.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.872 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.2 mmp_? -88.43 138.77 31.14 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.392 1.092 . . . . 0.0 113.471 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -149.3 151.66 34.55 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 100.0 m -95.62 116.3 28.65 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.24 1.019 . . . . 0.0 109.702 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 160.95 14.13 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.407 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.1 mmtp -56.96 140.78 47.69 Favored 'General case' 0 CA--C 1.491 -1.313 0 O-C-N 123.721 0.638 . . . . 0.0 109.762 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.0 ptm180 -76.62 144.38 73.41 Favored Pre-proline 0 C--N 1.284 -2.259 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.17 150.28 42.23 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 121.513 1.476 . . . . 0.0 108.823 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.8 m -107.54 -9.76 15.85 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.941 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.79 -151.28 47.48 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.552 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -93.74 120.18 66.32 Favored Pre-proline 0 C--N 1.269 -2.931 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.67 71.63 1.46 Allowed 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 123.345 2.696 . . . . 0.0 111.609 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 65.16 -161.14 41.83 Favored Glycine 0 N--CA 1.42 -2.41 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 119.93 13.11 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.244 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 t -122.55 105.44 35.95 Favored Pre-proline 0 N--CA 1.426 -1.639 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.14 8.52 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.956 1.771 . . . . 0.0 113.124 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -140.25 17.16 2.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.663 0.268 . . . . 0.0 111.438 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . -136.15 165.48 24.91 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.701 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 113' ' ' THR . 3.0 m -130.97 164.78 24.6 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -158.77 161.46 36.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -124.72 143.14 50.92 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.54 135.47 39.34 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 109' ' ' LYS . 7.4 t -124.85 17.87 8.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.467 0.651 . . . . 0.0 111.45 -173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.438 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -140.46 23.72 2.67 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.216 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.32 -178.87 20.0 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -108.62 11.69 26.43 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.426 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.3 p -140.1 -172.5 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.845 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.399 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.28 79.91 1.65 Allowed 'General case' 1 C--N 1.237 -4.3 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.689 -175.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.1 pt-20 -130.68 155.27 46.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.69 116.49 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.977 0.798 . . . . 0.0 110.816 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.75 -19.84 6.53 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.343 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.438 HG12 ' C ' ' A' ' 100' ' ' GLY . 12.6 m -83.27 140.64 15.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.7 ttmt -103.79 125.3 50.14 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 172.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.53 93.95 9.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.26 119.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.427 ' OH ' ' HA3' ' A' ' 94' ' ' GLY . 30.4 t80 -99.09 124.34 44.03 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.337 0.589 . . . . 0.0 110.812 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 95' ' ' THR . 1.2 m -162.97 148.5 11.91 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 59.5 m -113.98 -64.34 1.32 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.168 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -140.4 -168.92 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.76 -46.5 24.98 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.21 64.75 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 142' ' ' GLU . 89.7 m-85 -108.32 112.66 25.22 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 117.01 0.405 . . . . 0.0 110.743 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -119.24 -84.0 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.8 pp 172.52 157.82 0.1 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.861 0.864 . . . . 0.0 111.335 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.67 145.33 26.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.31 178.32 15.27 Favored Glycine 0 C--N 1.282 -2.444 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.395 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.07 -34.65 9.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' TYR . 37.3 mm -98.47 102.37 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.476 ' HB2' HD21 ' A' ' 120' ' ' LEU . 4.2 p-10 -89.9 28.15 1.42 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.49 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 124' ' ' ILE . 37.5 p90 -162.13 172.78 15.28 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -151.35 120.72 6.84 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.009 0.818 . . . . 0.0 109.263 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.6 150.32 20.47 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.634 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.63 128.2 34.98 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.6 t70 -113.11 -164.48 0.92 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.466 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.0 p -70.1 -40.26 75.04 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.539 1.136 . . . . 0.0 113.356 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.15 -32.54 12.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 122.031 -0.418 . . . . 0.0 111.348 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.1 -162.26 26.68 Favored Glycine 0 C--N 1.288 -2.113 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.967 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -76.73 149.5 36.34 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.321 0.581 . . . . 0.0 110.138 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -87.42 136.74 32.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 70.54 -176.23 0.2 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.02 0.528 . . . . 0.0 111.186 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -113.85 -164.85 0.95 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.757 HD11 ' HA3' ' A' ' 89' ' ' GLY . 46.6 mt -92.29 109.81 40.42 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 118.537 0.608 . . . . 0.0 109.427 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 14.6 Cg_endo -59.42 132.83 48.45 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.975 1.783 . . . . 0.0 109.993 175.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.6 mp -74.64 110.23 8.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.193 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 53.1 t -56.48 121.97 10.87 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.188 0.93 . . . . 0.0 110.244 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 13.5 tp10 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.439 -0.997 0 CA-C-O 121.729 0.776 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.7 m -83.45 127.96 34.12 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.94 20.58 17.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.827 0.822 . . . . 0.0 109.561 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.3 155.25 42.51 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.067 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 37' ' ' TRP . 34.2 mt -78.38 157.24 78.01 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 123.352 0.661 . . . . 0.0 111.514 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.0 Cg_endo -64.85 127.48 18.73 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.6 2.2 . . . . 0.0 110.771 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.6 Cg_exo -73.02 122.3 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.903 1.735 . . . . 0.0 110.299 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.39 158.43 35.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.617 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 15.0 mtp180 -113.74 167.52 10.55 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -69.46 -38.61 77.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.6 p -106.58 -0.01 24.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 46.1 mp0 -135.39 135.54 40.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.743 0.782 . . . . 0.0 111.979 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mt -125.2 143.31 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -64.09 149.68 47.11 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.556 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.8 p -105.5 111.07 23.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -171.77 16.96 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.964 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 t -104.2 136.58 43.54 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.569 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 76.7 m95 -139.82 106.01 5.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 m -135.25 16.15 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.593 0.711 . . . . 0.0 109.234 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.5 -167.3 1.42 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.725 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.3 -65.19 0.78 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.015 0.436 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -86.75 119.66 27.22 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -123.64 136.63 27.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.829 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.67 144.97 85.89 Favored 'Trans proline' 0 C--O 1.258 1.495 0 C-N-CA 122.534 2.156 . . . . 0.0 110.845 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.1 tt0 -61.21 137.68 58.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.22 51.9 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.463 ' C ' HG23 ' A' ' 65' ' ' VAL . 66.9 m -88.6 114.78 25.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.718 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 23.3 pt20 -92.83 139.12 30.88 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.101 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.46 121.63 45.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.18 130.21 43.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 72.9 m-85 -114.49 149.78 35.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 111.651 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -101.52 147.73 26.04 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.5 m -85.97 15.7 4.77 Favored 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 123.577 0.751 . . . . 0.0 112.589 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 58.9 mtp180 69.83 158.61 0.16 Allowed Pre-proline 0 C--O 1.248 1.006 0 C-N-CA 123.225 0.61 . . . . 0.0 109.36 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.0 125.81 11.28 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 109.223 -1.106 . . . . 0.0 109.223 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 110.24 -11.92 31.24 Favored Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.031 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 84.3 m-85 -117.28 168.53 10.24 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.765 -0.844 . . . . 0.0 109.813 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.93 -176.95 5.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 p -154.07 156.75 37.88 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.81 -4.1 58.39 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.198 0.999 . . . . 0.0 110.457 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.45 -119.96 1.73 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -159.96 148.29 17.12 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.29 97.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.983 0.897 . . . . 0.0 109.161 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.93 121.84 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.726 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.4 mtp -107.58 172.53 6.78 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 46' ' ' THR . 11.4 p -159.13 145.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.379 0.609 . . . . 0.0 111.003 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.6 t -70.78 119.3 14.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.581 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 30.7 tpt180 -150.05 113.68 5.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.3 mmtm 67.26 31.7 6.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.112 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.29 -16.39 52.84 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.474 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.27 152.0 25.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.061 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -90.06 114.35 26.22 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.33 171.53 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.579 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.08 124.09 35.91 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.47 -47.75 77.82 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -111.53 91.84 15.27 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.155 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.51 -23.79 16.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.631 2.221 . . . . 0.0 112.606 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.09 -22.16 49.41 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.041 0.924 . . . . 0.0 110.373 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.77 137.79 32.08 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.194 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.13 162.33 41.06 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -89.77 131.48 35.7 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.754 0.788 . . . . 0.0 111.413 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.04 165.56 20.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.881 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.3 mttt -58.45 146.93 33.42 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.4 ptm180 -82.9 154.85 67.91 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 72.5 Cg_endo -83.09 164.66 15.19 Favored 'Trans proline' 0 N--CA 1.432 -2.14 0 C-N-CA 121.314 1.343 . . . . 0.0 109.6 173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.0 -3.95 13.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.448 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.89 -116.02 4.7 Favored Glycine 0 CA--C 1.459 -3.454 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -137.33 144.17 44.43 Favored Pre-proline 0 C--N 1.265 -3.083 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.33 45.27 1.88 Allowed 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.704 2.269 . . . . 0.0 109.477 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.88 -147.71 33.94 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -170.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -161.85 122.02 2.56 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.0 t -107.28 120.23 48.4 Favored Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.273 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 4.9 Cg_exo -78.91 -7.86 15.5 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.615 2.21 . . . . 0.0 112.785 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -129.43 12.49 5.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.55 160.41 24.47 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -128.13 168.03 15.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.9 p90 -154.35 163.03 40.8 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -131.51 141.73 49.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.4 mt -98.29 124.41 42.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.9 t -109.76 -18.91 13.33 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.79 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.404 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -108.72 30.21 9.01 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 119.582 -1.294 . . . . 0.0 111.091 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.58 -173.3 30.94 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -127.44 18.42 6.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.33 0.565 . . . . 0.0 110.554 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.517 ' O ' HG11 ' A' ' 108' ' ' VAL . 20.9 m -146.95 178.61 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 66.8 m-85 -91.12 90.61 7.9 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.62 156.76 46.33 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.837 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 71.8 t80 -53.8 105.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.965 0.791 . . . . 0.0 111.36 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.39 -11.96 6.04 Favored Glycine 0 N--CA 1.418 -2.556 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.787 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 103' ' ' VAL . 19.1 m -82.95 141.34 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.015 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HB3' HG22 ' A' ' 99' ' ' THR . 37.0 ttmt -106.6 123.7 48.5 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 169.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 99.3 11.48 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 46.7 t -79.69 110.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -89.19 132.14 34.99 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 123.926 0.891 . . . . 0.0 108.77 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.1 m -155.12 156.53 35.96 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.28 -69.88 0.83 Allowed 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.167 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.64 -169.51 3.4 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.98 -50.65 11.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.722 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.45 73.9 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.636 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.73 130.06 23.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.43 0.633 . . . . 0.0 110.165 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -109.47 -76.79 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.7 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp 174.1 162.68 0.19 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.253 1.021 . . . . 0.0 110.282 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -97.46 143.81 27.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.13 159.37 12.94 Favored Glycine 0 C--N 1.289 -2.032 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.4 -27.48 22.73 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.557 0.694 . . . . 0.0 110.716 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.0 mm -95.93 103.15 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.022 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -92.87 33.56 1.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.072 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.83 174.07 15.84 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.262 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -134.26 127.44 31.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 18.3 mt-10 -111.33 143.18 42.53 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 118.654 0.661 . . . . 0.0 111.312 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 36.5 m -81.68 117.18 21.82 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.242 172.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.3 t70 -108.92 -165.38 1.02 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 61.2 p -67.31 -41.87 84.64 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.707 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.76 -30.66 20.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 -139.25 5.77 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.382 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 78.1 m95 -82.83 128.96 34.9 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.125 0.488 . . . . 0.0 110.473 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 p -63.36 -29.47 70.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.821 1.248 . . . . 0.0 113.427 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.37 170.08 14.09 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -105.54 174.32 5.93 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.99 110.47 4.65 Favored Pre-proline 0 C--N 1.319 -0.749 0 O-C-N 123.687 0.617 . . . . 0.0 111.723 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 130.49 29.61 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.152 1.901 . . . . 0.0 110.708 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.61 109.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.4 t -83.7 112.74 20.33 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.212 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB2' HD23 ' A' ' 121' ' ' LEU . 5.9 mm-40 . . . . . 0 CA--C 1.491 -1.322 0 C-N-CA 124.139 0.976 . . . . 0.0 108.902 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 N--CA 1.433 -1.305 0 CA-C-O 121.757 0.789 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.2 m -85.83 127.62 34.61 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.831 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -95.95 19.03 12.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.581 0.705 . . . . 0.0 110.528 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.14 157.13 43.14 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 39' ' ' ASP . 2.2 mm? -89.62 158.67 45.11 Favored Pre-proline 1 N--CA 1.342 -5.872 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.262 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.9 Cg_endo -58.81 138.38 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.028 2.485 . . . . 0.0 110.355 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 149.41 84.21 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.156 1.904 . . . . 0.0 112.577 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -89.61 143.45 26.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.82 168.3 10.02 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.436 0.636 . . . . 0.0 111.912 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -79.04 -33.95 44.27 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.805 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 p -98.28 -31.74 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.0 mp0 -114.83 146.22 41.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.73 0.3 . . . . 0.0 111.444 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.2 mt -120.35 146.19 25.58 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 37' ' ' TRP . 24.1 mt -75.84 130.22 38.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.1 p -99.02 127.67 44.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.92 -143.21 16.12 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 t -149.66 118.97 6.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.575 ' CD1' HD13 ' A' ' 33' ' ' LEU . 5.4 m95 -129.48 74.4 1.58 Allowed 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.856 0.836 . . . . 0.0 109.484 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 24.36 12.06 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.587 ' O ' HD21 ' A' ' 24' ' ' LEU . 24.3 m-20 -95.7 -150.76 0.33 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.943 -1.935 . . . . 0.0 111.863 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -132.41 -79.55 0.5 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 18.6 p -107.09 121.2 44.01 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -116.64 138.03 24.18 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.927 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.53 151.48 84.72 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.757 2.305 . . . . 0.0 111.938 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.4 tt0 -63.62 136.33 57.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.702 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.17 4.31 53.81 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -85.63 118.87 25.41 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 pt20 -91.99 142.04 27.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.828 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.88 131.79 56.15 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.022 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.4 mt -99.89 134.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.631 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 51.6 m-85 -113.21 156.5 23.15 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.685 0.755 . . . . 0.0 112.966 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 64.9 tttp -101.39 137.57 39.55 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.819 1.647 . . . . 0.0 106.708 173.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.781 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 76.7 m -81.33 15.0 2.15 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 67.8 mtp180 62.43 156.9 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 121.721 0.772 . . . . 0.0 111.545 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.74 107.08 2.25 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 120.744 0.963 . . . . 0.0 109.605 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 128.64 -24.49 4.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.671 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 60.2 m-85 -105.0 155.32 19.07 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.18 168.7 18.9 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 123.872 0.869 . . . . 0.0 109.725 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 58.6 p -164.69 154.4 13.61 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.126 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.87 -32.43 31.06 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.44 136.29 8.72 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.91 151.71 45.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.158 0.479 . . . . 0.0 111.134 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.05 108.84 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.636 0.732 . . . . 0.0 109.761 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.49 122.19 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.097 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 84.7 mtp -104.39 170.25 8.01 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.3 p -152.07 143.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.216 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.03 121.5 22.08 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 124.09 0.956 . . . . 0.0 108.804 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 57.2 ttp180 -146.51 121.94 10.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.5 mmtm 63.71 20.35 12.18 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.798 0.839 . . . . 0.0 112.92 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.33 72.57 Favored Glycine 0 N--CA 1.423 -2.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.45 150.87 38.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.242 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.44 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.7 m95 -87.38 113.44 23.09 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.66 0.743 . . . . 0.0 109.525 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.59 171.81 3.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.227 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.16 118.01 27.44 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 64' ' ' MET . 5.1 tp -58.88 -46.05 88.73 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -120.31 96.56 49.13 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.928 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.99 -10.77 21.38 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 112.743 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.67 -29.99 36.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.952 0.882 . . . . 0.0 109.931 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 37.3 mmt180 -91.32 132.82 35.91 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.676 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -154.35 150.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 62.5 m -86.61 114.76 23.59 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.917 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -112.89 169.82 8.64 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.477 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 105' ' ' GLU . 32.6 mmtp -55.08 119.41 5.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.443 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 11.1 ptm180 -55.64 145.51 50.12 Favored Pre-proline 0 C--N 1.295 -1.779 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.261 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.45 158.84 32.69 Favored 'Trans proline' 0 C--O 1.256 1.396 0 C-N-CA 122.272 1.982 . . . . 0.0 109.161 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.45 -16.72 5.78 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.246 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.11 -154.53 46.53 Favored Glycine 0 CA--C 1.464 -3.149 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.809 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.97 134.86 31.01 Favored Pre-proline 0 C--N 1.252 -3.642 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.256 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.7 33.57 0.49 Allowed 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.841 2.361 . . . . 0.0 110.772 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.46 157.9 33.97 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -127.58 145.34 50.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.8 t -120.66 148.9 49.21 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.074 -173.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 11.9 Cg_exo -72.4 -25.65 18.01 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.316 2.011 . . . . 0.0 111.087 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -146.56 110.05 4.83 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.361 0.6 . . . . 0.0 110.489 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . 152.75 173.09 21.81 Favored Glycine 0 N--CA 1.425 -2.065 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.317 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 m -146.73 163.45 35.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -144.52 165.52 27.75 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.4 p -135.26 148.08 49.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.23 128.28 54.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.548 HG22 ' HB3' ' A' ' 109' ' ' LYS . 12.5 t -121.44 6.82 10.09 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.435 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -124.06 23.06 6.62 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.72 -178.0 29.27 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.13 11.48 15.25 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.54 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 p -140.36 -168.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.407 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -105.64 83.4 1.93 Allowed 'General case' 0 C--N 1.245 -3.944 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.961 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 10.4 pt-20 -138.78 162.56 34.42 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.7 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -51.98 120.65 5.58 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.095 0.872 . . . . 0.0 110.205 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.74 -12.36 22.87 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.193 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 103' ' ' VAL . 20.3 m -85.14 140.26 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.496 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -101.31 116.98 34.05 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 127' ' ' ARG . . . -96.07 93.62 7.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -74.78 128.05 36.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.0 t80 -111.09 145.19 38.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.344 0.593 . . . . 0.0 111.185 -172.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 m -152.62 159.84 43.21 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 60.9 m -122.06 -68.39 0.9 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.488 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 15.7 m120 -133.91 -162.42 1.24 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.24 -55.01 4.11 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.34 0.591 . . . . 0.0 109.805 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.18 -23.38 59.14 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.969 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 86.8 m-85 -104.97 112.15 25.19 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 92.2 mt-30 -112.43 -87.83 0.54 Allowed 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.7 pp -178.87 145.2 0.28 Allowed 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 73.0 mt -87.51 139.76 30.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.62 170.05 12.98 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.67 -28.15 12.65 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.363 0.601 . . . . 0.0 110.335 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.84 99.36 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -87.07 30.71 0.74 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.846 0.858 . . . . 0.0 110.855 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.478 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 49.5 p90 -163.41 -177.83 5.53 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.516 -0.765 . . . . 0.0 108.96 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HD3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -148.76 131.51 16.0 Favored 'General case' 0 N--CA 1.403 -2.819 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 172.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 109' ' ' LYS . 31.9 mt-10 -107.67 145.86 32.81 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.86 112.41 22.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -94.6 -161.94 0.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.418 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.4 p -67.6 -44.94 76.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.902 0.881 . . . . 0.0 109.945 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.38 -37.03 68.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.879 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.76 -152.13 24.21 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.64 126.79 29.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.4 p -59.87 -34.85 73.68 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.807 0.843 . . . . 0.0 112.111 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -132.73 169.46 16.66 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 5.8 p-10 -102.37 -99.84 0.28 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.101 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.476 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 26.9 mt -127.24 99.43 28.01 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.3 Cg_endo -53.56 140.28 65.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.01 1.807 . . . . 0.0 110.018 172.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.36 118.59 31.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 -171.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 64.6 m -59.13 94.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.217 1.007 . . . . 0.0 112.47 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.4 mm-40 . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 32.5 m-20 . . . . . 0 C--O 1.242 0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.0 m -74.64 132.72 41.96 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.844 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -102.4 36.44 2.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.653 0.74 . . . . 0.0 109.395 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.18 158.06 32.0 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.213 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.2 mt -79.44 152.97 76.23 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 123.95 0.781 . . . . 0.0 110.31 175.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.27 131.7 42.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.542 2.161 . . . . 0.0 110.976 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.01 132.53 24.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.49 2.127 . . . . 0.0 113.23 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 mtm-85 -76.73 129.56 36.49 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -104.2 178.13 4.65 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.007 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -56.14 -44.62 79.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.862 0.465 . . . . 0.0 111.782 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 p -125.1 17.84 8.43 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.805 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 49.8 mp0 -135.35 134.4 39.76 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.312 0.577 . . . . 0.0 111.882 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -128.35 165.73 27.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.434 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -90.5 142.83 27.34 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -98.21 128.09 44.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.3 -165.35 12.46 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.2 m -130.98 124.53 31.17 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.607 ' HB3' HD22 ' A' ' 24' ' ' LEU . 76.0 m95 -122.4 121.48 36.76 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 m -132.74 3.4 3.8 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.966 0.413 . . . . 0.0 110.767 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 21.0 m-20 -95.63 -169.81 2.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.88 -59.57 1.34 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.241 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.3 p -93.82 124.4 37.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 57.6 m-85 -125.59 139.17 33.39 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.496 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.606 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 24.4 Cg_endo -61.44 142.56 95.78 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 123.178 2.586 . . . . 0.0 113.038 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.6 tt0 -61.7 132.97 54.94 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.12 43.37 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.403 ' C ' HG23 ' A' ' 65' ' ' VAL . 85.1 m -89.66 115.41 27.01 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.9 pt20 -89.16 144.17 26.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.605 0.717 . . . . 0.0 111.437 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 128.62 55.82 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.43 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.34 128.54 49.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 70.1 m-85 -103.43 158.01 16.64 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 60.2 tttm -106.06 142.4 35.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.981 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 86.6 m -95.93 38.44 1.18 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 29.9 mmt180 62.22 163.23 0.11 Allowed Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.696 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.94 100.45 0.37 Allowed 'Trans proline' 0 N--CA 1.418 -2.935 0 C-N-CA 121.273 1.315 . . . . 0.0 109.228 167.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.87 -3.17 3.78 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.494 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 45.6 m-85 -130.47 -177.73 4.46 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -153.02 -176.35 5.73 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.591 0.756 . . . . 0.0 109.341 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.2 p -162.04 165.09 27.77 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.21 -13.87 27.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.366 0.603 . . . . 0.0 109.76 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.94 161.13 34.05 Favored Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -75.05 143.06 43.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 117.694 0.747 . . . . 0.0 111.418 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 50.0 t -77.45 109.15 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 174.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.91 123.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.109 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 91.0 mtp -112.06 168.81 9.31 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.8 p -152.39 145.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.328 0.585 . . . . 0.0 110.383 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.9 t -71.71 120.38 17.22 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.542 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 44.2 ttm-85 -152.21 120.38 6.28 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.59 28.13 13.27 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.218 1.007 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.89 -15.95 61.52 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.723 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -110.64 158.61 18.41 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.181 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.22 115.89 28.49 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.94 151.37 32.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.399 0.619 . . . . 0.0 111.713 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.98 109.59 1.32 Allowed 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.457 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.79 -52.21 64.07 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -110.79 92.73 15.18 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -20.96 22.75 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 122.394 2.063 . . . . 0.0 111.176 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 mt -74.86 -25.58 59.07 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.403 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -89.49 128.37 35.97 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.331 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.76 158.08 40.41 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 65.0 m -88.49 139.99 29.92 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.765 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 48.1 mt-30 -132.69 168.46 18.28 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.225 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.72 160.22 33.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.838 0.828 . . . . 0.0 113.15 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -110.82 137.61 20.86 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.44 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 9.6 Cg_endo -71.02 148.82 57.77 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.392 2.061 . . . . 0.0 112.698 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.13 -55.28 3.49 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.976 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.18 -156.08 20.64 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.003 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -87.82 111.84 44.94 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 123.635 0.774 . . . . 0.0 109.201 -175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 81.1 Cg_endo -76.72 9.95 2.45 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.916 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 145.75 135.9 2.87 Favored Glycine 0 N--CA 1.397 -3.922 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -106.26 107.74 18.9 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 t -125.09 124.6 25.35 Favored Pre-proline 0 N--CA 1.411 -2.384 0 CA-C-O 121.564 0.697 . . . . 0.0 112.155 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -89.84 2.61 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 122.269 1.979 . . . . 0.0 112.335 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.9 4.86 2.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.81 13.79 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 p -142.39 163.36 33.06 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.295 0.638 . . . . 0.0 109.934 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.4 p90 -130.31 154.36 47.71 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.189 0.306 . . . . 0.0 110.404 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 74.7 p -114.21 178.3 4.33 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.86 142.25 31.75 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.8 t -127.88 -45.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.998 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.25 51.01 3.38 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.113 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 140.39 -176.84 21.14 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.42 10.61 10.55 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 121.16 0.505 . . . . 0.0 110.003 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.533 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.8 p -147.06 -164.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.432 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.361 -173.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 28.2 m-85 -100.23 82.49 2.52 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.8 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.47 154.98 50.61 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.466 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.18 112.89 0.8 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.137 0.898 . . . . 0.0 109.919 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.3 -27.61 4.2 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.908 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 103' ' ' VAL . 18.2 m -75.73 164.34 3.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.071 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -131.7 115.37 15.93 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.4 101.94 13.89 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.5 m -78.82 162.24 4.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 118.621 -1.231 . . . . 0.0 108.612 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.447 ' HE2' ' SG ' ' A' ' 141' ' ' CYS . 61.2 t80 -129.43 134.61 47.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.394 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -150.83 154.99 38.31 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 78.6 m -130.68 -41.08 1.19 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -153.55 -176.63 5.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -106.75 -40.31 5.55 Favored 'General case' 0 C--N 1.278 -2.533 0 O-C-N 123.633 0.583 . . . . 0.0 111.028 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.62 -37.1 94.19 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -122.98 125.59 45.55 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 48.2 mt-30 -99.15 -89.46 0.32 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 125' ' ' ASN . 2.0 pp -170.43 161.12 7.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.71 -61.28 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.53 158.14 13.59 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.293 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.43 -26.09 33.05 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.936 0.875 . . . . 0.0 109.932 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.92 95.26 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' HD11 ' A' ' 120' ' ' LEU . 4.0 p-10 -85.55 29.63 0.68 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 21.7 p90 -162.12 174.33 13.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -173.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 96' ' ' PHE . 2.2 mpp_? -134.14 122.37 22.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 26.5 mt-10 -103.62 150.58 23.84 Favored 'General case' 0 C--N 1.284 -2.271 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.744 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.3 m -81.2 121.73 26.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.748 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 131' ' ' THR . 11.8 t70 -96.55 -159.45 0.73 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 30.3 p -58.35 -62.15 2.05 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 124.183 0.993 . . . . 0.0 112.709 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.21 -24.27 15.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.57 -149.85 5.7 Favored Glycine 0 CA--C 1.486 -1.748 0 C-N-CA 118.603 -1.761 . . . . 0.0 113.489 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 73.2 m95 -93.52 147.69 22.75 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.191 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.8 p -77.69 -24.59 49.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.791 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -139.3 172.99 12.01 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.756 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 21.0 t70 -108.69 -158.25 0.64 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.5 mt -85.53 117.21 68.3 Favored Pre-proline 0 C--N 1.289 -2.065 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.75 143.78 46.99 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.222 1.948 . . . . 0.0 109.56 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 142' ' ' GLU . 2.3 mp -94.73 124.65 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 122.118 -0.363 . . . . 0.0 111.667 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 112' ' ' TYR . 64.4 m -77.8 111.49 13.67 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.161 0.984 . . . . 0.0 111.142 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 140' ' ' ILE . 6.9 mm-40 . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.8 m-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.7 m -76.46 152.78 36.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -119.01 16.88 13.36 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.741 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.94 160.61 28.02 Favored 'General case' 0 CA--C 1.462 -2.434 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -85.2 156.33 60.08 Favored Pre-proline 1 N--CA 1.355 -5.191 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.042 -177.492 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 6.5 Cg_endo -55.45 135.12 67.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.443 2.762 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.66 117.67 4.43 Favored 'Trans proline' 0 CA--C 1.519 -0.231 0 C-N-CA 123.023 2.482 . . . . 0.0 112.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.59 133.24 45.6 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 94.0 mtt180 -108.1 -179.74 3.98 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.513 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.595 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 59.7 t30 -89.38 -50.42 6.13 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.157 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 53' ' ' ARG . 7.7 p -88.15 -9.16 54.05 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.4 mp0 -124.6 135.52 53.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.614 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mt -117.1 135.98 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 37' ' ' TRP . 17.7 mt -67.97 117.66 10.12 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.427 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' LYS . 9.7 p -96.77 100.25 11.8 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.91 -159.28 28.39 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -132.71 113.53 13.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.61 ' CD1' HD13 ' A' ' 33' ' ' LEU . 10.1 m95 -125.18 84.67 2.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 m -118.66 5.94 11.6 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.207 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.598 ' O ' HD21 ' A' ' 24' ' ' LEU . 18.5 m-20 -85.25 -160.06 0.48 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.207 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -125.15 -69.26 0.8 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 23.3 p -93.38 133.69 36.37 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -128.48 141.29 40.97 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 35.1 Cg_endo -65.19 150.17 87.9 Favored 'Trans proline' 0 C--O 1.255 1.361 0 C-N-CA 122.718 2.279 . . . . 0.0 112.712 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -68.87 133.62 48.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 -6.11 38.81 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.516 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -80.96 118.52 22.52 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.4 pt20 -88.23 152.88 21.66 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.937 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.44 131.95 54.12 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -102.98 126.12 57.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 63.4 m-85 -108.87 143.65 37.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.217 0.532 . . . . 0.0 112.202 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' HG23 ' A' ' 34' ' ' THR . 63.4 tttm -93.66 142.68 27.08 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 85.4 m -90.19 40.34 1.0 Allowed 'General case' 0 C--N 1.279 -2.474 0 CA-C-O 120.521 0.2 . . . . 0.0 110.835 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 29' ' ' ASN . 22.0 mtp180 61.46 172.3 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 122.781 0.432 . . . . 0.0 110.689 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -76.12 -12.0 19.42 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 120.857 1.038 . . . . 0.0 112.225 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -104.18 -13.89 25.74 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 115.126 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 62.0 m-85 -114.23 176.07 5.2 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.137 -1.213 . . . . 0.0 109.806 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -152.55 -173.49 4.58 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -168.62 -175.01 2.32 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.79 -6.64 57.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.407 1.099 . . . . 0.0 109.062 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.31 -147.2 4.84 Favored Glycine 0 N--CA 1.403 -3.507 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -120.97 150.84 40.48 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 75.3 t -70.36 103.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.0 mm -101.0 119.53 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.927 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.1 169.84 8.47 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -155.23 147.51 12.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.609 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.35 123.49 24.72 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttt180 -152.19 124.22 8.06 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 62.33 26.17 15.64 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.783 0.833 . . . . 0.0 112.677 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.21 -9.9 74.17 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.761 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.87 162.43 20.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.471 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -92.63 112.0 23.8 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.29 167.62 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.396 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.553 0.216 . . . . 0.0 110.59 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -50.23 73.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.472 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 86.0 m-20 -111.93 93.82 22.48 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.03 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -73.56 -11.72 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.438 2.092 . . . . 0.0 111.693 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.12 -11.99 58.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.503 0.668 . . . . 0.0 110.13 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 25.8 mmt180 -89.32 126.95 35.73 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.392 0.615 . . . . 0.0 110.13 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -146.37 144.68 29.91 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.0 m -93.41 117.43 30.07 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-O 121.239 0.543 . . . . 0.0 109.892 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -117.34 167.48 11.21 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.128 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.6 mttt -63.6 145.76 55.06 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.787 0.327 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.6 ptp180 -85.46 138.05 36.3 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 40.6 Cg_endo -68.24 154.75 71.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.791 2.327 . . . . 0.0 111.348 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.05 -2.29 18.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 -112.57 3.68 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.168 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -127.13 119.58 22.2 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 95.6 Cg_endo -79.24 34.54 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.877 3.052 . . . . 0.0 114.058 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.74 137.78 6.71 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.614 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.74 128.06 34.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.298 0.57 . . . . 0.0 109.729 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -139.57 107.36 7.11 Favored Pre-proline 0 N--CA 1.409 -2.518 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.25 12.0 2.95 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.448 2.098 . . . . 0.0 110.477 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 -54.82 2.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.764 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.91 -166.1 14.58 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.116 -1.04 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 m -132.27 170.93 14.35 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 54.3 p90 -142.64 153.41 43.42 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.642 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 72.2 p -107.66 -178.65 3.69 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.431 HD22 HG21 ' A' ' 108' ' ' VAL . 96.2 mt -145.38 157.42 44.04 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 7.6 t -151.52 146.92 26.24 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.09 27.26 66.71 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.857 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.73 -44.59 0.21 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.181 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.03 13.24 9.08 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.42 171.75 14.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.4 m-85 -85.73 93.02 8.76 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.664 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -146.13 151.42 37.64 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.274 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 76.8 t80 -52.41 106.55 0.16 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.014 0.926 . . . . 0.0 111.208 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 139.47 -27.86 2.59 Favored Glycine 0 N--CA 1.422 -2.264 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.817 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' THR . 23.2 m -80.92 154.79 4.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.303 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -118.12 118.88 33.08 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 171.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.19 96.66 9.75 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.0 OUTLIER -77.45 156.25 5.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.709 -178.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.581 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 46.6 t80 -114.78 139.19 49.92 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -141.44 164.59 29.82 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 7.2 t -146.66 -57.7 0.28 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.748 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.38 -174.18 4.14 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -83.55 -45.01 14.03 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 121.892 0.853 . . . . 0.0 108.833 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.98 -24.11 64.97 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.846 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -115.15 125.97 54.07 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 122.654 -0.321 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.614 ' HB3' HD13 ' A' ' 120' ' ' LEU . 84.1 mm-40 -113.96 -87.36 0.57 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -162.15 161.49 28.08 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.247 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 88.7 mt -92.72 131.62 37.63 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.86 179.46 16.42 Favored Glycine 0 C--N 1.269 -3.154 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.417 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -102.87 -9.78 19.61 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.915 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 126' ' ' TYR . 48.5 mm -122.66 121.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.059 0.457 . . . . 0.0 109.969 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -104.58 29.23 6.31 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.799 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.9 p90 -163.77 176.86 9.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.042 0.449 . . . . 0.0 111.39 -173.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -141.97 126.94 18.31 Favored 'General case' 0 C--O 1.199 -1.583 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -104.11 147.74 27.07 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 118.555 0.616 . . . . 0.0 111.671 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.5 m -84.83 103.07 13.58 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.843 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.24 -167.95 1.47 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.3 p -64.55 -44.15 91.68 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.066 1.346 . . . . 0.0 110.745 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.56 -38.02 77.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.966 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.14 -115.11 0.7 Allowed Glycine 0 CA--C 1.486 -1.721 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 91.9 m95 -95.95 129.68 43.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.0 p -67.67 -26.93 66.44 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.604 0.762 . . . . 0.0 112.584 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.4 ' CG ' HG21 ' A' ' 124' ' ' ILE . 16.7 m120 -137.91 169.26 18.09 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -101.88 -171.75 2.03 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 123.824 0.703 . . . . 0.0 109.556 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.6 mt -74.98 113.2 22.44 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.586 0.354 . . . . 0.0 110.655 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.581 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 9.7 Cg_endo -66.48 141.17 60.24 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.399 2.066 . . . . 0.0 110.771 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 49.0 mm -92.66 119.73 40.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.446 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.9 m -64.59 118.85 9.44 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.529 0.518 . . . . 0.0 109.8 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.486 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 11.7 mm-40 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.5 m -79.49 129.67 34.69 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.956 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -98.01 35.48 1.72 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.0 110.566 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -160.0 152.89 21.51 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.585 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -71.1 149.42 94.58 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 124.26 0.975 . . . . 0.0 108.969 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.33 131.54 45.77 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.541 2.161 . . . . 0.0 111.821 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 116.79 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.736 2.291 . . . . 0.0 112.311 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -61.49 127.14 30.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.29 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -81.36 153.64 26.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.831 -170.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -72.21 -24.87 61.47 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -128.35 7.45 5.89 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.3 mp0 -137.45 164.48 28.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.117 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.82 150.51 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.46 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -71.54 142.96 50.08 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.302 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.5 p -103.42 108.25 19.42 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.98 -164.71 25.51 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -138.93 98.72 3.6 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 48.8 m95 -92.82 144.21 25.51 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.15 31.06 0.34 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.24 161.27 36.68 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.681 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -93.85 -26.67 16.81 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.099 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -116.64 110.26 18.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.822 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -110.06 139.33 21.26 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.5 Cg_endo -60.62 146.24 97.44 Favored 'Trans proline' 0 C--O 1.254 1.299 0 C-N-CA 123.202 2.601 . . . . 0.0 112.971 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.4 tt0 -66.0 138.03 57.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.1 7.22 56.43 Favored Glycine 0 N--CA 1.427 -1.96 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.287 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.432 ' C ' HG23 ' A' ' 65' ' ' VAL . 98.5 m -88.16 112.03 22.27 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.9 pt20 -84.2 140.22 31.86 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.276 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.57 56.57 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.2 mt -98.98 131.09 46.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 80.5 m-85 -115.73 138.95 50.62 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.672 0.748 . . . . 0.0 112.851 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -91.49 133.48 35.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.9 m -72.55 10.86 0.73 Allowed 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 66.77 154.78 0.13 Allowed Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.19 0.596 . . . . 0.0 111.219 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.62 98.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.117 1.878 . . . . 0.0 112.134 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.593 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 130.92 -13.65 5.52 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.391 -0.909 . . . . 0.0 114.212 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 82.2 m-85 -115.19 168.5 9.89 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.373 -1.075 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -146.49 169.38 19.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 59' ' ' LEU . 31.0 t -165.79 -10.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 123.816 0.697 . . . . 0.0 110.023 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 58' ' ' SER . 20.2 tp 75.15 -52.56 0.66 Allowed 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.425 173.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.8 20.35 39.1 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 61.76 -167.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.16 0.984 . . . . 0.0 110.867 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG23 ' SG ' ' A' ' 80' ' ' CYS . 69.4 t -118.31 123.82 72.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 168.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -117.64 122.21 69.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 64' ' ' MET . 88.1 mtp -108.17 178.0 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -161.98 143.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.074 0.464 . . . . 0.0 110.403 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 t -70.38 125.19 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.919 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.5 ttt180 -152.69 119.18 5.62 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 120.634 0.254 . . . . 0.0 110.755 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 62.23 23.17 13.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.11 -20.0 51.89 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.458 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.74 154.11 20.94 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.05 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -88.22 116.47 26.44 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.06 172.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.57 124.69 35.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.93 -51.21 34.77 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -114.0 89.54 17.01 Favored Pre-proline 0 N--CA 1.426 -1.634 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.786 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.58 -25.41 15.01 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 122.378 2.052 . . . . 0.0 110.629 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.05 -25.69 64.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.138 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 3.3 mmp_? -85.28 138.38 32.35 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.3 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -161.6 144.57 12.22 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 62' ' ' VAL . 73.9 m -86.01 109.18 18.62 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-O 121.79 0.805 . . . . 0.0 111.776 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -106.39 167.14 10.04 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.174 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 98.8 mttt -62.24 135.26 57.4 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 123.29 0.369 . . . . 0.0 111.503 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.7 ptp180 -80.4 146.19 61.17 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.74 142.96 10.48 Favored 'Trans proline' 0 N--CA 1.424 -2.576 0 C-N-CA 121.675 1.583 . . . . 0.0 112.336 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.5 m -84.33 -30.77 25.24 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.93 104.44 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 O-C-N 124.237 0.961 . . . . 0.0 115.072 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.8 t60 64.02 111.33 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 123.858 0.863 . . . . 0.0 111.993 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 127' ' ' ARG . 88.0 Cg_endo -81.47 43.13 1.47 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 123.635 2.89 . . . . 0.0 112.506 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 85.64 -171.53 45.41 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -107.67 91.58 3.71 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 m -112.61 91.31 16.82 Favored Pre-proline 0 N--CA 1.421 -1.9 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.191 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.59 -29.73 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.567 2.178 . . . . 0.0 112.679 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -110.78 146.24 36.71 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.66 178.34 36.68 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -143.2 156.8 44.84 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.671 -0.311 . . . . 0.0 110.937 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 p90 -141.35 149.56 41.31 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.226 0.536 . . . . 0.0 110.358 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.8 p -116.12 147.36 41.42 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.576 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.61 135.99 51.44 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -115.74 -4.32 12.17 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -119.0 16.82 10.84 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.536 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.26 32.74 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -107.32 2.83 24.8 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 117.771 0.786 . . . . 0.0 110.059 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.9 p -142.17 -164.04 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.535 -170.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -98.98 74.0 1.98 Allowed 'General case' 0 C--N 1.245 -3.938 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.59 151.75 46.03 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.883 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 73.4 t80 -47.08 117.56 1.76 Allowed 'General case' 0 C--N 1.315 -0.904 0 O-C-N 124.574 1.171 . . . . 0.0 111.759 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.42 -14.06 20.75 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.872 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -82.42 141.57 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 99' ' ' THR . 35.2 ttmt -111.22 122.53 48.11 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 127' ' ' ARG . . . -94.86 95.54 8.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 55.5 t -79.36 122.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 77.0 t80 -98.48 144.57 27.68 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.824 0.821 . . . . 0.0 112.063 -172.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.94 156.81 46.0 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.9 t -131.04 -68.32 0.68 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.181 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.12 -173.34 3.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -85.2 -48.6 8.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.425 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.21 -23.8 60.49 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.154 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -116.9 116.95 28.41 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 15.5 mm-40 -109.0 -80.98 0.57 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.1 pp -170.59 137.0 1.31 Allowed 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.96 -47.16 69.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.758 1.223 . . . . 0.0 112.035 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.04 174.98 48.61 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.132 -0.486 . . . . 0.0 113.743 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.62 -30.02 23.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.849 0.833 . . . . 0.0 110.146 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.18 98.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.536 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.98 20.4 2.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.147 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -154.48 -177.63 6.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.493 ' NH1' HG12 ' A' ' 138' ' ' ILE . 8.2 ptp180 -154.13 128.22 8.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 174.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 21.4 mt-10 -103.75 143.17 33.15 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 122.151 -0.343 . . . . 0.0 111.347 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -88.44 104.42 16.77 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.1 t70 -98.04 -156.55 0.55 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.471 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.0 p -70.49 -53.25 17.03 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.088 0.955 . . . . 0.0 112.064 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.82 -25.63 27.99 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.184 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.81 -156.36 28.27 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.168 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.6 m95 -78.51 142.27 37.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.813 0.445 . . . . 0.0 110.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -90.04 131.8 35.73 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 72.16 -175.46 0.17 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.773 0.829 . . . . 0.0 111.652 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -123.54 168.47 12.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.545 HD11 ' HA3' ' A' ' 89' ' ' GLY . 21.4 mt -57.04 116.11 12.45 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.411 1.085 . . . . 0.0 110.032 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 18.2 Cg_endo -64.69 138.52 59.09 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.274 1.983 . . . . 0.0 111.777 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 1.9 mp -87.06 129.13 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 0.0 110.091 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 12.1 m -63.13 113.48 3.17 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 123.782 0.833 . . . . 0.0 111.759 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.8 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 41' ' ' THR . 72.8 m -70.61 137.64 50.15 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.683 0.615 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.451 ' HA ' HG22 ' A' ' 41' ' ' THR . 89.4 m-20 -107.04 19.1 20.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.703 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.61 161.54 41.97 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.33 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 mt -78.2 150.17 77.03 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 123.401 0.68 . . . . 0.0 109.245 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.33 139.77 84.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.84 1.693 . . . . 0.0 110.022 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.55 147.02 50.85 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.036 1.824 . . . . 0.0 112.583 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -91.45 146.18 24.02 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -116.93 171.75 7.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 10.8 t30 -88.56 -39.09 14.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.984 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 p -93.57 -12.51 29.37 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 3.4 mp0 -127.48 138.29 52.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.956 0.408 . . . . 0.0 110.719 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 12.8 mt -114.74 144.19 22.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -78.72 125.27 29.14 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.7 p -86.99 -32.07 20.25 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.26 165.85 54.11 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.424 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 m -97.87 106.05 18.29 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -109.37 136.66 48.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -148.04 -20.31 0.35 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.0 152.87 18.3 Favored 'General case' 0 C--O 1.201 -1.487 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.568 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ASN . 25.5 p -120.71 139.79 52.55 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.903 -0.498 . . . . 0.0 111.74 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.74 140.91 33.33 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 122.257 0.223 . . . . 0.0 110.952 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.2 Cg_endo -60.3 145.63 98.2 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.412 2.741 . . . . 0.0 112.045 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 67' ' ' ARG . 22.6 tt0 -68.98 144.13 54.21 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.21 0.09 54.27 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -86.68 111.21 20.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.7 pt20 -86.4 147.89 25.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.26 120.79 37.12 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 HD12 ' A' ' 63' ' ' ILE . 66.7 mt -93.59 119.13 40.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.337 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 58.9 m-85 -95.39 143.8 26.45 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.89 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 5.0 tppp? -89.45 126.98 35.78 Favored 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 64.6 m -79.95 21.49 0.56 Allowed 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 18.8 mtp180 63.4 157.87 0.12 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 123.87 0.868 . . . . 0.0 112.273 -176.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.13 -2.35 8.73 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.026 1.817 . . . . 0.0 113.766 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -105.39 -1.64 40.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.882 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.6 m-85 -128.14 178.16 6.42 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.435 -1.038 . . . . 0.0 108.949 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -155.53 177.71 11.06 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -169.02 171.69 8.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.92 -35.55 20.44 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.28 143.63 15.36 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.45 160.41 32.78 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.478 0.639 . . . . 0.0 111.426 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.98 105.11 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 HG12 ' A' ' 49' ' ' ILE . 45.9 mm -104.66 116.93 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.263 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.4 mtp -105.52 172.32 6.86 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.606 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.0 p -159.47 148.88 7.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.25 0.548 . . . . 0.0 110.559 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.41 117.37 12.87 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.459 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 44' ' ' GLU . 5.4 tpm_? -146.63 123.07 11.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.09 25.69 14.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 0.0 113.19 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 94.25 -11.5 70.38 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.802 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.25 166.11 11.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.473 0.654 . . . . 0.0 110.644 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -106.46 106.74 17.4 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' ALA . 9.6 p -130.42 -161.52 0.3 Allowed 'Isoleucine or valine' 1 N--CA 1.37 -4.472 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -91.19 126.6 36.32 Favored 'General case' 1 C--N 1.228 -4.705 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.069 -169.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.23 -57.8 3.63 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 13.0 t-20 -116.5 102.56 53.35 Favored Pre-proline 0 N--CA 1.419 -1.998 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.537 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.45 -0.89 11.09 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 122.976 2.451 . . . . 0.0 112.989 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 mt -89.8 -26.5 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.859 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 34.9 mmt180 -85.28 147.75 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.227 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HG3' ' HG3' ' A' ' 81' ' ' GLN . 17.9 ptpt -154.58 163.15 40.65 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.95 111.38 23.63 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 49.6 mt-30 -101.37 151.05 22.37 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.357 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.8 mttt -65.24 129.03 38.24 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.2 ptp180 -71.74 137.37 82.83 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.077 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 143.66 76.57 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 122.711 2.274 . . . . 0.0 110.728 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.2 m -101.17 -13.76 18.0 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.24 -173.27 55.28 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.111 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.421 ' HE1' ' OD1' ' A' ' 90' ' ' ASP . 30.5 t-80 -72.26 134.13 82.9 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.91 65.78 4.06 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.025 2.483 . . . . 0.0 111.894 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.503 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 74.42 -95.33 0.86 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD1' ' HE1' ' A' ' 87' ' ' HIS . 18.8 t70 -178.94 138.53 0.15 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -144.82 99.86 4.69 Favored Pre-proline 0 C--N 1.286 -2.172 0 CA-C-O 121.127 0.489 . . . . 0.0 111.612 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.2 -50.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.554 1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 114.88 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -81.46 -34.42 31.41 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.828 -0.545 . . . . 0.0 111.191 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 150.56 30.68 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 m -111.35 -42.74 3.83 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 117.42 0.61 . . . . 0.0 110.696 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' HA ' ' H ' ' A' ' 113' ' ' THR . 4.2 p90 64.44 152.19 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.963 1.705 . . . . 0.0 115.11 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 p -124.13 143.64 50.36 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -103.82 137.04 42.4 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -119.29 -22.26 7.18 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.89 44.31 1.51 Allowed Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.09 20.16 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -128.35 15.89 6.61 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.92 178.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -93.32 85.98 5.16 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 12.3 pt-20 -127.18 145.59 50.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.576 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 63.8 t80 -46.47 126.82 8.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.25 -5.93 55.79 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.935 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.58 131.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.644 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.7 ttmt -100.29 127.57 46.55 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 98.21 8.18 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.41 115.75 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.429 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 4.9 t80 -82.96 94.55 7.77 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.647 0.737 . . . . 0.0 110.678 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.405 ' H ' ' HA ' ' A' ' 96' ' ' PHE . 1.7 p -105.82 151.13 24.9 Favored 'General case' 0 N--CA 1.402 -2.848 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.466 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.85 -166.14 1.17 Allowed 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.201 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -61.82 156.52 20.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.58 -42.43 11.13 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.609 1.564 . . . . 0.0 114.246 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.94 10.34 74.24 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.356 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -114.46 167.69 10.51 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.788 0.794 . . . . 0.0 111.738 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -133.45 -140.21 0.19 Allowed 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 102.539 -3.134 . . . . 0.0 102.539 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.3 pt? -160.28 152.78 20.88 Favored 'General case' 1 N--CA 1.335 -6.178 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 142' ' ' GLU . 0.5 OUTLIER -80.43 126.83 31.69 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 173.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.95 163.23 9.43 Favored Glycine 0 N--CA 1.402 -3.582 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.62 -24.58 14.09 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.276 1.036 . . . . 0.0 108.344 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.6 mm -102.48 101.64 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.74 ' HA ' HD11 ' A' ' 120' ' ' LEU . 30.3 p-10 -89.19 33.61 0.8 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.657 0.741 . . . . 0.0 111.269 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -165.18 171.24 13.96 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.398 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 124.87 14.73 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.122 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -99.04 142.37 30.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.6 t -82.12 126.57 32.18 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.01 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.8 t70 -117.28 -166.45 1.18 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.8 p -60.15 -48.74 80.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 124.894 1.278 . . . . 0.0 113.616 -172.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.65 -24.81 18.54 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.38 0.609 . . . . 0.0 111.515 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.37 -155.48 25.73 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -77.87 144.77 36.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.5 p -63.97 -34.85 78.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.858 0.837 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -138.48 152.43 48.28 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.28 2.5 p30 -82.36 -94.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.503 HD11 ' HA3' ' A' ' 89' ' ' GLY . 7.3 mt -133.61 98.19 15.17 Favored Pre-proline 0 C--N 1.292 -1.91 0 O-C-N 121.573 -0.704 . . . . 0.0 109.672 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.893 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.1 Cg_endo -51.78 141.43 44.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 166.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.98 115.18 26.86 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.684 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.53 120.66 9.83 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 122.266 0.226 . . . . 0.0 110.914 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 121.649 0.738 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.757 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.2 142.82 32.82 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -116.89 16.4 15.18 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 122.153 0.978 . . . . 0.0 108.609 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.45 163.18 34.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.8 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 37' ' ' TRP . 21.5 mt -91.51 154.96 44.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 123.699 0.8 . . . . 0.0 111.005 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.2 Cg_endo -64.79 130.9 27.45 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.224 1.949 . . . . 0.0 110.511 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.5 Cg_exo -64.25 146.32 90.05 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.153 1.902 . . . . 0.0 111.358 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -92.45 146.91 23.32 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.53 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.4 mpt_? -104.22 174.86 5.69 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.515 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -82.3 -34.88 28.45 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -100.38 -5.12 27.73 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 1.5 mp0 -133.06 145.81 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.58 153.9 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -74.82 143.05 44.13 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 123.846 0.716 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 49' ' ' ILE . 17.0 p -80.33 -52.53 7.59 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.489 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.23 177.62 54.13 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.625 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -95.23 127.75 41.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.655 ' HB3' HD22 ' A' ' 24' ' ' LEU . 75.6 m95 -124.31 103.78 8.41 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.6 m -121.65 7.67 10.01 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.753 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.52 -158.41 0.73 Allowed 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 41' ' ' THR . 18.2 pt20 -142.24 -36.92 0.4 Allowed 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -97.23 103.81 15.77 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.657 0.742 . . . . 0.0 111.658 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -117.63 145.45 36.41 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.049 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.22 140.47 92.28 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 123.323 2.682 . . . . 0.0 112.132 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.6 tt0 -64.97 138.1 58.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.04 6.6 53.75 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 m -86.14 117.93 25.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.7 pt20 -82.95 146.49 28.78 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.607 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.95 113.65 24.42 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 mt -88.4 129.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.6 m-85 -103.17 136.34 43.14 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 122.395 1.093 . . . . 0.0 113.038 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -75.7 -20.15 58.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.065 -1.88 . . . . 0.0 112.967 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.8 m 65.88 7.29 4.51 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 57.5 mtp180 68.45 165.82 0.13 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 55.1 Cg_endo -71.02 -22.16 26.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 120.956 1.104 . . . . 0.0 112.903 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.12 -17.93 48.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.745 -0.74 . . . . 0.0 114.467 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.2 m-85 -118.47 167.21 11.81 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -161.67 -175.42 4.72 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 0.0 109.898 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -166.84 -177.88 4.04 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.72 69.87 0.99 Allowed 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.064 0.935 . . . . 0.0 108.987 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.78 -21.21 0.6 Allowed Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.65 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.1 m120 72.33 149.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.619 1.168 . . . . 0.0 110.598 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' SG ' ' A' ' 80' ' ' CYS . 73.3 t -70.51 110.41 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.77 116.08 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.6 mtp -103.45 174.04 6.04 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -161.64 150.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.14 0.495 . . . . 0.0 109.832 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.19 127.41 35.74 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 49.0 ttp180 -149.83 131.87 15.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 65.51 20.58 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.916 0.486 . . . . 0.0 112.305 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.11 -13.73 66.96 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.663 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.99 159.19 16.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.356 0.598 . . . . 0.0 111.697 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -99.43 109.71 22.26 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 73' ' ' ALA . 12.1 p -127.18 -156.07 0.17 Allowed 'Isoleucine or valine' 1 N--CA 1.363 -4.78 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.678 -176.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -102.47 134.79 45.22 Favored 'General case' 1 C--N 1.223 -4.921 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -168.149 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.12 -58.81 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -117.6 88.83 30.72 Favored Pre-proline 0 N--CA 1.433 -1.309 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.89 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.24 -14.46 25.66 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.37 2.047 . . . . 0.0 110.688 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.68 -28.27 62.6 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.834 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 31.5 mmt180 -93.55 132.74 37.56 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.944 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.0 155.54 44.68 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 62' ' ' VAL . 36.0 m -94.31 116.22 28.57 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.538 0.685 . . . . 0.0 109.933 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -111.0 177.11 4.77 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.976 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.2 mmtp -57.21 145.22 32.31 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.867 0.729 . . . . 0.0 109.754 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 106' ' ' TYR . 12.2 ptm180 -85.66 131.61 46.95 Favored Pre-proline 0 C--N 1.279 -2.472 0 C-N-CA 118.906 -1.118 . . . . 0.0 108.693 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 139.43 39.6 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.415 2.076 . . . . 0.0 110.089 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.7 m -101.04 -2.82 30.62 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.66 -96.75 1.89 Allowed Glycine 0 C--N 1.308 -0.984 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.597 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -143.85 125.54 8.24 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.8 Cg_exo -68.89 -53.78 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.666 2.244 . . . . 0.0 111.726 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.73 166.69 18.3 Favored Glycine 0 N--CA 1.419 -2.46 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.338 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.45 109.58 20.89 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -92.33 131.96 33.27 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.24 -31.75 52.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.75 139.96 52.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.579 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . 71.61 -165.4 53.66 Favored Glycine 0 C--N 1.304 -1.214 0 O-C-N 123.961 0.788 . . . . 0.0 113.351 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.7 m -155.54 170.07 22.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 88' ' ' PRO . 45.7 p90 -104.7 160.68 14.78 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.934 -0.479 . . . . 0.0 109.784 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -115.59 144.86 43.28 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -106.22 135.01 48.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 100' ' ' GLY 0.25 3.8 t -87.42 -86.01 0.16 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.551 ' H ' HG23 ' A' ' 99' ' ' THR . . . -87.02 52.77 4.43 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 118.15 0.432 . . . . 0.0 113.053 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.5 162.66 17.2 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -121.75 15.12 10.97 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.711 0.767 . . . . 0.0 109.102 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.9 175.35 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -93.55 88.55 5.93 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.0 pt-20 -133.25 154.85 50.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . 70.0 t80 -50.05 119.54 3.69 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.537 0.684 . . . . 0.0 111.802 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.88 -19.76 18.04 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.839 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 105' ' ' GLU . 2.8 p -85.36 141.32 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -111.46 128.26 55.95 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.04 100.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.83 118.26 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.604 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -77.82 109.88 12.21 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.64 0.733 . . . . 0.0 110.616 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.17 109.15 12.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.03 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.579 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 97.7 m -129.84 111.07 12.23 Favored 'General case' 0 C--N 1.253 -3.628 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.76 -168.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 19.4 m120 57.25 -162.09 0.2 Allowed 'General case' 0 C--O 1.247 0.941 0 O-C-N 124.448 1.093 . . . . 0.0 112.744 172.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -121.48 -46.73 2.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.19 0.519 . . . . 0.0 110.477 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.47 72.82 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 68.8 m-85 -98.6 155.09 17.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -136.99 -88.46 0.28 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.4 pp 178.44 148.87 0.2 Allowed 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 123.895 0.747 . . . . 0.0 112.14 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.24 135.22 44.22 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.025 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.41 161.13 10.92 Favored Glycine 0 C--N 1.281 -2.516 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.82 -18.99 26.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.434 0.635 . . . . 0.0 109.838 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' ND2' ' A' ' 136' ' ' ASN . 41.1 mm -113.54 121.24 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.966 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.451 ' HB2' HD21 ' A' ' 120' ' ' LEU . 29.7 p-10 -92.31 24.63 3.3 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.723 0.809 . . . . 0.0 111.557 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 38.0 p90 -163.04 178.45 8.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -151.39 128.2 10.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.649 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.0 mt-10 -103.82 154.42 19.62 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.2 t -92.44 105.65 17.8 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.251 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.35 175.48 7.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.574 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 73.8 p -52.46 -33.79 46.06 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.521 1.528 . . . . 0.0 112.444 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.15 -32.53 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.407 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.31 -159.48 28.89 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 95.2 m95 -67.74 128.92 38.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.314 0.578 . . . . 0.0 112.087 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.8 p -78.72 157.25 28.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.721 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' HG13 ' A' ' 124' ' ' ILE . 11.4 m120 65.82 -162.56 0.25 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -119.26 -163.1 0.95 Allowed 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 60.4 mt -101.54 110.04 60.71 Favored Pre-proline 0 C--N 1.285 -2.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 11.2 Cg_endo -58.76 137.91 82.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.959 1.773 . . . . 0.0 110.501 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 47.9 mm -89.33 103.91 14.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.14 111.18 1.42 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.253 0.549 . . . . 0.0 110.551 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.432 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 8.8 tp10 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.089 0.471 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.9 m -78.73 133.57 37.14 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.756 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -104.06 25.02 10.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.444 0.64 . . . . 0.0 110.096 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.42 155.19 38.1 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.851 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 37' ' ' TRP . 32.0 mt -76.9 158.8 79.92 Favored Pre-proline 0 C--N 1.31 -1.13 0 O-C-N 123.738 0.649 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 141.4 74.23 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.319 2.012 . . . . 0.0 110.09 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.96 118.03 4.65 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 121.52 1.48 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -62.38 135.98 57.7 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.496 0.665 . . . . 0.0 110.194 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.562 HH11 ' HB3' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -85.94 176.89 7.81 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.769 -167.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -82.98 -24.1 33.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.963 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 p -132.29 10.27 4.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.92 0.391 . . . . 0.0 111.388 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 2.7 mp0 -133.7 158.78 42.42 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -133.34 163.42 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -85.58 156.65 20.64 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-O 120.81 0.338 . . . . 0.0 110.573 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -130.54 95.57 3.91 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 -149.5 15.38 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.2 m -131.13 117.79 19.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 117.836 0.818 . . . . 0.0 109.45 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.537 ' HB3' HD22 ' A' ' 24' ' ' LEU . 55.3 m95 -134.17 101.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.908 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.2 t -147.4 34.81 0.87 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.11 -163.86 1.31 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.588 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.93 -49.3 1.23 Allowed 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 70.1 p -95.43 127.12 41.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.73 136.98 26.4 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.857 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 37.4 Cg_endo -65.09 153.62 77.39 Favored 'Trans proline' 0 C--O 1.262 1.712 0 C-N-CA 122.825 2.35 . . . . 0.0 112.106 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.7 tt0 -67.49 139.99 57.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.97 2.2 55.0 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.202 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.437 ' C ' HG23 ' A' ' 65' ' ' VAL . 89.6 m -84.54 115.0 22.37 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.3 pt20 -83.16 139.82 32.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.557 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.18 108.68 20.24 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.0 mt -87.71 115.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.799 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 84.6 m-85 -95.96 149.05 22.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.371 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.46 130.94 39.1 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.8 t -87.18 102.41 14.44 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -32.81 144.21 0.14 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.981 1.712 . . . . 0.0 113.623 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -56.52 111.19 0.71 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 123.423 2.749 . . . . 0.0 112.534 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.96 -19.86 5.16 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -111.88 166.62 11.05 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.578 -0.811 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -155.54 167.27 30.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.925 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -174.64 126.11 0.3 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.7 77.59 5.18 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.403 0.62 . . . . 0.0 110.697 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.01 -29.83 1.23 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 70.67 158.49 0.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.412 1.085 . . . . 0.0 112.859 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.88 110.93 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.43 121.43 67.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -109.4 176.52 5.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 46' ' ' THR . 9.9 p -159.97 142.92 5.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.139 0.495 . . . . 0.0 110.668 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.79 121.97 18.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.905 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttm180 -152.57 117.87 5.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.589 0.233 . . . . 0.0 110.527 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 40.3 mmtm 69.2 25.05 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.593 1.157 . . . . 0.0 112.826 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.38 -12.82 67.57 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.075 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.22 154.13 31.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -87.64 118.21 26.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.0 175.04 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.742 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.52 122.28 31.03 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.001 0.429 . . . . 0.0 111.258 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.08 -57.4 3.86 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -108.88 91.29 8.78 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.198 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.92 -15.44 16.63 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.476 2.118 . . . . 0.0 112.647 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 -28.94 59.98 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.672 0.749 . . . . 0.0 109.723 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -84.23 134.49 34.54 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.028 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -154.48 160.86 41.82 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.509 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 16.9 m -79.81 112.94 17.58 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-O 121.777 0.798 . . . . 0.0 112.312 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.48 153.14 23.27 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.35 146.38 43.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.818 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.12 145.66 49.69 Favored Pre-proline 0 N--CA 1.417 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.887 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.83 153.51 48.05 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 N-CA-C 108.03 -1.566 . . . . 0.0 108.03 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.1 m -91.3 -24.11 19.93 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.677 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.01 -115.52 3.99 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -146.09 131.31 9.13 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.94 34.41 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 123.015 2.476 . . . . 0.0 113.349 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.96 155.5 27.8 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.66 84.38 2.12 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 t -73.58 136.78 77.61 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.872 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.97 -28.46 19.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.172 1.915 . . . . 0.0 111.71 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.31 121.44 34.99 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 173.01 16.56 Favored Glycine 0 N--CA 1.424 -2.145 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 m -154.66 171.72 19.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -136.41 157.66 46.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.661 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -126.25 155.3 42.1 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.26 131.49 56.93 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.4 t -125.98 144.43 50.7 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.06 68.99 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.86 168.09 25.35 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -112.91 9.51 18.87 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.006 0.908 . . . . 0.0 108.963 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.3 p -136.19 -167.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.712 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.043 -173.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -105.46 101.48 11.01 Favored 'General case' 1 C--N 1.241 -4.109 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.163 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -156.37 152.86 28.08 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.8 t80 -54.07 114.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.94 0 O-C-N 124.021 0.826 . . . . 0.0 111.168 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.84 -19.81 5.2 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.576 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 15.8 m -79.93 149.36 5.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.505 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -107.51 118.26 36.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.36 94.27 9.83 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.7 p -89.33 121.23 39.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.515 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -84.23 141.41 31.02 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.333 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -141.73 163.89 31.68 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.22 -59.64 0.06 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 118.972 0.805 . . . . 0.0 111.736 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -147.26 -170.76 3.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.0 -51.04 3.8 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 123.882 0.873 . . . . 0.0 109.861 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.1 8.49 70.27 Favored Glycine 0 C--O 1.24 0.503 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.99 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -133.83 129.53 36.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -94.42 -135.78 0.2 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 167.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -153.23 153.57 32.96 Favored 'General case' 1 N--CA 1.334 -6.243 0 C-N-CA 118.991 -1.083 . . . . 0.0 108.411 -175.69 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.5 mm? -77.77 125.89 30.03 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-O 121.475 0.655 . . . . 0.0 109.431 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.25 150.14 7.38 Favored Glycine 0 C--N 1.273 -2.947 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.56 -22.76 22.23 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 122.162 0.982 . . . . 0.0 109.149 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.93 109.4 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.869 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HD11 ' A' ' 120' ' ' LEU . 32.0 p-10 -86.14 33.67 0.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.779 0.8 . . . . 0.0 110.863 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 50.1 p90 -167.07 176.52 6.82 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.95 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.85 119.42 7.97 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 23.6 mt-10 -87.76 155.39 19.93 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 52.4 t -75.38 139.46 42.39 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.42 167.47 12.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.502 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.5 p -55.87 -28.5 56.81 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.791 1.637 . . . . 0.0 112.894 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -108.43 -28.93 9.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.244 0.545 . . . . 0.0 111.555 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.7 -106.24 0.19 Allowed Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.964 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -127.54 145.35 50.89 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -74.59 -26.79 60.16 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -128.12 170.02 13.43 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -99.28 -170.14 1.87 Allowed 'General case' 0 C--N 1.285 -2.212 0 O-C-N 124.055 0.847 . . . . 0.0 110.365 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.43 113.1 53.91 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-O 120.365 0.126 . . . . 0.0 110.694 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.727 ' HB2' HD12 ' A' ' 120' ' ' LEU . 11.2 Cg_endo -70.24 152.94 67.1 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 122.601 2.2 . . . . 0.0 110.287 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.26 125.96 72.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 12.3 p -76.96 108.54 10.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.633 ' HB2' HD23 ' A' ' 121' ' ' LEU . 28.3 mt-10 . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 125.678 1.591 . . . . 0.0 107.166 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 121.72 0.771 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.0 m -76.02 140.33 41.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.024 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -105.85 20.02 19.61 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.602 0.715 . . . . 0.0 109.915 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.1 155.95 40.76 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -88.53 158.41 48.55 Favored Pre-proline 1 N--CA 1.367 -4.577 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.248 -176.966 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 13.2 Cg_endo -58.34 130.04 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.541 2.827 . . . . 0.0 111.829 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.14 122.86 5.89 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.526 2.15 . . . . 0.0 112.597 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.74 154.23 41.24 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.975 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -117.08 176.14 5.27 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.74 -23.35 64.32 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.253 0.549 . . . . 0.0 111.517 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 p -119.02 7.13 11.35 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 5.2 mp0 -136.9 141.7 42.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.35 0.595 . . . . 0.0 112.148 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.95 151.92 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 3.6 mm? -67.84 155.52 39.17 Favored 'General case' 0 C--N 1.267 -2.981 0 O-C-N 123.629 0.581 . . . . 0.0 111.233 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 p -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.389 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 -163.4 38.84 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.782 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -121.09 108.21 13.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.52 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 18.7 m95 -107.52 88.16 2.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -104.11 4.74 34.54 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.774 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 24' ' ' LEU . 9.2 t70 -103.02 -150.02 0.41 Allowed 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.279 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -134.08 -57.8 0.86 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 69.8 p -88.03 122.12 31.25 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.171 -172.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -129.51 138.95 34.26 Favored Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.482 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.43 143.76 99.61 Favored 'Trans proline' 0 C--O 1.245 0.875 0 C-N-CA 123.316 2.677 . . . . 0.0 113.237 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 48.1 tt0 -63.6 131.65 48.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.965 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.36 4.59 46.83 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 65' ' ' VAL . 58.0 m -86.02 115.53 23.67 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.9 pt20 -84.45 142.23 30.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.365 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.46 124.15 51.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -94.12 132.04 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -110.19 144.47 38.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -93.75 142.23 27.6 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.734 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 m -84.51 22.36 1.3 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 64.83 162.26 0.12 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.347 0.659 . . . . 0.0 110.112 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 131' ' ' THR . 50.3 Cg_endo -71.63 112.5 3.38 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 120.509 0.806 . . . . 0.0 110.536 173.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.57 -26.22 6.04 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.333 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 89.5 m-85 -102.59 163.51 12.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.861 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -140.55 -178.79 5.68 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -143.67 -177.0 5.19 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.76 6.03 36.49 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.13 0.491 . . . . 0.0 109.745 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.04 -115.93 0.34 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -138.78 122.86 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 80' ' ' CYS . 60.7 t -84.08 110.38 18.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.06 130.44 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.401 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -111.03 175.13 5.54 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.456 HG23 ' C ' ' A' ' 46' ' ' THR . 11.2 p -157.71 143.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-O 121.33 0.586 . . . . 0.0 111.275 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.8 t -75.31 123.85 26.06 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.474 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 70.0 ttt180 -155.53 134.24 11.92 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 62.61 21.04 12.44 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.736 0.814 . . . . 0.0 112.369 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.65 69.36 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.675 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -121.36 159.87 25.21 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.571 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.406 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.5 m95 -90.19 117.6 29.07 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.689 0.756 . . . . 0.0 110.36 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.73 169.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.022 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.69 125.77 35.0 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.84 -56.78 6.87 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 174.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 8.9 t-20 -120.88 100.66 46.03 Favored Pre-proline 0 N--CA 1.413 -2.299 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.271 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.66 -5.65 17.15 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.912 2.408 . . . . 0.0 112.779 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.5 mt -88.91 -20.46 24.51 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 122.164 0.983 . . . . 0.0 110.827 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 31.7 mmt180 -91.15 132.15 36.25 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.42 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -149.41 158.93 44.6 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 62' ' ' VAL . 81.7 m -97.66 107.23 19.68 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.058 0.932 . . . . 0.0 110.276 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.51 168.83 9.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.954 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.0 mttt -66.71 144.86 56.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -85.44 139.58 36.03 Favored Pre-proline 0 N--CA 1.427 -1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.7 Cg_endo -68.81 140.45 46.41 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.351 1.368 . . . . 0.0 108.84 174.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.7 m -74.43 -38.33 63.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.291 0.567 . . . . 0.0 110.495 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.94 -86.03 0.38 Allowed Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -174.64 120.47 0.35 Allowed Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 123.33 0.652 . . . . 0.0 109.325 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 41.9 Cg_endo -69.06 157.15 62.86 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.567 2.178 . . . . 0.0 109.011 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -51.07 138.42 26.72 Favored Glycine 0 N--CA 1.438 -1.209 0 O-C-N 123.955 0.784 . . . . 0.0 112.218 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.76 137.52 37.24 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.1 0.476 . . . . 0.0 109.909 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -126.15 141.19 38.98 Favored Pre-proline 0 N--CA 1.404 -2.733 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.834 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.13 -29.89 9.36 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.17 1.913 . . . . 0.0 110.8 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.72 109.67 16.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.73 157.0 9.57 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.296 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 m -137.92 164.5 28.86 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.7 p90 -129.5 155.78 45.2 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.027 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.737 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 42.1 p -100.64 164.83 11.7 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.945 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 93.3 mt -130.85 123.43 29.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.0 t -129.91 20.91 5.43 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.463 0.649 . . . . 0.0 112.653 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 108' ' ' VAL . . . -143.23 33.23 1.83 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.443 ' HA3' ' CD ' ' A' ' 105' ' ' GLU . . . 147.57 -151.57 23.81 Favored Glycine 0 N--CA 1.413 -2.877 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -175.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -143.76 3.24 1.25 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.406 0.603 . . . . 0.0 111.533 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.26 -172.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 13.1 m-85 -85.2 95.47 9.18 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.0 pt-20 -137.83 145.83 42.73 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.343 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.404 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 47.0 t80 -49.21 123.86 8.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.342 0.591 . . . . 0.0 111.766 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.52 58.54 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.864 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.8 p -91.8 136.25 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.3 ttmt -101.62 132.26 47.39 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.737 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -109.11 101.9 10.91 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -88.45 132.19 34.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 119.401 -0.92 . . . . 0.0 108.828 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -98.31 123.97 42.69 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.555 0.693 . . . . 0.0 109.372 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.0 m -144.34 158.32 43.8 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 71.5 m -125.41 -61.71 1.25 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.405 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -151.92 -166.06 2.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.45 -56.33 10.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.004 0.43 . . . . 0.0 111.05 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.1 -13.71 61.65 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.42 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.495 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -93.75 115.04 27.44 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.242 0.544 . . . . 0.0 111.548 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -113.08 -117.91 0.31 Allowed 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -165.69 156.66 13.68 Favored 'General case' 1 N--CA 1.354 -5.264 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.463 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 95.4 mt -79.57 125.63 29.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.8 152.75 7.25 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.65 -10.32 32.21 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.126 0.489 . . . . 0.0 110.839 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -111.39 106.72 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.762 ' HA ' HD11 ' A' ' 120' ' ' LEU . 27.5 p-10 -90.62 34.96 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 42.0 p90 -163.63 169.22 18.89 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.45 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 88' ' ' PRO . 66.4 mtt180 -132.39 134.75 45.53 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 41.3 mt-10 -114.28 130.51 56.65 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 18.7 t -79.32 114.15 18.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -105.45 -162.28 0.86 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 54' ' ' PRO . 80.3 p -62.57 -42.76 99.75 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.12 -10.86 15.76 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.0 -163.22 34.15 Favored Glycine 0 CA--C 1.49 -1.496 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.837 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -82.91 144.06 30.3 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 117.143 0.472 . . . . 0.0 110.255 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -70.5 -20.79 62.82 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.235 0.541 . . . . 0.0 112.422 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -137.83 148.63 45.63 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -89.84 -103.14 0.09 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.654 0.596 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.488 HD11 ' HA3' ' A' ' 89' ' ' GLY . 29.7 mt -127.17 96.38 34.22 Favored Pre-proline 0 C--N 1.31 -1.151 0 O-C-N 120.782 -1.199 . . . . 0.0 111.754 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.832 ' HB2' HD12 ' A' ' 120' ' ' LEU . 6.5 Cg_endo -56.92 136.11 74.66 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 122.447 2.098 . . . . 0.0 108.575 167.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.5 mp -87.15 115.86 28.56 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.963 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.83 -171.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.02 112.81 0.85 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 35.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.275 1.43 . . . . 0.0 109.481 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.688 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.0 m-20 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.31 0.576 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 41' ' ' THR . 84.9 m -77.19 139.75 39.97 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.314 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.3 m-20 -106.64 25.86 10.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.732 0.777 . . . . 0.0 109.164 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.57 155.35 33.2 Favored 'General case' 0 CA--C 1.468 -2.199 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -86.88 156.98 55.11 Favored Pre-proline 1 N--CA 1.336 -6.161 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.528 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.1 Cg_endo -54.14 125.35 18.52 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.083 2.522 . . . . 0.0 110.99 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.46 110.85 3.18 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.499 1.466 . . . . 0.0 112.118 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.276 0.0 OUTLIER -72.14 161.24 31.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.081 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 72.1 mtp180 -122.93 -174.03 2.84 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -168.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -90.47 -14.33 32.99 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -99.9 -33.88 10.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.734 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 25.5 mp0 -121.04 145.93 47.25 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.233 0.54 . . . . 0.0 112.14 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mt -119.71 144.46 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.607 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 37' ' ' TRP . 25.3 mt -74.67 128.24 35.07 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -112.96 100.35 8.57 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.9 171.1 21.3 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m -105.46 110.67 23.1 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.382 0.611 . . . . 0.0 111.261 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CD1' HD13 ' A' ' 33' ' ' LEU . 2.7 m95 -132.34 82.24 2.0 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 m -108.43 -2.29 19.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.231 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.724 ' O ' HD21 ' A' ' 24' ' ' LEU . 16.2 t70 -93.72 -136.29 0.19 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.909 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -144.11 -55.43 0.36 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 27.5 p -91.85 129.05 37.89 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -133.1 135.0 24.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.099 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.688 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 17.8 Cg_endo -60.59 148.65 90.55 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.228 2.619 . . . . 0.0 113.278 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.49 134.77 55.13 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.39 14.68 37.56 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 65' ' ' VAL . 90.4 m -94.29 119.33 32.91 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.349 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.6 pt20 -89.3 150.09 22.75 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.454 0.645 . . . . 0.0 111.861 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 130.97 53.48 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.7 mt -101.56 126.62 55.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 66.4 m-85 -109.49 143.31 39.29 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 20.2 ttmm -92.33 129.75 38.2 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 73.5 m -70.99 7.46 1.18 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 68.4 mtp180 71.78 154.17 0.15 Allowed Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.618 0.767 . . . . 0.0 111.263 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.52 129.09 17.22 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.792 1.661 . . . . 0.0 109.186 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 104.69 -6.43 44.62 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.329 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 36.3 m-85 -126.39 170.65 11.73 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -160.16 177.54 10.58 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 49.5 p -155.37 179.97 8.66 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.72 -22.34 56.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.865 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.02 -96.59 0.14 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -155.73 155.32 32.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 80' ' ' CYS . 65.9 t -77.42 106.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.63 116.77 48.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.0 mtp -107.89 167.59 9.87 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 46' ' ' THR . 7.7 p -152.79 144.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.067 0.46 . . . . 0.0 110.088 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.43 118.84 12.81 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.577 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.4 ttt180 -151.12 115.22 5.02 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 69.24 27.98 5.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.016 . . . . 0.0 112.615 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.22 87.41 Favored Glycine 0 C--N 1.294 -1.784 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.59 152.96 38.68 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 79.9 m95 -92.77 121.22 33.94 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.2 172.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.84 119.4 21.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.82 -49.39 73.04 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.49 91.84 6.37 Favored Pre-proline 0 C--N 1.29 -1.992 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.167 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.4 -3.13 13.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 0.0 112.984 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.17 8.38 44.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.239 0.542 . . . . 0.0 109.715 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -119.23 149.08 42.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.311 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.83 161.18 28.92 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 62' ' ' VAL . 71.8 m -104.26 123.94 48.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.71 0.767 . . . . 0.0 109.746 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -112.32 165.63 12.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.71 157.45 17.76 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 117.962 0.346 . . . . 0.0 110.801 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.9 ptm180 -82.22 143.91 49.54 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 41.2 Cg_endo -72.75 157.16 52.42 Favored 'Trans proline' 0 N--CA 1.424 -2.617 0 N-CA-C 108.142 -1.522 . . . . 0.0 108.142 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -103.03 6.26 38.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.646 0.736 . . . . 0.0 110.224 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 -122.07 9.94 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.892 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -130.63 120.23 18.62 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 45.5 Cg_endo -75.76 139.52 22.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.73 1.62 . . . . 0.0 108.315 172.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.438 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -48.38 128.12 18.27 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.135 0.897 . . . . 0.0 113.638 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -98.29 178.09 5.17 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 94' ' ' GLY . 3.0 t -148.8 147.1 23.42 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.99 -18.52 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.739 1.626 . . . . 0.0 111.088 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.5 -25.44 28.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 114' ' ' CYS . . . -146.79 -147.74 4.62 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.723 -1.227 . . . . 0.0 114.072 -175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 96' ' ' PHE . 12.8 m -154.59 -169.3 3.17 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.589 ' H ' HG22 ' A' ' 95' ' ' THR . 38.5 p90 -148.62 161.74 41.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 119.274 0.943 . . . . 0.0 109.053 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG22 ' A' ' 111' ' ' VAL . 63.7 p -109.1 -176.51 3.05 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 108' ' ' VAL . 96.0 mt -143.73 164.95 29.02 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 109' ' ' LYS . 7.5 t -119.88 -148.76 0.42 Allowed 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.82 74.89 0.0 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 125.746 1.641 . . . . 0.0 115.938 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.79 -41.53 0.08 OUTLIER Glycine 0 C--N 1.276 -2.783 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.06 11.96 3.71 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.27 177.19 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 40.2 m-85 -90.79 87.78 6.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.55 150.82 44.15 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.553 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -45.32 115.38 0.91 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.477 1.11 . . . . 0.0 110.835 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.7 -33.92 2.87 Favored Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.73 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 98' ' ' LEU . 35.0 m -74.37 135.79 26.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.495 1.14 . . . . 0.0 113.424 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -93.69 118.13 31.0 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.235 170.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -96.62 109.21 21.87 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.2 m -86.72 158.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 51.1 t80 -119.52 132.84 55.84 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.518 0.675 . . . . 0.0 110.201 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.3 m -153.08 157.81 40.98 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.465 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 81.8 m -120.74 -61.87 1.52 Allowed 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.148 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -153.48 -153.0 0.44 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.57 -47.0 7.03 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.14 -29.16 69.08 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.23 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 96.1 m-85 -107.93 126.49 52.75 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.14 -74.93 0.54 Allowed 'General case' 1 CA--C 1.416 -4.179 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.269 2.3 tp -172.34 154.75 3.33 Favored 'General case' 1 N--CA 1.282 -8.852 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.541 -168.186 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 22.8 mt -129.0 130.05 46.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 132.45 -168.36 22.71 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -110.29 -40.17 4.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 117.937 0.869 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.1 mm -97.67 100.74 11.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.709 -176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.458 ' HB3' HD22 ' A' ' 120' ' ' LEU . 28.5 p-10 -86.93 32.12 0.68 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 35.0 p90 -161.27 173.17 15.42 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.539 0.685 . . . . 0.0 110.262 -175.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 88' ' ' PRO . 21.7 ptt180 -147.04 134.68 21.03 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.457 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.9 mt-10 -111.86 143.48 42.74 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.648 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.74 106.13 17.45 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.207 0.527 . . . . 0.0 109.831 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.89 -166.93 1.36 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.244 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -62.59 -43.44 98.8 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.048 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.5 -37.87 77.37 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.66 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 138.78 -147.14 19.01 Favored Glycine 0 N--CA 1.411 -2.982 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -65.82 122.48 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 p -60.21 -33.21 71.92 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.888 0.875 . . . . 0.0 111.778 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -132.1 165.69 23.46 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 25.8 t70 -98.72 -144.82 0.32 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.438 HD11 ' HA3' ' A' ' 89' ' ' GLY . 11.7 mt -89.16 113.65 57.12 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.483 ' HB2' HD11 ' A' ' 120' ' ' LEU . 3.4 Cg_endo -65.73 161.82 37.28 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.457 2.104 . . . . 0.0 111.263 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.9 mp -74.81 136.46 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.448 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 40.9 t -104.18 102.7 12.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 179.6 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 11.0 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 41' ' ' THR . 59.8 m -75.99 133.93 40.29 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.244 0.618 . . . . 0.0 109.925 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -104.01 36.79 2.23 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.409 0.623 . . . . 0.0 109.635 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.16 155.94 31.82 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.825 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.7 mt -80.28 153.25 74.14 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.23 132.39 46.49 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.05 1.834 . . . . 0.0 110.657 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.33 137.58 10.6 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.254 1.969 . . . . 0.0 112.682 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -80.25 126.02 30.6 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 30.4 mtp180 -99.53 178.24 4.92 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.178 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.45 -28.03 61.74 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.168 0.985 . . . . 0.0 109.996 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -107.06 -31.56 8.23 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.642 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.681 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 30.1 mp0 -116.34 158.76 22.93 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' HG2' ' A' ' 51' ' ' LYS . 14.7 mt -144.01 148.4 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 151.42 42.28 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -126.67 156.89 40.32 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.69 -156.91 18.24 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.803 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -133.66 130.6 38.46 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.0 m95 -134.11 139.81 46.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -154.57 -5.03 0.15 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.385 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -113.97 163.65 14.84 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.031 -172.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -83.9 -47.19 11.31 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.026 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 34.0 p -98.52 131.75 44.5 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.964 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -130.83 135.45 27.36 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.041 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.3 Cg_endo -61.71 148.9 92.01 Favored 'Trans proline' 0 C--O 1.257 1.474 0 C-N-CA 123.198 2.599 . . . . 0.0 112.001 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.45 139.87 58.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -11.25 55.69 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.062 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -68.54 118.34 11.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HA ' HG23 ' A' ' 65' ' ' VAL . 23.2 pt20 -93.4 138.77 31.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.558 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.2 119.72 39.95 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.815 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -93.2 111.78 25.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.1 m-85 -101.86 144.06 30.97 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 19.4 ptpt -89.0 161.45 16.58 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.35 118.85 34.73 Favored 'General case' 1 N--CA 1.368 -4.553 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -31.55 147.31 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 124.81 1.319 . . . . 0.0 111.507 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.62 -31.33 31.49 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.409 2.739 . . . . 0.0 115.339 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' C ' ' HG2' ' A' ' 83' ' ' ARG . . . -96.2 14.54 64.33 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.514 0.508 . . . . 0.0 112.515 177.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.91 167.97 16.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.139 -0.624 . . . . 0.0 110.093 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -157.9 -177.06 6.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 109.272 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -166.65 -167.99 1.08 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mp -88.78 3.93 49.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.98 -98.87 0.12 Allowed Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -141.93 158.22 44.04 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 65.8 t -88.21 107.98 18.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.67 108.46 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-O 121.835 0.826 . . . . 0.0 109.832 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mtp -97.73 175.15 6.28 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -157.04 147.79 10.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.676 -175.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.37 111.21 12.8 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 40.9 ttm180 -141.94 119.02 11.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 66.9 mmtt 64.53 22.1 12.6 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.591 1.157 . . . . 0.0 113.068 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.32 -8.62 69.5 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.387 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.63 161.01 17.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.235 0.54 . . . . 0.0 110.481 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -104.18 106.36 16.84 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 73' ' ' ALA . 13.5 p -127.93 -153.59 0.13 Allowed 'Isoleucine or valine' 1 N--CA 1.371 -4.42 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -109.82 115.03 29.08 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 3.0 tm? -59.47 -55.0 40.09 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 167.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -120.0 97.52 49.41 Favored Pre-proline 0 N--CA 1.415 -2.193 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.098 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.08 -4.82 15.62 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 123.478 2.786 . . . . 0.0 112.624 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.87 -29.35 25.34 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.901 0.858 . . . . 0.0 109.066 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -91.36 131.44 36.85 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.919 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.89 154.11 25.47 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.681 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 73.8 m -84.77 106.18 16.11 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 122.022 0.915 . . . . 0.0 110.593 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -98.88 161.0 13.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.55 145.36 52.65 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.633 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HG2' ' C ' ' A' ' 55' ' ' GLY . 12.2 ptp180 -85.77 137.86 35.73 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.08 142.96 63.5 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.282 1.988 . . . . 0.0 111.034 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.79 -27.91 63.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.8 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.14 -175.7 24.07 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.55 123.94 80.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.55 42.97 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 123.749 2.966 . . . . 0.0 112.845 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 72.28 -168.1 52.66 Favored Glycine 0 N--CA 1.412 -2.96 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.97 139.01 32.32 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -116.61 145.5 35.46 Favored Pre-proline 0 C--N 1.281 -2.391 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.36 -35.08 95.71 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.953 2.436 . . . . 0.0 111.415 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.32 150.37 19.85 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.74 163.46 11.49 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.522 -0.847 . . . . 0.0 110.992 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 m -145.44 172.58 12.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.65 159.64 42.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -118.33 152.13 36.39 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.26 138.5 46.56 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -127.24 13.38 7.17 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.496 0.665 . . . . 0.0 111.505 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -132.45 15.91 4.92 Favored Glycine 0 CA--C 1.494 -1.241 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.738 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.15 -173.15 31.36 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -110.64 3.08 19.0 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.629 0.715 . . . . 0.0 109.355 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 104' ' ' PHE . 3.9 p -142.72 -168.49 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.366 -170.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 103' ' ' VAL . 28.6 m-85 -96.9 98.93 10.51 Favored 'General case' 1 C--N 1.239 -4.219 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.618 -177.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.44 148.54 28.2 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.573 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.516 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.5 t80 -52.81 105.6 0.13 Allowed 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.292 0.995 . . . . 0.0 112.045 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.15 -8.23 4.76 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.857 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 103' ' ' VAL . 16.3 m -90.12 143.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.356 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -104.84 122.05 44.94 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.8 91.33 8.58 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.4 p -82.07 118.15 29.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.866 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -92.82 141.36 28.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.926 0.87 . . . . 0.0 111.604 -168.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 m -146.61 155.02 42.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.7 t -130.46 -72.7 0.56 Allowed 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 117.009 -1.876 . . . . 0.0 112.493 -172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 7.7 m-20 -143.67 -169.7 3.14 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -176.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -90.85 -48.05 7.25 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.79 -10.92 85.76 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.845 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 79.3 m-85 -123.52 126.48 46.78 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -104.76 -88.51 0.43 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.0 pp 175.66 143.0 0.06 Allowed 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.461 1.104 . . . . 0.0 111.212 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.19 126.92 45.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.98 172.24 12.93 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -100.05 -23.62 14.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.242 1.02 . . . . 0.0 110.08 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 126' ' ' TYR . 35.2 mm -107.29 98.76 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.82 30.73 0.31 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.849 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 124' ' ' ILE . 39.4 p90 -170.23 -177.49 2.51 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.93 115.74 5.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 31.7 mt-10 -80.09 143.69 33.75 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.576 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.8 t -74.61 142.09 44.63 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.029 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -124.75 -165.47 1.39 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 p -70.8 -53.32 15.81 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.967 0.889 . . . . 0.0 111.75 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -103.09 2.22 34.41 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.168 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.03 -125.47 1.03 Allowed Glycine 0 C--N 1.291 -1.947 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -127.96 162.05 27.67 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.3 p -80.91 -24.89 37.92 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -141.8 172.68 12.36 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 17.9 t70 -99.75 -161.99 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 124.135 0.897 . . . . 0.0 109.504 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.566 HD11 ' HA3' ' A' ' 89' ' ' GLY . 25.9 mt -83.05 124.14 76.83 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.7 138.45 34.88 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.769 1.646 . . . . 0.0 109.863 172.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 33.6 mm -86.43 118.63 33.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.986 -175.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 76.6 m -53.72 107.28 0.24 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.582 0.552 . . . . 0.0 111.326 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG2' HG22 ' A' ' 140' ' ' ILE . 7.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 34.4 m-20 . . . . . 0 C--O 1.242 0.686 0 CA-C-O 121.074 0.464 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -77.16 145.12 37.91 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -177.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -119.79 18.4 12.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.62 157.78 38.71 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -87.43 159.64 49.73 Favored Pre-proline 1 N--CA 1.356 -5.135 0 C-N-CA 125.1 1.36 . . . . 0.0 110.389 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.71 150.09 78.93 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.516 2.81 . . . . 0.0 111.396 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.32 169.07 17.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.195 1.93 . . . . 0.0 112.244 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -117.25 150.71 38.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.04 165.49 15.97 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.331 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.91 -39.25 26.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 5.5 p -89.98 -8.12 52.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -140.98 146.87 37.87 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.7 mt -113.43 126.55 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.058 0 CA-C-O 122.138 0.971 . . . . 0.0 109.945 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.33 113.45 11.56 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.097 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.9 p -90.28 157.31 17.73 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 -175.51 22.26 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.2 m -123.36 99.54 6.38 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.78 68.52 0.69 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 m -97.8 10.97 38.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.413 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.708 ' O ' HD21 ' A' ' 24' ' ' LEU . 22.1 t70 -97.48 -138.7 0.28 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.42 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 54.8 mt-30 -151.03 -58.09 0.16 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.7 p -89.27 129.26 35.86 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.673 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -137.79 149.09 63.36 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 123.903 0.881 . . . . 0.0 108.779 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 27.5 Cg_endo -65.11 150.87 87.25 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 122.516 2.144 . . . . 0.0 112.472 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 27.8 tt0 -67.36 138.71 56.95 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.56 56.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.274 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -81.15 119.13 23.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 24.1 pt20 -85.54 145.92 27.15 Favored 'General case' 0 N--CA 1.417 -2.088 0 O-C-N 123.802 0.689 . . . . 0.0 110.305 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 124.81 52.91 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.66 117.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.052 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 74.3 m-85 -98.07 134.6 40.93 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.041 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -77.37 134.78 38.37 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.3 t -80.53 98.82 7.76 Favored 'General case' 0 N--CA 1.396 -3.139 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -38.49 137.14 0.84 Allowed Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 112.224 -2.262 . . . . 0.0 111.769 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.7 122.41 11.69 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.695 2.263 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 113.87 -10.67 23.07 Favored Glycine 0 C--N 1.289 -2.031 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.347 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 89.9 m-85 -125.23 168.77 13.01 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 122.168 -0.607 . . . . 0.0 110.488 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -157.01 175.0 14.68 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.974 0.91 . . . . 0.0 108.654 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.0 p -159.61 -160.86 0.86 Allowed 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.82 4.18 48.55 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.968 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.21 -119.14 0.65 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -121.4 157.33 30.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 61.5 t -91.16 115.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.4 mm -111.5 121.68 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 CA-C-O 121.362 0.601 . . . . 0.0 110.983 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.413 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 80.0 mtp -106.26 172.58 6.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.5 p -153.78 155.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.497 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.9 t -97.27 132.45 43.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 87.5 mtt180 -149.6 134.08 17.52 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 124.215 0.947 . . . . 0.0 110.127 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 62.79 23.79 14.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.42 -6.5 80.65 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.81 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.02 155.79 30.79 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.116 0.484 . . . . 0.0 110.886 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -93.6 120.65 34.13 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.372 0.606 . . . . 0.0 109.465 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.14 175.6 4.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.036 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.74 115.02 27.7 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.766 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.7 tm? -59.2 -54.54 45.79 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -122.27 99.46 43.15 Favored Pre-proline 0 N--CA 1.404 -2.762 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.757 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.14 -14.21 20.91 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.791 2.327 . . . . 0.0 112.031 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.75 -28.19 55.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.585 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 8.9 mmp_? -91.08 135.17 33.94 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.003 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.23 151.07 5.52 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.533 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 97.4 m -81.58 109.39 15.98 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.731 0.777 . . . . 0.0 112.636 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -105.47 171.79 7.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.072 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -63.79 146.34 54.09 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.3 ptp180 -100.25 146.21 31.57 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 77.8 Cg_endo -82.85 152.01 14.6 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 121.932 1.755 . . . . 0.0 112.156 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.09 -1.19 34.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.493 0.663 . . . . 0.0 111.198 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.79 -92.45 1.12 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.253 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.59 129.9 21.54 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.1 36.08 0.6 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.913 3.075 . . . . 0.0 113.602 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.629 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 87.15 161.46 36.48 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.919 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -115.17 135.79 53.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.515 HG21 ' HE1' ' A' ' 112' ' ' TYR . 9.9 t -157.17 125.42 2.88 Favored Pre-proline 0 N--CA 1.416 -2.136 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.65 14.62 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.454 2.103 . . . . 0.0 111.602 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.06 -16.35 16.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.096 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 114' ' ' CYS . . . -179.67 -162.42 28.68 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.066 -1.54 . . . . 0.0 113.2 -176.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 t -134.74 -164.13 1.47 Allowed 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 123.27 0.628 . . . . 0.0 109.529 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 53.9 p90 -141.54 160.12 40.81 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.627 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 41.4 p -113.61 172.83 6.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 174.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.18 135.6 45.21 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 109' ' ' LYS . 13.1 t -138.01 18.27 2.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.314 1.054 . . . . 0.0 111.307 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 108' ' ' VAL . . . -142.04 38.1 1.51 Allowed Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.39 -176.23 20.46 Favored Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.38 17.59 11.4 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.595 0.712 . . . . 0.0 109.598 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 104' ' ' PHE . 4.9 p -144.67 -167.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 m-85 -104.31 93.72 4.96 Favored 'General case' 0 C--N 1.244 -3.983 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.974 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.4 pt-20 -142.39 152.11 42.5 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -51.4 114.52 1.25 Allowed 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.757 0.661 . . . . 0.0 110.445 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.47 -18.85 10.84 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.988 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.9 p -81.17 138.1 20.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.361 0.601 . . . . 0.0 110.787 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.1 ttmp? -104.61 128.49 52.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -104.66 96.52 6.64 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -81.37 146.4 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 91' ' ' THR . 63.0 t80 -96.79 131.85 43.1 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.694 0.759 . . . . 0.0 109.977 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 m -151.91 157.66 42.12 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.452 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -154.27 -66.4 0.14 Allowed 'General case' 0 C--N 1.251 -3.692 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.578 -173.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 49.8 m-80 -115.79 -177.56 3.19 Favored 'General case' 0 N--CA 1.398 -3.062 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.085 -174.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.51 -46.5 7.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.71 17.59 58.1 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.768 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 3.3 m-85 -125.45 150.63 47.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.244 -0.562 . . . . 0.0 109.941 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -122.1 -148.04 0.4 Allowed 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 171.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -142.99 154.79 44.37 Favored 'General case' 1 N--CA 1.332 -6.363 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.783 -169.469 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.3 mm? -81.63 128.68 34.19 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.24 142.61 5.08 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.4 -18.15 42.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.673 0.749 . . . . 0.0 109.09 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.35 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.747 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.2 p-10 -86.3 28.46 0.83 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.273 0.558 . . . . 0.0 111.474 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 111' ' ' VAL . 47.1 p90 -167.57 -177.6 3.61 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.182 -172.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.46 133.45 15.08 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 29.3 mt-10 -105.92 147.08 29.18 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 122.139 -0.351 . . . . 0.0 111.318 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.5 t -81.77 106.2 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.6 t70 -101.95 -160.82 0.81 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.7 p -63.84 -51.91 62.53 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 124.911 1.285 . . . . 0.0 112.877 -174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.12 -35.82 15.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.227 0.537 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.96 -151.97 10.45 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 79.7 m95 -76.91 139.99 40.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.267 0.533 . . . . 0.0 109.943 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.6 p -63.92 -32.43 73.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -138.21 176.51 8.64 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -92.6 -155.88 0.45 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.629 HD11 ' HA3' ' A' ' 89' ' ' GLY . 38.0 mt -99.17 111.44 61.0 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 122.964 0.506 . . . . 0.0 110.062 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 120' ' ' LEU . 9.4 Cg_endo -61.62 145.42 97.63 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.363 2.042 . . . . 0.0 109.682 170.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.73 123.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.515 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 8.1 t -67.11 120.42 13.68 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HD23 ' A' ' 121' ' ' LEU . 16.6 mm-40 . . . . . 0 C--N 1.313 -1.003 0 C-N-CA 125.343 1.457 . . . . 0.0 108.141 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 6.0 m-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 77.5 m -69.17 127.4 32.94 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.948 -178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.57 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.9 m-20 -100.14 31.85 3.19 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.216 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.1 158.8 25.32 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.4 mt -77.52 155.62 81.26 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.03 132.6 48.42 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.936 2.424 . . . . 0.0 112.747 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.54 110.94 3.11 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 122.468 2.112 . . . . 0.0 112.018 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -58.55 147.38 32.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.075 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -122.82 169.1 11.45 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.443 -170.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -50.05 -35.88 26.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -127.82 14.82 6.94 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.942 0.401 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 4.1 mp0 -130.79 144.44 51.45 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.428 HD11 ' HG2' ' A' ' 53' ' ' ARG . 8.6 mt -133.46 156.48 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -78.35 145.78 35.05 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-O 121.276 0.56 . . . . 0.0 112.262 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -106.73 109.97 22.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.93 -138.32 9.06 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 t -151.04 132.23 14.45 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.543 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.6 m95 -135.82 122.09 20.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -143.73 24.12 1.71 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . 5.1 t70 -100.7 -173.29 2.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.622 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.13 -25.36 2.24 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.234 0.614 . . . . 0.0 110.18 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 22' ' ' ASN . 6.9 p -142.45 131.18 22.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.839 0.352 . . . . 0.0 111.502 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 39' ' ' ASP . 31.3 m-85 -127.23 143.54 47.49 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.1 Cg_endo -62.56 147.21 95.14 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.7 2.267 . . . . 0.0 111.748 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.8 tt0 -67.73 129.55 40.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.06 1.46 28.39 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.572 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m -83.76 120.15 25.68 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.7 pt20 -93.02 152.23 19.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.379 0.609 . . . . 0.0 111.924 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.99 130.84 53.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.609 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.9 mt -101.47 125.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.3 m-85 -102.33 143.7 31.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 54.7 tttm -92.45 141.5 28.45 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 93.6 m -90.59 16.71 8.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 32' ' ' ILE . 79.0 mtt180 65.81 161.57 0.13 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.315 0.646 . . . . 0.0 111.104 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 40.3 Cg_endo -75.33 140.18 24.29 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 121.189 1.26 . . . . 0.0 110.2 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.66 0.07 60.91 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 92.8 m-85 -128.74 175.84 8.28 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.168 0.509 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 57' ' ' ARG . 4.0 ptm180 -154.99 -171.64 3.9 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 p -163.27 154.3 16.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 120.895 0.379 . . . . 0.0 110.721 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.15 -27.21 59.65 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.44 141.22 7.06 Favored Glycine 0 N--CA 1.408 -3.213 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.36 142.54 51.94 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.15 0.58 . . . . 0.0 111.238 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.4 118.22 10.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -116.11 124.28 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -113.04 166.79 11.08 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.6 p -149.66 143.05 17.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.492 0.663 . . . . 0.0 110.137 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.26 122.75 19.49 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 125.159 1.384 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.0 ttt180 -160.85 132.91 5.92 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 72.4 mmtt 66.19 25.7 10.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.12 0.568 . . . . 0.0 112.376 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 91.95 -10.96 73.35 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.574 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.57 171.92 12.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -93.45 123.35 36.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.33 168.11 9.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.056 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.17 114.89 18.48 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.721 0.296 . . . . 0.0 111.088 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.76 -39.02 92.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -143.65 98.87 5.28 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.72 -4.07 14.18 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.839 2.359 . . . . 0.0 113.101 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.65 -31.13 41.45 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.76 141.43 48.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.895 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -158.27 160.38 37.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -102.58 130.15 49.36 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -126.46 172.64 10.02 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.8 mmtp -64.86 151.52 45.31 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.033 0.533 . . . . 0.0 111.974 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -86.97 151.91 52.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 67.4 Cg_endo -77.07 160.83 33.13 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 121.535 1.49 . . . . 0.0 110.087 176.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -114.85 -22.51 9.6 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.344 -174.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.97 -179.2 53.39 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -78.33 128.12 78.99 Favored Pre-proline 0 C--N 1.289 -2.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 48.17 1.2 Allowed 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.076 3.184 . . . . 0.0 114.177 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 90.59 157.47 33.6 Favored Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.86 126.99 55.25 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.245 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 9.8 t -135.33 125.13 16.6 Favored Pre-proline 0 N--CA 1.412 -2.356 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 9.6 Cg_exo -74.2 -10.88 22.88 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.286 1.991 . . . . 0.0 112.042 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -127.55 141.39 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.14 47.9 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.119 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -163.79 -169.2 1.82 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.201 0.5 . . . . 0.0 109.872 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 46.5 p90 -142.34 160.29 40.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.476 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.6 p -113.61 173.0 6.63 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.2 mt -140.99 118.13 11.27 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -113.14 -7.65 13.61 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.354 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -113.84 28.94 8.11 Favored Glycine 0 CA--C 1.489 -1.562 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.03 -171.07 27.82 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -129.49 10.88 5.73 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.282 1.039 . . . . 0.0 109.616 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 108' ' ' VAL . 35.5 m -140.02 174.73 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 31.0 m-85 -88.94 88.15 7.48 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.76 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.543 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.2 pt-20 -136.24 150.22 48.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.241 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -46.16 116.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.374 1.046 . . . . 0.0 111.027 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.15 -23.43 6.5 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.651 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG12 ' C ' ' A' ' 100' ' ' GLY . 19.9 m -77.71 139.12 19.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.07 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.9 ttmp? -102.4 120.43 40.5 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -101.31 101.3 11.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -84.24 139.96 16.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.777 -176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -97.31 113.54 25.19 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.5 m -117.89 159.38 23.2 Favored 'General case' 0 N--CA 1.402 -2.836 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.09 -62.04 0.73 Allowed 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.473 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -155.83 -170.06 3.29 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.74 -53.27 8.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.582 0.706 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.68 -12.75 82.5 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.721 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -112.41 121.82 45.95 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.019 0.128 . . . . 0.0 110.903 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -102.8 -114.93 0.21 Allowed 'General case' 0 CA--C 1.466 -2.276 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -163.64 156.35 18.11 Favored 'General case' 1 N--CA 1.337 -6.119 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.573 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 67.3 mt -89.92 103.78 16.41 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.104 0.954 . . . . 0.0 109.387 173.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.09 155.14 8.87 Favored Glycine 0 N--CA 1.41 -3.086 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -93.44 -18.3 22.49 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.937 0.875 . . . . 0.0 109.585 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.4 mm -112.38 106.16 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.815 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.4 p-10 -83.81 30.58 0.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.136 0.493 . . . . 0.0 111.399 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -164.2 178.2 7.77 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -173.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.98 138.6 45.54 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 22.6 mt-10 -111.48 136.69 50.29 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.89 107.63 14.76 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.64 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -100.39 -170.43 1.87 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 p -66.64 -40.66 88.82 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 124.525 1.13 . . . . 0.0 110.601 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.0 -35.79 62.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.025 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.37 -152.46 24.34 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.26 126.93 30.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.126 0.463 . . . . 0.0 109.794 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 p -58.94 -35.84 73.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 123.566 0.746 . . . . 0.0 112.913 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -129.08 167.33 17.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.9 -96.95 0.3 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -173.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.427 HD11 ' HA3' ' A' ' 89' ' ' GLY . 24.4 mt -132.81 92.75 25.54 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 121.656 -0.653 . . . . 0.0 111.316 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.844 ' HB2' HD12 ' A' ' 120' ' ' LEU . 3.3 Cg_endo -53.6 137.22 66.15 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 122.736 2.291 . . . . 0.0 109.32 166.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 31.7 mm -87.69 122.87 39.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.898 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 21.0 t -52.29 124.41 13.16 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.952 0.342 . . . . 0.0 110.772 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.424 -1.744 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.239 0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.6 m -84.87 133.53 34.3 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -106.67 27.49 8.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.851 0.834 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 162.4 37.58 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -99.66 158.19 32.59 Favored Pre-proline 0 N--CA 1.39 -3.434 0 O-C-N 124.558 1.161 . . . . 0.0 110.277 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 17.9 Cg_endo -60.12 133.35 49.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.952 2.435 . . . . 0.0 110.684 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.89 170.66 19.55 Favored 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.437 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -117.27 139.02 51.33 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -113.37 -176.85 2.99 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -73.54 -27.12 61.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 21.4 p -116.94 0.5 12.45 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -133.3 140.4 47.43 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.515 0.674 . . . . 0.0 112.329 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -138.62 145.74 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.92 142.66 57.21 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.5 p -90.76 -28.32 18.35 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.568 0.699 . . . . 0.0 109.549 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.71 177.4 37.24 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.4 p -113.9 114.87 26.82 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 123.481 0.712 . . . . 0.0 110.316 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -110.48 110.77 21.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -115.89 3.52 13.74 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.631 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.643 ' O ' HD21 ' A' ' 24' ' ' LEU . 40.1 m-20 -101.91 -157.09 0.59 Allowed 'General case' 0 CA--C 1.479 -1.775 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.58 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -133.84 -58.84 0.86 Allowed 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 170.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.9 p -80.98 121.1 25.61 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.44 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 41.1 m-85 -129.33 145.0 54.97 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.086 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.03 143.56 66.24 Favored 'Trans proline' 0 C--O 1.262 1.695 0 C-N-CA 122.635 2.223 . . . . 0.0 111.086 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -63.16 138.82 58.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.36 1.73 50.69 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.203 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.442 ' C ' HG23 ' A' ' 65' ' ' VAL . 92.9 m -85.06 117.42 24.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 pt20 -85.74 149.76 25.06 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.245 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.11 130.08 53.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -100.24 132.8 45.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.57 143.94 44.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.596 0.712 . . . . 0.0 112.595 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.24 142.52 27.31 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 171.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.713 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.8 m -86.8 27.8 0.95 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 70.2 mtp180 61.62 166.61 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 121.451 0.643 . . . . 0.0 111.005 -174.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.14 118.09 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.194 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 171.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.4 -23.38 7.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.069 -1.063 . . . . 0.0 113.051 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.713 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 95.8 m-85 -102.74 179.56 4.25 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 122.023 -0.693 . . . . 0.0 109.368 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -155.75 -174.75 5.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -171.95 168.7 5.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 98.4 mt -87.73 14.48 8.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.861 0.839 . . . . 0.0 110.081 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.05 -146.01 5.78 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.33 150.08 48.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.6 t -73.06 101.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.9 118.64 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.53 175.5 5.48 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.7 p -161.02 144.72 4.54 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.166 0.508 . . . . 0.0 110.464 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.72 121.78 18.6 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.111 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 64.3 ttt180 -150.14 124.34 9.47 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 14.6 mmmm 61.69 22.39 12.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 113.017 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.38 -10.41 65.15 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.487 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.22 157.31 25.08 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.167 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 85.4 m95 -88.59 117.25 27.41 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.14 174.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.39 125.89 37.24 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.462 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.22 -48.39 51.63 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.3 88.23 7.08 Favored Pre-proline 0 N--CA 1.429 -1.515 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.891 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 77' ' ' LEU . 38.3 Cg_endo -69.51 -18.66 38.04 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.333 2.022 . . . . 0.0 111.758 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 ' HG2' ' A' ' 76' ' ' PRO . 3.5 mm? -80.61 -14.3 58.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.76 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' NH1' ' HB2' ' A' ' 59' ' ' LEU . 25.4 mmt180 -95.65 123.44 39.21 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 121.693 0.759 . . . . 0.0 110.231 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.11 151.55 37.02 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.64 112.44 22.32 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.089 0.947 . . . . 0.0 110.918 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -108.14 172.68 6.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.766 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.5 159.0 24.29 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.615 0.722 . . . . 0.0 111.671 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -94.24 144.77 28.58 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 174.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 60.5 Cg_endo -73.35 163.64 37.27 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 121.733 1.622 . . . . 0.0 109.351 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.9 m -115.75 1.11 13.39 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.46 -170.79 53.49 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.752 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -88.35 117.42 68.36 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.34 102.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 113.257 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 88.85 125.48 2.53 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.952 175.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.12 19.0 5.3 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.749 0.785 . . . . 0.0 109.101 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -60.82 134.47 92.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.171 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.5 -4.66 1.97 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.395 2.063 . . . . 0.0 112.349 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.06 -33.66 5.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.09 0.471 . . . . 0.0 111.131 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.22 138.58 18.05 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.329 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.82 156.31 30.9 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.8 p90 -128.77 158.72 37.85 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.241 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 76.8 p -108.87 168.33 9.43 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.87 123.82 22.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.34 0.59 . . . . 0.0 110.089 175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.2 t -132.65 141.46 48.64 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.95 14.12 67.84 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.427 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.18 -52.1 0.05 OUTLIER Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.256 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 79.32 -3.68 2.1 Favored 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 124.236 1.014 . . . . 0.0 112.946 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 m -144.65 175.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.4 m-85 -78.33 94.4 4.83 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.22 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.71 151.11 35.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -42.82 129.33 4.28 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.01 -9.93 74.57 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.679 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.96 138.35 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.285 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.1 ttmt -105.22 120.52 41.75 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.676 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -99.8 99.8 10.66 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -79.18 136.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.478 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 52.8 t80 -102.83 129.18 49.42 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -147.6 149.64 32.91 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.73 -52.78 2.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 -174.6 4.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -87.17 -45.04 11.03 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.7 -32.79 61.11 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.354 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -86.16 119.22 26.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.379 0.609 . . . . 0.0 110.839 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 85.7 mt-30 -110.21 -159.89 0.7 Allowed 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.63 155.1 44.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -82.8 137.99 34.14 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.781 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.2 158.87 12.65 Favored Glycine 0 C--N 1.285 -2.286 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -92.4 -17.45 24.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.219 0.509 . . . . 0.0 110.9 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 126' ' ' TYR . 40.0 mm -112.03 109.42 28.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -86.28 22.64 1.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.4 p90 -151.12 176.22 11.38 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 77.0 mtm180 -142.24 127.92 19.19 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -106.96 138.68 42.68 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.7 t -81.38 97.38 7.7 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.137 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.2 175.47 10.56 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.54 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.6 p -49.47 -41.37 40.18 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 125.666 1.586 . . . . 0.0 112.252 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.46 -27.08 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.017 0.436 . . . . 0.0 111.412 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.96 -170.08 36.73 Favored Glycine 0 C--N 1.303 -1.302 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -65.2 141.57 58.61 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 117.22 0.51 . . . . 0.0 111.71 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.7 p -85.12 133.46 34.21 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 73.81 171.27 0.3 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.543 0.737 . . . . 0.0 110.003 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 127' ' ' ARG . 6.3 p-10 -111.87 -102.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.985 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 89' ' ' GLY . 52.8 mt -126.95 102.65 24.49 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 19.0 Cg_endo -59.72 138.17 81.48 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.042 1.828 . . . . 0.0 110.166 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.48 113.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.478 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 93.9 m -72.85 112.36 8.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.759 0.314 . . . . 0.0 111.402 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.56 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 32.9 mt-10 . . . . . 0 C--N 1.317 -0.83 0 C-N-CA 125.157 1.383 . . . . 0.0 108.523 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.966 0.412 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 41' ' ' THR . 70.1 m -79.9 132.04 35.99 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.505 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -96.22 13.62 26.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.324 0.583 . . . . 0.0 110.414 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.18 160.83 38.41 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.658 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 38.0 mt -84.33 157.42 62.05 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 123.968 0.792 . . . . 0.0 109.262 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 28.7 Cg_endo -64.01 133.2 37.43 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 121.668 1.579 . . . . 0.0 109.946 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.79 162.55 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.026 1.817 . . . . 0.0 111.712 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -98.21 146.73 25.32 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -114.1 173.55 6.39 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -65.09 -34.39 78.3 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -117.63 1.24 12.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -131.78 147.05 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.25 0.547 . . . . 0.0 111.669 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 53' ' ' ARG . 12.6 mt -143.92 156.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 3.9 mm? -72.08 168.96 17.03 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-O 121.916 0.865 . . . . 0.0 112.594 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -123.85 145.48 49.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 171.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.09 -144.98 15.98 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.709 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -139.14 137.76 36.4 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 81.5 m95 -138.84 121.81 16.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.6 m -151.92 24.08 0.66 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.755 0.312 . . . . 0.0 111.331 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 15.8 m-20 -118.31 -169.63 1.74 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.1 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -119.27 -66.1 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.0 p -86.67 127.81 34.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -130.34 140.6 39.14 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.754 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.42 145.19 87.54 Favored 'Trans proline' 0 C--O 1.264 1.779 0 C-N-CA 122.616 2.211 . . . . 0.0 110.801 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.546 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.4 tt0 -65.44 140.99 58.66 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.75 57.36 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.206 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' HG23 ' A' ' 65' ' ' VAL . 75.8 m -85.95 117.91 25.09 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.313 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -88.11 146.08 25.61 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.782 0.801 . . . . 0.0 111.31 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.55 119.67 36.93 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 63' ' ' ILE . 62.4 mt -92.06 120.15 40.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 61.4 m-85 -102.75 141.47 35.51 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -88.35 153.58 21.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.1 m -91.6 25.93 2.5 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 32' ' ' ILE . 70.0 mtp180 62.88 167.91 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -77.59 100.0 1.35 Allowed 'Trans proline' 0 N--CA 1.428 -2.365 0 CA-C-N 119.162 0.736 . . . . 0.0 110.912 174.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 135.5 -17.9 3.95 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.123 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.9 m-85 -110.12 173.15 6.46 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 109.881 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -152.1 -174.66 4.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -168.77 -178.16 3.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.05 14.05 9.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.727 0.775 . . . . 0.0 110.482 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.32 174.7 38.6 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.72 145.93 34.21 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 118.425 1.113 . . . . 0.0 109.362 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 90.8 t -74.19 111.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.421 HD12 HG12 ' A' ' 49' ' ' ILE . 44.6 mm -106.18 122.84 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.011 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.6 mtp -112.07 172.77 6.71 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.418 HG23 ' C ' ' A' ' 46' ' ' THR . 8.2 p -157.41 145.31 10.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-O 121.335 0.588 . . . . 0.0 110.648 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.4 t -69.65 125.81 27.84 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.824 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 34.6 ttp180 -151.76 123.26 7.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm 62.37 25.96 15.5 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 124.267 1.027 . . . . 0.0 113.46 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.97 -15.74 61.19 Favored Glycine 0 N--CA 1.413 -2.883 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.515 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.69 163.7 15.73 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.706 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.415 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 82.1 m95 -97.19 123.87 41.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.329 0.585 . . . . 0.0 109.856 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 171.53 14.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.421 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.79 124.96 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -49.77 56.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -108.26 90.47 6.95 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.169 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.49 -11.95 26.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.791 2.327 . . . . 0.0 114.089 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -90.8 -19.87 22.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.087 0.47 . . . . 0.0 110.352 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 7.6 mmp_? -92.69 134.11 35.35 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.8 0.81 . . . . 0.0 112.468 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 166.3 32.92 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 172.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.9 m -91.96 129.4 37.93 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.59 0.709 . . . . 0.0 111.173 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.34 167.98 14.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.519 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 95.5 mttt -65.62 136.43 56.32 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.573 0.225 . . . . 0.0 111.351 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.7 ptp180 -78.35 147.01 71.59 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.45 159.46 32.51 Favored 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.868 1.712 . . . . 0.0 109.631 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.8 m -118.24 8.49 12.31 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 121.463 0.649 . . . . 0.0 111.488 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.33 -85.93 1.23 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.497 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -168.06 147.88 4.28 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.75 53.13 2.7 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.346 2.031 . . . . 0.0 111.615 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 80.97 -96.31 1.69 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.5 t70 169.56 126.63 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 125.493 1.517 . . . . 0.0 107.674 171.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -120.88 117.53 30.95 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.67 1.92 7.88 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.149 1.899 . . . . 0.0 111.112 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -115.19 -55.39 2.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.851 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 114' ' ' CYS . . . -73.54 150.58 43.55 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 m -92.63 -55.92 3.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . 0.274 1.9 p90 70.16 145.93 0.06 Allowed 'General case' 0 C--O 1.248 0.985 0 C-N-CA 126.558 1.943 . . . . 0.0 114.493 173.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.611 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -117.03 148.15 41.73 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.994 179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.584 HD22 ' CG1' ' A' ' 108' ' ' VAL . 83.0 mt -109.12 135.96 49.4 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.7 t -138.23 139.01 39.05 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.55 -26.36 16.53 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.18 164.69 34.17 Favored Glycine 0 CA--C 1.489 -1.568 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.458 ' O ' HG13 ' A' ' 103' ' ' VAL . 48.7 t-20 -123.12 60.18 1.06 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 118.173 0.986 . . . . 0.0 110.006 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.0 m -168.65 -178.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.634 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 172.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.08 84.31 5.26 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.911 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.26 157.42 39.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.804 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 62.7 t80 -58.55 122.32 13.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.758 0.79 . . . . 0.0 111.767 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.5 -19.38 12.87 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.584 ' CG1' HD22 ' A' ' 98' ' ' LEU . 24.1 t -71.72 129.94 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.723 0.773 . . . . 0.0 112.066 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.1 ttmt -102.91 119.71 39.32 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.61 93.24 7.03 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.611 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.5 p -79.14 109.29 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-O 122.35 1.071 . . . . 0.0 109.116 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.8 t80 -80.89 103.56 10.81 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 113.837 -1.528 . . . . 0.0 110.878 -169.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 m -74.47 -38.29 62.96 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.644 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 45.8 t 72.73 -92.83 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.348 0 O-C-N 125.312 1.632 . . . . 0.0 108.906 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -137.2 -174.48 3.76 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.96 -42.67 14.71 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.57 0.7 . . . . 0.0 109.198 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.68 -22.9 54.94 Favored Glycine 0 C--N 1.308 -1.001 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.909 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.03 128.73 55.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.481 -0.423 . . . . 0.0 111.001 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -111.34 -148.15 0.43 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -117.22 166.72 11.93 Favored 'General case' 1 N--CA 1.376 -4.131 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.604 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 32.6 mt -97.32 106.12 18.39 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.559 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.6 166.2 14.43 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -84.68 -27.56 26.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.132 0.968 . . . . 0.0 108.515 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.0 109.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.31 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -97.43 23.88 7.16 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.141 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 37.2 p90 -159.01 178.31 10.2 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.399 0.619 . . . . 0.0 110.519 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -149.68 129.03 12.91 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.962 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 36.3 mt-10 -101.51 157.48 16.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 122.8 34.96 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.841 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.9 t70 -101.98 -169.12 1.63 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.439 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 48.5 p -71.72 -37.35 70.64 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 124.585 1.154 . . . . 0.0 108.492 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.05 -52.11 15.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.044 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.02 -150.25 16.07 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.23 137.73 45.15 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.024 0.912 . . . . 0.0 110.336 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.2 p -81.05 167.64 19.53 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.48 -111.39 0.27 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.325 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -167.8 -178.61 3.9 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.469 HD11 ' HA3' ' A' ' 89' ' ' GLY . 82.9 mt -94.93 103.83 12.87 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.4 Cg_endo -48.24 127.79 16.02 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.269 2.646 . . . . 0.0 112.584 -176.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.8 mm -75.06 115.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.732 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.3 m -61.61 121.4 12.67 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 N--CA 1.425 -1.697 0 C-N-CA 126.445 1.898 . . . . 0.0 107.791 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 35.4 m-20 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 120.751 0.31 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.8 m -65.67 139.93 58.44 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HA ' HG22 ' A' ' 41' ' ' THR . 4.6 m-20 -117.89 18.74 13.94 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.357 0.599 . . . . 0.0 109.729 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.07 159.22 37.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.729 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 mt -79.5 153.3 76.19 Favored Pre-proline 0 C--N 1.31 -1.137 0 O-C-N 123.873 0.733 . . . . 0.0 109.15 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 128.67 30.72 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.457 2.104 . . . . 0.0 111.166 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.68 123.38 12.9 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.488 2.126 . . . . 0.0 111.409 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -68.1 149.55 49.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.501 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.1 mmp_? -112.51 178.56 4.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.229 -171.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -82.25 -58.94 2.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.48 -8.53 35.06 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.955 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.5 mp0 -109.02 142.53 39.58 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.985 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mt -133.09 150.4 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.848 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.75 140.42 53.44 Favored 'General case' 0 C--N 1.277 -2.58 0 O-C-N 124.245 0.966 . . . . 0.0 111.084 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.0 p -87.21 -34.33 19.03 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.207 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.4 167.43 26.1 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.434 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 p -105.26 118.23 36.02 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -99.71 161.97 13.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -130.79 -23.79 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -137.01 162.48 33.2 Favored 'General case' 0 C--O 1.183 -2.446 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.423 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.3 -29.48 26.34 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.498 0.666 . . . . 0.0 109.641 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.6 p -97.16 108.4 21.12 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-O 121.88 0.848 . . . . 0.0 112.431 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -118.1 157.83 47.75 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.511 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 47.6 Cg_endo -70.67 152.8 64.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 121.628 1.552 . . . . 0.0 110.875 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.42 151.8 45.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.24 74.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.617 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -83.05 121.14 26.65 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.956 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.6 pt20 -91.01 146.45 23.85 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.675 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.88 117.03 29.06 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.44 130.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 65.1 m-85 -104.19 139.43 39.25 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -75.13 -29.51 60.55 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.319 -1.764 . . . . 0.0 113.656 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.7 m 71.29 3.05 4.51 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 72.86 152.35 0.14 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.96 108.87 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.554 2.17 . . . . 0.0 112.738 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.41 7.01 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.476 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 96.4 m-85 -98.81 168.14 10.32 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 122.103 -0.645 . . . . 0.0 110.465 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -133.21 -175.93 3.96 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -157.08 -175.93 5.69 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -104.76 16.22 26.41 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.123 0.487 . . . . 0.0 110.073 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.45 29.82 0.07 OUTLIER Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.49 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.56 144.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.977 1.311 . . . . 0.0 112.049 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.6 t -76.98 116.4 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.25 124.55 69.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.804 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.44 168.77 9.15 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.9 p -155.45 149.99 11.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.8 t -84.08 128.73 34.75 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.84 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.423 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -144.95 124.84 13.44 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -178.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 35.3 mmtp 59.23 29.56 19.14 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 94.35 -17.48 58.88 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.934 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 167.17 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.715 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.79 122.46 46.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 -168.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.693 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.48 23.04 Favored 'General case' 1 C--N 1.225 -4.825 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.967 -171.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.85 -53.99 13.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.83 80.6 49.5 Favored Pre-proline 0 N--CA 1.419 -1.997 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.263 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.61 -13.06 22.44 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.743 2.295 . . . . 0.0 110.969 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.3 mm? -68.69 -30.1 68.69 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.714 177.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -81.25 143.56 32.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.566 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.8 158.65 43.54 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -94.57 106.95 18.94 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.45 160.75 14.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.95 146.56 39.54 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.11 140.23 61.54 Favored Pre-proline 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.421 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.51 145.47 47.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.095 1.863 . . . . 0.0 109.624 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.9 m -104.55 -14.99 15.46 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.997 0.427 . . . . 0.0 111.686 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.61 -167.67 54.77 Favored Glycine 0 N--CA 1.412 -2.927 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.433 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -68.74 119.73 71.1 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 124.323 1.049 . . . . 0.0 109.583 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 72.8 Cg_endo -80.34 -6.67 13.83 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.15 2.567 . . . . 0.0 112.295 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 112.73 134.65 6.2 Favored Glycine 0 N--CA 1.406 -3.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.93 174.39 7.26 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.861 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -162.53 127.37 2.07 Favored Pre-proline 0 N--CA 1.412 -2.362 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -88.85 -4.18 6.24 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.089 1.859 . . . . 0.0 111.555 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.71 -47.42 3.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.469 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.51 -172.31 25.83 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.262 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 m -145.98 167.37 23.48 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -143.72 157.52 44.33 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.255 0.479 . . . . 0.0 110.11 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -119.95 154.0 35.1 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.794 0.684 . . . . 0.0 110.5 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 94.6 mt -115.2 133.33 56.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 109' ' ' LYS . 6.1 t -127.39 148.17 50.27 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.72 -66.62 3.57 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.068 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.51 -43.24 6.59 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.427 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t30 75.37 -4.41 2.38 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 122.105 0.955 . . . . 0.0 111.684 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.16 -178.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -88.18 79.46 7.86 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.376 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.77 151.09 52.07 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.842 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -45.11 122.33 3.3 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.447 0.699 . . . . 0.0 111.756 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.36 -16.52 32.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.615 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.57 147.06 7.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 O-C-N 122.391 -0.476 . . . . 0.0 110.358 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.449 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.4 ttmp? -114.45 127.57 55.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.37 88.01 3.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.6 p -80.97 124.02 38.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.705 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -102.02 141.3 35.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.363 -168.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.27 161.94 34.87 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.29 -74.24 0.35 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.922 -1.511 . . . . 0.0 110.695 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -141.25 -177.79 5.29 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.56 152.54 21.05 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.38 -43.91 1.93 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.29 132.1 22.7 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -104.22 -61.43 1.45 Allowed 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.851 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 125' ' ' ASN . 4.2 pp 179.52 157.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.387 1.054 . . . . 0.0 109.17 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 81.3 mt -97.71 132.03 43.72 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.71 148.12 5.67 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -84.51 -19.94 32.44 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.286 1.041 . . . . 0.0 109.581 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 126' ' ' TYR . 38.6 mm -103.06 92.46 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.046 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 120' ' ' LEU . 23.0 p-10 -83.17 29.69 0.48 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 124.763 1.225 . . . . 0.0 110.312 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 124' ' ' ILE . 52.4 p90 -161.7 179.05 8.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -142.03 121.5 13.24 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.451 ' HG3' ' CD2' ' A' ' 126' ' ' TYR . 48.3 mt-10 -103.07 141.43 35.83 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -91.44 112.16 23.96 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.196 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 131' ' ' THR . 21.3 t70 -99.76 -164.61 1.14 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.261 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.461 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 46.9 p -66.01 -42.53 89.56 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.447 1.099 . . . . 0.0 110.327 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.61 -41.48 79.46 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.162 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.55 -141.45 9.53 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.516 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.5 m95 -72.44 130.96 41.92 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 117.007 0.403 . . . . 0.0 111.557 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.2 p -83.82 129.09 34.94 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.9 m120 74.73 166.92 0.29 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.74 0.781 . . . . 0.0 111.611 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.66 -173.29 2.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.474 HD11 ' HA3' ' A' ' 89' ' ' GLY . 17.9 mt -71.66 116.57 49.15 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.08 129.07 24.59 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 121.505 1.47 . . . . 0.0 110.927 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.3 123.17 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.642 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 65.9 m -66.19 109.22 2.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.46 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 8.4 tp10 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.071 0.939 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.2 m -77.93 124.61 28.21 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.717 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -95.65 21.37 8.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.133 0.968 . . . . 0.0 109.589 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.73 155.82 43.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.163 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.5 150.35 79.42 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 124.151 0.907 . . . . 0.0 111.558 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.93 139.94 44.48 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.187 1.925 . . . . 0.0 109.655 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.22 155.81 66.63 Favored 'Trans proline' 0 C--N 1.328 -0.538 0 C-N-CA 122.56 2.173 . . . . 0.0 113.743 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -97.09 134.47 40.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -109.11 151.05 26.94 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.617 -173.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -64.6 -31.48 72.71 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.0 -15.68 16.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -133.87 137.04 44.74 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 112.347 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 56.4 mt -115.73 158.98 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HB3' ' NE1' ' A' ' 37' ' ' TRP . 33.3 mt -94.07 142.21 27.65 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 119.012 0.824 . . . . 0.0 111.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.4 p -98.12 151.94 19.86 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.53 -155.01 20.82 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -133.54 114.86 14.04 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' NE1' ' HB3' ' A' ' 33' ' ' LEU . 44.6 m95 -122.69 99.23 6.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.7 m -135.0 -0.99 2.71 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.984 0.421 . . . . 0.0 110.348 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.33 150.1 22.04 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.522 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -82.61 -51.27 7.91 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.978 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 38.7 p -95.8 106.33 18.44 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.16 129.72 23.72 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.847 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.52 150.44 68.81 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.9 131.78 49.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.57 7.33 48.68 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.295 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -86.38 114.84 23.49 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.985 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.4 pt20 -90.01 136.33 33.11 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-O 121.766 0.793 . . . . 0.0 111.669 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.38 121.33 43.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.074 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 63' ' ' ILE . 68.5 mt -97.12 113.46 31.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.101 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -83.59 136.46 34.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.377 1.084 . . . . 0.0 113.177 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 60.9 tttp -66.18 -28.6 68.9 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.095 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 15.9 t 72.43 -4.39 2.06 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.947 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 71.91 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 124.487 1.115 . . . . 0.0 111.472 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 55.8 Cg_endo -70.15 120.82 7.47 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 121.462 1.442 . . . . 0.0 110.381 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 118.19 -20.12 10.65 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 93.5 m-85 -101.52 170.44 8.2 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -156.64 169.1 25.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.6 p -143.87 -177.05 5.24 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.23 21.73 1.35 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.67 0.748 . . . . 0.0 110.737 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.9 -96.1 0.12 Allowed Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -154.57 150.62 27.93 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.44 105.93 4.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG12 ' A' ' 49' ' ' ILE . 45.3 mm -105.84 120.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.617 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.5 mtp -106.73 164.99 11.64 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 6.8 p -150.35 145.83 16.86 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.742 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.114 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 48.1 t -73.68 121.37 20.64 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.288 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 34.2 ttt180 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 74.2 mmtt 65.12 23.65 12.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.82 0.848 . . . . 0.0 112.278 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.78 -2.43 72.84 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.889 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 153.24 47.43 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.77 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.2 121.66 28.27 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.771 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.04 173.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.655 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.23 123.64 29.2 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.77 -39.95 94.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -139.54 100.56 7.53 Favored Pre-proline 0 N--CA 1.422 -1.829 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.703 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.0 -3.38 13.7 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.846 2.364 . . . . 0.0 111.912 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.6 mt -91.09 -6.5 53.64 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 122.213 1.006 . . . . 0.0 109.801 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 78' ' ' ARG . 20.1 mmt180 -99.39 122.59 42.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.961 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.35 147.62 40.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.988 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.1 m -87.39 128.22 35.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.659 0.742 . . . . 0.0 111.848 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -128.6 169.21 14.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 106' ' ' TYR . 48.0 mtmt -82.46 144.73 30.26 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' NH1' ' HA ' ' A' ' 132' ' ' ASP . 12.8 ptm180 -67.32 156.77 87.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.643 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 73.3 Cg_endo -77.92 160.76 30.43 Favored 'Trans proline' 0 C--O 1.256 1.397 0 C-N-CA 121.968 1.779 . . . . 0.0 109.769 172.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.9 m -127.31 1.27 6.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.511 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.91 1.04 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.753 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -155.23 135.87 8.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.97 13.63 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.973 2.449 . . . . 0.0 113.059 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 81.27 -166.3 47.87 Favored Glycine 0 N--CA 1.41 -3.042 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.56 171.52 19.81 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -132.45 121.35 17.36 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.45 -43.72 43.11 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.416 2.744 . . . . 0.0 114.575 -171.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.24 26.49 5.91 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.63 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -142.13 174.94 23.01 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.265 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.21 168.09 19.8 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.423 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . 53.2 p90 -143.09 156.16 44.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.277 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 p -125.24 169.13 12.57 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 124.213 1.005 . . . . 0.0 108.864 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.64 164.36 19.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.387 0.613 . . . . 0.0 111.469 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.0 t -162.03 147.97 13.34 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 175.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 20.77 41.46 Favored Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.566 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.91 -58.8 0.32 Allowed Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 82.68 35.2 0.06 Allowed 'General case' 0 CA--C 1.457 -2.602 0 CA-C-O 123.807 1.765 . . . . 0.0 109.357 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 8.2 p -156.29 -162.3 0.02 OUTLIER 'Isoleucine or valine' 1 N--CA 1.373 -4.294 0 CA-C-N 110.868 -2.878 . . . . 0.0 103.587 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 75.4 m-85 -113.16 83.85 1.9 Allowed 'General case' 1 C--N 1.225 -4.848 0 CA-C-O 121.577 0.704 . . . . 0.0 111.554 -176.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 25.4 pt-20 -143.36 163.5 32.88 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.368 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.454 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 58.8 t80 -49.78 131.94 22.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.311 1.007 . . . . 0.0 111.498 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.39 -13.31 63.04 Favored Glycine 0 N--CA 1.421 -2.344 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.45 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -77.25 145.21 10.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.572 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.7 ttmt -108.93 118.83 37.82 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.043 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.38 98.17 11.61 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -91.04 122.64 42.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 82.1 m-85 -96.04 141.59 29.26 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.303 1.049 . . . . 0.0 111.768 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -145.91 138.76 25.78 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 103.106 -2.924 . . . . 0.0 103.106 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 120' ' ' LEU . 58.6 m -95.38 -87.69 0.27 Allowed 'General case' 0 C--N 1.252 -3.668 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.622 -168.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -148.72 -173.05 4.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -49.82 -54.03 21.8 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.953 1.301 . . . . 0.0 112.816 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.69 13.22 27.45 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.389 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' CYS . 35.4 m-85 -114.87 128.48 56.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.97 -159.7 0.69 Allowed 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 163.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.612 ' HB3' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -139.29 151.89 46.81 Favored 'General case' 1 N--CA 1.334 -6.23 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.766 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 107.71 9.13 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.365 0.602 . . . . 0.0 111.064 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.52 140.55 4.21 Favored Glycine 0 N--CA 1.419 -2.458 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.185 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.72 -5.95 52.3 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.405 0.621 . . . . 0.0 111.312 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.418 HG21 ' ND2' ' A' ' 136' ' ' ASN . 44.2 mm -108.82 90.96 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB3' HD21 ' A' ' 120' ' ' LEU . 26.8 p-10 -86.54 42.87 1.03 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.44 -176.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -167.5 174.06 8.18 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.719 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 135' ' ' THR . 6.2 ptm180 -156.35 134.44 11.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -102.88 158.54 16.21 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.593 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -94.28 126.55 39.6 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.848 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 131' ' ' THR . 20.7 t70 -100.07 -156.05 0.53 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.51 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 51.2 p -66.4 -25.54 66.82 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 125.217 1.407 . . . . 0.0 113.761 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 12.8 t70 -129.58 -44.48 1.22 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.216 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.67 -172.4 15.18 Favored Glycine 0 CA--C 1.486 -1.744 0 C-N-CA 119.355 -1.402 . . . . 0.0 112.48 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -85.87 142.26 29.01 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.927 0.394 . . . . 0.0 110.236 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 75.2 p -79.21 170.77 16.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.418 ' ND2' HG21 ' A' ' 124' ' ' ILE . 12.8 m120 61.7 -155.06 0.35 Allowed 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -141.84 178.1 7.73 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.482 HD11 ' HA3' ' A' ' 89' ' ' GLY . 89.0 mt -82.48 114.24 50.18 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.582 ' HB2' HD12 ' A' ' 120' ' ' LEU . 18.9 Cg_endo -66.86 126.54 15.45 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.065 2.51 . . . . 0.0 111.243 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.44 128.81 39.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 68.8 m -81.27 111.24 17.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.04 0.448 . . . . 0.0 110.485 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.735 1.214 . . . . 0.0 109.998 -175.724 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 15.6 m-20 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 121.743 0.783 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -72.99 138.08 45.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.42 -177.861 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -116.08 30.61 7.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -164.81 158.24 17.25 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.541 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.5 mt -80.38 154.03 74.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 123.499 0.72 . . . . 0.0 109.469 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 9.8 Cg_endo -54.48 130.27 39.18 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.707 2.272 . . . . 0.0 111.196 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.11 126.48 13.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.206 1.937 . . . . 0.0 111.165 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -60.37 134.67 57.29 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 121.552 0.691 . . . . 0.0 109.695 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 3.3 mmp_? -87.06 174.59 8.57 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.546 -171.174 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -73.66 -43.71 58.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.59 0.556 . . . . 0.0 110.569 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 80' ' ' CYS . 4.3 p -122.74 19.02 10.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.611 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 1.8 mp0 -137.67 150.12 47.1 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.038 0.446 . . . . 0.0 111.611 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.8 mt -133.55 154.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.0 mm? -76.36 147.55 38.01 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.253 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 44.0 p -114.54 113.9 25.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.41 -155.13 26.18 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.2 m -137.95 98.35 3.63 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.566 ' HB3' HD22 ' A' ' 24' ' ' LEU . 85.1 m95 -95.23 97.5 9.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.263 -177.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 p -106.53 1.27 25.27 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.061 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 1.6 m-20 -119.48 -169.49 1.77 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.777 -171.082 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -129.95 -43.46 1.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 71.4 p -98.29 131.94 44.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.189 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 48.8 m-85 -138.64 154.93 73.62 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.478 0.711 . . . . 0.0 109.568 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 23.4 Cg_endo -65.73 150.6 86.03 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.354 2.036 . . . . 0.0 112.502 178.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.27 147.64 49.47 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.97 -10.95 70.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.604 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 91.9 m -67.77 116.3 8.29 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 122.302 0.241 . . . . 0.0 110.474 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 27.8 pt20 -93.66 125.09 38.08 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.315 1.055 . . . . 0.0 110.003 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.78 122.06 35.86 Favored 'General case' 0 C--N 1.271 -2.805 0 C-N-CA 125.539 1.535 . . . . 0.0 107.592 178.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.1 mt -93.25 118.23 38.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.648 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.7 m-85 -96.51 144.68 26.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.76 0.79 . . . . 0.0 112.988 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 34' ' ' THR . 57.6 tttp -89.31 132.65 34.83 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 13.4 t -82.2 37.52 0.5 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 59.74 154.51 0.1 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.712 1.205 . . . . 0.0 113.671 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.27 92.69 0.47 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 121.304 1.336 . . . . 0.0 110.491 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 137.65 -21.34 3.23 Favored Glycine 0 N--CA 1.429 -1.814 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.564 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.687 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.5 m-85 -103.39 168.63 9.04 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.11 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -150.89 176.28 11.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 176.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 t -160.08 -165.62 1.52 Allowed 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.89 -12.94 60.05 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.959 0.885 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.77 44.85 Favored Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 177.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.32 138.21 57.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.455 0.627 . . . . 0.0 109.717 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.57 123.91 25.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 47' ' ' GLN . 46.3 mm -117.52 125.58 74.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.014 -176.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 28' ' ' ARG . 86.9 mtp -124.36 134.44 53.14 Favored 'General case' 0 CA--C 1.424 -3.871 0 CA-C-O 121.515 0.674 . . . . 0.0 110.038 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.699 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 1.3 m -129.85 149.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.84 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.873 -168.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.01 128.66 34.68 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.29 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -153.71 121.88 6.13 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.25 32.2 12.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.807 0.843 . . . . 0.0 110.935 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.03 -18.28 36.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.463 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.69 165.68 11.09 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.402 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.1 m95 -106.02 116.07 31.3 Favored 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -127.41 -166.71 0.48 Allowed 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.652 -173.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.78 127.71 45.91 Favored 'General case' 1 C--N 1.218 -5.149 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.319 -172.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HB2' ' CG1' ' A' ' 65' ' ' VAL . 2.2 tm? -80.61 -54.82 5.31 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -106.87 94.37 10.43 Favored Pre-proline 0 N--CA 1.407 -2.578 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.687 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.74 -9.91 24.39 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.705 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -90.0 26.81 1.74 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 110.347 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.86 139.88 53.55 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.241 179.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -166.86 145.26 5.14 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 50.0 m -78.02 126.49 30.9 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 122.116 0.96 . . . . 0.0 113.534 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -119.67 153.42 35.6 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.038 -179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -72.02 136.2 46.63 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.386 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.3 ptp180 -78.13 145.25 68.78 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.3 166.08 29.56 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.197 1.932 . . . . 0.0 112.185 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.6 m -120.05 8.09 10.95 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.066 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.96 -96.76 0.88 Allowed Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.785 177.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -150.1 138.61 12.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.85 53.68 4.51 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.122 2.548 . . . . 0.0 112.133 -177.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.651 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 75.55 -143.58 30.53 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.16 153.25 31.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -150.1 135.25 9.81 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.78 -60.12 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.919 1.746 . . . . 0.0 109.967 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -123.49 154.44 39.13 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 130.89 150.43 6.78 Favored Glycine 0 C--N 1.282 -2.466 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 114' ' ' CYS . 4.4 m -145.29 158.7 43.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -175.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -144.3 161.09 39.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -123.02 146.21 47.84 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 91.8 mt -104.41 153.88 20.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.603 0.24 . . . . 0.0 110.529 -176.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -149.05 138.93 21.99 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.14 -12.89 58.85 Favored Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.28 170.48 42.61 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -111.35 10.85 21.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 117.698 0.749 . . . . 0.0 109.65 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 104' ' ' PHE . 5.8 p -141.04 -166.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.503 ' H ' HG22 ' A' ' 103' ' ' VAL . 29.4 m-85 -99.19 86.03 3.34 Favored 'General case' 1 C--N 1.241 -4.119 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.046 -176.995 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.2 pt-20 -136.59 151.99 49.96 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.795 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.9 t80 -48.01 124.42 7.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.229 0.538 . . . . 0.0 112.167 176.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.89 56.3 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.832 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 105' ' ' GLU . 4.5 p -83.65 144.76 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-N 117.492 0.646 . . . . 0.0 109.64 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -111.03 125.98 54.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.44 95.31 7.57 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.15 114.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.09 132.83 34.26 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.3 m -142.66 -28.28 0.59 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -172.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.533 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 96.2 m 69.79 -99.09 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 177.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -148.76 -158.69 0.94 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.86 -58.05 3.53 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.915 0.486 . . . . 0.0 110.894 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.07 4.37 74.48 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.889 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -117.91 133.55 55.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -127.48 -100.01 0.36 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.347 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.2 pp -179.78 145.29 0.22 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.056 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 142' ' ' GLU . 2.5 mm? -95.04 142.77 27.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.511 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.67 -173.86 18.15 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.06 -12.0 12.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.635 0.718 . . . . 0.0 111.078 178.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.59 114.96 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -91.61 17.74 8.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.493 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.57 179.06 9.22 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.298 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -158.35 130.5 6.89 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.606 171.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.27 157.16 17.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 -176.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 48.1 m -87.64 117.39 26.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.744 172.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 131' ' ' THR . 22.3 t70 -103.92 -158.69 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.49 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 63.3 p -67.54 -44.69 77.7 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 124.142 0.977 . . . . 0.0 112.965 -173.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.4 -43.42 17.36 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.747 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.93 -129.82 1.91 Allowed Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.839 -176.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -78.95 125.45 29.39 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 0.0 112.137 -172.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -65.53 -25.97 67.68 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.404 1.082 . . . . 0.0 112.699 -177.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -138.47 169.09 18.41 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -91.57 -174.31 3.84 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.651 HD11 ' HA3' ' A' ' 89' ' ' GLY . 55.7 mt -86.62 112.6 47.84 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 123.55 0.74 . . . . 0.0 109.251 -176.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.34 147.0 96.68 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.752 1.635 . . . . 0.0 109.811 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.494 HG22 ' HG2' ' A' ' 142' ' ' GLU . 41.6 mm -81.78 108.63 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.127 -173.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 19.9 t -63.3 119.12 9.04 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 140' ' ' ILE . 22.7 mm-40 . . . . . 0 C--N 1.307 -1.241 0 C-N-CA 123.509 0.724 . . . . 0.0 109.217 -174.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 52.6 m-20 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.4 m -68.96 141.8 54.86 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.883 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -112.41 19.51 17.54 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.25 156.92 37.92 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' CD2' ' HA ' ' A' ' 40' ' ' GLN . 3.6 mm? -85.69 153.97 58.49 Favored Pre-proline 1 N--CA 1.373 -4.276 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.964 -179.04 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 Cg_endo -53.55 122.23 10.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 123.328 2.685 . . . . 0.0 112.32 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.8 Cg_exo -64.58 131.94 31.38 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.282 1.988 . . . . 0.0 110.448 179.228 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -62.54 145.13 55.12 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.264 0.554 . . . . 0.0 110.43 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 18.8 mmm180 -98.1 166.17 11.55 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -81.72 -51.39 8.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.758 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.21 -1.8 57.63 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.141 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 18.1 mp0 -132.65 158.54 42.01 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.979 0.419 . . . . 0.0 111.993 -178.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -142.36 150.2 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.37 154.53 31.64 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.336 0.588 . . . . 0.0 110.705 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.5 p -91.11 -23.57 20.26 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.566 0.698 . . . . 0.0 111.138 177.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.87 -178.27 15.35 Favored Glycine 0 C--N 1.289 -2.029 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.2 t -103.13 149.84 24.23 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.194 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.568 ' HB3' HD12 ' A' ' 24' ' ' LEU . 8.2 m95 -138.07 138.82 39.15 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -178.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -142.21 16.48 2.07 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.217 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 24' ' ' LEU . 15.1 m-20 -128.93 124.91 36.35 Favored 'General case' 0 CA--C 1.465 -2.311 0 C-N-CA 118.464 -1.294 . . . . 0.0 112.276 -175.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.587 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 21.7 mp0 -54.11 -49.84 68.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 124.764 1.29 . . . . 0.0 112.868 -175.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -96.25 128.74 43.44 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.198 -1.001 . . . . 0.0 113.682 -172.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -134.92 148.75 68.27 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.541 176.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -69.0 149.13 71.38 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.444 2.096 . . . . 0.0 112.705 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -66.3 136.24 55.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.68 -3.92 36.66 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.437 -177.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -82.86 118.85 23.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.0 pt20 -88.53 143.78 26.75 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.545 0.688 . . . . 0.0 111.982 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.24 114.45 27.94 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.225 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -89.36 127.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 90.6 m-85 -109.2 141.85 40.86 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.617 0.722 . . . . 0.0 111.988 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -89.67 147.69 23.73 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 168.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.791 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 91.2 m -102.44 37.47 1.9 Allowed 'General case' 0 C--N 1.249 -3.795 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.605 -174.052 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 65.86 159.6 0.13 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.574 0.702 . . . . 0.0 111.532 178.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.52 113.8 3.62 Favored 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 109.706 -0.921 . . . . 0.0 109.706 172.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 131' ' ' THR . . . 118.24 -20.43 10.48 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.593 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.791 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.1 m-85 -107.1 161.32 14.86 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.578 178.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.474 ' NE ' ' HD3' ' A' ' 84' ' ' PRO . 16.0 ptt180 -160.79 -176.34 5.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.558 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.7 p -169.22 177.92 4.58 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 170.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.12 31.8 0.71 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.86 0.838 . . . . 0.0 110.213 177.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.0 -140.32 3.21 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -142.66 157.72 44.39 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -78.97 104.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.33 122.1 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.963 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.5 mtp -109.44 169.79 8.47 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.2 p -155.39 144.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.659 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t -68.4 123.15 20.0 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.716 177.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.4 ttm180 -157.19 129.84 7.53 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 35.7 mmtp 66.53 15.89 10.24 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.891 0.876 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.58 65.87 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.959 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.67 172.34 9.35 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.459 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -103.58 119.65 39.32 Favored 'General case' 0 CA--C 1.462 -2.428 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.3 -170.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.943 -175.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.57 121.1 39.07 Favored 'General case' 1 C--N 1.22 -5.024 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.221 -172.319 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -71.43 -54.42 10.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -119.72 100.38 49.0 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.65 -4.45 13.51 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.042 2.495 . . . . 0.0 112.366 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.27 -31.94 22.83 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.633 -178.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -89.29 135.33 33.64 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.365 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 158.55 44.28 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . 0.383 67.5 m -95.59 127.67 41.81 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 117.745 -1.582 . . . . 0.0 114.82 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.36 -175.69 2.76 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.756 -2.02 . . . . 0.0 108.096 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -71.99 152.92 42.12 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.077 0.465 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.16 152.97 46.59 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' NE ' ' A' ' 57' ' ' ARG . 66.2 Cg_endo -90.24 152.62 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.451 1.434 . . . . 0.0 112.84 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 70.9 m -124.96 76.79 1.56 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.55 93.51 0.01 OUTLIER Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.242 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 70.93 125.59 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.968 1.707 . . . . 0.0 111.42 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.69 38.68 0.4 Allowed 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 114.427 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 108.63 -127.72 8.73 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 138' ' ' ILE . 4.0 p30 -162.87 158.88 23.12 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -171.65 129.53 0.68 Allowed Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.51 -14.23 11.73 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.374 1.383 . . . . 0.0 111.016 174.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.46 89.32 2.37 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.354 0.597 . . . . 0.0 111.129 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 164.81 165.88 22.83 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.9 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -139.37 165.46 27.16 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -139.06 155.91 47.57 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 p -130.73 140.42 50.34 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -103.39 140.38 37.53 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 109' ' ' LYS . 5.1 t -133.69 19.52 3.88 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 121.708 0.766 . . . . 0.0 111.876 -176.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -141.9 25.4 2.4 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.53 174.88 17.18 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -119.25 20.44 12.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 117.903 0.852 . . . . 0.0 109.751 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' HG11 ' A' ' 108' ' ' VAL . 23.4 m -138.2 175.11 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' CYS . 52.7 m-85 -90.89 97.73 11.36 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.001 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.96 154.36 41.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.428 -177.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -51.19 116.87 2.23 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.306 1.004 . . . . 0.0 111.083 177.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.05 -25.18 7.18 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.278 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -74.72 137.77 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.344 178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.5 ttmt -106.02 121.64 44.54 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.72 94.52 9.41 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.77 122.32 32.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -94.1 132.14 38.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -153.98 156.43 37.41 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 83.9 m -132.68 -72.62 0.51 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.95 -174.05 3.21 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.47 -51.53 6.46 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.352 0.596 . . . . 0.0 110.763 -177.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.27 -18.93 79.91 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.202 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -98.77 137.67 37.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.54 -107.42 0.37 Allowed 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.5 pp 179.19 141.5 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.779 1.232 . . . . 0.0 109.666 176.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.1 mm? -89.11 134.75 33.89 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.407 0.622 . . . . 0.0 110.338 176.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.09 161.38 11.03 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -174.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -92.42 -21.65 20.08 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.469 0.652 . . . . 0.0 109.415 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' ND2' ' A' ' 136' ' ' ASN . 25.7 mm -104.99 106.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.953 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -88.15 24.9 1.72 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.535 1.134 . . . . 0.0 111.395 -175.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.418 ' CE1' HG23 ' A' ' 124' ' ' ILE . 47.4 p90 -159.58 171.61 19.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.256 0.551 . . . . 0.0 110.768 -173.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -135.18 131.74 37.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 12.8 mt-10 -104.37 139.1 39.81 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 118.242 0.473 . . . . 0.0 110.794 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.72 104.14 10.11 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.0 t70 -105.94 -159.81 0.72 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.973 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.2 p -60.7 -29.49 69.36 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.743 1.617 . . . . 0.0 114.555 -171.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -118.44 -28.56 5.7 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.553 0.692 . . . . 0.0 110.959 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.91 -157.11 28.44 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -176.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 97.3 m95 -74.0 130.62 40.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.871 0.367 . . . . 0.0 111.663 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 34.8 p -81.83 158.29 24.12 Favored 'General case' 0 C--O 1.266 1.945 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 124' ' ' ILE . 54.9 t30 63.92 -171.79 0.18 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -126.48 -168.1 1.81 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.656 HD11 ' HA3' ' A' ' 89' ' ' GLY . 54.0 mt -82.61 117.69 69.35 Favored Pre-proline 0 C--N 1.282 -2.33 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 33.8 Cg_endo -70.96 144.86 48.75 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.751 2.301 . . . . 0.0 110.894 177.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -93.7 112.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 122.118 -0.364 . . . . 0.0 110.871 -174.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.33 112.28 3.93 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.619 ' HB2' HD23 ' A' ' 121' ' ' LEU . 33.6 mt-10 . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.3 m-20 . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -84.52 125.08 32.08 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -97.89 23.59 7.84 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.01 161.27 40.47 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.394 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 mt -82.81 149.07 59.12 Favored Pre-proline 0 C--N 1.306 -1.313 0 O-C-N 123.998 0.811 . . . . 0.0 109.807 174.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.8 Cg_endo -53.11 131.55 43.48 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 123.197 2.598 . . . . 0.0 113.312 -177.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 18.6 Cg_exo -65.73 119.51 6.55 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 122.617 2.212 . . . . 0.0 110.277 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.64 142.58 56.35 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.766 0.793 . . . . 0.0 111.759 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 18.2 mmm180 -87.31 168.46 13.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.377 -171.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -88.16 -35.4 17.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.046 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.0 p -107.8 6.31 27.38 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.772 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 10.3 mp0 -138.92 156.44 47.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.33 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.3 158.92 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.78 143.67 55.74 Favored 'General case' 0 C--N 1.269 -2.896 0 O-C-N 123.483 0.489 . . . . 0.0 110.553 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 p -71.73 -35.23 70.1 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.35 165.92 12.17 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -94.15 142.71 27.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 177.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.06 125.53 42.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -121.44 18.22 11.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.288 0.566 . . . . 0.0 110.738 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.79 -159.44 0.74 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' HG3' HG23 ' A' ' 41' ' ' THR . 17.6 pt20 -149.63 -35.01 0.18 Allowed 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 123.457 0.703 . . . . 0.0 110.355 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.7 p -107.88 126.21 52.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.798 -176.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -133.89 137.05 27.6 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 28.3 Cg_endo -63.08 147.37 94.39 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 123.126 2.551 . . . . 0.0 111.926 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.5 tt0 -63.56 129.85 41.9 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.23 30.33 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.9 m -81.4 113.31 19.4 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.7 pt20 -86.35 143.78 27.68 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.136 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.57 119.95 37.17 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.0 mt -91.51 119.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 59.9 m-85 -98.45 145.61 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.042 0.925 . . . . 0.0 113.33 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 32.2 ttmt -91.66 138.36 31.63 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.087 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 35.7 m -74.63 21.9 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 72.9 mtp180 64.95 154.95 0.12 Allowed Pre-proline 0 N--CA 1.476 0.864 0 CA-C-O 121.678 0.751 . . . . 0.0 111.612 -173.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.4 104.19 0.42 Allowed 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.523 1.482 . . . . 0.0 110.866 174.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.12 -3.6 18.78 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.326 176.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.793 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.0 m-85 -120.89 165.91 14.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.133 -1.216 . . . . 0.0 109.819 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -156.18 179.32 9.35 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 23.7 p -145.46 -92.41 0.1 Allowed 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.703 0.764 . . . . 0.0 110.665 174.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -142.23 -47.2 0.35 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -177.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.92 -134.72 3.31 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 176.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -115.06 146.73 41.0 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.1 t -75.12 116.76 18.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.3 mm -110.5 122.92 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-O 121.455 0.645 . . . . 0.0 109.783 -176.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.3 mtp -109.3 171.84 7.2 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.5 p -157.74 142.69 8.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.76 122.19 20.24 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.304 176.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.3 ttm180 -156.52 127.51 6.87 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 66.19 17.06 10.65 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.58 80.36 Favored Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.897 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 9.6 pt-20 -117.4 159.06 23.38 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -104.12 109.3 21.04 Favored 'General case' 0 CA--C 1.455 -2.69 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.0 -164.54 0.39 Allowed 'Isoleucine or valine' 1 N--CA 1.362 -4.846 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.252 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.14 40.67 Favored 'General case' 1 C--N 1.218 -5.123 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.601 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.9 -39.76 66.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.86 102.18 13.64 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 1.5 8.27 Favored 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.98 2.453 . . . . 0.0 113.74 -175.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.92 -20.33 18.19 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.691 0.758 . . . . 0.0 111.385 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 31.1 mmt180 -85.02 130.96 34.53 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.387 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -156.55 147.95 22.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 55.7 m -97.03 123.47 40.77 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.594 0.711 . . . . 0.0 111.484 -176.137 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.99 42.51 2.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -167.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 88.2 mttt 76.6 -179.98 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.753 1.221 . . . . 0.0 111.044 -178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 15.4 ptp180 -130.41 142.0 43.9 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.99 147.58 43.66 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.477 2.118 . . . . 0.0 109.633 173.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 m -102.32 -10.66 19.3 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.015 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.05 -117.2 4.43 Favored Glycine 0 CA--C 1.474 -2.481 0 C-N-CA 119.002 -1.571 . . . . 0.0 110.996 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -136.71 139.14 28.25 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -176.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.42 8.64 3.71 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.786 2.324 . . . . 0.0 111.143 178.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 97.3 -164.25 22.23 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -175.114 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.27 161.19 12.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -130.5 126.04 21.86 Favored Pre-proline 0 C--N 1.288 -2.086 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.182 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.29 10.1 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.548 2.165 . . . . 0.0 112.773 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -110.82 -12.16 14.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.506 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . -164.56 -146.66 4.84 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.792 -175.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.91 -172.86 4.21 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.804 0.442 . . . . 0.0 111.597 -175.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -148.11 166.42 27.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 p -130.49 159.09 38.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.551 0.74 . . . . 0.0 109.332 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.5 136.57 53.14 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.054 0.454 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.8 t -125.78 138.18 53.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.12 9.97 56.54 Favored Glycine 0 C--N 1.312 -0.77 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -175.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.01 167.73 11.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -178.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.06 31.52 5.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.797 0.798 . . . . 0.0 111.277 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.02 167.85 23.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.06 86.24 5.34 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.662 -176.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.92 154.16 49.52 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.397 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -51.29 120.6 5.18 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.714 0.634 . . . . 0.0 111.543 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.25 -20.05 7.12 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 99' ' ' THR . 10.5 m -83.51 146.48 6.86 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.427 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.1 ttmp? -111.12 126.72 55.13 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.52 92.82 8.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.69 115.11 27.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -81.87 139.91 34.42 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.509 -177.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.14 143.31 22.34 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.506 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 77.6 m -122.57 -73.38 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.113 -174.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -161.1 -165.61 1.39 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -172.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -79.81 -43.25 22.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.778 0.799 . . . . 0.0 109.042 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.48 -12.84 79.72 Favored Glycine 0 C--N 1.31 -0.906 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.407 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -124.47 127.86 48.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.73 -130.46 0.26 Allowed 'General case' 0 CA--C 1.457 -2.632 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 166.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -151.65 145.47 25.1 Favored 'General case' 1 N--CA 1.33 -6.467 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.996 -176.35 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 94.6 mt -87.27 109.76 19.73 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.76 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 156.11 161.01 10.37 Favored Glycine 0 C--N 1.272 -3.017 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 -178.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -97.21 -5.96 35.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 118.183 0.991 . . . . 0.0 110.251 179.033 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.91 106.94 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.615 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.768 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.2 p-10 -84.7 30.99 0.54 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.616 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.585 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -166.35 179.93 5.34 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.451 0.643 . . . . 0.0 111.857 -172.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -139.83 131.61 27.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 169.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 25.2 mt-10 -99.92 136.22 40.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.1 t -81.39 123.02 28.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.158 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.0 t70 -118.55 -160.24 0.79 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.456 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 43.2 p -66.85 -51.47 55.2 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.824 1.25 . . . . 0.0 112.101 -174.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.03 -28.72 39.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.77 0.795 . . . . 0.0 110.693 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.61 -148.13 17.57 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -80.97 132.84 35.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.189 0.494 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 49.6 p -81.0 148.95 29.51 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.423 178.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 67.53 -173.75 0.19 Allowed 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.273 0.983 . . . . 0.0 108.93 174.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -117.38 -173.62 2.45 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.459 HD11 ' HA3' ' A' ' 89' ' ' GLY . 73.0 mt -81.29 119.24 75.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 -174.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CG ' HD12 ' A' ' 120' ' ' LEU . 9.6 Cg_endo -58.72 132.52 48.47 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.424 2.083 . . . . 0.0 108.706 174.623 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.1 mp -78.03 106.62 8.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.016 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.8 t -61.42 118.17 6.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.165 0.507 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 10.2 tp10 . . . . . 0 N--CA 1.43 -1.445 0 C-N-CA 126.178 1.791 . . . . 0.0 106.651 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.662 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.7 m-20 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.9 m -74.37 138.23 43.27 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.425 ' HA ' HG22 ' A' ' 41' ' ' THR . 5.0 m-20 -100.97 15.17 29.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.344 0.592 . . . . 0.0 109.882 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.07 154.83 41.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.551 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.6 mt -75.12 149.82 85.16 Favored Pre-proline 0 C--O 1.253 1.289 0 O-C-N 124.073 0.858 . . . . 0.0 109.909 173.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 27.9 Cg_endo -58.84 142.02 98.56 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.828 2.352 . . . . 0.0 110.054 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.76 144.49 54.22 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.779 1.653 . . . . 0.0 111.67 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -76.21 141.76 41.69 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 24.7 mmm180 -98.28 162.03 13.4 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.647 -171.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -78.23 -42.22 31.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.342 0.592 . . . . 0.0 109.69 176.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.72 -7.72 21.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.648 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.8 mp0 -129.4 166.13 20.17 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.755 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.98 146.21 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 37' ' ' TRP . 4.5 mm? -70.65 140.15 51.48 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.506 178.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -126.67 101.41 6.63 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.988 172.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.78 -160.09 33.64 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 -176.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 m -129.43 114.53 16.27 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 117.699 0.749 . . . . 0.0 109.532 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB3' HD22 ' A' ' 24' ' ' LEU . 80.8 m95 -120.81 128.27 52.71 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.189 -175.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 m -148.54 8.08 0.78 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.312 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.0 m-20 -120.93 -173.37 2.59 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.635 -174.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -112.41 -61.1 1.77 Allowed 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.1 p -85.9 122.65 30.26 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.51 -175.125 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 63.9 m-85 -126.76 136.05 28.21 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.272 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 17.9 Cg_endo -60.51 145.68 98.31 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.345 2.697 . . . . 0.0 113.535 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 18.5 tt0 -62.85 120.47 11.37 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.89 12.89 14.94 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -175.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.6 m -92.38 113.23 25.45 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.567 176.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.9 149.21 25.38 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.643 0.59 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.25 133.84 51.36 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.759 0.824 . . . . 0.0 109.023 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.9 mt -102.59 129.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.5 m-85 -111.25 137.29 49.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' A' ' 53' ' ' ARG . 53.5 tptt -85.05 126.53 33.64 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.7 m -77.43 13.45 1.21 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 70.1 mtp180 69.64 150.11 0.12 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.512 0.725 . . . . 0.0 110.895 -172.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.71 120.67 7.43 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.728 1.619 . . . . 0.0 109.9 175.269 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.24 -13.98 13.71 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 72.8 m-85 -115.17 163.66 15.33 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.62 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -150.88 -179.31 7.17 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 p -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.57 -13.61 59.74 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.592 0.711 . . . . 0.0 109.899 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.58 144.53 9.72 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 174.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.21 154.71 39.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.708 0.754 . . . . 0.0 111.166 -178.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.449 HG23 ' SG ' ' A' ' 80' ' ' CYS . 76.7 t -71.49 102.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.25 118.41 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.2 mtp -107.27 171.45 7.37 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.04 146.48 12.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.64 122.32 23.0 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.825 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.1 ttm180 -153.39 124.71 7.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.934 0.397 . . . . 0.0 111.057 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 61.8 mmtt 68.66 11.55 8.39 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.852 1.261 . . . . 0.0 112.519 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.78 -12.61 46.13 Favored Glycine 0 N--CA 1.427 -1.945 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.33 178.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.55 158.3 21.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.595 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m95 -91.22 115.5 28.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.93 171.2 6.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.267 -175.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.22 119.49 26.56 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.3 -49.67 63.31 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -108.35 89.43 5.9 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.705 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.66 -19.84 9.69 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.568 2.179 . . . . 0.0 111.475 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.3 mt -74.77 -29.55 61.16 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.252 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -84.78 158.72 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.936 178.891 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -175.68 156.16 1.83 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.964 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 62' ' ' VAL . 60.2 m -93.64 123.82 37.22 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.738 -177.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.35 164.22 16.66 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.639 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 90.9 mttt -73.51 151.11 41.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.487 0.184 . . . . 0.0 110.958 -176.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.7 ptm180 -82.27 146.25 54.07 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.476 176.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 69.8 Cg_endo -79.42 151.74 22.98 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.42 2.08 . . . . 0.0 110.909 172.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 133' ' ' GLY . 52.5 m -110.95 -9.23 14.43 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.804 177.009 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.55 175.42 47.63 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.699 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.74 123.19 89.05 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 56.3 Cg_endo -70.2 83.66 0.76 Allowed 'Trans proline' 0 C--O 1.254 1.283 0 C-N-CA 123.076 2.517 . . . . 0.0 113.017 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 63.54 -142.55 47.07 Favored Glycine 0 C--O 1.215 -1.068 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.47 130.14 17.0 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 t -127.24 99.53 27.86 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-O 121.522 0.677 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.59 -39.41 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.485 2.123 . . . . 0.0 113.403 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.43 -20.49 17.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.33 176.91 18.77 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.739 -178.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 p -134.84 175.64 9.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 37.8 p90 -150.49 151.19 32.32 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.423 177.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.5 p -101.59 171.37 7.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 103' ' ' VAL . 96.2 mt -141.69 136.7 31.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 173.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 109' ' ' LYS . 9.1 t -113.31 -62.28 1.61 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.73 56.02 4.9 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.749 -176.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.13 -57.49 0.35 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.329 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 m120 87.74 18.17 0.07 Allowed 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.401 1.48 . . . . 0.0 107.873 -179.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.418 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 p -141.27 -161.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.819 0 CA-C-N 111.822 -2.444 . . . . 0.0 105.051 177.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 44.9 m-85 -112.07 86.26 2.31 Favored 'General case' 1 C--N 1.236 -4.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 -175.58 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 15.1 pt-20 -151.02 155.89 39.99 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.457 178.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 79.6 t80 -45.47 115.38 0.92 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 125.036 1.46 . . . . 0.0 112.273 -178.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.41 -21.76 6.0 Favored Glycine 0 N--CA 1.427 -1.959 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.1 m -78.1 137.51 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.886 -1.125 . . . . 0.0 111.438 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' H ' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -106.61 110.78 23.07 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -81.72 92.46 6.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -81.58 124.37 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.928 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 7.7 t80 -84.27 130.62 34.8 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.08 150.03 43.69 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 118' ' ' TYR . 26.6 m -130.18 148.72 52.05 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.9 173.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.411 1.069 . . . . 0.0 112.586 177.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -44.14 -53.02 6.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.626 1.57 . . . . 0.0 113.567 -176.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 22.45 34.82 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.139 -176.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 114' ' ' CYS . 95.6 m-85 -134.05 161.01 36.02 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.391 0.615 . . . . 0.0 111.691 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -156.39 -156.38 0.62 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 173.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 1.2 pp -140.26 142.52 35.75 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -175.01 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.2 mm? -83.5 135.52 34.62 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.72 171.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.25 152.01 9.03 Favored Glycine 0 C--N 1.267 -3.289 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -174.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.74 -13.06 37.61 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 117.343 0.572 . . . . 0.0 111.912 -176.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -111.21 116.44 52.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' HD21 ' A' ' 120' ' ' LEU . 3.1 p-10 -91.63 25.49 2.66 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.448 0.642 . . . . 0.0 111.123 -176.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 28.5 p90 -156.49 177.32 11.6 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.75 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.66 ' NH1' HG12 ' A' ' 138' ' ' ILE . 15.2 ptt180 -157.36 128.4 6.7 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.441 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 37.6 mt-10 -103.67 142.24 34.68 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.78 98.89 7.98 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -103.86 -158.51 0.67 Allowed 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.692 -173.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 38.9 p -64.94 -38.48 91.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.741 1.217 . . . . 0.0 113.14 -172.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.5 -33.99 11.64 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 120.95 0.405 . . . . 0.0 110.326 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 85' ' ' CYS . . . 161.24 -149.14 17.76 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.554 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -71.65 130.0 40.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.727 0.264 . . . . 0.0 110.766 -178.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.5 p -79.76 167.36 20.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.336 176.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.28 -101.99 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.04 0.936 . . . . 0.0 112.668 173.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 169.82 -158.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -177.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.66 HG12 ' NH1' ' A' ' 127' ' ' ARG . 62.6 mt -102.31 107.1 52.0 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 9.4 Cg_endo -58.37 137.36 80.05 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.483 1.456 . . . . 0.0 109.37 174.075 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.37 115.17 25.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.041 -171.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 8.8 t -75.09 99.81 4.04 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 123.437 0.461 . . . . 0.0 109.851 -178.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.77 1.628 . . . . 0.0 108.234 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 12.8 m-20 . . . . . 0 C--O 1.243 0.742 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.6 m -61.38 139.98 58.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 41' ' ' THR . 6.2 m-20 -116.32 16.44 15.77 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.542 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -156.45 161.35 40.08 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.702 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.06 153.44 79.95 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 123.984 0.914 . . . . 0.0 109.935 176.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 Cg_endo -55.41 123.68 14.4 Favored 'Trans proline' 0 C--O 1.254 1.303 0 C-N-CA 122.273 1.982 . . . . 0.0 111.516 178.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.5 Cg_exo -67.36 109.24 1.74 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.803 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -71.73 143.01 49.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.934 176.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -104.49 -171.81 1.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.25 -42.26 72.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.134 0.492 . . . . 0.0 110.316 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 15.8 p -109.63 11.68 24.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mp0 -138.28 134.25 34.11 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.706 -0.621 . . . . 0.0 112.601 -178.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.93 157.32 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.11 140.64 45.39 Favored 'General case' 0 C--N 1.264 -3.138 0 O-C-N 123.817 0.698 . . . . 0.0 110.735 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -73.51 -52.96 11.77 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.909 177.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.57 167.99 41.42 Favored Glycine 0 N--CA 1.421 -2.353 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.347 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 p -90.95 146.76 23.61 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 123.011 0.524 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -135.92 143.43 44.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.0 t -125.65 -44.12 1.84 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HE1' ' A' ' 42' ' ' TYR . 15.2 t70 -97.09 158.04 15.63 Favored 'General case' 0 C--O 1.186 -2.268 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -170.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -79.09 -30.01 43.62 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.21 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 77.9 p -101.08 119.95 39.5 Favored 'General case' 0 N--CA 1.41 -2.457 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.99 -174.344 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HE1' ' O ' ' A' ' 39' ' ' ASP . 40.4 m-85 -130.29 155.01 81.56 Favored Pre-proline 0 C--N 1.302 -1.46 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.078 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 147.09 88.94 Favored 'Trans proline' 0 C--O 1.252 1.208 0 C-N-CA 122.121 1.881 . . . . 0.0 111.555 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.9 146.75 49.38 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.8 9.12 62.94 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.992 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -89.08 120.32 30.38 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.87 -0.194 . . . . 0.0 111.222 177.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 11.9 pt20 -87.01 157.0 19.54 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.323 0.582 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.09 126.51 41.32 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.76 130.52 46.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 80.6 m-85 -99.76 138.8 36.34 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -78.2 -18.41 55.51 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 127.209 2.204 . . . . 0.0 112.531 -173.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 97.4 m 67.22 -2.87 1.11 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 62.4 mtp180 69.76 153.97 0.14 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.531 0.732 . . . . 0.0 111.131 -174.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.49 121.4 7.94 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.794 1.663 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 111.92 -5.43 27.39 Favored Glycine 0 C--N 1.306 -1.123 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.357 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.566 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 41.0 m-85 -120.49 174.57 6.47 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -162.45 -173.33 3.52 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 p -151.09 168.08 25.73 Favored 'General case' 0 C--N 1.266 -3.048 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.3 tp -105.59 32.23 4.45 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.53 109.74 0.38 Allowed Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 63' ' ' ILE . 95.4 m-20 -52.83 140.08 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 117.337 0.568 . . . . 0.0 111.695 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 93.0 t -64.86 112.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 61' ' ' ASN . 46.9 mm -113.2 118.37 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.69 170.94 7.59 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.1 p -156.21 148.32 11.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.9 t -81.25 134.29 35.58 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.242 -177.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 4.7 tpm_? -152.59 126.76 9.16 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 32.7 mmtp 63.12 18.49 10.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 175.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 99.81 -12.41 60.96 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.944 179.152 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.32 168.24 10.14 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -101.3 121.74 42.43 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.84 179.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.65 39.61 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.219 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -68.95 -42.57 76.49 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.589 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 9.0 t-20 -127.8 97.44 30.04 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.959 173.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.13 -7.45 16.22 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 0.0 112.864 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.61 -27.3 51.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.534 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 29.3 mmt180 -92.69 153.76 18.76 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.992 -177.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -158.03 147.3 19.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.56 123.57 28.22 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.548 -178.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -121.28 167.76 12.37 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.96 157.32 22.08 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.345 0.593 . . . . 0.0 111.963 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.6 ptm180 -99.01 154.61 37.24 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 46.6 Cg_endo -73.15 151.46 49.45 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.519 1.479 . . . . 0.0 109.386 169.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -78.52 -46.52 19.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.557 0.694 . . . . 0.0 110.111 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.51 -125.86 3.61 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -176.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -141.4 116.64 7.13 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.36 41.72 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 124.08 3.187 . . . . 0.0 114.904 -174.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.34 -137.28 30.96 Favored Glycine 0 C--N 1.311 -0.815 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -149.21 -176.54 5.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 t -171.83 106.44 0.37 Allowed Pre-proline 0 C--N 1.289 -2.061 0 C-N-CA 125.477 1.511 . . . . 0.0 107.563 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.34 -17.58 18.71 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.368 2.045 . . . . 0.0 113.435 -175.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CD1' ' HB3' ' A' ' 141' ' ' CYS . 0.1 OUTLIER -124.06 -5.22 7.91 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.641 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.97 -163.91 10.5 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -162.27 -177.98 6.04 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 117.277 0.538 . . . . 0.0 110.619 178.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -143.55 164.6 29.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.257 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 68.2 p -120.93 169.87 10.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.8 mt -129.64 135.38 48.46 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -120.43 1.38 10.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.256 0.551 . . . . 0.0 112.331 -174.357 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.74 24.9 4.8 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.28 148.19 5.61 Favored Glycine 0 N--CA 1.411 -2.977 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -174.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -93.59 32.7 1.36 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 122.517 1.151 . . . . 0.0 109.141 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.99 162.42 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.624 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.322 -174.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 45.0 m-85 -91.42 100.21 13.02 Favored 'General case' 0 C--N 1.26 -3.318 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.883 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.16 149.0 37.45 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 91.5 t80 -52.39 121.22 6.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.172 0.511 . . . . 0.0 110.473 177.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.5 -13.86 25.28 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.302 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.6 142.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 109.69 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -113.09 126.01 55.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -93.51 102.92 15.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.068 0.855 . . . . 0.0 108.898 177.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.409 HG22 ' OG1' ' A' ' 97' ' ' THR . 0.7 OUTLIER -87.84 126.67 41.35 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.281 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -93.17 142.5 27.24 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -135.17 155.75 50.17 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.603 ' HB3' ' O ' ' A' ' 119' ' ' GLN . 44.1 t -158.92 100.48 1.58 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 47.67 -160.65 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 164.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -98.77 -64.93 0.99 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.003 -0.435 . . . . 0.0 111.126 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.72 34.12 2.98 Favored Glycine 0 N--CA 1.469 0.892 0 CA-C-O 121.492 0.496 . . . . 0.0 112.58 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.13 173.65 11.3 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 120' ' ' LEU . 43.6 mt-30 -130.27 -66.09 0.79 Allowed 'General case' 0 CA--C 1.432 -3.596 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 167.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.5 pt? 165.36 157.46 0.02 OUTLIER 'General case' 1 N--CA 1.362 -4.86 0 N-CA-C 102.204 -3.258 . . . . 0.0 102.204 164.156 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.0 mt -97.26 112.53 24.29 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 119.521 1.055 . . . . 0.0 110.455 175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.23 150.54 5.3 Favored Glycine 0 C--N 1.283 -2.404 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.28 -32.27 43.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 117.787 0.794 . . . . 0.0 108.894 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -95.72 107.4 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.645 ' HA ' HD11 ' A' ' 120' ' ' LEU . 2.6 p-10 -88.04 29.45 0.94 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.881 0.848 . . . . 0.0 110.982 -175.33 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -162.24 175.68 11.4 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.937 -175.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.653 ' NH2' HG12 ' A' ' 138' ' ' ILE . 12.2 ttm180 -143.56 120.93 11.63 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.37 152.23 19.85 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.429 176.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 49.8 t -79.44 149.14 31.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' THR . 17.5 t70 -126.07 -177.97 4.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 39.5 p -61.42 -33.83 74.37 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.59 1.156 . . . . 0.0 113.303 -175.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.52 9.15 7.11 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.399 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.11 -126.08 1.11 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.543 -178.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -131.08 153.64 49.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 130' ' ' ASP . 59.8 p -91.17 128.97 37.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.171 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 80.22 176.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.897 0.879 . . . . 0.0 111.994 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 12.2 t70 -105.12 -156.21 0.57 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -174.256 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.653 HG12 ' NH2' ' A' ' 127' ' ' ARG . 62.2 mt -101.94 101.92 20.97 Favored Pre-proline 0 N--CA 1.42 -1.926 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB2' HD12 ' A' ' 120' ' ' LEU . 7.3 Cg_endo -52.86 133.43 51.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 122.263 1.975 . . . . 0.0 108.05 172.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 140' ' ' ILE . 3.3 mp -86.97 123.75 40.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -171.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . 48.9 t -68.64 91.51 0.43 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 CA--C 1.496 -1.129 0 C-N-CA 126.274 1.83 . . . . 0.0 107.254 -175.323 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.638 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' THR . 82.3 m -80.76 133.37 35.64 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.336 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.71 33.6 3.98 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.143 0.973 . . . . 0.0 108.958 -178.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.85 158.11 37.52 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.979 -176.069 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.5 mt -85.0 154.46 60.75 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 123.872 0.733 . . . . 0.0 110.392 178.012 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.09 145.04 93.68 Favored 'Trans proline' 0 C--O 1.255 1.326 0 C-N-CA 122.338 2.025 . . . . 0.0 110.382 177.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.76 155.42 53.89 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.266 1.977 . . . . 0.0 112.777 -177.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -83.5 147.91 27.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 35.8 mtt180 -114.45 170.58 8.2 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -172.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -79.11 -40.55 30.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.795 -176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p -115.92 4.15 13.8 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.417 177.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.529 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 8.2 mp0 -131.63 153.92 49.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.663 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.25 156.64 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.457 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.015 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.4 mm? -77.24 149.35 35.46 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -99.25 156.53 16.93 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.48 -159.96 25.33 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.791 178.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -140.89 120.98 13.73 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' HD22 ' A' ' 24' ' ' LEU . 71.7 m95 -113.75 115.75 28.3 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -175.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -134.49 26.73 3.75 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.115 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 26.6 m-20 -126.92 -167.18 1.69 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.963 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.57 -53.57 0.77 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.714 0.406 . . . . 0.0 111.156 175.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.4 p -85.11 105.51 15.9 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.937 0.875 . . . . 0.0 113.106 -175.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -114.12 136.57 22.22 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.957 178.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.638 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 22.5 Cg_endo -63.12 150.25 89.17 Favored 'Trans proline' 0 C--O 1.257 1.472 0 C-N-CA 122.878 2.385 . . . . 0.0 112.215 -177.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.654 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -66.13 133.14 50.09 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.14 1.08 41.55 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.218 -176.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -82.33 114.64 20.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.206 178.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.0 pt20 -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.429 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.3 113.28 25.97 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.14 121.31 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.781 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 62.3 m-85 -98.55 140.75 32.31 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.944 0.878 . . . . 0.0 113.24 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -94.2 111.97 23.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 171.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 98.2 m -79.11 32.61 0.22 Allowed 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 64.23 151.85 0.12 Allowed Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.148 1.379 . . . . 0.0 113.274 177.078 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.95 124.74 12.19 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.326 1.35 . . . . 0.0 108.883 173.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.14 -19.89 10.78 Favored Glycine 0 C--N 1.297 -1.591 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 75.5 m-85 -114.4 170.1 8.55 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -155.18 179.08 9.49 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.5 p -170.81 135.22 1.07 Allowed 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.298 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.2 -43.8 85.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 114.27 3.91 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 172.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -64.31 155.36 32.43 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 123.817 0.363 . . . . 0.0 110.66 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.548 HG23 ' SG ' ' A' ' 80' ' ' CYS . 98.7 t -72.55 102.2 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.04 118.44 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 81.5 mtp -104.62 169.15 8.62 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.6 p -156.66 146.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.286 0.565 . . . . 0.0 109.905 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.62 122.53 23.31 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.739 177.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.654 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 31.9 ttt180 -152.77 134.29 14.47 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.208 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 34.0 mmtp 67.23 12.13 8.77 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.302 1.041 . . . . 0.0 112.507 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.62 -4.27 57.97 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.81 157.48 33.99 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.16 0.505 . . . . 0.0 110.834 177.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -87.84 117.16 26.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.21 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.62 176.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.028 -178.018 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' MET . . . -89.78 128.97 36.23 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.433 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.11 -50.92 43.71 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.46 91.13 6.64 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.755 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.28 -15.55 22.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.619 2.212 . . . . 0.0 112.084 -177.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.1 mt -83.37 -9.34 59.11 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.038 0.923 . . . . 0.0 111.018 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -102.99 138.69 39.53 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.914 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.88 162.16 38.37 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 172.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 62' ' ' VAL . 83.1 m -101.79 130.26 48.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.572 -0.851 . . . . 0.0 113.016 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 172.79 7.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.955 -178.048 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.75 157.12 33.59 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -85.34 145.57 42.85 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.092 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.17 144.59 13.32 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.979 1.786 . . . . 0.0 109.582 176.198 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.6 m -103.53 5.81 37.0 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.268 0.556 . . . . 0.0 112.152 -173.306 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.31 -98.66 1.14 Allowed Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.927 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -152.58 142.68 15.09 Favored Pre-proline 0 C--N 1.278 -2.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.07 45.54 1.95 Allowed 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.523 2.815 . . . . 0.0 112.069 -176.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 86.4 -146.28 20.83 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -175.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.27 127.14 4.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 t -113.51 135.92 21.91 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.65 -35.07 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.759 2.306 . . . . 0.0 114.379 -178.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -143.53 11.19 1.67 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.091 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 176.96 32.17 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -137.56 174.65 10.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.37 156.79 34.49 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.642 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -118.94 154.88 32.3 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 175.076 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 110' ' ' ALA . 96.7 mt -120.74 135.58 55.1 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.5 t -112.99 139.04 48.99 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.16 -68.75 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.926 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.75 -72.48 0.82 Allowed Glycine 0 C--N 1.31 -0.868 0 CA-C-N 115.555 -0.322 . . . . 0.0 113.402 -173.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 82.24 18.44 0.34 Allowed 'General case' 0 CA--C 1.455 -2.684 0 CA-C-O 123.467 1.603 . . . . 0.0 108.599 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.21 165.04 1.13 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.215 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -88.47 85.32 6.83 Favored 'General case' 0 C--N 1.255 -3.503 0 O-C-N 123.673 0.608 . . . . 0.0 110.154 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.7 pt-20 -133.33 162.26 32.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.266 -176.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -52.74 128.26 25.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.026 176.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.74 -19.52 53.1 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.173 178.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.4 p -71.51 141.58 16.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.023 -177.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.0 ttmt -106.07 121.53 44.32 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.462 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -95.37 97.35 9.77 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.466 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.642 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.2 p -87.51 112.78 23.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.541 ' OH ' ' HB2' ' A' ' 141' ' ' CYS . 15.3 t80 -81.21 139.42 35.53 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.203 -170.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -142.34 170.9 14.84 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.23 -89.67 0.59 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.802 177.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -138.26 -149.2 0.29 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.01 -51.77 5.3 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.359 -179.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.31 -18.86 63.58 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.601 178.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.11 144.97 25.02 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.15 -68.47 0.89 Allowed 'General case' 0 CA--C 1.438 -3.348 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.241 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.667 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.263 1.0 OUTLIER 169.52 153.46 0.04 OUTLIER 'General case' 1 N--CA 1.297 -8.115 0 CA-C-N 111.605 -2.543 . . . . 0.0 105.145 -169.876 . . . . . . . . 5 4 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.667 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 36.6 tp -134.16 126.94 31.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.18 171.83 12.57 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.179 -1.969 . . . . 0.0 108.179 -176.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -92.52 -21.13 20.3 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 118.223 1.012 . . . . 0.0 110.814 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 136' ' ' ASN . 32.3 mm -114.33 114.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.401 ' HB3' HD22 ' A' ' 120' ' ' LEU . 27.6 p-10 -94.87 19.85 9.64 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -175.148 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -159.03 174.18 15.32 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.31 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 137' ' ' ASP . 8.5 ptm180 -151.88 127.82 10.34 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.34 171.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -99.53 160.7 14.09 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.026 0.53 . . . . 0.0 109.709 -178.121 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.3 t -98.55 114.82 27.4 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.955 175.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.438 ' HB2' HG22 ' A' ' 135' ' ' THR . 17.3 t70 -92.24 -179.64 5.3 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 125.401 1.48 . . . . 0.0 108.385 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 p -62.54 -36.25 82.02 Favored 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 123.714 0.805 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.85 -34.85 24.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.52 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.29 -157.53 29.43 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -69.02 129.56 40.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.69 1.245 . . . . 0.0 110.886 -177.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 130' ' ' ASP . 24.3 p -55.56 -38.9 69.93 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 125.054 1.341 . . . . 0.0 112.711 -174.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.481 HD21 HG13 ' A' ' 124' ' ' ILE . 11.6 t-20 -138.32 172.81 12.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -175.134 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 16.6 t70 -102.53 -168.69 1.56 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 123.422 0.451 . . . . 0.0 110.241 -176.12 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 89' ' ' GLY . 34.2 mt -76.81 123.15 87.47 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 124.435 1.094 . . . . 0.0 111.05 -171.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -73.58 163.24 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.717 1.611 . . . . 0.0 109.762 172.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mm -84.45 133.1 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.541 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 21.3 t -83.0 120.42 25.7 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 121' ' ' LEU . 13.2 tp10 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -174.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 31.2 m-20 . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 121.064 0.459 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 142.41 43.94 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 124.555 1.142 . . . . 0.0 110.757 -172.41 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 41' ' ' THR . 7.4 m-20 -116.56 19.99 14.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.925 0.869 . . . . 0.0 109.35 175.528 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.55 156.01 34.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.665 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 37' ' ' TRP . 40.4 mt -77.4 158.25 79.37 Favored Pre-proline 0 C--O 1.253 1.238 0 O-C-N 123.759 0.662 . . . . 0.0 110.82 176.374 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 20.3 Cg_endo -62.03 135.05 52.83 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.337 2.024 . . . . 0.0 109.581 175.359 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.02 137.09 21.23 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 121.986 1.791 . . . . 0.0 112.926 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -76.25 143.66 40.82 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -121.62 175.86 6.0 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.533 -170.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -59.02 -26.08 64.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 0.0 113.21 -175.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -134.3 12.05 3.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.88 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 3.1 mp0 -132.57 140.23 48.17 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.71 -0.796 . . . . 0.0 113.082 -172.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -135.67 142.62 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.74 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.463 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.0 mm? -69.65 142.06 53.51 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.998 -179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 p -101.76 87.98 3.28 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.413 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.25 -169.49 40.44 Favored Glycine 0 C--N 1.275 -2.815 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.751 -175.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -117.68 109.6 16.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 48.7 m95 -129.5 126.01 37.66 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 t -160.94 25.01 0.14 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.487 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.36 -164.48 1.13 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.782 -1.553 . . . . 0.0 110.053 -172.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -123.83 -64.87 1.11 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.94 0.4 . . . . 0.0 110.91 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.6 p -105.6 146.23 29.94 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.493 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.33 153.99 56.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.78 1.232 . . . . 0.0 109.207 178.009 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 57.6 Cg_endo -73.47 152.93 49.61 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.019 1.813 . . . . 0.0 112.311 179.362 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.9 147.77 52.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.88 5.86 65.91 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.065 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -83.94 115.95 22.55 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.467 178.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 26.9 pt20 -90.04 139.08 30.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.532 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.98 124.56 52.92 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.65 129.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.304 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 31' ' ' GLU . 75.4 m-85 -117.67 145.62 44.27 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.229 0.538 . . . . 0.0 112.303 -178.679 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.16 152.85 18.92 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 m -92.97 28.68 2.03 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -174.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 66.29 155.48 0.13 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-O 121.384 0.611 . . . . 0.0 111.511 -177.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.71 108.23 1.02 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.763 1.642 . . . . 0.0 111.53 176.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.17 -23.18 4.95 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.955 177.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.689 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.9 m-85 -102.5 172.48 6.84 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -154.81 -179.45 8.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -170.6 -179.95 3.09 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.95 8.16 27.61 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 -161.51 27.75 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.93 147.42 26.16 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.83 117.72 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.22 124.94 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.655 -176.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.417 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 88.9 mtp -112.39 172.29 7.0 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.37 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.9 p -155.56 148.3 12.27 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.227 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.83 129.27 34.94 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 55.8 ttp180 -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 64.68 19.27 11.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.043 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 -12.48 62.0 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.949 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.1 157.77 24.22 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.169 0.509 . . . . 0.0 111.736 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.1 m95 -91.99 116.21 28.73 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.489 178.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.44 172.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.496 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.68 108.54 19.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.088 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.2 tm? -61.15 -49.93 75.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 172.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -110.18 90.39 9.71 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.557 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.93 -17.91 15.11 Favored 'Trans proline' 0 N--CA 1.479 0.656 0 C-N-CA 122.478 2.119 . . . . 0.0 111.04 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.38 -27.62 60.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.442 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -92.18 131.66 37.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.745 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -140.02 163.36 32.9 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 71.5 m -92.91 110.53 21.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -105.33 162.7 13.21 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.369 -174.315 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HD3' ' CE2' ' A' ' 56' ' ' TYR . 33.8 mmtp -70.25 157.38 37.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -94.35 134.36 25.71 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.831 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 37.9 Cg_endo -71.62 136.76 28.88 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.288 1.992 . . . . 0.0 110.674 176.13 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.9 -1.79 39.2 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.059 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.78 -123.24 9.71 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.852 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -103.28 136.46 19.22 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.7 Cg_exo -69.29 75.22 1.03 Allowed 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.431 2.087 . . . . 0.0 113.602 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.32 -136.02 19.54 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.536 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.64 27.87 6.01 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.613 0.365 . . . . 0.0 110.233 -176.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -48.82 115.35 4.41 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.271 176.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.31 -53.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.688 2.259 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.16 154.5 49.47 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.37 -168.18 21.06 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -176.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 m -155.37 156.17 34.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 48.8 p90 -145.24 165.94 26.93 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.549 0.53 . . . . 0.0 111.216 -177.662 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 70.9 p -118.76 -178.02 3.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.921 -179.374 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.6 155.23 49.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 15.1 t -165.47 149.24 8.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.78 -0.79 88.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.949 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.03 -169.58 39.79 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.401 HD22 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -131.37 3.31 4.26 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-N 117.748 0.774 . . . . 0.0 112.808 -175.324 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.7 p -156.78 -160.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.068 -1.053 . . . . 0.0 108.698 -173.394 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 26.0 m-85 -90.87 77.28 6.21 Favored 'General case' 1 C--N 1.243 -4.034 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.771 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.485 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 15.8 pt-20 -136.48 152.28 50.38 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.201 -174.025 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -49.63 124.52 9.71 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.091 0.869 . . . . 0.0 110.165 173.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.25 -22.85 10.93 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.381 179.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.8 m -76.87 144.43 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.741 -179.023 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.508 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 22.2 ttmm -106.45 106.94 17.71 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -86.86 99.35 11.77 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -80.61 130.33 36.09 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.412 -177.983 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.88 108.92 21.72 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.912 0.863 . . . . 0.0 109.157 -172.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 m -100.95 -31.53 11.08 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.883 -172.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 33.6 m 65.74 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -166.36 -154.34 0.18 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.7 -60.47 2.34 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.442 -178.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.82 73.98 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.533 -177.293 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -115.02 128.41 56.25 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.513 0.197 . . . . 0.0 111.145 178.213 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.41 -134.21 0.33 Allowed 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 167.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -157.52 161.38 38.81 Favored 'General case' 1 N--CA 1.336 -6.158 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.247 . . . . . . . . 4 4 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 142' ' ' GLU . 4.1 mm? -88.58 125.04 34.61 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.331 0.586 . . . . 0.0 109.954 172.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.07 148.45 5.45 Favored Glycine 0 C--N 1.278 -2.688 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.44 -16.52 39.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.112 0.958 . . . . 0.0 109.484 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -109.93 106.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.3 p-10 -88.91 36.66 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.48 0.657 . . . . 0.0 111.758 -172.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.442 ' CD1' ' HG3' ' A' ' 109' ' ' LYS . 26.2 p90 -159.19 178.3 10.15 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.63 -177.659 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.464 ' NH2' HG23 ' A' ' 138' ' ' ILE . 6.3 ptp180 -148.98 124.31 10.24 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.615 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 17.7 mt-10 -96.76 157.22 16.0 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.35 107.1 18.35 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.557 175.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.29 -164.43 1.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.3 p -65.53 -42.96 91.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.974 0.91 . . . . 0.0 110.04 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.32 -46.28 73.94 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.253 177.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.28 -139.09 7.43 Favored Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.132 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.9 m95 -70.86 126.7 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 -176.226 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.9 p -80.37 170.24 16.65 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.607 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.4 m120 70.45 -81.22 0.03 OUTLIER 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.253 1.021 . . . . 0.0 111.857 173.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.1 t0 163.57 -161.62 0.0 OUTLIER 'General case' 0 C--O 1.242 0.661 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.464 HG23 ' NH2' ' A' ' 127' ' ' ARG . 4.0 mp -107.05 96.64 15.55 Favored Pre-proline 0 C--N 1.284 -2.277 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.2 Cg_endo -47.33 123.7 8.2 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.811 2.341 . . . . 0.0 109.737 173.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.2 mp -68.2 114.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.42 -174.697 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 14.0 t -59.67 112.86 1.97 Allowed 'General case' 0 C--O 1.254 1.336 0 O-C-N 123.794 0.683 . . . . 0.0 109.713 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.508 ' HB3' HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -173.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.129 0.49 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -70.4 138.96 51.73 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.04 0.936 . . . . 0.0 110.116 -174.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.04 24.93 6.32 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.787 0.804 . . . . 0.0 108.948 176.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.14 160.78 33.36 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.611 -178.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 37' ' ' TRP . 41.1 mt -83.94 152.92 63.25 Favored Pre-proline 0 C--N 1.313 -0.993 0 O-C-N 123.614 0.571 . . . . 0.0 110.325 176.429 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -54.01 142.84 64.03 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.909 2.406 . . . . 0.0 113.172 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.65 112.43 2.86 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.429 2.086 . . . . 0.0 111.896 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -76.35 151.05 36.77 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.638 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -121.05 -179.84 4.16 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -174.848 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -90.53 -20.17 22.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.153 0.501 . . . . 0.0 109.705 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 -10.34 17.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 177.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -134.74 137.56 43.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.263 0.554 . . . . 0.0 111.649 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.33 163.52 24.16 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.796 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.459 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -91.78 151.0 20.8 Favored 'General case' 0 C--N 1.266 -3.059 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.9 p -112.47 101.21 9.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.1 -171.43 32.09 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -108.34 115.18 29.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.532 ' HB3' HD22 ' A' ' 24' ' ' LEU . 53.9 m95 -132.7 107.38 8.35 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.215 0.531 . . . . 0.0 109.94 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 t -153.38 28.64 0.5 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 174.23 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.37 -161.49 0.76 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.413 -168.012 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.36 -67.09 0.41 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 82.3 p -94.62 128.76 41.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.172 -173.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.44 157.54 77.85 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.66 147.17 39.8 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.261 1.974 . . . . 0.0 111.834 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 22.1 tt0 -64.73 137.21 57.67 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.212 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.54 7.79 50.63 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.3 m -83.82 119.52 24.94 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.849 177.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.1 pt20 -87.56 146.41 25.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.31 0.576 . . . . 0.0 111.654 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.2 122.0 41.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.405 HG12 HD12 ' A' ' 63' ' ' ILE . 61.1 mt -94.36 129.84 44.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -104.04 153.6 20.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.493 1.139 . . . . 0.0 113.986 -178.489 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -103.65 118.35 36.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.872 172.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.5 m -69.73 12.31 0.21 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 123.98 0.912 . . . . 0.0 113.392 -178.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.5 mtp180 66.89 154.41 0.13 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.133 0.973 . . . . 0.0 109.158 -170.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 23.0 Cg_endo -61.87 -9.09 13.09 Favored 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 122.358 2.039 . . . . 0.0 115.091 -177.296 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.2 1.83 35.14 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.188 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 48.1 m-85 -123.49 173.28 8.13 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.349 -1.089 . . . . 0.0 111.475 -177.351 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.44 -172.57 4.17 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.888 0.875 . . . . 0.0 109.346 -175.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -174.08 162.49 3.8 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.47 -8.15 58.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.778 . . . . 0.0 109.861 177.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.33 -123.88 1.81 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.97 151.31 28.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.98 103.22 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.618 0.723 . . . . 0.0 109.114 177.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 HG12 ' A' ' 49' ' ' ILE . 48.5 mm -110.87 121.23 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.975 178.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.2 mtp -110.22 170.04 8.34 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 5.8 p -154.21 142.16 13.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.23 127.92 32.65 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.314 -178.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.5 ttp180 -150.5 125.83 10.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.524 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 44.1 mmtm 63.19 35.3 12.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.715 0.806 . . . . 0.0 112.525 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.36 53.55 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.001 176.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.62 163.97 12.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.806 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -104.9 114.15 28.18 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -179.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 p -123.24 -167.33 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.367 -4.599 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.012 -171.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.66 113.24 25.23 Favored 'General case' 1 C--N 1.224 -4.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 114.145 -168.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.4 -52.93 10.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 172.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -110.57 92.56 14.35 Favored Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.267 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.74 -1.04 11.22 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.401 2.067 . . . . 0.0 111.96 178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.72 -5.19 51.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.222 0.534 . . . . 0.0 109.925 178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -112.79 144.84 41.65 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.203 0.525 . . . . 0.0 111.001 -175.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -156.34 147.75 22.52 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 173.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -83.74 113.14 20.69 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.672 177.459 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -105.59 163.96 12.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.07 -177.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 96.8 mttt -64.05 143.45 57.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.261 0.553 . . . . 0.0 111.452 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -84.13 145.39 45.97 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 71.5 Cg_endo -74.48 157.67 44.76 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.539 1.493 . . . . 0.0 111.086 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.3 m -107.66 7.61 28.62 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 -176.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.51 -102.63 1.31 Allowed Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.611 178.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -152.65 130.96 6.3 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.89 37.22 0.4 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 123.069 2.513 . . . . 0.0 111.789 -177.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 79.92 -176.87 54.55 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -172.541 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -124.4 -171.32 2.31 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -172.29 126.77 0.55 Allowed Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.272 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.6 -22.72 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.976 1.784 . . . . 0.0 113.694 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -129.86 -5.35 4.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.89 171.77 20.22 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.782 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -136.25 160.65 38.06 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.5 p90 -144.69 149.98 36.56 Favored 'General case' 0 N--CA 1.418 -2.042 0 O-C-N 123.332 0.395 . . . . 0.0 111.211 174.281 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 61.5 p -101.45 175.67 5.49 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.423 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -140.67 131.33 25.63 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.0 t -127.26 9.06 6.66 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.577 0.703 . . . . 0.0 112.233 -171.123 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.32 34.24 2.21 Favored Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.339 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.24 175.15 13.66 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 106.379 -2.688 . . . . 0.0 106.379 -172.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -124.12 24.18 8.24 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 118.417 1.109 . . . . 0.0 108.773 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.8 m -143.09 -177.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.6 m-85 -89.96 85.38 6.33 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.039 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.39 144.25 51.27 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.144 -178.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 72.5 t80 -49.18 114.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.885 0.874 . . . . 0.0 111.385 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 127.33 -22.04 5.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.529 -179.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.74 139.09 19.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 122.053 0.93 . . . . 0.0 111.133 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.489 ' HB3' HG22 ' A' ' 99' ' ' THR . 33.8 ttmt -108.13 117.14 33.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 170.508 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -90.37 97.64 11.3 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.463 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -79.88 127.26 39.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.528 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.668 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 59.7 t80 -114.07 143.88 44.04 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 -171.547 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -151.54 160.55 43.63 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 75.6 m -149.15 126.49 11.49 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 66.77 178.3 0.22 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.23 -47.77 3.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.847 -178.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.02 74.27 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.191 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -141.28 -177.92 5.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.634 ' HB2' HD13 ' A' ' 120' ' ' LEU . 10.0 pt20 -153.79 -130.9 0.04 OUTLIER 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.191 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -99.26 163.88 12.36 Favored 'General case' 0 N--CA 1.386 -3.671 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.098 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 142' ' ' GLU . 3.8 mm? -88.87 142.44 27.65 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 166.801 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.94 154.88 10.13 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -83.8 -26.71 29.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.937 0.875 . . . . 0.0 109.72 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.95 111.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.89 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.96 26.43 3.21 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.488 1.115 . . . . 0.0 110.716 -178.027 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.516 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 7.3 p90 -153.49 -178.12 6.79 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.343 -172.801 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -139.52 121.89 16.05 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.356 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 24.9 mt-10 -99.5 141.12 32.71 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.363 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.93 115.94 23.86 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.532 177.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.9 172.16 7.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.627 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.1 p -52.08 -39.38 59.62 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 125.347 1.459 . . . . 0.0 112.197 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.25 -33.47 19.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.902 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.73 -162.23 33.85 Favored Glycine 0 C--O 1.212 -1.281 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 134.69 47.85 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.541 0.671 . . . . 0.0 111.443 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -68.43 -25.79 65.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.241 0.616 . . . . 0.0 111.375 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -130.15 168.19 17.19 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -176.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -107.46 -104.44 0.35 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.389 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.426 HD11 ' HA3' ' A' ' 89' ' ' GLY . 30.8 mt -127.5 96.74 32.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.178 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 4.7 Cg_endo -47.95 129.04 17.39 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.276 2.651 . . . . 0.0 111.64 178.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.2 mm -80.76 112.21 18.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.457 -173.235 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.668 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 57.4 m -79.24 114.13 17.93 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.785 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.662 ' HB3' HD23 ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.435 -1.19 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.356 0.598 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 138.4 58.41 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.404 -175.12 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' HA ' HG22 ' A' ' 41' ' ' THR . 5.3 m-20 -118.22 20.11 13.27 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.304 1.05 . . . . 0.0 108.772 175.333 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.84 153.6 39.36 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.624 179.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.3 mt -81.66 157.58 69.46 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.224 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 144.49 96.45 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 122.073 1.849 . . . . 0.0 111.31 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.6 178.99 5.68 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.046 1.831 . . . . 0.0 111.53 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -94.41 158.7 15.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 10.5 mmt85 -103.94 166.41 10.43 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.299 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -77.04 -62.15 1.75 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -95.77 13.69 25.72 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.193 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 28' ' ' ARG . 4.8 mp0 -135.66 161.83 34.42 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.5 mt -134.4 150.52 30.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 37' ' ' TRP . 35.2 mt -71.84 143.32 49.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.532 0.605 . . . . 0.0 110.226 174.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 p -87.44 -33.24 19.13 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.174 0.512 . . . . 0.0 112.067 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.92 168.4 18.09 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.865 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -87.93 138.2 31.66 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 175.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 33' ' ' LEU . 75.9 m95 -130.28 117.8 20.37 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.307 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 m -130.31 4.81 4.78 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.217 0.532 . . . . 0.0 110.874 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.78 -165.76 1.28 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.09 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -140.7 -40.67 0.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.052 175.466 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 22' ' ' ASN . 40.2 p -112.08 138.13 49.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.698 -178.199 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -139.55 154.88 71.83 Favored Pre-proline 0 C--N 1.303 -1.434 0 C-N-CA 123.874 0.87 . . . . 0.0 109.067 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.83 148.65 28.66 Favored 'Trans proline' 0 C--O 1.257 1.462 0 C-N-CA 121.756 1.638 . . . . 0.0 111.056 175.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -62.05 145.44 53.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.15 1.3 59.56 Favored Glycine 0 C--N 1.298 -1.545 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.226 -179.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.9 m -83.93 118.12 23.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.421 0.153 . . . . 0.0 111.12 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.4 pt20 -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-O 121.925 0.869 . . . . 0.0 111.731 -176.578 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 113.02 19.09 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.97 114.92 27.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.123 -177.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 45.0 m-85 -95.63 138.59 33.08 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.853 0.835 . . . . 0.0 112.353 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 85.7 tttt -80.41 139.04 36.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.401 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 12.2 t -84.57 10.29 11.42 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -170.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 73.0 ttt180 67.24 133.32 0.04 OUTLIER Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.705 174.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.72 104.39 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.441 2.761 . . . . 0.0 114.093 -176.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.71 -24.37 5.2 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.177 177.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.7 m-85 -95.77 173.17 7.6 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.363 -0.493 . . . . 0.0 110.559 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -136.85 161.45 35.96 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.59 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 99.9 p -136.36 173.21 11.95 Favored 'General case' 0 N--CA 1.382 -3.847 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.325 177.23 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -83.71 -4.89 58.99 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.965 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.74 45.41 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 176.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.55 131.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.352 1.061 . . . . 0.0 112.691 -177.347 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.7 t -76.07 111.52 12.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -105.77 114.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-O 121.513 0.673 . . . . 0.0 109.788 -178.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtp -103.5 172.59 6.72 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.612 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.9 p -160.74 150.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.87 128.19 33.57 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 40.3 ttp180 -153.72 127.42 8.76 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 67.64 19.92 9.71 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.52 -14.74 64.48 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.158 178.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.89 172.99 6.52 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.166 0.508 . . . . 0.0 110.007 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -110.5 112.53 24.51 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.11 -158.44 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.372 -4.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.954 -175.194 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.49 129.53 39.66 Favored 'General case' 1 C--N 1.231 -4.552 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.508 -170.697 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.1 tm? -89.47 -57.45 2.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 171.387 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 86.7 m-20 -112.29 95.05 29.18 Favored Pre-proline 0 N--CA 1.421 -1.911 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.163 178.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.71 -17.68 25.82 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.275 1.983 . . . . 0.0 111.382 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -79.14 -19.59 50.66 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.199 1.0 . . . . 0.0 110.834 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 29.6 mmt180 -81.11 129.7 34.68 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 174.064 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -145.21 152.73 40.45 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 16.9 m -104.95 114.81 29.23 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.189 0.995 . . . . 0.0 111.138 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -112.39 174.59 5.81 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.433 -178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -82.95 145.91 29.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.683 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.5 ptp180 -74.99 132.45 77.14 Favored Pre-proline 0 C--N 1.298 -1.648 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.214 178.053 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 47.2 Cg_endo -73.46 139.69 28.98 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 122.153 1.902 . . . . 0.0 110.115 176.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 m -89.49 -21.31 23.02 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.431 0.634 . . . . 0.0 109.761 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.61 -160.44 47.24 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.576 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.33 115.34 14.14 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 125.162 1.385 . . . . 0.0 110.653 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 138' ' ' ILE . 98.4 Cg_endo -78.76 -9.43 15.78 Favored 'Trans proline' 0 C--O 1.212 -0.794 0 C-N-CA 123.31 2.673 . . . . 0.0 113.151 -178.305 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 123.95 -155.65 17.93 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -145.05 157.9 43.98 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -150.11 125.99 5.04 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.78 -47.62 15.32 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.494 2.129 . . . . 0.0 111.445 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -109.82 140.04 44.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.46 -178.01 23.15 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.913 176.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 m -158.04 166.97 31.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -123.49 159.35 29.27 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.239 176.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.594 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.98 159.39 25.7 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.422 177.935 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.69 139.86 52.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.2 t -113.32 -18.86 11.95 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.28 21.44 Favored Glycine 0 CA--C 1.5 -0.853 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.587 -174.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.64 -175.79 32.63 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -178.396 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.7 15.09 18.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.147 0.975 . . . . 0.0 109.083 178.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.65 172.3 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -96.5 100.41 12.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.216 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' VAL . 14.7 pt-20 -147.14 160.63 42.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 -174.075 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.507 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 92.6 t80 -55.14 116.28 2.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.127 0.489 . . . . 0.0 110.439 175.065 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.98 -18.91 11.29 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 105' ' ' GLU . 1.4 p -91.08 167.64 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.4 ttmt -142.13 131.84 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -179.619 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.66 94.42 8.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.594 HG13 ' OG1' ' A' ' 97' ' ' THR . 3.7 p -93.49 114.71 30.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.883 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.65 144.09 26.51 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.387 1.089 . . . . 0.0 112.887 -173.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -134.81 150.83 50.56 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 103.479 -2.786 . . . . 0.0 103.479 174.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 118' ' ' TYR . 16.3 t -112.21 -80.92 0.59 Allowed 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.695 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 2.4 m-20 -137.7 -168.12 2.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.3 -43.17 70.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.264 0.554 . . . . 0.0 110.671 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.61 -1.91 46.69 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.81 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.721 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 91.2 m-85 -115.86 128.96 56.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 122.454 -0.439 . . . . 0.0 111.749 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 14.8 mm100 -139.2 -148.7 0.26 Allowed 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 170.695 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -111.66 169.88 8.52 Favored 'General case' 0 N--CA 1.382 -3.848 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.862 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 140' ' ' ILE . 3.5 mm? -66.21 -64.26 0.9 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.765 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.23 -154.42 16.77 Favored Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.072 -0.967 . . . . 0.0 114.764 -173.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.68 -13.78 22.54 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.392 0.677 . . . . 0.0 111.435 -177.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 139' ' ' PRO . 45.8 mm -94.43 94.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 CA-C-O 122.293 1.044 . . . . 0.0 110.56 -175.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -94.31 26.49 3.33 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.494 -177.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.09 174.64 7.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.866 0.841 . . . . 0.0 112.54 -171.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HG3' ' CE3' ' A' ' 134' ' ' TRP . 9.1 ptm180 -140.67 132.19 27.0 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 170.051 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -110.91 157.37 19.94 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -168.166 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 46.3 m -90.62 116.56 28.6 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.659 0.742 . . . . 0.0 112.384 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -110.97 179.17 4.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.2 p -57.36 -35.74 70.32 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.918 0.887 . . . . 0.0 110.527 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.9 -35.19 67.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.781 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 139.43 -127.61 3.7 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -174.062 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.512 ' CE3' ' HG3' ' A' ' 127' ' ' ARG . 91.4 m95 -82.66 127.47 33.42 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 118.173 0.987 . . . . 0.0 109.749 178.145 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.2 p -62.64 -60.79 3.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.066 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.38 -173.4 2.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 12.2 t70 -113.01 -166.75 1.11 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.589 HD11 ' HA3' ' A' ' 89' ' ' GLY . 71.5 mt -82.14 124.97 78.18 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 122.949 0.5 . . . . 0.0 110.916 -173.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 16.3 Cg_endo -58.13 147.91 80.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.553 2.835 . . . . 0.0 111.789 178.516 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 121' ' ' LEU . 37.1 mm -88.73 122.05 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.515 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 41.3 t -72.26 119.44 16.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.38 0.61 . . . . 0.0 111.079 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 121' ' ' LEU . 9.8 tp10 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.4 m -69.31 137.39 52.93 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.681 -1.145 . . . . 0.0 107.969 -177.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 41' ' ' THR . 74.7 m-20 -114.41 14.65 17.93 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.61 163.96 36.47 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.727 -175.165 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -98.0 159.06 31.74 Favored Pre-proline 0 N--CA 1.383 -3.825 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.721 -175.645 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.72 134.47 54.25 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 109.779 176.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.48 142.35 64.95 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.411 2.074 . . . . 0.0 113.439 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.97 134.61 35.39 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 171.092 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 31.8 mtp85 -118.99 179.52 4.13 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -169.457 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -78.51 -63.87 1.3 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.467 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 p -85.54 11.63 10.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.501 0.667 . . . . 0.0 112.44 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 4.0 mp0 -141.71 143.85 33.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.619 -176.155 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 51.9 mt -133.24 141.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 37' ' ' TRP . 51.2 mt -71.94 141.16 49.46 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.751 0.657 . . . . 0.0 110.348 177.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -71.29 -61.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 178.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.28 52.61 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.308 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -103.83 114.44 28.7 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CD1' HD13 ' A' ' 33' ' ' LEU . 27.1 m95 -101.77 92.27 4.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.116 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -99.59 -5.91 28.26 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.122 -177.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' HD21 ' A' ' 24' ' ' LEU . 6.0 m-20 -83.76 -163.1 0.72 Allowed 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -136.27 -54.74 0.75 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 45.3 p -90.98 129.02 37.03 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 121.528 0.68 . . . . 0.0 112.557 -176.038 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 40.5 m-85 -135.91 153.29 76.96 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 123.814 0.846 . . . . 0.0 109.382 179.083 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.46 149.48 87.84 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.176 1.918 . . . . 0.0 112.441 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 tt0 -69.73 135.59 49.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.7 7.66 50.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.038 -178.03 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -85.03 123.98 31.19 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.712 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 27.0 pt20 -92.22 147.82 22.63 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.019 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.73 134.23 55.3 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.38 132.29 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 82.7 m-85 -109.57 136.34 49.11 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.469 175.406 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 53' ' ' ARG . 36.1 mtpt -65.93 -26.81 67.76 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.211 1.004 . . . . 0.0 111.618 -176.114 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.659 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 19.2 m 71.33 8.74 6.41 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.472 -171.309 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 50.3 mtt180 66.57 170.2 0.1 Allowed Pre-proline 0 N--CA 1.494 1.752 0 CA-C-O 121.388 0.613 . . . . 0.0 111.198 -178.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.79 133.84 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 166.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.39 -17.11 34.36 Favored Glycine 0 C--N 1.302 -1.309 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.799 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 80.8 m-85 -118.85 161.94 19.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.176 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -149.23 -174.87 4.77 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 p -174.65 175.89 2.39 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.45 -8.94 58.79 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.78 48.09 0.1 OUTLIER Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 50.8 m-80 62.22 -172.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.657 0.783 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 53.7 t -110.86 116.13 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.8 114.39 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.766 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.5 mtp -105.75 167.32 9.85 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -151.39 146.39 15.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.2 t -84.75 132.23 34.46 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.768 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 51.2 ttp180 -154.27 120.75 5.44 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 42.2 mmtm 65.88 38.22 5.15 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.197 0.999 . . . . 0.0 112.198 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.26 -16.16 24.73 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 114.962 -1.017 . . . . 0.0 114.084 176.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -110.38 154.97 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.399 0.6 . . . . 0.0 111.107 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.439 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 78.6 m95 -95.1 121.0 36.29 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.224 0.535 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.93 174.53 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.527 -176.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.18 125.25 30.04 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.29 -59.13 3.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -109.74 105.99 57.83 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.523 177.042 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.94 -14.14 40.37 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 123.428 2.752 . . . . 0.0 111.945 -178.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.44 -11.58 58.43 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.498 1.142 . . . . 0.0 109.876 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 42.0 mmt-85 -90.85 114.28 26.66 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.156 176.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.51 148.05 27.57 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.614 -177.252 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -86.24 108.97 18.61 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.567 -178.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -101.19 157.5 16.73 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.635 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 86.5 mttt -75.5 138.89 41.87 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.223 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HD3' ' O ' ' A' ' 131' ' ' THR . 17.1 ptm180 -76.02 151.29 83.98 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.565 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 156.31 62.69 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.079 1.853 . . . . 0.0 111.796 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.3 m -114.3 5.53 15.8 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.651 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.36 -92.39 0.33 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.374 174.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -152.43 124.36 3.84 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -173.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HE ' ' A' ' 127' ' ' ARG . 89.9 Cg_endo -80.13 40.45 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 123.542 2.828 . . . . 0.0 112.865 -178.054 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 82.91 -179.43 52.99 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -177.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -103.72 162.63 12.92 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -161.45 109.76 1.22 Allowed Pre-proline 0 N--CA 1.42 -1.945 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.551 175.479 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.26 -50.72 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.905 1.737 . . . . 0.0 111.821 177.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -100.11 14.96 28.93 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -133.77 171.37 22.05 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.015 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 m -146.39 167.34 23.85 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 42.4 p90 -142.29 163.47 32.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.683 0.277 . . . . 0.0 111.038 -178.578 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 65.5 p -107.71 161.89 14.47 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.72 128.31 38.66 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.251 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.0 t -112.99 14.88 19.74 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.84 28.17 2.75 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.01 176.4 14.39 Favored Glycine 0 N--CA 1.411 -3.009 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 -173.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -112.25 32.5 5.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.12 165.69 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.184 -174.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -96.42 95.25 7.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 110.244 -177.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.98 155.65 49.94 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.567 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.546 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 52.2 t80 -50.9 124.47 11.3 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.072 0.857 . . . . 0.0 109.766 176.41 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.55 26.28 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.29 -1.433 . . . . 0.0 114.175 177.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.4 134.25 28.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 119.403 1.602 . . . . 0.0 109.498 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -97.83 117.19 31.59 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.02 104.71 16.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.531 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.512 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.1 m -87.65 130.32 37.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HG2' ' A' ' 139' ' ' PRO . 68.3 t80 -121.18 137.86 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.566 0.698 . . . . 0.0 112.051 -168.446 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.7 m -152.1 165.16 35.6 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.462 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.0 m -130.75 120.97 24.59 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.851 0.296 . . . . 0.0 110.529 -177.306 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 55.79 -155.64 0.28 Allowed 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.6 0.562 . . . . 0.0 110.317 178.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.5 -43.63 8.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.122 0.486 . . . . 0.0 110.835 177.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.39 11.72 68.54 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -173.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 70.0 m-85 -120.77 140.43 51.7 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.388 1.094 . . . . 0.0 111.9 177.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 42.5 mt-30 -133.96 -170.19 2.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 167.461 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -98.56 155.41 17.3 Favored 'General case' 2 N--CA 1.356 -5.143 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -175.716 . . . . . . . . 4 4 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.63 -31.99 57.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.302 -179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.16 174.6 53.19 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.202 177.124 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.65 -37.94 17.54 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.991 0.901 . . . . 0.0 109.592 -178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.1 mm -82.99 103.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.076 -175.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.418 ' HB3' HD21 ' A' ' 120' ' ' LEU . 4.6 p-10 -87.71 25.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.428 -176.387 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -159.15 173.87 15.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.089 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' A' ' 88' ' ' PRO . 29.2 ptt-85 -148.84 118.02 6.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.846 174.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.25 146.25 23.98 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.876 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . 43.5 t -91.24 124.45 35.46 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.515 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.7 t70 -105.38 -164.84 1.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 28.6 p -54.06 -58.64 6.58 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 125.857 1.663 . . . . 0.0 112.761 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.22 -40.11 52.95 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 172.52 -155.45 23.28 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.525 -176.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 70.0 m95 -69.9 132.49 46.07 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 48.5 p -77.29 142.04 39.65 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 72.17 -168.79 0.14 Allowed 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.015 0.822 . . . . 0.0 109.245 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.91 -164.35 1.3 Allowed 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.416 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt -86.28 107.97 15.56 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 7.1 Cg_endo -48.41 122.53 7.83 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.55 2.834 . . . . 0.0 112.196 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.0 mp -73.23 115.09 13.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.017 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 80.3 m -81.43 115.02 20.57 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.006 0.431 . . . . 0.0 111.437 179.178 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 140' ' ' ILE . 65.9 mm-40 . . . . . 0 C--N 1.303 -1.455 0 C-N-CA 124.327 1.051 . . . . 0.0 108.498 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -65.12 137.78 57.87 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.208 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.428 ' HA ' HG22 ' A' ' 41' ' ' THR . 3.3 m-80 -124.0 24.7 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.115 0.959 . . . . 0.0 109.184 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.1 150.79 24.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.666 -1.607 . . . . 0.0 107.823 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.01 152.55 84.47 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 123.66 0.6 . . . . 0.0 109.916 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.21 147.5 91.2 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.022 1.814 . . . . 0.0 110.347 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.95 165.57 19.51 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 113.447 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -110.35 150.11 29.25 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 16.1 mtp180 -123.07 178.93 4.86 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.684 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.63 -58.69 3.13 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.77 0.428 . . . . 0.0 110.094 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -90.23 -11.85 39.75 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -123.11 150.94 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.569 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' A' ' 53' ' ' ARG . 33.1 mt -131.1 148.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 mt -74.01 129.95 38.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 117.918 0.326 . . . . 0.0 111.487 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 19.9 p -121.34 104.39 9.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.525 0.679 . . . . 0.0 110.342 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.27 173.03 22.09 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -93.82 119.34 32.64 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 117.263 0.532 . . . . 0.0 110.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -126.9 121.68 32.47 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 t -149.86 13.27 0.8 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.934 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.95 152.65 49.17 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 121.508 -0.745 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.05 -30.49 62.43 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.751 0.31 . . . . 0.0 110.917 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.1 p -114.41 118.13 32.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.576 0.703 . . . . 0.0 112.714 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -119.97 153.15 54.96 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.099 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.92 140.07 44.9 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.175 1.917 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -61.74 136.54 58.03 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.25 -0.34 40.69 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.221 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -82.29 119.25 23.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.97 144.17 25.73 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.804 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.28 123.9 51.28 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.122 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.99 121.44 45.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.527 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 53.2 m-85 -99.73 145.72 27.34 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.985 0.897 . . . . 0.0 113.334 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 50.1 tptt -85.2 128.19 34.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.322 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.8 m -82.58 107.3 15.12 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 165.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HG2' HD11 ' A' ' 32' ' ' ILE . 76.1 mtp180 -40.11 153.98 0.2 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.086 1.354 . . . . 0.0 113.598 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.69 114.02 2.22 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.698 1.598 . . . . 0.0 108.898 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 114.03 -8.38 23.27 Favored Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.06 168.76 13.54 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -162.22 -179.27 6.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.0 p -139.63 -77.64 0.33 Allowed 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 58' ' ' SER . 24.8 mt -176.32 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 126.612 1.965 . . . . 0.0 106.203 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.25 -108.11 1.18 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.85 158.04 44.27 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.0 t -86.54 109.89 19.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.39 121.24 54.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.194 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.2 mtp -111.18 166.36 11.14 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -152.86 146.71 14.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.0 t -81.23 126.61 31.74 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 2.5 tpm_? -148.73 128.76 13.55 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 34.7 mmtp 67.77 12.16 8.71 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.42 -9.4 57.42 Favored Glycine 0 CA--C 1.495 -1.184 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.848 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -115.56 163.62 15.51 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.15 116.21 28.94 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 m -115.2 167.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.471 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.37 110.06 20.9 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.53 -45.89 92.17 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -115.71 91.06 28.71 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.147 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.99 -15.67 26.01 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.815 2.343 . . . . 0.0 111.661 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.19 -20.49 48.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.097 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.723 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -161.86 156.09 22.13 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 59.3 m -92.99 118.69 31.45 Favored 'General case' 0 C--N 1.27 -2.877 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -113.05 -179.48 3.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.0 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.4 mmtp -59.45 147.54 36.16 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.82 0.7 . . . . 0.0 111.565 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 131' ' ' THR . 10.9 ptp180 -98.17 143.13 25.73 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 55.2 Cg_endo -71.81 148.21 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.518 2.145 . . . . 0.0 111.533 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.06 -19.37 15.2 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.677 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.92 -163.55 52.48 Favored Glycine 0 CA--C 1.467 -2.958 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.793 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -73.21 129.47 86.04 Favored Pre-proline 0 C--N 1.261 -3.263 0 CA-C-N 114.427 -0.887 . . . . 0.0 112.539 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 84.4 Cg_endo -84.85 -3.36 9.78 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 C-N-CA 123.054 2.503 . . . . 0.0 111.748 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 114.35 3.85 Favored Glycine 1 N--CA 1.395 -4.043 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -99.91 175.38 5.79 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.025 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.459 HG21 ' OH ' ' A' ' 112' ' ' TYR . 5.4 t -151.22 145.19 17.77 Favored Pre-proline 0 N--CA 1.416 -2.167 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.24 -23.75 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.039 1.826 . . . . 0.0 111.331 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -127.56 105.14 8.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.84 168.04 11.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -142.08 169.44 17.59 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.7 155.75 38.95 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 p -128.95 141.0 51.41 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -98.21 129.02 44.97 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.566 0.698 . . . . 0.0 110.664 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.552 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.1 t -114.92 130.28 56.88 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.94 -16.06 33.41 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.36 -176.78 48.0 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -121.97 18.45 10.91 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.683 0.754 . . . . 0.0 109.519 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG11 ' A' ' 108' ' ' VAL . 30.0 m -140.21 169.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 30.3 m-85 -93.28 89.19 6.29 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.535 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.5 pt-20 -133.31 158.12 43.76 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.921 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 77.4 t80 -48.76 115.24 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.417 1.087 . . . . 0.0 110.969 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.08 -21.74 10.06 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.753 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 103' ' ' VAL . 11.4 m -79.27 149.97 5.28 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.8 ttmp? -113.63 124.55 52.59 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.02 90.85 8.05 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.8 114.91 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.459 ' OH ' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -79.94 138.46 37.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.7 167.55 16.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 118' ' ' TYR . 12.3 t -146.79 173.82 12.04 Favored 'General case' 0 N--CA 1.396 -3.172 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.278 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.09 155.33 20.69 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.881 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -50.78 -41.16 56.7 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.066 0.946 . . . . 0.0 112.205 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.96 64.88 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HB2' ' SG ' ' A' ' 114' ' ' CYS . 34.8 m-85 -136.59 167.02 22.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 119.094 1.447 . . . . 0.0 111.159 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.52 -93.97 0.51 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 168.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.1 pp 175.74 158.01 0.23 Allowed 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.58 0.752 . . . . 0.0 111.499 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 96.1 mt -96.91 135.69 38.53 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 122.16 168.18 13.22 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -96.88 -28.99 13.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.4 mm -100.03 105.15 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.267 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -89.37 36.18 0.83 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.886 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 127' ' ' ARG . 23.0 p90 -165.21 174.1 10.61 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.184 0.516 . . . . 0.0 111.114 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.471 ' HD3' ' C ' ' A' ' 126' ' ' TYR . 1.4 mpp_? -139.46 132.36 29.3 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -113.01 147.81 36.39 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 118.437 0.562 . . . . 0.0 111.182 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 11.6 m -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.157 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -101.4 -166.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.499 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 28.7 p -59.5 -46.17 89.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 124.939 1.296 . . . . 0.0 112.728 -174.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.74 21.93 15.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 132.02 -155.5 21.49 Favored Glycine 0 C--N 1.288 -2.115 0 C-N-CA 119.394 -1.384 . . . . 0.0 113.624 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.6 m95 -81.49 146.15 30.36 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.225 0.536 . . . . 0.0 111.355 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.5 p -78.65 -25.21 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.884 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.79 -179.62 5.76 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -171.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -107.98 -155.59 0.56 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.689 0.796 . . . . 0.0 110.585 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.25 107.75 34.42 Favored Pre-proline 0 C--N 1.313 -0.984 0 O-C-N 122.039 -0.413 . . . . 0.0 110.344 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 22.7 Cg_endo -66.89 133.61 31.89 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.486 2.124 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.1 mm -86.83 123.9 40.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.648 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.91 105.97 1.44 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 29.8 mm-40 . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 124.597 1.159 . . . . 0.0 108.097 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.6 m -80.67 121.95 26.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.418 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.422 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -97.59 33.56 2.02 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.843 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 10.8 pt-20 -155.6 148.78 24.64 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.908 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.2 mt -73.27 153.12 90.33 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 123.794 0.838 . . . . 0.0 109.56 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.8 Cg_endo -62.58 130.09 28.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.693 1.595 . . . . 0.0 109.39 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 2.9 Cg_exo -72.87 126.91 11.72 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.65 1.567 . . . . 0.0 112.542 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.91 136.08 57.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 168.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 HH21 ' CD ' ' A' ' 31' ' ' GLU . 12.9 mtm180 -111.03 163.16 14.13 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -171.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.25 -33.82 67.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.53 0.681 . . . . 0.0 112.357 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 56' ' ' TYR . 3.0 p -111.93 -0.33 15.83 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.663 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 58.8 mp0 -139.7 142.27 36.9 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 53' ' ' ARG . 34.7 mt -123.2 152.75 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -77.91 136.21 37.99 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.089 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 51' ' ' LYS . 2.6 p -120.68 105.9 11.21 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.618 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.62 -159.97 28.99 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -125.59 110.85 14.32 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HB3' HD22 ' A' ' 24' ' ' LEU . 73.8 m95 -110.72 112.27 24.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -116.12 -11.13 11.41 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.303 -171.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -128.99 152.94 48.05 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 118.749 -1.181 . . . . 0.0 112.437 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.587 ' NE2' ' HA ' ' A' ' 23' ' ' GLU . 54.6 tp60 -76.08 -23.69 55.0 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.4 p -116.36 122.77 45.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.512 0.672 . . . . 0.0 112.422 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.73 136.81 29.29 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.343 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 151.85 79.96 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.589 2.193 . . . . 0.0 112.043 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.3 tt0 -62.5 140.05 58.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.28 8.46 58.73 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.327 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.7 m -91.63 115.97 28.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.845 -0.178 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.6 pt20 -85.56 144.18 28.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.564 0.697 . . . . 0.0 111.197 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.12 117.37 31.03 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.354 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.81 121.62 41.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 68.5 m-85 -104.96 152.5 22.61 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB2' HG23 ' A' ' 34' ' ' THR . 65.1 tttm -109.89 136.3 49.41 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.569 -1.651 . . . . 0.0 107.144 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.6 m -78.49 17.64 0.65 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HG2' HD11 ' A' ' 32' ' ' ILE . 77.6 mtp180 65.24 159.42 0.13 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.458 0.647 . . . . 0.0 109.689 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.11 -8.01 18.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.568 1.512 . . . . 0.0 114.157 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.67 -5.42 20.62 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.047 -1.073 . . . . 0.0 115.223 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.8 m-85 -114.21 173.2 6.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.037 . . . . 0.0 109.182 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.0 179.13 6.68 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -165.12 -176.7 4.23 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -112.25 2.79 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.482 0.658 . . . . 0.0 109.749 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.75 155.13 14.85 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.94 135.76 57.48 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.018 0.481 . . . . 0.0 110.864 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.8 t -79.3 111.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -110.27 122.92 65.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.344 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.9 mtp -108.03 172.44 6.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.3 p -156.35 147.04 11.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.064 0.459 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.0 128.31 35.09 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.628 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.9 ttp180 -150.07 120.72 7.5 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm 57.97 21.62 7.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.68 -17.87 55.89 Favored Glycine 0 N--CA 1.415 -2.704 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.44 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 72' ' ' VAL . 16.3 pt-20 -103.83 154.86 19.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.128 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -93.18 121.46 34.56 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 70' ' ' GLU . 34.0 m -123.42 170.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.506 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.56 119.99 29.52 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 120.713 0.292 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.5 -50.14 66.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -112.23 87.99 9.91 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.183 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.83 -7.76 18.63 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.176 2.584 . . . . 0.0 111.289 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.82 -11.99 57.81 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -112.84 140.32 47.73 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.326 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.76 152.33 25.0 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 64.1 m -91.83 112.87 24.97 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.762 0.791 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -104.4 167.56 9.67 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.265 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.04 147.37 53.28 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -88.9 135.59 31.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.138 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.62 143.36 33.94 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.287 1.991 . . . . 0.0 110.074 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m -93.54 -20.4 20.28 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.612 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 -178.9 52.32 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -70.73 130.3 88.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 36.2 Cg_endo -69.86 91.34 0.52 Allowed 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.163 1.909 . . . . 0.0 111.227 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.38 -153.23 46.02 Favored Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.036 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.36 16.11 4.08 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -38.06 105.25 0.32 Allowed Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 126.133 1.773 . . . . 0.0 114.441 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -84.01 -24.22 2.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.369 2.046 . . . . 0.0 109.431 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -112.95 86.68 2.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.08 156.66 7.15 Favored Glycine 0 N--CA 1.411 -2.967 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 m -149.36 167.82 25.07 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.8 p90 -153.63 155.36 35.93 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.144 0.429 . . . . 0.0 110.725 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 p -121.13 143.82 48.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.16 136.16 40.48 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.8 t -114.39 2.08 14.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.454 0.645 . . . . 0.0 111.761 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.3 38.1 2.02 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.78 -172.58 19.49 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -120.72 20.43 11.71 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.839 0.828 . . . . 0.0 109.375 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.76 156.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.259 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.07 89.01 7.85 Favored 'General case' 0 C--N 1.244 -3.999 0 CA-C-N 112.638 -2.074 . . . . 0.0 109.949 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.05 150.41 41.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.033 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.501 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 55.1 t80 -47.96 112.78 0.61 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.431 0.634 . . . . 0.0 111.633 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.46 -19.99 7.96 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.754 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.31 141.82 13.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 117.468 0.634 . . . . 0.0 110.393 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.616 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.5 ttmp? -108.35 134.29 51.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.12 106.3 17.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 59.3 t -86.57 115.69 27.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 88' ' ' PRO . 18.8 m-85 -88.22 147.71 24.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.7 1.238 . . . . 0.0 112.998 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.9 m -155.55 177.64 11.15 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.5 t -140.38 -65.48 0.45 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 120.681 1.582 . . . . 0.0 110.051 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -146.29 -164.61 2.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.95 -43.83 17.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.479 0.656 . . . . 0.0 109.932 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.1 -11.63 61.13 Favored Glycine 0 C--N 1.305 -1.156 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.176 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 88.3 m-85 -123.11 129.33 51.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 65.7 mt-30 -122.85 -86.44 0.65 Allowed 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.616 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.6 pp -175.0 156.46 2.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 123.704 0.627 . . . . 0.0 112.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.37 156.18 16.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.68 179.02 24.69 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.523 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.01 -29.55 12.48 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.605 0.717 . . . . 0.0 109.508 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.427 HG13 ' ND2' ' A' ' 136' ' ' ASN . 47.4 mm -94.97 107.97 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.077 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -97.21 30.49 2.77 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.116 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.466 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 39.3 p90 -161.16 172.45 16.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.251 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -141.49 136.64 31.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 34.6 mt-10 -111.78 142.2 44.43 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.832 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 133' ' ' GLY . 11.8 m -74.52 89.51 2.18 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.492 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -99.4 -161.09 0.85 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.427 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 41.7 p -61.66 -36.01 79.59 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.49 -46.59 89.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.98 0.895 . . . . 0.0 110.242 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 129' ' ' CYS . . . 136.44 -54.82 0.72 Allowed Glycine 0 N--CA 1.407 -3.285 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -139.37 130.88 27.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 110.787 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 55.4 p -77.79 164.5 25.16 Favored 'General case' 0 C--O 1.264 1.836 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.427 ' ND2' HG13 ' A' ' 124' ' ' ILE . 17.8 m120 61.11 -149.67 0.41 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -140.39 -174.33 3.92 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.8 mt -79.53 115.79 55.94 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 118.42 0.554 . . . . 0.0 109.617 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.95 136.52 66.25 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.945 1.764 . . . . 0.0 110.842 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -77.27 113.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.775 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 20.0 t -57.48 114.92 2.44 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.706 0.629 . . . . 0.0 109.452 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 7.0 tp10 . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.574 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.9 m-20 . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -77.65 129.68 35.88 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.202 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.64 17.68 19.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.354 0.597 . . . . 0.0 110.252 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.27 153.51 39.85 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 37' ' ' TRP . 2.7 mm? -83.63 157.18 64.61 Favored Pre-proline 1 N--CA 1.349 -5.49 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.46 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 17.7 Cg_endo -58.09 144.62 94.64 Favored 'Trans proline' 0 C--O 1.258 1.481 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.97 152.9 78.84 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.345 2.03 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -88.22 156.58 19.14 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -117.59 152.41 35.2 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.813 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -77.96 -30.26 50.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.817 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -107.76 -12.37 15.23 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 9.2 mp0 -123.17 174.04 7.51 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.107 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.6 144.61 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 37' ' ' TRP . 43.5 mt -70.44 132.84 46.19 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 p -74.1 -56.81 4.47 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.672 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.63 169.36 54.93 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -99.75 125.08 45.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.768 ' HB3' HD12 ' A' ' 24' ' ' LEU . 11.0 m95 -116.17 95.04 4.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 m -108.68 11.42 26.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.358 0.599 . . . . 0.0 110.947 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.665 ' O ' HD21 ' A' ' 24' ' ' LEU . 10.2 t70 -103.97 -157.74 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.52 ' HA ' HD21 ' A' ' 24' ' ' LEU . 25.0 mt-30 -129.5 -47.38 1.18 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 33.0 p -96.7 123.81 40.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.077 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.95 138.0 32.22 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.526 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 23.7 Cg_endo -62.3 145.2 96.03 Favored 'Trans proline' 0 C--O 1.259 1.542 0 C-N-CA 123.07 2.513 . . . . 0.0 113.146 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -63.74 128.74 37.17 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.24 9.18 32.21 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -92.56 118.11 30.66 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.593 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -88.36 143.21 27.15 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 121.341 0.591 . . . . 0.0 111.108 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.2 121.28 44.82 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -93.58 127.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.554 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 76.2 m-85 -104.28 131.86 51.16 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.751 0.786 . . . . 0.0 112.057 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -87.88 131.4 34.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.026 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.3 m -71.57 5.51 2.37 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 68.35 144.23 0.1 OUTLIER Pre-proline 0 N--CA 1.486 1.365 0 CA-C-O 121.624 0.726 . . . . 0.0 112.416 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.17 110.2 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.941 1.761 . . . . 0.0 109.864 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.27 -12.99 6.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.732 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 55.1 m-85 -125.53 175.21 7.69 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -166.85 179.23 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -163.92 175.75 10.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -83.28 -11.76 57.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.518 0.675 . . . . 0.0 109.788 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.2 145.27 10.03 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.75 148.83 41.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.003 0.402 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 76.6 t -71.52 114.26 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.23 125.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -114.26 168.24 10.01 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -151.56 144.11 16.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.4 t -74.1 118.38 16.99 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.197 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.579 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.1 ttp180 -150.08 122.56 8.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 41.7 mmtm 66.61 27.41 9.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.488 0.715 . . . . 0.0 112.382 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.59 -14.45 62.82 Favored Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.824 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.88 153.26 28.19 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.557 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.4 m95 -85.82 115.05 23.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 168.25 4.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.953 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.74 106.32 18.38 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.674 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.69 -42.74 89.27 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 7.7 t-20 -130.92 99.05 18.46 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.955 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.03 -9.07 19.26 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.224 2.616 . . . . 0.0 112.195 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -83.74 -18.15 38.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.872 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.587 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 3.2 mmp_? -88.43 138.77 31.14 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.392 1.092 . . . . 0.0 113.471 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -149.3 151.66 34.55 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 100.0 m -95.62 116.3 28.65 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.24 1.019 . . . . 0.0 109.702 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 160.95 14.13 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.407 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.1 mmtp -56.96 140.78 47.69 Favored 'General case' 0 CA--C 1.491 -1.313 0 O-C-N 123.721 0.638 . . . . 0.0 109.762 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.0 ptm180 -76.62 144.38 73.41 Favored Pre-proline 0 C--N 1.284 -2.259 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.17 150.28 42.23 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 121.513 1.476 . . . . 0.0 108.823 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.8 m -107.54 -9.76 15.85 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.941 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.79 -151.28 47.48 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.552 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -93.74 120.18 66.32 Favored Pre-proline 0 C--N 1.269 -2.931 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.67 71.63 1.46 Allowed 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 123.345 2.696 . . . . 0.0 111.609 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 65.16 -161.14 41.83 Favored Glycine 0 N--CA 1.42 -2.41 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 119.93 13.11 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.244 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 t -122.55 105.44 35.95 Favored Pre-proline 0 N--CA 1.426 -1.639 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.14 8.52 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.956 1.771 . . . . 0.0 113.124 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -140.25 17.16 2.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.663 0.268 . . . . 0.0 111.438 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . -136.15 165.48 24.91 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.701 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 113' ' ' THR . 3.0 m -130.97 164.78 24.6 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -158.77 161.46 36.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -124.72 143.14 50.92 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.54 135.47 39.34 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 109' ' ' LYS . 7.4 t -124.85 17.87 8.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.467 0.651 . . . . 0.0 111.45 -173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.438 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -140.46 23.72 2.67 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.216 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.32 -178.87 20.0 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.62 11.69 26.43 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.426 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.3 p -140.1 -172.5 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.845 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.399 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.28 79.91 1.65 Allowed 'General case' 1 C--N 1.237 -4.3 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.689 -175.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.1 pt-20 -130.68 155.27 46.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.69 116.49 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.977 0.798 . . . . 0.0 110.816 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.75 -19.84 6.53 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.343 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.438 HG12 ' C ' ' A' ' 100' ' ' GLY . 12.6 m -83.27 140.64 15.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.7 ttmt -103.79 125.3 50.14 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 172.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.53 93.95 9.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.26 119.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.427 ' OH ' ' HA3' ' A' ' 94' ' ' GLY . 30.4 t80 -99.09 124.34 44.03 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.337 0.589 . . . . 0.0 110.812 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 95' ' ' THR . 1.2 m -162.97 148.5 11.91 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 59.5 m -113.98 -64.34 1.32 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.168 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -140.4 -168.92 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.76 -46.5 24.98 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.21 64.75 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 142' ' ' GLU . 89.7 m-85 -108.32 112.66 25.22 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 117.01 0.405 . . . . 0.0 110.743 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -119.24 -84.0 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.8 pp 172.52 157.82 0.1 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.861 0.864 . . . . 0.0 111.335 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.67 145.33 26.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.31 178.32 15.27 Favored Glycine 0 C--N 1.282 -2.444 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.395 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.07 -34.65 9.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' TYR . 37.3 mm -98.47 102.37 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.476 ' HB2' HD21 ' A' ' 120' ' ' LEU . 4.2 p-10 -89.9 28.15 1.42 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.49 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 124' ' ' ILE . 37.5 p90 -162.13 172.78 15.28 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -151.35 120.72 6.84 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.009 0.818 . . . . 0.0 109.263 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.6 150.32 20.47 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.634 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.63 128.2 34.98 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.6 t70 -113.11 -164.48 0.92 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.466 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.0 p -70.1 -40.26 75.04 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.539 1.136 . . . . 0.0 113.356 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.15 -32.54 12.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 122.031 -0.418 . . . . 0.0 111.348 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.1 -162.26 26.68 Favored Glycine 0 C--N 1.288 -2.113 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.967 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -76.73 149.5 36.34 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.321 0.581 . . . . 0.0 110.138 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -87.42 136.74 32.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 70.54 -176.23 0.2 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.02 0.528 . . . . 0.0 111.186 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -113.85 -164.85 0.95 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.757 HD11 ' HA3' ' A' ' 89' ' ' GLY . 46.6 mt -92.29 109.81 40.42 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 118.537 0.608 . . . . 0.0 109.427 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 14.6 Cg_endo -59.42 132.83 48.45 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.975 1.783 . . . . 0.0 109.993 175.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.6 mp -74.64 110.23 8.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.193 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 53.1 t -56.48 121.97 10.87 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.188 0.93 . . . . 0.0 110.244 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 13.5 tp10 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.439 -0.997 0 CA-C-O 121.729 0.776 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.7 m -83.45 127.96 34.12 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER -102.94 20.58 17.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.827 0.822 . . . . 0.0 109.561 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.3 155.25 42.51 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.067 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 37' ' ' TRP . 34.2 mt -78.38 157.24 78.01 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 123.352 0.661 . . . . 0.0 111.514 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.0 Cg_endo -64.85 127.48 18.73 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.6 2.2 . . . . 0.0 110.771 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.6 Cg_exo -73.02 122.3 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.903 1.735 . . . . 0.0 110.299 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.39 158.43 35.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.617 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 15.0 mtp180 -113.74 167.52 10.55 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -69.46 -38.61 77.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.6 p -106.58 -0.01 24.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 46.1 mp0 -135.39 135.54 40.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.743 0.782 . . . . 0.0 111.979 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mt -125.2 143.31 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -64.09 149.68 47.11 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.556 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.8 p -105.5 111.07 23.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -171.77 16.96 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.964 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 t -104.2 136.58 43.54 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.569 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 76.7 m95 -139.82 106.01 5.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 m -135.25 16.15 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.593 0.711 . . . . 0.0 109.234 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.5 -167.3 1.42 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.725 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.3 -65.19 0.78 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.015 0.436 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -86.75 119.66 27.22 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -123.64 136.63 27.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.829 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.67 144.97 85.89 Favored 'Trans proline' 0 C--O 1.258 1.495 0 C-N-CA 122.534 2.156 . . . . 0.0 110.845 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.1 tt0 -61.21 137.68 58.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.22 51.9 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.463 ' C ' HG23 ' A' ' 65' ' ' VAL . 66.9 m -88.6 114.78 25.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.718 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -92.83 139.12 30.88 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.101 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.46 121.63 45.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.18 130.21 43.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 72.9 m-85 -114.49 149.78 35.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 111.651 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -101.52 147.73 26.04 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.5 m -85.97 15.7 4.77 Favored 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 123.577 0.751 . . . . 0.0 112.589 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 58.9 mtp180 69.83 158.61 0.16 Allowed Pre-proline 0 C--O 1.248 1.006 0 C-N-CA 123.225 0.61 . . . . 0.0 109.36 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.0 125.81 11.28 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 109.223 -1.106 . . . . 0.0 109.223 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 110.24 -11.92 31.24 Favored Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.031 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 84.3 m-85 -117.28 168.53 10.24 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.765 -0.844 . . . . 0.0 109.813 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.93 -176.95 5.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 p -154.07 156.75 37.88 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.81 -4.1 58.39 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.198 0.999 . . . . 0.0 110.457 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.45 -119.96 1.73 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -159.96 148.29 17.12 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.29 97.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.983 0.897 . . . . 0.0 109.161 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.93 121.84 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.726 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.4 mtp -107.58 172.53 6.78 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 46' ' ' THR . 11.4 p -159.13 145.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.379 0.609 . . . . 0.0 111.003 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.6 t -70.78 119.3 14.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.581 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 30.7 tpt180 -150.05 113.68 5.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.3 mmtm 67.26 31.7 6.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.112 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.29 -16.39 52.84 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.474 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.27 152.0 25.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.061 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -90.06 114.35 26.22 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.33 171.53 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.579 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.08 124.09 35.91 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.47 -47.75 77.82 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -111.53 91.84 15.27 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.155 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.51 -23.79 16.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.631 2.221 . . . . 0.0 112.606 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.09 -22.16 49.41 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.041 0.924 . . . . 0.0 110.373 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.77 137.79 32.08 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.194 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.13 162.33 41.06 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -89.77 131.48 35.7 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.754 0.788 . . . . 0.0 111.413 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.04 165.56 20.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.881 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.3 mttt -58.45 146.93 33.42 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.4 ptm180 -82.9 154.85 67.91 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 72.5 Cg_endo -83.09 164.66 15.19 Favored 'Trans proline' 0 N--CA 1.432 -2.14 0 C-N-CA 121.314 1.343 . . . . 0.0 109.6 173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.0 -3.95 13.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.448 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.89 -116.02 4.7 Favored Glycine 0 CA--C 1.459 -3.454 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -137.33 144.17 44.43 Favored Pre-proline 0 C--N 1.265 -3.083 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.33 45.27 1.88 Allowed 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.704 2.269 . . . . 0.0 109.477 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.88 -147.71 33.94 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -170.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -161.85 122.02 2.56 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.0 t -107.28 120.23 48.4 Favored Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.273 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 4.9 Cg_exo -78.91 -7.86 15.5 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.615 2.21 . . . . 0.0 112.785 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -129.43 12.49 5.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.55 160.41 24.47 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -128.13 168.03 15.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.9 p90 -154.35 163.03 40.8 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -131.51 141.73 49.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.4 mt -98.29 124.41 42.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.9 t -109.76 -18.91 13.33 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.79 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.404 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -108.72 30.21 9.01 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 119.582 -1.294 . . . . 0.0 111.091 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.58 -173.3 30.94 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -127.44 18.42 6.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.33 0.565 . . . . 0.0 110.554 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.517 ' O ' HG11 ' A' ' 108' ' ' VAL . 20.9 m -146.95 178.61 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 66.8 m-85 -91.12 90.61 7.9 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.62 156.76 46.33 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.837 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 71.8 t80 -53.8 105.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.965 0.791 . . . . 0.0 111.36 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.39 -11.96 6.04 Favored Glycine 0 N--CA 1.418 -2.556 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.787 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 103' ' ' VAL . 19.1 m -82.95 141.34 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.015 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HB3' HG22 ' A' ' 99' ' ' THR . 37.0 ttmt -106.6 123.7 48.5 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 169.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 99.3 11.48 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 46.7 t -79.69 110.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -89.19 132.14 34.99 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 123.926 0.891 . . . . 0.0 108.77 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.1 m -155.12 156.53 35.96 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.28 -69.88 0.83 Allowed 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.167 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.64 -169.51 3.4 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.98 -50.65 11.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.722 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.45 73.9 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.636 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.73 130.06 23.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.43 0.633 . . . . 0.0 110.165 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -109.47 -76.79 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.7 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp 174.1 162.68 0.19 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.253 1.021 . . . . 0.0 110.282 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -97.46 143.81 27.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.13 159.37 12.94 Favored Glycine 0 C--N 1.289 -2.032 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.4 -27.48 22.73 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.557 0.694 . . . . 0.0 110.716 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.0 mm -95.93 103.15 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.022 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -92.87 33.56 1.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.072 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.83 174.07 15.84 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.262 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -134.26 127.44 31.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 18.3 mt-10 -111.33 143.18 42.53 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 118.654 0.661 . . . . 0.0 111.312 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 36.5 m -81.68 117.18 21.82 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.242 172.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.3 t70 -108.92 -165.38 1.02 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 61.2 p -67.31 -41.87 84.64 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.707 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.76 -30.66 20.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 -139.25 5.77 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.382 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 78.1 m95 -82.83 128.96 34.9 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.125 0.488 . . . . 0.0 110.473 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 p -63.36 -29.47 70.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.821 1.248 . . . . 0.0 113.427 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.37 170.08 14.09 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -105.54 174.32 5.93 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.99 110.47 4.65 Favored Pre-proline 0 C--N 1.319 -0.749 0 O-C-N 123.687 0.617 . . . . 0.0 111.723 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 130.49 29.61 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.152 1.901 . . . . 0.0 110.708 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.61 109.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.4 t -83.7 112.74 20.33 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.212 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB2' HD23 ' A' ' 121' ' ' LEU . 5.9 mm-40 . . . . . 0 CA--C 1.491 -1.322 0 C-N-CA 124.139 0.976 . . . . 0.0 108.902 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 N--CA 1.433 -1.305 0 CA-C-O 121.757 0.789 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.2 m -85.83 127.62 34.61 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.831 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.95 19.03 12.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.581 0.705 . . . . 0.0 110.528 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.14 157.13 43.14 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 39' ' ' ASP . 2.2 mm? -89.62 158.67 45.11 Favored Pre-proline 1 N--CA 1.342 -5.872 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.262 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.9 Cg_endo -58.81 138.38 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.028 2.485 . . . . 0.0 110.355 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 149.41 84.21 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.156 1.904 . . . . 0.0 112.577 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -89.61 143.45 26.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.82 168.3 10.02 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.436 0.636 . . . . 0.0 111.912 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -79.04 -33.95 44.27 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.805 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 p -98.28 -31.74 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.0 mp0 -114.83 146.22 41.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.73 0.3 . . . . 0.0 111.444 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.2 mt -120.35 146.19 25.58 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 37' ' ' TRP . 24.1 mt -75.84 130.22 38.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.1 p -99.02 127.67 44.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.92 -143.21 16.12 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 t -149.66 118.97 6.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.575 ' CD1' HD13 ' A' ' 33' ' ' LEU . 5.4 m95 -129.48 74.4 1.58 Allowed 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.856 0.836 . . . . 0.0 109.484 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 24.36 12.06 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.587 ' O ' HD21 ' A' ' 24' ' ' LEU . 24.3 m-20 -95.7 -150.76 0.33 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.943 -1.935 . . . . 0.0 111.863 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -132.41 -79.55 0.5 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 18.6 p -107.09 121.2 44.01 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -116.64 138.03 24.18 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.927 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.53 151.48 84.72 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.757 2.305 . . . . 0.0 111.938 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.4 tt0 -63.62 136.33 57.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.702 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.17 4.31 53.81 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -85.63 118.87 25.41 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.8 pt20 -91.99 142.04 27.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.828 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.88 131.79 56.15 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.022 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.4 mt -99.89 134.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.631 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 51.6 m-85 -113.21 156.5 23.15 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.685 0.755 . . . . 0.0 112.966 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 64.9 tttp -101.39 137.57 39.55 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.819 1.647 . . . . 0.0 106.708 173.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.781 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 76.7 m -81.33 15.0 2.15 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 67.8 mtp180 62.43 156.9 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 121.721 0.772 . . . . 0.0 111.545 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.74 107.08 2.25 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 120.744 0.963 . . . . 0.0 109.605 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 128.64 -24.49 4.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.671 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 60.2 m-85 -105.0 155.32 19.07 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.18 168.7 18.9 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 123.872 0.869 . . . . 0.0 109.725 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 58.6 p -164.69 154.4 13.61 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.126 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.87 -32.43 31.06 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.44 136.29 8.72 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.91 151.71 45.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.158 0.479 . . . . 0.0 111.134 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.05 108.84 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.636 0.732 . . . . 0.0 109.761 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.49 122.19 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.097 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 84.7 mtp -104.39 170.25 8.01 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.3 p -152.07 143.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.216 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.03 121.5 22.08 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 124.09 0.956 . . . . 0.0 108.804 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 57.2 ttp180 -146.51 121.94 10.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.5 mmtm 63.71 20.35 12.18 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.798 0.839 . . . . 0.0 112.92 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.33 72.57 Favored Glycine 0 N--CA 1.423 -2.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.45 150.87 38.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.242 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.44 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.7 m95 -87.38 113.44 23.09 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.66 0.743 . . . . 0.0 109.525 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.59 171.81 3.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.227 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.16 118.01 27.44 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 64' ' ' MET . 5.1 tp -58.88 -46.05 88.73 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -120.31 96.56 49.13 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.928 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.99 -10.77 21.38 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 112.743 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.67 -29.99 36.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.952 0.882 . . . . 0.0 109.931 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 37.3 mmt180 -91.32 132.82 35.91 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.676 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -154.35 150.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 62.5 m -86.61 114.76 23.59 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.917 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.89 169.82 8.64 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.477 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 105' ' ' GLU . 32.6 mmtp -55.08 119.41 5.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.443 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 11.1 ptm180 -55.64 145.51 50.12 Favored Pre-proline 0 C--N 1.295 -1.779 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.261 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.45 158.84 32.69 Favored 'Trans proline' 0 C--O 1.256 1.396 0 C-N-CA 122.272 1.982 . . . . 0.0 109.161 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.45 -16.72 5.78 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.246 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.11 -154.53 46.53 Favored Glycine 0 CA--C 1.464 -3.149 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.809 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.97 134.86 31.01 Favored Pre-proline 0 C--N 1.252 -3.642 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.256 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.7 33.57 0.49 Allowed 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.841 2.361 . . . . 0.0 110.772 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.46 157.9 33.97 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -127.58 145.34 50.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.8 t -120.66 148.9 49.21 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.074 -173.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 11.9 Cg_exo -72.4 -25.65 18.01 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.316 2.011 . . . . 0.0 111.087 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -146.56 110.05 4.83 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.361 0.6 . . . . 0.0 110.489 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . 152.75 173.09 21.81 Favored Glycine 0 N--CA 1.425 -2.065 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.317 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 m -146.73 163.45 35.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -144.52 165.52 27.75 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.4 p -135.26 148.08 49.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.23 128.28 54.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.548 HG22 ' HB3' ' A' ' 109' ' ' LYS . 12.5 t -121.44 6.82 10.09 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.435 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -124.06 23.06 6.62 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.72 -178.0 29.27 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.13 11.48 15.25 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.54 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 p -140.36 -168.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.407 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -105.64 83.4 1.93 Allowed 'General case' 0 C--N 1.245 -3.944 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.961 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 10.4 pt-20 -138.78 162.56 34.42 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.7 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -51.98 120.65 5.58 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.095 0.872 . . . . 0.0 110.205 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.74 -12.36 22.87 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.193 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 103' ' ' VAL . 20.3 m -85.14 140.26 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.496 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -101.31 116.98 34.05 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 127' ' ' ARG . . . -96.07 93.62 7.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -74.78 128.05 36.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.0 t80 -111.09 145.19 38.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.344 0.593 . . . . 0.0 111.185 -172.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 m -152.62 159.84 43.21 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 60.9 m -122.06 -68.39 0.9 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.488 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 15.7 m120 -133.91 -162.42 1.24 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.24 -55.01 4.11 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.34 0.591 . . . . 0.0 109.805 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.18 -23.38 59.14 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.969 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 86.8 m-85 -104.97 112.15 25.19 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 92.2 mt-30 -112.43 -87.83 0.54 Allowed 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.7 pp -178.87 145.2 0.28 Allowed 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 73.0 mt -87.51 139.76 30.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.62 170.05 12.98 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.67 -28.15 12.65 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.363 0.601 . . . . 0.0 110.335 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.84 99.36 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -87.07 30.71 0.74 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.846 0.858 . . . . 0.0 110.855 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.478 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 49.5 p90 -163.41 -177.83 5.53 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.516 -0.765 . . . . 0.0 108.96 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HD3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -148.76 131.51 16.0 Favored 'General case' 0 N--CA 1.403 -2.819 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 172.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 109' ' ' LYS . 31.9 mt-10 -107.67 145.86 32.81 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.86 112.41 22.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -94.6 -161.94 0.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.418 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.4 p -67.6 -44.94 76.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.902 0.881 . . . . 0.0 109.945 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.38 -37.03 68.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.879 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.76 -152.13 24.21 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.64 126.79 29.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.4 p -59.87 -34.85 73.68 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.807 0.843 . . . . 0.0 112.111 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -132.73 169.46 16.66 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 5.8 p-10 -102.37 -99.84 0.28 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.101 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.476 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 26.9 mt -127.24 99.43 28.01 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.3 Cg_endo -53.56 140.28 65.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.01 1.807 . . . . 0.0 110.018 172.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.36 118.59 31.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 -171.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 64.6 m -59.13 94.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.217 1.007 . . . . 0.0 112.47 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.4 mm-40 . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 32.5 m-20 . . . . . 0 C--O 1.242 0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.0 m -74.64 132.72 41.96 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.844 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.4 36.44 2.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.653 0.74 . . . . 0.0 109.395 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.18 158.06 32.0 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.213 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.2 mt -79.44 152.97 76.23 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 123.95 0.781 . . . . 0.0 110.31 175.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.27 131.7 42.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.542 2.161 . . . . 0.0 110.976 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.01 132.53 24.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.49 2.127 . . . . 0.0 113.23 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 mtm-85 -76.73 129.56 36.49 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -104.2 178.13 4.65 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.007 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -56.14 -44.62 79.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.862 0.465 . . . . 0.0 111.782 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 p -125.1 17.84 8.43 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.805 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 49.8 mp0 -135.35 134.4 39.76 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.312 0.577 . . . . 0.0 111.882 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -128.35 165.73 27.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.434 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -90.5 142.83 27.34 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -98.21 128.09 44.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.3 -165.35 12.46 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.2 m -130.98 124.53 31.17 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.607 ' HB3' HD22 ' A' ' 24' ' ' LEU . 76.0 m95 -122.4 121.48 36.76 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 m -132.74 3.4 3.8 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.966 0.413 . . . . 0.0 110.767 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 21.0 m-20 -95.63 -169.81 2.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.88 -59.57 1.34 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.241 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.3 p -93.82 124.4 37.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 57.6 m-85 -125.59 139.17 33.39 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.496 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.606 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 24.4 Cg_endo -61.44 142.56 95.78 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 123.178 2.586 . . . . 0.0 113.038 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.6 tt0 -61.7 132.97 54.94 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.12 43.37 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.403 ' C ' HG23 ' A' ' 65' ' ' VAL . 85.1 m -89.66 115.41 27.01 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -89.16 144.17 26.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.605 0.717 . . . . 0.0 111.437 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 128.62 55.82 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.43 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.34 128.54 49.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 70.1 m-85 -103.43 158.01 16.64 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 60.2 tttm -106.06 142.4 35.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.981 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 86.6 m -95.93 38.44 1.18 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 29.9 mmt180 62.22 163.23 0.11 Allowed Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.696 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.94 100.45 0.37 Allowed 'Trans proline' 0 N--CA 1.418 -2.935 0 C-N-CA 121.273 1.315 . . . . 0.0 109.228 167.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.87 -3.17 3.78 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.494 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 45.6 m-85 -130.47 -177.73 4.46 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -153.02 -176.35 5.73 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.591 0.756 . . . . 0.0 109.341 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.2 p -162.04 165.09 27.77 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.21 -13.87 27.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.366 0.603 . . . . 0.0 109.76 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.94 161.13 34.05 Favored Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -75.05 143.06 43.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 117.694 0.747 . . . . 0.0 111.418 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 50.0 t -77.45 109.15 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 174.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.91 123.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.109 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 91.0 mtp -112.06 168.81 9.31 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.8 p -152.39 145.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.328 0.585 . . . . 0.0 110.383 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.9 t -71.71 120.38 17.22 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.542 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 44.2 ttm-85 -152.21 120.38 6.28 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.59 28.13 13.27 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.218 1.007 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.89 -15.95 61.52 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.723 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -110.64 158.61 18.41 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.181 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.22 115.89 28.49 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.94 151.37 32.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.399 0.619 . . . . 0.0 111.713 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.98 109.59 1.32 Allowed 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.457 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.79 -52.21 64.07 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -110.79 92.73 15.18 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -20.96 22.75 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 122.394 2.063 . . . . 0.0 111.176 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 mt -74.86 -25.58 59.07 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.403 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -89.49 128.37 35.97 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.331 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.76 158.08 40.41 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 65.0 m -88.49 139.99 29.92 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.765 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 48.1 mt-30 -132.69 168.46 18.28 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.225 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.72 160.22 33.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.838 0.828 . . . . 0.0 113.15 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -110.82 137.61 20.86 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.44 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 9.6 Cg_endo -71.02 148.82 57.77 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.392 2.061 . . . . 0.0 112.698 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.13 -55.28 3.49 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.976 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.18 -156.08 20.64 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.003 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -87.82 111.84 44.94 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 123.635 0.774 . . . . 0.0 109.201 -175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 81.1 Cg_endo -76.72 9.95 2.45 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.916 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 145.75 135.9 2.87 Favored Glycine 0 N--CA 1.397 -3.922 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -106.26 107.74 18.9 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 t -125.09 124.6 25.35 Favored Pre-proline 0 N--CA 1.411 -2.384 0 CA-C-O 121.564 0.697 . . . . 0.0 112.155 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -89.84 2.61 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 122.269 1.979 . . . . 0.0 112.335 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.9 4.86 2.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.81 13.79 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 p -142.39 163.36 33.06 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.295 0.638 . . . . 0.0 109.934 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.4 p90 -130.31 154.36 47.71 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.189 0.306 . . . . 0.0 110.404 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 74.7 p -114.21 178.3 4.33 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.86 142.25 31.75 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.8 t -127.88 -45.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.998 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.25 51.01 3.38 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.113 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 140.39 -176.84 21.14 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.42 10.61 10.55 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 121.16 0.505 . . . . 0.0 110.003 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.533 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.8 p -147.06 -164.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.432 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.361 -173.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 28.2 m-85 -100.23 82.49 2.52 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.8 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.47 154.98 50.61 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.466 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.18 112.89 0.8 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.137 0.898 . . . . 0.0 109.919 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.3 -27.61 4.2 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.908 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 103' ' ' VAL . 18.2 m -75.73 164.34 3.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.071 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -131.7 115.37 15.93 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.4 101.94 13.89 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.5 m -78.82 162.24 4.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 118.621 -1.231 . . . . 0.0 108.612 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.447 ' HE2' ' SG ' ' A' ' 141' ' ' CYS . 61.2 t80 -129.43 134.61 47.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.394 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -150.83 154.99 38.31 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 78.6 m -130.68 -41.08 1.19 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -153.55 -176.63 5.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -106.75 -40.31 5.55 Favored 'General case' 0 C--N 1.278 -2.533 0 O-C-N 123.633 0.583 . . . . 0.0 111.028 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.62 -37.1 94.19 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -122.98 125.59 45.55 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 48.2 mt-30 -99.15 -89.46 0.32 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 125' ' ' ASN . 2.0 pp -170.43 161.12 7.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.71 -61.28 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.53 158.14 13.59 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.293 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.43 -26.09 33.05 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.936 0.875 . . . . 0.0 109.932 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.92 95.26 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' HD11 ' A' ' 120' ' ' LEU . 4.0 p-10 -85.55 29.63 0.68 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 21.7 p90 -162.12 174.33 13.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -173.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 96' ' ' PHE . 2.2 mpp_? -134.14 122.37 22.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 26.5 mt-10 -103.62 150.58 23.84 Favored 'General case' 0 C--N 1.284 -2.271 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.744 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.3 m -81.2 121.73 26.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.748 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 131' ' ' THR . 11.8 t70 -96.55 -159.45 0.73 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 30.3 p -58.35 -62.15 2.05 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 124.183 0.993 . . . . 0.0 112.709 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.21 -24.27 15.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.57 -149.85 5.7 Favored Glycine 0 CA--C 1.486 -1.748 0 C-N-CA 118.603 -1.761 . . . . 0.0 113.489 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 73.2 m95 -93.52 147.69 22.75 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.191 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.8 p -77.69 -24.59 49.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.791 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -139.3 172.99 12.01 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.756 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 21.0 t70 -108.69 -158.25 0.64 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.5 mt -85.53 117.21 68.3 Favored Pre-proline 0 C--N 1.289 -2.065 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.75 143.78 46.99 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.222 1.948 . . . . 0.0 109.56 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 142' ' ' GLU . 2.3 mp -94.73 124.65 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 122.118 -0.363 . . . . 0.0 111.667 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 112' ' ' TYR . 64.4 m -77.8 111.49 13.67 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.161 0.984 . . . . 0.0 111.142 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 140' ' ' ILE . 6.9 mm-40 . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.8 m-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.7 m -76.46 152.78 36.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.01 16.88 13.36 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.741 -174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.94 160.61 28.02 Favored 'General case' 0 CA--C 1.462 -2.434 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -85.2 156.33 60.08 Favored Pre-proline 1 N--CA 1.355 -5.191 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.042 -177.492 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 6.5 Cg_endo -55.45 135.12 67.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.443 2.762 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.66 117.67 4.43 Favored 'Trans proline' 0 CA--C 1.519 -0.231 0 C-N-CA 123.023 2.482 . . . . 0.0 112.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.59 133.24 45.6 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 94.0 mtt180 -108.1 -179.74 3.98 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.513 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.595 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 59.7 t30 -89.38 -50.42 6.13 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.157 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 53' ' ' ARG . 7.7 p -88.15 -9.16 54.05 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.4 mp0 -124.6 135.52 53.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.614 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mt -117.1 135.98 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 37' ' ' TRP . 17.7 mt -67.97 117.66 10.12 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.427 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' LYS . 9.7 p -96.77 100.25 11.8 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.91 -159.28 28.39 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -132.71 113.53 13.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.61 ' CD1' HD13 ' A' ' 33' ' ' LEU . 10.1 m95 -125.18 84.67 2.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 m -118.66 5.94 11.6 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.207 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.598 ' O ' HD21 ' A' ' 24' ' ' LEU . 18.5 m-20 -85.25 -160.06 0.48 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.207 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -125.15 -69.26 0.8 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 23.3 p -93.38 133.69 36.37 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -128.48 141.29 40.97 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 35.1 Cg_endo -65.19 150.17 87.9 Favored 'Trans proline' 0 C--O 1.255 1.361 0 C-N-CA 122.718 2.279 . . . . 0.0 112.712 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -68.87 133.62 48.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 -6.11 38.81 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.516 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -80.96 118.52 22.52 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.23 152.88 21.66 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.937 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.44 131.95 54.12 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -102.98 126.12 57.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 63.4 m-85 -108.87 143.65 37.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.217 0.532 . . . . 0.0 112.202 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' HG23 ' A' ' 34' ' ' THR . 63.4 tttm -93.66 142.68 27.08 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 85.4 m -90.19 40.34 1.0 Allowed 'General case' 0 C--N 1.279 -2.474 0 CA-C-O 120.521 0.2 . . . . 0.0 110.835 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 29' ' ' ASN . 22.0 mtp180 61.46 172.3 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 122.781 0.432 . . . . 0.0 110.689 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -76.12 -12.0 19.42 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 120.857 1.038 . . . . 0.0 112.225 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -104.18 -13.89 25.74 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 115.126 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 62.0 m-85 -114.23 176.07 5.2 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.137 -1.213 . . . . 0.0 109.806 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -152.55 -173.49 4.58 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -168.62 -175.01 2.32 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.79 -6.64 57.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.407 1.099 . . . . 0.0 109.062 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.31 -147.2 4.84 Favored Glycine 0 N--CA 1.403 -3.507 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -120.97 150.84 40.48 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 75.3 t -70.36 103.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.0 mm -101.0 119.53 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.927 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.1 169.84 8.47 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -155.23 147.51 12.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.609 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.35 123.49 24.72 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttt180 -152.19 124.22 8.06 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 62.33 26.17 15.64 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.783 0.833 . . . . 0.0 112.677 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.21 -9.9 74.17 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.761 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.87 162.43 20.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.471 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -92.63 112.0 23.8 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.29 167.62 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.396 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.553 0.216 . . . . 0.0 110.59 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -50.23 73.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.472 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.3 m120 -111.93 93.82 22.48 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.03 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -73.56 -11.72 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.438 2.092 . . . . 0.0 111.693 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.12 -11.99 58.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.503 0.668 . . . . 0.0 110.13 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 25.8 mmt180 -89.32 126.95 35.73 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.392 0.615 . . . . 0.0 110.13 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -146.37 144.68 29.91 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.0 m -93.41 117.43 30.07 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-O 121.239 0.543 . . . . 0.0 109.892 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -117.34 167.48 11.21 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.128 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.6 mttt -63.6 145.76 55.06 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.787 0.327 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.6 ptp180 -85.46 138.05 36.3 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 40.6 Cg_endo -68.24 154.75 71.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.791 2.327 . . . . 0.0 111.348 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.05 -2.29 18.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 -112.57 3.68 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.168 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -127.13 119.58 22.2 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 95.6 Cg_endo -79.24 34.54 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.877 3.052 . . . . 0.0 114.058 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.74 137.78 6.71 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.614 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.74 128.06 34.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.298 0.57 . . . . 0.0 109.729 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -139.57 107.36 7.11 Favored Pre-proline 0 N--CA 1.409 -2.518 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.25 12.0 2.95 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.448 2.098 . . . . 0.0 110.477 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 -54.82 2.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.764 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.91 -166.1 14.58 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.116 -1.04 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 m -132.27 170.93 14.35 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 54.3 p90 -142.64 153.41 43.42 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.642 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 72.2 p -107.66 -178.65 3.69 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.431 HD22 HG21 ' A' ' 108' ' ' VAL . 96.2 mt -145.38 157.42 44.04 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 7.6 t -151.52 146.92 26.24 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.09 27.26 66.71 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.857 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.73 -44.59 0.21 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.181 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.03 13.24 9.08 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.42 171.75 14.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.4 m-85 -85.73 93.02 8.76 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.664 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -146.13 151.42 37.64 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.274 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 76.8 t80 -52.41 106.55 0.16 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.014 0.926 . . . . 0.0 111.208 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 139.47 -27.86 2.59 Favored Glycine 0 N--CA 1.422 -2.264 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.817 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' THR . 23.2 m -80.92 154.79 4.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.303 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -118.12 118.88 33.08 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 171.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.19 96.66 9.75 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.0 OUTLIER -77.45 156.25 5.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.709 -178.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.581 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 46.6 t80 -114.78 139.19 49.92 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -141.44 164.59 29.82 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 7.2 t -146.66 -57.7 0.28 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.748 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.38 -174.18 4.14 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -83.55 -45.01 14.03 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 121.892 0.853 . . . . 0.0 108.833 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.98 -24.11 64.97 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.846 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -115.15 125.97 54.07 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 122.654 -0.321 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.614 ' HB3' HD13 ' A' ' 120' ' ' LEU . 84.1 mm-40 -113.96 -87.36 0.57 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -162.15 161.49 28.08 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.247 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 88.7 mt -92.72 131.62 37.63 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.86 179.46 16.42 Favored Glycine 0 C--N 1.269 -3.154 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.417 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -102.87 -9.78 19.61 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.915 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 126' ' ' TYR . 48.5 mm -122.66 121.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.059 0.457 . . . . 0.0 109.969 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -104.58 29.23 6.31 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.799 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.9 p90 -163.77 176.86 9.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.042 0.449 . . . . 0.0 111.39 -173.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -141.97 126.94 18.31 Favored 'General case' 0 C--O 1.199 -1.583 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -104.11 147.74 27.07 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 118.555 0.616 . . . . 0.0 111.671 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.5 m -84.83 103.07 13.58 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.843 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.24 -167.95 1.47 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.3 p -64.55 -44.15 91.68 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.066 1.346 . . . . 0.0 110.745 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.56 -38.02 77.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.966 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.14 -115.11 0.7 Allowed Glycine 0 CA--C 1.486 -1.721 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 91.9 m95 -95.95 129.68 43.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.0 p -67.67 -26.93 66.44 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.604 0.762 . . . . 0.0 112.584 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.4 ' CG ' HG21 ' A' ' 124' ' ' ILE . 16.7 m120 -137.91 169.26 18.09 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -101.88 -171.75 2.03 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 123.824 0.703 . . . . 0.0 109.556 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.6 mt -74.98 113.2 22.44 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.586 0.354 . . . . 0.0 110.655 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.581 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 9.7 Cg_endo -66.48 141.17 60.24 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.399 2.066 . . . . 0.0 110.771 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 49.0 mm -92.66 119.73 40.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.446 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.9 m -64.59 118.85 9.44 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.529 0.518 . . . . 0.0 109.8 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.486 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 11.7 mm-40 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.5 m -79.49 129.67 34.69 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.956 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.01 35.48 1.72 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.0 110.566 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -160.0 152.89 21.51 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.585 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -71.1 149.42 94.58 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 124.26 0.975 . . . . 0.0 108.969 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.33 131.54 45.77 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.541 2.161 . . . . 0.0 111.821 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 116.79 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.736 2.291 . . . . 0.0 112.311 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -61.49 127.14 30.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.29 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -81.36 153.64 26.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.831 -170.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -72.21 -24.87 61.47 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -128.35 7.45 5.89 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.3 mp0 -137.45 164.48 28.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.117 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.82 150.51 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.46 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -71.54 142.96 50.08 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.302 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.5 p -103.42 108.25 19.42 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.98 -164.71 25.51 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -138.93 98.72 3.6 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 48.8 m95 -92.82 144.21 25.51 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.15 31.06 0.34 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.24 161.27 36.68 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.681 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -93.85 -26.67 16.81 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.099 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -116.64 110.26 18.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.822 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -110.06 139.33 21.26 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.5 Cg_endo -60.62 146.24 97.44 Favored 'Trans proline' 0 C--O 1.254 1.299 0 C-N-CA 123.202 2.601 . . . . 0.0 112.971 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.4 tt0 -66.0 138.03 57.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.1 7.22 56.43 Favored Glycine 0 N--CA 1.427 -1.96 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.287 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.432 ' C ' HG23 ' A' ' 65' ' ' VAL . 98.5 m -88.16 112.03 22.27 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -84.2 140.22 31.86 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.276 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.57 56.57 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.2 mt -98.98 131.09 46.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 80.5 m-85 -115.73 138.95 50.62 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.672 0.748 . . . . 0.0 112.851 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -91.49 133.48 35.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.9 m -72.55 10.86 0.73 Allowed 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 66.77 154.78 0.13 Allowed Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.19 0.596 . . . . 0.0 111.219 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.62 98.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.117 1.878 . . . . 0.0 112.134 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.593 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 130.92 -13.65 5.52 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.391 -0.909 . . . . 0.0 114.212 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 82.2 m-85 -115.19 168.5 9.89 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.373 -1.075 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -146.49 169.38 19.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 59' ' ' LEU . 31.0 t -165.79 -10.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 123.816 0.697 . . . . 0.0 110.023 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 58' ' ' SER . 20.2 tp 75.15 -52.56 0.66 Allowed 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.425 173.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.8 20.35 39.1 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 61.76 -167.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.16 0.984 . . . . 0.0 110.867 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.504 HG23 ' SG ' ' A' ' 80' ' ' CYS . 69.4 t -118.31 123.82 72.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 168.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -117.64 122.21 69.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 64' ' ' MET . 88.1 mtp -108.17 178.0 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -161.98 143.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.074 0.464 . . . . 0.0 110.403 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 t -70.38 125.19 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.919 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.5 ttt180 -152.69 119.18 5.62 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 120.634 0.254 . . . . 0.0 110.755 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 62.23 23.17 13.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.11 -20.0 51.89 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.458 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.74 154.11 20.94 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.05 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -88.22 116.47 26.44 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.06 172.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.57 124.69 35.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.93 -51.21 34.77 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -114.0 89.54 17.01 Favored Pre-proline 0 N--CA 1.426 -1.634 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.786 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.58 -25.41 15.01 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 122.378 2.052 . . . . 0.0 110.629 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.05 -25.69 64.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.138 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mmp_? -85.28 138.38 32.35 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.3 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -161.6 144.57 12.22 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 62' ' ' VAL . 73.9 m -86.01 109.18 18.62 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-O 121.79 0.805 . . . . 0.0 111.776 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -106.39 167.14 10.04 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.174 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 98.8 mttt -62.24 135.26 57.4 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 123.29 0.369 . . . . 0.0 111.503 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.7 ptp180 -80.4 146.19 61.17 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.74 142.96 10.48 Favored 'Trans proline' 0 N--CA 1.424 -2.576 0 C-N-CA 121.675 1.583 . . . . 0.0 112.336 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.5 m -84.33 -30.77 25.24 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.93 104.44 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 O-C-N 124.237 0.961 . . . . 0.0 115.072 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.8 t60 64.02 111.33 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 123.858 0.863 . . . . 0.0 111.993 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 127' ' ' ARG . 88.0 Cg_endo -81.47 43.13 1.47 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 123.635 2.89 . . . . 0.0 112.506 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 85.64 -171.53 45.41 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -107.67 91.58 3.71 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 m -112.61 91.31 16.82 Favored Pre-proline 0 N--CA 1.421 -1.9 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.191 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.59 -29.73 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.567 2.178 . . . . 0.0 112.679 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -110.78 146.24 36.71 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.66 178.34 36.68 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -143.2 156.8 44.84 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.671 -0.311 . . . . 0.0 110.937 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 p90 -141.35 149.56 41.31 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.226 0.536 . . . . 0.0 110.358 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.8 p -116.12 147.36 41.42 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.576 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.61 135.99 51.44 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -115.74 -4.32 12.17 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -119.0 16.82 10.84 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.536 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.26 32.74 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -107.32 2.83 24.8 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 117.771 0.786 . . . . 0.0 110.059 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.9 p -142.17 -164.04 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.535 -170.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -98.98 74.0 1.98 Allowed 'General case' 0 C--N 1.245 -3.938 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.59 151.75 46.03 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.883 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 73.4 t80 -47.08 117.56 1.76 Allowed 'General case' 0 C--N 1.315 -0.904 0 O-C-N 124.574 1.171 . . . . 0.0 111.759 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.42 -14.06 20.75 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.872 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -82.42 141.57 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 99' ' ' THR . 35.2 ttmt -111.22 122.53 48.11 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 127' ' ' ARG . . . -94.86 95.54 8.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 55.5 t -79.36 122.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 77.0 t80 -98.48 144.57 27.68 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.824 0.821 . . . . 0.0 112.063 -172.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.94 156.81 46.0 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.9 t -131.04 -68.32 0.68 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.181 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.12 -173.34 3.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -85.2 -48.6 8.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.425 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.21 -23.8 60.49 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.154 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -116.9 116.95 28.41 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 15.5 mm-40 -109.0 -80.98 0.57 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.1 pp -170.59 137.0 1.31 Allowed 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.96 -47.16 69.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.758 1.223 . . . . 0.0 112.035 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.04 174.98 48.61 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.132 -0.486 . . . . 0.0 113.743 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.62 -30.02 23.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.849 0.833 . . . . 0.0 110.146 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.18 98.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.536 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.98 20.4 2.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.147 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -154.48 -177.63 6.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.493 ' NH1' HG12 ' A' ' 138' ' ' ILE . 8.2 ptp180 -154.13 128.22 8.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 174.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 21.4 mt-10 -103.75 143.17 33.15 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 122.151 -0.343 . . . . 0.0 111.347 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -88.44 104.42 16.77 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.1 t70 -98.04 -156.55 0.55 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.471 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.0 p -70.49 -53.25 17.03 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.088 0.955 . . . . 0.0 112.064 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.82 -25.63 27.99 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.184 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.81 -156.36 28.27 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.168 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.6 m95 -78.51 142.27 37.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.813 0.445 . . . . 0.0 110.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -90.04 131.8 35.73 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 72.16 -175.46 0.17 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.773 0.829 . . . . 0.0 111.652 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -123.54 168.47 12.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.545 HD11 ' HA3' ' A' ' 89' ' ' GLY . 21.4 mt -57.04 116.11 12.45 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.411 1.085 . . . . 0.0 110.032 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 18.2 Cg_endo -64.69 138.52 59.09 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.274 1.983 . . . . 0.0 111.777 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 1.9 mp -87.06 129.13 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 0.0 110.091 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 12.1 m -63.13 113.48 3.17 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 123.782 0.833 . . . . 0.0 111.759 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.8 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 41' ' ' THR . 72.8 m -70.61 137.64 50.15 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.683 0.615 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.451 ' HA ' HG22 ' A' ' 41' ' ' THR . 12.5 m120 -107.04 19.1 20.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.703 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.61 161.54 41.97 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.33 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 mt -78.2 150.17 77.03 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 123.401 0.68 . . . . 0.0 109.245 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.33 139.77 84.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.84 1.693 . . . . 0.0 110.022 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.55 147.02 50.85 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.036 1.824 . . . . 0.0 112.583 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -91.45 146.18 24.02 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -116.93 171.75 7.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 10.8 t30 -88.56 -39.09 14.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.984 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 p -93.57 -12.51 29.37 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 3.4 mp0 -127.48 138.29 52.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.956 0.408 . . . . 0.0 110.719 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 12.8 mt -114.74 144.19 22.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -78.72 125.27 29.14 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.7 p -86.99 -32.07 20.25 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.26 165.85 54.11 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.424 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 m -97.87 106.05 18.29 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -109.37 136.66 48.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -148.04 -20.31 0.35 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.0 152.87 18.3 Favored 'General case' 0 C--O 1.201 -1.487 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.568 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ASN . 25.5 p -120.71 139.79 52.55 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.903 -0.498 . . . . 0.0 111.74 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.74 140.91 33.33 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 122.257 0.223 . . . . 0.0 110.952 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.2 Cg_endo -60.3 145.63 98.2 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.412 2.741 . . . . 0.0 112.045 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 67' ' ' ARG . 22.6 tt0 -68.98 144.13 54.21 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.21 0.09 54.27 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -86.68 111.21 20.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -86.4 147.89 25.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.26 120.79 37.12 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 HD12 ' A' ' 63' ' ' ILE . 66.7 mt -93.59 119.13 40.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.337 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 58.9 m-85 -95.39 143.8 26.45 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.89 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 5.0 tppp? -89.45 126.98 35.78 Favored 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 64.6 m -79.95 21.49 0.56 Allowed 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 18.8 mtp180 63.4 157.87 0.12 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 123.87 0.868 . . . . 0.0 112.273 -176.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.13 -2.35 8.73 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.026 1.817 . . . . 0.0 113.766 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -105.39 -1.64 40.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.882 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.6 m-85 -128.14 178.16 6.42 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.435 -1.038 . . . . 0.0 108.949 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -155.53 177.71 11.06 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -169.02 171.69 8.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.92 -35.55 20.44 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.28 143.63 15.36 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.45 160.41 32.78 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.478 0.639 . . . . 0.0 111.426 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.98 105.11 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 HG12 ' A' ' 49' ' ' ILE . 45.9 mm -104.66 116.93 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.263 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.4 mtp -105.52 172.32 6.86 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.606 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.0 p -159.47 148.88 7.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.25 0.548 . . . . 0.0 110.559 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.41 117.37 12.87 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.459 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 44' ' ' GLU . 5.4 tpm_? -146.63 123.07 11.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.09 25.69 14.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 0.0 113.19 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 94.25 -11.5 70.38 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.802 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.25 166.11 11.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.473 0.654 . . . . 0.0 110.644 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -106.46 106.74 17.4 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' ALA . 9.6 p -130.42 -161.52 0.3 Allowed 'Isoleucine or valine' 1 N--CA 1.37 -4.472 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -91.19 126.6 36.32 Favored 'General case' 1 C--N 1.228 -4.705 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.069 -169.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.23 -57.8 3.63 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 13.0 t-20 -116.5 102.56 53.35 Favored Pre-proline 0 N--CA 1.419 -1.998 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.537 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.45 -0.89 11.09 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 122.976 2.451 . . . . 0.0 112.989 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 mt -89.8 -26.5 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.859 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 34.9 mmt180 -85.28 147.75 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.227 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HG3' ' HG3' ' A' ' 81' ' ' GLN . 17.9 ptpt -154.58 163.15 40.65 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.95 111.38 23.63 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 49.6 mt-30 -101.37 151.05 22.37 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.357 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.8 mttt -65.24 129.03 38.24 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.2 ptp180 -71.74 137.37 82.83 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.077 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 143.66 76.57 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 122.711 2.274 . . . . 0.0 110.728 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.2 m -101.17 -13.76 18.0 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.24 -173.27 55.28 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.111 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.51 ' HD2' ' O ' ' A' ' 89' ' ' GLY . 32.9 t60 -72.26 134.13 82.9 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.91 65.78 4.06 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.025 2.483 . . . . 0.0 111.894 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' HD2' ' A' ' 87' ' ' HIS . . . 74.42 -95.33 0.86 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -178.94 138.53 0.15 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -144.82 99.86 4.69 Favored Pre-proline 0 C--N 1.286 -2.172 0 CA-C-O 121.127 0.489 . . . . 0.0 111.612 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.2 -50.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.554 1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 114.88 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -81.46 -34.42 31.41 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.828 -0.545 . . . . 0.0 111.191 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 150.56 30.68 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 m -111.35 -42.74 3.83 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 117.42 0.61 . . . . 0.0 110.696 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.405 ' HA ' ' H ' ' A' ' 113' ' ' THR . 4.2 p90 64.44 152.19 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.963 1.705 . . . . 0.0 115.11 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 p -124.13 143.64 50.36 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -103.82 137.04 42.4 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -119.29 -22.26 7.18 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.89 44.31 1.51 Allowed Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.09 20.16 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -128.35 15.89 6.61 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.92 178.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -93.32 85.98 5.16 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 12.3 pt-20 -127.18 145.59 50.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.576 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 63.8 t80 -46.47 126.82 8.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.25 -5.93 55.79 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.935 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.58 131.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.644 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.7 ttmt -100.29 127.57 46.55 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 98.21 8.18 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.41 115.75 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.429 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 4.9 t80 -82.96 94.55 7.77 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.647 0.737 . . . . 0.0 110.678 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.405 ' H ' ' HA ' ' A' ' 96' ' ' PHE . 1.7 p -105.82 151.13 24.9 Favored 'General case' 0 N--CA 1.402 -2.848 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.466 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.85 -166.14 1.17 Allowed 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.201 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -61.82 156.52 20.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.58 -42.43 11.13 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.609 1.564 . . . . 0.0 114.246 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.94 10.34 74.24 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.356 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -114.46 167.69 10.51 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.788 0.794 . . . . 0.0 111.738 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -133.45 -140.21 0.19 Allowed 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 102.539 -3.134 . . . . 0.0 102.539 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.3 pt? -160.28 152.78 20.88 Favored 'General case' 1 N--CA 1.335 -6.178 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 142' ' ' GLU . 0.5 OUTLIER -80.43 126.83 31.69 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 173.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.95 163.23 9.43 Favored Glycine 0 N--CA 1.402 -3.582 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.62 -24.58 14.09 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.276 1.036 . . . . 0.0 108.344 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.6 mm -102.48 101.64 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.74 ' HA ' HD11 ' A' ' 120' ' ' LEU . 30.3 p-10 -89.19 33.61 0.8 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.657 0.741 . . . . 0.0 111.269 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -165.18 171.24 13.96 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.398 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 124.87 14.73 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.122 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -99.04 142.37 30.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.6 t -82.12 126.57 32.18 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.01 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.8 t70 -117.28 -166.45 1.18 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.8 p -60.15 -48.74 80.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 124.894 1.278 . . . . 0.0 113.616 -172.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.65 -24.81 18.54 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.38 0.609 . . . . 0.0 111.515 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.37 -155.48 25.73 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -77.87 144.77 36.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.5 p -63.97 -34.85 78.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.858 0.837 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -138.48 152.43 48.28 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.28 2.5 p30 -82.36 -94.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.503 HD11 ' HA3' ' A' ' 89' ' ' GLY . 7.3 mt -133.61 98.19 15.17 Favored Pre-proline 0 C--N 1.292 -1.91 0 O-C-N 121.573 -0.704 . . . . 0.0 109.672 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.893 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.1 Cg_endo -51.78 141.43 44.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 166.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.98 115.18 26.86 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.684 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.53 120.66 9.83 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 122.266 0.226 . . . . 0.0 110.914 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 121.649 0.738 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.757 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.2 142.82 32.82 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.89 16.4 15.18 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 122.153 0.978 . . . . 0.0 108.609 173.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.45 163.18 34.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.8 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 37' ' ' TRP . 21.5 mt -91.51 154.96 44.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 123.699 0.8 . . . . 0.0 111.005 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.2 Cg_endo -64.79 130.9 27.45 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.224 1.949 . . . . 0.0 110.511 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.5 Cg_exo -64.25 146.32 90.05 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.153 1.902 . . . . 0.0 111.358 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -92.45 146.91 23.32 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.53 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.4 mpt_? -104.22 174.86 5.69 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.515 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -82.3 -34.88 28.45 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -100.38 -5.12 27.73 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 1.5 mp0 -133.06 145.81 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.58 153.9 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -74.82 143.05 44.13 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 123.846 0.716 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 49' ' ' ILE . 17.0 p -80.33 -52.53 7.59 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.489 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.23 177.62 54.13 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.625 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -95.23 127.75 41.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.655 ' HB3' HD22 ' A' ' 24' ' ' LEU . 75.6 m95 -124.31 103.78 8.41 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.6 m -121.65 7.67 10.01 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.753 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.52 -158.41 0.73 Allowed 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 41' ' ' THR . 2.8 pt20 -142.24 -36.92 0.4 Allowed 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -97.23 103.81 15.77 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.657 0.742 . . . . 0.0 111.658 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -117.63 145.45 36.41 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.049 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.22 140.47 92.28 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 123.323 2.682 . . . . 0.0 112.132 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.6 tt0 -64.97 138.1 58.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.04 6.6 53.75 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 m -86.14 117.93 25.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.6 pt20 -82.95 146.49 28.78 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.607 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.95 113.65 24.42 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 mt -88.4 129.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.6 m-85 -103.17 136.34 43.14 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 122.395 1.093 . . . . 0.0 113.038 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -75.7 -20.15 58.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.065 -1.88 . . . . 0.0 112.967 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.8 m 65.88 7.29 4.51 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 57.5 mtp180 68.45 165.82 0.13 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 55.1 Cg_endo -71.02 -22.16 26.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 120.956 1.104 . . . . 0.0 112.903 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.12 -17.93 48.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.745 -0.74 . . . . 0.0 114.467 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.2 m-85 -118.47 167.21 11.81 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -161.67 -175.42 4.72 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 0.0 109.898 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -166.84 -177.88 4.04 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.72 69.87 0.99 Allowed 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.064 0.935 . . . . 0.0 108.987 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.78 -21.21 0.6 Allowed Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.65 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.1 m120 72.33 149.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.619 1.168 . . . . 0.0 110.598 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' SG ' ' A' ' 80' ' ' CYS . 73.3 t -70.51 110.41 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.77 116.08 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.6 mtp -103.45 174.04 6.04 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -161.64 150.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.14 0.495 . . . . 0.0 109.832 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.19 127.41 35.74 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 49.0 ttp180 -149.83 131.87 15.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 65.51 20.58 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.916 0.486 . . . . 0.0 112.305 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.11 -13.73 66.96 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.663 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.99 159.19 16.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.356 0.598 . . . . 0.0 111.697 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -99.43 109.71 22.26 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 73' ' ' ALA . 12.1 p -127.18 -156.07 0.17 Allowed 'Isoleucine or valine' 1 N--CA 1.363 -4.78 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.678 -176.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -102.47 134.79 45.22 Favored 'General case' 1 C--N 1.223 -4.921 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -168.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.12 -58.81 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -117.6 88.83 30.72 Favored Pre-proline 0 N--CA 1.433 -1.309 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.89 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.24 -14.46 25.66 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.37 2.047 . . . . 0.0 110.688 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.68 -28.27 62.6 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.834 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 31.5 mmt180 -93.55 132.74 37.56 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.944 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.0 155.54 44.68 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 62' ' ' VAL . 36.0 m -94.31 116.22 28.57 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.538 0.685 . . . . 0.0 109.933 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -111.0 177.11 4.77 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.976 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.2 mmtp -57.21 145.22 32.31 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.867 0.729 . . . . 0.0 109.754 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 106' ' ' TYR . 12.2 ptm180 -85.66 131.61 46.95 Favored Pre-proline 0 C--N 1.279 -2.472 0 C-N-CA 118.906 -1.118 . . . . 0.0 108.693 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 139.43 39.6 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.415 2.076 . . . . 0.0 110.089 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.7 m -101.04 -2.82 30.62 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.66 -96.75 1.89 Allowed Glycine 0 C--N 1.308 -0.984 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.597 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -143.85 125.54 8.24 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.8 Cg_exo -68.89 -53.78 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.666 2.244 . . . . 0.0 111.726 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.73 166.69 18.3 Favored Glycine 0 N--CA 1.419 -2.46 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.338 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.45 109.58 20.89 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -92.33 131.96 33.27 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.24 -31.75 52.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.75 139.96 52.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.579 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . 71.61 -165.4 53.66 Favored Glycine 0 C--N 1.304 -1.214 0 O-C-N 123.961 0.788 . . . . 0.0 113.351 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.7 m -155.54 170.07 22.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 88' ' ' PRO . 45.7 p90 -104.7 160.68 14.78 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.934 -0.479 . . . . 0.0 109.784 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -115.59 144.86 43.28 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -106.22 135.01 48.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 100' ' ' GLY 0.25 3.8 t -87.42 -86.01 0.16 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.551 ' H ' HG23 ' A' ' 99' ' ' THR . . . -87.02 52.77 4.43 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 118.15 0.432 . . . . 0.0 113.053 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.5 162.66 17.2 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -121.75 15.12 10.97 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.711 0.767 . . . . 0.0 109.102 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.9 175.35 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -93.55 88.55 5.93 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.0 pt-20 -133.25 154.85 50.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . 70.0 t80 -50.05 119.54 3.69 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.537 0.684 . . . . 0.0 111.802 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.88 -19.76 18.04 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.839 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 105' ' ' GLU . 2.8 p -85.36 141.32 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -111.46 128.26 55.95 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.04 100.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.83 118.26 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.604 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -77.82 109.88 12.21 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.64 0.733 . . . . 0.0 110.616 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.17 109.15 12.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.03 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.579 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 97.7 m -129.84 111.07 12.23 Favored 'General case' 0 C--N 1.253 -3.628 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.76 -168.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 19.4 m120 57.25 -162.09 0.2 Allowed 'General case' 0 C--O 1.247 0.941 0 O-C-N 124.448 1.093 . . . . 0.0 112.744 172.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -121.48 -46.73 2.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.19 0.519 . . . . 0.0 110.477 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.47 72.82 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 68.8 m-85 -98.6 155.09 17.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -136.99 -88.46 0.28 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.4 pp 178.44 148.87 0.2 Allowed 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 123.895 0.747 . . . . 0.0 112.14 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.24 135.22 44.22 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.025 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.41 161.13 10.92 Favored Glycine 0 C--N 1.281 -2.516 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.82 -18.99 26.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.434 0.635 . . . . 0.0 109.838 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' ND2' ' A' ' 136' ' ' ASN . 41.1 mm -113.54 121.24 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.966 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.451 ' HB2' HD21 ' A' ' 120' ' ' LEU . 29.7 p-10 -92.31 24.63 3.3 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.723 0.809 . . . . 0.0 111.557 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 38.0 p90 -163.04 178.45 8.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -151.39 128.2 10.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.649 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.0 mt-10 -103.82 154.42 19.62 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.2 t -92.44 105.65 17.8 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.251 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.35 175.48 7.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.574 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 73.8 p -52.46 -33.79 46.06 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.521 1.528 . . . . 0.0 112.444 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.15 -32.53 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.407 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.31 -159.48 28.89 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 95.2 m95 -67.74 128.92 38.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.314 0.578 . . . . 0.0 112.087 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.8 p -78.72 157.25 28.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.721 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' HG13 ' A' ' 124' ' ' ILE . 11.4 m120 65.82 -162.56 0.25 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -119.26 -163.1 0.95 Allowed 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 60.4 mt -101.54 110.04 60.71 Favored Pre-proline 0 C--N 1.285 -2.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 11.2 Cg_endo -58.76 137.91 82.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.959 1.773 . . . . 0.0 110.501 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 47.9 mm -89.33 103.91 14.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.14 111.18 1.42 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.253 0.549 . . . . 0.0 110.551 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.432 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 8.8 tp10 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.089 0.471 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.9 m -78.73 133.57 37.14 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.756 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.06 25.02 10.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.444 0.64 . . . . 0.0 110.096 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.42 155.19 38.1 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.851 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 37' ' ' TRP . 32.0 mt -76.9 158.8 79.92 Favored Pre-proline 0 C--N 1.31 -1.13 0 O-C-N 123.738 0.649 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 141.4 74.23 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.319 2.012 . . . . 0.0 110.09 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.96 118.03 4.65 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 121.52 1.48 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -62.38 135.98 57.7 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.496 0.665 . . . . 0.0 110.194 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.562 ' HB3' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -85.94 176.89 7.81 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.769 -167.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -82.98 -24.1 33.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.963 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 p -132.29 10.27 4.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.92 0.391 . . . . 0.0 111.388 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 2.7 mp0 -133.7 158.78 42.42 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -133.34 163.42 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -85.58 156.65 20.64 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-O 120.81 0.338 . . . . 0.0 110.573 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -130.54 95.57 3.91 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 -149.5 15.38 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.2 m -131.13 117.79 19.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 117.836 0.818 . . . . 0.0 109.45 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.537 ' HB3' HD22 ' A' ' 24' ' ' LEU . 55.3 m95 -134.17 101.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.908 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.2 t -147.4 34.81 0.87 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.11 -163.86 1.31 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.588 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.93 -49.3 1.23 Allowed 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 70.1 p -95.43 127.12 41.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.73 136.98 26.4 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.857 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 37.4 Cg_endo -65.09 153.62 77.39 Favored 'Trans proline' 0 C--O 1.262 1.712 0 C-N-CA 122.825 2.35 . . . . 0.0 112.106 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.7 tt0 -67.49 139.99 57.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.97 2.2 55.0 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.202 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.437 ' C ' HG23 ' A' ' 65' ' ' VAL . 89.6 m -84.54 115.0 22.37 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -83.16 139.82 32.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.557 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.18 108.68 20.24 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.0 mt -87.71 115.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.799 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 84.6 m-85 -95.96 149.05 22.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.371 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.46 130.94 39.1 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.8 t -87.18 102.41 14.44 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -32.81 144.21 0.14 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.981 1.712 . . . . 0.0 113.623 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -56.52 111.19 0.71 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 123.423 2.749 . . . . 0.0 112.534 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.96 -19.86 5.16 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -111.88 166.62 11.05 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.578 -0.811 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -155.54 167.27 30.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.925 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -174.64 126.11 0.3 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.7 77.59 5.18 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.403 0.62 . . . . 0.0 110.697 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.01 -29.83 1.23 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 70.67 158.49 0.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.412 1.085 . . . . 0.0 112.859 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.88 110.93 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.43 121.43 67.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -109.4 176.52 5.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 46' ' ' THR . 9.9 p -159.97 142.92 5.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.139 0.495 . . . . 0.0 110.668 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.79 121.97 18.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.905 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttm180 -152.57 117.87 5.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.589 0.233 . . . . 0.0 110.527 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 40.3 mmtm 69.2 25.05 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.593 1.157 . . . . 0.0 112.826 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.38 -12.82 67.57 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.075 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.22 154.13 31.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -87.64 118.21 26.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.0 175.04 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.742 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.52 122.28 31.03 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.001 0.429 . . . . 0.0 111.258 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.08 -57.4 3.86 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.88 91.29 8.78 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.198 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.92 -15.44 16.63 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.476 2.118 . . . . 0.0 112.647 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 -28.94 59.98 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.672 0.749 . . . . 0.0 109.723 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -84.23 134.49 34.54 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.028 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -154.48 160.86 41.82 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.509 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 16.9 m -79.81 112.94 17.58 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-O 121.777 0.798 . . . . 0.0 112.312 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.48 153.14 23.27 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.35 146.38 43.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.818 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.12 145.66 49.69 Favored Pre-proline 0 N--CA 1.417 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.887 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.83 153.51 48.05 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 N-CA-C 108.03 -1.566 . . . . 0.0 108.03 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.1 m -91.3 -24.11 19.93 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.677 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.01 -115.52 3.99 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -146.09 131.31 9.13 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.94 34.41 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 123.015 2.476 . . . . 0.0 113.349 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.96 155.5 27.8 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.66 84.38 2.12 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 t -73.58 136.78 77.61 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.872 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.97 -28.46 19.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.172 1.915 . . . . 0.0 111.71 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.31 121.44 34.99 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 173.01 16.56 Favored Glycine 0 N--CA 1.424 -2.145 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 m -154.66 171.72 19.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -136.41 157.66 46.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.661 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -126.25 155.3 42.1 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.26 131.49 56.93 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.4 t -125.98 144.43 50.7 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.06 68.99 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.86 168.09 25.35 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -112.91 9.51 18.87 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.006 0.908 . . . . 0.0 108.963 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.3 p -136.19 -167.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.712 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.043 -173.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -105.46 101.48 11.01 Favored 'General case' 1 C--N 1.241 -4.109 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.163 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -156.37 152.86 28.08 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.8 t80 -54.07 114.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.94 0 O-C-N 124.021 0.826 . . . . 0.0 111.168 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.84 -19.81 5.2 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.576 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 15.8 m -79.93 149.36 5.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.505 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -107.51 118.26 36.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.36 94.27 9.83 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.7 p -89.33 121.23 39.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.515 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -84.23 141.41 31.02 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.333 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -141.73 163.89 31.68 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.22 -59.64 0.06 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 118.972 0.805 . . . . 0.0 111.736 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -147.26 -170.76 3.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.0 -51.04 3.8 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 123.882 0.873 . . . . 0.0 109.861 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.1 8.49 70.27 Favored Glycine 0 C--O 1.24 0.503 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.99 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -133.83 129.53 36.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.42 -135.78 0.2 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 167.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -153.23 153.57 32.96 Favored 'General case' 1 N--CA 1.334 -6.243 0 C-N-CA 118.991 -1.083 . . . . 0.0 108.411 -175.69 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.5 mm? -77.77 125.89 30.03 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-O 121.475 0.655 . . . . 0.0 109.431 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.25 150.14 7.38 Favored Glycine 0 C--N 1.273 -2.947 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.56 -22.76 22.23 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 122.162 0.982 . . . . 0.0 109.149 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.93 109.4 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.869 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HD11 ' A' ' 120' ' ' LEU . 32.0 p-10 -86.14 33.67 0.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.779 0.8 . . . . 0.0 110.863 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 50.1 p90 -167.07 176.52 6.82 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.95 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.85 119.42 7.97 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 23.6 mt-10 -87.76 155.39 19.93 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 52.4 t -75.38 139.46 42.39 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.42 167.47 12.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.502 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.5 p -55.87 -28.5 56.81 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.791 1.637 . . . . 0.0 112.894 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -108.43 -28.93 9.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.244 0.545 . . . . 0.0 111.555 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.7 -106.24 0.19 Allowed Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.964 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -127.54 145.35 50.89 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -74.59 -26.79 60.16 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -128.12 170.02 13.43 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -99.28 -170.14 1.87 Allowed 'General case' 0 C--N 1.285 -2.212 0 O-C-N 124.055 0.847 . . . . 0.0 110.365 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.43 113.1 53.91 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-O 120.365 0.126 . . . . 0.0 110.694 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.727 ' HB2' HD12 ' A' ' 120' ' ' LEU . 11.2 Cg_endo -70.24 152.94 67.1 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 122.601 2.2 . . . . 0.0 110.287 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.26 125.96 72.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 12.3 p -76.96 108.54 10.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.633 ' HB2' HD23 ' A' ' 121' ' ' LEU . 28.3 mt-10 . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 125.678 1.591 . . . . 0.0 107.166 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 121.72 0.771 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.0 m -76.02 140.33 41.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.024 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.85 20.02 19.61 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.602 0.715 . . . . 0.0 109.915 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.1 155.95 40.76 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -88.53 158.41 48.55 Favored Pre-proline 1 N--CA 1.367 -4.577 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.248 -176.966 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 13.2 Cg_endo -58.34 130.04 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.541 2.827 . . . . 0.0 111.829 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.14 122.86 5.89 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.526 2.15 . . . . 0.0 112.597 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.74 154.23 41.24 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.975 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -117.08 176.14 5.27 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.74 -23.35 64.32 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.253 0.549 . . . . 0.0 111.517 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 p -119.02 7.13 11.35 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 5.2 mp0 -136.9 141.7 42.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.35 0.595 . . . . 0.0 112.148 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.95 151.92 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 3.6 mm? -67.84 155.52 39.17 Favored 'General case' 0 C--N 1.267 -2.981 0 O-C-N 123.629 0.581 . . . . 0.0 111.233 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 p -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.389 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 -163.4 38.84 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.782 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -121.09 108.21 13.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.52 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 18.7 m95 -107.52 88.16 2.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -104.11 4.74 34.54 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.774 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 24' ' ' LEU . 9.2 t70 -103.02 -150.02 0.41 Allowed 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.279 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -134.08 -57.8 0.86 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 69.8 p -88.03 122.12 31.25 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.171 -172.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -129.51 138.95 34.26 Favored Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.482 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.43 143.76 99.61 Favored 'Trans proline' 0 C--O 1.245 0.875 0 C-N-CA 123.316 2.677 . . . . 0.0 113.237 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 48.1 tt0 -63.6 131.65 48.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.965 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.36 4.59 46.83 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 65' ' ' VAL . 58.0 m -86.02 115.53 23.67 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -84.45 142.23 30.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.365 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.46 124.15 51.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -94.12 132.04 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -110.19 144.47 38.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -93.75 142.23 27.6 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.734 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 m -84.51 22.36 1.3 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 64.83 162.26 0.12 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.347 0.659 . . . . 0.0 110.112 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 131' ' ' THR . 50.3 Cg_endo -71.63 112.5 3.38 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 120.509 0.806 . . . . 0.0 110.536 173.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.57 -26.22 6.04 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.333 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 89.5 m-85 -102.59 163.51 12.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.861 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -140.55 -178.79 5.68 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -143.67 -177.0 5.19 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.76 6.03 36.49 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.13 0.491 . . . . 0.0 109.745 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.04 -115.93 0.34 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -138.78 122.86 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 80' ' ' CYS . 60.7 t -84.08 110.38 18.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.06 130.44 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.401 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -111.03 175.13 5.54 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.456 HG23 ' C ' ' A' ' 46' ' ' THR . 11.2 p -157.71 143.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-O 121.33 0.586 . . . . 0.0 111.275 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.8 t -75.31 123.85 26.06 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.474 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 70.0 ttt180 -155.53 134.24 11.92 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 62.61 21.04 12.44 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.736 0.814 . . . . 0.0 112.369 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.65 69.36 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.675 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -121.36 159.87 25.21 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.571 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.406 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.5 m95 -90.19 117.6 29.07 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.689 0.756 . . . . 0.0 110.36 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.73 169.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.022 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.69 125.77 35.0 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.84 -56.78 6.87 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 174.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 8.9 t-20 -120.88 100.66 46.03 Favored Pre-proline 0 N--CA 1.413 -2.299 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.271 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.66 -5.65 17.15 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.912 2.408 . . . . 0.0 112.779 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.5 mt -88.91 -20.46 24.51 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 122.164 0.983 . . . . 0.0 110.827 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 31.7 mmt180 -91.15 132.15 36.25 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.42 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -149.41 158.93 44.6 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 62' ' ' VAL . 81.7 m -97.66 107.23 19.68 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.058 0.932 . . . . 0.0 110.276 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.51 168.83 9.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.954 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.0 mttt -66.71 144.86 56.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -85.44 139.58 36.03 Favored Pre-proline 0 N--CA 1.427 -1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.7 Cg_endo -68.81 140.45 46.41 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.351 1.368 . . . . 0.0 108.84 174.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.7 m -74.43 -38.33 63.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.291 0.567 . . . . 0.0 110.495 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.94 -86.03 0.38 Allowed Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -174.64 120.47 0.35 Allowed Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 123.33 0.652 . . . . 0.0 109.325 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 41.9 Cg_endo -69.06 157.15 62.86 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.567 2.178 . . . . 0.0 109.011 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -51.07 138.42 26.72 Favored Glycine 0 N--CA 1.438 -1.209 0 O-C-N 123.955 0.784 . . . . 0.0 112.218 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.76 137.52 37.24 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.1 0.476 . . . . 0.0 109.909 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -126.15 141.19 38.98 Favored Pre-proline 0 N--CA 1.404 -2.733 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.834 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.13 -29.89 9.36 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.17 1.913 . . . . 0.0 110.8 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.72 109.67 16.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.73 157.0 9.57 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.296 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 m -137.92 164.5 28.86 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.7 p90 -129.5 155.78 45.2 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.027 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.737 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 42.1 p -100.64 164.83 11.7 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.945 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 93.3 mt -130.85 123.43 29.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.0 t -129.91 20.91 5.43 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.463 0.649 . . . . 0.0 112.653 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 108' ' ' VAL . . . -143.23 33.23 1.83 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.443 ' HA3' ' CD ' ' A' ' 105' ' ' GLU . . . 147.57 -151.57 23.81 Favored Glycine 0 N--CA 1.413 -2.877 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -175.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.76 3.24 1.25 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.406 0.603 . . . . 0.0 111.533 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.26 -172.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 13.1 m-85 -85.2 95.47 9.18 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.0 pt-20 -137.83 145.83 42.73 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.343 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.404 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 47.0 t80 -49.21 123.86 8.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.342 0.591 . . . . 0.0 111.766 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.52 58.54 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.864 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.8 p -91.8 136.25 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.3 ttmt -101.62 132.26 47.39 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.737 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -109.11 101.9 10.91 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -88.45 132.19 34.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 119.401 -0.92 . . . . 0.0 108.828 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -98.31 123.97 42.69 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.555 0.693 . . . . 0.0 109.372 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.0 m -144.34 158.32 43.8 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 71.5 m -125.41 -61.71 1.25 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.405 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -151.92 -166.06 2.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.45 -56.33 10.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.004 0.43 . . . . 0.0 111.05 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.1 -13.71 61.65 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.42 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.495 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -93.75 115.04 27.44 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.242 0.544 . . . . 0.0 111.548 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -113.08 -117.91 0.31 Allowed 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -165.69 156.66 13.68 Favored 'General case' 1 N--CA 1.354 -5.264 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.463 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 95.4 mt -79.57 125.63 29.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.8 152.75 7.25 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.65 -10.32 32.21 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.126 0.489 . . . . 0.0 110.839 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -111.39 106.72 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.762 ' HA ' HD11 ' A' ' 120' ' ' LEU . 27.5 p-10 -90.62 34.96 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 42.0 p90 -163.63 169.22 18.89 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.45 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 88' ' ' PRO . 66.4 mtt180 -132.39 134.75 45.53 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 41.3 mt-10 -114.28 130.51 56.65 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 18.7 t -79.32 114.15 18.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -105.45 -162.28 0.86 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 54' ' ' PRO . 80.3 p -62.57 -42.76 99.75 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.12 -10.86 15.76 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.0 -163.22 34.15 Favored Glycine 0 CA--C 1.49 -1.496 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.837 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -82.91 144.06 30.3 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 117.143 0.472 . . . . 0.0 110.255 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -70.5 -20.79 62.82 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.235 0.541 . . . . 0.0 112.422 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -137.83 148.63 45.63 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -89.84 -103.14 0.09 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.654 0.596 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.488 HD11 ' HA3' ' A' ' 89' ' ' GLY . 29.7 mt -127.17 96.38 34.22 Favored Pre-proline 0 C--N 1.31 -1.151 0 O-C-N 120.782 -1.199 . . . . 0.0 111.754 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.832 ' HB2' HD12 ' A' ' 120' ' ' LEU . 6.5 Cg_endo -56.92 136.11 74.66 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 122.447 2.098 . . . . 0.0 108.575 167.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.5 mp -87.15 115.86 28.56 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.963 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.83 -171.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.02 112.81 0.85 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 35.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.275 1.43 . . . . 0.0 109.481 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.688 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.0 m-20 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.31 0.576 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 41' ' ' THR . 84.9 m -77.19 139.75 39.97 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.314 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -106.64 25.86 10.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.732 0.777 . . . . 0.0 109.164 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.57 155.35 33.2 Favored 'General case' 0 CA--C 1.468 -2.199 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -86.88 156.98 55.11 Favored Pre-proline 1 N--CA 1.336 -6.161 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.528 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.1 Cg_endo -54.14 125.35 18.52 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.083 2.522 . . . . 0.0 110.99 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.46 110.85 3.18 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.499 1.466 . . . . 0.0 112.118 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.276 0.0 OUTLIER -72.14 161.24 31.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.081 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 72.1 mtp180 -122.93 -174.03 2.84 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -168.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -90.47 -14.33 32.99 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -99.9 -33.88 10.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.734 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 25.5 mp0 -121.04 145.93 47.25 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.233 0.54 . . . . 0.0 112.14 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mt -119.71 144.46 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.607 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 37' ' ' TRP . 25.3 mt -74.67 128.24 35.07 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -112.96 100.35 8.57 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.9 171.1 21.3 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m -105.46 110.67 23.1 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.382 0.611 . . . . 0.0 111.261 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CD1' HD13 ' A' ' 33' ' ' LEU . 2.7 m95 -132.34 82.24 2.0 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 m -108.43 -2.29 19.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.231 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.724 ' O ' HD21 ' A' ' 24' ' ' LEU . 16.2 t70 -93.72 -136.29 0.19 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.909 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -144.11 -55.43 0.36 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 27.5 p -91.85 129.05 37.89 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -133.1 135.0 24.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.099 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.688 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 17.8 Cg_endo -60.59 148.65 90.55 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.228 2.619 . . . . 0.0 113.278 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.49 134.77 55.13 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.39 14.68 37.56 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 65' ' ' VAL . 90.4 m -94.29 119.33 32.91 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.349 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -89.3 150.09 22.75 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.454 0.645 . . . . 0.0 111.861 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 130.97 53.48 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.7 mt -101.56 126.62 55.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 66.4 m-85 -109.49 143.31 39.29 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 20.2 ttmm -92.33 129.75 38.2 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 73.5 m -70.99 7.46 1.18 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 68.4 mtp180 71.78 154.17 0.15 Allowed Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.618 0.767 . . . . 0.0 111.263 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.52 129.09 17.22 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.792 1.661 . . . . 0.0 109.186 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 104.69 -6.43 44.62 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.329 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 36.3 m-85 -126.39 170.65 11.73 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -160.16 177.54 10.58 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 49.5 p -155.37 179.97 8.66 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.72 -22.34 56.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.865 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.02 -96.59 0.14 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -155.73 155.32 32.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 80' ' ' CYS . 65.9 t -77.42 106.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.63 116.77 48.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.0 mtp -107.89 167.59 9.87 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.7 p -152.79 144.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.067 0.46 . . . . 0.0 110.088 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.43 118.84 12.81 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.577 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.4 ttt180 -151.12 115.22 5.02 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 69.24 27.98 5.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.016 . . . . 0.0 112.615 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.22 87.41 Favored Glycine 0 C--N 1.294 -1.784 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.59 152.96 38.68 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 79.9 m95 -92.77 121.22 33.94 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.2 172.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.84 119.4 21.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.82 -49.39 73.04 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.49 91.84 6.37 Favored Pre-proline 0 C--N 1.29 -1.992 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.167 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.4 -3.13 13.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 0.0 112.984 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.17 8.38 44.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.239 0.542 . . . . 0.0 109.715 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -119.23 149.08 42.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.311 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.83 161.18 28.92 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 62' ' ' VAL . 71.8 m -104.26 123.94 48.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.71 0.767 . . . . 0.0 109.746 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -112.32 165.63 12.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.71 157.45 17.76 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 117.962 0.346 . . . . 0.0 110.801 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.9 ptm180 -82.22 143.91 49.54 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 41.2 Cg_endo -72.75 157.16 52.42 Favored 'Trans proline' 0 N--CA 1.424 -2.617 0 N-CA-C 108.142 -1.522 . . . . 0.0 108.142 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -103.03 6.26 38.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.646 0.736 . . . . 0.0 110.224 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 -122.07 9.94 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.892 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -130.63 120.23 18.62 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 45.5 Cg_endo -75.76 139.52 22.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.73 1.62 . . . . 0.0 108.315 172.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.438 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -48.38 128.12 18.27 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.135 0.897 . . . . 0.0 113.638 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -98.29 178.09 5.17 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 94' ' ' GLY . 3.0 t -148.8 147.1 23.42 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.99 -18.52 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.739 1.626 . . . . 0.0 111.088 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.5 -25.44 28.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 114' ' ' CYS . . . -146.79 -147.74 4.62 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.723 -1.227 . . . . 0.0 114.072 -175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 96' ' ' PHE . 12.8 m -154.59 -169.3 3.17 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.589 ' H ' HG22 ' A' ' 95' ' ' THR . 38.5 p90 -148.62 161.74 41.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 119.274 0.943 . . . . 0.0 109.053 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG22 ' A' ' 111' ' ' VAL . 63.7 p -109.1 -176.51 3.05 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 108' ' ' VAL . 96.0 mt -143.73 164.95 29.02 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 109' ' ' LYS . 7.5 t -119.88 -148.76 0.42 Allowed 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.82 74.89 0.0 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 125.746 1.641 . . . . 0.0 115.938 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.79 -41.53 0.08 OUTLIER Glycine 0 C--N 1.276 -2.783 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.06 11.96 3.71 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.27 177.19 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 40.2 m-85 -90.79 87.78 6.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.55 150.82 44.15 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.553 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -45.32 115.38 0.91 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.477 1.11 . . . . 0.0 110.835 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.7 -33.92 2.87 Favored Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.73 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 98' ' ' LEU . 35.0 m -74.37 135.79 26.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.495 1.14 . . . . 0.0 113.424 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -93.69 118.13 31.0 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.235 170.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -96.62 109.21 21.87 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.2 m -86.72 158.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 51.1 t80 -119.52 132.84 55.84 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.518 0.675 . . . . 0.0 110.201 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.3 m -153.08 157.81 40.98 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.465 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 81.8 m -120.74 -61.87 1.52 Allowed 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.148 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -153.48 -153.0 0.44 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.57 -47.0 7.03 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.14 -29.16 69.08 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.23 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 96.1 m-85 -107.93 126.49 52.75 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.14 -74.93 0.54 Allowed 'General case' 1 CA--C 1.416 -4.179 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.269 2.3 tp -172.34 154.75 3.33 Favored 'General case' 1 N--CA 1.282 -8.852 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.541 -168.186 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 22.8 mt -129.0 130.05 46.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 132.45 -168.36 22.71 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -110.29 -40.17 4.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 117.937 0.869 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.1 mm -97.67 100.74 11.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.709 -176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.458 ' HB3' HD22 ' A' ' 120' ' ' LEU . 28.5 p-10 -86.93 32.12 0.68 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 35.0 p90 -161.27 173.17 15.42 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.539 0.685 . . . . 0.0 110.262 -175.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 88' ' ' PRO . 21.7 ptt180 -147.04 134.68 21.03 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.457 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.9 mt-10 -111.86 143.48 42.74 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.648 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.74 106.13 17.45 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.207 0.527 . . . . 0.0 109.831 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.89 -166.93 1.36 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.244 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -62.59 -43.44 98.8 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.048 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.5 -37.87 77.37 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.66 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 138.78 -147.14 19.01 Favored Glycine 0 N--CA 1.411 -2.982 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -65.82 122.48 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 p -60.21 -33.21 71.92 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.888 0.875 . . . . 0.0 111.778 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -132.1 165.69 23.46 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 25.8 t70 -98.72 -144.82 0.32 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.438 HD11 ' HA3' ' A' ' 89' ' ' GLY . 11.7 mt -89.16 113.65 57.12 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.483 ' HB2' HD11 ' A' ' 120' ' ' LEU . 3.4 Cg_endo -65.73 161.82 37.28 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.457 2.104 . . . . 0.0 111.263 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.9 mp -74.81 136.46 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.448 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 40.9 t -104.18 102.7 12.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 179.6 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 11.0 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 41' ' ' THR . 59.8 m -75.99 133.93 40.29 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.244 0.618 . . . . 0.0 109.925 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.01 36.79 2.23 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.409 0.623 . . . . 0.0 109.635 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.16 155.94 31.82 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.825 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.7 mt -80.28 153.25 74.14 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.23 132.39 46.49 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.05 1.834 . . . . 0.0 110.657 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.33 137.58 10.6 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.254 1.969 . . . . 0.0 112.682 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -80.25 126.02 30.6 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 30.4 mtp180 -99.53 178.24 4.92 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.178 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.45 -28.03 61.74 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.168 0.985 . . . . 0.0 109.996 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -107.06 -31.56 8.23 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.642 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.681 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 30.1 mp0 -116.34 158.76 22.93 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' HG2' ' A' ' 51' ' ' LYS . 14.7 mt -144.01 148.4 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 151.42 42.28 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -126.67 156.89 40.32 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.69 -156.91 18.24 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.803 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -133.66 130.6 38.46 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.0 m95 -134.11 139.81 46.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -154.57 -5.03 0.15 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.385 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -113.97 163.65 14.84 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.031 -172.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.625 HE21 ' HA ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -83.9 -47.19 11.31 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.026 178.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 34.0 p -98.52 131.75 44.5 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.964 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -130.83 135.45 27.36 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.041 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.3 Cg_endo -61.71 148.9 92.01 Favored 'Trans proline' 0 C--O 1.257 1.474 0 C-N-CA 123.198 2.599 . . . . 0.0 112.001 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.45 139.87 58.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -11.25 55.69 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.062 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -68.54 118.34 11.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HA ' HG23 ' A' ' 65' ' ' VAL . 3.4 pt20 -93.4 138.77 31.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.558 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.2 119.72 39.95 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.815 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -93.2 111.78 25.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.1 m-85 -101.86 144.06 30.97 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 19.4 ptpt -89.0 161.45 16.58 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.35 118.85 34.73 Favored 'General case' 1 N--CA 1.368 -4.553 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -31.55 147.31 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 124.81 1.319 . . . . 0.0 111.507 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.62 -31.33 31.49 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.409 2.739 . . . . 0.0 115.339 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' C ' ' HG2' ' A' ' 83' ' ' ARG . . . -96.2 14.54 64.33 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.514 0.508 . . . . 0.0 112.515 177.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.91 167.97 16.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.139 -0.624 . . . . 0.0 110.093 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -157.9 -177.06 6.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 109.272 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -166.65 -167.99 1.08 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mp -88.78 3.93 49.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.98 -98.87 0.12 Allowed Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -141.93 158.22 44.04 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 65.8 t -88.21 107.98 18.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.67 108.46 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-O 121.835 0.826 . . . . 0.0 109.832 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mtp -97.73 175.15 6.28 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -157.04 147.79 10.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.676 -175.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.37 111.21 12.8 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 40.9 ttm180 -141.94 119.02 11.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 66.9 mmtt 64.53 22.1 12.6 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.591 1.157 . . . . 0.0 113.068 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.32 -8.62 69.5 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.387 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.63 161.01 17.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.235 0.54 . . . . 0.0 110.481 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -104.18 106.36 16.84 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 73' ' ' ALA . 13.5 p -127.93 -153.59 0.13 Allowed 'Isoleucine or valine' 1 N--CA 1.371 -4.42 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -109.82 115.03 29.08 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 3.0 tm? -59.47 -55.0 40.09 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 167.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -120.0 97.52 49.41 Favored Pre-proline 0 N--CA 1.415 -2.193 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.098 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.08 -4.82 15.62 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 123.478 2.786 . . . . 0.0 112.624 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.87 -29.35 25.34 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.901 0.858 . . . . 0.0 109.066 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -91.36 131.44 36.85 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.919 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.89 154.11 25.47 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.681 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 73.8 m -84.77 106.18 16.11 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 122.022 0.915 . . . . 0.0 110.593 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -98.88 161.0 13.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.55 145.36 52.65 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.633 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HG2' ' C ' ' A' ' 55' ' ' GLY . 12.2 ptp180 -85.77 137.86 35.73 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.08 142.96 63.5 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.282 1.988 . . . . 0.0 111.034 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.79 -27.91 63.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.8 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.14 -175.7 24.07 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.55 123.94 80.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.55 42.97 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 123.749 2.966 . . . . 0.0 112.845 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 72.28 -168.1 52.66 Favored Glycine 0 N--CA 1.412 -2.96 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.97 139.01 32.32 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -116.61 145.5 35.46 Favored Pre-proline 0 C--N 1.281 -2.391 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.36 -35.08 95.71 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.953 2.436 . . . . 0.0 111.415 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.32 150.37 19.85 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.74 163.46 11.49 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.522 -0.847 . . . . 0.0 110.992 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 m -145.44 172.58 12.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.65 159.64 42.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -118.33 152.13 36.39 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.26 138.5 46.56 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -127.24 13.38 7.17 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.496 0.665 . . . . 0.0 111.505 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -132.45 15.91 4.92 Favored Glycine 0 CA--C 1.494 -1.241 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.738 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.15 -173.15 31.36 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -110.64 3.08 19.0 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.629 0.715 . . . . 0.0 109.355 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 104' ' ' PHE . 3.9 p -142.72 -168.49 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.366 -170.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 103' ' ' VAL . 28.6 m-85 -96.9 98.93 10.51 Favored 'General case' 1 C--N 1.239 -4.219 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.618 -177.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.44 148.54 28.2 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.573 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.516 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.5 t80 -52.81 105.6 0.13 Allowed 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.292 0.995 . . . . 0.0 112.045 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.15 -8.23 4.76 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.857 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 103' ' ' VAL . 16.3 m -90.12 143.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.356 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -104.84 122.05 44.94 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.8 91.33 8.58 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.4 p -82.07 118.15 29.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.866 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -92.82 141.36 28.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.926 0.87 . . . . 0.0 111.604 -168.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 m -146.61 155.02 42.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.7 t -130.46 -72.7 0.56 Allowed 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 117.009 -1.876 . . . . 0.0 112.493 -172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 0.9 OUTLIER -143.67 -169.7 3.14 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -176.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -90.85 -48.05 7.25 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.79 -10.92 85.76 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.845 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 79.3 m-85 -123.52 126.48 46.78 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -104.76 -88.51 0.43 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.0 pp 175.66 143.0 0.06 Allowed 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.461 1.104 . . . . 0.0 111.212 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.19 126.92 45.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.98 172.24 12.93 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -100.05 -23.62 14.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.242 1.02 . . . . 0.0 110.08 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 126' ' ' TYR . 35.2 mm -107.29 98.76 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.82 30.73 0.31 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.849 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 124' ' ' ILE . 39.4 p90 -170.23 -177.49 2.51 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.93 115.74 5.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 31.7 mt-10 -80.09 143.69 33.75 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.576 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.8 t -74.61 142.09 44.63 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.029 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -124.75 -165.47 1.39 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 p -70.8 -53.32 15.81 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.967 0.889 . . . . 0.0 111.75 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -103.09 2.22 34.41 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.168 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.03 -125.47 1.03 Allowed Glycine 0 C--N 1.291 -1.947 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -127.96 162.05 27.67 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.3 p -80.91 -24.89 37.92 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -141.8 172.68 12.36 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 17.9 t70 -99.75 -161.99 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 124.135 0.897 . . . . 0.0 109.504 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.566 HD11 ' HA3' ' A' ' 89' ' ' GLY . 25.9 mt -83.05 124.14 76.83 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.7 138.45 34.88 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.769 1.646 . . . . 0.0 109.863 172.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 33.6 mm -86.43 118.63 33.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.986 -175.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 76.6 m -53.72 107.28 0.24 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.582 0.552 . . . . 0.0 111.326 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG2' HG22 ' A' ' 140' ' ' ILE . 7.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 34.4 m-20 . . . . . 0 C--O 1.242 0.686 0 CA-C-O 121.074 0.464 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -77.16 145.12 37.91 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -177.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.79 18.4 12.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.62 157.78 38.71 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -87.43 159.64 49.73 Favored Pre-proline 1 N--CA 1.356 -5.135 0 C-N-CA 125.1 1.36 . . . . 0.0 110.389 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.71 150.09 78.93 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.516 2.81 . . . . 0.0 111.396 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.32 169.07 17.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.195 1.93 . . . . 0.0 112.244 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -117.25 150.71 38.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.04 165.49 15.97 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.331 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.91 -39.25 26.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 5.5 p -89.98 -8.12 52.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -140.98 146.87 37.87 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.7 mt -113.43 126.55 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.058 0 CA-C-O 122.138 0.971 . . . . 0.0 109.945 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.33 113.45 11.56 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.097 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.9 p -90.28 157.31 17.73 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 -175.51 22.26 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.2 m -123.36 99.54 6.38 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.78 68.52 0.69 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 m -97.8 10.97 38.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.413 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.708 ' O ' HD21 ' A' ' 24' ' ' LEU . 22.1 t70 -97.48 -138.7 0.28 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.42 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 54.8 mt-30 -151.03 -58.09 0.16 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.7 p -89.27 129.26 35.86 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.673 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -137.79 149.09 63.36 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 123.903 0.881 . . . . 0.0 108.779 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 27.5 Cg_endo -65.11 150.87 87.25 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 122.516 2.144 . . . . 0.0 112.472 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 27.8 tt0 -67.36 138.71 56.95 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.56 56.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.274 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -81.15 119.13 23.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 2.9 pt20 -85.54 145.92 27.15 Favored 'General case' 0 N--CA 1.417 -2.088 0 O-C-N 123.802 0.689 . . . . 0.0 110.305 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 124.81 52.91 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.66 117.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.052 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 74.3 m-85 -98.07 134.6 40.93 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.041 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -77.37 134.78 38.37 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.3 t -80.53 98.82 7.76 Favored 'General case' 0 N--CA 1.396 -3.139 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -38.49 137.14 0.84 Allowed Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 112.224 -2.262 . . . . 0.0 111.769 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.7 122.41 11.69 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.695 2.263 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 113.87 -10.67 23.07 Favored Glycine 0 C--N 1.289 -2.031 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.347 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 89.9 m-85 -125.23 168.77 13.01 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 122.168 -0.607 . . . . 0.0 110.488 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -157.01 175.0 14.68 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.974 0.91 . . . . 0.0 108.654 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.0 p -159.61 -160.86 0.86 Allowed 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.82 4.18 48.55 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.968 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.21 -119.14 0.65 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -121.4 157.33 30.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 61.5 t -91.16 115.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.4 mm -111.5 121.68 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 CA-C-O 121.362 0.601 . . . . 0.0 110.983 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.413 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 80.0 mtp -106.26 172.58 6.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.5 p -153.78 155.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.497 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.9 t -97.27 132.45 43.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 87.5 mtt180 -149.6 134.08 17.52 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 124.215 0.947 . . . . 0.0 110.127 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 62.79 23.79 14.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.42 -6.5 80.65 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.81 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.02 155.79 30.79 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.116 0.484 . . . . 0.0 110.886 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -93.6 120.65 34.13 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.372 0.606 . . . . 0.0 109.465 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.14 175.6 4.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.036 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.74 115.02 27.7 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.766 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.7 tm? -59.2 -54.54 45.79 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -122.27 99.46 43.15 Favored Pre-proline 0 N--CA 1.404 -2.762 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.757 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.14 -14.21 20.91 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.791 2.327 . . . . 0.0 112.031 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.75 -28.19 55.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.585 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 8.9 mmp_? -91.08 135.17 33.94 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.003 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.23 151.07 5.52 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.533 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 97.4 m -81.58 109.39 15.98 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.731 0.777 . . . . 0.0 112.636 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -105.47 171.79 7.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.072 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -63.79 146.34 54.09 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.3 ptp180 -100.25 146.21 31.57 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 77.8 Cg_endo -82.85 152.01 14.6 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 121.932 1.755 . . . . 0.0 112.156 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.09 -1.19 34.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.493 0.663 . . . . 0.0 111.198 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.79 -92.45 1.12 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.253 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.59 129.9 21.54 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.1 36.08 0.6 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.913 3.075 . . . . 0.0 113.602 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.629 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 87.15 161.46 36.48 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.919 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -115.17 135.79 53.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.515 HG21 ' HE1' ' A' ' 112' ' ' TYR . 9.9 t -157.17 125.42 2.88 Favored Pre-proline 0 N--CA 1.416 -2.136 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.65 14.62 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.454 2.103 . . . . 0.0 111.602 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.06 -16.35 16.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.096 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 114' ' ' CYS . . . -179.67 -162.42 28.68 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.066 -1.54 . . . . 0.0 113.2 -176.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 t -134.74 -164.13 1.47 Allowed 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 123.27 0.628 . . . . 0.0 109.529 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 53.9 p90 -141.54 160.12 40.81 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.627 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 41.4 p -113.61 172.83 6.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 174.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.18 135.6 45.21 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 109' ' ' LYS . 13.1 t -138.01 18.27 2.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.314 1.054 . . . . 0.0 111.307 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 108' ' ' VAL . . . -142.04 38.1 1.51 Allowed Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.39 -176.23 20.46 Favored Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.38 17.59 11.4 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.595 0.712 . . . . 0.0 109.598 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 104' ' ' PHE . 4.9 p -144.67 -167.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 m-85 -104.31 93.72 4.96 Favored 'General case' 0 C--N 1.244 -3.983 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.974 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.4 pt-20 -142.39 152.11 42.5 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -51.4 114.52 1.25 Allowed 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.757 0.661 . . . . 0.0 110.445 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.47 -18.85 10.84 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.988 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.9 p -81.17 138.1 20.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.361 0.601 . . . . 0.0 110.787 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.1 ttmp? -104.61 128.49 52.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -104.66 96.52 6.64 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -81.37 146.4 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 91' ' ' THR . 63.0 t80 -96.79 131.85 43.1 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.694 0.759 . . . . 0.0 109.977 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 m -151.91 157.66 42.12 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.452 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -154.27 -66.4 0.14 Allowed 'General case' 0 C--N 1.251 -3.692 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.578 -173.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 49.8 m-80 -115.79 -177.56 3.19 Favored 'General case' 0 N--CA 1.398 -3.062 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.085 -174.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.51 -46.5 7.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.71 17.59 58.1 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.768 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 3.3 m-85 -125.45 150.63 47.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.244 -0.562 . . . . 0.0 109.941 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -122.1 -148.04 0.4 Allowed 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 171.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -142.99 154.79 44.37 Favored 'General case' 1 N--CA 1.332 -6.363 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.783 -169.469 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.3 mm? -81.63 128.68 34.19 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.24 142.61 5.08 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.4 -18.15 42.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.673 0.749 . . . . 0.0 109.09 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.35 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.747 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.2 p-10 -86.3 28.46 0.83 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.273 0.558 . . . . 0.0 111.474 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 111' ' ' VAL . 47.1 p90 -167.57 -177.6 3.61 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.182 -172.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.46 133.45 15.08 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 29.3 mt-10 -105.92 147.08 29.18 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 122.139 -0.351 . . . . 0.0 111.318 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.5 t -81.77 106.2 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.6 t70 -101.95 -160.82 0.81 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.7 p -63.84 -51.91 62.53 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 124.911 1.285 . . . . 0.0 112.877 -174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.12 -35.82 15.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.227 0.537 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.96 -151.97 10.45 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 79.7 m95 -76.91 139.99 40.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.267 0.533 . . . . 0.0 109.943 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.6 p -63.92 -32.43 73.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -138.21 176.51 8.64 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -92.6 -155.88 0.45 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.629 HD11 ' HA3' ' A' ' 89' ' ' GLY . 38.0 mt -99.17 111.44 61.0 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 122.964 0.506 . . . . 0.0 110.062 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 120' ' ' LEU . 9.4 Cg_endo -61.62 145.42 97.63 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.363 2.042 . . . . 0.0 109.682 170.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.73 123.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.515 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 8.1 t -67.11 120.42 13.68 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HD23 ' A' ' 121' ' ' LEU . 16.6 mm-40 . . . . . 0 C--N 1.313 -1.003 0 C-N-CA 125.343 1.457 . . . . 0.0 108.141 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 6.0 m-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 77.5 m -69.17 127.4 32.94 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.948 -178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.57 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.216 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.1 158.8 25.32 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.4 mt -77.52 155.62 81.26 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.03 132.6 48.42 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.936 2.424 . . . . 0.0 112.747 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.54 110.94 3.11 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 122.468 2.112 . . . . 0.0 112.018 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -58.55 147.38 32.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.075 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -122.82 169.1 11.45 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.443 -170.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -35.88 26.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -127.82 14.82 6.94 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.942 0.401 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 4.1 mp0 -130.79 144.44 51.45 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.428 HD11 ' HG2' ' A' ' 53' ' ' ARG . 8.6 mt -133.46 156.48 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -78.35 145.78 35.05 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-O 121.276 0.56 . . . . 0.0 112.262 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -106.73 109.97 22.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.93 -138.32 9.06 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 t -151.04 132.23 14.45 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.543 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.6 m95 -135.82 122.09 20.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -143.73 24.12 1.71 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . 5.1 t70 -100.7 -173.29 2.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.622 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.13 -25.36 2.24 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.234 0.614 . . . . 0.0 110.18 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 22' ' ' ASN . 6.9 p -142.45 131.18 22.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.839 0.352 . . . . 0.0 111.502 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 39' ' ' ASP . 31.3 m-85 -127.23 143.54 47.49 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.1 Cg_endo -62.56 147.21 95.14 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.7 2.267 . . . . 0.0 111.748 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.8 tt0 -67.73 129.55 40.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.06 1.46 28.39 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.572 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m -83.76 120.15 25.68 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -93.02 152.23 19.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.379 0.609 . . . . 0.0 111.924 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.99 130.84 53.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.609 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.9 mt -101.47 125.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.3 m-85 -102.33 143.7 31.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 54.7 tttm -92.45 141.5 28.45 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 93.6 m -90.59 16.71 8.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 32' ' ' ILE . 79.0 mtt180 65.81 161.57 0.13 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.315 0.646 . . . . 0.0 111.104 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 40.3 Cg_endo -75.33 140.18 24.29 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 121.189 1.26 . . . . 0.0 110.2 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.66 0.07 60.91 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 92.8 m-85 -128.74 175.84 8.28 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.168 0.509 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 57' ' ' ARG . 4.0 ptm180 -154.99 -171.64 3.9 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 p -163.27 154.3 16.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 120.895 0.379 . . . . 0.0 110.721 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.15 -27.21 59.65 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.44 141.22 7.06 Favored Glycine 0 N--CA 1.408 -3.213 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.36 142.54 51.94 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.15 0.58 . . . . 0.0 111.238 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.4 118.22 10.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -116.11 124.28 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -113.04 166.79 11.08 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.6 p -149.66 143.05 17.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.492 0.663 . . . . 0.0 110.137 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.26 122.75 19.49 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 125.159 1.384 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.0 ttt180 -160.85 132.91 5.92 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 72.4 mmtt 66.19 25.7 10.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.12 0.568 . . . . 0.0 112.376 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 91.95 -10.96 73.35 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.574 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.57 171.92 12.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -93.45 123.35 36.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.33 168.11 9.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.056 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.17 114.89 18.48 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.721 0.296 . . . . 0.0 111.088 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.76 -39.02 92.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -143.65 98.87 5.28 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.72 -4.07 14.18 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.839 2.359 . . . . 0.0 113.101 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.65 -31.13 41.45 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.76 141.43 48.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.895 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -158.27 160.38 37.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -102.58 130.15 49.36 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -126.46 172.64 10.02 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.8 mmtp -64.86 151.52 45.31 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.033 0.533 . . . . 0.0 111.974 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -86.97 151.91 52.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 67.4 Cg_endo -77.07 160.83 33.13 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 121.535 1.49 . . . . 0.0 110.087 176.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -114.85 -22.51 9.6 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.344 -174.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.97 -179.2 53.39 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -78.33 128.12 78.99 Favored Pre-proline 0 C--N 1.289 -2.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 48.17 1.2 Allowed 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.076 3.184 . . . . 0.0 114.177 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 90.59 157.47 33.6 Favored Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.86 126.99 55.25 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.245 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 9.8 t -135.33 125.13 16.6 Favored Pre-proline 0 N--CA 1.412 -2.356 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 9.6 Cg_exo -74.2 -10.88 22.88 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.286 1.991 . . . . 0.0 112.042 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -127.55 141.39 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.14 47.9 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.119 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -163.79 -169.2 1.82 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.201 0.5 . . . . 0.0 109.872 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 46.5 p90 -142.34 160.29 40.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.476 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.6 p -113.61 173.0 6.63 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.2 mt -140.99 118.13 11.27 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -113.14 -7.65 13.61 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.354 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -113.84 28.94 8.11 Favored Glycine 0 CA--C 1.489 -1.562 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.03 -171.07 27.82 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -129.49 10.88 5.73 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.282 1.039 . . . . 0.0 109.616 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 108' ' ' VAL . 35.5 m -140.02 174.73 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 31.0 m-85 -88.94 88.15 7.48 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.76 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.543 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.2 pt-20 -136.24 150.22 48.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.241 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -46.16 116.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.374 1.046 . . . . 0.0 111.027 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.15 -23.43 6.5 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.651 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG12 ' C ' ' A' ' 100' ' ' GLY . 19.9 m -77.71 139.12 19.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.07 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.9 ttmp? -102.4 120.43 40.5 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -101.31 101.3 11.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -84.24 139.96 16.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.777 -176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -97.31 113.54 25.19 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.5 m -117.89 159.38 23.2 Favored 'General case' 0 N--CA 1.402 -2.836 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.09 -62.04 0.73 Allowed 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.473 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -155.83 -170.06 3.29 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.74 -53.27 8.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.582 0.706 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.68 -12.75 82.5 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.721 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -112.41 121.82 45.95 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.019 0.128 . . . . 0.0 110.903 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -102.8 -114.93 0.21 Allowed 'General case' 0 CA--C 1.466 -2.276 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -163.64 156.35 18.11 Favored 'General case' 1 N--CA 1.337 -6.119 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.573 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 67.3 mt -89.92 103.78 16.41 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.104 0.954 . . . . 0.0 109.387 173.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.09 155.14 8.87 Favored Glycine 0 N--CA 1.41 -3.086 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -93.44 -18.3 22.49 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.937 0.875 . . . . 0.0 109.585 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.4 mm -112.38 106.16 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.815 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.4 p-10 -83.81 30.58 0.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.136 0.493 . . . . 0.0 111.399 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -164.2 178.2 7.77 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -173.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.98 138.6 45.54 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 22.6 mt-10 -111.48 136.69 50.29 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.89 107.63 14.76 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.64 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -100.39 -170.43 1.87 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 p -66.64 -40.66 88.82 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 124.525 1.13 . . . . 0.0 110.601 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.0 -35.79 62.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.025 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.37 -152.46 24.34 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.26 126.93 30.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.126 0.463 . . . . 0.0 109.794 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 p -58.94 -35.84 73.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 123.566 0.746 . . . . 0.0 112.913 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.08 167.33 17.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.9 -96.95 0.3 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -173.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.427 HD11 ' HA3' ' A' ' 89' ' ' GLY . 24.4 mt -132.81 92.75 25.54 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 121.656 -0.653 . . . . 0.0 111.316 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.844 ' HB2' HD12 ' A' ' 120' ' ' LEU . 3.3 Cg_endo -53.6 137.22 66.15 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 122.736 2.291 . . . . 0.0 109.32 166.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 31.7 mm -87.69 122.87 39.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.898 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 21.0 t -52.29 124.41 13.16 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.952 0.342 . . . . 0.0 110.772 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.424 -1.744 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.239 0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.6 m -84.87 133.53 34.3 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER -106.67 27.49 8.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.851 0.834 . . . . 0.0 109.605 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 162.4 37.58 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -99.66 158.19 32.59 Favored Pre-proline 0 N--CA 1.39 -3.434 0 O-C-N 124.558 1.161 . . . . 0.0 110.277 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 17.9 Cg_endo -60.12 133.35 49.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.952 2.435 . . . . 0.0 110.684 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.89 170.66 19.55 Favored 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -117.27 139.02 51.33 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -113.37 -176.85 2.99 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -73.54 -27.12 61.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 21.4 p -116.94 0.5 12.45 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -133.3 140.4 47.43 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.515 0.674 . . . . 0.0 112.329 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -138.62 145.74 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.92 142.66 57.21 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.5 p -90.76 -28.32 18.35 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.568 0.699 . . . . 0.0 109.549 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.71 177.4 37.24 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.4 p -113.9 114.87 26.82 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 123.481 0.712 . . . . 0.0 110.316 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -110.48 110.77 21.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -115.89 3.52 13.74 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.631 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.643 ' O ' HD21 ' A' ' 24' ' ' LEU . 40.1 m-20 -101.91 -157.09 0.59 Allowed 'General case' 0 CA--C 1.479 -1.775 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.58 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 40' ' ' GLN . 18.9 mt-30 -133.84 -58.84 0.86 Allowed 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 170.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.9 p -80.98 121.1 25.61 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.44 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 41.1 m-85 -129.33 145.0 54.97 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.086 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.03 143.56 66.24 Favored 'Trans proline' 0 C--O 1.262 1.695 0 C-N-CA 122.635 2.223 . . . . 0.0 111.086 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -63.16 138.82 58.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.36 1.73 50.69 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.203 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.442 ' C ' HG23 ' A' ' 65' ' ' VAL . 92.9 m -85.06 117.42 24.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -85.74 149.76 25.06 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.245 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.11 130.08 53.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -100.24 132.8 45.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.57 143.94 44.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.596 0.712 . . . . 0.0 112.595 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.24 142.52 27.31 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 171.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.713 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.8 m -86.8 27.8 0.95 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 70.2 mtp180 61.62 166.61 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 121.451 0.643 . . . . 0.0 111.005 -174.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.14 118.09 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.194 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 171.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.4 -23.38 7.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.069 -1.063 . . . . 0.0 113.051 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.713 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 95.8 m-85 -102.74 179.56 4.25 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 122.023 -0.693 . . . . 0.0 109.368 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -155.75 -174.75 5.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -171.95 168.7 5.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 98.4 mt -87.73 14.48 8.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.861 0.839 . . . . 0.0 110.081 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.05 -146.01 5.78 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.33 150.08 48.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.6 t -73.06 101.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.9 118.64 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.53 175.5 5.48 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.7 p -161.02 144.72 4.54 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.166 0.508 . . . . 0.0 110.464 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.72 121.78 18.6 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.111 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 64.3 ttt180 -150.14 124.34 9.47 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 14.6 mmmm 61.69 22.39 12.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 113.017 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.38 -10.41 65.15 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.487 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.22 157.31 25.08 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.167 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 85.4 m95 -88.59 117.25 27.41 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.14 174.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.39 125.89 37.24 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.462 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.22 -48.39 51.63 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -110.3 88.23 7.08 Favored Pre-proline 0 N--CA 1.429 -1.515 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.891 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 77' ' ' LEU . 38.3 Cg_endo -69.51 -18.66 38.04 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.333 2.022 . . . . 0.0 111.758 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 ' HG2' ' A' ' 76' ' ' PRO . 3.5 mm? -80.61 -14.3 58.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.76 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' NH1' ' HB2' ' A' ' 59' ' ' LEU . 25.4 mmt180 -95.65 123.44 39.21 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 121.693 0.759 . . . . 0.0 110.231 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.11 151.55 37.02 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.64 112.44 22.32 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.089 0.947 . . . . 0.0 110.918 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -108.14 172.68 6.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.766 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.5 159.0 24.29 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.615 0.722 . . . . 0.0 111.671 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -94.24 144.77 28.58 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 174.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 60.5 Cg_endo -73.35 163.64 37.27 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 121.733 1.622 . . . . 0.0 109.351 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.9 m -115.75 1.11 13.39 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.46 -170.79 53.49 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.752 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -88.35 117.42 68.36 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.34 102.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 113.257 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 88.85 125.48 2.53 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.952 175.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.12 19.0 5.3 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.749 0.785 . . . . 0.0 109.101 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -60.82 134.47 92.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.171 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.5 -4.66 1.97 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.395 2.063 . . . . 0.0 112.349 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.06 -33.66 5.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.09 0.471 . . . . 0.0 111.131 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.22 138.58 18.05 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.329 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.82 156.31 30.9 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.8 p90 -128.77 158.72 37.85 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.241 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 76.8 p -108.87 168.33 9.43 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.87 123.82 22.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.34 0.59 . . . . 0.0 110.089 175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.2 t -132.65 141.46 48.64 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.95 14.12 67.84 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.427 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.18 -52.1 0.05 OUTLIER Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.256 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.32 -3.68 2.1 Favored 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 124.236 1.014 . . . . 0.0 112.946 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 m -144.65 175.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.4 m-85 -78.33 94.4 4.83 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.22 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.71 151.11 35.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -42.82 129.33 4.28 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.01 -9.93 74.57 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.679 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.96 138.35 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.285 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.1 ttmt -105.22 120.52 41.75 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.676 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -99.8 99.8 10.66 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -79.18 136.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.478 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 52.8 t80 -102.83 129.18 49.42 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -147.6 149.64 32.91 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.73 -52.78 2.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 -174.6 4.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -87.17 -45.04 11.03 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.7 -32.79 61.11 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.354 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -86.16 119.22 26.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.379 0.609 . . . . 0.0 110.839 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 24.5 mt-30 -110.21 -159.89 0.7 Allowed 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.63 155.1 44.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -82.8 137.99 34.14 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.781 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.2 158.87 12.65 Favored Glycine 0 C--N 1.285 -2.286 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -92.4 -17.45 24.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.219 0.509 . . . . 0.0 110.9 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 126' ' ' TYR . 40.0 mm -112.03 109.42 28.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -86.28 22.64 1.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.4 p90 -151.12 176.22 11.38 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 77.0 mtm180 -142.24 127.92 19.19 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -106.96 138.68 42.68 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.7 t -81.38 97.38 7.7 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.137 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.2 175.47 10.56 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.54 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.6 p -49.47 -41.37 40.18 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 125.666 1.586 . . . . 0.0 112.252 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.46 -27.08 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.017 0.436 . . . . 0.0 111.412 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.96 -170.08 36.73 Favored Glycine 0 C--N 1.303 -1.302 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -65.2 141.57 58.61 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 117.22 0.51 . . . . 0.0 111.71 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.7 p -85.12 133.46 34.21 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 73.81 171.27 0.3 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.543 0.737 . . . . 0.0 110.003 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 127' ' ' ARG . 6.3 p-10 -111.87 -102.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.985 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 89' ' ' GLY . 52.8 mt -126.95 102.65 24.49 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 19.0 Cg_endo -59.72 138.17 81.48 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.042 1.828 . . . . 0.0 110.166 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.48 113.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.478 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 93.9 m -72.85 112.36 8.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.759 0.314 . . . . 0.0 111.402 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.56 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 32.9 mt-10 . . . . . 0 C--N 1.317 -0.83 0 C-N-CA 125.157 1.383 . . . . 0.0 108.523 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.966 0.412 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 41' ' ' THR . 70.1 m -79.9 132.04 35.99 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.505 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.22 13.62 26.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.324 0.583 . . . . 0.0 110.414 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.18 160.83 38.41 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.658 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 38.0 mt -84.33 157.42 62.05 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 123.968 0.792 . . . . 0.0 109.262 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 28.7 Cg_endo -64.01 133.2 37.43 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 121.668 1.579 . . . . 0.0 109.946 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.79 162.55 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.026 1.817 . . . . 0.0 111.712 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -98.21 146.73 25.32 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -114.1 173.55 6.39 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -65.09 -34.39 78.3 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -117.63 1.24 12.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -131.78 147.05 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.25 0.547 . . . . 0.0 111.669 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 53' ' ' ARG . 12.6 mt -143.92 156.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 3.9 mm? -72.08 168.96 17.03 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-O 121.916 0.865 . . . . 0.0 112.594 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -123.85 145.48 49.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 171.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.09 -144.98 15.98 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.709 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -139.14 137.76 36.4 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 81.5 m95 -138.84 121.81 16.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.6 m -151.92 24.08 0.66 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.755 0.312 . . . . 0.0 111.331 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 15.8 m-20 -118.31 -169.63 1.74 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.1 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -119.27 -66.1 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.0 p -86.67 127.81 34.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -130.34 140.6 39.14 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.754 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.42 145.19 87.54 Favored 'Trans proline' 0 C--O 1.264 1.779 0 C-N-CA 122.616 2.211 . . . . 0.0 110.801 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.546 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.4 tt0 -65.44 140.99 58.66 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.75 57.36 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.206 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' HG23 ' A' ' 65' ' ' VAL . 75.8 m -85.95 117.91 25.09 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.313 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -88.11 146.08 25.61 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.782 0.801 . . . . 0.0 111.31 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.55 119.67 36.93 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 63' ' ' ILE . 62.4 mt -92.06 120.15 40.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 61.4 m-85 -102.75 141.47 35.51 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -88.35 153.58 21.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.1 m -91.6 25.93 2.5 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 32' ' ' ILE . 70.0 mtp180 62.88 167.91 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -77.59 100.0 1.35 Allowed 'Trans proline' 0 N--CA 1.428 -2.365 0 CA-C-N 119.162 0.736 . . . . 0.0 110.912 174.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 135.5 -17.9 3.95 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.123 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.9 m-85 -110.12 173.15 6.46 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 109.881 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -152.1 -174.66 4.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -168.77 -178.16 3.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.05 14.05 9.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.727 0.775 . . . . 0.0 110.482 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.32 174.7 38.6 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.72 145.93 34.21 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 118.425 1.113 . . . . 0.0 109.362 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 90.8 t -74.19 111.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.421 HD12 HG12 ' A' ' 49' ' ' ILE . 44.6 mm -106.18 122.84 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.011 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.6 mtp -112.07 172.77 6.71 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.418 HG23 ' C ' ' A' ' 46' ' ' THR . 8.2 p -157.41 145.31 10.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-O 121.335 0.588 . . . . 0.0 110.648 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.4 t -69.65 125.81 27.84 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.824 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 34.6 ttp180 -151.76 123.26 7.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm 62.37 25.96 15.5 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 124.267 1.027 . . . . 0.0 113.46 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.97 -15.74 61.19 Favored Glycine 0 N--CA 1.413 -2.883 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.515 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.69 163.7 15.73 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.706 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.415 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 82.1 m95 -97.19 123.87 41.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.329 0.585 . . . . 0.0 109.856 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 171.53 14.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.421 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.79 124.96 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -49.77 56.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -108.26 90.47 6.95 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.169 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.49 -11.95 26.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.791 2.327 . . . . 0.0 114.089 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -90.8 -19.87 22.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.087 0.47 . . . . 0.0 110.352 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 7.6 mmp_? -92.69 134.11 35.35 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.8 0.81 . . . . 0.0 112.468 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 166.3 32.92 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 172.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.9 m -91.96 129.4 37.93 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.59 0.709 . . . . 0.0 111.173 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.34 167.98 14.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.519 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 95.5 mttt -65.62 136.43 56.32 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.573 0.225 . . . . 0.0 111.351 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.7 ptp180 -78.35 147.01 71.59 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.45 159.46 32.51 Favored 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.868 1.712 . . . . 0.0 109.631 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.8 m -118.24 8.49 12.31 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 121.463 0.649 . . . . 0.0 111.488 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.33 -85.93 1.23 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.497 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -168.06 147.88 4.28 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.75 53.13 2.7 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.346 2.031 . . . . 0.0 111.615 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 80.97 -96.31 1.69 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.5 t70 169.56 126.63 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 125.493 1.517 . . . . 0.0 107.674 171.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -120.88 117.53 30.95 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.67 1.92 7.88 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.149 1.899 . . . . 0.0 111.112 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -115.19 -55.39 2.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.851 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 114' ' ' CYS . . . -73.54 150.58 43.55 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 m -92.63 -55.92 3.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . 0.274 1.9 p90 70.16 145.93 0.06 Allowed 'General case' 0 C--O 1.248 0.985 0 C-N-CA 126.558 1.943 . . . . 0.0 114.493 173.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.611 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -117.03 148.15 41.73 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.994 179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.584 HD22 ' CG1' ' A' ' 108' ' ' VAL . 83.0 mt -109.12 135.96 49.4 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.7 t -138.23 139.01 39.05 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.55 -26.36 16.53 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.18 164.69 34.17 Favored Glycine 0 CA--C 1.489 -1.568 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.458 ' O ' HG13 ' A' ' 103' ' ' VAL . 48.7 t-20 -123.12 60.18 1.06 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 118.173 0.986 . . . . 0.0 110.006 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.0 m -168.65 -178.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.634 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 172.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.08 84.31 5.26 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.911 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.26 157.42 39.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.804 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 62.7 t80 -58.55 122.32 13.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.758 0.79 . . . . 0.0 111.767 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.5 -19.38 12.87 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.584 ' CG1' HD22 ' A' ' 98' ' ' LEU . 24.1 t -71.72 129.94 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.723 0.773 . . . . 0.0 112.066 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.1 ttmt -102.91 119.71 39.32 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.61 93.24 7.03 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.611 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.5 p -79.14 109.29 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-O 122.35 1.071 . . . . 0.0 109.116 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.8 t80 -80.89 103.56 10.81 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 113.837 -1.528 . . . . 0.0 110.878 -169.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 m -74.47 -38.29 62.96 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.644 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 45.8 t 72.73 -92.83 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.348 0 O-C-N 125.312 1.632 . . . . 0.0 108.906 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -137.2 -174.48 3.76 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.96 -42.67 14.71 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.57 0.7 . . . . 0.0 109.198 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.68 -22.9 54.94 Favored Glycine 0 C--N 1.308 -1.001 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.909 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.03 128.73 55.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.481 -0.423 . . . . 0.0 111.001 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -111.34 -148.15 0.43 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -117.22 166.72 11.93 Favored 'General case' 1 N--CA 1.376 -4.131 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.604 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 32.6 mt -97.32 106.12 18.39 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.559 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.6 166.2 14.43 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -84.68 -27.56 26.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.132 0.968 . . . . 0.0 108.515 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.0 109.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.31 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -97.43 23.88 7.16 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.141 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 37.2 p90 -159.01 178.31 10.2 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.399 0.619 . . . . 0.0 110.519 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -149.68 129.03 12.91 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.962 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 36.3 mt-10 -101.51 157.48 16.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 122.8 34.96 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.841 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.9 t70 -101.98 -169.12 1.63 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.439 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 48.5 p -71.72 -37.35 70.64 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 124.585 1.154 . . . . 0.0 108.492 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.05 -52.11 15.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.044 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.02 -150.25 16.07 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.23 137.73 45.15 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.024 0.912 . . . . 0.0 110.336 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.2 p -81.05 167.64 19.53 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.48 -111.39 0.27 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.325 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -167.8 -178.61 3.9 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.469 HD11 ' HA3' ' A' ' 89' ' ' GLY . 82.9 mt -94.93 103.83 12.87 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.4 Cg_endo -48.24 127.79 16.02 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.269 2.646 . . . . 0.0 112.584 -176.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.8 mm -75.06 115.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.732 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.3 m -61.61 121.4 12.67 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 N--CA 1.425 -1.697 0 C-N-CA 126.445 1.898 . . . . 0.0 107.791 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 35.4 m-20 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 120.751 0.31 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.8 m -65.67 139.93 58.44 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -117.89 18.74 13.94 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.357 0.599 . . . . 0.0 109.729 176.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.07 159.22 37.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.729 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 mt -79.5 153.3 76.19 Favored Pre-proline 0 C--N 1.31 -1.137 0 O-C-N 123.873 0.733 . . . . 0.0 109.15 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 128.67 30.72 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.457 2.104 . . . . 0.0 111.166 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.68 123.38 12.9 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.488 2.126 . . . . 0.0 111.409 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -68.1 149.55 49.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.501 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.1 mmp_? -112.51 178.56 4.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.229 -171.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -82.25 -58.94 2.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.48 -8.53 35.06 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.955 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.5 mp0 -109.02 142.53 39.58 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.985 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mt -133.09 150.4 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.848 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.75 140.42 53.44 Favored 'General case' 0 C--N 1.277 -2.58 0 O-C-N 124.245 0.966 . . . . 0.0 111.084 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.0 p -87.21 -34.33 19.03 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.207 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.4 167.43 26.1 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.434 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 p -105.26 118.23 36.02 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -99.71 161.97 13.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -130.79 -23.79 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -137.01 162.48 33.2 Favored 'General case' 0 C--O 1.183 -2.446 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.423 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.3 -29.48 26.34 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.498 0.666 . . . . 0.0 109.641 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.6 p -97.16 108.4 21.12 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-O 121.88 0.848 . . . . 0.0 112.431 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -118.1 157.83 47.75 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.511 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 47.6 Cg_endo -70.67 152.8 64.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 121.628 1.552 . . . . 0.0 110.875 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.42 151.8 45.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.24 74.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.617 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -83.05 121.14 26.65 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.956 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.01 146.45 23.85 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.675 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.88 117.03 29.06 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.44 130.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 65.1 m-85 -104.19 139.43 39.25 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -75.13 -29.51 60.55 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.319 -1.764 . . . . 0.0 113.656 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.7 m 71.29 3.05 4.51 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 72.86 152.35 0.14 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.96 108.87 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.554 2.17 . . . . 0.0 112.738 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.41 7.01 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.476 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 96.4 m-85 -98.81 168.14 10.32 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 122.103 -0.645 . . . . 0.0 110.465 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -133.21 -175.93 3.96 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -157.08 -175.93 5.69 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -104.76 16.22 26.41 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.123 0.487 . . . . 0.0 110.073 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.45 29.82 0.07 OUTLIER Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.49 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.56 144.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.977 1.311 . . . . 0.0 112.049 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.6 t -76.98 116.4 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.25 124.55 69.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.804 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.44 168.77 9.15 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.9 p -155.45 149.99 11.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.8 t -84.08 128.73 34.75 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.84 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.423 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -144.95 124.84 13.44 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -178.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 35.3 mmtp 59.23 29.56 19.14 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 94.35 -17.48 58.88 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.934 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 167.17 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.715 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.79 122.46 46.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 -168.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.693 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.48 23.04 Favored 'General case' 1 C--N 1.225 -4.825 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.967 -171.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.85 -53.99 13.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.83 80.6 49.5 Favored Pre-proline 0 N--CA 1.419 -1.997 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.263 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.61 -13.06 22.44 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.743 2.295 . . . . 0.0 110.969 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.3 mm? -68.69 -30.1 68.69 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.714 177.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -81.25 143.56 32.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.566 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.8 158.65 43.54 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -94.57 106.95 18.94 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.45 160.75 14.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.95 146.56 39.54 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.11 140.23 61.54 Favored Pre-proline 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.421 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.51 145.47 47.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.095 1.863 . . . . 0.0 109.624 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.9 m -104.55 -14.99 15.46 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.997 0.427 . . . . 0.0 111.686 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.61 -167.67 54.77 Favored Glycine 0 N--CA 1.412 -2.927 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.433 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -68.74 119.73 71.1 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 124.323 1.049 . . . . 0.0 109.583 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 72.8 Cg_endo -80.34 -6.67 13.83 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.15 2.567 . . . . 0.0 112.295 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 112.73 134.65 6.2 Favored Glycine 0 N--CA 1.406 -3.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.93 174.39 7.26 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.861 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -162.53 127.37 2.07 Favored Pre-proline 0 N--CA 1.412 -2.362 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -88.85 -4.18 6.24 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.089 1.859 . . . . 0.0 111.555 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.71 -47.42 3.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.469 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.51 -172.31 25.83 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.262 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 m -145.98 167.37 23.48 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -143.72 157.52 44.33 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.255 0.479 . . . . 0.0 110.11 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -119.95 154.0 35.1 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.794 0.684 . . . . 0.0 110.5 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 94.6 mt -115.2 133.33 56.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 109' ' ' LYS . 6.1 t -127.39 148.17 50.27 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.72 -66.62 3.57 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.068 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.51 -43.24 6.59 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.427 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t30 75.37 -4.41 2.38 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 122.105 0.955 . . . . 0.0 111.684 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.16 -178.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -88.18 79.46 7.86 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.376 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.77 151.09 52.07 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.842 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -45.11 122.33 3.3 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.447 0.699 . . . . 0.0 111.756 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.36 -16.52 32.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.615 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.57 147.06 7.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 O-C-N 122.391 -0.476 . . . . 0.0 110.358 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.449 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.4 ttmp? -114.45 127.57 55.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.37 88.01 3.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.6 p -80.97 124.02 38.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.705 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -102.02 141.3 35.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.363 -168.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.27 161.94 34.87 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.29 -74.24 0.35 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.922 -1.511 . . . . 0.0 110.695 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -141.25 -177.79 5.29 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.56 152.54 21.05 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.38 -43.91 1.93 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.29 132.1 22.7 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -104.22 -61.43 1.45 Allowed 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.851 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 125' ' ' ASN . 4.2 pp 179.52 157.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.387 1.054 . . . . 0.0 109.17 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 81.3 mt -97.71 132.03 43.72 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.71 148.12 5.67 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -84.51 -19.94 32.44 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.286 1.041 . . . . 0.0 109.581 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 126' ' ' TYR . 38.6 mm -103.06 92.46 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.046 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 120' ' ' LEU . 23.0 p-10 -83.17 29.69 0.48 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 124.763 1.225 . . . . 0.0 110.312 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 124' ' ' ILE . 52.4 p90 -161.7 179.05 8.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -142.03 121.5 13.24 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.451 ' HG3' ' CD2' ' A' ' 126' ' ' TYR . 48.3 mt-10 -103.07 141.43 35.83 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -91.44 112.16 23.96 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.196 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 131' ' ' THR . 21.3 t70 -99.76 -164.61 1.14 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.261 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.461 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 46.9 p -66.01 -42.53 89.56 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.447 1.099 . . . . 0.0 110.327 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.61 -41.48 79.46 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.162 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.55 -141.45 9.53 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.516 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.5 m95 -72.44 130.96 41.92 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 117.007 0.403 . . . . 0.0 111.557 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.2 p -83.82 129.09 34.94 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 74.73 166.92 0.29 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.74 0.781 . . . . 0.0 111.611 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.66 -173.29 2.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.474 HD11 ' HA3' ' A' ' 89' ' ' GLY . 17.9 mt -71.66 116.57 49.15 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.08 129.07 24.59 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 121.505 1.47 . . . . 0.0 110.927 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.3 123.17 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.642 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 65.9 m -66.19 109.22 2.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.46 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 8.4 tp10 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.071 0.939 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.2 m -77.93 124.61 28.21 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.717 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER -95.65 21.37 8.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.133 0.968 . . . . 0.0 109.589 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.73 155.82 43.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.163 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.5 150.35 79.42 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 124.151 0.907 . . . . 0.0 111.558 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.93 139.94 44.48 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.187 1.925 . . . . 0.0 109.655 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.22 155.81 66.63 Favored 'Trans proline' 0 C--N 1.328 -0.538 0 C-N-CA 122.56 2.173 . . . . 0.0 113.743 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -97.09 134.47 40.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -109.11 151.05 26.94 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.617 -173.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -64.6 -31.48 72.71 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.0 -15.68 16.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -133.87 137.04 44.74 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 112.347 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 56.4 mt -115.73 158.98 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HB3' ' NE1' ' A' ' 37' ' ' TRP . 33.3 mt -94.07 142.21 27.65 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 119.012 0.824 . . . . 0.0 111.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.4 p -98.12 151.94 19.86 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.53 -155.01 20.82 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -133.54 114.86 14.04 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' NE1' ' HB3' ' A' ' 33' ' ' LEU . 44.6 m95 -122.69 99.23 6.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.7 m -135.0 -0.99 2.71 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.984 0.421 . . . . 0.0 110.348 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.33 150.1 22.04 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.522 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -82.61 -51.27 7.91 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.978 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 38.7 p -95.8 106.33 18.44 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.16 129.72 23.72 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.847 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.52 150.44 68.81 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.9 131.78 49.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.57 7.33 48.68 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.295 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -86.38 114.84 23.49 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.985 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.0 pt20 -90.01 136.33 33.11 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-O 121.766 0.793 . . . . 0.0 111.669 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.38 121.33 43.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.074 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 63' ' ' ILE . 68.5 mt -97.12 113.46 31.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.101 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -83.59 136.46 34.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.377 1.084 . . . . 0.0 113.177 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 60.9 tttp -66.18 -28.6 68.9 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.095 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 15.9 t 72.43 -4.39 2.06 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.947 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 71.91 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 124.487 1.115 . . . . 0.0 111.472 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 55.8 Cg_endo -70.15 120.82 7.47 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 121.462 1.442 . . . . 0.0 110.381 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 118.19 -20.12 10.65 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 93.5 m-85 -101.52 170.44 8.2 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -156.64 169.1 25.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.6 p -143.87 -177.05 5.24 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.23 21.73 1.35 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.67 0.748 . . . . 0.0 110.737 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.9 -96.1 0.12 Allowed Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -154.57 150.62 27.93 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.44 105.93 4.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG12 ' A' ' 49' ' ' ILE . 45.3 mm -105.84 120.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.617 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.5 mtp -106.73 164.99 11.64 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 6.8 p -150.35 145.83 16.86 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.742 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.114 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 48.1 t -73.68 121.37 20.64 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.288 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 34.2 ttt180 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 74.2 mmtt 65.12 23.65 12.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.82 0.848 . . . . 0.0 112.278 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.78 -2.43 72.84 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.889 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 153.24 47.43 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.77 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.2 121.66 28.27 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.771 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.04 173.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.655 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.23 123.64 29.2 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.77 -39.95 94.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -139.54 100.56 7.53 Favored Pre-proline 0 N--CA 1.422 -1.829 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.703 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.0 -3.38 13.7 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.846 2.364 . . . . 0.0 111.912 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.6 mt -91.09 -6.5 53.64 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 122.213 1.006 . . . . 0.0 109.801 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 78' ' ' ARG . 20.1 mmt180 -99.39 122.59 42.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.961 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.35 147.62 40.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.988 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.1 m -87.39 128.22 35.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.659 0.742 . . . . 0.0 111.848 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -128.6 169.21 14.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 106' ' ' TYR . 48.0 mtmt -82.46 144.73 30.26 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.531 ' NH1' ' HA ' ' A' ' 132' ' ' ASP . 12.8 ptm180 -67.32 156.77 87.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.643 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 73.3 Cg_endo -77.92 160.76 30.43 Favored 'Trans proline' 0 C--O 1.256 1.397 0 C-N-CA 121.968 1.779 . . . . 0.0 109.769 172.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.9 m -127.31 1.27 6.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.511 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.91 1.04 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.753 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -155.23 135.87 8.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.97 13.63 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.973 2.449 . . . . 0.0 113.059 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 81.27 -166.3 47.87 Favored Glycine 0 N--CA 1.41 -3.042 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.56 171.52 19.81 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -132.45 121.35 17.36 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.45 -43.72 43.11 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.416 2.744 . . . . 0.0 114.575 -171.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.24 26.49 5.91 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.63 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -142.13 174.94 23.01 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.265 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.21 168.09 19.8 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.423 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . 53.2 p90 -143.09 156.16 44.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.277 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 p -125.24 169.13 12.57 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 124.213 1.005 . . . . 0.0 108.864 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.64 164.36 19.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.387 0.613 . . . . 0.0 111.469 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.0 t -162.03 147.97 13.34 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 175.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 20.77 41.46 Favored Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.566 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.91 -58.8 0.32 Allowed Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 82.68 35.2 0.06 Allowed 'General case' 0 CA--C 1.457 -2.602 0 CA-C-O 123.807 1.765 . . . . 0.0 109.357 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 8.2 p -156.29 -162.3 0.02 OUTLIER 'Isoleucine or valine' 1 N--CA 1.373 -4.294 0 CA-C-N 110.868 -2.878 . . . . 0.0 103.587 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 75.4 m-85 -113.16 83.85 1.9 Allowed 'General case' 1 C--N 1.225 -4.848 0 CA-C-O 121.577 0.704 . . . . 0.0 111.554 -176.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 25.4 pt-20 -143.36 163.5 32.88 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.368 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.454 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 58.8 t80 -49.78 131.94 22.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.311 1.007 . . . . 0.0 111.498 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.39 -13.31 63.04 Favored Glycine 0 N--CA 1.421 -2.344 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.45 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -77.25 145.21 10.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.572 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.7 ttmt -108.93 118.83 37.82 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.043 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.38 98.17 11.61 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -91.04 122.64 42.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 82.1 m-85 -96.04 141.59 29.26 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.303 1.049 . . . . 0.0 111.768 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -145.91 138.76 25.78 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 103.106 -2.924 . . . . 0.0 103.106 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 120' ' ' LEU . 58.6 m -95.38 -87.69 0.27 Allowed 'General case' 0 C--N 1.252 -3.668 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.622 -168.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -148.72 -173.05 4.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -49.82 -54.03 21.8 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.953 1.301 . . . . 0.0 112.816 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.69 13.22 27.45 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.389 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' CYS . 35.4 m-85 -114.87 128.48 56.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.97 -159.7 0.69 Allowed 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 163.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.612 ' HB3' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -139.29 151.89 46.81 Favored 'General case' 1 N--CA 1.334 -6.23 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.766 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 107.71 9.13 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.365 0.602 . . . . 0.0 111.064 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.52 140.55 4.21 Favored Glycine 0 N--CA 1.419 -2.458 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.185 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.72 -5.95 52.3 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.405 0.621 . . . . 0.0 111.312 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.418 HG21 ' ND2' ' A' ' 136' ' ' ASN . 44.2 mm -108.82 90.96 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB3' HD21 ' A' ' 120' ' ' LEU . 26.8 p-10 -86.54 42.87 1.03 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.44 -176.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -167.5 174.06 8.18 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.719 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 135' ' ' THR . 6.2 ptm180 -156.35 134.44 11.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -102.88 158.54 16.21 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.593 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -94.28 126.55 39.6 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.848 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 131' ' ' THR . 20.7 t70 -100.07 -156.05 0.53 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.51 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 51.2 p -66.4 -25.54 66.82 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 125.217 1.407 . . . . 0.0 113.761 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 12.8 t70 -129.58 -44.48 1.22 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.216 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.67 -172.4 15.18 Favored Glycine 0 CA--C 1.486 -1.744 0 C-N-CA 119.355 -1.402 . . . . 0.0 112.48 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -85.87 142.26 29.01 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.927 0.394 . . . . 0.0 110.236 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 75.2 p -79.21 170.77 16.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.418 ' ND2' HG21 ' A' ' 124' ' ' ILE . 12.8 m120 61.7 -155.06 0.35 Allowed 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -141.84 178.1 7.73 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.482 HD11 ' HA3' ' A' ' 89' ' ' GLY . 89.0 mt -82.48 114.24 50.18 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.582 ' HB2' HD12 ' A' ' 120' ' ' LEU . 18.9 Cg_endo -66.86 126.54 15.45 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.065 2.51 . . . . 0.0 111.243 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.44 128.81 39.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 68.8 m -81.27 111.24 17.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.04 0.448 . . . . 0.0 110.485 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.735 1.214 . . . . 0.0 109.998 -175.724 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 15.6 m-20 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 121.743 0.783 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -72.99 138.08 45.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.42 -177.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.08 30.61 7.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -164.81 158.24 17.25 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.541 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.5 mt -80.38 154.03 74.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 123.499 0.72 . . . . 0.0 109.469 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 9.8 Cg_endo -54.48 130.27 39.18 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.707 2.272 . . . . 0.0 111.196 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.11 126.48 13.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.206 1.937 . . . . 0.0 111.165 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -60.37 134.67 57.29 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 121.552 0.691 . . . . 0.0 109.695 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 3.3 mmp_? -87.06 174.59 8.57 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.546 -171.174 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -73.66 -43.71 58.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.59 0.556 . . . . 0.0 110.569 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 80' ' ' CYS . 4.3 p -122.74 19.02 10.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.611 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 1.8 mp0 -137.67 150.12 47.1 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.038 0.446 . . . . 0.0 111.611 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.8 mt -133.55 154.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.0 mm? -76.36 147.55 38.01 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 44.0 p -114.54 113.9 25.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.41 -155.13 26.18 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.2 m -137.95 98.35 3.63 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.566 ' HB3' HD22 ' A' ' 24' ' ' LEU . 85.1 m95 -95.23 97.5 9.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.263 -177.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 p -106.53 1.27 25.27 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.061 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 1.6 m-20 -119.48 -169.49 1.77 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.777 -171.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -129.95 -43.46 1.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 71.4 p -98.29 131.94 44.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.189 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 48.8 m-85 -138.64 154.93 73.62 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.478 0.711 . . . . 0.0 109.568 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 23.4 Cg_endo -65.73 150.6 86.03 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.354 2.036 . . . . 0.0 112.502 178.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.27 147.64 49.47 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.97 -10.95 70.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.604 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 91.9 m -67.77 116.3 8.29 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 122.302 0.241 . . . . 0.0 110.474 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 3.7 pt20 -93.66 125.09 38.08 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.315 1.055 . . . . 0.0 110.003 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.78 122.06 35.86 Favored 'General case' 0 C--N 1.271 -2.805 0 C-N-CA 125.539 1.535 . . . . 0.0 107.592 178.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.1 mt -93.25 118.23 38.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.648 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.7 m-85 -96.51 144.68 26.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.76 0.79 . . . . 0.0 112.988 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 34' ' ' THR . 57.6 tttp -89.31 132.65 34.83 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 13.4 t -82.2 37.52 0.5 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 59.74 154.51 0.1 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.712 1.205 . . . . 0.0 113.671 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.27 92.69 0.47 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 121.304 1.336 . . . . 0.0 110.491 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 137.65 -21.34 3.23 Favored Glycine 0 N--CA 1.429 -1.814 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.564 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.687 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.5 m-85 -103.39 168.63 9.04 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.11 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -150.89 176.28 11.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 176.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 t -160.08 -165.62 1.52 Allowed 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.89 -12.94 60.05 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.959 0.885 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.77 44.85 Favored Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 177.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.32 138.21 57.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.455 0.627 . . . . 0.0 109.717 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.57 123.91 25.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 47' ' ' GLN . 46.3 mm -117.52 125.58 74.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.014 -176.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 28' ' ' ARG . 86.9 mtp -124.36 134.44 53.14 Favored 'General case' 0 CA--C 1.424 -3.871 0 CA-C-O 121.515 0.674 . . . . 0.0 110.038 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.699 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 1.3 m -129.85 149.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.84 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.873 -168.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.01 128.66 34.68 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.29 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -153.71 121.88 6.13 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.25 32.2 12.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.807 0.843 . . . . 0.0 110.935 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.03 -18.28 36.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.463 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.69 165.68 11.09 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.402 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.1 m95 -106.02 116.07 31.3 Favored 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -127.41 -166.71 0.48 Allowed 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.652 -173.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.78 127.71 45.91 Favored 'General case' 1 C--N 1.218 -5.149 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.319 -172.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HB2' ' CG1' ' A' ' 65' ' ' VAL . 2.2 tm? -80.61 -54.82 5.31 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -106.87 94.37 10.43 Favored Pre-proline 0 N--CA 1.407 -2.578 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.687 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.74 -9.91 24.39 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.705 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -90.0 26.81 1.74 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 110.347 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.86 139.88 53.55 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.241 179.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -166.86 145.26 5.14 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 50.0 m -78.02 126.49 30.9 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 122.116 0.96 . . . . 0.0 113.534 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -119.67 153.42 35.6 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.038 -179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -72.02 136.2 46.63 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.386 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.3 ptp180 -78.13 145.25 68.78 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.3 166.08 29.56 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.197 1.932 . . . . 0.0 112.185 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.6 m -120.05 8.09 10.95 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.066 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.96 -96.76 0.88 Allowed Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.785 177.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -150.1 138.61 12.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.85 53.68 4.51 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.122 2.548 . . . . 0.0 112.133 -177.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.651 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 75.55 -143.58 30.53 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.16 153.25 31.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -150.1 135.25 9.81 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.78 -60.12 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.919 1.746 . . . . 0.0 109.967 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -123.49 154.44 39.13 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 130.89 150.43 6.78 Favored Glycine 0 C--N 1.282 -2.466 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 114' ' ' CYS . 4.4 m -145.29 158.7 43.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -175.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -144.3 161.09 39.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -123.02 146.21 47.84 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 91.8 mt -104.41 153.88 20.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.603 0.24 . . . . 0.0 110.529 -176.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -149.05 138.93 21.99 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.14 -12.89 58.85 Favored Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.28 170.48 42.61 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -111.35 10.85 21.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 117.698 0.749 . . . . 0.0 109.65 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 104' ' ' PHE . 5.8 p -141.04 -166.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.503 ' H ' HG22 ' A' ' 103' ' ' VAL . 29.4 m-85 -99.19 86.03 3.34 Favored 'General case' 1 C--N 1.241 -4.119 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.046 -176.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.2 pt-20 -136.59 151.99 49.96 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.795 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.9 t80 -48.01 124.42 7.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.229 0.538 . . . . 0.0 112.167 176.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.89 56.3 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.832 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 105' ' ' GLU . 4.5 p -83.65 144.76 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-N 117.492 0.646 . . . . 0.0 109.64 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -111.03 125.98 54.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.44 95.31 7.57 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.15 114.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.09 132.83 34.26 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.3 m -142.66 -28.28 0.59 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -172.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.533 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 96.2 m 69.79 -99.09 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 177.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -148.76 -158.69 0.94 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.86 -58.05 3.53 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.915 0.486 . . . . 0.0 110.894 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.07 4.37 74.48 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.889 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -117.91 133.55 55.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -127.48 -100.01 0.36 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.2 pp -179.78 145.29 0.22 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.056 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 142' ' ' GLU . 2.5 mm? -95.04 142.77 27.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.511 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.67 -173.86 18.15 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.06 -12.0 12.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.635 0.718 . . . . 0.0 111.078 178.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.59 114.96 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -91.61 17.74 8.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.493 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.57 179.06 9.22 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.298 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -158.35 130.5 6.89 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.606 171.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.27 157.16 17.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 -176.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 48.1 m -87.64 117.39 26.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.744 172.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 131' ' ' THR . 22.3 t70 -103.92 -158.69 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.49 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 63.3 p -67.54 -44.69 77.7 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 124.142 0.977 . . . . 0.0 112.965 -173.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.4 -43.42 17.36 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.747 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.93 -129.82 1.91 Allowed Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.839 -176.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -78.95 125.45 29.39 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 0.0 112.137 -172.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -65.53 -25.97 67.68 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.404 1.082 . . . . 0.0 112.699 -177.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -138.47 169.09 18.41 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -91.57 -174.31 3.84 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.651 HD11 ' HA3' ' A' ' 89' ' ' GLY . 55.7 mt -86.62 112.6 47.84 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 123.55 0.74 . . . . 0.0 109.251 -176.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.34 147.0 96.68 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.752 1.635 . . . . 0.0 109.811 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.494 HG22 ' HG2' ' A' ' 142' ' ' GLU . 41.6 mm -81.78 108.63 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.127 -173.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 19.9 t -63.3 119.12 9.04 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 140' ' ' ILE . 22.7 mm-40 . . . . . 0 C--N 1.307 -1.241 0 C-N-CA 123.509 0.724 . . . . 0.0 109.217 -174.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 52.6 m-20 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.4 m -68.96 141.8 54.86 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.883 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.41 19.51 17.54 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.25 156.92 37.92 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' CD2' ' HA ' ' A' ' 40' ' ' GLN . 3.6 mm? -85.69 153.97 58.49 Favored Pre-proline 1 N--CA 1.373 -4.276 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.964 -179.04 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 Cg_endo -53.55 122.23 10.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 123.328 2.685 . . . . 0.0 112.32 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.8 Cg_exo -64.58 131.94 31.38 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.282 1.988 . . . . 0.0 110.448 179.228 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -62.54 145.13 55.12 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.264 0.554 . . . . 0.0 110.43 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 18.8 mmm180 -98.1 166.17 11.55 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -81.72 -51.39 8.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.758 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.21 -1.8 57.63 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.141 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 18.1 mp0 -132.65 158.54 42.01 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.979 0.419 . . . . 0.0 111.993 -178.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -142.36 150.2 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.37 154.53 31.64 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.336 0.588 . . . . 0.0 110.705 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.5 p -91.11 -23.57 20.26 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.566 0.698 . . . . 0.0 111.138 177.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.87 -178.27 15.35 Favored Glycine 0 C--N 1.289 -2.029 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.2 t -103.13 149.84 24.23 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.568 ' HB3' HD12 ' A' ' 24' ' ' LEU . 8.2 m95 -138.07 138.82 39.15 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -178.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -142.21 16.48 2.07 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.217 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 24' ' ' LEU . 15.1 m-20 -128.93 124.91 36.35 Favored 'General case' 0 CA--C 1.465 -2.311 0 C-N-CA 118.464 -1.294 . . . . 0.0 112.276 -175.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.587 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 21.7 mp0 -54.11 -49.84 68.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 124.764 1.29 . . . . 0.0 112.868 -175.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -96.25 128.74 43.44 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.198 -1.001 . . . . 0.0 113.682 -172.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -134.92 148.75 68.27 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.541 176.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -69.0 149.13 71.38 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.444 2.096 . . . . 0.0 112.705 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -66.3 136.24 55.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.68 -3.92 36.66 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.437 -177.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -82.86 118.85 23.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -88.53 143.78 26.75 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.545 0.688 . . . . 0.0 111.982 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.24 114.45 27.94 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -89.36 127.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.54 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 90.6 m-85 -109.2 141.85 40.86 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.617 0.722 . . . . 0.0 111.988 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -89.67 147.69 23.73 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 168.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.791 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 91.2 m -102.44 37.47 1.9 Allowed 'General case' 0 C--N 1.249 -3.795 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.605 -174.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 65.86 159.6 0.13 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.574 0.702 . . . . 0.0 111.532 178.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.52 113.8 3.62 Favored 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 109.706 -0.921 . . . . 0.0 109.706 172.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 131' ' ' THR . . . 118.24 -20.43 10.48 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.593 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.791 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.1 m-85 -107.1 161.32 14.86 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.578 178.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.474 ' NE ' ' HD3' ' A' ' 84' ' ' PRO . 16.0 ptt180 -160.79 -176.34 5.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.558 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.7 p -169.22 177.92 4.58 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 170.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.12 31.8 0.71 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.86 0.838 . . . . 0.0 110.213 177.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.0 -140.32 3.21 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -142.66 157.72 44.39 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -78.97 104.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.33 122.1 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.963 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.5 mtp -109.44 169.79 8.47 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.2 p -155.39 144.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.659 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t -68.4 123.15 20.0 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.716 177.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.4 ttm180 -157.19 129.84 7.53 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 35.7 mmtp 66.53 15.89 10.24 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.891 0.876 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.58 65.87 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.959 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.67 172.34 9.35 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.459 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -103.58 119.65 39.32 Favored 'General case' 0 CA--C 1.462 -2.428 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.3 -170.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.943 -175.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.57 121.1 39.07 Favored 'General case' 1 C--N 1.22 -5.024 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.221 -172.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -71.43 -54.42 10.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -119.72 100.38 49.0 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.65 -4.45 13.51 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.042 2.495 . . . . 0.0 112.366 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.27 -31.94 22.83 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.633 -178.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -89.29 135.33 33.64 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.365 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 158.55 44.28 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . 0.383 67.5 m -95.59 127.67 41.81 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 117.745 -1.582 . . . . 0.0 114.82 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.36 -175.69 2.76 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.756 -2.02 . . . . 0.0 108.096 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -71.99 152.92 42.12 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.077 0.465 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.16 152.97 46.59 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' NE ' ' A' ' 57' ' ' ARG . 66.2 Cg_endo -90.24 152.62 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.451 1.434 . . . . 0.0 112.84 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 70.9 m -124.96 76.79 1.56 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.55 93.51 0.01 OUTLIER Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.242 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t60 70.93 125.59 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.968 1.707 . . . . 0.0 111.42 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.69 38.68 0.4 Allowed 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 114.427 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 108.63 -127.72 8.73 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 138' ' ' ILE . 4.0 p30 -162.87 158.88 23.12 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -171.65 129.53 0.68 Allowed Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.51 -14.23 11.73 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.374 1.383 . . . . 0.0 111.016 174.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.46 89.32 2.37 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.354 0.597 . . . . 0.0 111.129 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 164.81 165.88 22.83 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.9 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -139.37 165.46 27.16 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -139.06 155.91 47.57 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 p -130.73 140.42 50.34 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -103.39 140.38 37.53 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 109' ' ' LYS . 5.1 t -133.69 19.52 3.88 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 121.708 0.766 . . . . 0.0 111.876 -176.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -141.9 25.4 2.4 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.53 174.88 17.18 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -119.25 20.44 12.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 117.903 0.852 . . . . 0.0 109.751 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' HG11 ' A' ' 108' ' ' VAL . 23.4 m -138.2 175.11 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' CYS . 52.7 m-85 -90.89 97.73 11.36 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.001 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.96 154.36 41.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.428 -177.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -51.19 116.87 2.23 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.306 1.004 . . . . 0.0 111.083 177.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.05 -25.18 7.18 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.278 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -74.72 137.77 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.344 178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.5 ttmt -106.02 121.64 44.54 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.72 94.52 9.41 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.77 122.32 32.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -94.1 132.14 38.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -153.98 156.43 37.41 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 83.9 m -132.68 -72.62 0.51 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.95 -174.05 3.21 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.47 -51.53 6.46 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.352 0.596 . . . . 0.0 110.763 -177.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.27 -18.93 79.91 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.202 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -98.77 137.67 37.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.54 -107.42 0.37 Allowed 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.5 pp 179.19 141.5 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.779 1.232 . . . . 0.0 109.666 176.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.1 mm? -89.11 134.75 33.89 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.407 0.622 . . . . 0.0 110.338 176.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.09 161.38 11.03 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -174.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -92.42 -21.65 20.08 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.469 0.652 . . . . 0.0 109.415 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' ND2' ' A' ' 136' ' ' ASN . 25.7 mm -104.99 106.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.953 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -88.15 24.9 1.72 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.535 1.134 . . . . 0.0 111.395 -175.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.418 ' CE1' HG23 ' A' ' 124' ' ' ILE . 47.4 p90 -159.58 171.61 19.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.256 0.551 . . . . 0.0 110.768 -173.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -135.18 131.74 37.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 12.8 mt-10 -104.37 139.1 39.81 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 118.242 0.473 . . . . 0.0 110.794 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.72 104.14 10.11 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.0 t70 -105.94 -159.81 0.72 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.973 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.2 p -60.7 -29.49 69.36 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.743 1.617 . . . . 0.0 114.555 -171.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -118.44 -28.56 5.7 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.553 0.692 . . . . 0.0 110.959 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.91 -157.11 28.44 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -176.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 97.3 m95 -74.0 130.62 40.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.871 0.367 . . . . 0.0 111.663 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 34.8 p -81.83 158.29 24.12 Favored 'General case' 0 C--O 1.266 1.945 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 124' ' ' ILE . 54.9 t30 63.92 -171.79 0.18 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -126.48 -168.1 1.81 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.656 HD11 ' HA3' ' A' ' 89' ' ' GLY . 54.0 mt -82.61 117.69 69.35 Favored Pre-proline 0 C--N 1.282 -2.33 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 33.8 Cg_endo -70.96 144.86 48.75 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.751 2.301 . . . . 0.0 110.894 177.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -93.7 112.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 122.118 -0.364 . . . . 0.0 110.871 -174.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.33 112.28 3.93 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.619 ' HB2' HD23 ' A' ' 121' ' ' LEU . 33.6 mt-10 . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.3 m-20 . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -84.52 125.08 32.08 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.89 23.59 7.84 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.01 161.27 40.47 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.394 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 mt -82.81 149.07 59.12 Favored Pre-proline 0 C--N 1.306 -1.313 0 O-C-N 123.998 0.811 . . . . 0.0 109.807 174.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.8 Cg_endo -53.11 131.55 43.48 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 123.197 2.598 . . . . 0.0 113.312 -177.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 18.6 Cg_exo -65.73 119.51 6.55 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 122.617 2.212 . . . . 0.0 110.277 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.64 142.58 56.35 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.766 0.793 . . . . 0.0 111.759 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 18.2 mmm180 -87.31 168.46 13.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.377 -171.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -35.4 17.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.046 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.0 p -107.8 6.31 27.38 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.772 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 10.3 mp0 -138.92 156.44 47.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.33 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.3 158.92 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.78 143.67 55.74 Favored 'General case' 0 C--N 1.269 -2.896 0 O-C-N 123.483 0.489 . . . . 0.0 110.553 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 p -71.73 -35.23 70.1 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.35 165.92 12.17 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -94.15 142.71 27.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 177.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.06 125.53 42.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -121.44 18.22 11.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.288 0.566 . . . . 0.0 110.738 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.79 -159.44 0.74 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.425 ' HG3' HG23 ' A' ' 41' ' ' THR . 17.6 pt20 -149.63 -35.01 0.18 Allowed 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 123.457 0.703 . . . . 0.0 110.355 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.7 p -107.88 126.21 52.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.798 -176.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -133.89 137.05 27.6 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 28.3 Cg_endo -63.08 147.37 94.39 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 123.126 2.551 . . . . 0.0 111.926 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.5 tt0 -63.56 129.85 41.9 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.23 30.33 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.9 m -81.4 113.31 19.4 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -86.35 143.78 27.68 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.136 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.57 119.95 37.17 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.0 mt -91.51 119.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 59.9 m-85 -98.45 145.61 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.042 0.925 . . . . 0.0 113.33 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 32.2 ttmt -91.66 138.36 31.63 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 35.7 m -74.63 21.9 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 72.9 mtp180 64.95 154.95 0.12 Allowed Pre-proline 0 N--CA 1.476 0.864 0 CA-C-O 121.678 0.751 . . . . 0.0 111.612 -173.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.4 104.19 0.42 Allowed 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.523 1.482 . . . . 0.0 110.866 174.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.12 -3.6 18.78 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.326 176.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.793 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.0 m-85 -120.89 165.91 14.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.133 -1.216 . . . . 0.0 109.819 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -156.18 179.32 9.35 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 23.7 p -145.46 -92.41 0.1 Allowed 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.703 0.764 . . . . 0.0 110.665 174.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -142.23 -47.2 0.35 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -177.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.92 -134.72 3.31 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 176.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -115.06 146.73 41.0 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.1 t -75.12 116.76 18.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.3 mm -110.5 122.92 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-O 121.455 0.645 . . . . 0.0 109.783 -176.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.3 mtp -109.3 171.84 7.2 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.5 p -157.74 142.69 8.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.76 122.19 20.24 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.304 176.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.3 ttm180 -156.52 127.51 6.87 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 66.19 17.06 10.65 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.58 80.36 Favored Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.897 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 9.6 pt-20 -117.4 159.06 23.38 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -104.12 109.3 21.04 Favored 'General case' 0 CA--C 1.455 -2.69 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.0 -164.54 0.39 Allowed 'Isoleucine or valine' 1 N--CA 1.362 -4.846 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.252 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.14 40.67 Favored 'General case' 1 C--N 1.218 -5.123 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.601 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.9 -39.76 66.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.86 102.18 13.64 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 1.5 8.27 Favored 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.98 2.453 . . . . 0.0 113.74 -175.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.92 -20.33 18.19 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.691 0.758 . . . . 0.0 111.385 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 31.1 mmt180 -85.02 130.96 34.53 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.387 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -156.55 147.95 22.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 55.7 m -97.03 123.47 40.77 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.594 0.711 . . . . 0.0 111.484 -176.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.99 42.51 2.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -167.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 88.2 mttt 76.6 -179.98 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.753 1.221 . . . . 0.0 111.044 -178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 15.4 ptp180 -130.41 142.0 43.9 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.99 147.58 43.66 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.477 2.118 . . . . 0.0 109.633 173.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 m -102.32 -10.66 19.3 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.05 -117.2 4.43 Favored Glycine 0 CA--C 1.474 -2.481 0 C-N-CA 119.002 -1.571 . . . . 0.0 110.996 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -136.71 139.14 28.25 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -176.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.42 8.64 3.71 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.786 2.324 . . . . 0.0 111.143 178.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 97.3 -164.25 22.23 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -175.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.27 161.19 12.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -130.5 126.04 21.86 Favored Pre-proline 0 C--N 1.288 -2.086 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.182 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.29 10.1 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.548 2.165 . . . . 0.0 112.773 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -110.82 -12.16 14.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.506 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . -164.56 -146.66 4.84 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.792 -175.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.91 -172.86 4.21 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.804 0.442 . . . . 0.0 111.597 -175.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -148.11 166.42 27.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 p -130.49 159.09 38.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.551 0.74 . . . . 0.0 109.332 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.5 136.57 53.14 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.054 0.454 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.8 t -125.78 138.18 53.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.12 9.97 56.54 Favored Glycine 0 C--N 1.312 -0.77 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -175.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.01 167.73 11.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -178.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.06 31.52 5.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.797 0.798 . . . . 0.0 111.277 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.02 167.85 23.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.06 86.24 5.34 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.662 -176.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.92 154.16 49.52 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.397 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -51.29 120.6 5.18 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.714 0.634 . . . . 0.0 111.543 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.25 -20.05 7.12 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 99' ' ' THR . 10.5 m -83.51 146.48 6.86 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.427 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.1 ttmp? -111.12 126.72 55.13 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.52 92.82 8.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.69 115.11 27.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -81.87 139.91 34.42 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.509 -177.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.14 143.31 22.34 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.506 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 77.6 m -122.57 -73.38 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.113 -174.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -161.1 -165.61 1.39 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -172.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -79.81 -43.25 22.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.778 0.799 . . . . 0.0 109.042 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.48 -12.84 79.72 Favored Glycine 0 C--N 1.31 -0.906 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.407 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -124.47 127.86 48.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.73 -130.46 0.26 Allowed 'General case' 0 CA--C 1.457 -2.632 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 166.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -151.65 145.47 25.1 Favored 'General case' 1 N--CA 1.33 -6.467 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.996 -176.35 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 94.6 mt -87.27 109.76 19.73 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.76 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 156.11 161.01 10.37 Favored Glycine 0 C--N 1.272 -3.017 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 -178.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -97.21 -5.96 35.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 118.183 0.991 . . . . 0.0 110.251 179.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.91 106.94 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.615 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.768 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.2 p-10 -84.7 30.99 0.54 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.616 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.585 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -166.35 179.93 5.34 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.451 0.643 . . . . 0.0 111.857 -172.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -139.83 131.61 27.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 169.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 25.2 mt-10 -99.92 136.22 40.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.1 t -81.39 123.02 28.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.158 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.0 t70 -118.55 -160.24 0.79 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.456 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 43.2 p -66.85 -51.47 55.2 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.824 1.25 . . . . 0.0 112.101 -174.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.03 -28.72 39.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.77 0.795 . . . . 0.0 110.693 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.61 -148.13 17.57 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -80.97 132.84 35.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.189 0.494 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 49.6 p -81.0 148.95 29.51 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.423 178.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 67.53 -173.75 0.19 Allowed 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.273 0.983 . . . . 0.0 108.93 174.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -117.38 -173.62 2.45 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.459 HD11 ' HA3' ' A' ' 89' ' ' GLY . 73.0 mt -81.29 119.24 75.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 -174.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CG ' HD12 ' A' ' 120' ' ' LEU . 9.6 Cg_endo -58.72 132.52 48.47 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.424 2.083 . . . . 0.0 108.706 174.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.1 mp -78.03 106.62 8.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.8 t -61.42 118.17 6.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.165 0.507 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 10.2 tp10 . . . . . 0 N--CA 1.43 -1.445 0 C-N-CA 126.178 1.791 . . . . 0.0 106.651 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.662 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.7 m-20 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.9 m -74.37 138.23 43.27 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.425 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -100.97 15.17 29.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.344 0.592 . . . . 0.0 109.882 -179.075 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.07 154.83 41.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.551 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.6 mt -75.12 149.82 85.16 Favored Pre-proline 0 C--O 1.253 1.289 0 O-C-N 124.073 0.858 . . . . 0.0 109.909 173.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 27.9 Cg_endo -58.84 142.02 98.56 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.828 2.352 . . . . 0.0 110.054 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.76 144.49 54.22 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.779 1.653 . . . . 0.0 111.67 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -76.21 141.76 41.69 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 24.7 mmm180 -98.28 162.03 13.4 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.647 -171.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -78.23 -42.22 31.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.342 0.592 . . . . 0.0 109.69 176.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.72 -7.72 21.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.648 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.8 mp0 -129.4 166.13 20.17 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.755 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.98 146.21 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 37' ' ' TRP . 4.5 mm? -70.65 140.15 51.48 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.506 178.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -126.67 101.41 6.63 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.988 172.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.78 -160.09 33.64 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 -176.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 m -129.43 114.53 16.27 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 117.699 0.749 . . . . 0.0 109.532 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB3' HD22 ' A' ' 24' ' ' LEU . 80.8 m95 -120.81 128.27 52.71 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.189 -175.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 m -148.54 8.08 0.78 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.312 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.0 m-20 -120.93 -173.37 2.59 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.635 -174.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -112.41 -61.1 1.77 Allowed 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.1 p -85.9 122.65 30.26 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.51 -175.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 63.9 m-85 -126.76 136.05 28.21 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.272 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 17.9 Cg_endo -60.51 145.68 98.31 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.345 2.697 . . . . 0.0 113.535 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 18.5 tt0 -62.85 120.47 11.37 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.89 12.89 14.94 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -175.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.6 m -92.38 113.23 25.45 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.567 176.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.9 149.21 25.38 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.643 0.59 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.25 133.84 51.36 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.759 0.824 . . . . 0.0 109.023 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.9 mt -102.59 129.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.5 m-85 -111.25 137.29 49.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' A' ' 53' ' ' ARG . 53.5 tptt -85.05 126.53 33.64 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.7 m -77.43 13.45 1.21 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 70.1 mtp180 69.64 150.11 0.12 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.512 0.725 . . . . 0.0 110.895 -172.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.71 120.67 7.43 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.728 1.619 . . . . 0.0 109.9 175.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.24 -13.98 13.71 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 72.8 m-85 -115.17 163.66 15.33 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -150.88 -179.31 7.17 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 p -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.57 -13.61 59.74 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.592 0.711 . . . . 0.0 109.899 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.58 144.53 9.72 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 174.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.21 154.71 39.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.708 0.754 . . . . 0.0 111.166 -178.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.449 HG23 ' SG ' ' A' ' 80' ' ' CYS . 76.7 t -71.49 102.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.25 118.41 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.2 mtp -107.27 171.45 7.37 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.04 146.48 12.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.64 122.32 23.0 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.825 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.1 ttm180 -153.39 124.71 7.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.934 0.397 . . . . 0.0 111.057 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 61.8 mmtt 68.66 11.55 8.39 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.852 1.261 . . . . 0.0 112.519 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.78 -12.61 46.13 Favored Glycine 0 N--CA 1.427 -1.945 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.33 178.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.55 158.3 21.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.595 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m95 -91.22 115.5 28.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.93 171.2 6.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.267 -175.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.22 119.49 26.56 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.3 -49.67 63.31 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.35 89.43 5.9 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.705 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.66 -19.84 9.69 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.568 2.179 . . . . 0.0 111.475 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.3 mt -74.77 -29.55 61.16 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.252 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -84.78 158.72 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.936 178.891 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -175.68 156.16 1.83 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.964 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 62' ' ' VAL . 60.2 m -93.64 123.82 37.22 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.738 -177.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.35 164.22 16.66 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.639 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 90.9 mttt -73.51 151.11 41.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.487 0.184 . . . . 0.0 110.958 -176.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.7 ptm180 -82.27 146.25 54.07 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.476 176.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 69.8 Cg_endo -79.42 151.74 22.98 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.42 2.08 . . . . 0.0 110.909 172.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 133' ' ' GLY . 52.5 m -110.95 -9.23 14.43 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.804 177.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.55 175.42 47.63 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.699 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.74 123.19 89.05 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 56.3 Cg_endo -70.2 83.66 0.76 Allowed 'Trans proline' 0 C--O 1.254 1.283 0 C-N-CA 123.076 2.517 . . . . 0.0 113.017 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 63.54 -142.55 47.07 Favored Glycine 0 C--O 1.215 -1.068 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.47 130.14 17.0 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 t -127.24 99.53 27.86 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-O 121.522 0.677 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.59 -39.41 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.485 2.123 . . . . 0.0 113.403 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.43 -20.49 17.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.33 176.91 18.77 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.739 -178.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 p -134.84 175.64 9.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 37.8 p90 -150.49 151.19 32.32 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.423 177.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.5 p -101.59 171.37 7.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 103' ' ' VAL . 96.2 mt -141.69 136.7 31.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 173.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 109' ' ' LYS . 9.1 t -113.31 -62.28 1.61 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.73 56.02 4.9 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.749 -176.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.13 -57.49 0.35 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.329 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 m120 87.74 18.17 0.07 Allowed 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.401 1.48 . . . . 0.0 107.873 -179.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.418 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 p -141.27 -161.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.819 0 CA-C-N 111.822 -2.444 . . . . 0.0 105.051 177.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 44.9 m-85 -112.07 86.26 2.31 Favored 'General case' 1 C--N 1.236 -4.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 -175.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 15.1 pt-20 -151.02 155.89 39.99 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.457 178.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 79.6 t80 -45.47 115.38 0.92 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 125.036 1.46 . . . . 0.0 112.273 -178.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.41 -21.76 6.0 Favored Glycine 0 N--CA 1.427 -1.959 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.1 m -78.1 137.51 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.886 -1.125 . . . . 0.0 111.438 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.469 ' H ' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -106.61 110.78 23.07 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -81.72 92.46 6.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -81.58 124.37 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 7.7 t80 -84.27 130.62 34.8 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.08 150.03 43.69 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 118' ' ' TYR . 26.6 m -130.18 148.72 52.05 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.9 173.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.411 1.069 . . . . 0.0 112.586 177.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -44.14 -53.02 6.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.626 1.57 . . . . 0.0 113.567 -176.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 22.45 34.82 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.139 -176.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 114' ' ' CYS . 95.6 m-85 -134.05 161.01 36.02 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.391 0.615 . . . . 0.0 111.691 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -156.39 -156.38 0.62 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 173.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 1.2 pp -140.26 142.52 35.75 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -175.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.2 mm? -83.5 135.52 34.62 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.72 171.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.25 152.01 9.03 Favored Glycine 0 C--N 1.267 -3.289 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -174.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.74 -13.06 37.61 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 117.343 0.572 . . . . 0.0 111.912 -176.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -111.21 116.44 52.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' HD21 ' A' ' 120' ' ' LEU . 3.1 p-10 -91.63 25.49 2.66 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.448 0.642 . . . . 0.0 111.123 -176.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 28.5 p90 -156.49 177.32 11.6 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.75 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.66 ' NH1' HG12 ' A' ' 138' ' ' ILE . 15.2 ptt180 -157.36 128.4 6.7 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.441 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 37.6 mt-10 -103.67 142.24 34.68 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.78 98.89 7.98 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -103.86 -158.51 0.67 Allowed 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.692 -173.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 38.9 p -64.94 -38.48 91.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.741 1.217 . . . . 0.0 113.14 -172.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.5 -33.99 11.64 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 120.95 0.405 . . . . 0.0 110.326 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 85' ' ' CYS . . . 161.24 -149.14 17.76 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.554 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -71.65 130.0 40.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.727 0.264 . . . . 0.0 110.766 -178.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.5 p -79.76 167.36 20.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.336 176.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.28 -101.99 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.04 0.936 . . . . 0.0 112.668 173.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 169.82 -158.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -177.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.66 HG12 ' NH1' ' A' ' 127' ' ' ARG . 62.6 mt -102.31 107.1 52.0 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 9.4 Cg_endo -58.37 137.36 80.05 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.483 1.456 . . . . 0.0 109.37 174.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.37 115.17 25.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.041 -171.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 8.8 t -75.09 99.81 4.04 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 123.437 0.461 . . . . 0.0 109.851 -178.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.77 1.628 . . . . 0.0 108.234 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 12.8 m-20 . . . . . 0 C--O 1.243 0.742 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.6 m -61.38 139.98 58.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -116.32 16.44 15.77 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.542 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -156.45 161.35 40.08 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.702 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.06 153.44 79.95 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 123.984 0.914 . . . . 0.0 109.935 176.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 Cg_endo -55.41 123.68 14.4 Favored 'Trans proline' 0 C--O 1.254 1.303 0 C-N-CA 122.273 1.982 . . . . 0.0 111.516 178.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.5 Cg_exo -67.36 109.24 1.74 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.803 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -71.73 143.01 49.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.934 176.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -104.49 -171.81 1.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.25 -42.26 72.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.134 0.492 . . . . 0.0 110.316 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 15.8 p -109.63 11.68 24.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mp0 -138.28 134.25 34.11 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.706 -0.621 . . . . 0.0 112.601 -178.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.93 157.32 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.11 140.64 45.39 Favored 'General case' 0 C--N 1.264 -3.138 0 O-C-N 123.817 0.698 . . . . 0.0 110.735 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -73.51 -52.96 11.77 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.909 177.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.57 167.99 41.42 Favored Glycine 0 N--CA 1.421 -2.353 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.347 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 p -90.95 146.76 23.61 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 123.011 0.524 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -135.92 143.43 44.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.0 t -125.65 -44.12 1.84 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HE1' ' A' ' 42' ' ' TYR . 15.2 t70 -97.09 158.04 15.63 Favored 'General case' 0 C--O 1.186 -2.268 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -170.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -79.09 -30.01 43.62 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.21 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 77.9 p -101.08 119.95 39.5 Favored 'General case' 0 N--CA 1.41 -2.457 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.99 -174.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HE1' ' O ' ' A' ' 39' ' ' ASP . 40.4 m-85 -130.29 155.01 81.56 Favored Pre-proline 0 C--N 1.302 -1.46 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.078 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 147.09 88.94 Favored 'Trans proline' 0 C--O 1.252 1.208 0 C-N-CA 122.121 1.881 . . . . 0.0 111.555 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.9 146.75 49.38 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.8 9.12 62.94 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.992 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -89.08 120.32 30.38 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.87 -0.194 . . . . 0.0 111.222 177.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -87.01 157.0 19.54 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.323 0.582 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.09 126.51 41.32 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.76 130.52 46.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 80.6 m-85 -99.76 138.8 36.34 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -78.2 -18.41 55.51 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 127.209 2.204 . . . . 0.0 112.531 -173.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 97.4 m 67.22 -2.87 1.11 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 62.4 mtp180 69.76 153.97 0.14 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.531 0.732 . . . . 0.0 111.131 -174.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.49 121.4 7.94 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.794 1.663 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 111.92 -5.43 27.39 Favored Glycine 0 C--N 1.306 -1.123 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.357 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.566 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 41.0 m-85 -120.49 174.57 6.47 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -162.45 -173.33 3.52 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 p -151.09 168.08 25.73 Favored 'General case' 0 C--N 1.266 -3.048 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.3 tp -105.59 32.23 4.45 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.53 109.74 0.38 Allowed Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 63' ' ' ILE . 11.6 m120 -52.83 140.08 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 117.337 0.568 . . . . 0.0 111.695 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 93.0 t -64.86 112.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 61' ' ' ASN . 46.9 mm -113.2 118.37 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.69 170.94 7.59 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.1 p -156.21 148.32 11.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.9 t -81.25 134.29 35.58 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.242 -177.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 4.7 tpm_? -152.59 126.76 9.16 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 32.7 mmtp 63.12 18.49 10.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 175.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 99.81 -12.41 60.96 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.944 179.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.32 168.24 10.14 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -101.3 121.74 42.43 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.84 179.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.65 39.61 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.219 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -68.95 -42.57 76.49 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.589 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 9.0 t-20 -127.8 97.44 30.04 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.959 173.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.13 -7.45 16.22 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 0.0 112.864 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.61 -27.3 51.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.534 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 29.3 mmt180 -92.69 153.76 18.76 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.992 -177.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -158.03 147.3 19.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.56 123.57 28.22 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.548 -178.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -121.28 167.76 12.37 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.96 157.32 22.08 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.345 0.593 . . . . 0.0 111.963 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.6 ptm180 -99.01 154.61 37.24 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 46.6 Cg_endo -73.15 151.46 49.45 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.519 1.479 . . . . 0.0 109.386 169.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -78.52 -46.52 19.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.557 0.694 . . . . 0.0 110.111 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.51 -125.86 3.61 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -176.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -141.4 116.64 7.13 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.36 41.72 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 124.08 3.187 . . . . 0.0 114.904 -174.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.34 -137.28 30.96 Favored Glycine 0 C--N 1.311 -0.815 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -149.21 -176.54 5.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 t -171.83 106.44 0.37 Allowed Pre-proline 0 C--N 1.289 -2.061 0 C-N-CA 125.477 1.511 . . . . 0.0 107.563 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.34 -17.58 18.71 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.368 2.045 . . . . 0.0 113.435 -175.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CD1' ' HB3' ' A' ' 141' ' ' CYS . 0.1 OUTLIER -124.06 -5.22 7.91 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.641 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.97 -163.91 10.5 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -162.27 -177.98 6.04 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 117.277 0.538 . . . . 0.0 110.619 178.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -143.55 164.6 29.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.257 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 68.2 p -120.93 169.87 10.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.8 mt -129.64 135.38 48.46 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -120.43 1.38 10.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.256 0.551 . . . . 0.0 112.331 -174.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.74 24.9 4.8 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.28 148.19 5.61 Favored Glycine 0 N--CA 1.411 -2.977 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -174.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -93.59 32.7 1.36 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 122.517 1.151 . . . . 0.0 109.141 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.99 162.42 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.624 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.322 -174.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 45.0 m-85 -91.42 100.21 13.02 Favored 'General case' 0 C--N 1.26 -3.318 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.883 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.16 149.0 37.45 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 91.5 t80 -52.39 121.22 6.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.172 0.511 . . . . 0.0 110.473 177.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.5 -13.86 25.28 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.302 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.6 142.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 109.69 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -113.09 126.01 55.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -93.51 102.92 15.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.068 0.855 . . . . 0.0 108.898 177.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.409 HG22 ' OG1' ' A' ' 97' ' ' THR . 0.7 OUTLIER -87.84 126.67 41.35 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.281 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -93.17 142.5 27.24 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -135.17 155.75 50.17 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.603 ' HB3' ' O ' ' A' ' 119' ' ' GLN . 44.1 t -158.92 100.48 1.58 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 47.67 -160.65 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 164.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -98.77 -64.93 0.99 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.003 -0.435 . . . . 0.0 111.126 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.72 34.12 2.98 Favored Glycine 0 N--CA 1.469 0.892 0 CA-C-O 121.492 0.496 . . . . 0.0 112.58 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.13 173.65 11.3 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 120' ' ' LEU . 43.6 mt-30 -130.27 -66.09 0.79 Allowed 'General case' 0 CA--C 1.432 -3.596 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 167.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.5 pt? 165.36 157.46 0.02 OUTLIER 'General case' 1 N--CA 1.362 -4.86 0 N-CA-C 102.204 -3.258 . . . . 0.0 102.204 164.156 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.0 mt -97.26 112.53 24.29 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 119.521 1.055 . . . . 0.0 110.455 175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.23 150.54 5.3 Favored Glycine 0 C--N 1.283 -2.404 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.28 -32.27 43.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 117.787 0.794 . . . . 0.0 108.894 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -95.72 107.4 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.645 ' HA ' HD11 ' A' ' 120' ' ' LEU . 2.6 p-10 -88.04 29.45 0.94 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.881 0.848 . . . . 0.0 110.982 -175.33 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -162.24 175.68 11.4 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.937 -175.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.653 ' NH2' HG12 ' A' ' 138' ' ' ILE . 12.2 ttm180 -143.56 120.93 11.63 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.37 152.23 19.85 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.429 176.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 49.8 t -79.44 149.14 31.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' THR . 17.5 t70 -126.07 -177.97 4.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 39.5 p -61.42 -33.83 74.37 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.59 1.156 . . . . 0.0 113.303 -175.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.52 9.15 7.11 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.399 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.11 -126.08 1.11 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.543 -178.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -131.08 153.64 49.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 130' ' ' ASP . 59.8 p -91.17 128.97 37.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 80.22 176.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.897 0.879 . . . . 0.0 111.994 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 12.2 t70 -105.12 -156.21 0.57 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -174.256 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.653 HG12 ' NH2' ' A' ' 127' ' ' ARG . 62.2 mt -101.94 101.92 20.97 Favored Pre-proline 0 N--CA 1.42 -1.926 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB2' HD12 ' A' ' 120' ' ' LEU . 7.3 Cg_endo -52.86 133.43 51.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 122.263 1.975 . . . . 0.0 108.05 172.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 140' ' ' ILE . 3.3 mp -86.97 123.75 40.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -171.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . 48.9 t -68.64 91.51 0.43 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 CA--C 1.496 -1.129 0 C-N-CA 126.274 1.83 . . . . 0.0 107.254 -175.323 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.638 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' THR . 82.3 m -80.76 133.37 35.64 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.71 33.6 3.98 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.143 0.973 . . . . 0.0 108.958 -178.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.85 158.11 37.52 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.979 -176.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.5 mt -85.0 154.46 60.75 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 123.872 0.733 . . . . 0.0 110.392 178.012 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.09 145.04 93.68 Favored 'Trans proline' 0 C--O 1.255 1.326 0 C-N-CA 122.338 2.025 . . . . 0.0 110.382 177.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.76 155.42 53.89 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.266 1.977 . . . . 0.0 112.777 -177.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -83.5 147.91 27.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 35.8 mtt180 -114.45 170.58 8.2 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -172.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -79.11 -40.55 30.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.795 -176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p -115.92 4.15 13.8 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.417 177.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.529 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 8.2 mp0 -131.63 153.92 49.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.663 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.25 156.64 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.457 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.4 mm? -77.24 149.35 35.46 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -99.25 156.53 16.93 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.48 -159.96 25.33 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.791 178.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -140.89 120.98 13.73 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' HD22 ' A' ' 24' ' ' LEU . 71.7 m95 -113.75 115.75 28.3 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -175.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -134.49 26.73 3.75 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.115 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 26.6 m-20 -126.92 -167.18 1.69 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.963 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.57 -53.57 0.77 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.714 0.406 . . . . 0.0 111.156 175.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.4 p -85.11 105.51 15.9 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.937 0.875 . . . . 0.0 113.106 -175.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -114.12 136.57 22.22 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.957 178.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.638 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 22.5 Cg_endo -63.12 150.25 89.17 Favored 'Trans proline' 0 C--O 1.257 1.472 0 C-N-CA 122.878 2.385 . . . . 0.0 112.215 -177.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.654 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -66.13 133.14 50.09 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.14 1.08 41.55 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.218 -176.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -82.33 114.64 20.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.206 178.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.429 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.3 113.28 25.97 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.14 121.31 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.781 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 62.3 m-85 -98.55 140.75 32.31 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.944 0.878 . . . . 0.0 113.24 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -94.2 111.97 23.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 171.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 98.2 m -79.11 32.61 0.22 Allowed 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 64.23 151.85 0.12 Allowed Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.148 1.379 . . . . 0.0 113.274 177.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.95 124.74 12.19 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.326 1.35 . . . . 0.0 108.883 173.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.14 -19.89 10.78 Favored Glycine 0 C--N 1.297 -1.591 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 75.5 m-85 -114.4 170.1 8.55 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -155.18 179.08 9.49 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.5 p -170.81 135.22 1.07 Allowed 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.2 -43.8 85.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 114.27 3.91 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 172.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -64.31 155.36 32.43 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 123.817 0.363 . . . . 0.0 110.66 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.548 HG23 ' SG ' ' A' ' 80' ' ' CYS . 98.7 t -72.55 102.2 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.04 118.44 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 81.5 mtp -104.62 169.15 8.62 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.6 p -156.66 146.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.286 0.565 . . . . 0.0 109.905 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.62 122.53 23.31 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.739 177.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.654 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 31.9 ttt180 -152.77 134.29 14.47 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 34.0 mmtp 67.23 12.13 8.77 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.302 1.041 . . . . 0.0 112.507 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.62 -4.27 57.97 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.81 157.48 33.99 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.16 0.505 . . . . 0.0 110.834 177.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -87.84 117.16 26.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.62 176.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.028 -178.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' MET . . . -89.78 128.97 36.23 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.433 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.11 -50.92 43.71 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.46 91.13 6.64 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.755 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.28 -15.55 22.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.619 2.212 . . . . 0.0 112.084 -177.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.1 mt -83.37 -9.34 59.11 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.038 0.923 . . . . 0.0 111.018 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -102.99 138.69 39.53 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.914 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.88 162.16 38.37 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 172.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 62' ' ' VAL . 83.1 m -101.79 130.26 48.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.572 -0.851 . . . . 0.0 113.016 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 172.79 7.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.955 -178.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.75 157.12 33.59 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -85.34 145.57 42.85 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.17 144.59 13.32 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.979 1.786 . . . . 0.0 109.582 176.198 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.6 m -103.53 5.81 37.0 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.268 0.556 . . . . 0.0 112.152 -173.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.31 -98.66 1.14 Allowed Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.927 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -152.58 142.68 15.09 Favored Pre-proline 0 C--N 1.278 -2.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.07 45.54 1.95 Allowed 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.523 2.815 . . . . 0.0 112.069 -176.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 86.4 -146.28 20.83 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -175.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.27 127.14 4.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 t -113.51 135.92 21.91 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.65 -35.07 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.759 2.306 . . . . 0.0 114.379 -178.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -143.53 11.19 1.67 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.091 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 176.96 32.17 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -137.56 174.65 10.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.37 156.79 34.49 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.642 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -118.94 154.88 32.3 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 175.076 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 110' ' ' ALA . 96.7 mt -120.74 135.58 55.1 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.5 t -112.99 139.04 48.99 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.16 -68.75 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.926 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.75 -72.48 0.82 Allowed Glycine 0 C--N 1.31 -0.868 0 CA-C-N 115.555 -0.322 . . . . 0.0 113.402 -173.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 82.24 18.44 0.34 Allowed 'General case' 0 CA--C 1.455 -2.684 0 CA-C-O 123.467 1.603 . . . . 0.0 108.599 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.21 165.04 1.13 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.215 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -88.47 85.32 6.83 Favored 'General case' 0 C--N 1.255 -3.503 0 O-C-N 123.673 0.608 . . . . 0.0 110.154 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.7 pt-20 -133.33 162.26 32.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.266 -176.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -52.74 128.26 25.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.026 176.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.74 -19.52 53.1 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.173 178.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.4 p -71.51 141.58 16.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.023 -177.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.0 ttmt -106.07 121.53 44.32 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -95.37 97.35 9.77 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.642 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.2 p -87.51 112.78 23.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.541 ' OH ' ' HB2' ' A' ' 141' ' ' CYS . 15.3 t80 -81.21 139.42 35.53 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.203 -170.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -142.34 170.9 14.84 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.23 -89.67 0.59 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.802 177.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -138.26 -149.2 0.29 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.01 -51.77 5.3 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.359 -179.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.31 -18.86 63.58 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.601 178.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.11 144.97 25.02 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -122.15 -68.47 0.89 Allowed 'General case' 0 CA--C 1.438 -3.348 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.667 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.263 1.0 OUTLIER 169.52 153.46 0.04 OUTLIER 'General case' 1 N--CA 1.297 -8.115 0 CA-C-N 111.605 -2.543 . . . . 0.0 105.145 -169.876 . . . . . . . . 5 4 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.667 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 36.6 tp -134.16 126.94 31.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.18 171.83 12.57 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.179 -1.969 . . . . 0.0 108.179 -176.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -92.52 -21.13 20.3 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 118.223 1.012 . . . . 0.0 110.814 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 136' ' ' ASN . 32.3 mm -114.33 114.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.401 ' HB3' HD22 ' A' ' 120' ' ' LEU . 27.6 p-10 -94.87 19.85 9.64 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -175.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -159.03 174.18 15.32 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.31 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 137' ' ' ASP . 8.5 ptm180 -151.88 127.82 10.34 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.34 171.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -99.53 160.7 14.09 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.026 0.53 . . . . 0.0 109.709 -178.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.3 t -98.55 114.82 27.4 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.955 175.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.438 ' HB2' HG22 ' A' ' 135' ' ' THR . 17.3 t70 -92.24 -179.64 5.3 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 125.401 1.48 . . . . 0.0 108.385 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 p -62.54 -36.25 82.02 Favored 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 123.714 0.805 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.85 -34.85 24.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.52 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.29 -157.53 29.43 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -69.02 129.56 40.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.69 1.245 . . . . 0.0 110.886 -177.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 130' ' ' ASP . 24.3 p -55.56 -38.9 69.93 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 125.054 1.341 . . . . 0.0 112.711 -174.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.481 HD21 HG13 ' A' ' 124' ' ' ILE . 11.6 t-20 -138.32 172.81 12.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -175.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 16.6 t70 -102.53 -168.69 1.56 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 123.422 0.451 . . . . 0.0 110.241 -176.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 89' ' ' GLY . 34.2 mt -76.81 123.15 87.47 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 124.435 1.094 . . . . 0.0 111.05 -171.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -73.58 163.24 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.717 1.611 . . . . 0.0 109.762 172.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mm -84.45 133.1 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.541 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 21.3 t -83.0 120.42 25.7 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 121' ' ' LEU . 13.2 tp10 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -174.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 31.2 m-20 . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 121.064 0.459 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 142.41 43.94 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 124.555 1.142 . . . . 0.0 110.757 -172.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -116.56 19.99 14.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.925 0.869 . . . . 0.0 109.35 175.528 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.55 156.01 34.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.665 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 37' ' ' TRP . 40.4 mt -77.4 158.25 79.37 Favored Pre-proline 0 C--O 1.253 1.238 0 O-C-N 123.759 0.662 . . . . 0.0 110.82 176.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 20.3 Cg_endo -62.03 135.05 52.83 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.337 2.024 . . . . 0.0 109.581 175.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.02 137.09 21.23 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 121.986 1.791 . . . . 0.0 112.926 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -76.25 143.66 40.82 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -121.62 175.86 6.0 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.533 -170.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -59.02 -26.08 64.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 0.0 113.21 -175.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -134.3 12.05 3.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.88 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 3.1 mp0 -132.57 140.23 48.17 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.71 -0.796 . . . . 0.0 113.082 -172.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -135.67 142.62 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.74 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.463 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.0 mm? -69.65 142.06 53.51 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.998 -179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 p -101.76 87.98 3.28 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.25 -169.49 40.44 Favored Glycine 0 C--N 1.275 -2.815 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.751 -175.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -117.68 109.6 16.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 48.7 m95 -129.5 126.01 37.66 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 t -160.94 25.01 0.14 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.36 -164.48 1.13 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.782 -1.553 . . . . 0.0 110.053 -172.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -123.83 -64.87 1.11 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.94 0.4 . . . . 0.0 110.91 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.6 p -105.6 146.23 29.94 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.33 153.99 56.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.78 1.232 . . . . 0.0 109.207 178.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 57.6 Cg_endo -73.47 152.93 49.61 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.019 1.813 . . . . 0.0 112.311 179.362 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.9 147.77 52.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.88 5.86 65.91 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.065 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -83.94 115.95 22.55 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.467 178.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -90.04 139.08 30.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.532 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.98 124.56 52.92 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.65 129.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 31' ' ' GLU . 75.4 m-85 -117.67 145.62 44.27 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.229 0.538 . . . . 0.0 112.303 -178.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.16 152.85 18.92 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 m -92.97 28.68 2.03 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -174.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 66.29 155.48 0.13 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-O 121.384 0.611 . . . . 0.0 111.511 -177.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.71 108.23 1.02 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.763 1.642 . . . . 0.0 111.53 176.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.17 -23.18 4.95 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.955 177.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.689 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.9 m-85 -102.5 172.48 6.84 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -154.81 -179.45 8.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -170.6 -179.95 3.09 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.95 8.16 27.61 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 -161.51 27.75 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.93 147.42 26.16 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.83 117.72 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.22 124.94 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.655 -176.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.417 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 88.9 mtp -112.39 172.29 7.0 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.9 p -155.56 148.3 12.27 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.227 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.83 129.27 34.94 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 55.8 ttp180 -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 64.68 19.27 11.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.043 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 -12.48 62.0 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.949 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.1 157.77 24.22 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.169 0.509 . . . . 0.0 111.736 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.1 m95 -91.99 116.21 28.73 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.489 178.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.44 172.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.496 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.68 108.54 19.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.2 tm? -61.15 -49.93 75.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 172.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.18 90.39 9.71 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.557 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.93 -17.91 15.11 Favored 'Trans proline' 0 N--CA 1.479 0.656 0 C-N-CA 122.478 2.119 . . . . 0.0 111.04 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.38 -27.62 60.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.442 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -92.18 131.66 37.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.745 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -140.02 163.36 32.9 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 71.5 m -92.91 110.53 21.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -105.33 162.7 13.21 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.369 -174.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HD3' ' CE2' ' A' ' 56' ' ' TYR . 33.8 mmtp -70.25 157.38 37.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -94.35 134.36 25.71 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.831 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 37.9 Cg_endo -71.62 136.76 28.88 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.288 1.992 . . . . 0.0 110.674 176.13 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.9 -1.79 39.2 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.059 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.78 -123.24 9.71 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.852 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -103.28 136.46 19.22 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.7 Cg_exo -69.29 75.22 1.03 Allowed 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.431 2.087 . . . . 0.0 113.602 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.32 -136.02 19.54 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.536 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.64 27.87 6.01 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.613 0.365 . . . . 0.0 110.233 -176.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -48.82 115.35 4.41 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.271 176.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.31 -53.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.688 2.259 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.16 154.5 49.47 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.37 -168.18 21.06 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -176.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 m -155.37 156.17 34.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 48.8 p90 -145.24 165.94 26.93 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.549 0.53 . . . . 0.0 111.216 -177.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 70.9 p -118.76 -178.02 3.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.921 -179.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.6 155.23 49.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 15.1 t -165.47 149.24 8.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.78 -0.79 88.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.949 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.03 -169.58 39.79 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' H ' HD22 ' A' ' 102' ' ' ASN . 0.1 OUTLIER -131.37 3.31 4.26 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-N 117.748 0.774 . . . . 0.0 112.808 -175.324 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.7 p -156.78 -160.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.068 -1.053 . . . . 0.0 108.698 -173.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 26.0 m-85 -90.87 77.28 6.21 Favored 'General case' 1 C--N 1.243 -4.034 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.771 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.485 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 15.8 pt-20 -136.48 152.28 50.38 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.201 -174.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -49.63 124.52 9.71 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.091 0.869 . . . . 0.0 110.165 173.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.25 -22.85 10.93 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.381 179.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.8 m -76.87 144.43 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.741 -179.023 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.508 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 22.2 ttmm -106.45 106.94 17.71 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -86.86 99.35 11.77 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -80.61 130.33 36.09 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.412 -177.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.88 108.92 21.72 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.912 0.863 . . . . 0.0 109.157 -172.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 m -100.95 -31.53 11.08 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.883 -172.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 33.6 m 65.74 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -166.36 -154.34 0.18 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.7 -60.47 2.34 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.442 -178.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.82 73.98 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.533 -177.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -115.02 128.41 56.25 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.513 0.197 . . . . 0.0 111.145 178.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.41 -134.21 0.33 Allowed 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 167.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -157.52 161.38 38.81 Favored 'General case' 1 N--CA 1.336 -6.158 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.247 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 142' ' ' GLU . 4.1 mm? -88.58 125.04 34.61 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.331 0.586 . . . . 0.0 109.954 172.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.07 148.45 5.45 Favored Glycine 0 C--N 1.278 -2.688 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.44 -16.52 39.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.112 0.958 . . . . 0.0 109.484 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -109.93 106.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.3 p-10 -88.91 36.66 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.48 0.657 . . . . 0.0 111.758 -172.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.442 ' CD1' ' HG3' ' A' ' 109' ' ' LYS . 26.2 p90 -159.19 178.3 10.15 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.63 -177.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' NH2' HG23 ' A' ' 138' ' ' ILE . 6.3 ptp180 -148.98 124.31 10.24 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 17.7 mt-10 -96.76 157.22 16.0 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.35 107.1 18.35 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.557 175.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.29 -164.43 1.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.3 p -65.53 -42.96 91.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.974 0.91 . . . . 0.0 110.04 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.32 -46.28 73.94 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.253 177.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.28 -139.09 7.43 Favored Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.9 m95 -70.86 126.7 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 -176.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.9 p -80.37 170.24 16.65 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.607 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.4 m120 70.45 -81.22 0.03 OUTLIER 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.253 1.021 . . . . 0.0 111.857 173.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.1 t0 163.57 -161.62 0.0 OUTLIER 'General case' 0 C--O 1.242 0.661 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.464 HG23 ' NH2' ' A' ' 127' ' ' ARG . 4.0 mp -107.05 96.64 15.55 Favored Pre-proline 0 C--N 1.284 -2.277 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.2 Cg_endo -47.33 123.7 8.2 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.811 2.341 . . . . 0.0 109.737 173.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.2 mp -68.2 114.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.42 -174.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 14.0 t -59.67 112.86 1.97 Allowed 'General case' 0 C--O 1.254 1.336 0 O-C-N 123.794 0.683 . . . . 0.0 109.713 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.508 ' HB3' HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -173.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.129 0.49 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -70.4 138.96 51.73 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.04 0.936 . . . . 0.0 110.116 -174.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.04 24.93 6.32 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.787 0.804 . . . . 0.0 108.948 176.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.14 160.78 33.36 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.611 -178.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 37' ' ' TRP . 41.1 mt -83.94 152.92 63.25 Favored Pre-proline 0 C--N 1.313 -0.993 0 O-C-N 123.614 0.571 . . . . 0.0 110.325 176.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -54.01 142.84 64.03 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.909 2.406 . . . . 0.0 113.172 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.65 112.43 2.86 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.429 2.086 . . . . 0.0 111.896 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -76.35 151.05 36.77 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.638 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -121.05 -179.84 4.16 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -174.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -90.53 -20.17 22.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.153 0.501 . . . . 0.0 109.705 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 -10.34 17.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 177.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -134.74 137.56 43.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.263 0.554 . . . . 0.0 111.649 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.33 163.52 24.16 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.796 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.459 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -91.78 151.0 20.8 Favored 'General case' 0 C--N 1.266 -3.059 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.9 p -112.47 101.21 9.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.1 -171.43 32.09 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -108.34 115.18 29.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.532 ' HB3' HD22 ' A' ' 24' ' ' LEU . 53.9 m95 -132.7 107.38 8.35 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.215 0.531 . . . . 0.0 109.94 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 t -153.38 28.64 0.5 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 174.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.37 -161.49 0.76 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.413 -168.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.36 -67.09 0.41 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 82.3 p -94.62 128.76 41.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.172 -173.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.44 157.54 77.85 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.66 147.17 39.8 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.261 1.974 . . . . 0.0 111.834 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 22.1 tt0 -64.73 137.21 57.67 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.212 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.54 7.79 50.63 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.3 m -83.82 119.52 24.94 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.849 177.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -87.56 146.41 25.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.31 0.576 . . . . 0.0 111.654 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.2 122.0 41.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.405 HG12 HD12 ' A' ' 63' ' ' ILE . 61.1 mt -94.36 129.84 44.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -104.04 153.6 20.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.493 1.139 . . . . 0.0 113.986 -178.489 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -103.65 118.35 36.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.872 172.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.5 m -69.73 12.31 0.21 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 123.98 0.912 . . . . 0.0 113.392 -178.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.5 mtp180 66.89 154.41 0.13 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.133 0.973 . . . . 0.0 109.158 -170.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 23.0 Cg_endo -61.87 -9.09 13.09 Favored 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 122.358 2.039 . . . . 0.0 115.091 -177.296 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.2 1.83 35.14 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.188 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 48.1 m-85 -123.49 173.28 8.13 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.349 -1.089 . . . . 0.0 111.475 -177.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.44 -172.57 4.17 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.888 0.875 . . . . 0.0 109.346 -175.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -174.08 162.49 3.8 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.47 -8.15 58.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.778 . . . . 0.0 109.861 177.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.33 -123.88 1.81 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.97 151.31 28.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.98 103.22 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.618 0.723 . . . . 0.0 109.114 177.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 HG12 ' A' ' 49' ' ' ILE . 48.5 mm -110.87 121.23 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.975 178.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.2 mtp -110.22 170.04 8.34 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 5.8 p -154.21 142.16 13.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.23 127.92 32.65 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.314 -178.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.5 ttp180 -150.5 125.83 10.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 44.1 mmtm 63.19 35.3 12.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.715 0.806 . . . . 0.0 112.525 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.36 53.55 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.001 176.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.62 163.97 12.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.806 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -104.9 114.15 28.18 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -179.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 p -123.24 -167.33 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.367 -4.599 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.012 -171.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.66 113.24 25.23 Favored 'General case' 1 C--N 1.224 -4.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 114.145 -168.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.4 -52.93 10.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 172.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.57 92.56 14.35 Favored Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.267 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.74 -1.04 11.22 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.401 2.067 . . . . 0.0 111.96 178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.72 -5.19 51.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.222 0.534 . . . . 0.0 109.925 178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -112.79 144.84 41.65 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.203 0.525 . . . . 0.0 111.001 -175.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -156.34 147.75 22.52 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 173.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -83.74 113.14 20.69 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.672 177.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -105.59 163.96 12.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.07 -177.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 96.8 mttt -64.05 143.45 57.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.261 0.553 . . . . 0.0 111.452 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -84.13 145.39 45.97 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 71.5 Cg_endo -74.48 157.67 44.76 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.539 1.493 . . . . 0.0 111.086 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.3 m -107.66 7.61 28.62 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 -176.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.51 -102.63 1.31 Allowed Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.611 178.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -152.65 130.96 6.3 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.89 37.22 0.4 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 123.069 2.513 . . . . 0.0 111.789 -177.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 79.92 -176.87 54.55 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -172.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -124.4 -171.32 2.31 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -172.29 126.77 0.55 Allowed Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.6 -22.72 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.976 1.784 . . . . 0.0 113.694 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -129.86 -5.35 4.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.89 171.77 20.22 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.782 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -136.25 160.65 38.06 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.5 p90 -144.69 149.98 36.56 Favored 'General case' 0 N--CA 1.418 -2.042 0 O-C-N 123.332 0.395 . . . . 0.0 111.211 174.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 61.5 p -101.45 175.67 5.49 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.423 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -140.67 131.33 25.63 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.0 t -127.26 9.06 6.66 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.577 0.703 . . . . 0.0 112.233 -171.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.32 34.24 2.21 Favored Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.24 175.15 13.66 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 106.379 -2.688 . . . . 0.0 106.379 -172.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -124.12 24.18 8.24 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 118.417 1.109 . . . . 0.0 108.773 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.8 m -143.09 -177.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.6 m-85 -89.96 85.38 6.33 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.039 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.39 144.25 51.27 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.144 -178.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 72.5 t80 -49.18 114.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.885 0.874 . . . . 0.0 111.385 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 127.33 -22.04 5.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.529 -179.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.74 139.09 19.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 122.053 0.93 . . . . 0.0 111.133 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.489 ' HB3' HG22 ' A' ' 99' ' ' THR . 33.8 ttmt -108.13 117.14 33.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 170.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -90.37 97.64 11.3 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -79.88 127.26 39.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.668 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 59.7 t80 -114.07 143.88 44.04 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 -171.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -151.54 160.55 43.63 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 75.6 m -149.15 126.49 11.49 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 66.77 178.3 0.22 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.23 -47.77 3.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.847 -178.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.02 74.27 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.191 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -141.28 -177.92 5.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.634 ' HB2' HD13 ' A' ' 120' ' ' LEU . 2.8 pt20 -153.79 -130.9 0.04 OUTLIER 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -99.26 163.88 12.36 Favored 'General case' 0 N--CA 1.386 -3.671 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.098 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 142' ' ' GLU . 3.8 mm? -88.87 142.44 27.65 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 166.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.94 154.88 10.13 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -83.8 -26.71 29.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.937 0.875 . . . . 0.0 109.72 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.95 111.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.89 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.96 26.43 3.21 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.488 1.115 . . . . 0.0 110.716 -178.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.516 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 7.3 p90 -153.49 -178.12 6.79 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.343 -172.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -139.52 121.89 16.05 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 24.9 mt-10 -99.5 141.12 32.71 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.363 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.93 115.94 23.86 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.532 177.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.9 172.16 7.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.627 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.1 p -52.08 -39.38 59.62 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 125.347 1.459 . . . . 0.0 112.197 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.25 -33.47 19.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.902 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.73 -162.23 33.85 Favored Glycine 0 C--O 1.212 -1.281 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 134.69 47.85 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.541 0.671 . . . . 0.0 111.443 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -68.43 -25.79 65.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.241 0.616 . . . . 0.0 111.375 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -130.15 168.19 17.19 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -176.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -107.46 -104.44 0.35 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.389 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.426 HD11 ' HA3' ' A' ' 89' ' ' GLY . 30.8 mt -127.5 96.74 32.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 4.7 Cg_endo -47.95 129.04 17.39 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.276 2.651 . . . . 0.0 111.64 178.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.2 mm -80.76 112.21 18.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.457 -173.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.668 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 57.4 m -79.24 114.13 17.93 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.785 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.662 ' HB3' HD23 ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.435 -1.19 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.356 0.598 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 138.4 58.41 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.404 -175.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -118.22 20.11 13.27 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.304 1.05 . . . . 0.0 108.772 175.333 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.84 153.6 39.36 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.624 179.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.3 mt -81.66 157.58 69.46 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.224 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 144.49 96.45 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 122.073 1.849 . . . . 0.0 111.31 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.6 178.99 5.68 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.046 1.831 . . . . 0.0 111.53 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -94.41 158.7 15.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 10.5 mmt85 -103.94 166.41 10.43 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -77.04 -62.15 1.75 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -95.77 13.69 25.72 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.193 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 28' ' ' ARG . 4.8 mp0 -135.66 161.83 34.42 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.5 mt -134.4 150.52 30.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 37' ' ' TRP . 35.2 mt -71.84 143.32 49.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.532 0.605 . . . . 0.0 110.226 174.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 p -87.44 -33.24 19.13 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.174 0.512 . . . . 0.0 112.067 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.92 168.4 18.09 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.865 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -87.93 138.2 31.66 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 175.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 33' ' ' LEU . 75.9 m95 -130.28 117.8 20.37 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.307 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 m -130.31 4.81 4.78 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.217 0.532 . . . . 0.0 110.874 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.78 -165.76 1.28 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.09 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -140.7 -40.67 0.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.052 175.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 22' ' ' ASN . 40.2 p -112.08 138.13 49.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.698 -178.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -139.55 154.88 71.83 Favored Pre-proline 0 C--N 1.303 -1.434 0 C-N-CA 123.874 0.87 . . . . 0.0 109.067 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.83 148.65 28.66 Favored 'Trans proline' 0 C--O 1.257 1.462 0 C-N-CA 121.756 1.638 . . . . 0.0 111.056 175.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -62.05 145.44 53.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.15 1.3 59.56 Favored Glycine 0 C--N 1.298 -1.545 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.226 -179.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.9 m -83.93 118.12 23.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.421 0.153 . . . . 0.0 111.12 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.8 pt20 -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-O 121.925 0.869 . . . . 0.0 111.731 -176.578 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 113.02 19.09 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.97 114.92 27.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.123 -177.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 45.0 m-85 -95.63 138.59 33.08 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.853 0.835 . . . . 0.0 112.353 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 85.7 tttt -80.41 139.04 36.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.401 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 12.2 t -84.57 10.29 11.42 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -170.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 73.0 ttt180 67.24 133.32 0.04 OUTLIER Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.705 174.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.72 104.39 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.441 2.761 . . . . 0.0 114.093 -176.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.71 -24.37 5.2 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.177 177.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.7 m-85 -95.77 173.17 7.6 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.363 -0.493 . . . . 0.0 110.559 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -136.85 161.45 35.96 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.59 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 99.9 p -136.36 173.21 11.95 Favored 'General case' 0 N--CA 1.382 -3.847 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.325 177.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -83.71 -4.89 58.99 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.965 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.74 45.41 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 176.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.55 131.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.352 1.061 . . . . 0.0 112.691 -177.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.7 t -76.07 111.52 12.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -105.77 114.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-O 121.513 0.673 . . . . 0.0 109.788 -178.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtp -103.5 172.59 6.72 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.612 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.9 p -160.74 150.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.87 128.19 33.57 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 40.3 ttp180 -153.72 127.42 8.76 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 67.64 19.92 9.71 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.52 -14.74 64.48 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.158 178.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.89 172.99 6.52 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.166 0.508 . . . . 0.0 110.007 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -110.5 112.53 24.51 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.11 -158.44 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.372 -4.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.954 -175.194 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.49 129.53 39.66 Favored 'General case' 1 C--N 1.231 -4.552 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.508 -170.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.1 tm? -89.47 -57.45 2.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 171.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.7 m120 -112.29 95.05 29.18 Favored Pre-proline 0 N--CA 1.421 -1.911 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.163 178.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.71 -17.68 25.82 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.275 1.983 . . . . 0.0 111.382 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -79.14 -19.59 50.66 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.199 1.0 . . . . 0.0 110.834 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 29.6 mmt180 -81.11 129.7 34.68 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 174.064 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -145.21 152.73 40.45 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 16.9 m -104.95 114.81 29.23 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.189 0.995 . . . . 0.0 111.138 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -112.39 174.59 5.81 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.433 -178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -82.95 145.91 29.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.5 ptp180 -74.99 132.45 77.14 Favored Pre-proline 0 C--N 1.298 -1.648 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.214 178.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 47.2 Cg_endo -73.46 139.69 28.98 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 122.153 1.902 . . . . 0.0 110.115 176.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 m -89.49 -21.31 23.02 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.431 0.634 . . . . 0.0 109.761 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.61 -160.44 47.24 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.576 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.33 115.34 14.14 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 125.162 1.385 . . . . 0.0 110.653 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 138' ' ' ILE . 98.4 Cg_endo -78.76 -9.43 15.78 Favored 'Trans proline' 0 C--O 1.212 -0.794 0 C-N-CA 123.31 2.673 . . . . 0.0 113.151 -178.305 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 123.95 -155.65 17.93 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -145.05 157.9 43.98 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -150.11 125.99 5.04 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.78 -47.62 15.32 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.494 2.129 . . . . 0.0 111.445 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -109.82 140.04 44.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.46 -178.01 23.15 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.913 176.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 m -158.04 166.97 31.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -123.49 159.35 29.27 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.239 176.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.594 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.98 159.39 25.7 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.422 177.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.69 139.86 52.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.2 t -113.32 -18.86 11.95 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.28 21.44 Favored Glycine 0 CA--C 1.5 -0.853 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.587 -174.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.64 -175.79 32.63 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -178.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.7 15.09 18.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.147 0.975 . . . . 0.0 109.083 178.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.65 172.3 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -96.5 100.41 12.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.216 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' VAL . 14.7 pt-20 -147.14 160.63 42.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 -174.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.507 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 92.6 t80 -55.14 116.28 2.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.127 0.489 . . . . 0.0 110.439 175.065 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.98 -18.91 11.29 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 105' ' ' GLU . 1.4 p -91.08 167.64 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.4 ttmt -142.13 131.84 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -179.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.66 94.42 8.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.594 HG13 ' OG1' ' A' ' 97' ' ' THR . 3.7 p -93.49 114.71 30.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.883 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.65 144.09 26.51 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.387 1.089 . . . . 0.0 112.887 -173.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -134.81 150.83 50.56 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 103.479 -2.786 . . . . 0.0 103.479 174.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 118' ' ' TYR . 16.3 t -112.21 -80.92 0.59 Allowed 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.695 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 2.4 m-20 -137.7 -168.12 2.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.3 -43.17 70.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.264 0.554 . . . . 0.0 110.671 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.61 -1.91 46.69 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.81 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.721 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 91.2 m-85 -115.86 128.96 56.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 122.454 -0.439 . . . . 0.0 111.749 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 14.8 mm100 -139.2 -148.7 0.26 Allowed 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 170.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -111.66 169.88 8.52 Favored 'General case' 0 N--CA 1.382 -3.848 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.862 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 140' ' ' ILE . 3.5 mm? -66.21 -64.26 0.9 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.765 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.23 -154.42 16.77 Favored Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.072 -0.967 . . . . 0.0 114.764 -173.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.68 -13.78 22.54 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.392 0.677 . . . . 0.0 111.435 -177.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 139' ' ' PRO . 45.8 mm -94.43 94.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 CA-C-O 122.293 1.044 . . . . 0.0 110.56 -175.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -94.31 26.49 3.33 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.494 -177.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.09 174.64 7.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.866 0.841 . . . . 0.0 112.54 -171.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HG3' ' CE3' ' A' ' 134' ' ' TRP . 9.1 ptm180 -140.67 132.19 27.0 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 170.051 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -110.91 157.37 19.94 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -168.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 46.3 m -90.62 116.56 28.6 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.659 0.742 . . . . 0.0 112.384 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -110.97 179.17 4.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.2 p -57.36 -35.74 70.32 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.918 0.887 . . . . 0.0 110.527 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.9 -35.19 67.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.781 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 139.43 -127.61 3.7 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -174.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.512 ' CE3' ' HG3' ' A' ' 127' ' ' ARG . 91.4 m95 -82.66 127.47 33.42 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 118.173 0.987 . . . . 0.0 109.749 178.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.2 p -62.64 -60.79 3.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.066 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.38 -173.4 2.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 12.2 t70 -113.01 -166.75 1.11 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.589 HD11 ' HA3' ' A' ' 89' ' ' GLY . 71.5 mt -82.14 124.97 78.18 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 122.949 0.5 . . . . 0.0 110.916 -173.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 16.3 Cg_endo -58.13 147.91 80.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.553 2.835 . . . . 0.0 111.789 178.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 121' ' ' LEU . 37.1 mm -88.73 122.05 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.515 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 41.3 t -72.26 119.44 16.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.38 0.61 . . . . 0.0 111.079 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 121' ' ' LEU . 9.8 tp10 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.4 m -69.31 137.39 52.93 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.681 -1.145 . . . . 0.0 107.969 -177.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 41' ' ' THR . 11.2 m120 -114.41 14.65 17.93 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.61 163.96 36.47 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.727 -175.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -98.0 159.06 31.74 Favored Pre-proline 0 N--CA 1.383 -3.825 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.721 -175.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.72 134.47 54.25 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 109.779 176.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.48 142.35 64.95 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.411 2.074 . . . . 0.0 113.439 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.97 134.61 35.39 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 171.092 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 31.8 mtp85 -118.99 179.52 4.13 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -169.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -78.51 -63.87 1.3 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.467 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 p -85.54 11.63 10.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.501 0.667 . . . . 0.0 112.44 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 4.0 mp0 -141.71 143.85 33.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.619 -176.155 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 51.9 mt -133.24 141.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 37' ' ' TRP . 51.2 mt -71.94 141.16 49.46 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.751 0.657 . . . . 0.0 110.348 177.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -71.29 -61.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 178.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.28 52.61 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.308 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -103.83 114.44 28.7 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CD1' HD13 ' A' ' 33' ' ' LEU . 27.1 m95 -101.77 92.27 4.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.116 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -99.59 -5.91 28.26 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.122 -177.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' HD21 ' A' ' 24' ' ' LEU . 6.0 m-20 -83.76 -163.1 0.72 Allowed 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -136.27 -54.74 0.75 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 45.3 p -90.98 129.02 37.03 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 121.528 0.68 . . . . 0.0 112.557 -176.038 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 40.5 m-85 -135.91 153.29 76.96 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 123.814 0.846 . . . . 0.0 109.382 179.083 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.46 149.48 87.84 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.176 1.918 . . . . 0.0 112.441 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 tt0 -69.73 135.59 49.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.7 7.66 50.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.038 -178.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -85.03 123.98 31.19 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.712 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -92.22 147.82 22.63 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.019 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.73 134.23 55.3 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.38 132.29 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 82.7 m-85 -109.57 136.34 49.11 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.469 175.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 53' ' ' ARG . 36.1 mtpt -65.93 -26.81 67.76 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.211 1.004 . . . . 0.0 111.618 -176.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.659 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 19.2 m 71.33 8.74 6.41 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.472 -171.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 50.3 mtt180 66.57 170.2 0.1 Allowed Pre-proline 0 N--CA 1.494 1.752 0 CA-C-O 121.388 0.613 . . . . 0.0 111.198 -178.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.79 133.84 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 166.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.39 -17.11 34.36 Favored Glycine 0 C--N 1.302 -1.309 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.799 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 80.8 m-85 -118.85 161.94 19.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.176 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -149.23 -174.87 4.77 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 p -174.65 175.89 2.39 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.45 -8.94 58.79 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.78 48.09 0.1 OUTLIER Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 50.8 m-80 62.22 -172.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.657 0.783 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 53.7 t -110.86 116.13 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.8 114.39 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.766 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.5 mtp -105.75 167.32 9.85 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -151.39 146.39 15.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.2 t -84.75 132.23 34.46 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.768 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 51.2 ttp180 -154.27 120.75 5.44 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 42.2 mmtm 65.88 38.22 5.15 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.197 0.999 . . . . 0.0 112.198 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.26 -16.16 24.73 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 114.962 -1.017 . . . . 0.0 114.084 176.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -110.38 154.97 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.399 0.6 . . . . 0.0 111.107 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.439 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 78.6 m95 -95.1 121.0 36.29 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.224 0.535 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.93 174.53 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.527 -176.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.18 125.25 30.04 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.29 -59.13 3.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -109.74 105.99 57.83 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.523 177.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.94 -14.14 40.37 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 123.428 2.752 . . . . 0.0 111.945 -178.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.44 -11.58 58.43 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.498 1.142 . . . . 0.0 109.876 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 42.0 mmt-85 -90.85 114.28 26.66 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.156 176.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.51 148.05 27.57 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.614 -177.252 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -86.24 108.97 18.61 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.567 -178.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -101.19 157.5 16.73 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.635 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 86.5 mttt -75.5 138.89 41.87 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HD3' ' O ' ' A' ' 131' ' ' THR . 17.1 ptm180 -76.02 151.29 83.98 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.565 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 156.31 62.69 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.079 1.853 . . . . 0.0 111.796 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.3 m -114.3 5.53 15.8 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.651 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.36 -92.39 0.33 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.374 174.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -152.43 124.36 3.84 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -173.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HE ' ' A' ' 127' ' ' ARG . 89.9 Cg_endo -80.13 40.45 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 123.542 2.828 . . . . 0.0 112.865 -178.054 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 82.91 -179.43 52.99 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -177.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -103.72 162.63 12.92 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -161.45 109.76 1.22 Allowed Pre-proline 0 N--CA 1.42 -1.945 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.551 175.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.26 -50.72 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.905 1.737 . . . . 0.0 111.821 177.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -100.11 14.96 28.93 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -133.77 171.37 22.05 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.015 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 m -146.39 167.34 23.85 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 42.4 p90 -142.29 163.47 32.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.683 0.277 . . . . 0.0 111.038 -178.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 65.5 p -107.71 161.89 14.47 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.72 128.31 38.66 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.0 t -112.99 14.88 19.74 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.84 28.17 2.75 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.01 176.4 14.39 Favored Glycine 0 N--CA 1.411 -3.009 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 -173.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -112.25 32.5 5.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.12 165.69 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.184 -174.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -96.42 95.25 7.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 110.244 -177.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.98 155.65 49.94 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.567 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.546 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 52.2 t80 -50.9 124.47 11.3 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.072 0.857 . . . . 0.0 109.766 176.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.55 26.28 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.29 -1.433 . . . . 0.0 114.175 177.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.4 134.25 28.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 119.403 1.602 . . . . 0.0 109.498 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -97.83 117.19 31.59 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.02 104.71 16.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.512 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.1 m -87.65 130.32 37.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HG2' ' A' ' 139' ' ' PRO . 68.3 t80 -121.18 137.86 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.566 0.698 . . . . 0.0 112.051 -168.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.7 m -152.1 165.16 35.6 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.0 m -130.75 120.97 24.59 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.851 0.296 . . . . 0.0 110.529 -177.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 55.79 -155.64 0.28 Allowed 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.6 0.562 . . . . 0.0 110.317 178.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.5 -43.63 8.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.122 0.486 . . . . 0.0 110.835 177.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.39 11.72 68.54 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -173.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 70.0 m-85 -120.77 140.43 51.7 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.388 1.094 . . . . 0.0 111.9 177.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 42.5 mt-30 -133.96 -170.19 2.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 167.461 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -98.56 155.41 17.3 Favored 'General case' 2 N--CA 1.356 -5.143 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -175.716 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.63 -31.99 57.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.302 -179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.16 174.6 53.19 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.202 177.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.65 -37.94 17.54 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.991 0.901 . . . . 0.0 109.592 -178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.1 mm -82.99 103.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.076 -175.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.418 ' HB3' HD21 ' A' ' 120' ' ' LEU . 4.6 p-10 -87.71 25.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.428 -176.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -159.15 173.87 15.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.089 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' A' ' 88' ' ' PRO . 29.2 ptt-85 -148.84 118.02 6.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.846 174.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.25 146.25 23.98 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.876 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . 43.5 t -91.24 124.45 35.46 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.515 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.7 t70 -105.38 -164.84 1.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 28.6 p -54.06 -58.64 6.58 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 125.857 1.663 . . . . 0.0 112.761 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.22 -40.11 52.95 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 172.52 -155.45 23.28 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.525 -176.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 70.0 m95 -69.9 132.49 46.07 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 48.5 p -77.29 142.04 39.65 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 72.17 -168.79 0.14 Allowed 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.015 0.822 . . . . 0.0 109.245 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.91 -164.35 1.3 Allowed 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt -86.28 107.97 15.56 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 7.1 Cg_endo -48.41 122.53 7.83 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.55 2.834 . . . . 0.0 112.196 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.0 mp -73.23 115.09 13.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.017 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 80.3 m -81.43 115.02 20.57 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.006 0.431 . . . . 0.0 111.437 179.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 140' ' ' ILE . 65.9 mm-40 . . . . . 0 C--N 1.303 -1.455 0 C-N-CA 124.327 1.051 . . . . 0.0 108.498 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -65.12 137.78 57.87 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.208 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.428 ' HA ' HG22 ' A' ' 41' ' ' THR . 3.3 m-80 -124.0 24.7 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.115 0.959 . . . . 0.0 109.184 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.1 150.79 24.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.666 -1.607 . . . . 0.0 107.823 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.01 152.55 84.47 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 123.66 0.6 . . . . 0.0 109.916 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.21 147.5 91.2 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.022 1.814 . . . . 0.0 110.347 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.95 165.57 19.51 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 113.447 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -110.35 150.11 29.25 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 16.1 mtp180 -123.07 178.93 4.86 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.684 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.63 -58.69 3.13 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.77 0.428 . . . . 0.0 110.094 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -90.23 -11.85 39.75 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -123.11 150.94 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.569 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' A' ' 53' ' ' ARG . 33.1 mt -131.1 148.04 32.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 mt -74.01 129.95 38.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 117.918 0.326 . . . . 0.0 111.487 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 19.9 p -121.34 104.39 9.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.525 0.679 . . . . 0.0 110.342 174.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.27 173.03 22.09 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -93.82 119.34 32.64 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 117.263 0.532 . . . . 0.0 110.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -126.9 121.68 32.47 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 t -149.86 13.27 0.8 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.142 -1.023 . . . . 0.0 112.934 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.95 152.65 49.17 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 121.508 -0.745 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.05 -30.49 62.43 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 120.751 0.31 . . . . 0.0 110.917 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.1 p -114.41 118.13 32.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.576 0.703 . . . . 0.0 112.714 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -119.97 153.15 54.96 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.099 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.92 140.07 44.9 Favored 'Trans proline' 0 C--O 1.258 1.485 0 C-N-CA 122.175 1.917 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -61.74 136.54 58.03 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.25 -0.34 40.69 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.221 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -82.29 119.25 23.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.97 144.17 25.73 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.804 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.28 123.9 51.28 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.122 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.99 121.44 45.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.527 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 53.2 m-85 -99.73 145.72 27.34 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.985 0.897 . . . . 0.0 113.334 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 50.1 tptt -85.2 128.19 34.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.322 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.8 m -82.58 107.3 15.12 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 165.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HG2' HD11 ' A' ' 32' ' ' ILE . 76.1 mtp180 -40.11 153.98 0.2 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.086 1.354 . . . . 0.0 113.598 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.69 114.02 2.22 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.698 1.598 . . . . 0.0 108.898 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 114.03 -8.38 23.27 Favored Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.06 168.76 13.54 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -162.22 -179.27 6.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.0 p -139.63 -77.64 0.33 Allowed 'General case' 0 N--CA 1.409 -2.515 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 58' ' ' SER . 24.8 mt -176.32 -40.35 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 126.612 1.965 . . . . 0.0 106.203 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.25 -108.11 1.18 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.85 158.04 44.27 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.0 t -86.54 109.89 19.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.39 121.24 54.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.194 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.2 mtp -111.18 166.36 11.14 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -152.86 146.71 14.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.0 t -81.23 126.61 31.74 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 2.5 tpm_? -148.73 128.76 13.55 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 34.7 mmtp 67.77 12.16 8.71 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.42 -9.4 57.42 Favored Glycine 0 CA--C 1.495 -1.184 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.848 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -115.56 163.62 15.51 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.15 116.21 28.94 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 m -115.2 167.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.471 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.37 110.06 20.9 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.53 -45.89 92.17 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -115.71 91.06 28.71 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.147 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.99 -15.67 26.01 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.815 2.343 . . . . 0.0 111.661 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.19 -20.49 48.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.097 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.723 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -161.86 156.09 22.13 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 59.3 m -92.99 118.69 31.45 Favored 'General case' 0 C--N 1.27 -2.877 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -113.05 -179.48 3.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.0 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.4 mmtp -59.45 147.54 36.16 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 123.82 0.7 . . . . 0.0 111.565 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 131' ' ' THR . 10.9 ptp180 -98.17 143.13 25.73 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 55.2 Cg_endo -71.81 148.21 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.518 2.145 . . . . 0.0 111.533 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.06 -19.37 15.2 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.677 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.92 -163.55 52.48 Favored Glycine 0 CA--C 1.467 -2.958 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.793 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -73.21 129.47 86.04 Favored Pre-proline 0 C--N 1.261 -3.263 0 CA-C-N 114.427 -0.887 . . . . 0.0 112.539 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 84.4 Cg_endo -84.85 -3.36 9.78 Favored 'Trans proline' 0 CA--C 1.502 -1.101 0 C-N-CA 123.054 2.503 . . . . 0.0 111.748 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 114.35 3.85 Favored Glycine 1 N--CA 1.395 -4.043 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -99.91 175.38 5.79 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.025 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.459 HG21 ' OH ' ' A' ' 112' ' ' TYR . 5.4 t -151.22 145.19 17.77 Favored Pre-proline 0 N--CA 1.416 -2.167 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.24 -23.75 32.83 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.039 1.826 . . . . 0.0 111.331 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -127.56 105.14 8.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.84 168.04 11.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 m -142.08 169.44 17.59 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.7 155.75 38.95 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 p -128.95 141.0 51.41 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -98.21 129.02 44.97 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.566 0.698 . . . . 0.0 110.664 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.552 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.1 t -114.92 130.28 56.88 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.94 -16.06 33.41 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.36 -176.78 48.0 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -121.97 18.45 10.91 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.683 0.754 . . . . 0.0 109.519 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' O ' HG11 ' A' ' 108' ' ' VAL . 30.0 m -140.21 169.87 15.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 30.3 m-85 -93.28 89.19 6.29 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.535 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.5 pt-20 -133.31 158.12 43.76 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.921 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 77.4 t80 -48.76 115.24 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.417 1.087 . . . . 0.0 110.969 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.08 -21.74 10.06 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.753 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 103' ' ' VAL . 11.4 m -79.27 149.97 5.28 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 C-N-CA 118.914 -1.114 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 4.8 ttmp? -113.63 124.55 52.59 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.02 90.85 8.05 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.8 114.91 14.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.459 ' OH ' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -79.94 138.46 37.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.7 167.55 16.29 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 118' ' ' TYR . 12.3 t -146.79 173.82 12.04 Favored 'General case' 0 N--CA 1.396 -3.172 0 C-N-CA 118.452 -1.299 . . . . 0.0 109.278 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.09 155.33 20.69 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.881 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -50.78 -41.16 56.7 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.066 0.946 . . . . 0.0 112.205 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.96 64.88 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HB2' ' SG ' ' A' ' 114' ' ' CYS . 34.8 m-85 -136.59 167.02 22.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 119.094 1.447 . . . . 0.0 111.159 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.52 -93.97 0.51 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 168.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.1 pp 175.74 158.01 0.23 Allowed 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.58 0.752 . . . . 0.0 111.499 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 96.1 mt -96.91 135.69 38.53 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 122.16 168.18 13.22 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -96.88 -28.99 13.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.4 mm -100.03 105.15 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.267 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -89.37 36.18 0.83 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.886 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 127' ' ' ARG . 23.0 p90 -165.21 174.1 10.61 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.184 0.516 . . . . 0.0 111.114 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.471 ' HD3' ' C ' ' A' ' 126' ' ' TYR . 1.4 mpp_? -139.46 132.36 29.3 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -113.01 147.81 36.39 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 118.437 0.562 . . . . 0.0 111.182 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 11.6 m -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.157 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -101.4 -166.78 1.34 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.499 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 28.7 p -59.5 -46.17 89.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 124.939 1.296 . . . . 0.0 112.728 -174.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.74 21.93 15.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 132.02 -155.5 21.49 Favored Glycine 0 C--N 1.288 -2.115 0 C-N-CA 119.394 -1.384 . . . . 0.0 113.624 173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.6 m95 -81.49 146.15 30.36 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.225 0.536 . . . . 0.0 111.355 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.5 p -78.65 -25.21 44.92 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.884 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.79 -179.62 5.76 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -171.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -107.98 -155.59 0.56 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.689 0.796 . . . . 0.0 110.585 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.7 mt -95.25 107.75 34.42 Favored Pre-proline 0 C--N 1.313 -0.984 0 O-C-N 122.039 -0.413 . . . . 0.0 110.344 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 22.7 Cg_endo -66.89 133.61 31.89 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.486 2.124 . . . . 0.0 110.19 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.1 mm -86.83 123.9 40.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.648 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.91 105.97 1.44 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 29.8 mm-40 . . . . . 0 C--N 1.313 -1.012 0 C-N-CA 124.597 1.159 . . . . 0.0 108.097 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.649 0.738 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' THR . 77.6 m -80.67 121.95 26.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.418 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -97.59 33.56 2.02 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.843 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 10.8 pt-20 -155.6 148.78 24.64 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.908 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.2 mt -73.27 153.12 90.33 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 123.794 0.838 . . . . 0.0 109.56 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.8 Cg_endo -62.58 130.09 28.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.693 1.595 . . . . 0.0 109.39 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 2.9 Cg_exo -72.87 126.91 11.72 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 121.65 1.567 . . . . 0.0 112.542 -174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -59.91 136.08 57.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 168.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 HH21 ' CD ' ' A' ' 31' ' ' GLU . 12.9 mtm180 -111.03 163.16 14.13 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -171.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.25 -33.82 67.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.53 0.681 . . . . 0.0 112.357 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 56' ' ' TYR . 3.0 p -111.93 -0.33 15.83 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.663 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 58.8 mp0 -139.7 142.27 36.9 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 53' ' ' ARG . 34.7 mt -123.2 152.75 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.369 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -77.91 136.21 37.99 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.089 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 51' ' ' LYS . 2.6 p -120.68 105.9 11.21 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.618 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.62 -159.97 28.99 Favored Glycine 0 N--CA 1.413 -2.851 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -125.59 110.85 14.32 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HB3' HD22 ' A' ' 24' ' ' LEU . 73.8 m95 -110.72 112.27 24.03 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -116.12 -11.13 11.41 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.303 -171.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -128.99 152.94 48.05 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 118.749 -1.181 . . . . 0.0 112.437 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.587 ' NE2' ' HA ' ' A' ' 23' ' ' GLU . 54.6 tp60 -76.08 -23.69 55.0 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.397 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.4 p -116.36 122.77 45.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.512 0.672 . . . . 0.0 112.422 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.73 136.81 29.29 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.343 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 151.85 79.96 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.589 2.193 . . . . 0.0 112.043 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.3 tt0 -62.5 140.05 58.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.28 8.46 58.73 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.327 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.7 m -91.63 115.97 28.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.845 -0.178 . . . . 0.0 111.167 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.6 pt20 -85.56 144.18 28.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.564 0.697 . . . . 0.0 111.197 -177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.12 117.37 31.03 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.354 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.81 121.62 41.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 68.5 m-85 -104.96 152.5 22.61 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB2' HG23 ' A' ' 34' ' ' THR . 65.1 tttm -109.89 136.3 49.41 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.569 -1.651 . . . . 0.0 107.144 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.6 m -78.49 17.64 0.65 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HG2' HD11 ' A' ' 32' ' ' ILE . 77.6 mtp180 65.24 159.42 0.13 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.458 0.647 . . . . 0.0 109.689 -175.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.11 -8.01 18.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.568 1.512 . . . . 0.0 114.157 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.67 -5.42 20.62 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.047 -1.073 . . . . 0.0 115.223 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.8 m-85 -114.21 173.2 6.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.037 . . . . 0.0 109.182 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.0 179.13 6.68 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -165.12 -176.7 4.23 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -112.25 2.79 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.482 0.658 . . . . 0.0 109.749 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.75 155.13 14.85 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.94 135.76 57.48 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.018 0.481 . . . . 0.0 110.864 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.8 t -79.3 111.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.3 mm -110.27 122.92 65.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.344 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.9 mtp -108.03 172.44 6.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.3 p -156.35 147.04 11.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 121.064 0.459 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.0 128.31 35.09 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.628 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.9 ttp180 -150.07 120.72 7.5 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm 57.97 21.62 7.93 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.68 -17.87 55.89 Favored Glycine 0 N--CA 1.415 -2.704 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.44 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 72' ' ' VAL . 16.3 pt-20 -103.83 154.86 19.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.128 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -93.18 121.46 34.56 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 70' ' ' GLU . 34.0 m -123.42 170.88 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.506 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.56 119.99 29.52 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 120.713 0.292 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.5 -50.14 66.39 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -112.23 87.99 9.91 Favored Pre-proline 0 N--CA 1.422 -1.862 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.183 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.83 -7.76 18.63 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.176 2.584 . . . . 0.0 111.289 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.82 -11.99 57.81 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -112.84 140.32 47.73 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.326 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.76 152.33 25.0 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 64.1 m -91.83 112.87 24.97 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.762 0.791 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -104.4 167.56 9.67 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.265 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.04 147.37 53.28 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.316 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -88.9 135.59 31.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.138 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.62 143.36 33.94 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.287 1.991 . . . . 0.0 110.074 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m -93.54 -20.4 20.28 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.612 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 -178.9 52.32 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -70.73 130.3 88.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 36.2 Cg_endo -69.86 91.34 0.52 Allowed 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.163 1.909 . . . . 0.0 111.227 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.38 -153.23 46.02 Favored Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.036 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.36 16.11 4.08 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -38.06 105.25 0.32 Allowed Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 126.133 1.773 . . . . 0.0 114.441 -174.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -84.01 -24.22 2.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.369 2.046 . . . . 0.0 109.431 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -112.95 86.68 2.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.08 156.66 7.15 Favored Glycine 0 N--CA 1.411 -2.967 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 m -149.36 167.82 25.07 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.8 p90 -153.63 155.36 35.93 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.144 0.429 . . . . 0.0 110.725 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 p -121.13 143.82 48.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.16 136.16 40.48 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.8 t -114.39 2.08 14.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.454 0.645 . . . . 0.0 111.761 -173.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.3 38.1 2.02 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.78 -172.58 19.49 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -120.72 20.43 11.71 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.839 0.828 . . . . 0.0 109.375 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.76 156.64 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.259 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.07 89.01 7.85 Favored 'General case' 0 C--N 1.244 -3.999 0 CA-C-N 112.638 -2.074 . . . . 0.0 109.949 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.05 150.41 41.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.033 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.501 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 55.1 t80 -47.96 112.78 0.61 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.431 0.634 . . . . 0.0 111.633 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.46 -19.99 7.96 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.754 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -87.31 141.82 13.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 117.468 0.634 . . . . 0.0 110.393 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.616 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.5 ttmp? -108.35 134.29 51.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.12 106.3 17.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 59.3 t -86.57 115.69 27.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 88' ' ' PRO . 18.8 m-85 -88.22 147.71 24.72 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.7 1.238 . . . . 0.0 112.998 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 27.9 m -155.55 177.64 11.15 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.5 t -140.38 -65.48 0.45 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 120.681 1.582 . . . . 0.0 110.051 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -146.29 -164.61 2.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.95 -43.83 17.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.479 0.656 . . . . 0.0 109.932 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.1 -11.63 61.13 Favored Glycine 0 C--N 1.305 -1.156 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.176 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 88.3 m-85 -123.11 129.33 51.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 65.7 mt-30 -122.85 -86.44 0.65 Allowed 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.616 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.6 pp -175.0 156.46 2.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 123.704 0.627 . . . . 0.0 112.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.37 156.18 16.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.68 179.02 24.69 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.523 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.01 -29.55 12.48 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.605 0.717 . . . . 0.0 109.508 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.427 HG13 ' ND2' ' A' ' 136' ' ' ASN . 47.4 mm -94.97 107.97 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.077 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -97.21 30.49 2.77 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.116 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.466 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 39.3 p90 -161.16 172.45 16.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.251 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -141.49 136.64 31.42 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 34.6 mt-10 -111.78 142.2 44.43 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.832 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 133' ' ' GLY . 11.8 m -74.52 89.51 2.18 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.492 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -99.4 -161.09 0.85 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.427 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 41.7 p -61.66 -36.01 79.59 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.49 -46.59 89.55 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.98 0.895 . . . . 0.0 110.242 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 129' ' ' CYS . . . 136.44 -54.82 0.72 Allowed Glycine 0 N--CA 1.407 -3.285 0 N-CA-C 107.22 -2.352 . . . . 0.0 107.22 -169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -139.37 130.88 27.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 110.787 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 55.4 p -77.79 164.5 25.16 Favored 'General case' 0 C--O 1.264 1.836 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.427 ' ND2' HG13 ' A' ' 124' ' ' ILE . 17.8 m120 61.11 -149.67 0.41 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -140.39 -174.33 3.92 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.8 mt -79.53 115.79 55.94 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 118.42 0.554 . . . . 0.0 109.617 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.95 136.52 66.25 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.945 1.764 . . . . 0.0 110.842 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -77.27 113.7 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.775 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 20.0 t -57.48 114.92 2.44 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.706 0.629 . . . . 0.0 109.452 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 7.0 tp10 . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.574 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.9 m-20 . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -77.65 129.68 35.88 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.202 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.64 17.68 19.93 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.354 0.597 . . . . 0.0 110.252 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.27 153.51 39.85 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 37' ' ' TRP . 2.7 mm? -83.63 157.18 64.61 Favored Pre-proline 1 N--CA 1.349 -5.49 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.46 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 17.7 Cg_endo -58.09 144.62 94.64 Favored 'Trans proline' 0 C--O 1.258 1.481 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.97 152.9 78.84 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.345 2.03 . . . . 0.0 111.726 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -88.22 156.58 19.14 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -117.59 152.41 35.2 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.813 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -77.96 -30.26 50.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.817 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -107.76 -12.37 15.23 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 9.2 mp0 -123.17 174.04 7.51 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.107 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.6 144.61 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 37' ' ' TRP . 43.5 mt -70.44 132.84 46.19 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 p -74.1 -56.81 4.47 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.672 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.63 169.36 54.93 Favored Glycine 0 C--O 1.241 0.581 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -99.75 125.08 45.6 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.768 ' HB3' HD12 ' A' ' 24' ' ' LEU . 11.0 m95 -116.17 95.04 4.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 m -108.68 11.42 26.51 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.358 0.599 . . . . 0.0 110.947 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.665 ' O ' HD21 ' A' ' 24' ' ' LEU . 10.2 t70 -103.97 -157.74 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.52 ' HA ' HD21 ' A' ' 24' ' ' LEU . 25.0 mt-30 -129.5 -47.38 1.18 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 33.0 p -96.7 123.81 40.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.077 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.95 138.0 32.22 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.526 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 23.7 Cg_endo -62.3 145.2 96.03 Favored 'Trans proline' 0 C--O 1.259 1.542 0 C-N-CA 123.07 2.513 . . . . 0.0 113.146 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -63.74 128.74 37.17 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.24 9.18 32.21 Favored Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -92.56 118.11 30.66 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.593 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -88.36 143.21 27.15 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 121.341 0.591 . . . . 0.0 111.108 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.2 121.28 44.82 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -93.58 127.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.554 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 76.2 m-85 -104.28 131.86 51.16 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.751 0.786 . . . . 0.0 112.057 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -87.88 131.4 34.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.026 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.3 m -71.57 5.51 2.37 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 68.35 144.23 0.1 OUTLIER Pre-proline 0 N--CA 1.486 1.365 0 CA-C-O 121.624 0.726 . . . . 0.0 112.416 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.17 110.2 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.941 1.761 . . . . 0.0 109.864 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.27 -12.99 6.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.732 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 55.1 m-85 -125.53 175.21 7.69 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -166.85 179.23 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -163.92 175.75 10.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -83.28 -11.76 57.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.518 0.675 . . . . 0.0 109.788 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.2 145.27 10.03 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.75 148.83 41.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 117.003 0.402 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 76.6 t -71.52 114.26 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.23 125.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.4 mtp -114.26 168.24 10.01 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -151.56 144.11 16.28 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.4 t -74.1 118.38 16.99 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.197 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.579 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.1 ttp180 -150.08 122.56 8.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 41.7 mmtm 66.61 27.41 9.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 123.488 0.715 . . . . 0.0 112.382 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.59 -14.45 62.82 Favored Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.824 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.88 153.26 28.19 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.557 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.4 m95 -85.82 115.05 23.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.61 168.25 4.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.953 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.74 106.32 18.38 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.674 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.69 -42.74 89.27 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.548 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 7.7 t-20 -130.92 99.05 18.46 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.955 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.03 -9.07 19.26 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.224 2.616 . . . . 0.0 112.195 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -83.74 -18.15 38.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.872 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.587 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 3.2 mmp_? -88.43 138.77 31.14 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.392 1.092 . . . . 0.0 113.471 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -149.3 151.66 34.55 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 100.0 m -95.62 116.3 28.65 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.24 1.019 . . . . 0.0 109.702 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 160.95 14.13 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.407 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.1 mmtp -56.96 140.78 47.69 Favored 'General case' 0 CA--C 1.491 -1.313 0 O-C-N 123.721 0.638 . . . . 0.0 109.762 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.0 ptm180 -76.62 144.38 73.41 Favored Pre-proline 0 C--N 1.284 -2.259 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.17 150.28 42.23 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 121.513 1.476 . . . . 0.0 108.823 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.8 m -107.54 -9.76 15.85 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.941 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.79 -151.28 47.48 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.552 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -93.74 120.18 66.32 Favored Pre-proline 0 C--N 1.269 -2.931 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.67 71.63 1.46 Allowed 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 123.345 2.696 . . . . 0.0 111.609 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.757 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 65.16 -161.14 41.83 Favored Glycine 0 N--CA 1.42 -2.41 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 119.93 13.11 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.244 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.1 t -122.55 105.44 35.95 Favored Pre-proline 0 N--CA 1.426 -1.639 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.14 8.52 4.45 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.956 1.771 . . . . 0.0 113.124 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -140.25 17.16 2.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.663 0.268 . . . . 0.0 111.438 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . -136.15 165.48 24.91 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.701 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 113' ' ' THR . 3.0 m -130.97 164.78 24.6 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -158.77 161.46 36.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -124.72 143.14 50.92 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.54 135.47 39.34 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 109' ' ' LYS . 7.4 t -124.85 17.87 8.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.467 0.651 . . . . 0.0 111.45 -173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.438 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -140.46 23.72 2.67 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.216 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.32 -178.87 20.0 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -108.62 11.69 26.43 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.426 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.3 p -140.1 -172.5 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.845 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.399 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.28 79.91 1.65 Allowed 'General case' 1 C--N 1.237 -4.3 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.689 -175.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.1 pt-20 -130.68 155.27 46.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.69 116.49 2.15 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.977 0.798 . . . . 0.0 110.816 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.75 -19.84 6.53 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.343 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.438 HG12 ' C ' ' A' ' 100' ' ' GLY . 12.6 m -83.27 140.64 15.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.7 ttmt -103.79 125.3 50.14 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 172.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.53 93.95 9.69 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.26 119.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.427 ' OH ' ' HA3' ' A' ' 94' ' ' GLY . 30.4 t80 -99.09 124.34 44.03 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.337 0.589 . . . . 0.0 110.812 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 95' ' ' THR . 1.2 m -162.97 148.5 11.91 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 59.5 m -113.98 -64.34 1.32 Allowed 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.168 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -140.4 -168.92 2.66 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -76.76 -46.5 24.98 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.21 64.75 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 142' ' ' GLU . 89.7 m-85 -108.32 112.66 25.22 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 117.01 0.405 . . . . 0.0 110.743 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -119.24 -84.0 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.8 pp 172.52 157.82 0.1 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.861 0.864 . . . . 0.0 111.335 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.67 145.33 26.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.31 178.32 15.27 Favored Glycine 0 C--N 1.282 -2.444 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.395 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.07 -34.65 9.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' TYR . 37.3 mm -98.47 102.37 13.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.476 ' HB2' HD21 ' A' ' 120' ' ' LEU . 4.2 p-10 -89.9 28.15 1.42 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.49 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 124' ' ' ILE . 37.5 p90 -162.13 172.78 15.28 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -151.35 120.72 6.84 Favored 'General case' 0 N--CA 1.413 -2.316 0 O-C-N 124.009 0.818 . . . . 0.0 109.263 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.6 150.32 20.47 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.634 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.63 128.2 34.98 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.6 t70 -113.11 -164.48 0.92 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.466 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.0 p -70.1 -40.26 75.04 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 124.539 1.136 . . . . 0.0 113.356 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.15 -32.54 12.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 122.031 -0.418 . . . . 0.0 111.348 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.1 -162.26 26.68 Favored Glycine 0 C--N 1.288 -2.113 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.967 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -76.73 149.5 36.34 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.321 0.581 . . . . 0.0 110.138 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -87.42 136.74 32.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 70.54 -176.23 0.2 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.02 0.528 . . . . 0.0 111.186 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -113.85 -164.85 0.95 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.757 HD11 ' HA3' ' A' ' 89' ' ' GLY . 46.6 mt -92.29 109.81 40.42 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 118.537 0.608 . . . . 0.0 109.427 -176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 14.6 Cg_endo -59.42 132.83 48.45 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.975 1.783 . . . . 0.0 109.993 175.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.6 mp -74.64 110.23 8.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.193 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 53.1 t -56.48 121.97 10.87 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.188 0.93 . . . . 0.0 110.244 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 13.5 tp10 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.439 -0.997 0 CA-C-O 121.729 0.776 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.7 m -83.45 127.96 34.12 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER -102.94 20.58 17.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.827 0.822 . . . . 0.0 109.561 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.3 155.25 42.51 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.067 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 37' ' ' TRP . 34.2 mt -78.38 157.24 78.01 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 123.352 0.661 . . . . 0.0 111.514 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.0 Cg_endo -64.85 127.48 18.73 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.6 2.2 . . . . 0.0 110.771 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.6 Cg_exo -73.02 122.3 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 121.903 1.735 . . . . 0.0 110.299 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.39 158.43 35.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.617 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 15.0 mtp180 -113.74 167.52 10.55 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -69.46 -38.61 77.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.6 p -106.58 -0.01 24.18 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 46.1 mp0 -135.39 135.54 40.73 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.743 0.782 . . . . 0.0 111.979 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mt -125.2 143.31 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -64.09 149.68 47.11 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.556 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.8 p -105.5 111.07 23.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.87 -171.77 16.96 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.964 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 t -104.2 136.58 43.54 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.569 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 76.7 m95 -139.82 106.01 5.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 m -135.25 16.15 3.46 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.593 0.711 . . . . 0.0 109.234 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.5 -167.3 1.42 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.725 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.3 -65.19 0.78 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.015 0.436 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -86.75 119.66 27.22 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -123.64 136.63 27.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.829 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.67 144.97 85.89 Favored 'Trans proline' 0 C--O 1.258 1.495 0 C-N-CA 122.534 2.156 . . . . 0.0 110.845 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.1 tt0 -61.21 137.68 58.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.22 51.9 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.463 ' C ' HG23 ' A' ' 65' ' ' VAL . 66.9 m -88.6 114.78 25.58 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.718 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -92.83 139.12 30.88 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.101 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.46 121.63 45.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -94.18 130.21 43.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 72.9 m-85 -114.49 149.78 35.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 111.651 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -101.52 147.73 26.04 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.5 m -85.97 15.7 4.77 Favored 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 123.577 0.751 . . . . 0.0 112.589 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 58.9 mtp180 69.83 158.61 0.16 Allowed Pre-proline 0 C--O 1.248 1.006 0 C-N-CA 123.225 0.61 . . . . 0.0 109.36 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.0 125.81 11.28 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 109.223 -1.106 . . . . 0.0 109.223 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 110.24 -11.92 31.24 Favored Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.031 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 84.3 m-85 -117.28 168.53 10.24 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.765 -0.844 . . . . 0.0 109.813 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.93 -176.95 5.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.6 p -154.07 156.75 37.88 Favored 'General case' 0 N--CA 1.404 -2.735 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.81 -4.1 58.39 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.198 0.999 . . . . 0.0 110.457 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.45 -119.96 1.73 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -159.96 148.29 17.12 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.29 97.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.983 0.897 . . . . 0.0 109.161 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.93 121.84 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.726 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.4 mtp -107.58 172.53 6.78 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 46' ' ' THR . 11.4 p -159.13 145.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.379 0.609 . . . . 0.0 111.003 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.6 t -70.78 119.3 14.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.581 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 30.7 tpt180 -150.05 113.68 5.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.3 mmtm 67.26 31.7 6.44 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.112 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.29 -16.39 52.84 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.474 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.27 152.0 25.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.061 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -90.06 114.35 26.22 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.33 171.53 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.579 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.08 124.09 35.91 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.47 -47.75 77.82 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -111.53 91.84 15.27 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.155 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.51 -23.79 16.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.631 2.221 . . . . 0.0 112.606 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.09 -22.16 49.41 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.041 0.924 . . . . 0.0 110.373 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.77 137.79 32.08 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.194 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.13 162.33 41.06 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -89.77 131.48 35.7 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.754 0.788 . . . . 0.0 111.413 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.04 165.56 20.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.881 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.3 mttt -58.45 146.93 33.42 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.4 ptm180 -82.9 154.85 67.91 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 72.5 Cg_endo -83.09 164.66 15.19 Favored 'Trans proline' 0 N--CA 1.432 -2.14 0 C-N-CA 121.314 1.343 . . . . 0.0 109.6 173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.0 -3.95 13.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.448 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.89 -116.02 4.7 Favored Glycine 0 CA--C 1.459 -3.454 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -137.33 144.17 44.43 Favored Pre-proline 0 C--N 1.265 -3.083 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.33 45.27 1.88 Allowed 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.704 2.269 . . . . 0.0 109.477 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.88 -147.71 33.94 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -170.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -161.85 122.02 2.56 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.0 t -107.28 120.23 48.4 Favored Pre-proline 0 C--N 1.294 -1.831 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.273 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 4.9 Cg_exo -78.91 -7.86 15.5 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.615 2.21 . . . . 0.0 112.785 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -129.43 12.49 5.96 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.55 160.41 24.47 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -128.13 168.03 15.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.9 p90 -154.35 163.03 40.8 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -131.51 141.73 49.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.4 mt -98.29 124.41 42.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.9 t -109.76 -18.91 13.33 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.79 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.404 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -108.72 30.21 9.01 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 119.582 -1.294 . . . . 0.0 111.091 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.58 -173.3 30.94 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -127.44 18.42 6.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.33 0.565 . . . . 0.0 110.554 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.517 ' O ' HG11 ' A' ' 108' ' ' VAL . 20.9 m -146.95 178.61 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 66.8 m-85 -91.12 90.61 7.9 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.62 156.76 46.33 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.837 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 71.8 t80 -53.8 105.28 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.965 0.791 . . . . 0.0 111.36 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.39 -11.96 6.04 Favored Glycine 0 N--CA 1.418 -2.556 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.787 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 103' ' ' VAL . 19.1 m -82.95 141.34 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.015 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HB3' HG22 ' A' ' 99' ' ' THR . 37.0 ttmt -106.6 123.7 48.5 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 169.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 99.3 11.48 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 46.7 t -79.69 110.18 15.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -89.19 132.14 34.99 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 123.926 0.891 . . . . 0.0 108.77 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.1 m -155.12 156.53 35.96 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.28 -69.88 0.83 Allowed 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.167 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.64 -169.51 3.4 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.98 -50.65 11.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.722 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.98 -27.45 73.9 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.636 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.73 130.06 23.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.43 0.633 . . . . 0.0 110.165 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -109.47 -76.79 0.6 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.7 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp 174.1 162.68 0.19 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.253 1.021 . . . . 0.0 110.282 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -97.46 143.81 27.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.13 159.37 12.94 Favored Glycine 0 C--N 1.289 -2.032 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.4 -27.48 22.73 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.557 0.694 . . . . 0.0 110.716 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.0 mm -95.93 103.15 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.022 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -92.87 33.56 1.15 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.072 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.83 174.07 15.84 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.262 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -134.26 127.44 31.85 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 18.3 mt-10 -111.33 143.18 42.53 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 118.654 0.661 . . . . 0.0 111.312 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 36.5 m -81.68 117.18 21.82 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.242 172.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.3 t70 -108.92 -165.38 1.02 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 61.2 p -67.31 -41.87 84.64 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 124.177 0.991 . . . . 0.0 112.707 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.76 -30.66 20.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 -139.25 5.77 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.382 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 78.1 m95 -82.83 128.96 34.9 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.125 0.488 . . . . 0.0 110.473 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 p -63.36 -29.47 70.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.821 1.248 . . . . 0.0 113.427 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -129.37 170.08 14.09 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -105.54 174.32 5.93 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.7 mt -65.99 110.47 4.65 Favored Pre-proline 0 C--N 1.319 -0.749 0 O-C-N 123.687 0.617 . . . . 0.0 111.723 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 130.49 29.61 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.152 1.901 . . . . 0.0 110.708 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.61 109.76 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.4 t -83.7 112.74 20.33 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.212 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB2' HD23 ' A' ' 121' ' ' LEU . 5.9 mm-40 . . . . . 0 CA--C 1.491 -1.322 0 C-N-CA 124.139 0.976 . . . . 0.0 108.902 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 N--CA 1.433 -1.305 0 CA-C-O 121.757 0.789 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 76.2 m -85.83 127.62 34.61 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.831 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.95 19.03 12.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.581 0.705 . . . . 0.0 110.528 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.14 157.13 43.14 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 39' ' ' ASP . 2.2 mm? -89.62 158.67 45.11 Favored Pre-proline 1 N--CA 1.342 -5.872 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.262 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.9 Cg_endo -58.81 138.38 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.028 2.485 . . . . 0.0 110.355 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 149.41 84.21 Favored 'Trans proline' 0 C--N 1.33 -0.43 0 C-N-CA 122.156 1.904 . . . . 0.0 112.577 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -89.61 143.45 26.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.82 168.3 10.02 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.436 0.636 . . . . 0.0 111.912 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -79.04 -33.95 44.27 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.805 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 p -98.28 -31.74 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.0 mp0 -114.83 146.22 41.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.73 0.3 . . . . 0.0 111.444 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.2 mt -120.35 146.19 25.58 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 37' ' ' TRP . 24.1 mt -75.84 130.22 38.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.1 p -99.02 127.67 44.99 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.92 -143.21 16.12 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 t -149.66 118.97 6.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.575 ' CD1' HD13 ' A' ' 33' ' ' LEU . 5.4 m95 -129.48 74.4 1.58 Allowed 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.856 0.836 . . . . 0.0 109.484 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 24.36 12.06 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.587 ' O ' HD21 ' A' ' 24' ' ' LEU . 24.3 m-20 -95.7 -150.76 0.33 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.943 -1.935 . . . . 0.0 111.863 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -132.41 -79.55 0.5 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 18.6 p -107.09 121.2 44.01 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -169.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -116.64 138.03 24.18 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.927 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.53 151.48 84.72 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.757 2.305 . . . . 0.0 111.938 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.4 tt0 -63.62 136.33 57.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.702 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.17 4.31 53.81 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -85.63 118.87 25.41 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.8 pt20 -91.99 142.04 27.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.828 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.88 131.79 56.15 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.022 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.4 mt -99.89 134.66 38.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.631 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 51.6 m-85 -113.21 156.5 23.15 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.685 0.755 . . . . 0.0 112.966 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 64.9 tttp -101.39 137.57 39.55 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.819 1.647 . . . . 0.0 106.708 173.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.781 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 76.7 m -81.33 15.0 2.15 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 67.8 mtp180 62.43 156.9 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 121.721 0.772 . . . . 0.0 111.545 -172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.74 107.08 2.25 Favored 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 120.744 0.963 . . . . 0.0 109.605 171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 128.64 -24.49 4.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.671 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 60.2 m-85 -105.0 155.32 19.07 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -136.18 168.7 18.9 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 123.872 0.869 . . . . 0.0 109.725 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 58.6 p -164.69 154.4 13.61 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.126 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.87 -32.43 31.06 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.44 136.29 8.72 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.91 151.71 45.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.158 0.479 . . . . 0.0 111.134 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.05 108.84 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.636 0.732 . . . . 0.0 109.761 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -114.49 122.19 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.097 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 84.7 mtp -104.39 170.25 8.01 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.3 p -152.07 143.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.216 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.03 121.5 22.08 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 124.09 0.956 . . . . 0.0 108.804 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 57.2 ttp180 -146.51 121.94 10.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 41.5 mmtm 63.71 20.35 12.18 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.798 0.839 . . . . 0.0 112.92 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.33 72.57 Favored Glycine 0 N--CA 1.423 -2.188 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.45 150.87 38.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.242 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.44 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.7 m95 -87.38 113.44 23.09 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.66 0.743 . . . . 0.0 109.525 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.59 171.81 3.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.227 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.16 118.01 27.44 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 64' ' ' MET . 5.1 tp -58.88 -46.05 88.73 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -120.31 96.56 49.13 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.928 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.99 -10.77 21.38 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 112.743 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.67 -29.99 36.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.952 0.882 . . . . 0.0 109.931 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 37.3 mmt180 -91.32 132.82 35.91 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.676 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -154.35 150.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 62.5 m -86.61 114.76 23.59 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.917 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.89 169.82 8.64 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.477 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 105' ' ' GLU . 32.6 mmtp -55.08 119.41 5.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.443 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 11.1 ptm180 -55.64 145.51 50.12 Favored Pre-proline 0 C--N 1.295 -1.779 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.261 170.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.45 158.84 32.69 Favored 'Trans proline' 0 C--O 1.256 1.396 0 C-N-CA 122.272 1.982 . . . . 0.0 109.161 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.45 -16.72 5.78 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.246 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.11 -154.53 46.53 Favored Glycine 0 CA--C 1.464 -3.149 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.809 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.97 134.86 31.01 Favored Pre-proline 0 C--N 1.252 -3.642 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.256 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.7 33.57 0.49 Allowed 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 122.841 2.361 . . . . 0.0 110.772 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.46 157.9 33.97 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -127.58 145.34 50.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.8 t -120.66 148.9 49.21 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.074 -173.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 11.9 Cg_exo -72.4 -25.65 18.01 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.316 2.011 . . . . 0.0 111.087 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -146.56 110.05 4.83 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.361 0.6 . . . . 0.0 110.489 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . 152.75 173.09 21.81 Favored Glycine 0 N--CA 1.425 -2.065 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.317 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 m -146.73 163.45 35.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -144.52 165.52 27.75 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.4 p -135.26 148.08 49.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.23 128.28 54.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.548 HG22 ' HB3' ' A' ' 109' ' ' LYS . 12.5 t -121.44 6.82 10.09 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.435 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -124.06 23.06 6.62 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.72 -178.0 29.27 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.13 11.48 15.25 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.54 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.5 p -140.36 -168.45 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.407 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -105.64 83.4 1.93 Allowed 'General case' 0 C--N 1.245 -3.944 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.961 -174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 10.4 pt-20 -138.78 162.56 34.42 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.7 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -51.98 120.65 5.58 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.095 0.872 . . . . 0.0 110.205 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.74 -12.36 22.87 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.193 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 103' ' ' VAL . 20.3 m -85.14 140.26 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.496 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -101.31 116.98 34.05 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 172.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 127' ' ' ARG . . . -96.07 93.62 7.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.0 t -74.78 128.05 36.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.0 t80 -111.09 145.19 38.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.344 0.593 . . . . 0.0 111.185 -172.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 m -152.62 159.84 43.21 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 60.9 m -122.06 -68.39 0.9 Allowed 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.488 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 15.7 m120 -133.91 -162.42 1.24 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.24 -55.01 4.11 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.34 0.591 . . . . 0.0 109.805 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.18 -23.38 59.14 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.969 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 86.8 m-85 -104.97 112.15 25.19 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 92.2 mt-30 -112.43 -87.83 0.54 Allowed 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.7 pp -178.87 145.2 0.28 Allowed 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 73.0 mt -87.51 139.76 30.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.62 170.05 12.98 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.67 -28.15 12.65 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.363 0.601 . . . . 0.0 110.335 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.4 mm -97.84 99.36 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -87.07 30.71 0.74 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.846 0.858 . . . . 0.0 110.855 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.478 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 49.5 p90 -163.41 -177.83 5.53 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.516 -0.765 . . . . 0.0 108.96 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HD3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -148.76 131.51 16.0 Favored 'General case' 0 N--CA 1.403 -2.819 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 172.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 109' ' ' LYS . 31.9 mt-10 -107.67 145.86 32.81 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.86 112.41 22.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.9 t70 -94.6 -161.94 0.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.418 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 74.4 p -67.6 -44.94 76.91 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.902 0.881 . . . . 0.0 109.945 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.38 -37.03 68.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.879 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.76 -152.13 24.21 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -64.64 126.79 29.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.4 p -59.87 -34.85 73.68 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.807 0.843 . . . . 0.0 112.111 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -132.73 169.46 16.66 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 5.8 p-10 -102.37 -99.84 0.28 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.101 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.476 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 26.9 mt -127.24 99.43 28.01 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.3 Cg_endo -53.56 140.28 65.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.01 1.807 . . . . 0.0 110.018 172.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.36 118.59 31.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 -171.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 64.6 m -59.13 94.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.217 1.007 . . . . 0.0 112.47 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.4 mm-40 . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.606 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 32.5 m-20 . . . . . 0 C--O 1.242 0.677 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' THR . 63.0 m -74.64 132.72 41.96 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.844 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.4 36.44 2.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.653 0.74 . . . . 0.0 109.395 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.18 158.06 32.0 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.213 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.2 mt -79.44 152.97 76.23 Favored Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 123.95 0.781 . . . . 0.0 110.31 175.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.27 131.7 42.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.542 2.161 . . . . 0.0 110.976 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.01 132.53 24.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.49 2.127 . . . . 0.0 113.23 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.4 mtm-85 -76.73 129.56 36.49 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -104.2 178.13 4.65 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.007 -168.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -56.14 -44.62 79.38 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.862 0.465 . . . . 0.0 111.782 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 p -125.1 17.84 8.43 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.805 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 49.8 mp0 -135.35 134.4 39.76 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.312 0.577 . . . . 0.0 111.882 -176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -128.35 165.73 27.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.434 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -90.5 142.83 27.34 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -98.21 128.09 44.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.3 -165.35 12.46 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.2 m -130.98 124.53 31.17 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.607 ' HB3' HD22 ' A' ' 24' ' ' LEU . 76.0 m95 -122.4 121.48 36.76 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 m -132.74 3.4 3.8 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.966 0.413 . . . . 0.0 110.767 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 21.0 m-20 -95.63 -169.81 2.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.88 -59.57 1.34 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.241 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.3 p -93.82 124.4 37.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 57.6 m-85 -125.59 139.17 33.39 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.496 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.606 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 24.4 Cg_endo -61.44 142.56 95.78 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 123.178 2.586 . . . . 0.0 113.038 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.6 tt0 -61.7 132.97 54.94 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.12 43.37 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.403 ' C ' HG23 ' A' ' 65' ' ' VAL . 85.1 m -89.66 115.41 27.01 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -89.16 144.17 26.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.605 0.717 . . . . 0.0 111.437 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 128.62 55.82 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.43 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.34 128.54 49.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 70.1 m-85 -103.43 158.01 16.64 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 60.2 tttm -106.06 142.4 35.82 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.981 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 86.6 m -95.93 38.44 1.18 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 29.9 mmt180 62.22 163.23 0.11 Allowed Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 121.889 0.852 . . . . 0.0 111.696 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.94 100.45 0.37 Allowed 'Trans proline' 0 N--CA 1.418 -2.935 0 C-N-CA 121.273 1.315 . . . . 0.0 109.228 167.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.87 -3.17 3.78 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.494 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 45.6 m-85 -130.47 -177.73 4.46 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -153.02 -176.35 5.73 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.591 0.756 . . . . 0.0 109.341 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.2 p -162.04 165.09 27.77 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.21 -13.87 27.81 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.366 0.603 . . . . 0.0 109.76 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.94 161.13 34.05 Favored Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -75.05 143.06 43.65 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 117.694 0.747 . . . . 0.0 111.418 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 50.0 t -77.45 109.15 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 174.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.91 123.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.109 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 91.0 mtp -112.06 168.81 9.31 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.8 p -152.39 145.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.328 0.585 . . . . 0.0 110.383 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.9 t -71.71 120.38 17.22 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.542 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.482 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 44.2 ttm-85 -152.21 120.38 6.28 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.59 28.13 13.27 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.218 1.007 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.89 -15.95 61.52 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.723 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -110.64 158.61 18.41 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.181 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.22 115.89 28.49 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.94 151.37 32.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.399 0.619 . . . . 0.0 111.713 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.98 109.59 1.32 Allowed 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.457 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.79 -52.21 64.07 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -110.79 92.73 15.18 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -20.96 22.75 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 122.394 2.063 . . . . 0.0 111.176 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 mt -74.86 -25.58 59.07 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.403 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -89.49 128.37 35.97 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.331 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.76 158.08 40.41 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 65.0 m -88.49 139.99 29.92 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.765 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 56' ' ' TYR . 48.1 mt-30 -132.69 168.46 18.28 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.225 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.72 160.22 33.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.838 0.828 . . . . 0.0 113.15 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -110.82 137.61 20.86 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.44 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 9.6 Cg_endo -71.02 148.82 57.77 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.392 2.061 . . . . 0.0 112.698 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.13 -55.28 3.49 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.976 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.18 -156.08 20.64 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.003 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -87.82 111.84 44.94 Favored Pre-proline 0 C--N 1.307 -1.259 0 C-N-CA 123.635 0.774 . . . . 0.0 109.201 -175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 81.1 Cg_endo -76.72 9.95 2.45 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.916 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 145.75 135.9 2.87 Favored Glycine 0 N--CA 1.397 -3.922 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -106.26 107.74 18.9 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 t -125.09 124.6 25.35 Favored Pre-proline 0 N--CA 1.411 -2.384 0 CA-C-O 121.564 0.697 . . . . 0.0 112.155 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -89.84 2.61 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 122.269 1.979 . . . . 0.0 112.335 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.9 4.86 2.8 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.81 13.79 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.884 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 p -142.39 163.36 33.06 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.295 0.638 . . . . 0.0 109.934 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 45.4 p90 -130.31 154.36 47.71 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.189 0.306 . . . . 0.0 110.404 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 74.7 p -114.21 178.3 4.33 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.86 142.25 31.75 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.8 t -127.88 -45.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.998 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.25 51.01 3.38 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.113 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 140.39 -176.84 21.14 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -121.42 10.61 10.55 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 121.16 0.505 . . . . 0.0 110.003 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.533 ' O ' HG11 ' A' ' 108' ' ' VAL . 2.8 p -147.06 -164.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.432 0 C-N-CA 118.793 -1.163 . . . . 0.0 109.361 -173.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 28.2 m-85 -100.23 82.49 2.52 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.8 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.47 154.98 50.61 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.466 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.18 112.89 0.8 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.137 0.898 . . . . 0.0 109.919 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.3 -27.61 4.2 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.908 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 103' ' ' VAL . 18.2 m -75.73 164.34 3.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.071 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.518 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.7 ttmp? -131.7 115.37 15.93 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.4 101.94 13.89 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.5 m -78.82 162.24 4.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 118.621 -1.231 . . . . 0.0 108.612 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.447 ' HE2' ' SG ' ' A' ' 141' ' ' CYS . 61.2 t80 -129.43 134.61 47.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.394 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -150.83 154.99 38.31 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 78.6 m -130.68 -41.08 1.19 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -153.55 -176.63 5.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -106.75 -40.31 5.55 Favored 'General case' 0 C--N 1.278 -2.533 0 O-C-N 123.633 0.583 . . . . 0.0 111.028 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.62 -37.1 94.19 Favored Glycine 0 C--N 1.317 -0.515 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -122.98 125.59 45.55 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 48.2 mt-30 -99.15 -89.46 0.32 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 125' ' ' ASN . 2.0 pp -170.43 161.12 7.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.71 -61.28 1.84 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.53 158.14 13.59 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.293 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.43 -26.09 33.05 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.936 0.875 . . . . 0.0 109.932 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.92 95.26 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' HD11 ' A' ' 120' ' ' LEU . 4.0 p-10 -85.55 29.63 0.68 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 21.7 p90 -162.12 174.33 13.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -173.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 96' ' ' PHE . 2.2 mpp_? -134.14 122.37 22.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 26.5 mt-10 -103.62 150.58 23.84 Favored 'General case' 0 C--N 1.284 -2.271 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.744 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 16.3 m -81.2 121.73 26.5 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.748 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 131' ' ' THR . 11.8 t70 -96.55 -159.45 0.73 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 30.3 p -58.35 -62.15 2.05 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 124.183 0.993 . . . . 0.0 112.709 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.21 -24.27 15.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.57 -149.85 5.7 Favored Glycine 0 CA--C 1.486 -1.748 0 C-N-CA 118.603 -1.761 . . . . 0.0 113.489 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 73.2 m95 -93.52 147.69 22.75 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.741 0.305 . . . . 0.0 110.191 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.8 p -77.69 -24.59 49.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.791 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -139.3 172.99 12.01 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.756 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 21.0 t70 -108.69 -158.25 0.64 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 34.5 mt -85.53 117.21 68.3 Favored Pre-proline 0 C--N 1.289 -2.065 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.75 143.78 46.99 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.222 1.948 . . . . 0.0 109.56 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 142' ' ' GLU . 2.3 mp -94.73 124.65 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 122.118 -0.363 . . . . 0.0 111.667 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 112' ' ' TYR . 64.4 m -77.8 111.49 13.67 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.161 0.984 . . . . 0.0 111.142 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 140' ' ' ILE . 6.9 mm-40 . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.8 m-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.7 m -76.46 152.78 36.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.01 16.88 13.36 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.741 -174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.94 160.61 28.02 Favored 'General case' 0 CA--C 1.462 -2.434 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -85.2 156.33 60.08 Favored Pre-proline 1 N--CA 1.355 -5.191 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.042 -177.492 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 6.5 Cg_endo -55.45 135.12 67.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.443 2.762 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.66 117.67 4.43 Favored 'Trans proline' 0 CA--C 1.519 -0.231 0 C-N-CA 123.023 2.482 . . . . 0.0 112.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.59 133.24 45.6 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 94.0 mtt180 -108.1 -179.74 3.98 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.513 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.595 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 59.7 t30 -89.38 -50.42 6.13 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.157 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 53' ' ' ARG . 7.7 p -88.15 -9.16 54.05 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.4 mp0 -124.6 135.52 53.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.614 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mt -117.1 135.98 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 37' ' ' TRP . 17.7 mt -67.97 117.66 10.12 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.874 0.368 . . . . 0.0 111.427 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 51' ' ' LYS . 9.7 p -96.77 100.25 11.8 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.91 -159.28 28.39 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -132.71 113.53 13.09 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.61 ' CD1' HD13 ' A' ' 33' ' ' LEU . 10.1 m95 -125.18 84.67 2.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 m -118.66 5.94 11.6 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.207 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.598 ' O ' HD21 ' A' ' 24' ' ' LEU . 18.5 m-20 -85.25 -160.06 0.48 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.207 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -125.15 -69.26 0.8 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 23.3 p -93.38 133.69 36.37 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -128.48 141.29 40.97 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 35.1 Cg_endo -65.19 150.17 87.9 Favored 'Trans proline' 0 C--O 1.255 1.361 0 C-N-CA 122.718 2.279 . . . . 0.0 112.712 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -68.87 133.62 48.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.38 -6.11 38.81 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.516 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -80.96 118.52 22.52 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.23 152.88 21.66 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.937 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.44 131.95 54.12 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -102.98 126.12 57.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 63.4 m-85 -108.87 143.65 37.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.217 0.532 . . . . 0.0 112.202 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' HG23 ' A' ' 34' ' ' THR . 63.4 tttm -93.66 142.68 27.08 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 175.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 85.4 m -90.19 40.34 1.0 Allowed 'General case' 0 C--N 1.279 -2.474 0 CA-C-O 120.521 0.2 . . . . 0.0 110.835 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 29' ' ' ASN . 22.0 mtp180 61.46 172.3 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 122.781 0.432 . . . . 0.0 110.689 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -76.12 -12.0 19.42 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 120.857 1.038 . . . . 0.0 112.225 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -104.18 -13.89 25.74 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 115.126 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 62.0 m-85 -114.23 176.07 5.2 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.137 -1.213 . . . . 0.0 109.806 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -152.55 -173.49 4.58 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -168.62 -175.01 2.32 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.79 -6.64 57.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.407 1.099 . . . . 0.0 109.062 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.31 -147.2 4.84 Favored Glycine 0 N--CA 1.403 -3.507 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -120.97 150.84 40.48 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 75.3 t -70.36 103.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.0 mm -101.0 119.53 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.927 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.1 169.84 8.47 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.6 p -155.23 147.51 12.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.609 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.35 123.49 24.72 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttt180 -152.19 124.22 8.06 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 62.33 26.17 15.64 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.783 0.833 . . . . 0.0 112.677 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.21 -9.9 74.17 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.761 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -121.87 162.43 20.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.471 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -92.63 112.0 23.8 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.29 167.62 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.396 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.553 0.216 . . . . 0.0 110.59 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -50.23 73.62 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.472 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.3 m120 -111.93 93.82 22.48 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.03 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -73.56 -11.72 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.438 2.092 . . . . 0.0 111.693 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.12 -11.99 58.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.503 0.668 . . . . 0.0 110.13 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 25.8 mmt180 -89.32 126.95 35.73 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.392 0.615 . . . . 0.0 110.13 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -146.37 144.68 29.91 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.0 m -93.41 117.43 30.07 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-O 121.239 0.543 . . . . 0.0 109.892 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -117.34 167.48 11.21 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.128 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.6 mttt -63.6 145.76 55.06 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.787 0.327 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.6 ptp180 -85.46 138.05 36.3 Favored Pre-proline 0 C--N 1.313 -0.989 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 40.6 Cg_endo -68.24 154.75 71.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.791 2.327 . . . . 0.0 111.348 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.05 -2.29 18.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 -112.57 3.68 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.168 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -127.13 119.58 22.2 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' CZ2' ' A' ' 134' ' ' TRP . 95.6 Cg_endo -79.24 34.54 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.877 3.052 . . . . 0.0 114.058 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.74 137.78 6.71 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.614 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.74 128.06 34.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.298 0.57 . . . . 0.0 109.729 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -139.57 107.36 7.11 Favored Pre-proline 0 N--CA 1.409 -2.518 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.25 12.0 2.95 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.448 2.098 . . . . 0.0 110.477 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 -54.82 2.46 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.764 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.91 -166.1 14.58 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.116 -1.04 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 m -132.27 170.93 14.35 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 54.3 p90 -142.64 153.41 43.42 Favored 'General case' 0 N--CA 1.423 -1.794 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.642 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 72.2 p -107.66 -178.65 3.69 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.431 HD22 HG21 ' A' ' 108' ' ' VAL . 96.2 mt -145.38 157.42 44.04 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 7.6 t -151.52 146.92 26.24 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.09 27.26 66.71 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.857 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.73 -44.59 0.21 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.181 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.03 13.24 9.08 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.42 171.75 14.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.4 m-85 -85.73 93.02 8.76 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.664 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -146.13 151.42 37.64 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.274 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 129' ' ' CYS . 76.8 t80 -52.41 106.55 0.16 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.014 0.926 . . . . 0.0 111.208 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 139.47 -27.86 2.59 Favored Glycine 0 N--CA 1.422 -2.264 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.817 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' THR . 23.2 m -80.92 154.79 4.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.303 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -118.12 118.88 33.08 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 171.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.19 96.66 9.75 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.0 OUTLIER -77.45 156.25 5.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.709 -178.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.581 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 46.6 t80 -114.78 139.19 49.92 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.5 m -141.44 164.59 29.82 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 7.2 t -146.66 -57.7 0.28 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.748 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.38 -174.18 4.14 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -83.55 -45.01 14.03 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 121.892 0.853 . . . . 0.0 108.833 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.98 -24.11 64.97 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.846 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -115.15 125.97 54.07 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 122.654 -0.321 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.614 ' HB3' HD13 ' A' ' 120' ' ' LEU . 84.1 mm-40 -113.96 -87.36 0.57 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -162.15 161.49 28.08 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.247 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 88.7 mt -92.72 131.62 37.63 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.86 179.46 16.42 Favored Glycine 0 C--N 1.269 -3.154 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.417 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -102.87 -9.78 19.61 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.915 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 126' ' ' TYR . 48.5 mm -122.66 121.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.059 0.457 . . . . 0.0 109.969 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -104.58 29.23 6.31 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.799 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.488 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.9 p90 -163.77 176.86 9.14 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.042 0.449 . . . . 0.0 111.39 -173.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -141.97 126.94 18.31 Favored 'General case' 0 C--O 1.199 -1.583 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -104.11 147.74 27.07 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 118.555 0.616 . . . . 0.0 111.671 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 23.5 m -84.83 103.07 13.58 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.843 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.24 -167.95 1.47 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 45.3 p -64.55 -44.15 91.68 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.066 1.346 . . . . 0.0 110.745 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.56 -38.02 77.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.966 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.14 -115.11 0.7 Allowed Glycine 0 CA--C 1.486 -1.721 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 91.9 m95 -95.95 129.68 43.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.0 p -67.67 -26.93 66.44 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 123.604 0.762 . . . . 0.0 112.584 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.4 ' CG ' HG21 ' A' ' 124' ' ' ILE . 16.7 m120 -137.91 169.26 18.09 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -101.88 -171.75 2.03 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 123.824 0.703 . . . . 0.0 109.556 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.6 mt -74.98 113.2 22.44 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.586 0.354 . . . . 0.0 110.655 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.581 ' HG2' ' CG ' ' A' ' 112' ' ' TYR . 9.7 Cg_endo -66.48 141.17 60.24 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.399 2.066 . . . . 0.0 110.771 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 49.0 mm -92.66 119.73 40.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.446 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.9 m -64.59 118.85 9.44 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.529 0.518 . . . . 0.0 109.8 177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.486 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 11.7 mm-40 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.5 m -79.49 129.67 34.69 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.956 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.01 35.48 1.72 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.0 110.566 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -160.0 152.89 21.51 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.585 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -71.1 149.42 94.58 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 124.26 0.975 . . . . 0.0 108.969 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.33 131.54 45.77 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.541 2.161 . . . . 0.0 111.821 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 116.79 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.736 2.291 . . . . 0.0 112.311 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -61.49 127.14 30.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.29 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -81.36 153.64 26.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.831 -170.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -72.21 -24.87 61.47 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -128.35 7.45 5.89 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.3 mp0 -137.45 164.48 28.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.117 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.82 150.51 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.46 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -71.54 142.96 50.08 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.302 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.5 p -103.42 108.25 19.42 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.98 -164.71 25.51 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -138.93 98.72 3.6 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 48.8 m95 -92.82 144.21 25.51 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -156.15 31.06 0.34 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.24 161.27 36.68 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.681 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -93.85 -26.67 16.81 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.099 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -116.64 110.26 18.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.822 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -110.06 139.33 21.26 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.5 Cg_endo -60.62 146.24 97.44 Favored 'Trans proline' 0 C--O 1.254 1.299 0 C-N-CA 123.202 2.601 . . . . 0.0 112.971 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.4 tt0 -66.0 138.03 57.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.1 7.22 56.43 Favored Glycine 0 N--CA 1.427 -1.96 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.287 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.432 ' C ' HG23 ' A' ' 65' ' ' VAL . 98.5 m -88.16 112.03 22.27 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -84.2 140.22 31.86 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.276 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.57 56.57 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.2 mt -98.98 131.09 46.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 80.5 m-85 -115.73 138.95 50.62 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.672 0.748 . . . . 0.0 112.851 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -91.49 133.48 35.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.9 m -72.55 10.86 0.73 Allowed 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 66.77 154.78 0.13 Allowed Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.19 0.596 . . . . 0.0 111.219 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.62 98.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.117 1.878 . . . . 0.0 112.134 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.593 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 130.92 -13.65 5.52 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.391 -0.909 . . . . 0.0 114.212 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 82.2 m-85 -115.19 168.5 9.89 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.373 -1.075 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -146.49 169.38 19.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 59' ' ' LEU . 31.0 t -165.79 -10.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 O-C-N 123.816 0.697 . . . . 0.0 110.023 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 58' ' ' SER . 20.2 tp 75.15 -52.56 0.66 Allowed 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 111.425 173.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.8 20.35 39.1 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 61.76 -167.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.16 0.984 . . . . 0.0 110.867 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG23 ' SG ' ' A' ' 80' ' ' CYS . 69.4 t -118.31 123.82 72.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 168.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -117.64 122.21 69.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 64' ' ' MET . 88.1 mtp -108.17 178.0 4.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.2 p -161.98 143.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.074 0.464 . . . . 0.0 110.403 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.5 t -70.38 125.19 26.08 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.919 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.5 ttt180 -152.69 119.18 5.62 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 120.634 0.254 . . . . 0.0 110.755 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm 62.23 23.17 13.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.11 -20.0 51.89 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.458 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.74 154.11 20.94 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.05 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -88.22 116.47 26.44 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.06 172.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.57 124.69 35.92 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.93 -51.21 34.77 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -114.0 89.54 17.01 Favored Pre-proline 0 N--CA 1.426 -1.634 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.786 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.58 -25.41 15.01 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 122.378 2.052 . . . . 0.0 110.629 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.05 -25.69 64.59 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.138 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mmp_? -85.28 138.38 32.35 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.3 174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -161.6 144.57 12.22 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' A' ' 62' ' ' VAL . 73.9 m -86.01 109.18 18.62 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-O 121.79 0.805 . . . . 0.0 111.776 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -106.39 167.14 10.04 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.174 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 98.8 mttt -62.24 135.26 57.4 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 123.29 0.369 . . . . 0.0 111.503 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.7 ptp180 -80.4 146.19 61.17 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.74 142.96 10.48 Favored 'Trans proline' 0 N--CA 1.424 -2.576 0 C-N-CA 121.675 1.583 . . . . 0.0 112.336 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.5 m -84.33 -30.77 25.24 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.93 104.44 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 O-C-N 124.237 0.961 . . . . 0.0 115.072 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 66.8 t60 64.02 111.33 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 123.858 0.863 . . . . 0.0 111.993 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 127' ' ' ARG . 88.0 Cg_endo -81.47 43.13 1.47 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 123.635 2.89 . . . . 0.0 112.506 -177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 85.64 -171.53 45.41 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -107.67 91.58 3.71 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 m -112.61 91.31 16.82 Favored Pre-proline 0 N--CA 1.421 -1.9 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.191 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.59 -29.73 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.567 2.178 . . . . 0.0 112.679 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -110.78 146.24 36.71 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.66 178.34 36.68 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 p -143.2 156.8 44.84 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.671 -0.311 . . . . 0.0 110.937 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 p90 -141.35 149.56 41.31 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.226 0.536 . . . . 0.0 110.358 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.8 p -116.12 147.36 41.42 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.576 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.61 135.99 51.44 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -115.74 -4.32 12.17 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -119.0 16.82 10.84 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.536 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.26 32.74 Favored Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -107.32 2.83 24.8 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 117.771 0.786 . . . . 0.0 110.059 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.9 p -142.17 -164.04 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.535 -170.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -98.98 74.0 1.98 Allowed 'General case' 0 C--N 1.245 -3.938 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.59 151.75 46.03 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.883 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 73.4 t80 -47.08 117.56 1.76 Allowed 'General case' 0 C--N 1.315 -0.904 0 O-C-N 124.574 1.171 . . . . 0.0 111.759 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.42 -14.06 20.75 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.872 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -82.42 141.57 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.497 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 99' ' ' THR . 35.2 ttmt -111.22 122.53 48.11 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 127' ' ' ARG . . . -94.86 95.54 8.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 55.5 t -79.36 122.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 77.0 t80 -98.48 144.57 27.68 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.824 0.821 . . . . 0.0 112.063 -172.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.94 156.81 46.0 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.9 t -131.04 -68.32 0.68 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.181 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -136.12 -173.34 3.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -85.2 -48.6 8.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.425 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.21 -23.8 60.49 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.154 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -116.9 116.95 28.41 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 15.5 mm-40 -109.0 -80.98 0.57 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.1 pp -170.59 137.0 1.31 Allowed 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.96 -47.16 69.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 124.758 1.223 . . . . 0.0 112.035 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -74.04 174.98 48.61 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.132 -0.486 . . . . 0.0 113.743 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.62 -30.02 23.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.849 0.833 . . . . 0.0 110.146 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -88.18 98.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.536 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.98 20.4 2.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.147 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -154.48 -177.63 6.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.493 ' NH1' HG12 ' A' ' 138' ' ' ILE . 8.2 ptp180 -154.13 128.22 8.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 174.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 21.4 mt-10 -103.75 143.17 33.15 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 122.151 -0.343 . . . . 0.0 111.347 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -88.44 104.42 16.77 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.1 t70 -98.04 -156.55 0.55 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.471 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.0 p -70.49 -53.25 17.03 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.088 0.955 . . . . 0.0 112.064 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.82 -25.63 27.99 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.184 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.81 -156.36 28.27 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.168 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.6 m95 -78.51 142.27 37.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.813 0.445 . . . . 0.0 110.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -90.04 131.8 35.73 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 72.16 -175.46 0.17 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.773 0.829 . . . . 0.0 111.652 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -123.54 168.47 12.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.545 HD11 ' HA3' ' A' ' 89' ' ' GLY . 21.4 mt -57.04 116.11 12.45 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.411 1.085 . . . . 0.0 110.032 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 18.2 Cg_endo -64.69 138.52 59.09 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.274 1.983 . . . . 0.0 111.777 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 1.9 mp -87.06 129.13 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 0.0 110.091 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 12.1 m -63.13 113.48 3.17 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 123.782 0.833 . . . . 0.0 111.759 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.8 m-20 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 41' ' ' THR . 72.8 m -70.61 137.64 50.15 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.683 0.615 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.451 ' HA ' HG22 ' A' ' 41' ' ' THR . 12.5 m120 -107.04 19.1 20.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.703 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.61 161.54 41.97 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.33 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.2 mt -78.2 150.17 77.03 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 123.401 0.68 . . . . 0.0 109.245 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.33 139.77 84.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.84 1.693 . . . . 0.0 110.022 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.55 147.02 50.85 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.036 1.824 . . . . 0.0 112.583 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -91.45 146.18 24.02 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -116.93 171.75 7.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' O ' ' HD2' ' A' ' 53' ' ' ARG . 10.8 t30 -88.56 -39.09 14.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.984 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 p -93.57 -12.51 29.37 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 3.4 mp0 -127.48 138.29 52.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.956 0.408 . . . . 0.0 110.719 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 12.8 mt -114.74 144.19 22.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -78.72 125.27 29.14 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.073 0.463 . . . . 0.0 110.314 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.7 p -86.99 -32.07 20.25 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.26 165.85 54.11 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.424 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 m -97.87 106.05 18.29 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -109.37 136.66 48.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -148.04 -20.31 0.35 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.0 152.87 18.3 Favored 'General case' 0 C--O 1.201 -1.487 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.568 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ASN . 25.5 p -120.71 139.79 52.55 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.903 -0.498 . . . . 0.0 111.74 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.74 140.91 33.33 Favored Pre-proline 0 C--N 1.314 -0.94 0 C-N-CA 122.257 0.223 . . . . 0.0 110.952 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.2 Cg_endo -60.3 145.63 98.2 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.412 2.741 . . . . 0.0 112.045 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 67' ' ' ARG . 22.6 tt0 -68.98 144.13 54.21 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.21 0.09 54.27 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -86.68 111.21 20.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -86.4 147.89 25.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.26 120.79 37.12 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.439 HG12 HD12 ' A' ' 63' ' ' ILE . 66.7 mt -93.59 119.13 40.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.337 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 58.9 m-85 -95.39 143.8 26.45 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.89 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 5.0 tppp? -89.45 126.98 35.78 Favored 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 64.6 m -79.95 21.49 0.56 Allowed 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 18.8 mtp180 63.4 157.87 0.12 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 123.87 0.868 . . . . 0.0 112.273 -176.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.13 -2.35 8.73 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.026 1.817 . . . . 0.0 113.766 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . -105.39 -1.64 40.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.882 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 68.6 m-85 -128.14 178.16 6.42 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.435 -1.038 . . . . 0.0 108.949 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -155.53 177.71 11.06 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -169.02 171.69 8.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.92 -35.55 20.44 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.28 143.63 15.36 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.45 160.41 32.78 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.478 0.639 . . . . 0.0 111.426 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.98 105.11 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 HG12 ' A' ' 49' ' ' ILE . 45.9 mm -104.66 116.93 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.263 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.4 mtp -105.52 172.32 6.86 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.606 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.0 p -159.47 148.88 7.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.25 0.548 . . . . 0.0 110.559 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.1 t -71.41 117.37 12.87 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.459 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 44' ' ' GLU . 5.4 tpm_? -146.63 123.07 11.03 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 59.09 25.69 14.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.188 0.995 . . . . 0.0 113.19 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 94.25 -11.5 70.38 Favored Glycine 0 C--N 1.29 -2.005 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.802 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -113.25 166.11 11.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.473 0.654 . . . . 0.0 110.644 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -106.46 106.74 17.4 Favored 'General case' 0 N--CA 1.409 -2.475 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' ALA . 9.6 p -130.42 -161.52 0.3 Allowed 'Isoleucine or valine' 1 N--CA 1.37 -4.472 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -91.19 126.6 36.32 Favored 'General case' 1 C--N 1.228 -4.705 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.069 -169.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.23 -57.8 3.63 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 13.0 t-20 -116.5 102.56 53.35 Favored Pre-proline 0 N--CA 1.419 -1.998 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.537 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.45 -0.89 11.09 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 122.976 2.451 . . . . 0.0 112.989 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 mt -89.8 -26.5 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.859 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 34.9 mmt180 -85.28 147.75 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.227 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HG3' ' HG3' ' A' ' 81' ' ' GLN . 17.9 ptpt -154.58 163.15 40.65 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.95 111.38 23.63 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 49.6 mt-30 -101.37 151.05 22.37 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.357 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 94.8 mttt -65.24 129.03 38.24 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.2 ptp180 -71.74 137.37 82.83 Favored Pre-proline 0 C--N 1.313 -0.985 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.077 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 143.66 76.57 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 122.711 2.274 . . . . 0.0 110.728 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.2 m -101.17 -13.76 18.0 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.24 -173.27 55.28 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.111 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.51 ' HD2' ' O ' ' A' ' 89' ' ' GLY . 32.9 t60 -72.26 134.13 82.9 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.91 65.78 4.06 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.025 2.483 . . . . 0.0 111.894 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' O ' ' HD2' ' A' ' 87' ' ' HIS . . . 74.42 -95.33 0.86 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -178.94 138.53 0.15 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 96.4 m -144.82 99.86 4.69 Favored Pre-proline 0 C--N 1.286 -2.172 0 CA-C-O 121.127 0.489 . . . . 0.0 111.612 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.2 -50.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.554 1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 114.88 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -81.46 -34.42 31.41 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.828 -0.545 . . . . 0.0 111.191 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.07 150.56 30.68 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.5 m -111.35 -42.74 3.83 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 117.42 0.61 . . . . 0.0 110.696 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' HA ' ' H ' ' A' ' 113' ' ' THR . 4.2 p90 64.44 152.19 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.963 1.705 . . . . 0.0 115.11 174.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 p -124.13 143.64 50.36 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -103.82 137.04 42.4 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -119.29 -22.26 7.18 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.89 44.31 1.51 Allowed Glycine 0 CA--C 1.496 -1.106 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.09 20.16 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -128.35 15.89 6.61 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.92 178.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -93.32 85.98 5.16 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 12.3 pt-20 -127.18 145.59 50.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.576 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 63.8 t80 -46.47 126.82 8.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.25 -5.93 55.79 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.935 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.3 p -84.58 131.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.644 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.7 ttmt -100.29 127.57 46.55 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 98.21 8.18 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.41 115.75 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.429 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 4.9 t80 -82.96 94.55 7.77 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.647 0.737 . . . . 0.0 110.678 -171.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.405 ' H ' ' HA ' ' A' ' 96' ' ' PHE . 1.7 p -105.82 151.13 24.9 Favored 'General case' 0 N--CA 1.402 -2.848 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.466 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.85 -166.14 1.17 Allowed 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.201 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -61.82 156.52 20.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.58 -42.43 11.13 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.609 1.564 . . . . 0.0 114.246 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.94 10.34 74.24 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.356 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -114.46 167.69 10.51 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.788 0.794 . . . . 0.0 111.738 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -133.45 -140.21 0.19 Allowed 'General case' 0 CA--C 1.469 -2.137 0 N-CA-C 102.539 -3.134 . . . . 0.0 102.539 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.3 pt? -160.28 152.78 20.88 Favored 'General case' 1 N--CA 1.335 -6.178 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 142' ' ' GLU . 0.5 OUTLIER -80.43 126.83 31.69 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 173.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.95 163.23 9.43 Favored Glycine 0 N--CA 1.402 -3.582 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.62 -24.58 14.09 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.276 1.036 . . . . 0.0 108.344 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.6 mm -102.48 101.64 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.74 ' HA ' HD11 ' A' ' 120' ' ' LEU . 30.3 p-10 -89.19 33.61 0.8 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.657 0.741 . . . . 0.0 111.269 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -165.18 171.24 13.96 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.398 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.45 124.87 14.73 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.122 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -99.04 142.37 30.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.6 t -82.12 126.57 32.18 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.01 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.8 t70 -117.28 -166.45 1.18 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.8 p -60.15 -48.74 80.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 124.894 1.278 . . . . 0.0 113.616 -172.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.65 -24.81 18.54 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.38 0.609 . . . . 0.0 111.515 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.37 -155.48 25.73 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -77.87 144.77 36.7 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.5 p -63.97 -34.85 78.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.858 0.837 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -138.48 152.43 48.28 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.28 2.5 p30 -82.36 -94.29 0.06 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.503 HD11 ' HA3' ' A' ' 89' ' ' GLY . 7.3 mt -133.61 98.19 15.17 Favored Pre-proline 0 C--N 1.292 -1.91 0 O-C-N 121.573 -0.704 . . . . 0.0 109.672 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.893 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.1 Cg_endo -51.78 141.43 44.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 166.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.98 115.18 26.86 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.684 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.53 120.66 9.83 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 122.266 0.226 . . . . 0.0 110.914 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 121.649 0.738 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.757 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.2 142.82 32.82 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.89 16.4 15.18 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 122.153 0.978 . . . . 0.0 108.609 173.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.45 163.18 34.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.8 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 37' ' ' TRP . 21.5 mt -91.51 154.96 44.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 123.699 0.8 . . . . 0.0 111.005 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.2 Cg_endo -64.79 130.9 27.45 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.224 1.949 . . . . 0.0 110.511 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.5 Cg_exo -64.25 146.32 90.05 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.153 1.902 . . . . 0.0 111.358 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -92.45 146.91 23.32 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.53 178.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.4 mpt_? -104.22 174.86 5.69 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.515 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -82.3 -34.88 28.45 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -100.38 -5.12 27.73 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 1.5 mp0 -133.06 145.81 51.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.58 153.9 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.1 mm? -74.82 143.05 44.13 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 123.846 0.716 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 49' ' ' ILE . 17.0 p -80.33 -52.53 7.59 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.489 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.23 177.62 54.13 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.625 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -95.23 127.75 41.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.655 ' HB3' HD22 ' A' ' 24' ' ' LEU . 75.6 m95 -124.31 103.78 8.41 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.6 m -121.65 7.67 10.01 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.753 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.52 -158.41 0.73 Allowed 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 41' ' ' THR . 2.8 pt20 -142.24 -36.92 0.4 Allowed 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.9 p -97.23 103.81 15.77 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.657 0.742 . . . . 0.0 111.658 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -117.63 145.45 36.41 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.049 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.22 140.47 92.28 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 123.323 2.682 . . . . 0.0 112.132 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.6 tt0 -64.97 138.1 58.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.04 6.6 53.75 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 m -86.14 117.93 25.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.6 pt20 -82.95 146.49 28.78 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.607 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.95 113.65 24.42 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 mt -88.4 129.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.6 m-85 -103.17 136.34 43.14 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 122.395 1.093 . . . . 0.0 113.038 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -75.7 -20.15 58.6 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.065 -1.88 . . . . 0.0 112.967 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 90.8 m 65.88 7.29 4.51 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 57.5 mtp180 68.45 165.82 0.13 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 55.1 Cg_endo -71.02 -22.16 26.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 120.956 1.104 . . . . 0.0 112.903 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.12 -17.93 48.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.745 -0.74 . . . . 0.0 114.467 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.2 m-85 -118.47 167.21 11.81 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -161.67 -175.42 4.72 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 0.0 109.898 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 p -166.84 -177.88 4.04 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.72 69.87 0.99 Allowed 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.064 0.935 . . . . 0.0 108.987 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.78 -21.21 0.6 Allowed Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.65 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.1 m120 72.33 149.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.619 1.168 . . . . 0.0 110.598 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' SG ' ' A' ' 80' ' ' CYS . 73.3 t -70.51 110.41 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.77 116.08 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 60.6 mtp -103.45 174.04 6.04 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -161.64 150.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.14 0.495 . . . . 0.0 109.832 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.19 127.41 35.74 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 49.0 ttp180 -149.83 131.87 15.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 65.51 20.58 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.916 0.486 . . . . 0.0 112.305 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.11 -13.73 66.96 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.663 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -106.99 159.19 16.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.356 0.598 . . . . 0.0 111.697 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -99.43 109.71 22.26 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 73' ' ' ALA . 12.1 p -127.18 -156.07 0.17 Allowed 'Isoleucine or valine' 1 N--CA 1.363 -4.78 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.678 -176.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -102.47 134.79 45.22 Favored 'General case' 1 C--N 1.223 -4.921 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -168.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.12 -58.81 2.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -117.6 88.83 30.72 Favored Pre-proline 0 N--CA 1.433 -1.309 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.89 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.24 -14.46 25.66 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.37 2.047 . . . . 0.0 110.688 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.68 -28.27 62.6 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.834 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 31.5 mmt180 -93.55 132.74 37.56 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.944 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.0 155.54 44.68 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 62' ' ' VAL . 36.0 m -94.31 116.22 28.57 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.538 0.685 . . . . 0.0 109.933 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -111.0 177.11 4.77 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.976 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 34.2 mmtp -57.21 145.22 32.31 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.867 0.729 . . . . 0.0 109.754 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 106' ' ' TYR . 12.2 ptm180 -85.66 131.61 46.95 Favored Pre-proline 0 C--N 1.279 -2.472 0 C-N-CA 118.906 -1.118 . . . . 0.0 108.693 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 139.43 39.6 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.415 2.076 . . . . 0.0 110.089 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.7 m -101.04 -2.82 30.62 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.66 -96.75 1.89 Allowed Glycine 0 C--N 1.308 -0.984 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.597 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -143.85 125.54 8.24 Favored Pre-proline 0 C--N 1.313 -1.003 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.8 Cg_exo -68.89 -53.78 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.666 2.244 . . . . 0.0 111.726 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.73 166.69 18.3 Favored Glycine 0 N--CA 1.419 -2.46 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.338 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.45 109.58 20.89 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -92.33 131.96 33.27 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.24 -31.75 52.85 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.501 2.134 . . . . 0.0 112.41 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.75 139.96 52.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.579 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . 71.61 -165.4 53.66 Favored Glycine 0 C--N 1.304 -1.214 0 O-C-N 123.961 0.788 . . . . 0.0 113.351 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.7 m -155.54 170.07 22.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.465 ' CZ ' ' HG2' ' A' ' 88' ' ' PRO . 45.7 p90 -104.7 160.68 14.78 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.934 -0.479 . . . . 0.0 109.784 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -115.59 144.86 43.28 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -106.22 135.01 48.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 100' ' ' GLY 0.25 3.8 t -87.42 -86.01 0.16 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.551 ' H ' HG23 ' A' ' 99' ' ' THR . . . -87.02 52.77 4.43 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 118.15 0.432 . . . . 0.0 113.053 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.5 162.66 17.2 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -121.75 15.12 10.97 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.711 0.767 . . . . 0.0 109.102 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.9 175.35 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -93.55 88.55 5.93 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.0 pt-20 -133.25 154.85 50.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.624 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . 70.0 t80 -50.05 119.54 3.69 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.537 0.684 . . . . 0.0 111.802 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.88 -19.76 18.04 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.839 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 105' ' ' GLU . 2.8 p -85.36 141.32 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -111.46 128.26 55.95 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.04 100.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -91.83 118.26 36.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.604 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -77.82 109.88 12.21 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.64 0.733 . . . . 0.0 110.616 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.17 109.15 12.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.03 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.579 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 97.7 m -129.84 111.07 12.23 Favored 'General case' 0 C--N 1.253 -3.628 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.76 -168.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 19.4 m120 57.25 -162.09 0.2 Allowed 'General case' 0 C--O 1.247 0.941 0 O-C-N 124.448 1.093 . . . . 0.0 112.744 172.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -121.48 -46.73 2.26 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.19 0.519 . . . . 0.0 110.477 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.47 72.82 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 68.8 m-85 -98.6 155.09 17.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -136.99 -88.46 0.28 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.4 pp 178.44 148.87 0.2 Allowed 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 123.895 0.747 . . . . 0.0 112.14 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -102.24 135.22 44.22 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.025 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.41 161.13 10.92 Favored Glycine 0 C--N 1.281 -2.516 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.82 -18.99 26.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.434 0.635 . . . . 0.0 109.838 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' ND2' ' A' ' 136' ' ' ASN . 41.1 mm -113.54 121.24 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.966 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.451 ' HB2' HD21 ' A' ' 120' ' ' LEU . 29.7 p-10 -92.31 24.63 3.3 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.723 0.809 . . . . 0.0 111.557 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 38.0 p90 -163.04 178.45 8.31 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -151.39 128.2 10.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.999 -1.455 . . . . 0.0 107.649 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.0 mt-10 -103.82 154.42 19.62 Favored 'General case' 0 CA--C 1.482 -1.659 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.2 t -92.44 105.65 17.8 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.251 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.35 175.48 7.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.574 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 54' ' ' PRO . 73.8 p -52.46 -33.79 46.06 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.521 1.528 . . . . 0.0 112.444 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.15 -32.53 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.407 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.31 -159.48 28.89 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 95.2 m95 -67.74 128.92 38.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.314 0.578 . . . . 0.0 112.087 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.8 p -78.72 157.25 28.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.721 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' HG13 ' A' ' 124' ' ' ILE . 11.4 m120 65.82 -162.56 0.25 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -119.26 -163.1 0.95 Allowed 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 60.4 mt -101.54 110.04 60.71 Favored Pre-proline 0 C--N 1.285 -2.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 11.2 Cg_endo -58.76 137.91 82.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.959 1.773 . . . . 0.0 110.501 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 47.9 mm -89.33 103.91 14.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.14 111.18 1.42 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.253 0.549 . . . . 0.0 110.551 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.432 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 8.8 tp10 . . . . . 0 N--CA 1.418 -2.064 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.089 0.471 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 41' ' ' THR . 83.9 m -78.73 133.57 37.14 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.756 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.06 25.02 10.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.444 0.64 . . . . 0.0 110.096 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.42 155.19 38.1 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.851 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 37' ' ' TRP . 32.0 mt -76.9 158.8 79.92 Favored Pre-proline 0 C--N 1.31 -1.13 0 O-C-N 123.738 0.649 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 141.4 74.23 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.319 2.012 . . . . 0.0 110.09 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.96 118.03 4.65 Favored 'Trans proline' 0 N--CA 1.437 -1.807 0 C-N-CA 121.52 1.48 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -62.38 135.98 57.7 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.496 0.665 . . . . 0.0 110.194 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.562 ' HB3' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -85.94 176.89 7.81 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.769 -167.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -82.98 -24.1 33.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.963 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 p -132.29 10.27 4.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.92 0.391 . . . . 0.0 111.388 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 2.7 mp0 -133.7 158.78 42.42 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -133.34 163.42 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -85.58 156.65 20.64 Favored 'General case' 0 C--N 1.263 -3.161 0 CA-C-O 120.81 0.338 . . . . 0.0 110.573 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -130.54 95.57 3.91 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 -149.5 15.38 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.2 m -131.13 117.79 19.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 117.836 0.818 . . . . 0.0 109.45 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.537 ' HB3' HD22 ' A' ' 24' ' ' LEU . 55.3 m95 -134.17 101.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.908 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.2 t -147.4 34.81 0.87 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.11 -163.86 1.31 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.588 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -128.93 -49.3 1.23 Allowed 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 70.1 p -95.43 127.12 41.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.73 136.98 26.4 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.857 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 37.4 Cg_endo -65.09 153.62 77.39 Favored 'Trans proline' 0 C--O 1.262 1.712 0 C-N-CA 122.825 2.35 . . . . 0.0 112.106 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 23.7 tt0 -67.49 139.99 57.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.97 2.2 55.0 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.202 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.437 ' C ' HG23 ' A' ' 65' ' ' VAL . 89.6 m -84.54 115.0 22.37 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -83.16 139.82 32.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.557 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.18 108.68 20.24 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.0 mt -87.71 115.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.799 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 84.6 m-85 -95.96 149.05 22.0 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.371 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.46 130.94 39.1 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.8 t -87.18 102.41 14.44 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -32.81 144.21 0.14 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.981 1.712 . . . . 0.0 113.623 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -56.52 111.19 0.71 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 123.423 2.749 . . . . 0.0 112.534 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.96 -19.86 5.16 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -111.88 166.62 11.05 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.578 -0.811 . . . . 0.0 110.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -155.54 167.27 30.92 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.925 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 t -174.64 126.11 0.3 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.7 77.59 5.18 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.403 0.62 . . . . 0.0 110.697 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.01 -29.83 1.23 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 70.67 158.49 0.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.412 1.085 . . . . 0.0 112.859 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.88 110.93 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.43 121.43 67.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -109.4 176.52 5.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 46' ' ' THR . 9.9 p -159.97 142.92 5.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.139 0.495 . . . . 0.0 110.668 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.79 121.97 18.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.905 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.9 ttm180 -152.57 117.87 5.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 120.589 0.233 . . . . 0.0 110.527 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 40.3 mmtm 69.2 25.05 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.593 1.157 . . . . 0.0 112.826 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.38 -12.82 67.57 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.075 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.22 154.13 31.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -87.64 118.21 26.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.0 175.04 3.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.742 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.52 122.28 31.03 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.001 0.429 . . . . 0.0 111.258 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.08 -57.4 3.86 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.88 91.29 8.78 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.198 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.92 -15.44 16.63 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.476 2.118 . . . . 0.0 112.647 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.28 -28.94 59.98 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.672 0.749 . . . . 0.0 109.723 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -84.23 134.49 34.54 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.028 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -154.48 160.86 41.82 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.509 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 16.9 m -79.81 112.94 17.58 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-O 121.777 0.798 . . . . 0.0 112.312 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.48 153.14 23.27 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.35 146.38 43.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.818 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.12 145.66 49.69 Favored Pre-proline 0 N--CA 1.417 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.887 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.83 153.51 48.05 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 N-CA-C 108.03 -1.566 . . . . 0.0 108.03 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.1 m -91.3 -24.11 19.93 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.677 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.01 -115.52 3.99 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -146.09 131.31 9.13 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.94 34.41 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 123.015 2.476 . . . . 0.0 113.349 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.96 155.5 27.8 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.66 84.38 2.12 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 t -73.58 136.78 77.61 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.872 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.97 -28.46 19.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.172 1.915 . . . . 0.0 111.71 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.31 121.44 34.99 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 173.01 16.56 Favored Glycine 0 N--CA 1.424 -2.145 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.7 m -154.66 171.72 19.05 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -136.41 157.66 46.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.661 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -126.25 155.3 42.1 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.26 131.49 56.93 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.4 t -125.98 144.43 50.7 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.06 68.99 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.86 168.09 25.35 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -112.91 9.51 18.87 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.006 0.908 . . . . 0.0 108.963 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 3.3 p -136.19 -167.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.712 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.043 -173.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -105.46 101.48 11.01 Favored 'General case' 1 C--N 1.241 -4.109 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.163 -176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -156.37 152.86 28.08 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.8 t80 -54.07 114.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.94 0 O-C-N 124.021 0.826 . . . . 0.0 111.168 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.84 -19.81 5.2 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.576 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 15.8 m -79.93 149.36 5.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.206 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.505 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -107.51 118.26 36.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.36 94.27 9.83 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.7 p -89.33 121.23 39.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.515 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -84.23 141.41 31.02 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.333 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -141.73 163.89 31.68 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.22 -59.64 0.06 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 118.972 0.805 . . . . 0.0 111.736 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -147.26 -170.76 3.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.0 -51.04 3.8 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 123.882 0.873 . . . . 0.0 109.861 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.1 8.49 70.27 Favored Glycine 0 C--O 1.24 0.503 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.99 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -133.83 129.53 36.63 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.42 -135.78 0.2 Allowed 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 167.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.727 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -153.23 153.57 32.96 Favored 'General case' 1 N--CA 1.334 -6.243 0 C-N-CA 118.991 -1.083 . . . . 0.0 108.411 -175.69 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.5 mm? -77.77 125.89 30.03 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-O 121.475 0.655 . . . . 0.0 109.431 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.25 150.14 7.38 Favored Glycine 0 C--N 1.273 -2.947 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 -172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.56 -22.76 22.23 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 122.162 0.982 . . . . 0.0 109.149 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.93 109.4 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.869 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HD11 ' A' ' 120' ' ' LEU . 32.0 p-10 -86.14 33.67 0.61 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.779 0.8 . . . . 0.0 110.863 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 50.1 p90 -167.07 176.52 6.82 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.95 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.85 119.42 7.97 Favored 'General case' 0 N--CA 1.401 -2.905 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 23.6 mt-10 -87.76 155.39 19.93 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 52.4 t -75.38 139.46 42.39 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.42 167.47 12.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.502 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.5 p -55.87 -28.5 56.81 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.791 1.637 . . . . 0.0 112.894 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -108.43 -28.93 9.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.244 0.545 . . . . 0.0 111.555 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.7 -106.24 0.19 Allowed Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.964 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -127.54 145.35 50.89 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -74.59 -26.79 60.16 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -128.12 170.02 13.43 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -99.28 -170.14 1.87 Allowed 'General case' 0 C--N 1.285 -2.212 0 O-C-N 124.055 0.847 . . . . 0.0 110.365 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.43 113.1 53.91 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-O 120.365 0.126 . . . . 0.0 110.694 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.727 ' HB2' HD12 ' A' ' 120' ' ' LEU . 11.2 Cg_endo -70.24 152.94 67.1 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 122.601 2.2 . . . . 0.0 110.287 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.26 125.96 72.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 12.3 p -76.96 108.54 10.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.633 ' HB2' HD23 ' A' ' 121' ' ' LEU . 28.3 mt-10 . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 125.678 1.591 . . . . 0.0 107.166 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 121.72 0.771 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.0 m -76.02 140.33 41.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.024 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.85 20.02 19.61 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.602 0.715 . . . . 0.0 109.915 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.1 155.95 40.76 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -88.53 158.41 48.55 Favored Pre-proline 1 N--CA 1.367 -4.577 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.248 -176.966 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 13.2 Cg_endo -58.34 130.04 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.541 2.827 . . . . 0.0 111.829 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.14 122.86 5.89 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.526 2.15 . . . . 0.0 112.597 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.74 154.23 41.24 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.975 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -117.08 176.14 5.27 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.74 -23.35 64.32 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.253 0.549 . . . . 0.0 111.517 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 p -119.02 7.13 11.35 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 5.2 mp0 -136.9 141.7 42.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.35 0.595 . . . . 0.0 112.148 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.95 151.92 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 3.6 mm? -67.84 155.52 39.17 Favored 'General case' 0 C--N 1.267 -2.981 0 O-C-N 123.629 0.581 . . . . 0.0 111.233 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 p -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.389 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 -163.4 38.84 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.782 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -121.09 108.21 13.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.52 ' CD1' ' HG ' ' A' ' 33' ' ' LEU . 18.7 m95 -107.52 88.16 2.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -104.11 4.74 34.54 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.774 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' O ' HD21 ' A' ' 24' ' ' LEU . 9.2 t70 -103.02 -150.02 0.41 Allowed 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.279 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -134.08 -57.8 0.86 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 69.8 p -88.03 122.12 31.25 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.171 -172.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -129.51 138.95 34.26 Favored Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.482 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.43 143.76 99.61 Favored 'Trans proline' 0 C--O 1.245 0.875 0 C-N-CA 123.316 2.677 . . . . 0.0 113.237 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 48.1 tt0 -63.6 131.65 48.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.965 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.36 4.59 46.83 Favored Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 65' ' ' VAL . 58.0 m -86.02 115.53 23.67 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -84.45 142.23 30.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.365 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.46 124.15 51.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.9 mt -94.12 132.04 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -110.19 144.47 38.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -93.75 142.23 27.6 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.734 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 m -84.51 22.36 1.3 Allowed 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 64.83 162.26 0.12 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.347 0.659 . . . . 0.0 110.112 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 131' ' ' THR . 50.3 Cg_endo -71.63 112.5 3.38 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 120.509 0.806 . . . . 0.0 110.536 173.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.57 -26.22 6.04 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.333 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 89.5 m-85 -102.59 163.51 12.18 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.861 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -140.55 -178.79 5.68 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -143.67 -177.0 5.19 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.76 6.03 36.49 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.13 0.491 . . . . 0.0 109.745 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.04 -115.93 0.34 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -138.78 122.86 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.483 HG21 ' SG ' ' A' ' 80' ' ' CYS . 60.7 t -84.08 110.38 18.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mm -124.06 130.44 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.401 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.2 mtp -111.03 175.13 5.54 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.456 HG23 ' C ' ' A' ' 46' ' ' THR . 11.2 p -157.71 143.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-O 121.33 0.586 . . . . 0.0 111.275 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.8 t -75.31 123.85 26.06 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.474 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 70.0 ttt180 -155.53 134.24 11.92 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 62.61 21.04 12.44 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.736 0.814 . . . . 0.0 112.369 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.33 -10.65 69.36 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.675 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -121.36 159.87 25.21 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.571 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.406 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.5 m95 -90.19 117.6 29.07 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.689 0.756 . . . . 0.0 110.36 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.73 169.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.022 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.69 125.77 35.0 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.84 -56.78 6.87 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 174.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 8.9 t-20 -120.88 100.66 46.03 Favored Pre-proline 0 N--CA 1.413 -2.299 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.271 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.66 -5.65 17.15 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.912 2.408 . . . . 0.0 112.779 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.5 mt -88.91 -20.46 24.51 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 122.164 0.983 . . . . 0.0 110.827 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 31.7 mmt180 -91.15 132.15 36.25 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.42 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -149.41 158.93 44.6 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.483 ' SG ' HG21 ' A' ' 62' ' ' VAL . 81.7 m -97.66 107.23 19.68 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 122.058 0.932 . . . . 0.0 110.276 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.51 168.83 9.47 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.954 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 99.0 mttt -66.71 144.86 56.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -85.44 139.58 36.03 Favored Pre-proline 0 N--CA 1.427 -1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 22.7 Cg_endo -68.81 140.45 46.41 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 121.351 1.368 . . . . 0.0 108.84 174.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.7 m -74.43 -38.33 63.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.291 0.567 . . . . 0.0 110.495 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.94 -86.03 0.38 Allowed Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -174.64 120.47 0.35 Allowed Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 123.33 0.652 . . . . 0.0 109.325 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 41.9 Cg_endo -69.06 157.15 62.86 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.567 2.178 . . . . 0.0 109.011 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.488 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -51.07 138.42 26.72 Favored Glycine 0 N--CA 1.438 -1.209 0 O-C-N 123.955 0.784 . . . . 0.0 112.218 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.76 137.52 37.24 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.1 0.476 . . . . 0.0 109.909 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -126.15 141.19 38.98 Favored Pre-proline 0 N--CA 1.404 -2.733 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.834 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.13 -29.89 9.36 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.17 1.913 . . . . 0.0 110.8 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.72 109.67 16.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.73 157.0 9.57 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.296 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 m -137.92 164.5 28.86 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.7 p90 -129.5 155.78 45.2 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.027 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.737 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 42.1 p -100.64 164.83 11.7 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.945 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 93.3 mt -130.85 123.43 29.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.0 t -129.91 20.91 5.43 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.463 0.649 . . . . 0.0 112.653 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 108' ' ' VAL . . . -143.23 33.23 1.83 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.443 ' HA3' ' CD ' ' A' ' 105' ' ' GLU . . . 147.57 -151.57 23.81 Favored Glycine 0 N--CA 1.413 -2.877 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -175.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.76 3.24 1.25 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.406 0.603 . . . . 0.0 111.533 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.26 -172.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 13.1 m-85 -85.2 95.47 9.18 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.0 pt-20 -137.83 145.83 42.73 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.343 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.404 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 47.0 t80 -49.21 123.86 8.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.342 0.591 . . . . 0.0 111.766 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.52 58.54 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.864 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.8 p -91.8 136.25 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.3 ttmt -101.62 132.26 47.39 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.737 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -109.11 101.9 10.91 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -88.45 132.19 34.04 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 119.401 -0.92 . . . . 0.0 108.828 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -98.31 123.97 42.69 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.555 0.693 . . . . 0.0 109.372 -173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.0 m -144.34 158.32 43.8 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 71.5 m -125.41 -61.71 1.25 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.405 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -151.92 -166.06 2.4 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.45 -56.33 10.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.004 0.43 . . . . 0.0 111.05 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.1 -13.71 61.65 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.42 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.495 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -93.75 115.04 27.44 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.242 0.544 . . . . 0.0 111.548 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -113.08 -117.91 0.31 Allowed 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -165.69 156.66 13.68 Favored 'General case' 1 N--CA 1.354 -5.264 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.463 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 95.4 mt -79.57 125.63 29.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.8 152.75 7.25 Favored Glycine 0 N--CA 1.41 -3.034 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.65 -10.32 32.21 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.126 0.489 . . . . 0.0 110.839 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -111.39 106.72 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.762 ' HA ' HD11 ' A' ' 120' ' ' LEU . 27.5 p-10 -90.62 34.96 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 42.0 p90 -163.63 169.22 18.89 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.45 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 88' ' ' PRO . 66.4 mtt180 -132.39 134.75 45.53 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 41.3 mt-10 -114.28 130.51 56.65 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 18.7 t -79.32 114.15 18.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -105.45 -162.28 0.86 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 54' ' ' PRO . 80.3 p -62.57 -42.76 99.75 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.12 -10.86 15.76 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.0 -163.22 34.15 Favored Glycine 0 CA--C 1.49 -1.496 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.837 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -82.91 144.06 30.3 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 117.143 0.472 . . . . 0.0 110.255 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -70.5 -20.79 62.82 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.235 0.541 . . . . 0.0 112.422 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -137.83 148.63 45.63 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -89.84 -103.14 0.09 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.654 0.596 . . . . 0.0 111.31 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.488 HD11 ' HA3' ' A' ' 89' ' ' GLY . 29.7 mt -127.17 96.38 34.22 Favored Pre-proline 0 C--N 1.31 -1.151 0 O-C-N 120.782 -1.199 . . . . 0.0 111.754 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.832 ' HB2' HD12 ' A' ' 120' ' ' LEU . 6.5 Cg_endo -56.92 136.11 74.66 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 122.447 2.098 . . . . 0.0 108.575 167.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.5 mp -87.15 115.86 28.56 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.963 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.83 -171.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.02 112.81 0.85 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 35.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.275 1.43 . . . . 0.0 109.481 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.688 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.0 m-20 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.31 0.576 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 41' ' ' THR . 84.9 m -77.19 139.75 39.97 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.314 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -106.64 25.86 10.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.732 0.777 . . . . 0.0 109.164 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.57 155.35 33.2 Favored 'General case' 0 CA--C 1.468 -2.199 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -86.88 156.98 55.11 Favored Pre-proline 1 N--CA 1.336 -6.161 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.528 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 10.1 Cg_endo -54.14 125.35 18.52 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.083 2.522 . . . . 0.0 110.99 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.46 110.85 3.18 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.499 1.466 . . . . 0.0 112.118 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.276 0.0 OUTLIER -72.14 161.24 31.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.081 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 72.1 mtp180 -122.93 -174.03 2.84 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -168.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -90.47 -14.33 32.99 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -99.9 -33.88 10.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.734 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 25.5 mp0 -121.04 145.93 47.25 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.233 0.54 . . . . 0.0 112.14 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mt -119.71 144.46 28.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.607 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 37' ' ' TRP . 25.3 mt -74.67 128.24 35.07 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 p -112.96 100.35 8.57 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.9 171.1 21.3 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m -105.46 110.67 23.1 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.382 0.611 . . . . 0.0 111.261 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CD1' HD13 ' A' ' 33' ' ' LEU . 2.7 m95 -132.34 82.24 2.0 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 m -108.43 -2.29 19.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.231 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.724 ' O ' HD21 ' A' ' 24' ' ' LEU . 16.2 t70 -93.72 -136.29 0.19 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.909 -176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -144.11 -55.43 0.36 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 27.5 p -91.85 129.05 37.89 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -133.1 135.0 24.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.099 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.688 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 17.8 Cg_endo -60.59 148.65 90.55 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.228 2.619 . . . . 0.0 113.278 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.49 134.77 55.13 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.39 14.68 37.56 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 65' ' ' VAL . 90.4 m -94.29 119.33 32.91 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.349 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -89.3 150.09 22.75 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.454 0.645 . . . . 0.0 111.861 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.25 130.97 53.48 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.7 mt -101.56 126.62 55.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 66.4 m-85 -109.49 143.31 39.29 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 20.2 ttmm -92.33 129.75 38.2 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 73.5 m -70.99 7.46 1.18 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 68.4 mtp180 71.78 154.17 0.15 Allowed Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 123.618 0.767 . . . . 0.0 111.263 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.52 129.09 17.22 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.792 1.661 . . . . 0.0 109.186 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 104.69 -6.43 44.62 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.329 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 36.3 m-85 -126.39 170.65 11.73 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -160.16 177.54 10.58 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 49.5 p -155.37 179.97 8.66 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.72 -22.34 56.68 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.865 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.02 -96.59 0.14 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -155.73 155.32 32.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 80' ' ' CYS . 65.9 t -77.42 106.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.63 116.77 48.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.0 mtp -107.89 167.59 9.87 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.7 p -152.79 144.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.067 0.46 . . . . 0.0 110.088 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.43 118.84 12.81 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.577 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 71.4 ttt180 -151.12 115.22 5.02 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 69.24 27.98 5.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.016 . . . . 0.0 112.615 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.22 87.41 Favored Glycine 0 C--N 1.294 -1.784 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.59 152.96 38.68 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 79.9 m95 -92.77 121.22 33.94 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.2 172.25 13.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.84 119.4 21.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.82 -49.39 73.04 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.49 91.84 6.37 Favored Pre-proline 0 C--N 1.29 -1.992 0 CA-C-N 113.375 -1.739 . . . . 0.0 109.167 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.4 -3.13 13.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 0.0 112.984 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.17 8.38 44.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.239 0.542 . . . . 0.0 109.715 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -119.23 149.08 42.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.311 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.83 161.18 28.92 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 62' ' ' VAL . 71.8 m -104.26 123.94 48.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.71 0.767 . . . . 0.0 109.746 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -112.32 165.63 12.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.71 157.45 17.76 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 117.962 0.346 . . . . 0.0 110.801 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.9 ptm180 -82.22 143.91 49.54 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 41.2 Cg_endo -72.75 157.16 52.42 Favored 'Trans proline' 0 N--CA 1.424 -2.617 0 N-CA-C 108.142 -1.522 . . . . 0.0 108.142 169.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -103.03 6.26 38.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.646 0.736 . . . . 0.0 110.224 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 -122.07 9.94 Favored Glycine 0 N--CA 1.423 -2.192 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.892 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -130.63 120.23 18.62 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 45.5 Cg_endo -75.76 139.52 22.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.73 1.62 . . . . 0.0 108.315 172.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.438 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . -48.38 128.12 18.27 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.135 0.897 . . . . 0.0 113.638 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -98.29 178.09 5.17 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 94' ' ' GLY . 3.0 t -148.8 147.1 23.42 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.99 -18.52 12.96 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.739 1.626 . . . . 0.0 111.088 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -84.5 -25.44 28.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 114' ' ' CYS . . . -146.79 -147.74 4.62 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.723 -1.227 . . . . 0.0 114.072 -175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 96' ' ' PHE . 12.8 m -154.59 -169.3 3.17 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.589 ' H ' HG22 ' A' ' 95' ' ' THR . 38.5 p90 -148.62 161.74 41.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 119.274 0.943 . . . . 0.0 109.053 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG22 ' A' ' 111' ' ' VAL . 63.7 p -109.1 -176.51 3.05 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 108' ' ' VAL . 96.0 mt -143.73 164.95 29.02 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 170.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 109' ' ' LYS . 7.5 t -119.88 -148.76 0.42 Allowed 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -48.82 74.89 0.0 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 125.746 1.641 . . . . 0.0 115.938 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.79 -41.53 0.08 OUTLIER Glycine 0 C--N 1.276 -2.783 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.06 11.96 3.71 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.27 177.19 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 40.2 m-85 -90.79 87.78 6.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.507 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.55 150.82 44.15 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.553 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -45.32 115.38 0.91 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.477 1.11 . . . . 0.0 110.835 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.7 -33.92 2.87 Favored Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.73 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 98' ' ' LEU . 35.0 m -74.37 135.79 26.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 122.495 1.14 . . . . 0.0 113.424 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -93.69 118.13 31.0 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.235 170.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -96.62 109.21 21.87 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.2 m -86.72 158.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 118.774 -1.17 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 139' ' ' PRO . 51.1 t80 -119.52 132.84 55.84 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.518 0.675 . . . . 0.0 110.201 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.3 m -153.08 157.81 40.98 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.465 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 81.8 m -120.74 -61.87 1.52 Allowed 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.148 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -153.48 -153.0 0.44 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.57 -47.0 7.03 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.14 -29.16 69.08 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.23 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 96.1 m-85 -107.93 126.49 52.75 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.14 -74.93 0.54 Allowed 'General case' 1 CA--C 1.416 -4.179 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.269 2.3 tp -172.34 154.75 3.33 Favored 'General case' 1 N--CA 1.282 -8.852 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.541 -168.186 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 22.8 mt -129.0 130.05 46.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 132.45 -168.36 22.71 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -110.29 -40.17 4.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 117.937 0.869 . . . . 0.0 109.927 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.1 mm -97.67 100.74 11.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.709 -176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.458 ' HB3' HD22 ' A' ' 120' ' ' LEU . 28.5 p-10 -86.93 32.12 0.68 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 35.0 p90 -161.27 173.17 15.42 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.539 0.685 . . . . 0.0 110.262 -175.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 88' ' ' PRO . 21.7 ptt180 -147.04 134.68 21.03 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.457 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 39.9 mt-10 -111.86 143.48 42.74 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.648 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.74 106.13 17.45 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.207 0.527 . . . . 0.0 109.831 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.89 -166.93 1.36 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.244 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -62.59 -43.44 98.8 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.048 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.5 -37.87 77.37 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.66 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 138.78 -147.14 19.01 Favored Glycine 0 N--CA 1.411 -2.982 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -65.82 122.48 17.42 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 p -60.21 -33.21 71.92 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.888 0.875 . . . . 0.0 111.778 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -132.1 165.69 23.46 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 25.8 t70 -98.72 -144.82 0.32 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.438 HD11 ' HA3' ' A' ' 89' ' ' GLY . 11.7 mt -89.16 113.65 57.12 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.483 ' HB2' HD11 ' A' ' 120' ' ' LEU . 3.4 Cg_endo -65.73 161.82 37.28 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.457 2.104 . . . . 0.0 111.263 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.9 mp -74.81 136.46 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.448 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 40.9 t -104.18 102.7 12.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 179.6 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 11.0 m-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 41' ' ' THR . 59.8 m -75.99 133.93 40.29 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.244 0.618 . . . . 0.0 109.925 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.01 36.79 2.23 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.409 0.623 . . . . 0.0 109.635 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -157.16 155.94 31.82 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.825 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.7 mt -80.28 153.25 74.14 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.23 132.39 46.49 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.05 1.834 . . . . 0.0 110.657 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.33 137.58 10.6 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.254 1.969 . . . . 0.0 112.682 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -80.25 126.02 30.6 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 30.4 mtp180 -99.53 178.24 4.92 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.178 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.45 -28.03 61.74 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.168 0.985 . . . . 0.0 109.996 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -107.06 -31.56 8.23 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.642 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.681 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 30.1 mp0 -116.34 158.76 22.93 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' HG2' ' A' ' 51' ' ' LYS . 14.7 mt -144.01 148.4 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 151.42 42.28 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 p -126.67 156.89 40.32 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.69 -156.91 18.24 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.803 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -133.66 130.6 38.46 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.0 m95 -134.11 139.81 46.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -154.57 -5.03 0.15 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.385 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -113.97 163.65 14.84 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.031 -172.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.625 HE21 ' HA ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -83.9 -47.19 11.31 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.026 178.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 34.0 p -98.52 131.75 44.5 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.964 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -130.83 135.45 27.36 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.041 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.3 Cg_endo -61.71 148.9 92.01 Favored 'Trans proline' 0 C--O 1.257 1.474 0 C-N-CA 123.198 2.599 . . . . 0.0 112.001 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.45 139.87 58.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -11.25 55.69 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.062 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -68.54 118.34 11.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HA ' HG23 ' A' ' 65' ' ' VAL . 3.4 pt20 -93.4 138.77 31.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.558 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.2 119.72 39.95 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.815 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.9 mt -93.2 111.78 25.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.1 m-85 -101.86 144.06 30.97 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 19.4 ptpt -89.0 161.45 16.58 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.35 118.85 34.73 Favored 'General case' 1 N--CA 1.368 -4.553 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -31.55 147.31 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 124.81 1.319 . . . . 0.0 111.507 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.62 -31.33 31.49 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.409 2.739 . . . . 0.0 115.339 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' C ' ' HG2' ' A' ' 83' ' ' ARG . . . -96.2 14.54 64.33 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 121.514 0.508 . . . . 0.0 112.515 177.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -128.91 167.97 16.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.139 -0.624 . . . . 0.0 110.093 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -157.9 -177.06 6.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 109.272 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -166.65 -167.99 1.08 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.7 mp -88.78 3.93 49.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.98 -98.87 0.12 Allowed Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -141.93 158.22 44.04 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 65.8 t -88.21 107.98 18.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.67 108.46 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 CA-C-O 121.835 0.826 . . . . 0.0 109.832 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.3 mtp -97.73 175.15 6.28 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -157.04 147.79 10.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.676 -175.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.37 111.21 12.8 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 40.9 ttm180 -141.94 119.02 11.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 66.9 mmtt 64.53 22.1 12.6 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.591 1.157 . . . . 0.0 113.068 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.32 -8.62 69.5 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.387 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.63 161.01 17.3 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.235 0.54 . . . . 0.0 110.481 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -104.18 106.36 16.84 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 73' ' ' ALA . 13.5 p -127.93 -153.59 0.13 Allowed 'Isoleucine or valine' 1 N--CA 1.371 -4.42 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' H ' HG22 ' A' ' 72' ' ' VAL . . . -109.82 115.03 29.08 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 3.0 tm? -59.47 -55.0 40.09 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 167.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -120.0 97.52 49.41 Favored Pre-proline 0 N--CA 1.415 -2.193 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.098 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.08 -4.82 15.62 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 123.478 2.786 . . . . 0.0 112.624 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.87 -29.35 25.34 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.901 0.858 . . . . 0.0 109.066 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -91.36 131.44 36.85 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.919 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.89 154.11 25.47 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.681 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 73.8 m -84.77 106.18 16.11 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 122.022 0.915 . . . . 0.0 110.593 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -98.88 161.0 13.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.55 145.36 52.65 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.633 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HG2' ' C ' ' A' ' 55' ' ' GLY . 12.2 ptp180 -85.77 137.86 35.73 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.08 142.96 63.5 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.282 1.988 . . . . 0.0 111.034 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.79 -27.91 63.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.8 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.14 -175.7 24.07 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.55 123.94 80.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.55 42.97 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 123.749 2.966 . . . . 0.0 112.845 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 72.28 -168.1 52.66 Favored Glycine 0 N--CA 1.412 -2.96 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.97 139.01 32.32 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -116.61 145.5 35.46 Favored Pre-proline 0 C--N 1.281 -2.391 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.36 -35.08 95.71 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.953 2.436 . . . . 0.0 111.415 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.32 150.37 19.85 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.74 163.46 11.49 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.522 -0.847 . . . . 0.0 110.992 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 m -145.44 172.58 12.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.65 159.64 42.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -118.33 152.13 36.39 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.26 138.5 46.56 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -127.24 13.38 7.17 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.496 0.665 . . . . 0.0 111.505 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -132.45 15.91 4.92 Favored Glycine 0 CA--C 1.494 -1.241 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.738 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.15 -173.15 31.36 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -110.64 3.08 19.0 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.629 0.715 . . . . 0.0 109.355 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 104' ' ' PHE . 3.9 p -142.72 -168.49 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.171 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.366 -170.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 103' ' ' VAL . 28.6 m-85 -96.9 98.93 10.51 Favored 'General case' 1 C--N 1.239 -4.219 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.618 -177.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.44 148.54 28.2 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.573 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.516 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 87.5 t80 -52.81 105.6 0.13 Allowed 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.292 0.995 . . . . 0.0 112.045 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.15 -8.23 4.76 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.857 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 103' ' ' VAL . 16.3 m -90.12 143.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.356 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -104.84 122.05 44.94 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 171.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.8 91.33 8.58 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.4 p -82.07 118.15 29.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.866 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -92.82 141.36 28.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.926 0.87 . . . . 0.0 111.604 -168.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 m -146.61 155.02 42.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 21.7 t -130.46 -72.7 0.56 Allowed 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 117.009 -1.876 . . . . 0.0 112.493 -172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 0.9 OUTLIER -143.67 -169.7 3.14 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -176.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -90.85 -48.05 7.25 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.79 -10.92 85.76 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.845 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 79.3 m-85 -123.52 126.48 46.78 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -104.76 -88.51 0.43 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.0 pp 175.66 143.0 0.06 Allowed 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 124.461 1.104 . . . . 0.0 111.212 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.19 126.92 45.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.98 172.24 12.93 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -100.05 -23.62 14.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.242 1.02 . . . . 0.0 110.08 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 126' ' ' TYR . 35.2 mm -107.29 98.76 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.82 30.73 0.31 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.849 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.506 ' O ' HG22 ' A' ' 124' ' ' ILE . 39.4 p90 -170.23 -177.49 2.51 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.93 115.74 5.23 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 31.7 mt-10 -80.09 143.69 33.75 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.576 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 43.8 t -74.61 142.09 44.63 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.029 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -124.75 -165.47 1.39 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.2 p -70.8 -53.32 15.81 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.967 0.889 . . . . 0.0 111.75 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -103.09 2.22 34.41 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.168 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.03 -125.47 1.03 Allowed Glycine 0 C--N 1.291 -1.947 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -127.96 162.05 27.67 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.3 p -80.91 -24.89 37.92 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -141.8 172.68 12.36 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 17.9 t70 -99.75 -161.99 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 124.135 0.897 . . . . 0.0 109.504 -177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.566 HD11 ' HA3' ' A' ' 89' ' ' GLY . 25.9 mt -83.05 124.14 76.83 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.7 138.45 34.88 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.769 1.646 . . . . 0.0 109.863 172.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 33.6 mm -86.43 118.63 33.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.986 -175.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 76.6 m -53.72 107.28 0.24 Allowed 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.582 0.552 . . . . 0.0 111.326 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG2' HG22 ' A' ' 140' ' ' ILE . 7.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 34.4 m-20 . . . . . 0 C--O 1.242 0.686 0 CA-C-O 121.074 0.464 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -77.16 145.12 37.91 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -177.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.79 18.4 12.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.62 157.78 38.71 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -87.43 159.64 49.73 Favored Pre-proline 1 N--CA 1.356 -5.135 0 C-N-CA 125.1 1.36 . . . . 0.0 110.389 -176.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.71 150.09 78.93 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.516 2.81 . . . . 0.0 111.396 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.32 169.07 17.74 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.195 1.93 . . . . 0.0 112.244 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -117.25 150.71 38.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.04 165.49 15.97 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.331 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -80.91 -39.25 26.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 5.5 p -89.98 -8.12 52.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 28.7 mp0 -140.98 146.87 37.87 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.7 mt -113.43 126.55 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.058 0 CA-C-O 122.138 0.971 . . . . 0.0 109.945 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.33 113.45 11.56 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.097 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.9 p -90.28 157.31 17.73 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 -175.51 22.26 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.2 m -123.36 99.54 6.38 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.78 68.52 0.69 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 m -97.8 10.97 38.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.413 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.708 ' O ' HD21 ' A' ' 24' ' ' LEU . 22.1 t70 -97.48 -138.7 0.28 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.42 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 54.8 mt-30 -151.03 -58.09 0.16 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 63.7 p -89.27 129.26 35.86 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.673 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -137.79 149.09 63.36 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 123.903 0.881 . . . . 0.0 108.779 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.566 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 27.5 Cg_endo -65.11 150.87 87.25 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 122.516 2.144 . . . . 0.0 112.472 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 27.8 tt0 -67.36 138.71 56.95 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.56 56.58 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.274 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -81.15 119.13 23.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 2.9 pt20 -85.54 145.92 27.15 Favored 'General case' 0 N--CA 1.417 -2.088 0 O-C-N 123.802 0.689 . . . . 0.0 110.305 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.34 124.81 52.91 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.66 117.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.052 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 74.3 m-85 -98.07 134.6 40.93 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.041 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -77.37 134.78 38.37 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.3 t -80.53 98.82 7.76 Favored 'General case' 0 N--CA 1.396 -3.139 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -38.49 137.14 0.84 Allowed Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 112.224 -2.262 . . . . 0.0 111.769 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.7 122.41 11.69 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.695 2.263 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 113.87 -10.67 23.07 Favored Glycine 0 C--N 1.289 -2.031 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.347 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' CYS . 89.9 m-85 -125.23 168.77 13.01 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 122.168 -0.607 . . . . 0.0 110.488 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -157.01 175.0 14.68 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.974 0.91 . . . . 0.0 108.654 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.0 p -159.61 -160.86 0.86 Allowed 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.82 4.18 48.55 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.968 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.21 -119.14 0.65 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -121.4 157.33 30.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 61.5 t -91.16 115.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.4 mm -111.5 121.68 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 CA-C-O 121.362 0.601 . . . . 0.0 110.983 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.413 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 80.0 mtp -106.26 172.58 6.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.5 p -153.78 155.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.497 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.9 t -97.27 132.45 43.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.46 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 87.5 mtt180 -149.6 134.08 17.52 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 124.215 0.947 . . . . 0.0 110.127 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 62.79 23.79 14.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.42 -6.5 80.65 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.81 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.02 155.79 30.79 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.116 0.484 . . . . 0.0 110.886 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -93.6 120.65 34.13 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.372 0.606 . . . . 0.0 109.465 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.14 175.6 4.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.036 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.74 115.02 27.7 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.766 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.7 tm? -59.2 -54.54 45.79 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -122.27 99.46 43.15 Favored Pre-proline 0 N--CA 1.404 -2.762 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.757 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.14 -14.21 20.91 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.791 2.327 . . . . 0.0 112.031 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.75 -28.19 55.65 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.585 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 8.9 mmp_? -91.08 135.17 33.94 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.003 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.23 151.07 5.52 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.533 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 97.4 m -81.58 109.39 15.98 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.731 0.777 . . . . 0.0 112.636 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -105.47 171.79 7.14 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.072 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -63.79 146.34 54.09 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 14.3 ptp180 -100.25 146.21 31.57 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 77.8 Cg_endo -82.85 152.01 14.6 Favored 'Trans proline' 0 N--CA 1.439 -1.71 0 C-N-CA 121.932 1.755 . . . . 0.0 112.156 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.3 m -101.09 -1.19 34.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.493 0.663 . . . . 0.0 111.198 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.79 -92.45 1.12 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.265 -0.879 . . . . 0.0 114.253 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.59 129.9 21.54 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.1 36.08 0.6 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.913 3.075 . . . . 0.0 113.602 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.629 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 87.15 161.46 36.48 Favored Glycine 0 N--CA 1.422 -2.27 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.919 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -115.17 135.79 53.81 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.515 HG21 ' HE1' ' A' ' 112' ' ' TYR . 9.9 t -157.17 125.42 2.88 Favored Pre-proline 0 N--CA 1.416 -2.136 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.65 14.62 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.454 2.103 . . . . 0.0 111.602 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.06 -16.35 16.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.096 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 114' ' ' CYS . . . -179.67 -162.42 28.68 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.066 -1.54 . . . . 0.0 113.2 -176.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.0 t -134.74 -164.13 1.47 Allowed 'General case' 0 N--CA 1.424 -1.754 0 C-N-CA 123.27 0.628 . . . . 0.0 109.529 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 53.9 p90 -141.54 160.12 40.81 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.627 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 41.4 p -113.61 172.83 6.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 174.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.18 135.6 45.21 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 109' ' ' LYS . 13.1 t -138.01 18.27 2.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.314 1.054 . . . . 0.0 111.307 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 108' ' ' VAL . . . -142.04 38.1 1.51 Allowed Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.39 -176.23 20.46 Favored Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -121.38 17.59 11.4 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.595 0.712 . . . . 0.0 109.598 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 104' ' ' PHE . 4.9 p -144.67 -167.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 m-85 -104.31 93.72 4.96 Favored 'General case' 0 C--N 1.244 -3.983 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.974 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.4 pt-20 -142.39 152.11 42.5 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -175.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -51.4 114.52 1.25 Allowed 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.757 0.661 . . . . 0.0 110.445 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.47 -18.85 10.84 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.988 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.9 p -81.17 138.1 20.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-O 121.361 0.601 . . . . 0.0 110.787 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.551 ' HB3' HG22 ' A' ' 99' ' ' THR . 5.1 ttmp? -104.61 128.49 52.64 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -104.66 96.52 6.64 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -81.37 146.4 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 91' ' ' THR . 63.0 t80 -96.79 131.85 43.1 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.694 0.759 . . . . 0.0 109.977 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 m -151.91 157.66 42.12 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.452 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -154.27 -66.4 0.14 Allowed 'General case' 0 C--N 1.251 -3.692 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.578 -173.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 49.8 m-80 -115.79 -177.56 3.19 Favored 'General case' 0 N--CA 1.398 -3.062 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.085 -174.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.51 -46.5 7.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.71 17.59 58.1 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.768 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 115' ' ' ASN . 3.3 m-85 -125.45 150.63 47.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.244 -0.562 . . . . 0.0 109.941 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -122.1 -148.04 0.4 Allowed 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 171.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -142.99 154.79 44.37 Favored 'General case' 1 N--CA 1.332 -6.363 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.783 -169.469 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.544 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.3 mm? -81.63 128.68 34.19 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.24 142.61 5.08 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.4 -18.15 42.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.673 0.749 . . . . 0.0 109.09 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -109.35 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.747 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.2 p-10 -86.3 28.46 0.83 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.273 0.558 . . . . 0.0 111.474 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.408 ' CB ' ' HA ' ' A' ' 111' ' ' VAL . 47.1 p90 -167.57 -177.6 3.61 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.182 -172.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.46 133.45 15.08 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 29.3 mt-10 -105.92 147.08 29.18 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 122.139 -0.351 . . . . 0.0 111.318 -177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.5 t -81.77 106.2 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.6 t70 -101.95 -160.82 0.81 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.7 p -63.84 -51.91 62.53 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 124.911 1.285 . . . . 0.0 112.877 -174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.12 -35.82 15.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.227 0.537 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.96 -151.97 10.45 Favored Glycine 0 CA--C 1.49 -1.502 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 79.7 m95 -76.91 139.99 40.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.267 0.533 . . . . 0.0 109.943 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.6 p -63.92 -32.43 73.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -138.21 176.51 8.64 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -92.6 -155.88 0.45 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.629 HD11 ' HA3' ' A' ' 89' ' ' GLY . 38.0 mt -99.17 111.44 61.0 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 122.964 0.506 . . . . 0.0 110.062 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 120' ' ' LEU . 9.4 Cg_endo -61.62 145.42 97.63 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.363 2.042 . . . . 0.0 109.682 170.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.73 123.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.515 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 8.1 t -67.11 120.42 13.68 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HD23 ' A' ' 121' ' ' LEU . 16.6 mm-40 . . . . . 0 C--N 1.313 -1.003 0 C-N-CA 125.343 1.457 . . . . 0.0 108.141 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 6.0 m-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 77.5 m -69.17 127.4 32.94 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.948 -178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.57 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.216 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.1 158.8 25.32 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.4 mt -77.52 155.62 81.26 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.03 132.6 48.42 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.936 2.424 . . . . 0.0 112.747 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.54 110.94 3.11 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 122.468 2.112 . . . . 0.0 112.018 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -58.55 147.38 32.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.075 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -122.82 169.1 11.45 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.443 -170.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -35.88 26.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -176.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -127.82 14.82 6.94 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 120.942 0.401 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 4.1 mp0 -130.79 144.44 51.45 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.428 HD11 ' HG2' ' A' ' 53' ' ' ARG . 8.6 mt -133.46 156.48 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.2 mm? -78.35 145.78 35.05 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-O 121.276 0.56 . . . . 0.0 112.262 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -106.73 109.97 22.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.93 -138.32 9.06 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 t -151.04 132.23 14.45 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.543 ' HB3' HD22 ' A' ' 24' ' ' LEU . 68.6 m95 -135.82 122.09 20.41 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -143.73 24.12 1.71 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . 5.1 t70 -100.7 -173.29 2.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.622 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.13 -25.36 2.24 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.234 0.614 . . . . 0.0 110.18 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 22' ' ' ASN . 6.9 p -142.45 131.18 22.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.839 0.352 . . . . 0.0 111.502 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 39' ' ' ASP . 31.3 m-85 -127.23 143.54 47.49 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 21.1 Cg_endo -62.56 147.21 95.14 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.7 2.267 . . . . 0.0 111.748 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.8 tt0 -67.73 129.55 40.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.06 1.46 28.39 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.572 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m -83.76 120.15 25.68 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -93.02 152.23 19.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.379 0.609 . . . . 0.0 111.924 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.99 130.84 53.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.609 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.9 mt -101.47 125.63 55.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.3 m-85 -102.33 143.7 31.75 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' GLU . 54.7 tttm -92.45 141.5 28.45 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 93.6 m -90.59 16.71 8.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 32' ' ' ILE . 79.0 mtt180 65.81 161.57 0.13 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.315 0.646 . . . . 0.0 111.104 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 40.3 Cg_endo -75.33 140.18 24.29 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 121.189 1.26 . . . . 0.0 110.2 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.66 0.07 60.91 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 92.8 m-85 -128.74 175.84 8.28 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.168 0.509 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 57' ' ' ARG . 4.0 ptm180 -154.99 -171.64 3.9 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.5 p -163.27 154.3 16.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 120.895 0.379 . . . . 0.0 110.721 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.6 mt -75.15 -27.21 59.65 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.44 141.22 7.06 Favored Glycine 0 N--CA 1.408 -3.213 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.36 142.54 51.94 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.15 0.58 . . . . 0.0 111.238 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.4 118.22 10.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.0 mm -116.11 124.28 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -113.04 166.79 11.08 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.6 p -149.66 143.05 17.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.492 0.663 . . . . 0.0 110.137 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.26 122.75 19.49 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 125.159 1.384 . . . . 0.0 110.151 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.0 ttt180 -160.85 132.91 5.92 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 72.4 mmtt 66.19 25.7 10.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.12 0.568 . . . . 0.0 112.376 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . 91.95 -10.96 73.35 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.574 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.57 171.92 12.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -93.45 123.35 36.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.33 168.11 9.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.056 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.17 114.89 18.48 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.721 0.296 . . . . 0.0 111.088 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.76 -39.02 92.86 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -143.65 98.87 5.28 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.72 -4.07 14.18 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.839 2.359 . . . . 0.0 113.101 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.65 -31.13 41.45 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -72.76 141.43 48.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.895 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -158.27 160.38 37.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -102.58 130.15 49.36 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -126.46 172.64 10.02 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.017 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 33.8 mmtp -64.86 151.52 45.31 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.033 0.533 . . . . 0.0 111.974 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -86.97 151.91 52.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 67.4 Cg_endo -77.07 160.83 33.13 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 121.535 1.49 . . . . 0.0 110.087 176.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.6 m -114.85 -22.51 9.6 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.344 -174.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.97 -179.2 53.39 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -78.33 128.12 78.99 Favored Pre-proline 0 C--N 1.289 -2.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 48.17 1.2 Allowed 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.076 3.184 . . . . 0.0 114.177 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 90.59 157.47 33.6 Favored Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -110.86 126.99 55.25 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.245 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 9.8 t -135.33 125.13 16.6 Favored Pre-proline 0 N--CA 1.412 -2.356 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 9.6 Cg_exo -74.2 -10.88 22.88 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.286 1.991 . . . . 0.0 112.042 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -127.55 141.39 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.14 47.9 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.119 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -163.79 -169.2 1.82 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.201 0.5 . . . . 0.0 109.872 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 46.5 p90 -142.34 160.29 40.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.476 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.6 p -113.61 173.0 6.63 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.2 mt -140.99 118.13 11.27 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -113.14 -7.65 13.61 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.354 -174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -113.84 28.94 8.11 Favored Glycine 0 CA--C 1.489 -1.562 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.03 -171.07 27.82 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -129.49 10.88 5.73 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.282 1.039 . . . . 0.0 109.616 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 108' ' ' VAL . 35.5 m -140.02 174.73 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 31.0 m-85 -88.94 88.15 7.48 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.76 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.543 ' OE2' ' HG3' ' A' ' 82' ' ' LYS . 9.2 pt-20 -136.24 150.22 48.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.241 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -46.16 116.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.374 1.046 . . . . 0.0 111.027 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.15 -23.43 6.5 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.651 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG12 ' C ' ' A' ' 100' ' ' GLY . 19.9 m -77.71 139.12 19.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.914 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.07 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.9 ttmp? -102.4 120.43 40.5 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -101.31 101.3 11.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -84.24 139.96 16.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.777 -176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -97.31 113.54 25.19 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.5 m -117.89 159.38 23.2 Favored 'General case' 0 N--CA 1.402 -2.836 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.1 t -135.09 -62.04 0.73 Allowed 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.473 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -155.83 -170.06 3.29 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.74 -53.27 8.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.582 0.706 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.68 -12.75 82.5 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.721 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -112.41 121.82 45.95 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.019 0.128 . . . . 0.0 110.903 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -102.8 -114.93 0.21 Allowed 'General case' 0 CA--C 1.466 -2.276 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -163.64 156.35 18.11 Favored 'General case' 1 N--CA 1.337 -6.119 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.573 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 67.3 mt -89.92 103.78 16.41 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.104 0.954 . . . . 0.0 109.387 173.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.09 155.14 8.87 Favored Glycine 0 N--CA 1.41 -3.086 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -93.44 -18.3 22.49 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.937 0.875 . . . . 0.0 109.585 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.4 mm -112.38 106.16 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.815 ' HA ' HD11 ' A' ' 120' ' ' LEU . 29.4 p-10 -83.81 30.58 0.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.136 0.493 . . . . 0.0 111.399 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -164.2 178.2 7.77 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -173.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.98 138.6 45.54 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 22.6 mt-10 -111.48 136.69 50.29 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.89 107.63 14.76 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.64 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -100.39 -170.43 1.87 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 p -66.64 -40.66 88.82 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 124.525 1.13 . . . . 0.0 110.601 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -75.0 -35.79 62.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.025 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.37 -152.46 24.34 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -67.26 126.93 30.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.126 0.463 . . . . 0.0 109.794 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 p -58.94 -35.84 73.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 123.566 0.746 . . . . 0.0 112.913 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.08 167.33 17.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.9 -96.95 0.3 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -173.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.427 HD11 ' HA3' ' A' ' 89' ' ' GLY . 24.4 mt -132.81 92.75 25.54 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 121.656 -0.653 . . . . 0.0 111.316 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.844 ' HB2' HD12 ' A' ' 120' ' ' LEU . 3.3 Cg_endo -53.6 137.22 66.15 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 122.736 2.291 . . . . 0.0 109.32 166.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 31.7 mm -87.69 122.87 39.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.898 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 21.0 t -52.29 124.41 13.16 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.952 0.342 . . . . 0.0 110.772 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.424 -1.744 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.239 0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.6 m -84.87 133.53 34.3 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER -106.67 27.49 8.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.851 0.834 . . . . 0.0 109.605 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.42 162.4 37.58 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.3 mm? -99.66 158.19 32.59 Favored Pre-proline 0 N--CA 1.39 -3.434 0 O-C-N 124.558 1.161 . . . . 0.0 110.277 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 17.9 Cg_endo -60.12 133.35 49.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.952 2.435 . . . . 0.0 110.684 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.89 170.66 19.55 Favored 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 112.093 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.437 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -117.27 139.02 51.33 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -113.37 -176.85 2.99 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -73.54 -27.12 61.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 0.0 110.625 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 21.4 p -116.94 0.5 12.45 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -133.3 140.4 47.43 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.515 0.674 . . . . 0.0 112.329 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -138.62 145.74 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.92 142.66 57.21 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.5 p -90.76 -28.32 18.35 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.568 0.699 . . . . 0.0 109.549 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.71 177.4 37.24 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.4 p -113.9 114.87 26.82 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 123.481 0.712 . . . . 0.0 110.316 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -110.48 110.77 21.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -115.89 3.52 13.74 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.631 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.643 ' O ' HD21 ' A' ' 24' ' ' LEU . 40.1 m-20 -101.91 -157.09 0.59 Allowed 'General case' 0 CA--C 1.479 -1.775 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.58 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 40' ' ' GLN . 18.9 mt-30 -133.84 -58.84 0.86 Allowed 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 170.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.9 p -80.98 121.1 25.61 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.44 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 41.1 m-85 -129.33 145.0 54.97 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.086 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.03 143.56 66.24 Favored 'Trans proline' 0 C--O 1.262 1.695 0 C-N-CA 122.635 2.223 . . . . 0.0 111.086 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 35.6 tt0 -63.16 138.82 58.67 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.36 1.73 50.69 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.203 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.442 ' C ' HG23 ' A' ' 65' ' ' VAL . 92.9 m -85.06 117.42 24.01 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -85.74 149.76 25.06 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.245 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.11 130.08 53.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -100.24 132.8 45.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.57 143.94 44.98 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.596 0.712 . . . . 0.0 112.595 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.24 142.52 27.31 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 171.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.713 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.8 m -86.8 27.8 0.95 Allowed 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 70.2 mtp180 61.62 166.61 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 121.451 0.643 . . . . 0.0 111.005 -174.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.14 118.09 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.194 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 171.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.4 -23.38 7.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.069 -1.063 . . . . 0.0 113.051 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.713 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 95.8 m-85 -102.74 179.56 4.25 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 122.023 -0.693 . . . . 0.0 109.368 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -155.75 -174.75 5.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.1 t -171.95 168.7 5.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 98.4 mt -87.73 14.48 8.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.861 0.839 . . . . 0.0 110.081 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.05 -146.01 5.78 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.33 150.08 48.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.6 t -73.06 101.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.9 118.64 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.9 mtp -106.53 175.5 5.48 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.7 p -161.02 144.72 4.54 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-O 121.166 0.508 . . . . 0.0 110.464 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.72 121.78 18.6 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.111 177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 64.3 ttt180 -150.14 124.34 9.47 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 14.6 mmmm 61.69 22.39 12.92 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 113.017 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.38 -10.41 65.15 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.487 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.22 157.31 25.08 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.167 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 85.4 m95 -88.59 117.25 27.41 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.14 174.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.39 125.89 37.24 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.462 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -71.22 -48.39 51.63 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -110.3 88.23 7.08 Favored Pre-proline 0 N--CA 1.429 -1.515 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.891 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 77' ' ' LEU . 38.3 Cg_endo -69.51 -18.66 38.04 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.333 2.022 . . . . 0.0 111.758 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 ' HG2' ' A' ' 76' ' ' PRO . 3.5 mm? -80.61 -14.3 58.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.76 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' NH1' ' HB2' ' A' ' 59' ' ' LEU . 25.4 mmt180 -95.65 123.44 39.21 Favored 'General case' 0 CA--C 1.481 -1.706 0 CA-C-O 121.693 0.759 . . . . 0.0 110.231 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.11 151.55 37.02 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.64 112.44 22.32 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.089 0.947 . . . . 0.0 110.918 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -108.14 172.68 6.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.766 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.5 159.0 24.29 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.615 0.722 . . . . 0.0 111.671 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -94.24 144.77 28.58 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 174.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 60.5 Cg_endo -73.35 163.64 37.27 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 121.733 1.622 . . . . 0.0 109.351 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.9 m -115.75 1.11 13.39 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.46 -170.79 53.49 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.752 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -88.35 117.42 68.36 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.34 102.89 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 113.257 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 88.85 125.48 2.53 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.952 175.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.12 19.0 5.3 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.749 0.785 . . . . 0.0 109.101 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -60.82 134.47 92.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.171 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.5 -4.66 1.97 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.395 2.063 . . . . 0.0 112.349 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.06 -33.66 5.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.09 0.471 . . . . 0.0 111.131 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.22 138.58 18.05 Favored Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.329 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.82 156.31 30.9 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.8 p90 -128.77 158.72 37.85 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.241 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 76.8 p -108.87 168.33 9.43 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.87 123.82 22.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.34 0.59 . . . . 0.0 110.089 175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.2 t -132.65 141.46 48.64 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.95 14.12 67.84 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.427 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.18 -52.1 0.05 OUTLIER Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.256 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.32 -3.68 2.1 Favored 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 124.236 1.014 . . . . 0.0 112.946 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 m -144.65 175.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.4 m-85 -78.33 94.4 4.83 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.22 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.71 151.11 35.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -42.82 129.33 4.28 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.01 -9.93 74.57 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.679 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.96 138.35 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.285 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 39.1 ttmt -105.22 120.52 41.75 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.676 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -99.8 99.8 10.66 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -79.18 136.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.478 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 52.8 t80 -102.83 129.18 49.42 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -174.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -147.6 149.64 32.91 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.73 -52.78 2.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 -174.6 4.29 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -87.17 -45.04 11.03 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.7 -32.79 61.11 Favored Glycine 0 C--N 1.307 -1.044 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.354 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -86.16 119.22 26.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.379 0.609 . . . . 0.0 110.839 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 24.5 mt-30 -110.21 -159.89 0.7 Allowed 'General case' 0 N--CA 1.4 -2.948 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.63 155.1 44.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 142' ' ' GLU . 4.0 mm? -82.8 137.99 34.14 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.781 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.2 158.87 12.65 Favored Glycine 0 C--N 1.285 -2.286 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -92.4 -17.45 24.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.219 0.509 . . . . 0.0 110.9 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 126' ' ' TYR . 40.0 mm -112.03 109.42 28.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -86.28 22.64 1.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 124' ' ' ILE . 41.4 p90 -151.12 176.22 11.38 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 77.0 mtm180 -142.24 127.92 19.19 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -106.96 138.68 42.68 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.7 t -81.38 97.38 7.7 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.137 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.2 175.47 10.56 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.54 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.6 p -49.47 -41.37 40.18 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 125.666 1.586 . . . . 0.0 112.252 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.46 -27.08 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.017 0.436 . . . . 0.0 111.412 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.96 -170.08 36.73 Favored Glycine 0 C--N 1.303 -1.302 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -65.2 141.57 58.61 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 117.22 0.51 . . . . 0.0 111.71 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.7 p -85.12 133.46 34.21 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 73.81 171.27 0.3 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.543 0.737 . . . . 0.0 110.003 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 127' ' ' ARG . 6.3 p-10 -111.87 -102.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.985 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 89' ' ' GLY . 52.8 mt -126.95 102.65 24.49 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 138' ' ' ILE . 19.0 Cg_endo -59.72 138.17 81.48 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.042 1.828 . . . . 0.0 110.166 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.48 113.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.478 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 93.9 m -72.85 112.36 8.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.759 0.314 . . . . 0.0 111.402 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.56 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 32.9 mt-10 . . . . . 0 C--N 1.317 -0.83 0 C-N-CA 125.157 1.383 . . . . 0.0 108.523 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.966 0.412 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 41' ' ' THR . 70.1 m -79.9 132.04 35.99 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.505 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.22 13.62 26.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.324 0.583 . . . . 0.0 110.414 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -138.18 160.83 38.41 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.658 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 38.0 mt -84.33 157.42 62.05 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 123.968 0.792 . . . . 0.0 109.262 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 28.7 Cg_endo -64.01 133.2 37.43 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 121.668 1.579 . . . . 0.0 109.946 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.79 162.55 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.026 1.817 . . . . 0.0 111.712 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -98.21 146.73 25.32 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -114.1 173.55 6.39 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -65.09 -34.39 78.3 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -117.63 1.24 12.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -131.78 147.05 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.25 0.547 . . . . 0.0 111.669 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.525 HD11 ' HG2' ' A' ' 53' ' ' ARG . 12.6 mt -143.92 156.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.864 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 3.9 mm? -72.08 168.96 17.03 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-O 121.916 0.865 . . . . 0.0 112.594 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -123.85 145.48 49.06 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 171.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.09 -144.98 15.98 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.709 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -139.14 137.76 36.4 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 81.5 m95 -138.84 121.81 16.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.6 m -151.92 24.08 0.66 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.755 0.312 . . . . 0.0 111.331 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 15.8 m-20 -118.31 -169.63 1.74 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.1 -177.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -119.27 -66.1 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.0 p -86.67 127.81 34.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -130.34 140.6 39.14 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.754 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.42 145.19 87.54 Favored 'Trans proline' 0 C--O 1.264 1.779 0 C-N-CA 122.616 2.211 . . . . 0.0 110.801 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.546 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 20.4 tt0 -65.44 140.99 58.66 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.88 5.75 57.36 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.206 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' HG23 ' A' ' 65' ' ' VAL . 75.8 m -85.95 117.91 25.09 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.313 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -88.11 146.08 25.61 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-O 121.782 0.801 . . . . 0.0 111.31 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.55 119.67 36.93 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 63' ' ' ILE . 62.4 mt -92.06 120.15 40.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 61.4 m-85 -102.75 141.47 35.51 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -88.35 153.58 21.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.1 m -91.6 25.93 2.5 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 32' ' ' ILE . 70.0 mtp180 62.88 167.91 0.1 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 54.2 Cg_endo -77.59 100.0 1.35 Allowed 'Trans proline' 0 N--CA 1.428 -2.365 0 CA-C-N 119.162 0.736 . . . . 0.0 110.912 174.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 135.5 -17.9 3.95 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.123 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 64.9 m-85 -110.12 173.15 6.46 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 109.881 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -152.1 -174.66 4.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -168.77 -178.16 3.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.05 14.05 9.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.727 0.775 . . . . 0.0 110.482 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.32 174.7 38.6 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.72 145.93 34.21 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 118.425 1.113 . . . . 0.0 109.362 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 90.8 t -74.19 111.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.421 HD12 HG12 ' A' ' 49' ' ' ILE . 44.6 mm -106.18 122.84 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.011 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.6 mtp -112.07 172.77 6.71 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.418 HG23 ' C ' ' A' ' 46' ' ' THR . 8.2 p -157.41 145.31 10.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-O 121.335 0.588 . . . . 0.0 110.648 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 44.4 t -69.65 125.81 27.84 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.824 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.546 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 34.6 ttp180 -151.76 123.26 7.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm 62.37 25.96 15.5 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 124.267 1.027 . . . . 0.0 113.46 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.97 -15.74 61.19 Favored Glycine 0 N--CA 1.413 -2.883 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.515 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.69 163.7 15.73 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.706 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.415 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 82.1 m95 -97.19 123.87 41.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.329 0.585 . . . . 0.0 109.856 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 171.53 14.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.421 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.79 124.96 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -49.77 56.71 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -108.26 90.47 6.95 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.169 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.49 -11.95 26.79 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.791 2.327 . . . . 0.0 114.089 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -90.8 -19.87 22.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.087 0.47 . . . . 0.0 110.352 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 7.6 mmp_? -92.69 134.11 35.35 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.8 0.81 . . . . 0.0 112.468 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 166.3 32.92 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 172.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 80.9 m -91.96 129.4 37.93 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-O 121.59 0.709 . . . . 0.0 111.173 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -126.34 167.98 14.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.519 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 95.5 mttt -65.62 136.43 56.32 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.573 0.225 . . . . 0.0 111.351 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.7 ptp180 -78.35 147.01 71.59 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.45 159.46 32.51 Favored 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 121.868 1.712 . . . . 0.0 109.631 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.8 m -118.24 8.49 12.31 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 121.463 0.649 . . . . 0.0 111.488 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.33 -85.93 1.23 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.497 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -168.06 147.88 4.28 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.75 53.13 2.7 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.346 2.031 . . . . 0.0 111.615 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 80.97 -96.31 1.69 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.5 t70 169.56 126.63 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 125.493 1.517 . . . . 0.0 107.674 171.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -120.88 117.53 30.95 Favored Pre-proline 0 N--CA 1.41 -2.446 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.67 1.92 7.88 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 122.149 1.899 . . . . 0.0 111.112 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -115.19 -55.39 2.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.851 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 114' ' ' CYS . . . -73.54 150.58 43.55 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.3 m -92.63 -55.92 3.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . 0.274 1.9 p90 70.16 145.93 0.06 Allowed 'General case' 0 C--O 1.248 0.985 0 C-N-CA 126.558 1.943 . . . . 0.0 114.493 173.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.611 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -117.03 148.15 41.73 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.994 179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.584 HD22 ' CG1' ' A' ' 108' ' ' VAL . 83.0 mt -109.12 135.96 49.4 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.7 t -138.23 139.01 39.05 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.55 -26.36 16.53 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.18 164.69 34.17 Favored Glycine 0 CA--C 1.489 -1.568 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.458 ' O ' HG13 ' A' ' 103' ' ' VAL . 48.7 t-20 -123.12 60.18 1.06 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 118.173 0.986 . . . . 0.0 110.006 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.0 m -168.65 -178.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.634 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 172.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.08 84.31 5.26 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.911 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.26 157.42 39.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.804 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 62.7 t80 -58.55 122.32 13.1 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.758 0.79 . . . . 0.0 111.767 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.5 -19.38 12.87 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.584 ' CG1' HD22 ' A' ' 98' ' ' LEU . 24.1 t -71.72 129.94 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.723 0.773 . . . . 0.0 112.066 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.1 ttmt -102.91 119.71 39.32 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.61 93.24 7.03 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.611 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.5 p -79.14 109.29 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-O 122.35 1.071 . . . . 0.0 109.116 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 67.8 t80 -80.89 103.56 10.81 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 113.837 -1.528 . . . . 0.0 110.878 -169.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 m -74.47 -38.29 62.96 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.644 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 45.8 t 72.73 -92.83 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.348 0 O-C-N 125.312 1.632 . . . . 0.0 108.906 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -137.2 -174.48 3.76 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.96 -42.67 14.71 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.57 0.7 . . . . 0.0 109.198 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.68 -22.9 54.94 Favored Glycine 0 C--N 1.308 -1.001 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.909 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.03 128.73 55.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.481 -0.423 . . . . 0.0 111.001 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -111.34 -148.15 0.43 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -117.22 166.72 11.93 Favored 'General case' 1 N--CA 1.376 -4.131 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.604 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 142' ' ' GLU . 32.6 mt -97.32 106.12 18.39 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.559 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.6 166.2 14.43 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -84.68 -27.56 26.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.132 0.968 . . . . 0.0 108.515 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -98.0 109.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.31 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -97.43 23.88 7.16 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.141 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 128' ' ' GLU . 37.2 p90 -159.01 178.31 10.2 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.399 0.619 . . . . 0.0 110.519 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -149.68 129.03 12.91 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.962 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 126' ' ' TYR . 36.3 mt-10 -101.51 157.48 16.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.13 122.8 34.96 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.841 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.9 t70 -101.98 -169.12 1.63 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.439 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 48.5 p -71.72 -37.35 70.64 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 124.585 1.154 . . . . 0.0 108.492 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.05 -52.11 15.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.044 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.02 -150.25 16.07 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -73.23 137.73 45.15 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.024 0.912 . . . . 0.0 110.336 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.2 p -81.05 167.64 19.53 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.0 m120 64.48 -111.39 0.27 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.325 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -167.8 -178.61 3.9 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.469 HD11 ' HA3' ' A' ' 89' ' ' GLY . 82.9 mt -94.93 103.83 12.87 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 6.4 Cg_endo -48.24 127.79 16.02 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.269 2.646 . . . . 0.0 112.584 -176.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.8 mm -75.06 115.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.732 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 52.3 m -61.61 121.4 12.67 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 N--CA 1.425 -1.697 0 C-N-CA 126.445 1.898 . . . . 0.0 107.791 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 35.4 m-20 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 120.751 0.31 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.8 m -65.67 139.93 58.44 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.495 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -117.89 18.74 13.94 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.357 0.599 . . . . 0.0 109.729 176.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.07 159.22 37.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.729 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 mt -79.5 153.3 76.19 Favored Pre-proline 0 C--N 1.31 -1.137 0 O-C-N 123.873 0.733 . . . . 0.0 109.15 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 128.67 30.72 Favored 'Trans proline' 0 C--O 1.253 1.251 0 C-N-CA 122.457 2.104 . . . . 0.0 111.166 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.68 123.38 12.9 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.488 2.126 . . . . 0.0 111.409 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -68.1 149.55 49.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.501 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 2.1 mmp_? -112.51 178.56 4.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.229 -171.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -82.25 -58.94 2.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.48 -8.53 35.06 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.955 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 4.5 mp0 -109.02 142.53 39.58 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.985 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mt -133.09 150.4 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.848 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.75 140.42 53.44 Favored 'General case' 0 C--N 1.277 -2.58 0 O-C-N 124.245 0.966 . . . . 0.0 111.084 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.0 p -87.21 -34.33 19.03 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.207 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.4 167.43 26.1 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.434 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 p -105.26 118.23 36.02 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -99.71 161.97 13.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -130.79 -23.79 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -137.01 162.48 33.2 Favored 'General case' 0 C--O 1.183 -2.446 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.423 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.3 -29.48 26.34 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.498 0.666 . . . . 0.0 109.641 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.6 p -97.16 108.4 21.12 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-O 121.88 0.848 . . . . 0.0 112.431 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -118.1 157.83 47.75 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.511 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 47.6 Cg_endo -70.67 152.8 64.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 121.628 1.552 . . . . 0.0 110.875 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.42 151.8 45.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.24 74.02 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.617 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -83.05 121.14 26.65 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.956 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 pt20 -91.01 146.45 23.85 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.675 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.88 117.03 29.06 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.44 130.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 65.1 m-85 -104.19 139.43 39.25 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -75.13 -29.51 60.55 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.319 -1.764 . . . . 0.0 113.656 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 68.7 m 71.29 3.05 4.51 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 72.86 152.35 0.14 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.96 108.87 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.554 2.17 . . . . 0.0 112.738 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.34 -17.41 7.01 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.476 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 96.4 m-85 -98.81 168.14 10.32 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 122.103 -0.645 . . . . 0.0 110.465 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -133.21 -175.93 3.96 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -157.08 -175.93 5.69 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -104.76 16.22 26.41 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.123 0.487 . . . . 0.0 110.073 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.45 29.82 0.07 OUTLIER Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.49 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.56 144.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.977 1.311 . . . . 0.0 112.049 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.6 t -76.98 116.4 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.25 124.55 69.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.804 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.44 168.77 9.15 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 3.9 p -155.45 149.99 11.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.8 t -84.08 128.73 34.75 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.84 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.423 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -144.95 124.84 13.44 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -178.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 35.3 mmtp 59.23 29.56 19.14 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 94.35 -17.48 58.88 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.934 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 167.17 10.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.715 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.79 122.46 46.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 -168.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.693 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.48 23.04 Favored 'General case' 1 C--N 1.225 -4.825 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.967 -171.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.85 -53.99 13.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.83 80.6 49.5 Favored Pre-proline 0 N--CA 1.419 -1.997 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.263 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.61 -13.06 22.44 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.743 2.295 . . . . 0.0 110.969 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.3 mm? -68.69 -30.1 68.69 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.714 177.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -81.25 143.56 32.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.566 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -141.8 158.65 43.54 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.3 m -94.57 106.95 18.94 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.45 160.75 14.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -75.95 146.56 39.54 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.11 140.23 61.54 Favored Pre-proline 0 C--N 1.298 -1.642 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.421 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.51 145.47 47.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.095 1.863 . . . . 0.0 109.624 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.9 m -104.55 -14.99 15.46 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.997 0.427 . . . . 0.0 111.686 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.61 -167.67 54.77 Favored Glycine 0 N--CA 1.412 -2.927 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.433 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -68.74 119.73 71.1 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 124.323 1.049 . . . . 0.0 109.583 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HB3' ' CE2' ' A' ' 134' ' ' TRP . 72.8 Cg_endo -80.34 -6.67 13.83 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.15 2.567 . . . . 0.0 112.295 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 112.73 134.65 6.2 Favored Glycine 0 N--CA 1.406 -3.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.93 174.39 7.26 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 123.595 0.758 . . . . 0.0 110.861 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 t -162.53 127.37 2.07 Favored Pre-proline 0 N--CA 1.412 -2.362 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -88.85 -4.18 6.24 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.089 1.859 . . . . 0.0 111.555 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.71 -47.42 3.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.469 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.51 -172.31 25.83 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.262 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.4 m -145.98 167.37 23.48 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -143.72 157.52 44.33 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.255 0.479 . . . . 0.0 110.11 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.583 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -119.95 154.0 35.1 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.794 0.684 . . . . 0.0 110.5 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 94.6 mt -115.2 133.33 56.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.965 0.412 . . . . 0.0 110.934 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 109' ' ' LYS . 6.1 t -127.39 148.17 50.27 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.72 -66.62 3.57 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.068 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.51 -43.24 6.59 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.427 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t30 75.37 -4.41 2.38 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 122.105 0.955 . . . . 0.0 111.684 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.16 -178.98 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -88.18 79.46 7.86 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.376 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.77 151.09 52.07 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.842 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -45.11 122.33 3.3 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.447 0.699 . . . . 0.0 111.756 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.36 -16.52 32.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.615 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.57 147.06 7.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 O-C-N 122.391 -0.476 . . . . 0.0 110.358 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.449 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.4 ttmp? -114.45 127.57 55.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.37 88.01 3.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' OG1' ' A' ' 97' ' ' THR . 2.6 p -80.97 124.02 38.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.705 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -102.02 141.3 35.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.363 -168.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.27 161.94 34.87 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.29 -74.24 0.35 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.922 -1.511 . . . . 0.0 110.695 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -141.25 -177.79 5.29 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.56 152.54 21.05 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.38 -43.91 1.93 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -143.29 132.1 22.7 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -104.22 -61.43 1.45 Allowed 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.851 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 125' ' ' ASN . 4.2 pp 179.52 157.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.387 1.054 . . . . 0.0 109.17 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 142' ' ' GLU . 81.3 mt -97.71 132.03 43.72 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.71 148.12 5.67 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -84.51 -19.94 32.44 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.286 1.041 . . . . 0.0 109.581 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 126' ' ' TYR . 38.6 mm -103.06 92.46 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.046 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 120' ' ' LEU . 23.0 p-10 -83.17 29.69 0.48 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 124.763 1.225 . . . . 0.0 110.312 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 124' ' ' ILE . 52.4 p90 -161.7 179.05 8.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -142.03 121.5 13.24 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.451 ' HG3' ' CD2' ' A' ' 126' ' ' TYR . 48.3 mt-10 -103.07 141.43 35.83 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.2 t -91.44 112.16 23.96 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.196 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 131' ' ' THR . 21.3 t70 -99.76 -164.61 1.14 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.261 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.461 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 46.9 p -66.01 -42.53 89.56 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.447 1.099 . . . . 0.0 110.327 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.61 -41.48 79.46 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.162 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.55 -141.45 9.53 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.516 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 88.5 m95 -72.44 130.96 41.92 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 117.007 0.403 . . . . 0.0 111.557 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.2 p -83.82 129.09 34.94 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 74.73 166.92 0.29 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.74 0.781 . . . . 0.0 111.611 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -98.66 -173.29 2.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.474 HD11 ' HA3' ' A' ' 89' ' ' GLY . 17.9 mt -71.66 116.57 49.15 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.08 129.07 24.59 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 121.505 1.47 . . . . 0.0 110.927 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.3 123.17 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.642 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 65.9 m -66.19 109.22 2.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.46 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . 8.4 tp10 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.071 0.939 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.2 m -77.93 124.61 28.21 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.717 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER -95.65 21.37 8.44 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.133 0.968 . . . . 0.0 109.589 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.73 155.82 43.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.163 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.8 mt -77.5 150.35 79.42 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 124.151 0.907 . . . . 0.0 111.558 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.93 139.94 44.48 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.187 1.925 . . . . 0.0 109.655 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.22 155.81 66.63 Favored 'Trans proline' 0 C--N 1.328 -0.538 0 C-N-CA 122.56 2.173 . . . . 0.0 113.743 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -97.09 134.47 40.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -109.11 151.05 26.94 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.617 -173.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -64.6 -31.48 72.71 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.851 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.0 -15.68 16.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -133.87 137.04 44.74 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 112.347 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 56.4 mt -115.73 158.98 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HB3' ' NE1' ' A' ' 37' ' ' TRP . 33.3 mt -94.07 142.21 27.65 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 119.012 0.824 . . . . 0.0 111.543 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.4 p -98.12 151.94 19.86 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.53 -155.01 20.82 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -133.54 114.86 14.04 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' NE1' ' HB3' ' A' ' 33' ' ' LEU . 44.6 m95 -122.69 99.23 6.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.7 m -135.0 -0.99 2.71 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.984 0.421 . . . . 0.0 110.348 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.33 150.1 22.04 Favored 'General case' 0 C--O 1.204 -1.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.522 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -82.61 -51.27 7.91 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.978 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 38.7 p -95.8 106.33 18.44 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -108.16 129.72 23.72 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.847 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.52 150.44 68.81 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.9 131.78 49.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.57 7.33 48.68 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.295 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -86.38 114.84 23.49 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.985 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.0 pt20 -90.01 136.33 33.11 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-O 121.766 0.793 . . . . 0.0 111.669 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.38 121.33 43.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.074 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 63' ' ' ILE . 68.5 mt -97.12 113.46 31.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.101 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -83.59 136.46 34.23 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.377 1.084 . . . . 0.0 113.177 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 60.9 tttp -66.18 -28.6 68.9 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.095 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 15.9 t 72.43 -4.39 2.06 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.947 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 71.91 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 124.487 1.115 . . . . 0.0 111.472 -175.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 55.8 Cg_endo -70.15 120.82 7.47 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 121.462 1.442 . . . . 0.0 110.381 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 118.19 -20.12 10.65 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 93.5 m-85 -101.52 170.44 8.2 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -156.64 169.1 25.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.6 p -143.87 -177.05 5.24 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.23 21.73 1.35 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.67 0.748 . . . . 0.0 110.737 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.9 -96.1 0.12 Allowed Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -154.57 150.62 27.93 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.44 105.93 4.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG12 ' A' ' 49' ' ' ILE . 45.3 mm -105.84 120.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.617 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 84.5 mtp -106.73 164.99 11.64 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 6.8 p -150.35 145.83 16.86 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.742 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.114 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 48.1 t -73.68 121.37 20.64 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.288 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 34.2 ttt180 -147.92 123.22 10.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 74.2 mmtt 65.12 23.65 12.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.82 0.848 . . . . 0.0 112.278 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.78 -2.43 72.84 Favored Glycine 0 N--CA 1.424 -2.128 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.889 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 153.24 47.43 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.77 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.2 121.66 28.27 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.771 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.04 173.29 14.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.655 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.23 123.64 29.2 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.642 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.77 -39.95 94.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -139.54 100.56 7.53 Favored Pre-proline 0 N--CA 1.422 -1.829 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.703 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.0 -3.38 13.7 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.846 2.364 . . . . 0.0 111.912 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 39.6 mt -91.09 -6.5 53.64 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 122.213 1.006 . . . . 0.0 109.801 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 78' ' ' ARG . 20.1 mmt180 -99.39 122.59 42.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.961 172.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.35 147.62 40.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.988 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.1 m -87.39 128.22 35.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.659 0.742 . . . . 0.0 111.848 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -128.6 169.21 14.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 106' ' ' TYR . 48.0 mtmt -82.46 144.73 30.26 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' NH1' ' HA ' ' A' ' 132' ' ' ASP . 12.8 ptm180 -67.32 156.77 87.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.643 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 73.3 Cg_endo -77.92 160.76 30.43 Favored 'Trans proline' 0 C--O 1.256 1.397 0 C-N-CA 121.968 1.779 . . . . 0.0 109.769 172.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.9 m -127.31 1.27 6.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.511 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.91 1.04 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.753 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -155.23 135.87 8.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.97 13.63 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.973 2.449 . . . . 0.0 113.059 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 81.27 -166.3 47.87 Favored Glycine 0 N--CA 1.41 -3.042 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.56 171.52 19.81 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -132.45 121.35 17.36 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.45 -43.72 43.11 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.416 2.744 . . . . 0.0 114.575 -171.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.24 26.49 5.91 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.63 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -142.13 174.94 23.01 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.265 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.21 168.09 19.8 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.423 ' HB3' ' CD2' ' A' ' 112' ' ' TYR . 53.2 p90 -143.09 156.16 44.75 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.277 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 p -125.24 169.13 12.57 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 124.213 1.005 . . . . 0.0 108.864 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.64 164.36 19.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.387 0.613 . . . . 0.0 111.469 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 10.0 t -162.03 147.97 13.34 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 175.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 20.77 41.46 Favored Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.566 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.91 -58.8 0.32 Allowed Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 82.68 35.2 0.06 Allowed 'General case' 0 CA--C 1.457 -2.602 0 CA-C-O 123.807 1.765 . . . . 0.0 109.357 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 108' ' ' VAL . 8.2 p -156.29 -162.3 0.02 OUTLIER 'Isoleucine or valine' 1 N--CA 1.373 -4.294 0 CA-C-N 110.868 -2.878 . . . . 0.0 103.587 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 75.4 m-85 -113.16 83.85 1.9 Allowed 'General case' 1 C--N 1.225 -4.848 0 CA-C-O 121.577 0.704 . . . . 0.0 111.554 -176.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 25.4 pt-20 -143.36 163.5 32.88 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.368 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.454 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 58.8 t80 -49.78 131.94 22.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.311 1.007 . . . . 0.0 111.498 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.39 -13.31 63.04 Favored Glycine 0 N--CA 1.421 -2.344 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.45 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 103' ' ' VAL . 10.3 m -77.25 145.21 10.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.572 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 37.7 ttmt -108.93 118.83 37.82 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.043 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.38 98.17 11.61 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -91.04 122.64 42.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 82.1 m-85 -96.04 141.59 29.26 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.303 1.049 . . . . 0.0 111.768 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -145.91 138.76 25.78 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 103.106 -2.924 . . . . 0.0 103.106 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 120' ' ' LEU . 58.6 m -95.38 -87.69 0.27 Allowed 'General case' 0 C--N 1.252 -3.668 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.622 -168.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -148.72 -173.05 4.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -49.82 -54.03 21.8 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.953 1.301 . . . . 0.0 112.816 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.69 13.22 27.45 Favored Glycine 0 C--N 1.296 -1.656 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.389 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' CYS . 35.4 m-85 -114.87 128.48 56.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.97 -159.7 0.69 Allowed 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 163.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.612 ' HB3' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -139.29 151.89 46.81 Favored 'General case' 1 N--CA 1.334 -6.23 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.766 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 107.71 9.13 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.365 0.602 . . . . 0.0 111.064 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.52 140.55 4.21 Favored Glycine 0 N--CA 1.419 -2.458 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.185 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.72 -5.95 52.3 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.405 0.621 . . . . 0.0 111.312 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.418 HG21 ' ND2' ' A' ' 136' ' ' ASN . 44.2 mm -108.82 90.96 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB3' HD21 ' A' ' 120' ' ' LEU . 26.8 p-10 -86.54 42.87 1.03 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.44 -176.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -167.5 174.06 8.18 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.719 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 135' ' ' THR . 6.2 ptm180 -156.35 134.44 11.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -102.88 158.54 16.21 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.593 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 43.9 t -94.28 126.55 39.6 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.848 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 131' ' ' THR . 20.7 t70 -100.07 -156.05 0.53 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.51 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 51.2 p -66.4 -25.54 66.82 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 125.217 1.407 . . . . 0.0 113.761 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.531 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 12.8 t70 -129.58 -44.48 1.22 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.216 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.67 -172.4 15.18 Favored Glycine 0 CA--C 1.486 -1.744 0 C-N-CA 119.355 -1.402 . . . . 0.0 112.48 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -85.87 142.26 29.01 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.927 0.394 . . . . 0.0 110.236 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 75.2 p -79.21 170.77 16.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.418 ' ND2' HG21 ' A' ' 124' ' ' ILE . 12.8 m120 61.7 -155.06 0.35 Allowed 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -141.84 178.1 7.73 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.482 HD11 ' HA3' ' A' ' 89' ' ' GLY . 89.0 mt -82.48 114.24 50.18 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.582 ' HB2' HD12 ' A' ' 120' ' ' LEU . 18.9 Cg_endo -66.86 126.54 15.45 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.065 2.51 . . . . 0.0 111.243 175.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.44 128.81 39.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 68.8 m -81.27 111.24 17.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.04 0.448 . . . . 0.0 110.485 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.735 1.214 . . . . 0.0 109.998 -175.724 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 15.6 m-20 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 121.743 0.783 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -72.99 138.08 45.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.42 -177.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.08 30.61 7.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -164.81 158.24 17.25 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.541 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 37' ' ' TRP . 18.5 mt -80.38 154.03 74.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 123.499 0.72 . . . . 0.0 109.469 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 9.8 Cg_endo -54.48 130.27 39.18 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.707 2.272 . . . . 0.0 111.196 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.11 126.48 13.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.206 1.937 . . . . 0.0 111.165 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -60.37 134.67 57.29 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 121.552 0.691 . . . . 0.0 109.695 -177.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 3.3 mmp_? -87.06 174.59 8.57 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.546 -171.174 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -73.66 -43.71 58.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.59 0.556 . . . . 0.0 110.569 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 80' ' ' CYS . 4.3 p -122.74 19.02 10.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.611 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 1.8 mp0 -137.67 150.12 47.1 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.038 0.446 . . . . 0.0 111.611 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.8 mt -133.55 154.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.0 mm? -76.36 147.55 38.01 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 44.0 p -114.54 113.9 25.04 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.41 -155.13 26.18 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.2 m -137.95 98.35 3.63 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.566 ' HB3' HD22 ' A' ' 24' ' ' LEU . 85.1 m95 -95.23 97.5 9.93 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.263 -177.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 p -106.53 1.27 25.27 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.061 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 1.6 m-20 -119.48 -169.49 1.77 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.777 -171.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -129.95 -43.46 1.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 71.4 p -98.29 131.94 44.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.189 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 48.8 m-85 -138.64 154.93 73.62 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.478 0.711 . . . . 0.0 109.568 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 23.4 Cg_endo -65.73 150.6 86.03 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.354 2.036 . . . . 0.0 112.502 178.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.27 147.64 49.47 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 176.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.97 -10.95 70.01 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.604 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 91.9 m -67.77 116.3 8.29 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 122.302 0.241 . . . . 0.0 110.474 -179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 3.7 pt20 -93.66 125.09 38.08 Favored 'General case' 0 N--CA 1.395 -3.189 0 CA-C-O 122.315 1.055 . . . . 0.0 110.003 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.78 122.06 35.86 Favored 'General case' 0 C--N 1.271 -2.805 0 C-N-CA 125.539 1.535 . . . . 0.0 107.592 178.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.1 mt -93.25 118.23 38.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.648 -179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 64.7 m-85 -96.51 144.68 26.37 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.76 0.79 . . . . 0.0 112.988 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 34' ' ' THR . 57.6 tttp -89.31 132.65 34.83 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 169.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 13.4 t -82.2 37.52 0.5 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 59.74 154.51 0.1 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.712 1.205 . . . . 0.0 113.671 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.27 92.69 0.47 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 121.304 1.336 . . . . 0.0 110.491 173.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 137.65 -21.34 3.23 Favored Glycine 0 N--CA 1.429 -1.814 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.564 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.687 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 81.5 m-85 -103.39 168.63 9.04 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.11 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -150.89 176.28 11.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 176.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 t -160.08 -165.62 1.52 Allowed 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.89 -12.94 60.05 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.959 0.885 . . . . 0.0 109.075 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.77 44.85 Favored Glycine 0 N--CA 1.417 -2.589 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 177.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.32 138.21 57.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 117.455 0.627 . . . . 0.0 109.717 177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.57 123.91 25.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 47' ' ' GLN . 46.3 mm -117.52 125.58 74.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.014 -176.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 28' ' ' ARG . 86.9 mtp -124.36 134.44 53.14 Favored 'General case' 0 CA--C 1.424 -3.871 0 CA-C-O 121.515 0.674 . . . . 0.0 110.038 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.699 ' CG1' ' HB2' ' A' ' 74' ' ' LEU . 1.3 m -129.85 149.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.84 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.873 -168.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.01 128.66 34.68 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.29 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -153.71 121.88 6.13 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.25 32.2 12.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.807 0.843 . . . . 0.0 110.935 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.03 -18.28 36.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.463 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.69 165.68 11.09 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.402 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 87.1 m95 -106.02 116.07 31.3 Favored 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -127.41 -166.71 0.48 Allowed 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.652 -173.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.78 127.71 45.91 Favored 'General case' 1 C--N 1.218 -5.149 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.319 -172.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HB2' ' CG1' ' A' ' 65' ' ' VAL . 2.2 tm? -80.61 -54.82 5.31 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -106.87 94.37 10.43 Favored Pre-proline 0 N--CA 1.407 -2.578 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.687 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.74 -9.91 24.39 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.373 2.049 . . . . 0.0 112.705 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -90.0 26.81 1.74 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 110.347 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.86 139.88 53.55 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.241 179.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -166.86 145.26 5.14 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 50.0 m -78.02 126.49 30.9 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 122.116 0.96 . . . . 0.0 113.534 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -119.67 153.42 35.6 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.038 -179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -72.02 136.2 46.63 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.386 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.3 ptp180 -78.13 145.25 68.78 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.3 166.08 29.56 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.197 1.932 . . . . 0.0 112.185 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.6 m -120.05 8.09 10.95 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.066 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.96 -96.76 0.88 Allowed Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.785 177.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -150.1 138.61 12.46 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.85 53.68 4.51 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.122 2.548 . . . . 0.0 112.133 -177.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.651 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 75.55 -143.58 30.53 Favored Glycine 0 N--CA 1.42 -2.42 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.16 153.25 31.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -150.1 135.25 9.81 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.78 -60.12 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.919 1.746 . . . . 0.0 109.967 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -123.49 154.44 39.13 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 130.89 150.43 6.78 Favored Glycine 0 C--N 1.282 -2.466 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 114' ' ' CYS . 4.4 m -145.29 158.7 43.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -175.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -144.3 161.09 39.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -123.02 146.21 47.84 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 91.8 mt -104.41 153.88 20.54 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.603 0.24 . . . . 0.0 110.529 -176.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 109' ' ' LYS . 15.2 t -149.05 138.93 21.99 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.14 -12.89 58.85 Favored Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -177.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.28 170.48 42.61 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -111.35 10.85 21.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 117.698 0.749 . . . . 0.0 109.65 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 104' ' ' PHE . 5.8 p -141.04 -166.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -177.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.503 ' H ' HG22 ' A' ' 103' ' ' VAL . 29.4 m-85 -99.19 86.03 3.34 Favored 'General case' 1 C--N 1.241 -4.119 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.046 -176.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.2 pt-20 -136.59 151.99 49.96 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.795 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.9 t80 -48.01 124.42 7.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.229 0.538 . . . . 0.0 112.167 176.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.89 56.3 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.832 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 105' ' ' GLU . 4.5 p -83.65 144.76 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-N 117.492 0.646 . . . . 0.0 109.64 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -111.03 125.98 54.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.44 95.31 7.57 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.15 114.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -85.09 132.83 34.26 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.3 m -142.66 -28.28 0.59 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -172.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.533 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 96.2 m 69.79 -99.09 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 177.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -148.76 -158.69 0.94 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -168.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.86 -58.05 3.53 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.915 0.486 . . . . 0.0 110.894 -177.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.07 4.37 74.48 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.889 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -117.91 133.55 55.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -127.48 -100.01 0.36 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 3.2 pp -179.78 145.29 0.22 Allowed 'General case' 0 C--O 1.242 0.672 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.056 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 142' ' ' GLU . 2.5 mm? -95.04 142.77 27.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.511 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.67 -173.86 18.15 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.06 -12.0 12.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.635 0.718 . . . . 0.0 111.078 178.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.59 114.96 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -91.61 17.74 8.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.493 -175.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.57 179.06 9.22 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.298 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -158.35 130.5 6.89 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.606 171.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.27 157.16 17.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 -176.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 106' ' ' TYR . 48.1 m -87.64 117.39 26.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.744 172.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 131' ' ' THR . 22.3 t70 -103.92 -158.69 0.68 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 175.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.49 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 63.3 p -67.54 -44.69 77.7 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 124.142 0.977 . . . . 0.0 112.965 -173.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.4 -43.42 17.36 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.747 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.93 -129.82 1.91 Allowed Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.839 -176.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -78.95 125.45 29.39 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.179 0.514 . . . . 0.0 112.137 -172.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.4 p -65.53 -25.97 67.68 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.404 1.082 . . . . 0.0 112.699 -177.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -138.47 169.09 18.41 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -91.57 -174.31 3.84 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.651 HD11 ' HA3' ' A' ' 89' ' ' GLY . 55.7 mt -86.62 112.6 47.84 Favored Pre-proline 0 C--N 1.3 -1.566 0 C-N-CA 123.55 0.74 . . . . 0.0 109.251 -176.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.34 147.0 96.68 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.752 1.635 . . . . 0.0 109.811 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.494 HG22 ' HG2' ' A' ' 142' ' ' GLU . 41.6 mm -81.78 108.63 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.127 -173.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 19.9 t -63.3 119.12 9.04 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 140' ' ' ILE . 22.7 mm-40 . . . . . 0 C--N 1.307 -1.241 0 C-N-CA 123.509 0.724 . . . . 0.0 109.217 -174.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 52.6 m-20 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' THR . 80.4 m -68.96 141.8 54.86 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.883 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.41 19.51 17.54 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.25 156.92 37.92 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' CD2' ' HA ' ' A' ' 40' ' ' GLN . 3.6 mm? -85.69 153.97 58.49 Favored Pre-proline 1 N--CA 1.373 -4.276 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.964 -179.04 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 Cg_endo -53.55 122.23 10.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 123.328 2.685 . . . . 0.0 112.32 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 23.8 Cg_exo -64.58 131.94 31.38 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.282 1.988 . . . . 0.0 110.448 179.228 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -62.54 145.13 55.12 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.264 0.554 . . . . 0.0 110.43 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 18.8 mmm180 -98.1 166.17 11.55 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -175.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -81.72 -51.39 8.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.758 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.21 -1.8 57.63 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.141 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 18.1 mp0 -132.65 158.54 42.01 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.979 0.419 . . . . 0.0 111.993 -178.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mt -142.36 150.2 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.37 154.53 31.64 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.336 0.588 . . . . 0.0 110.705 177.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.5 p -91.11 -23.57 20.26 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.566 0.698 . . . . 0.0 111.138 177.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.87 -178.27 15.35 Favored Glycine 0 C--N 1.289 -2.029 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.2 t -103.13 149.84 24.23 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.568 ' HB3' HD12 ' A' ' 24' ' ' LEU . 8.2 m95 -138.07 138.82 39.15 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -178.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -142.21 16.48 2.07 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.217 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 24' ' ' LEU . 15.1 m-20 -128.93 124.91 36.35 Favored 'General case' 0 CA--C 1.465 -2.311 0 C-N-CA 118.464 -1.294 . . . . 0.0 112.276 -175.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.587 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 21.7 mp0 -54.11 -49.84 68.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 124.764 1.29 . . . . 0.0 112.868 -175.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 75.4 p -96.25 128.74 43.44 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.198 -1.001 . . . . 0.0 113.682 -172.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -134.92 148.75 68.27 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.541 176.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -69.0 149.13 71.38 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.444 2.096 . . . . 0.0 112.705 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 25.2 tt0 -66.3 136.24 55.54 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.68 -3.92 36.66 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.437 -177.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -82.86 118.85 23.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.1 pt20 -88.53 143.78 26.75 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.545 0.688 . . . . 0.0 111.982 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.24 114.45 27.94 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.3 mt -89.36 127.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 90.6 m-85 -109.2 141.85 40.86 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-O 121.617 0.722 . . . . 0.0 111.988 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -89.67 147.69 23.73 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 168.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.791 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 91.2 m -102.44 37.47 1.9 Allowed 'General case' 0 C--N 1.249 -3.795 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.605 -174.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 65.86 159.6 0.13 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.574 0.702 . . . . 0.0 111.532 178.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.52 113.8 3.62 Favored 'Trans proline' 0 N--CA 1.428 -2.342 0 N-CA-C 109.706 -0.921 . . . . 0.0 109.706 172.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 131' ' ' THR . . . 118.24 -20.43 10.48 Favored Glycine 0 C--O 1.239 0.445 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.593 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.791 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.1 m-85 -107.1 161.32 14.86 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.578 178.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.474 ' NE ' ' HD3' ' A' ' 84' ' ' PRO . 16.0 ptt180 -160.79 -176.34 5.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.558 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.7 p -169.22 177.92 4.58 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 170.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.12 31.8 0.71 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.86 0.838 . . . . 0.0 110.213 177.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.0 -140.32 3.21 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -142.66 157.72 44.39 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -78.97 104.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.33 122.1 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.963 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.5 mtp -109.44 169.79 8.47 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.2 p -155.39 144.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.659 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t -68.4 123.15 20.0 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.716 177.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.4 ttm180 -157.19 129.84 7.53 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 35.7 mmtp 66.53 15.89 10.24 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.891 0.876 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.58 65.87 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 121.201 -0.523 . . . . 0.0 111.959 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -124.67 172.34 9.35 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 120.933 0.397 . . . . 0.0 110.459 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -103.58 119.65 39.32 Favored 'General case' 0 CA--C 1.462 -2.428 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.3 -170.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.943 -175.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.57 121.1 39.07 Favored 'General case' 1 C--N 1.22 -5.024 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.221 -172.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -71.43 -54.42 10.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -119.72 100.38 49.0 Favored Pre-proline 0 N--CA 1.409 -2.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.65 -4.45 13.51 Favored 'Trans proline' 0 N--CA 1.482 0.808 0 C-N-CA 123.042 2.495 . . . . 0.0 112.366 -179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.6 mt -85.27 -31.94 22.83 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.633 -178.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -89.29 135.33 33.64 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.365 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 158.55 44.28 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . 0.383 67.5 m -95.59 127.67 41.81 Favored 'General case' 0 C--N 1.272 -2.79 0 C-N-CA 117.745 -1.582 . . . . 0.0 114.82 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.36 -175.69 2.76 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 112.756 -2.02 . . . . 0.0 108.096 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -71.99 152.92 42.12 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.077 0.465 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -90.16 152.97 46.59 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' NE ' ' A' ' 57' ' ' ARG . 66.2 Cg_endo -90.24 152.62 4.61 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.451 1.434 . . . . 0.0 112.84 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 70.9 m -124.96 76.79 1.56 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.55 93.51 0.01 OUTLIER Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.242 -176.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t60 70.93 125.59 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.968 1.707 . . . . 0.0 111.42 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.69 38.68 0.4 Allowed 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.999 3.133 . . . . 0.0 114.427 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 108.63 -127.72 8.73 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 138' ' ' ILE . 4.0 p30 -162.87 158.88 23.12 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -171.65 129.53 0.68 Allowed Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -80.51 -14.23 11.73 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.374 1.383 . . . . 0.0 111.016 174.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.46 89.32 2.37 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.354 0.597 . . . . 0.0 111.129 -178.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.669 ' HA2' ' SG ' ' A' ' 114' ' ' CYS . . . 164.81 165.88 22.83 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.9 178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 m -139.37 165.46 27.16 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -139.06 155.91 47.57 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 p -130.73 140.42 50.34 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -103.39 140.38 37.53 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 109' ' ' LYS . 5.1 t -133.69 19.52 3.88 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 121.708 0.766 . . . . 0.0 111.876 -176.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.402 ' C ' HG12 ' A' ' 108' ' ' VAL . . . -141.9 25.4 2.4 Favored Glycine 0 CA--C 1.492 -1.356 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.53 174.88 17.18 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -119.25 20.44 12.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 117.903 0.852 . . . . 0.0 109.751 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.449 ' O ' HG11 ' A' ' 108' ' ' VAL . 23.4 m -138.2 175.11 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' CYS . 52.7 m-85 -90.89 97.73 11.36 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.001 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.96 154.36 41.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.428 -177.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -51.19 116.87 2.23 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.306 1.004 . . . . 0.0 111.083 177.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.05 -25.18 7.18 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.278 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 103' ' ' VAL . 12.6 m -74.72 137.77 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.344 178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.5 ttmt -106.02 121.64 44.54 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.72 94.52 9.41 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.6 t -77.77 122.32 32.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -94.1 132.14 38.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -153.98 156.43 37.41 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.669 ' SG ' ' HA2' ' A' ' 94' ' ' GLY . 83.9 m -132.68 -72.62 0.51 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -129.95 -174.05 3.21 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -174.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -85.47 -51.53 6.46 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.352 0.596 . . . . 0.0 110.763 -177.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.27 -18.93 79.91 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.202 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -98.77 137.67 37.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.54 -107.42 0.37 Allowed 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 2.5 pp 179.19 141.5 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.779 1.232 . . . . 0.0 109.666 176.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.1 mm? -89.11 134.75 33.89 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.407 0.622 . . . . 0.0 110.338 176.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.09 161.38 11.03 Favored Glycine 0 N--CA 1.417 -2.602 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -174.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -92.42 -21.65 20.08 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.469 0.652 . . . . 0.0 109.415 -177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.428 ' HB ' ' ND2' ' A' ' 136' ' ' ASN . 25.7 mm -104.99 106.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-N 115.45 -0.796 . . . . 0.0 108.953 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -88.15 24.9 1.72 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.535 1.134 . . . . 0.0 111.395 -175.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.418 ' CE1' HG23 ' A' ' 124' ' ' ILE . 47.4 p90 -159.58 171.61 19.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.256 0.551 . . . . 0.0 110.768 -173.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -135.18 131.74 37.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 12.8 mt-10 -104.37 139.1 39.81 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 118.242 0.473 . . . . 0.0 110.794 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.72 104.14 10.11 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 131' ' ' THR . 14.0 t70 -105.94 -159.81 0.72 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.973 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 40.2 p -60.7 -29.49 69.36 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.743 1.617 . . . . 0.0 114.555 -171.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -118.44 -28.56 5.7 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.553 0.692 . . . . 0.0 110.959 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.91 -157.11 28.44 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -176.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 97.3 m95 -74.0 130.62 40.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.871 0.367 . . . . 0.0 111.663 -178.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 34.8 p -81.83 158.29 24.12 Favored 'General case' 0 C--O 1.266 1.945 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 173.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 124' ' ' ILE . 54.9 t30 63.92 -171.79 0.18 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -126.48 -168.1 1.81 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.656 HD11 ' HA3' ' A' ' 89' ' ' GLY . 54.0 mt -82.61 117.69 69.35 Favored Pre-proline 0 C--N 1.282 -2.33 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 33.8 Cg_endo -70.96 144.86 48.75 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.751 2.301 . . . . 0.0 110.894 177.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.1 mp -93.7 112.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 122.118 -0.364 . . . . 0.0 110.871 -174.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.33 112.28 3.93 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.619 ' HB2' HD23 ' A' ' 121' ' ' LEU . 33.6 mt-10 . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 12.3 m-20 . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.5 m -84.52 125.08 32.08 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.89 23.59 7.84 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.01 161.27 40.47 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.394 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 mt -82.81 149.07 59.12 Favored Pre-proline 0 C--N 1.306 -1.313 0 O-C-N 123.998 0.811 . . . . 0.0 109.807 174.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.8 Cg_endo -53.11 131.55 43.48 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 123.197 2.598 . . . . 0.0 113.312 -177.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 18.6 Cg_exo -65.73 119.51 6.55 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 122.617 2.212 . . . . 0.0 110.277 176.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.64 142.58 56.35 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.766 0.793 . . . . 0.0 111.759 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 18.2 mmm180 -87.31 168.46 13.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.377 -171.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -35.4 17.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.046 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 5.0 p -107.8 6.31 27.38 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.772 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 10.3 mp0 -138.92 156.44 47.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.33 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.3 158.92 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.78 143.67 55.74 Favored 'General case' 0 C--N 1.269 -2.896 0 O-C-N 123.483 0.489 . . . . 0.0 110.553 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.1 p -71.73 -35.23 70.1 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.35 165.92 12.17 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.3 m -94.15 142.71 27.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 177.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.06 125.53 42.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -174.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -121.44 18.22 11.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.288 0.566 . . . . 0.0 110.738 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.79 -159.44 0.74 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' HG3' HG23 ' A' ' 41' ' ' THR . 17.6 pt20 -149.63 -35.01 0.18 Allowed 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 123.457 0.703 . . . . 0.0 110.355 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 41.7 p -107.88 126.21 52.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.798 -176.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -133.89 137.05 27.6 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 28.3 Cg_endo -63.08 147.37 94.39 Favored 'Trans proline' 0 C--O 1.258 1.518 0 C-N-CA 123.126 2.551 . . . . 0.0 111.926 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 31.5 tt0 -63.56 129.85 41.9 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.23 30.33 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.9 m -81.4 113.31 19.4 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.2 pt20 -86.35 143.78 27.68 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.136 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.57 119.95 37.17 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.0 mt -91.51 119.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 59.9 m-85 -98.45 145.61 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.042 0.925 . . . . 0.0 113.33 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 32.2 ttmt -91.66 138.36 31.63 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 35.7 m -74.63 21.9 0.1 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 72.9 mtp180 64.95 154.95 0.12 Allowed Pre-proline 0 N--CA 1.476 0.864 0 CA-C-O 121.678 0.751 . . . . 0.0 111.612 -173.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.4 104.19 0.42 Allowed 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.523 1.482 . . . . 0.0 110.866 174.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.12 -3.6 18.78 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.326 176.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.793 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.0 m-85 -120.89 165.91 14.53 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.133 -1.216 . . . . 0.0 109.819 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -156.18 179.32 9.35 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 174.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 80' ' ' CYS . 23.7 p -145.46 -92.41 0.1 Allowed 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.703 0.764 . . . . 0.0 110.665 174.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -142.23 -47.2 0.35 Allowed 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -177.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.92 -134.72 3.31 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 176.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -115.06 146.73 41.0 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.1 t -75.12 116.76 18.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.3 mm -110.5 122.92 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-O 121.455 0.645 . . . . 0.0 109.783 -176.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.3 mtp -109.3 171.84 7.2 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 8.5 p -157.74 142.69 8.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.408 0.623 . . . . 0.0 110.646 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.76 122.19 20.24 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.304 176.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 42.3 ttm180 -156.52 127.51 6.87 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 66.19 17.06 10.65 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.58 80.36 Favored Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.897 179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 9.6 pt-20 -117.4 159.06 23.38 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -104.12 109.3 21.04 Favored 'General case' 0 CA--C 1.455 -2.69 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.0 -164.54 0.39 Allowed 'Isoleucine or valine' 1 N--CA 1.362 -4.846 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.252 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.14 40.67 Favored 'General case' 1 C--N 1.218 -5.123 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.601 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.9 -39.76 66.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.86 102.18 13.64 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 1.5 8.27 Favored 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.98 2.453 . . . . 0.0 113.74 -175.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.92 -20.33 18.19 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.691 0.758 . . . . 0.0 111.385 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 78' ' ' ARG . 31.1 mmt180 -85.02 130.96 34.53 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.387 -178.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -156.55 147.95 22.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 55.7 m -97.03 123.47 40.77 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.594 0.711 . . . . 0.0 111.484 -176.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.99 42.51 2.91 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -167.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 88.2 mttt 76.6 -179.98 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.753 1.221 . . . . 0.0 111.044 -178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 15.4 ptp180 -130.41 142.0 43.9 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.99 147.58 43.66 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.477 2.118 . . . . 0.0 109.633 173.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 m -102.32 -10.66 19.3 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.05 -117.2 4.43 Favored Glycine 0 CA--C 1.474 -2.481 0 C-N-CA 119.002 -1.571 . . . . 0.0 110.996 -176.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -136.71 139.14 28.25 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -176.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -89.42 8.64 3.71 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.786 2.324 . . . . 0.0 111.143 178.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 97.3 -164.25 22.23 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -175.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.27 161.19 12.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -130.5 126.04 21.86 Favored Pre-proline 0 C--N 1.288 -2.086 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.182 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.29 10.1 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.548 2.165 . . . . 0.0 112.773 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -110.82 -12.16 14.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.506 ' HA3' ' SG ' ' A' ' 114' ' ' CYS . . . -164.56 -146.66 4.84 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.792 -175.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.91 -172.86 4.21 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.804 0.442 . . . . 0.0 111.597 -175.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -148.11 166.42 27.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 p -130.49 159.09 38.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.551 0.74 . . . . 0.0 109.332 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.5 136.57 53.14 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.054 0.454 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 9.8 t -125.78 138.18 53.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.12 9.97 56.54 Favored Glycine 0 C--N 1.312 -0.77 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -175.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.01 167.73 11.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -178.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.06 31.52 5.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.797 0.798 . . . . 0.0 111.277 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.02 167.85 23.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.06 86.24 5.34 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.662 -176.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.92 154.16 49.52 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.397 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -51.29 120.6 5.18 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.714 0.634 . . . . 0.0 111.543 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.25 -20.05 7.12 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 99' ' ' THR . 10.5 m -83.51 146.48 6.86 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.427 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 5.1 ttmp? -111.12 126.72 55.13 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.52 92.82 8.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.69 115.11 27.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -81.87 139.91 34.42 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.509 -177.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.14 143.31 22.34 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.506 ' SG ' ' HA3' ' A' ' 94' ' ' GLY . 77.6 m -122.57 -73.38 0.65 Allowed 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.113 -174.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -161.1 -165.61 1.39 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -172.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -79.81 -43.25 22.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.778 0.799 . . . . 0.0 109.042 175.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.48 -12.84 79.72 Favored Glycine 0 C--N 1.31 -0.906 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.407 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.431 ' HA ' ' OXT' ' A' ' 142' ' ' GLU . 73.5 m-85 -124.47 127.86 48.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.73 -130.46 0.26 Allowed 'General case' 0 CA--C 1.457 -2.632 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 166.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.768 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -151.65 145.47 25.1 Favored 'General case' 1 N--CA 1.33 -6.467 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.996 -176.35 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 94.6 mt -87.27 109.76 19.73 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.76 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 156.11 161.01 10.37 Favored Glycine 0 C--N 1.272 -3.017 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 -178.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -97.21 -5.96 35.76 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 118.183 0.991 . . . . 0.0 110.251 179.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.91 106.94 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.615 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.768 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.2 p-10 -84.7 30.99 0.54 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.616 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.585 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 19.5 p90 -166.35 179.93 5.34 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.451 0.643 . . . . 0.0 111.857 -172.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -139.83 131.61 27.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 169.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 25.2 mt-10 -99.92 136.22 40.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 53.1 t -81.39 123.02 28.21 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.158 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 131' ' ' THR . 9.0 t70 -118.55 -160.24 0.79 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.456 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 43.2 p -66.85 -51.47 55.2 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.824 1.25 . . . . 0.0 112.101 -174.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.03 -28.72 39.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.77 0.795 . . . . 0.0 110.693 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.61 -148.13 17.57 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -80.97 132.84 35.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.189 0.494 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 49.6 p -81.0 148.95 29.51 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.423 178.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 67.53 -173.75 0.19 Allowed 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.273 0.983 . . . . 0.0 108.93 174.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -117.38 -173.62 2.45 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.459 HD11 ' HA3' ' A' ' 89' ' ' GLY . 73.0 mt -81.29 119.24 75.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 110.769 -0.086 . . . . 0.0 110.769 -174.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CG ' HD12 ' A' ' 120' ' ' LEU . 9.6 Cg_endo -58.72 132.52 48.47 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.424 2.083 . . . . 0.0 108.706 174.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 121' ' ' LEU . 3.1 mp -78.03 106.62 8.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.8 t -61.42 118.17 6.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.165 0.507 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 118' ' ' TYR . 10.2 tp10 . . . . . 0 N--CA 1.43 -1.445 0 C-N-CA 126.178 1.791 . . . . 0.0 106.651 -174.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.662 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 3.7 m-20 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 41' ' ' THR . 64.9 m -74.37 138.23 43.27 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.425 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -100.97 15.17 29.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.344 0.592 . . . . 0.0 109.882 -179.075 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.07 154.83 41.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.551 -174.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.6 mt -75.12 149.82 85.16 Favored Pre-proline 0 C--O 1.253 1.289 0 O-C-N 124.073 0.858 . . . . 0.0 109.909 173.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 27.9 Cg_endo -58.84 142.02 98.56 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.828 2.352 . . . . 0.0 110.054 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.76 144.49 54.22 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.779 1.653 . . . . 0.0 111.67 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -76.21 141.76 41.69 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 24.7 mmm180 -98.28 162.03 13.4 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.647 -171.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -78.23 -42.22 31.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.342 0.592 . . . . 0.0 109.69 176.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p -102.72 -7.72 21.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.648 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . 2.8 mp0 -129.4 166.13 20.17 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.755 -179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.5 mt -140.98 146.21 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 37' ' ' TRP . 4.5 mm? -70.65 140.15 51.48 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.506 178.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 p -126.67 101.41 6.63 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.988 172.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.78 -160.09 33.64 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 -176.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 m -129.43 114.53 16.27 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 117.699 0.749 . . . . 0.0 109.532 178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB3' HD22 ' A' ' 24' ' ' LEU . 80.8 m95 -120.81 128.27 52.71 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.189 -175.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 m -148.54 8.08 0.78 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.312 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.0 m-20 -120.93 -173.37 2.59 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.635 -174.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -112.41 -61.1 1.77 Allowed 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 40.1 p -85.9 122.65 30.26 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.51 -175.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 39' ' ' ASP . 63.9 m-85 -126.76 136.05 28.21 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.272 177.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 17.9 Cg_endo -60.51 145.68 98.31 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.345 2.697 . . . . 0.0 113.535 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 18.5 tt0 -62.85 120.47 11.37 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.89 12.89 14.94 Favored Glycine 0 C--N 1.298 -1.572 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -175.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.6 m -92.38 113.23 25.45 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.567 176.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.9 149.21 25.38 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.643 0.59 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.25 133.84 51.36 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.759 0.824 . . . . 0.0 109.023 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.9 mt -102.59 129.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 67.5 m-85 -111.25 137.29 49.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' A' ' 53' ' ' ARG . 53.5 tptt -85.05 126.53 33.64 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 89.7 m -77.43 13.45 1.21 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 51' ' ' LYS . 70.1 mtp180 69.64 150.11 0.12 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.512 0.725 . . . . 0.0 110.895 -172.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.71 120.67 7.43 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.728 1.619 . . . . 0.0 109.9 175.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 117.24 -13.98 13.71 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 72.8 m-85 -115.17 163.66 15.33 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -150.88 -179.31 7.17 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 p -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.57 -13.61 59.74 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.592 0.711 . . . . 0.0 109.899 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.58 144.53 9.72 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 174.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.21 154.71 39.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.708 0.754 . . . . 0.0 111.166 -178.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.449 HG23 ' SG ' ' A' ' 80' ' ' CYS . 76.7 t -71.49 102.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.25 118.41 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.364 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.2 mtp -107.27 171.45 7.37 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.04 146.48 12.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.64 122.32 23.0 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.825 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 37.1 ttm180 -153.39 124.71 7.54 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.934 0.397 . . . . 0.0 111.057 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 61.8 mmtt 68.66 11.55 8.39 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.852 1.261 . . . . 0.0 112.519 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.78 -12.61 46.13 Favored Glycine 0 N--CA 1.427 -1.945 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.33 178.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.55 158.3 21.86 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.595 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 88.1 m95 -91.22 115.5 28.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.93 171.2 6.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.267 -175.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.22 119.49 26.56 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.3 -49.67 63.31 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.35 89.43 5.9 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.705 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.66 -19.84 9.69 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.568 2.179 . . . . 0.0 111.475 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.3 mt -74.77 -29.55 61.16 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.252 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -84.78 158.72 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.936 178.891 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -175.68 156.16 1.83 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.964 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 62' ' ' VAL . 60.2 m -93.64 123.82 37.22 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.738 -177.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.35 164.22 16.66 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.639 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 90.9 mttt -73.51 151.11 41.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.487 0.184 . . . . 0.0 110.958 -176.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 9.7 ptm180 -82.27 146.25 54.07 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.476 176.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 69.8 Cg_endo -79.42 151.74 22.98 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.42 2.08 . . . . 0.0 110.909 172.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 133' ' ' GLY . 52.5 m -110.95 -9.23 14.43 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.804 177.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.55 175.42 47.63 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.699 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.74 123.19 89.05 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HB2' ' NH1' ' A' ' 127' ' ' ARG . 56.3 Cg_endo -70.2 83.66 0.76 Allowed 'Trans proline' 0 C--O 1.254 1.283 0 C-N-CA 123.076 2.517 . . . . 0.0 113.017 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 63.54 -142.55 47.07 Favored Glycine 0 C--O 1.215 -1.068 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.47 130.14 17.0 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 t -127.24 99.53 27.86 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-O 121.522 0.677 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -68.59 -39.41 9.21 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.485 2.123 . . . . 0.0 113.403 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.43 -20.49 17.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -173.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.33 176.91 18.77 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.739 -178.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 p -134.84 175.64 9.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 37.8 p90 -150.49 151.19 32.32 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.423 177.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 69.5 p -101.59 171.37 7.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 103' ' ' VAL . 96.2 mt -141.69 136.7 31.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 173.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 109' ' ' LYS . 9.1 t -113.31 -62.28 1.61 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.73 56.02 4.9 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.749 -176.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.13 -57.49 0.35 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.329 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 m120 87.74 18.17 0.07 Allowed 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.401 1.48 . . . . 0.0 107.873 -179.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.418 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 p -141.27 -161.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.819 0 CA-C-N 111.822 -2.444 . . . . 0.0 105.051 177.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 44.9 m-85 -112.07 86.26 2.31 Favored 'General case' 1 C--N 1.236 -4.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.728 -175.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 82' ' ' LYS . 15.1 pt-20 -151.02 155.89 39.99 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.457 178.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 79.6 t80 -45.47 115.38 0.92 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 125.036 1.46 . . . . 0.0 112.273 -178.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.41 -21.76 6.0 Favored Glycine 0 N--CA 1.427 -1.959 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.181 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.1 m -78.1 137.51 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.886 -1.125 . . . . 0.0 111.438 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' H ' HG22 ' A' ' 99' ' ' THR . 5.0 ttmp? -106.61 110.78 23.07 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -81.72 92.46 6.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -81.58 124.37 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 139' ' ' PRO . 7.7 t80 -84.27 130.62 34.8 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.08 150.03 43.69 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 118' ' ' TYR . 26.6 m -130.18 148.72 52.05 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.9 173.67 0.42 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 124.411 1.069 . . . . 0.0 112.586 177.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -44.14 -53.02 6.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.626 1.57 . . . . 0.0 113.567 -176.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 22.45 34.82 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.139 -176.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 114' ' ' CYS . 95.6 m-85 -134.05 161.01 36.02 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.391 0.615 . . . . 0.0 111.691 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -156.39 -156.38 0.62 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 173.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 1.2 pp -140.26 142.52 35.75 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -175.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 142' ' ' GLU . 4.2 mm? -83.5 135.52 34.62 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.182 -1.372 . . . . 0.0 107.72 171.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.25 152.01 9.03 Favored Glycine 0 C--N 1.267 -3.289 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -174.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.74 -13.06 37.61 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 117.343 0.572 . . . . 0.0 111.912 -176.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -111.21 116.44 52.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.411 ' HB2' HD21 ' A' ' 120' ' ' LEU . 3.1 p-10 -91.63 25.49 2.66 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.448 0.642 . . . . 0.0 111.123 -176.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 28.5 p90 -156.49 177.32 11.6 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.75 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.66 ' NH1' HG12 ' A' ' 138' ' ' ILE . 15.2 ptt180 -157.36 128.4 6.7 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.441 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 37.6 mt-10 -103.67 142.24 34.68 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.78 98.89 7.98 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 131' ' ' THR . 16.4 t70 -103.86 -158.51 0.67 Allowed 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.692 -173.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 130' ' ' ASP . 38.9 p -64.94 -38.48 91.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.741 1.217 . . . . 0.0 113.14 -172.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.5 -33.99 11.64 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 120.95 0.405 . . . . 0.0 110.326 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 85' ' ' CYS . . . 161.24 -149.14 17.76 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.554 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -71.65 130.0 40.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.727 0.264 . . . . 0.0 110.766 -178.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.5 p -79.76 167.36 20.72 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.336 176.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.28 -101.99 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.04 0.936 . . . . 0.0 112.668 173.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 169.82 -158.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 -177.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.66 HG12 ' NH1' ' A' ' 127' ' ' ARG . 62.6 mt -102.31 107.1 52.0 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 112' ' ' TYR . 9.4 Cg_endo -58.37 137.36 80.05 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.483 1.456 . . . . 0.0 109.37 174.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.3 mp -84.37 115.17 25.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.041 -171.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 8.8 t -75.09 99.81 4.04 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 123.437 0.461 . . . . 0.0 109.851 -178.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 121' ' ' LEU . 10.9 mm-40 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.77 1.628 . . . . 0.0 108.234 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 12.8 m-20 . . . . . 0 C--O 1.243 0.742 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.6 m -61.38 139.98 58.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -116.32 16.44 15.77 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.542 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -156.45 161.35 40.08 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.702 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.06 153.44 79.95 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 123.984 0.914 . . . . 0.0 109.935 176.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 Cg_endo -55.41 123.68 14.4 Favored 'Trans proline' 0 C--O 1.254 1.303 0 C-N-CA 122.273 1.982 . . . . 0.0 111.516 178.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 6.5 Cg_exo -67.36 109.24 1.74 Allowed 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.803 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -71.73 143.01 49.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.934 176.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -104.49 -171.81 1.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -171.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.25 -42.26 72.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.134 0.492 . . . . 0.0 110.316 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 15.8 p -109.63 11.68 24.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -177.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . 3.2 mp0 -138.28 134.25 34.11 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.706 -0.621 . . . . 0.0 112.601 -178.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.93 157.32 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.11 140.64 45.39 Favored 'General case' 0 C--N 1.264 -3.138 0 O-C-N 123.817 0.698 . . . . 0.0 110.735 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.4 p -73.51 -52.96 11.77 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.909 177.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.57 167.99 41.42 Favored Glycine 0 N--CA 1.421 -2.353 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.347 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 p -90.95 146.76 23.61 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 123.011 0.524 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -135.92 143.43 44.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.0 t -125.65 -44.12 1.84 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HE1' ' A' ' 42' ' ' TYR . 15.2 t70 -97.09 158.04 15.63 Favored 'General case' 0 C--O 1.186 -2.268 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -170.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -79.09 -30.01 43.62 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.21 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 77.9 p -101.08 119.95 39.5 Favored 'General case' 0 N--CA 1.41 -2.457 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.99 -174.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HE1' ' O ' ' A' ' 39' ' ' ASP . 40.4 m-85 -130.29 155.01 81.56 Favored Pre-proline 0 C--N 1.302 -1.46 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.078 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.96 147.09 88.94 Favored 'Trans proline' 0 C--O 1.252 1.208 0 C-N-CA 122.121 1.881 . . . . 0.0 111.555 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.9 146.75 49.38 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.8 9.12 62.94 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.992 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -89.08 120.32 30.38 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.87 -0.194 . . . . 0.0 111.222 177.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.9 pt20 -87.01 157.0 19.54 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.323 0.582 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.09 126.51 41.32 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.76 130.52 46.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 80.6 m-85 -99.76 138.8 36.34 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -78.2 -18.41 55.51 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 127.209 2.204 . . . . 0.0 112.531 -173.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 97.4 m 67.22 -2.87 1.11 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 62.4 mtp180 69.76 153.97 0.14 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.531 0.732 . . . . 0.0 111.131 -174.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.49 121.4 7.94 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.794 1.663 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 111.92 -5.43 27.39 Favored Glycine 0 C--N 1.306 -1.123 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.357 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.566 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 41.0 m-85 -120.49 174.57 6.47 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -162.45 -173.33 3.52 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 p -151.09 168.08 25.73 Favored 'General case' 0 C--N 1.266 -3.048 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 174.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.3 tp -105.59 32.23 4.45 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.53 109.74 0.38 Allowed Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 63' ' ' ILE . 11.6 m120 -52.83 140.08 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 117.337 0.568 . . . . 0.0 111.695 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 93.0 t -64.86 112.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 61' ' ' ASN . 46.9 mm -113.2 118.37 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.69 170.94 7.59 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.1 p -156.21 148.32 11.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.9 t -81.25 134.29 35.58 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.242 -177.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 4.7 tpm_? -152.59 126.76 9.16 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 67' ' ' ARG . 32.7 mmtp 63.12 18.49 10.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 175.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 20' ' ' ASP . . . 99.81 -12.41 60.96 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.944 179.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.32 168.24 10.14 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -101.3 121.74 42.43 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.84 179.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.65 39.61 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.219 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.0 tt -68.95 -42.57 76.49 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.589 ' OD1' ' HG2' ' A' ' 78' ' ' ARG . 9.0 t-20 -127.8 97.44 30.04 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.959 173.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.13 -7.45 16.22 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 0.0 112.864 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.61 -27.3 51.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.534 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' HG2' ' OD1' ' A' ' 75' ' ' ASN . 29.3 mmt180 -92.69 153.76 18.76 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.992 -177.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -158.03 147.3 19.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.56 123.57 28.22 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.548 -178.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -121.28 167.76 12.37 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.96 157.32 22.08 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.345 0.593 . . . . 0.0 111.963 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 13.6 ptm180 -99.01 154.61 37.24 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 46.6 Cg_endo -73.15 151.46 49.45 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.519 1.479 . . . . 0.0 109.386 169.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 29.5 m -78.52 -46.52 19.37 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.557 0.694 . . . . 0.0 110.111 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.51 -125.86 3.61 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -176.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -141.4 116.64 7.13 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.36 41.72 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 124.08 3.187 . . . . 0.0 114.904 -174.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.34 -137.28 30.96 Favored Glycine 0 C--N 1.311 -0.815 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -149.21 -176.54 5.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 t -171.83 106.44 0.37 Allowed Pre-proline 0 C--N 1.289 -2.061 0 C-N-CA 125.477 1.511 . . . . 0.0 107.563 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.34 -17.58 18.71 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.368 2.045 . . . . 0.0 113.435 -175.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CD1' ' HB3' ' A' ' 141' ' ' CYS . 0.1 OUTLIER -124.06 -5.22 7.91 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.641 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.97 -163.91 10.5 Favored Glycine 0 CA--C 1.497 -1.058 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -162.27 -177.98 6.04 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 117.277 0.538 . . . . 0.0 110.619 178.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -143.55 164.6 29.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.257 -177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 68.2 p -120.93 169.87 10.05 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.8 mt -129.64 135.38 48.46 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 109' ' ' LYS . 14.6 t -120.43 1.38 10.68 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.256 0.551 . . . . 0.0 112.331 -174.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.74 24.9 4.8 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.28 148.19 5.61 Favored Glycine 0 N--CA 1.411 -2.977 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 -174.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -93.59 32.7 1.36 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 122.517 1.151 . . . . 0.0 109.141 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.99 162.42 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.624 0 CA-C-N 113.955 -1.475 . . . . 0.0 107.322 -174.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 45.0 m-85 -91.42 100.21 13.02 Favored 'General case' 0 C--N 1.26 -3.318 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.883 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.16 149.0 37.45 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' SG ' ' A' ' 129' ' ' CYS . 91.5 t80 -52.39 121.22 6.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.172 0.511 . . . . 0.0 110.473 177.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.5 -13.86 25.28 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.302 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.6 142.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 109.69 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HB3' HG22 ' A' ' 99' ' ' THR . 4.6 ttmp? -113.09 126.01 55.0 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -93.51 102.92 15.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.068 0.855 . . . . 0.0 108.898 177.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.409 HG22 ' OG1' ' A' ' 97' ' ' THR . 0.7 OUTLIER -87.84 126.67 41.35 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.281 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -93.17 142.5 27.24 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -174.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -135.17 155.75 50.17 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.603 ' HB3' ' O ' ' A' ' 119' ' ' GLN . 44.1 t -158.92 100.48 1.58 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -173.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 47.67 -160.65 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 164.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -98.77 -64.93 0.99 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.003 -0.435 . . . . 0.0 111.126 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.72 34.12 2.98 Favored Glycine 0 N--CA 1.469 0.892 0 CA-C-O 121.492 0.496 . . . . 0.0 112.58 -177.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.13 173.65 11.3 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 120' ' ' LEU . 43.6 mt-30 -130.27 -66.09 0.79 Allowed 'General case' 0 CA--C 1.432 -3.596 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 167.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 139' ' ' PRO . 1.5 pt? 165.36 157.46 0.02 OUTLIER 'General case' 1 N--CA 1.362 -4.86 0 N-CA-C 102.204 -3.258 . . . . 0.0 102.204 164.156 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.0 mt -97.26 112.53 24.29 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 119.521 1.055 . . . . 0.0 110.455 175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.23 150.54 5.3 Favored Glycine 0 C--N 1.283 -2.404 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.28 -32.27 43.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 117.787 0.794 . . . . 0.0 108.894 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -95.72 107.4 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.645 ' HA ' HD11 ' A' ' 120' ' ' LEU . 2.6 p-10 -88.04 29.45 0.94 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.881 0.848 . . . . 0.0 110.982 -175.33 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -162.24 175.68 11.4 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.937 -175.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.653 ' NH2' HG12 ' A' ' 138' ' ' ILE . 12.2 ttm180 -143.56 120.93 11.63 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.37 152.23 19.85 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.429 176.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 106' ' ' TYR . 49.8 t -79.44 149.14 31.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' THR . 17.5 t70 -126.07 -177.97 4.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 39.5 p -61.42 -33.83 74.37 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.59 1.156 . . . . 0.0 113.303 -175.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.52 9.15 7.11 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.399 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.11 -126.08 1.11 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.543 -178.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -131.08 153.64 49.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 130' ' ' ASP . 59.8 p -91.17 128.97 37.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 80.22 176.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.897 0.879 . . . . 0.0 111.994 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 12.2 t70 -105.12 -156.21 0.57 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -174.256 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.653 HG12 ' NH2' ' A' ' 127' ' ' ARG . 62.2 mt -101.94 101.92 20.97 Favored Pre-proline 0 N--CA 1.42 -1.926 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB2' HD12 ' A' ' 120' ' ' LEU . 7.3 Cg_endo -52.86 133.43 51.11 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 122.263 1.975 . . . . 0.0 108.05 172.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 140' ' ' ILE . 3.3 mp -86.97 123.75 40.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -171.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . 48.9 t -68.64 91.51 0.43 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 CA--C 1.496 -1.129 0 C-N-CA 126.274 1.83 . . . . 0.0 107.254 -175.323 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.638 ' OD2' ' HA ' ' A' ' 43' ' ' PRO . 10.1 m-20 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' THR . 82.3 m -80.76 133.37 35.64 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.71 33.6 3.98 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 122.143 0.973 . . . . 0.0 108.958 -178.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.85 158.11 37.52 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.979 -176.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 37' ' ' TRP . 19.5 mt -85.0 154.46 60.75 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 123.872 0.733 . . . . 0.0 110.392 178.012 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.09 145.04 93.68 Favored 'Trans proline' 0 C--O 1.255 1.326 0 C-N-CA 122.338 2.025 . . . . 0.0 110.382 177.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.76 155.42 53.89 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.266 1.977 . . . . 0.0 112.777 -177.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -83.5 147.91 27.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' HD3' ' OE1' ' A' ' 31' ' ' GLU . 35.8 mtt180 -114.45 170.58 8.2 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -172.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -79.11 -40.55 30.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.795 -176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p -115.92 4.15 13.8 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.417 177.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.529 ' OE1' ' HD3' ' A' ' 28' ' ' ARG . 8.2 mp0 -131.63 153.92 49.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 111.663 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.0 mt -134.25 156.64 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.457 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 177.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.4 mm? -77.24 149.35 35.46 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.1 p -99.25 156.53 16.93 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.48 -159.96 25.33 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.791 178.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.5 t -140.89 120.98 13.73 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' HD22 ' A' ' 24' ' ' LEU . 71.7 m95 -113.75 115.75 28.3 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -175.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -134.49 26.73 3.75 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.115 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 26.6 m-20 -126.92 -167.18 1.69 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.963 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.57 -53.57 0.77 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.714 0.406 . . . . 0.0 111.156 175.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 61.4 p -85.11 105.51 15.9 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.937 0.875 . . . . 0.0 113.106 -175.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -114.12 136.57 22.22 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.957 178.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.638 ' HA ' ' OD2' ' A' ' 20' ' ' ASP . 22.5 Cg_endo -63.12 150.25 89.17 Favored 'Trans proline' 0 C--O 1.257 1.472 0 C-N-CA 122.878 2.385 . . . . 0.0 112.215 -177.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.654 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -66.13 133.14 50.09 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.14 1.08 41.55 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.218 -176.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -82.33 114.64 20.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.206 178.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -88.45 140.52 29.38 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.429 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.3 113.28 25.97 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.14 121.31 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.781 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 62.3 m-85 -98.55 140.75 32.31 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.944 0.878 . . . . 0.0 113.24 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -94.2 111.97 23.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 171.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 98.2 m -79.11 32.61 0.22 Allowed 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -173.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 64.23 151.85 0.12 Allowed Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.148 1.379 . . . . 0.0 113.274 177.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.95 124.74 12.19 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.326 1.35 . . . . 0.0 108.883 173.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.14 -19.89 10.78 Favored Glycine 0 C--N 1.297 -1.591 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 75.5 m-85 -114.4 170.1 8.55 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -155.18 179.08 9.49 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.5 p -170.81 135.22 1.07 Allowed 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.2 -43.8 85.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 114.27 3.91 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 172.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -64.31 155.36 32.43 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 123.817 0.363 . . . . 0.0 110.66 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.548 HG23 ' SG ' ' A' ' 80' ' ' CYS . 98.7 t -72.55 102.2 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -107.04 118.44 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 81.5 mtp -104.62 169.15 8.62 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.6 p -156.66 146.29 11.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.286 0.565 . . . . 0.0 109.905 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.62 122.53 23.31 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.739 177.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.654 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 31.9 ttt180 -152.77 134.29 14.47 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 34.0 mmtp 67.23 12.13 8.77 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.302 1.041 . . . . 0.0 112.507 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.62 -4.27 57.97 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.81 157.48 33.99 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.16 0.505 . . . . 0.0 110.834 177.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -87.84 117.16 26.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.62 176.46 4.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.028 -178.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' MET . . . -89.78 128.97 36.23 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.433 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.11 -50.92 43.71 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.46 91.13 6.64 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.755 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -74.28 -15.55 22.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.619 2.212 . . . . 0.0 112.084 -177.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.1 mt -83.37 -9.34 59.11 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.038 0.923 . . . . 0.0 111.018 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -102.99 138.69 39.53 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.914 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.88 162.16 38.37 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 172.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 62' ' ' VAL . 83.1 m -101.79 130.26 48.17 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.572 -0.851 . . . . 0.0 113.016 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.02 172.79 7.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.955 -178.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.75 157.12 33.59 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -85.34 145.57 42.85 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.17 144.59 13.32 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.979 1.786 . . . . 0.0 109.582 176.198 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.6 m -103.53 5.81 37.0 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.268 0.556 . . . . 0.0 112.152 -173.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.31 -98.66 1.14 Allowed Glycine 0 CA--C 1.465 -3.06 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.927 178.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -152.58 142.68 15.09 Favored Pre-proline 0 C--N 1.278 -2.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.07 45.54 1.95 Allowed 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.523 2.815 . . . . 0.0 112.069 -176.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 86.4 -146.28 20.83 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -175.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -159.27 127.14 4.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 t -113.51 135.92 21.91 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.65 -35.07 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.759 2.306 . . . . 0.0 114.379 -178.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -143.53 11.19 1.67 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.091 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 176.96 32.17 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -137.56 174.65 10.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.37 156.79 34.49 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.642 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -118.94 154.88 32.3 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 175.076 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 110' ' ' ALA . 96.7 mt -120.74 135.58 55.1 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.5 t -112.99 139.04 48.99 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.16 -68.75 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.926 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.75 -72.48 0.82 Allowed Glycine 0 C--N 1.31 -0.868 0 CA-C-N 115.555 -0.322 . . . . 0.0 113.402 -173.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 82.24 18.44 0.34 Allowed 'General case' 0 CA--C 1.455 -2.684 0 CA-C-O 123.467 1.603 . . . . 0.0 108.599 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.3 p -156.21 165.04 1.13 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.215 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -88.47 85.32 6.83 Favored 'General case' 0 C--N 1.255 -3.503 0 O-C-N 123.673 0.608 . . . . 0.0 110.154 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 108' ' ' VAL . 11.7 pt-20 -133.33 162.26 32.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.266 -176.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -52.74 128.26 25.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.026 176.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.74 -19.52 53.1 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.173 178.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 105' ' ' GLU . 5.4 p -71.51 141.58 16.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.023 -177.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.0 ttmt -106.07 121.53 44.32 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -95.37 97.35 9.77 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.642 HG13 ' OG1' ' A' ' 97' ' ' THR . 1.2 p -87.51 112.78 23.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.541 ' OH ' ' HB2' ' A' ' 141' ' ' CYS . 15.3 t80 -81.21 139.42 35.53 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.203 -170.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -142.34 170.9 14.84 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.23 -89.67 0.59 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.802 177.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -138.26 -149.2 0.29 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.01 -51.77 5.3 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.359 -179.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.31 -18.86 63.58 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.601 178.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -94.11 144.97 25.02 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -122.15 -68.47 0.89 Allowed 'General case' 0 CA--C 1.438 -3.348 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.667 ' HG ' ' N ' ' A' ' 121' ' ' LEU 0.263 1.0 OUTLIER 169.52 153.46 0.04 OUTLIER 'General case' 1 N--CA 1.297 -8.115 0 CA-C-N 111.605 -2.543 . . . . 0.0 105.145 -169.876 . . . . . . . . 5 4 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.667 ' N ' ' HG ' ' A' ' 120' ' ' LEU . 36.6 tp -134.16 126.94 31.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.18 171.83 12.57 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.179 -1.969 . . . . 0.0 108.179 -176.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -92.52 -21.13 20.3 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 118.223 1.012 . . . . 0.0 110.814 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.481 HG13 HD21 ' A' ' 136' ' ' ASN . 32.3 mm -114.33 114.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.401 ' HB3' HD22 ' A' ' 120' ' ' LEU . 27.6 p-10 -94.87 19.85 9.64 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -175.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -159.03 174.18 15.32 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.31 -175.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 137' ' ' ASP . 8.5 ptm180 -151.88 127.82 10.34 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.34 171.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -99.53 160.7 14.09 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 123.026 0.53 . . . . 0.0 109.709 -178.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.3 t -98.55 114.82 27.4 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.955 175.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.438 ' HB2' HG22 ' A' ' 135' ' ' THR . 17.3 t70 -92.24 -179.64 5.3 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 125.401 1.48 . . . . 0.0 108.385 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 51.2 p -62.54 -36.25 82.02 Favored 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 123.714 0.805 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.85 -34.85 24.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.52 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.29 -157.53 29.43 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -69.02 129.56 40.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.69 1.245 . . . . 0.0 110.886 -177.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 130' ' ' ASP . 24.3 p -55.56 -38.9 69.93 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 125.054 1.341 . . . . 0.0 112.711 -174.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.481 HD21 HG13 ' A' ' 124' ' ' ILE . 11.6 t-20 -138.32 172.81 12.35 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -175.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 138' ' ' ILE . 16.6 t70 -102.53 -168.69 1.56 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 123.422 0.451 . . . . 0.0 110.241 -176.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 89' ' ' GLY . 34.2 mt -76.81 123.15 87.47 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 124.435 1.094 . . . . 0.0 111.05 -171.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -73.58 163.24 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.717 1.611 . . . . 0.0 109.762 172.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mm -84.45 133.1 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.541 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 21.3 t -83.0 120.42 25.7 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 121' ' ' LEU . 13.2 tp10 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -174.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' OD1' ' HA ' ' A' ' 43' ' ' PRO . 31.2 m-20 . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 121.064 0.459 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 142.41 43.94 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 124.555 1.142 . . . . 0.0 110.757 -172.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -116.56 19.99 14.32 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.925 0.869 . . . . 0.0 109.35 175.528 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.55 156.01 34.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.665 -177.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 37' ' ' TRP . 40.4 mt -77.4 158.25 79.37 Favored Pre-proline 0 C--O 1.253 1.238 0 O-C-N 123.759 0.662 . . . . 0.0 110.82 176.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.401 ' HD3' ' CZ2' ' A' ' 71' ' ' TRP . 20.3 Cg_endo -62.03 135.05 52.83 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.337 2.024 . . . . 0.0 109.581 175.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.02 137.09 21.23 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 121.986 1.791 . . . . 0.0 112.926 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -76.25 143.66 40.82 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -121.62 175.86 6.0 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.533 -170.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -59.02 -26.08 64.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 0.0 113.21 -175.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 p -134.3 12.05 3.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.88 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' SG ' ' A' ' 80' ' ' CYS . 3.1 mp0 -132.57 140.23 48.17 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.71 -0.796 . . . . 0.0 113.082 -172.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -135.67 142.62 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.74 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.463 ' HG ' ' CD1' ' A' ' 37' ' ' TRP . 4.0 mm? -69.65 142.06 53.51 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.998 -179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.8 p -101.76 87.98 3.28 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.25 -169.49 40.44 Favored Glycine 0 C--N 1.275 -2.815 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.751 -175.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -117.68 109.6 16.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 48.7 m95 -129.5 126.01 37.66 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.7 t -160.94 25.01 0.14 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.36 -164.48 1.13 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.782 -1.553 . . . . 0.0 110.053 -172.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -123.83 -64.87 1.11 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.94 0.4 . . . . 0.0 110.91 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 22' ' ' ASN . 26.6 p -105.6 146.23 29.94 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -144.33 153.99 56.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.78 1.232 . . . . 0.0 109.207 178.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 57.6 Cg_endo -73.47 152.93 49.61 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.019 1.813 . . . . 0.0 112.311 179.362 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 28.4 tt0 -64.9 147.77 52.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.88 5.86 65.91 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.065 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -83.94 115.95 22.55 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.467 178.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 pt20 -90.04 139.08 30.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.532 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.98 124.56 52.92 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.65 129.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 31' ' ' GLU . 75.4 m-85 -117.67 145.62 44.27 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.229 0.538 . . . . 0.0 112.303 -178.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.16 152.85 18.92 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 m -92.97 28.68 2.03 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -174.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 66.29 155.48 0.13 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-O 121.384 0.611 . . . . 0.0 111.511 -177.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.71 108.23 1.02 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.763 1.642 . . . . 0.0 111.53 176.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 129.17 -23.18 4.95 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.955 177.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.689 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.9 m-85 -102.5 172.48 6.84 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.587 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -154.81 -179.45 8.03 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -170.6 -179.95 3.09 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.95 8.16 27.61 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 -161.51 27.75 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.93 147.42 26.16 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.83 117.72 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.22 124.94 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.655 -176.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.417 ' HA ' ' H ' ' A' ' 74' ' ' LEU . 88.9 mtp -112.39 172.29 7.0 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.9 p -155.56 148.3 12.27 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.227 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.83 129.27 34.94 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 55.8 ttp180 -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 32.3 mmmt 64.68 19.27 11.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.043 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.18 -12.48 62.0 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.949 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.1 157.77 24.22 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.169 0.509 . . . . 0.0 111.736 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.401 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 86.1 m95 -91.99 116.21 28.73 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.489 178.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.44 172.27 4.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.496 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.68 108.54 19.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' H ' ' HA ' ' A' ' 64' ' ' MET . 1.2 tm? -61.15 -49.93 75.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 172.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.18 90.39 9.71 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.557 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.93 -17.91 15.11 Favored 'Trans proline' 0 N--CA 1.479 0.656 0 C-N-CA 122.478 2.119 . . . . 0.0 111.04 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.38 -27.62 60.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.442 -177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -92.18 131.66 37.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.745 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -140.02 163.36 32.9 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 31' ' ' GLU . 71.5 m -92.91 110.53 21.99 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -105.33 162.7 13.21 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.369 -174.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HD3' ' CE2' ' A' ' 56' ' ' TYR . 33.8 mmtp -70.25 157.38 37.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -94.35 134.36 25.71 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.831 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 37.9 Cg_endo -71.62 136.76 28.88 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.288 1.992 . . . . 0.0 110.674 176.13 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.9 -1.79 39.2 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.059 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.78 -123.24 9.71 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.852 176.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -103.28 136.46 19.22 Favored Pre-proline 0 C--N 1.284 -2.273 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 96' ' ' PHE . 14.7 Cg_exo -69.29 75.22 1.03 Allowed 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.431 2.087 . . . . 0.0 113.602 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.32 -136.02 19.54 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.536 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.64 27.87 6.01 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.613 0.365 . . . . 0.0 110.233 -176.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -48.82 115.35 4.41 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.271 176.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.31 -53.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.688 2.259 . . . . 0.0 111.684 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.16 154.5 49.47 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.37 -168.18 21.06 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -176.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 m -155.37 156.17 34.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 48.8 p90 -145.24 165.94 26.93 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.549 0.53 . . . . 0.0 111.216 -177.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 70.9 p -118.76 -178.02 3.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.921 -179.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.6 155.23 49.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' HB3' ' A' ' 109' ' ' LYS . 15.1 t -165.47 149.24 8.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.78 -0.79 88.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.949 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.03 -169.58 39.79 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' H ' HD22 ' A' ' 102' ' ' ASN . 0.1 OUTLIER -131.37 3.31 4.26 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-N 117.748 0.774 . . . . 0.0 112.808 -175.324 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' HG11 ' A' ' 108' ' ' VAL . 5.7 p -156.78 -160.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.068 -1.053 . . . . 0.0 108.698 -173.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 26.0 m-85 -90.87 77.28 6.21 Favored 'General case' 1 C--N 1.243 -4.034 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.771 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.485 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 15.8 pt-20 -136.48 152.28 50.38 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.201 -174.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -49.63 124.52 9.71 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.091 0.869 . . . . 0.0 110.165 173.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.25 -22.85 10.93 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.381 179.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 103' ' ' VAL . 35.8 m -76.87 144.43 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.741 -179.023 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.508 ' HB3' ' CG2' ' A' ' 99' ' ' THR . 22.2 ttmm -106.45 106.94 17.71 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -86.86 99.35 11.77 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -80.61 130.33 36.09 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.412 -177.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.88 108.92 21.72 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.912 0.863 . . . . 0.0 109.157 -172.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 m -100.95 -31.53 11.08 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.883 -172.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 33.6 m 65.74 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -166.36 -154.34 0.18 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -79.7 -60.47 2.34 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.4 0.619 . . . . 0.0 110.442 -178.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.82 73.98 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.533 -177.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -115.02 128.41 56.25 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.513 0.197 . . . . 0.0 111.145 178.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -117.41 -134.21 0.33 Allowed 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 167.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -157.52 161.38 38.81 Favored 'General case' 1 N--CA 1.336 -6.158 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.247 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' A' ' 142' ' ' GLU . 4.1 mm? -88.58 125.04 34.61 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.331 0.586 . . . . 0.0 109.954 172.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.07 148.45 5.45 Favored Glycine 0 C--N 1.278 -2.688 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.44 -16.52 39.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.112 0.958 . . . . 0.0 109.484 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -109.93 106.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 120' ' ' LEU . 26.3 p-10 -88.91 36.66 0.82 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.48 0.657 . . . . 0.0 111.758 -172.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.442 ' CD1' ' HG3' ' A' ' 109' ' ' LYS . 26.2 p90 -159.19 178.3 10.15 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.63 -177.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.464 ' NH2' HG23 ' A' ' 138' ' ' ILE . 6.3 ptp180 -148.98 124.31 10.24 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 134' ' ' TRP . 17.7 mt-10 -96.76 157.22 16.0 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.35 107.1 18.35 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.557 175.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.29 -164.43 1.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.3 p -65.53 -42.96 91.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 123.974 0.91 . . . . 0.0 110.04 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.32 -46.28 73.94 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.253 177.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.28 -139.09 7.43 Favored Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' O ' ' A' ' 128' ' ' GLU . 87.9 m95 -70.86 126.7 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.16 0.505 . . . . 0.0 111.113 -176.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.9 p -80.37 170.24 16.65 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.607 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.4 m120 70.45 -81.22 0.03 OUTLIER 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.253 1.021 . . . . 0.0 111.857 173.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.1 t0 163.57 -161.62 0.0 OUTLIER 'General case' 0 C--O 1.242 0.661 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.464 HG23 ' NH2' ' A' ' 127' ' ' ARG . 4.0 mp -107.05 96.64 15.55 Favored Pre-proline 0 C--N 1.284 -2.277 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HB2' HD12 ' A' ' 120' ' ' LEU . 1.2 Cg_endo -47.33 123.7 8.2 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.811 2.341 . . . . 0.0 109.737 173.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 3.2 mp -68.2 114.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.42 -174.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 14.0 t -59.67 112.86 1.97 Allowed 'General case' 0 C--O 1.254 1.336 0 O-C-N 123.794 0.683 . . . . 0.0 109.713 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.508 ' HB3' HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -173.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.129 0.49 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' THR . 1.6 m -70.4 138.96 51.73 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.04 0.936 . . . . 0.0 110.116 -174.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.04 24.93 6.32 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.787 0.804 . . . . 0.0 108.948 176.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -160.14 160.78 33.36 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.611 -178.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 37' ' ' TRP . 41.1 mt -83.94 152.92 63.25 Favored Pre-proline 0 C--N 1.313 -0.993 0 O-C-N 123.614 0.571 . . . . 0.0 110.325 176.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -54.01 142.84 64.03 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.909 2.406 . . . . 0.0 113.172 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.65 112.43 2.86 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.429 2.086 . . . . 0.0 111.896 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -76.35 151.05 36.77 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.638 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -121.05 -179.84 4.16 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -174.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -90.53 -20.17 22.96 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.153 0.501 . . . . 0.0 109.705 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 -10.34 17.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 177.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -134.74 137.56 43.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.263 0.554 . . . . 0.0 111.649 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.33 163.52 24.16 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.796 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.459 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . 4.3 mm? -91.78 151.0 20.8 Favored 'General case' 0 C--N 1.266 -3.059 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.9 p -112.47 101.21 9.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.1 -171.43 32.09 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -108.34 115.18 29.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.532 ' HB3' HD22 ' A' ' 24' ' ' LEU . 53.9 m95 -132.7 107.38 8.35 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.215 0.531 . . . . 0.0 109.94 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 t -153.38 28.64 0.5 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 174.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -112.37 -161.49 0.76 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.413 -168.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.36 -67.09 0.41 Allowed 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 82.3 p -94.62 128.76 41.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.172 -173.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.44 157.54 77.85 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.66 147.17 39.8 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.261 1.974 . . . . 0.0 111.834 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 22.1 tt0 -64.73 137.21 57.67 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.212 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.54 7.79 50.63 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.3 m -83.82 119.52 24.94 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.849 177.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.6 pt20 -87.56 146.41 25.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.31 0.576 . . . . 0.0 111.654 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.2 122.0 41.9 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.405 HG12 HD12 ' A' ' 63' ' ' ILE . 61.1 mt -94.36 129.84 44.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -104.04 153.6 20.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.493 1.139 . . . . 0.0 113.986 -178.489 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -103.65 118.35 36.52 Favored 'General case' 0 N--CA 1.406 -2.639 0 CA-C-N 112.92 -1.945 . . . . 0.0 105.872 172.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 87.5 m -69.73 12.31 0.21 Allowed 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 123.98 0.912 . . . . 0.0 113.392 -178.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.5 mtp180 66.89 154.41 0.13 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.133 0.973 . . . . 0.0 109.158 -170.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ARG . 23.0 Cg_endo -61.87 -9.09 13.09 Favored 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 122.358 2.039 . . . . 0.0 115.091 -177.296 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.2 1.83 35.14 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.188 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 48.1 m-85 -123.49 173.28 8.13 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.349 -1.089 . . . . 0.0 111.475 -177.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.44 -172.57 4.17 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.888 0.875 . . . . 0.0 109.346 -175.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.3 t -174.08 162.49 3.8 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.47 -8.15 58.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.778 . . . . 0.0 109.861 177.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.33 -123.88 1.81 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.97 151.31 28.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.98 103.22 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.618 0.723 . . . . 0.0 109.114 177.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 HG12 ' A' ' 49' ' ' ILE . 48.5 mm -110.87 121.23 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.975 178.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.2 mtp -110.22 170.04 8.34 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 177.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 5.8 p -154.21 142.16 13.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.212 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.23 127.92 32.65 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.314 -178.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.501 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 53.5 ttp180 -150.5 125.83 10.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 44.1 mmtm 63.19 35.3 12.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.715 0.806 . . . . 0.0 112.525 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.36 53.55 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.001 176.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.62 163.97 12.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.806 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -104.9 114.15 28.18 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -179.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 p -123.24 -167.33 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.367 -4.599 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.012 -171.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.66 113.24 25.23 Favored 'General case' 1 C--N 1.224 -4.889 0 CA-C-N 114.241 -1.345 . . . . 0.0 114.145 -168.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.4 -52.93 10.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 172.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.57 92.56 14.35 Favored Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.267 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.74 -1.04 11.22 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.401 2.067 . . . . 0.0 111.96 178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.72 -5.19 51.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.222 0.534 . . . . 0.0 109.925 178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -112.79 144.84 41.65 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.203 0.525 . . . . 0.0 111.001 -175.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -156.34 147.75 22.52 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 173.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -83.74 113.14 20.69 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.672 177.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -105.59 163.96 12.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.07 -177.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 96.8 mttt -64.05 143.45 57.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.261 0.553 . . . . 0.0 111.452 -177.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -84.13 145.39 45.97 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 71.5 Cg_endo -74.48 157.67 44.76 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.539 1.493 . . . . 0.0 111.086 -177.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.3 m -107.66 7.61 28.62 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 -176.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.51 -102.63 1.31 Allowed Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.611 178.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -152.65 130.96 6.3 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.89 37.22 0.4 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 123.069 2.513 . . . . 0.0 111.789 -177.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 79.92 -176.87 54.55 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -172.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -124.4 -171.32 2.31 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -172.29 126.77 0.55 Allowed Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.6 -22.72 2.98 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.976 1.784 . . . . 0.0 113.694 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -129.86 -5.35 4.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.89 171.77 20.22 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.782 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -136.25 160.65 38.06 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 51.5 p90 -144.69 149.98 36.56 Favored 'General case' 0 N--CA 1.418 -2.042 0 O-C-N 123.332 0.395 . . . . 0.0 111.211 174.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.719 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 61.5 p -101.45 175.67 5.49 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.423 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -140.67 131.33 25.63 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 109' ' ' LYS . 8.0 t -127.26 9.06 6.66 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.577 0.703 . . . . 0.0 112.233 -171.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.32 34.24 2.21 Favored Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.24 175.15 13.66 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 106.379 -2.688 . . . . 0.0 106.379 -172.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -124.12 24.18 8.24 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 118.417 1.109 . . . . 0.0 108.773 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.8 m -143.09 -177.49 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 34.6 m-85 -89.96 85.38 6.33 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.039 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.39 144.25 51.27 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.144 -178.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 72.5 t80 -49.18 114.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.885 0.874 . . . . 0.0 111.385 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 127.33 -22.04 5.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.529 -179.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.74 139.09 19.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 122.053 0.93 . . . . 0.0 111.133 178.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.489 ' HB3' HG22 ' A' ' 99' ' ' THR . 33.8 ttmt -108.13 117.14 33.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 170.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -90.37 97.64 11.3 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 96' ' ' PHE . 1.2 m -79.88 127.26 39.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.668 ' HE1' ' SG ' ' A' ' 141' ' ' CYS . 59.7 t80 -114.07 143.88 44.04 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 -171.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 m -151.54 160.55 43.63 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 75.6 m -149.15 126.49 11.49 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 66.77 178.3 0.22 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.23 -47.77 3.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.847 -178.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.02 74.27 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.191 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -141.28 -177.92 5.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.634 ' HB2' HD13 ' A' ' 120' ' ' LEU . 2.8 pt20 -153.79 -130.9 0.04 OUTLIER 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -99.26 163.88 12.36 Favored 'General case' 0 N--CA 1.386 -3.671 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.098 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 142' ' ' GLU . 3.8 mm? -88.87 142.44 27.65 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 166.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.94 154.88 10.13 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -83.8 -26.71 29.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.937 0.875 . . . . 0.0 109.72 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.95 111.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.89 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.96 26.43 3.21 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.488 1.115 . . . . 0.0 110.716 -178.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.516 ' CE1' ' HG3' ' A' ' 128' ' ' GLU . 7.3 p90 -153.49 -178.12 6.79 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.343 -172.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -139.52 121.89 16.05 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 24.9 mt-10 -99.5 141.12 32.71 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.363 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.93 115.94 23.86 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.532 177.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.9 172.16 7.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.627 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.1 p -52.08 -39.38 59.62 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 125.347 1.459 . . . . 0.0 112.197 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.25 -33.47 19.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.902 -178.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.73 -162.23 33.85 Favored Glycine 0 C--O 1.212 -1.281 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -70.59 134.69 47.85 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.541 0.671 . . . . 0.0 111.443 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -68.43 -25.79 65.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.241 0.616 . . . . 0.0 111.375 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -130.15 168.19 17.19 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -176.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -107.46 -104.44 0.35 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.389 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.426 HD11 ' HA3' ' A' ' 89' ' ' GLY . 30.8 mt -127.5 96.74 32.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 4.7 Cg_endo -47.95 129.04 17.39 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.276 2.651 . . . . 0.0 111.64 178.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 49.2 mm -80.76 112.21 18.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.457 -173.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.668 ' SG ' ' HE1' ' A' ' 112' ' ' TYR . 57.4 m -79.24 114.13 17.93 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.785 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.662 ' HB3' HD23 ' A' ' 121' ' ' LEU . 9.9 tp10 . . . . . 0 N--CA 1.435 -1.19 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.356 0.598 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 138.4 58.41 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.404 -175.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -118.22 20.11 13.27 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.304 1.05 . . . . 0.0 108.772 175.333 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.84 153.6 39.36 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.624 179.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 37' ' ' TRP . 24.3 mt -81.66 157.58 69.46 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.224 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 144.49 96.45 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 122.073 1.849 . . . . 0.0 111.31 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.6 178.99 5.68 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.046 1.831 . . . . 0.0 111.53 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -94.41 158.7 15.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CB ' ' HB2' ' A' ' 31' ' ' GLU . 10.5 mmt85 -103.94 166.41 10.43 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -77.04 -62.15 1.75 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -95.77 13.69 25.72 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.193 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 28' ' ' ARG . 4.8 mp0 -135.66 161.83 34.42 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.5 mt -134.4 150.52 30.81 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.478 HD13 ' CD1' ' A' ' 37' ' ' TRP . 35.2 mt -71.84 143.32 49.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.532 0.605 . . . . 0.0 110.226 174.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 p -87.44 -33.24 19.13 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.174 0.512 . . . . 0.0 112.067 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.92 168.4 18.09 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.865 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -87.93 138.2 31.66 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 175.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CD1' HD13 ' A' ' 33' ' ' LEU . 75.9 m95 -130.28 117.8 20.37 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.307 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 m -130.31 4.81 4.78 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.217 0.532 . . . . 0.0 110.874 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.78 -165.76 1.28 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.09 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -140.7 -40.67 0.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.052 175.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 22' ' ' ASN . 40.2 p -112.08 138.13 49.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.698 -178.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -139.55 154.88 71.83 Favored Pre-proline 0 C--N 1.303 -1.434 0 C-N-CA 123.874 0.87 . . . . 0.0 109.067 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.83 148.65 28.66 Favored 'Trans proline' 0 C--O 1.257 1.462 0 C-N-CA 121.756 1.638 . . . . 0.0 111.056 175.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 24.8 tt0 -62.05 145.44 53.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.15 1.3 59.56 Favored Glycine 0 C--N 1.298 -1.545 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.226 -179.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.9 m -83.93 118.12 23.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.421 0.153 . . . . 0.0 111.12 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.8 pt20 -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-O 121.925 0.869 . . . . 0.0 111.731 -176.578 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.79 113.02 19.09 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.2 mt -87.97 114.92 27.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.123 -177.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 31' ' ' GLU . 45.0 m-85 -95.63 138.59 33.08 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.853 0.835 . . . . 0.0 112.353 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 53' ' ' ARG . 85.7 tttt -80.41 139.04 36.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.401 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 12.2 t -84.57 10.29 11.42 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -170.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 73.0 ttt180 67.24 133.32 0.04 OUTLIER Pre-proline 0 N--CA 1.425 -1.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.705 174.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.72 104.39 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.441 2.761 . . . . 0.0 114.093 -176.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 127.71 -24.37 5.2 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.177 177.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 97.7 m-85 -95.77 173.17 7.6 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.363 -0.493 . . . . 0.0 110.559 -178.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -136.85 161.45 35.96 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.59 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 99.9 p -136.36 173.21 11.95 Favored 'General case' 0 N--CA 1.382 -3.847 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.325 177.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -83.71 -4.89 58.99 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.965 178.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.74 45.41 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 176.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 m120 68.55 131.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.352 1.061 . . . . 0.0 112.691 -177.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.7 t -76.07 111.52 12.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -105.77 114.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-O 121.513 0.673 . . . . 0.0 109.788 -178.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 77.0 mtp -103.5 172.59 6.72 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.612 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 7.9 p -160.74 150.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.87 128.19 33.57 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 40.3 ttp180 -153.72 127.42 8.76 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 67.64 19.92 9.71 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.52 -14.74 64.48 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.158 178.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -106.89 172.99 6.52 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.166 0.508 . . . . 0.0 110.007 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -110.5 112.53 24.51 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.11 -158.44 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.372 -4.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.954 -175.194 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.49 129.53 39.66 Favored 'General case' 1 C--N 1.231 -4.552 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.508 -170.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.1 tm? -89.47 -57.45 2.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 171.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 12.7 m120 -112.29 95.05 29.18 Favored Pre-proline 0 N--CA 1.421 -1.911 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.163 178.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.71 -17.68 25.82 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.275 1.983 . . . . 0.0 111.382 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -79.14 -19.59 50.66 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.199 1.0 . . . . 0.0 110.834 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 75' ' ' ASN . 29.6 mmt180 -81.11 129.7 34.68 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 174.064 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -145.21 152.73 40.45 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 58' ' ' SER . 16.9 m -104.95 114.81 29.23 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.189 0.995 . . . . 0.0 111.138 176.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -112.39 174.59 5.81 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.433 -178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 97.5 mttt -82.95 145.91 29.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 55' ' ' GLY . 17.5 ptp180 -74.99 132.45 77.14 Favored Pre-proline 0 C--N 1.298 -1.648 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.214 178.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 47.2 Cg_endo -73.46 139.69 28.98 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 122.153 1.902 . . . . 0.0 110.115 176.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 m -89.49 -21.31 23.02 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.431 0.634 . . . . 0.0 109.761 -179.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.61 -160.44 47.24 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.576 177.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.33 115.34 14.14 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 125.162 1.385 . . . . 0.0 110.653 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' O ' HD11 ' A' ' 138' ' ' ILE . 98.4 Cg_endo -78.76 -9.43 15.78 Favored 'Trans proline' 0 C--O 1.212 -0.794 0 C-N-CA 123.31 2.673 . . . . 0.0 113.151 -178.305 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 123.95 -155.65 17.93 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -145.05 157.9 43.98 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -150.11 125.99 5.04 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.78 -47.62 15.32 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.494 2.129 . . . . 0.0 111.445 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -109.82 140.04 44.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.46 -178.01 23.15 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.913 176.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 m -158.04 166.97 31.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -123.49 159.35 29.27 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.239 176.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.594 ' OG1' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.98 159.39 25.7 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.422 177.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.69 139.86 52.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 109' ' ' LYS . 9.2 t -113.32 -18.86 11.95 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.28 21.44 Favored Glycine 0 CA--C 1.5 -0.853 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.587 -174.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.64 -175.79 32.63 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -178.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.7 15.09 18.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.147 0.975 . . . . 0.0 109.083 178.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.5 m -133.65 172.3 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 52.7 m-85 -96.5 100.41 12.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.216 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' VAL . 14.7 pt-20 -147.14 160.63 42.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 -174.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.507 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 92.6 t80 -55.14 116.28 2.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.127 0.489 . . . . 0.0 110.439 175.065 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.98 -18.91 11.29 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 105' ' ' GLU . 1.4 p -91.08 167.64 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 99' ' ' THR . 39.4 ttmt -142.13 131.84 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -179.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.66 94.42 8.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.594 HG13 ' OG1' ' A' ' 97' ' ' THR . 3.7 p -93.49 114.71 30.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.883 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.65 144.09 26.51 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.387 1.089 . . . . 0.0 112.887 -173.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -134.81 150.83 50.56 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 103.479 -2.786 . . . . 0.0 103.479 174.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 118' ' ' TYR . 16.3 t -112.21 -80.92 0.59 Allowed 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.695 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 2.4 m-20 -137.7 -168.12 2.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.3 -43.17 70.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.264 0.554 . . . . 0.0 110.671 177.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.61 -1.91 46.69 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.81 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.721 ' HB3' ' SG ' ' A' ' 141' ' ' CYS . 91.2 m-85 -115.86 128.96 56.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 122.454 -0.439 . . . . 0.0 111.749 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 14.8 mm100 -139.2 -148.7 0.26 Allowed 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 170.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -111.66 169.88 8.52 Favored 'General case' 0 N--CA 1.382 -3.848 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.862 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 140' ' ' ILE . 3.5 mm? -66.21 -64.26 0.9 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.765 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.23 -154.42 16.77 Favored Glycine 0 C--N 1.294 -1.805 0 CA-C-N 115.072 -0.967 . . . . 0.0 114.764 -173.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -96.68 -13.78 22.54 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.392 0.677 . . . . 0.0 111.435 -177.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 139' ' ' PRO . 45.8 mm -94.43 94.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 CA-C-O 122.293 1.044 . . . . 0.0 110.56 -175.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -94.31 26.49 3.33 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.494 -177.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -168.09 174.64 7.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.866 0.841 . . . . 0.0 112.54 -171.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HG3' ' CE3' ' A' ' 134' ' ' TRP . 9.1 ptm180 -140.67 132.19 27.0 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 170.051 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -110.91 157.37 19.94 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -168.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 46.3 m -90.62 116.56 28.6 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.659 0.742 . . . . 0.0 112.384 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -110.97 179.17 4.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 53.2 p -57.36 -35.74 70.32 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.918 0.887 . . . . 0.0 110.527 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.9 -35.19 67.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.781 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 139.43 -127.61 3.7 Favored Glycine 0 C--N 1.295 -1.708 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -174.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.512 ' CE3' ' HG3' ' A' ' 127' ' ' ARG . 91.4 m95 -82.66 127.47 33.42 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 118.173 0.987 . . . . 0.0 109.749 178.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.2 p -62.64 -60.79 3.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.066 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.38 -173.4 2.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -176.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 12.2 t70 -113.01 -166.75 1.11 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.589 HD11 ' HA3' ' A' ' 89' ' ' GLY . 71.5 mt -82.14 124.97 78.18 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 122.949 0.5 . . . . 0.0 110.916 -173.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 16.3 Cg_endo -58.13 147.91 80.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.553 2.835 . . . . 0.0 111.789 178.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 121' ' ' LEU . 37.1 mm -88.73 122.05 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.515 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 118' ' ' TYR . 41.3 t -72.26 119.44 16.46 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.38 0.61 . . . . 0.0 111.079 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 121' ' ' LEU . 9.8 tp10 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 41' ' ' THR . 2.4 m -69.31 137.39 52.93 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.681 -1.145 . . . . 0.0 107.969 -177.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 41' ' ' THR . 11.2 m120 -114.41 14.65 17.93 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.61 163.96 36.47 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.727 -175.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 39' ' ' ASP . 1.5 mm? -98.0 159.06 31.74 Favored Pre-proline 0 N--CA 1.383 -3.825 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.721 -175.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.72 134.47 54.25 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.704 2.269 . . . . 0.0 109.779 176.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.48 142.35 64.95 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.411 2.074 . . . . 0.0 113.439 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.97 134.61 35.39 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 171.092 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 31.8 mtp85 -118.99 179.52 4.13 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -169.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -78.51 -63.87 1.3 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.467 -178.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 p -85.54 11.63 10.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.501 0.667 . . . . 0.0 112.44 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 4.0 mp0 -141.71 143.85 33.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.619 -176.155 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 51.9 mt -133.24 141.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 37' ' ' TRP . 51.2 mt -71.94 141.16 49.46 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.751 0.657 . . . . 0.0 110.348 177.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -71.29 -61.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 178.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.28 52.61 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.308 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -103.83 114.44 28.7 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CD1' HD13 ' A' ' 33' ' ' LEU . 27.1 m95 -101.77 92.27 4.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.116 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -99.59 -5.91 28.26 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.122 -177.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' HD21 ' A' ' 24' ' ' LEU . 6.0 m-20 -83.76 -163.1 0.72 Allowed 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -136.27 -54.74 0.75 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 45.3 p -90.98 129.02 37.03 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 121.528 0.68 . . . . 0.0 112.557 -176.038 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 39' ' ' ASP . 40.5 m-85 -135.91 153.29 76.96 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 123.814 0.846 . . . . 0.0 109.382 179.083 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.46 149.48 87.84 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.176 1.918 . . . . 0.0 112.441 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 tt0 -69.73 135.59 49.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.7 7.66 50.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.038 -178.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -85.03 123.98 31.19 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.712 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 pt20 -92.22 147.82 22.63 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.019 -179.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.73 134.23 55.3 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.38 132.29 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 82.7 m-85 -109.57 136.34 49.11 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.469 175.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 53' ' ' ARG . 36.1 mtpt -65.93 -26.81 67.76 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.211 1.004 . . . . 0.0 111.618 -176.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.659 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 19.2 m 71.33 8.74 6.41 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.472 -171.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 50.3 mtt180 66.57 170.2 0.1 Allowed Pre-proline 0 N--CA 1.494 1.752 0 CA-C-O 121.388 0.613 . . . . 0.0 111.198 -178.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -82.79 133.84 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 166.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.39 -17.11 34.36 Favored Glycine 0 C--N 1.302 -1.309 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.799 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 80.8 m-85 -118.85 161.94 19.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.176 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -149.23 -174.87 4.77 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 p -174.65 175.89 2.39 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.45 -8.94 58.79 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.78 48.09 0.1 OUTLIER Glycine 0 CA--C 1.49 -1.472 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 50.8 m-80 62.22 -172.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.657 0.783 . . . . 0.0 110.677 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 53.7 t -110.86 116.13 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.876 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.8 114.39 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.766 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.5 mtp -105.75 167.32 9.85 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 9.9 p -151.39 146.39 15.95 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.2 t -84.75 132.23 34.46 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.768 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 44' ' ' GLU . 51.2 ttp180 -154.27 120.75 5.44 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 42.2 mmtm 65.88 38.22 5.15 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 124.197 0.999 . . . . 0.0 112.198 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.26 -16.16 24.73 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 114.962 -1.017 . . . . 0.0 114.084 176.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -110.38 154.97 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.399 0.6 . . . . 0.0 111.107 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.439 ' CZ2' ' HD3' ' A' ' 25' ' ' PRO . 78.6 m95 -95.1 121.0 36.29 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.224 0.535 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.93 174.53 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.527 -176.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.18 125.25 30.04 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.29 -59.13 3.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -109.74 105.99 57.83 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.523 177.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.94 -14.14 40.37 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 123.428 2.752 . . . . 0.0 111.945 -178.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.44 -11.58 58.43 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.498 1.142 . . . . 0.0 109.876 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 62' ' ' VAL . 42.0 mmt-85 -90.85 114.28 26.66 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.156 176.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.51 148.05 27.57 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.614 -177.252 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.1 m -86.24 108.97 18.61 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.567 -178.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -101.19 157.5 16.73 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.635 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 106' ' ' TYR . 86.5 mttt -75.5 138.89 41.87 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -178.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HD3' ' O ' ' A' ' 131' ' ' THR . 17.1 ptm180 -76.02 151.29 83.98 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.565 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 156.31 62.69 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.079 1.853 . . . . 0.0 111.796 177.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.3 m -114.3 5.53 15.8 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.651 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.36 -92.39 0.33 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.49 -0.777 . . . . 0.0 114.374 174.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -152.43 124.36 3.84 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -173.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HE ' ' A' ' 127' ' ' ARG . 89.9 Cg_endo -80.13 40.45 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 123.542 2.828 . . . . 0.0 112.865 -178.054 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 82.91 -179.43 52.99 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -177.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -103.72 162.63 12.92 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -161.45 109.76 1.22 Allowed Pre-proline 0 N--CA 1.42 -1.945 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.551 175.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.26 -50.72 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 121.905 1.737 . . . . 0.0 111.821 177.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -100.11 14.96 28.93 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 114' ' ' CYS . . . -133.77 171.37 22.05 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.597 -1.287 . . . . 0.0 112.015 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 m -146.39 167.34 23.85 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 42.4 p90 -142.29 163.47 32.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.683 0.277 . . . . 0.0 111.038 -178.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 110' ' ' ALA . 65.5 p -107.71 161.89 14.47 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.72 128.31 38.66 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 109' ' ' LYS . 11.0 t -112.99 14.88 19.74 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.84 28.17 2.75 Favored Glycine 0 CA--C 1.49 -1.493 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.01 176.4 14.39 Favored Glycine 0 N--CA 1.411 -3.009 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 -173.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -112.25 32.5 5.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.12 165.69 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.184 -174.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -96.42 95.25 7.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 110.244 -177.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.98 155.65 49.94 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.567 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.546 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 52.2 t80 -50.9 124.47 11.3 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.072 0.857 . . . . 0.0 109.766 176.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.55 26.28 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.29 -1.433 . . . . 0.0 114.175 177.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.4 134.25 28.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-N 119.403 1.602 . . . . 0.0 109.498 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 99' ' ' THR . 40.3 ttmt -97.83 117.19 31.59 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -94.02 104.71 16.74 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.512 HG22 ' OG1' ' A' ' 97' ' ' THR . 1.1 m -87.65 130.32 37.57 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HG2' ' A' ' 139' ' ' PRO . 68.3 t80 -121.18 137.86 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.566 0.698 . . . . 0.0 112.051 -168.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.7 m -152.1 165.16 35.6 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.0 m -130.75 120.97 24.59 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.851 0.296 . . . . 0.0 110.529 -177.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 55.79 -155.64 0.28 Allowed 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.6 0.562 . . . . 0.0 110.317 178.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.5 -43.63 8.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.122 0.486 . . . . 0.0 110.835 177.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.39 11.72 68.54 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -173.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 114' ' ' CYS . 70.0 m-85 -120.77 140.43 51.7 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.388 1.094 . . . . 0.0 111.9 177.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' CYS . 42.5 mt-30 -133.96 -170.19 2.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 167.461 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -98.56 155.41 17.3 Favored 'General case' 2 N--CA 1.356 -5.143 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -175.716 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -76.63 -31.99 57.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.302 -179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.16 174.6 53.19 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.202 177.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.65 -37.94 17.54 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.991 0.901 . . . . 0.0 109.592 -178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.1 mm -82.99 103.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.076 -175.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.418 ' HB3' HD21 ' A' ' 120' ' ' LEU . 4.6 p-10 -87.71 25.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.428 -176.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -159.15 173.87 15.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.089 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' A' ' 88' ' ' PRO . 29.2 ptt-85 -148.84 118.02 6.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.846 174.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.25 146.25 23.98 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.876 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . 43.5 t -91.24 124.45 35.46 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.515 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 131' ' ' THR . 13.7 t70 -105.38 -164.84 1.06 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.353 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 28.6 p -54.06 -58.64 6.58 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 125.857 1.663 . . . . 0.0 112.761 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.22 -40.11 52.95 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 172.52 -155.45 23.28 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.525 -176.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 70.0 m95 -69.9 132.49 46.07 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 48.5 p -77.29 142.04 39.65 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 72.17 -168.79 0.14 Allowed 'General case' 0 C--O 1.245 0.831 0 O-C-N 124.015 0.822 . . . . 0.0 109.245 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -125.91 -164.35 1.3 Allowed 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt -86.28 107.97 15.56 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 112' ' ' TYR . 7.1 Cg_endo -48.41 122.53 7.83 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.55 2.834 . . . . 0.0 112.196 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 2.0 mp -73.23 115.09 13.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.017 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 80.3 m -81.43 115.02 20.57 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.006 0.431 . . . . 0.0 111.437 179.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 140' ' ' ILE . 65.9 mm-40 . . . . . 0 C--N 1.303 -1.455 0 C-N-CA 124.327 1.051 . . . . 0.0 108.498 -179.64 . . . . . . . . 1 1 . 1 stop_ save_